Citrus Sinensis ID: 005691
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | 2.2.26 [Sep-21-2011] | |||||||
| O04086 | 625 | Probable receptor-like pr | yes | no | 0.891 | 0.974 | 0.675 | 0.0 | |
| P93050 | 617 | Probable LRR receptor-lik | no | no | 0.809 | 0.896 | 0.373 | 1e-100 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.497 | 0.327 | 0.407 | 2e-67 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.497 | 0.328 | 0.410 | 2e-67 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.443 | 0.297 | 0.419 | 7e-67 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.522 | 0.345 | 0.393 | 7e-65 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.420 | 0.608 | 0.435 | 1e-64 | |
| Q9FNE1 | 651 | Cysteine-rich receptor-li | no | no | 0.491 | 0.516 | 0.411 | 1e-64 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.540 | 0.357 | 0.381 | 1e-64 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.469 | 0.507 | 0.406 | 2e-64 |
| >sp|O04086|Y1105_ARATH Probable receptor-like protein kinase At1g11050 OS=Arabidopsis thaliana GN=At1g11050 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 845 bits (2184), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/628 (67%), Positives = 495/628 (78%), Gaps = 19/628 (3%)
Query: 25 TSPSSKNDSTTCPMDLNYVLRIPWNKTSCENYEANSTNIRNNKNPCCLSLLSLYGVAFAQ 84
T+ +++ S TCP+D ++VL IPWN T C+ + ++ ++KN CC SLL+L G+ A
Sbjct: 16 TNCVAQSPSQTCPLDFSHVLTIPWNTTDCQKSDKSA----DSKNSCCQSLLTLIGIPLAH 71
Query: 85 HLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNKCASIESLQ 144
LK+T+ FRLPNL TS+SCL + QTKLS+ SLS L S C DP FV + CA I++ Q
Sbjct: 72 RLKQTSNFRLPNLATSISCLNNLQTKLSSLSLSSNLTSLCFDPNQFVINNETCAGIQTTQ 131
Query: 145 DWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNTSHATDCFYFTILY 204
DW S+LG ST LDS+C S LTDL+ CD+CVAAGF+VQ QLI +DGN+SH C++F + Y
Sbjct: 132 DWVSRLGPSTALDSACSSGLTDLTRCDACVAAGFRVQKQLITLDGNSSHGVYCYHFVVTY 191
Query: 205 AAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHS-ALVFGLTGAGVAIFVMFALLGLY 263
AAGIVN+ GPES+ ALSC+F LSL SP+ S KRH+ AL G+TGA V+ L+ LY
Sbjct: 192 AAGIVNKKGPESDDALSCLFSLSLRSPLNSKKKRHTVALALGITGAIFGALVIAGLICLY 251
Query: 264 FWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGR 323
F + K ++ G E Q SRPK RPNTGSIWFKI++LE+AT+ FSQKNFIGR
Sbjct: 252 FRFGKAVKGGEVG--------WEDQGSRPKWRPNTGSIWFKIEELEKATNNFSQKNFIGR 303
Query: 324 GGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383
GGFG VYKG+L DG+ +AVKKVIES+FQGDAEF NEVEIISNLKHRNLVPLRGC +VD D
Sbjct: 304 GGFGFVYKGVLPDGSVIAVKKVIESEFQGDAEFRNEVEIISNLKHRNLVPLRGCSMVDDD 363
Query: 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYG 443
+E S+RYLVYDYM NGN+DDHLFP K PL+WPQRK+IILDVAKGLAYLHYG
Sbjct: 364 SE--SQRYLVYDYMSNGNLDDHLFPR----GETTKMPLSWPQRKSIILDVAKGLAYLHYG 417
Query: 444 VKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG 503
VKPAIYHRDIK TNILLD DMRARVADFGLAKQSREG+SHLTTRVAGTHGYLAPEYALYG
Sbjct: 418 VKPAIYHRDIKGTNILLDVDMRARVADFGLAKQSREGESHLTTRVAGTHGYLAPEYALYG 477
Query: 504 QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLL 563
QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP LITDW WSLVKAGK +AL+ SLL
Sbjct: 478 QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPNTFLITDWAWSLVKAGKTEEALEQSLL 537
Query: 564 KEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPPLPDRPMPLGH 623
+E+ NPK IMERF+ VGILCAHV+VALRPTI DALKMLEGDIEVPP+PDRP+PL H
Sbjct: 538 REEGSGLSNPKGIMERFLQVGILCAHVLVALRPTILDALKMLEGDIEVPPIPDRPVPLAH 597
Query: 624 PSFYGDDSTFGISPALSGLQLHTGDMLR 651
PS+ D + F ISPALSGLQ+H+GDMLR
Sbjct: 598 PSYRMDGNGFTISPALSGLQIHSGDMLR 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P93050|RKF3_ARATH Probable LRR receptor-like serine/threonine-protein kinase RKF3 OS=Arabidopsis thaliana GN=RKF3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 365 bits (937), Expect = e-100, Method: Compositional matrix adjust.
Identities = 223/597 (37%), Positives = 324/597 (54%), Gaps = 44/597 (7%)
Query: 29 SKNDSTTCPMDLNYVLRIPWNKTSCENYEANSTNIRNNKNPCCLSLLSLYGVAFAQHLKE 88
S ++TCP+D + VL P+ + + + C LL + ++ HL++
Sbjct: 18 SAAQNSTCPLDFS-VLE-PFRRP------------KPDGATTCQYLLQGLRLLYSHHLRQ 63
Query: 89 TTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNKCASIESLQDWKS 148
T F LP ++ SC Q+ ++ F + S C F C I + ++S
Sbjct: 64 TGSF-LPPPESAASCWAALQSSVAGFLPRFDVRSTC--GFQTPWISQGCMDITTRSQFES 120
Query: 149 KLGGSTQLDSS--CKSDLTDLSACDSCVAAGFKVQSQLIAVD-GNTSHATDCFYFTILYA 205
+ S+ ++ C + L + C SC + Q L GN S DC F +YA
Sbjct: 121 LIPNSSLATTAMRCNTSLESNTPCASCTQSLSAFQPYLSGPSLGNVS---DCASFPSIYA 177
Query: 206 AGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGVAIFVMFALLGLYFW 265
A N GP G C+F L L SP S + LV + V + ++ +FW
Sbjct: 178 AAFANSLGPTDKGTAKCLFQLDLASPTSSGANKVKVLVSSFS---VLLVASVLVITAWFW 234
Query: 266 WDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGG 325
+ ++ + + D+S QS + +T + F ++++AT+ FS+ N IGRGG
Sbjct: 235 YCRRKKSKLLKP-RDTSLEAGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIGRGG 293
Query: 326 FGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385
+G V+KG L DGT VA K+ GDA F +EVE+I++++H NL+ LRG C E
Sbjct: 294 YGNVFKGALPDGTQVAFKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATTPYE 353
Query: 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK 445
G +R +V D + NG++ DHLF G + L WP R+ I L +A+GLAYLHYG +
Sbjct: 354 -GHQRIIVCDLVSNGSLHDHLF-------GDLEAQLAWPLRQRIALGMARGLAYLHYGAQ 405
Query: 446 PAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL 505
P+I HRDIKA+NILLD A+VADFGLAK + EG +H++TRVAGT GY+APEYALYGQL
Sbjct: 406 PSIIHRDIKASNILLDERFEAKVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQL 465
Query: 506 TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKE 565
TEKSDVYSFGVV+LE++ RKA+ G P + + DW WSLV+ G Q LD + E
Sbjct: 466 TEKSDVYSFGVVLLELLSRRKAIVTDEEGQPVS--VADWAWSLVREG---QTLD---VVE 517
Query: 566 DDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE-GDIEVPPLPDRPMPL 621
D P ++E++VL+ +LC+H + RPT+ +KMLE + V +P RP+PL
Sbjct: 518 DGMPEKGPPEVLEKYVLIAVLCSHPQLHARPTMDQVVKMLESNEFTVIAIPQRPIPL 574
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 154/378 (40%), Positives = 219/378 (57%), Gaps = 38/378 (10%)
Query: 243 VFGLTGAGVAIFVMFALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIW 302
V G+ A A+F + L+ L +L G +D + L G L TGS
Sbjct: 611 VAGIVIAACAVFGLLVLVIL------RLTGYLGGKEVDENEELRG------LDLQTGS-- 656
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
F ++ ++RAT+ F +N IG GGFG VYKG+L DG T+AVK++ QG+ EF E+ +
Sbjct: 657 FTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGM 716
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
IS L+H NLV L GCC+ G E LVY+Y+ N ++ LF G+ + L
Sbjct: 717 ISALQHPNLVKLYGCCI------EGKELLLVYEYLENNSLARALF-----GTEKQRLHLD 765
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
W R I + +AKGLAYLH + I HRDIKATN+LLD + A+++DFGLAK + + +
Sbjct: 766 WSTRNKICIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENT 825
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA--CL 540
H++TR+AGT GY+APEYA+ G LT+K+DVYSFGVV LEI+ G+ +T+ P+
Sbjct: 826 HISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKS----NTNYRPKEEFVY 881
Query: 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600
+ DW + L + G + + +DP L S + K M R + + +LC + LRP +S
Sbjct: 882 LLDWAYVLQEQGSLLELVDPDL-----GTSFSKKEAM-RMLNIALLCTNPSPTLRPPMSS 935
Query: 601 ALKMLEGDIEV-PPLPDR 617
+ MLEG I+V PPL R
Sbjct: 936 VVSMLEGKIKVQPPLVKR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 257 bits (657), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 154/375 (41%), Positives = 216/375 (57%), Gaps = 35/375 (9%)
Query: 246 LTGAGVAIFVMFALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKI 305
+ G +A V F LL L +L G +D + L G L TGS F +
Sbjct: 609 VAGIVIAACVAFGLLVLVIL---RLTGYLGGKEVDENEELRG------LDLQTGS--FTL 657
Query: 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISN 365
+ ++RAT+ F +N IG GGFG VYKG+L DG T+AVK++ QG+ EF E+ +IS
Sbjct: 658 KQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISA 717
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
L+H NLV L GCC+ G E LVY+Y+ N ++ LF G+ + L W
Sbjct: 718 LQHPNLVKLYGCCI------EGKELLLVYEYLENNSLARALF-----GTEKQRLHLDWST 766
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
R + + +AKGLAYLH + I HRDIKATN+LLD + A+++DFGLAK E +H++
Sbjct: 767 RNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHIS 826
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI--TD 543
TR+AGT GY+APEYA+ G LT+K+DVYSFGVV LEI+ G+ +T+ P+ I D
Sbjct: 827 TRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKS----NTNYRPKEEFIYLLD 882
Query: 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
W + L + G + + +DP L S + K M R + + +LC + LRP +S +
Sbjct: 883 WAYVLQEQGSLLELVDPDL-----GTSFSKKEAM-RMLNIALLCTNPSPTLRPPMSSVVS 936
Query: 604 MLEGDIEV-PPLPDR 617
ML+G I+V PPL R
Sbjct: 937 MLQGKIKVQPPLVKR 951
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 255 bits (652), Expect = 7e-67, Method: Compositional matrix adjust.
Identities = 136/324 (41%), Positives = 199/324 (61%), Gaps = 21/324 (6%)
Query: 300 SIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNE 359
++ F + L+ AT+ F Q N +G GGFG V+KG L DGT +AVK++ QG+ EF NE
Sbjct: 658 TVCFSWRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNE 717
Query: 360 VEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR 419
+ +IS L H NLV L GCCV ER + LVY+YM N ++ LF G
Sbjct: 718 IGMISGLNHPNLVKLYGCCV-----ER-DQLLLVYEYMENNSLALALF-------GQNSL 764
Query: 420 PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479
L W R+ I + +A+GL +LH G + HRDIK TN+LLD D+ A+++DFGLA+
Sbjct: 765 KLDWAARQKICVGIARGLEFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEA 824
Query: 480 GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539
+H++T+VAGT GY+APEYAL+GQLTEK+DVYSFGVV +EI+ G+ + G+ +
Sbjct: 825 EHTHISTKVAGTIGYMAPEYALWGQLTEKADVYSFGVVAMEIVSGKS--NTKQQGNADSV 882
Query: 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS 599
+ +W +L + G + + +D L E +F ++ R + V ++C + +LRPT+S
Sbjct: 883 SLINWALTLQQTGDILEIVDRML--EGEF----NRSEAVRMIKVALVCTNSSPSLRPTMS 936
Query: 600 DALKMLEGDIEVPPLPDRPMPLGH 623
+A+KMLEG+IE+ + P GH
Sbjct: 937 EAVKMLEGEIEITQVMSDPGIYGH 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 249 bits (635), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 160/407 (39%), Positives = 219/407 (53%), Gaps = 50/407 (12%)
Query: 246 LTGAGVAIFVMFALL----GLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSI 301
+TG V + V LL G+ + +K RKR+ D L ++P T
Sbjct: 633 MTGTIVGVIVGVGLLSIISGVVIFIIRKRRKRY----TDDEEILS-----MDVKPYT--- 680
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVE 361
F +L+ AT F N +G GGFG VYKG L DG VAVK + QG +F E+
Sbjct: 681 -FTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIV 739
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
IS ++HRNLV L GCC G R LVY+Y+PNG++D LF G L
Sbjct: 740 AISAVQHRNLVKLYGCCY------EGEHRLLVYEYLPNGSLDQALF-------GEKTLHL 786
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
W R I L VA+GL YLH + I HRD+KA+NILLD+ + +V+DFGLAK + +
Sbjct: 787 DWSTRYEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKK 846
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541
+H++TRVAGT GYLAPEYA+ G LTEK+DVY+FGVV LE++ GR D + R L
Sbjct: 847 THISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLL- 905
Query: 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIME---RFVLVGILCAHVMVALRPTI 598
+W W+L + G+ + +D L + + ME R + + +LC ALRP +
Sbjct: 906 -EWAWNLHEKGREVELIDHQLTEFN----------MEEGKRMIGIALLCTQTSHALRPPM 954
Query: 599 SDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLH 645
S + ML GD+EV + +P L F DD+T + ++SG L
Sbjct: 955 SRVVAMLSGDVEVSDVTSKPGYLTDWRF--DDTT---ASSISGFPLR 996
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 134/308 (43%), Positives = 191/308 (62%), Gaps = 21/308 (6%)
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVE 361
W+ +++LE AT+ ++N IG GG+G+VY+GIL DGT VAVK ++ + Q + EF EVE
Sbjct: 141 WYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVE 200
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
+I ++H+NLV L G CV G+ R LVYD++ NGN++ + D S PL
Sbjct: 201 VIGRVRHKNLVRLLGYCV------EGAYRMLVYDFVDNGNLEQWIHGDVGDVS-----PL 249
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
TW R NIIL +AKGLAYLH G++P + HRDIK++NILLD A+V+DFGLAK
Sbjct: 250 TWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSES 309
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA-CL 540
S++TTRV GT GY+APEYA G L EKSD+YSFG++I+EI+ GR +D S P+
Sbjct: 310 SYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYS---RPQGETN 366
Query: 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600
+ DW+ S+V + + +DP + + +L +R +LV + C RP +
Sbjct: 367 LVDWLKSMVGNRRSEEVVDPKIPEPPSSKAL------KRVLLVALRCVDPDANKRPKMGH 420
Query: 601 ALKMLEGD 608
+ MLE +
Sbjct: 421 IIHMLEAE 428
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 151/367 (41%), Positives = 211/367 (57%), Gaps = 31/367 (8%)
Query: 254 FVMFALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATD 313
FVM LL Y K + + L G SR + N FK + LE+ATD
Sbjct: 264 FVMLILLATYVIMTKVSKTKQEKRNL-------GLVSR---KFNNSKTKFKYETLEKATD 313
Query: 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVP 373
FS K +G+GG G V+ GIL +G VAVK+++ + EF NEV +IS ++H+NLV
Sbjct: 314 YFSHKKMLGQGGNGTVFLGILPNGKNVAVKRLVFNTRDWVEEFFNEVNLISGIQHKNLVK 373
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L GC + G E LVY+Y+PN ++D LF D S + L W QR NIIL
Sbjct: 374 LLGCSI------EGPESLLVYEYVPNKSLDQFLF----DES--QSKVLNWSQRLNIILGT 421
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
A+GLAYLH G I HRDIK +N+LLD + ++ADFGLA+ ++HL+T +AGT G
Sbjct: 422 AEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLARCFGLDKTHLSTGIAGTLG 481
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553
Y+APEY + GQLTEK+DVYSFGV++LEI CG + + P + VW+L +
Sbjct: 482 YMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRI----NAFVPETGHLLQRVWNLYTLNR 537
Query: 554 VWQALDPSLLKEDDFLSLN-PKAIMERFVLVGILCAHVMVALRPTISDALKML-EGDIEV 611
+ +ALDP L +D+FL + +A + + VG+LC +LRP++ + ++ML E D +
Sbjct: 538 LVEALDPCL--KDEFLQVQGSEAEACKVLRVGLLCTQASPSLRPSMEEVIRMLTERDYPI 595
Query: 612 PPLPDRP 618
P P P
Sbjct: 596 PS-PTSP 601
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 158/414 (38%), Positives = 220/414 (53%), Gaps = 45/414 (10%)
Query: 231 PMKSSNKRHSALVFGLTGAGVAIFVMFALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSS 290
P K N+ + + G V + ++ L G+ + +K RKR+ L G
Sbjct: 628 PSKGKNRTGT-----IVGVIVGVGLLSILAGVVMFTIRKRRKRY-----TDDEELLGMDV 677
Query: 291 RPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF 350
+P + F +L+ AT F N +G GGFG VYKG L DG VAVK +
Sbjct: 678 KPYI--------FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSR 729
Query: 351 QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSF 410
QG +F E+ IS++ HRNLV L GCC G R LVY+Y+PNG++D LF
Sbjct: 730 QGKGQFVAEIVAISSVLHRNLVKLYGCCF------EGEHRMLVYEYLPNGSLDQALF--- 780
Query: 411 NDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470
G L W R I L VA+GL YLH I HRD+KA+NILLD+ + +++D
Sbjct: 781 ----GDKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISD 836
Query: 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530
FGLAK + ++H++TRVAGT GYLAPEYA+ G LTEK+DVY+FGVV LE++ GR D
Sbjct: 837 FGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDE 896
Query: 531 STSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHV 590
+ + L +W W+L + + + +D L DF K R + + +LC
Sbjct: 897 NLEEEKKYLL--EWAWNLHEKSRDIELIDDKL---TDFNMEEAK----RMIGIALLCTQT 947
Query: 591 MVALRPTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQL 644
ALRP +S + ML GD+E+ + +P G+ S + D T G S LSG Q+
Sbjct: 948 SHALRPPMSRVVAMLSGDVEIGDVTSKP---GYVSDWRFDDTTGSS--LSGFQI 996
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 142/349 (40%), Positives = 198/349 (56%), Gaps = 28/349 (8%)
Query: 261 GLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNF 320
G++ WW + K+ + D + + + S L+ + ++L AT+ F+ KN
Sbjct: 256 GMFLWWRYRRNKQIF---FDVNEQYDPEVSLGHLKR------YTFKELRSATNHFNSKNI 306
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCV 379
+GRGG+G+VYKG L DGT VAVK++ + + G + +F EVE IS HRNL+ LRG C
Sbjct: 307 LGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFC- 365
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
ER LVY YMPNG+V L + + L W +RK I + A+GL Y
Sbjct: 366 -----SSNQERILVYPYMPNGSVASRLKDNIR-----GEPALDWSRRKKIAVGTARGLVY 415
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEY 499
LH P I HRD+KA NILLD D A V DFGLAK SH+TT V GT G++APEY
Sbjct: 416 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 475
Query: 500 ALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALD 559
GQ +EK+DV+ FG+++LE++ G+KALD S + ++ DWV L + GK+ Q +D
Sbjct: 476 LSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVML-DWVKKLHQEGKLKQLID 534
Query: 560 PSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608
L + D + L E V V +LC + RP +S+ +KMLEGD
Sbjct: 535 KDLNDKFDRVEL------EEIVQVALLCTQFNPSHRPKMSEVMKMLEGD 577
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | ||||||
| 224065114 | 652 | predicted protein [Populus trichocarpa] | 0.937 | 0.981 | 0.717 | 0.0 | |
| 224065122 | 652 | predicted protein [Populus trichocarpa] | 0.937 | 0.981 | 0.713 | 0.0 | |
| 224079543 | 620 | predicted protein [Populus trichocarpa] | 0.879 | 0.969 | 0.752 | 0.0 | |
| 225447949 | 658 | PREDICTED: probable receptor-like protei | 0.920 | 0.955 | 0.708 | 0.0 | |
| 356528805 | 736 | PREDICTED: probable receptor-like protei | 0.907 | 0.842 | 0.702 | 0.0 | |
| 356558471 | 642 | PREDICTED: probable receptor-like protei | 0.920 | 0.979 | 0.695 | 0.0 | |
| 449519892 | 649 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.915 | 0.963 | 0.702 | 0.0 | |
| 449457103 | 726 | PREDICTED: probable receptor-like protei | 0.938 | 0.882 | 0.690 | 0.0 | |
| 357445489 | 656 | Kinase-like protein [Medicago truncatula | 0.897 | 0.934 | 0.697 | 0.0 | |
| 359486052 | 620 | PREDICTED: probable receptor-like protei | 0.890 | 0.980 | 0.696 | 0.0 |
| >gi|224065114|ref|XP_002301677.1| predicted protein [Populus trichocarpa] gi|222843403|gb|EEE80950.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2478), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/656 (71%), Positives = 541/656 (82%), Gaps = 16/656 (2%)
Query: 3 SLHLLQIVSLLSLSAFSFTTSATSPSSKNDSTTCPMDLNYVLRIPWNKTSCENYEANSTN 62
+L L+ + L+S T++A S+ N CPMDLNYVLRIPWN+T C N+ + N
Sbjct: 6 NLDFLRFLVLISF-CLPLTSAAAETSTSN---ICPMDLNYVLRIPWNQTLCRNFNPLAQN 61
Query: 63 IRNN---KNPCCLSLLSLYGVAFAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDK 119
N K PCC ++LSL+GVA +QHLKET+FF+LPNL TS SCL+D+Q+KLS+FSLSD
Sbjct: 62 DNTNSTSKPPCCQTILSLFGVALSQHLKETSFFQLPNLATSSSCLQDYQSKLSSFSLSDD 121
Query: 120 LVSYCLDPFHFVTSRNKCASIESLQDWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFK 179
LVS+C +P FVT+ N CA IE+ QDW +LG ST LDS C+SDLTDL+ACDSC+ AG K
Sbjct: 122 LVSHCFNPLQFVTAPNICARIETSQDWVDQLGKSTSLDSDCRSDLTDLTACDSCLRAGNK 181
Query: 180 VQSQLIAVDGNTSHATDCFYFTILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRH 239
VQS L++ DGN +HA DCFYF +LYAAG+VNEFGPES+G +SCIFGL L S + S++ H
Sbjct: 182 VQSLLLSADGNQTHAQDCFYFAVLYAAGVVNEFGPESDGVVSCIFGLELNSRVGSASNSH 241
Query: 240 SALVFGLTGAGVAIFVMFALLGLYFWWDKKLR-KRFYGSGLDSSSSLEGQSSRPKLRPNT 298
SALVFGLTGAGVAI VM +LLGLY W+DKK R K+ G G D E Q SRPKLRPNT
Sbjct: 242 SALVFGLTGAGVAILVMSSLLGLYLWYDKKWRRKKNLGFGFDLD---EQQGSRPKLRPNT 298
Query: 299 GSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCN 358
GSIWFKI+DLE+ATD FSQKNFIGRGGFG VYKG+L DGT VA+K+VIESDFQGDAEFCN
Sbjct: 299 GSIWFKIRDLEKATDNFSQKNFIGRGGFGFVYKGVLSDGTVVAIKRVIESDFQGDAEFCN 358
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGD---NERGSERYLVYDYMPNGNVDDHLFPSFNDGSG 415
EVEIISNLKHRNLVPLRGCCV+D D +ERG++RYLVYDYM NGN+DDHLFPS ++
Sbjct: 359 EVEIISNLKHRNLVPLRGCCVIDDDVNSDERGNQRYLVYDYMSNGNLDDHLFPSSDNQ-- 416
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475
+ K+ L+WPQRK+IILDVAKGLAYLH+GVKP IYHRDIK TNILLDA+MRARVADFGLAK
Sbjct: 417 IQKQLLSWPQRKSIILDVAKGLAYLHHGVKPGIYHRDIKGTNILLDAEMRARVADFGLAK 476
Query: 476 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535
QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVV+LEIM GRKALDLS+SGS
Sbjct: 477 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVVLEIMSGRKALDLSSSGS 536
Query: 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR 595
PRA LITDW WSLVKAGKV QALD SLL+ D + NPK IMERFVLVGILCAH+MVALR
Sbjct: 537 PRALLITDWAWSLVKAGKVEQALDASLLRGGDSSNSNPKGIMERFVLVGILCAHIMVALR 596
Query: 596 PTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLR 651
PTI DALKMLEGDIEVP +PDRP+PLGHPSF+ D ++F ISP LSG +L GDMLR
Sbjct: 597 PTILDALKMLEGDIEVPQIPDRPVPLGHPSFHADGNSFSISPVLSGPKLQPGDMLR 652
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065122|ref|XP_002301680.1| predicted protein [Populus trichocarpa] gi|222843406|gb|EEE80953.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2459), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/656 (71%), Positives = 537/656 (81%), Gaps = 16/656 (2%)
Query: 3 SLHLLQIVSLLSLSAFSFTTSATSPSSKNDSTTCPMDLNYVLRIPWNKTSCENYEANSTN 62
+L L+ + L+S T +A S+ N CPMDLNYVLRIPWN+T C N+ + N
Sbjct: 6 NLDFLRFLVLISF-CLPLTYAAAETSTSN---ICPMDLNYVLRIPWNQTLCRNFNPLAQN 61
Query: 63 IRNN---KNPCCLSLLSLYGVAFAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDK 119
N K PCC ++LSL+GVA +QHLKET+FF+LPNL TS SCL+D+Q+KL +FSLSD
Sbjct: 62 DNTNSTSKPPCCQTILSLFGVALSQHLKETSFFQLPNLATSSSCLQDYQSKLISFSLSDN 121
Query: 120 LVSYCLDPFHFVTSRNKCASIESLQDWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFK 179
LVS+C +P FVT+ N CA IE+ QDW +LG ST LDS C+SDLTDL+ACDSC+ AG K
Sbjct: 122 LVSHCFNPLQFVTAPNICARIETSQDWVDQLGKSTSLDSDCRSDLTDLTACDSCLRAGNK 181
Query: 180 VQSQLIAVDGNTSHATDCFYFTILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRH 239
VQS L++ DGN +HA DCFYF +LYAAG+VNEFGPES+G +SCIFGL L S + S++ H
Sbjct: 182 VQSLLLSADGNQTHAQDCFYFAVLYAAGVVNEFGPESDGVVSCIFGLELNSRVGSASNSH 241
Query: 240 SALVFGLTGAGVAIFVMFALLGLYFWWDKKLR-KRFYGSGLDSSSSLEGQSSRPKLRPNT 298
SALVFGLTGAGVAI V+ +LLGLY W+DKK R K+ G G D E Q SRPKLRPNT
Sbjct: 242 SALVFGLTGAGVAILVISSLLGLYLWYDKKWRRKKNLGFGFDLD---EQQGSRPKLRPNT 298
Query: 299 GSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCN 358
GSIWFKI+DLE+ATD FSQKNFIGRGGFG VYKG+L DGT VA+K+VIESDFQGDAEFCN
Sbjct: 299 GSIWFKIRDLEKATDNFSQKNFIGRGGFGFVYKGVLSDGTVVAIKRVIESDFQGDAEFCN 358
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGD---NERGSERYLVYDYMPNGNVDDHLFPSFNDGSG 415
EVEIISNLKHRNLVPLRGCCV+D D +ERG++RYLVYDYM NGN+DDHLFPS ++
Sbjct: 359 EVEIISNLKHRNLVPLRGCCVIDDDVNSDERGNQRYLVYDYMSNGNLDDHLFPSSDNQ-- 416
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475
+ K+ L+WPQRK+IILDVAKGLAYLH+GVKP IYHRDIK TNILLDA+MRARVADFGLAK
Sbjct: 417 IQKQLLSWPQRKSIILDVAKGLAYLHHGVKPGIYHRDIKGTNILLDAEMRARVADFGLAK 476
Query: 476 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535
QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVV+LEIM GRKALDLS+SGS
Sbjct: 477 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVVLEIMSGRKALDLSSSGS 536
Query: 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR 595
PRA LITDW WSLVKA KV QALD SLL+ D + NPK IMERFVLVGILCAH+MVALR
Sbjct: 537 PRALLITDWAWSLVKAAKVEQALDASLLRGGDSSNSNPKGIMERFVLVGILCAHIMVALR 596
Query: 596 PTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLR 651
PTI DALKMLEGDIEVP +PDRP+PLGHPSF D + F ISP LSG +L +GDMLR
Sbjct: 597 PTILDALKMLEGDIEVPQIPDRPVPLGHPSFQADGNNFSISPVLSGPKLQSGDMLR 652
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079543|ref|XP_002305887.1| predicted protein [Populus trichocarpa] gi|222848851|gb|EEE86398.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2447), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/614 (75%), Positives = 518/614 (84%), Gaps = 13/614 (2%)
Query: 38 MDLNYVLRIPWNKTSCENYEANSTNIRNN---KNPCCLSLLSLYGVAFAQHLKETTFFRL 94
MD +YVLRIPWN++ C+N++ N N K CC SLLSL+GVA AQHLKET+ FRL
Sbjct: 1 MDFSYVLRIPWNRSLCQNFQPPDENDNTNTTSKPQCCQSLLSLFGVAVAQHLKETSLFRL 60
Query: 95 PNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNKCASIESLQDWKSKLGGST 154
PNL TS SCLRD+Q+KL++FSL++ LVSYCLDP FVT N CA I+SLQDW ++LG ST
Sbjct: 61 PNLATSNSCLRDYQSKLNSFSLANNLVSYCLDPLQFVTKPNICARIQSLQDWVARLGKST 120
Query: 155 QLDSSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNTSHATDCFYFTILYAAGIVNEFGP 214
LD++CKSDLTD +ACD CV AG+KVQS L+++D N +HAT CFYF ILYAAGIVNEFGP
Sbjct: 121 SLDTACKSDLTDNTACDGCVRAGYKVQSTLLSIDSNQTHATSCFYFAILYAAGIVNEFGP 180
Query: 215 ESNGALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGVAIFVMFALLGLYFWWDKKLR-KR 273
ES+GA+SCI GL L S + S++K HSALVFGLTGAGVA+ VMF+LLGLYFW+DKK R K+
Sbjct: 181 ESDGAVSCILGLELNSRVGSASKAHSALVFGLTGAGVALLVMFSLLGLYFWYDKKWRRKK 240
Query: 274 FYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI 333
G G D E Q SRPKLRPNTGSIWFKIQDLE+AT FSQ NFIGRGGFG VYKG
Sbjct: 241 NSGFGFDLD---EQQGSRPKLRPNTGSIWFKIQDLEKATHNFSQNNFIGRGGFGFVYKGT 297
Query: 334 LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN----ERGSE 389
L DGT VA+K+VIESDFQG AEFCNEVEIISNLKHRNLVPLRGCCV+D D+ ERG++
Sbjct: 298 LSDGTVVAIKRVIESDFQGAAEFCNEVEIISNLKHRNLVPLRGCCVIDDDDGNNDERGNQ 357
Query: 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIY 449
RYLVYDYM NGN+DDHLFPS G+ + K+PL+WPQRK+IILDVAKGLAYLHYGVKPAIY
Sbjct: 358 RYLVYDYMSNGNLDDHLFPS--SGNQIGKQPLSWPQRKSIILDVAKGLAYLHYGVKPAIY 415
Query: 450 HRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKS 509
HRDIK TNILLDADMRARVADFGL KQS+EGQSHLTTRVAGTHGYLAPEYALYGQLTEKS
Sbjct: 416 HRDIKGTNILLDADMRARVADFGLVKQSKEGQSHLTTRVAGTHGYLAPEYALYGQLTEKS 475
Query: 510 DVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFL 569
DVYSFGVV+LEIMCGRKALDLS+ GSPRA LITDW WSLVKAGKV +ALD SLL+ D
Sbjct: 476 DVYSFGVVVLEIMCGRKALDLSSGGSPRALLITDWAWSLVKAGKVEEALDASLLRCGDSS 535
Query: 570 SLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGD 629
+ NPK IMERFVLVGILCAHVMVALRPTI ALKMLEGDIEVPP+PDRPMPLGHPSF+ D
Sbjct: 536 NSNPKGIMERFVLVGILCAHVMVALRPTILVALKMLEGDIEVPPIPDRPMPLGHPSFHAD 595
Query: 630 DSTFGISPALSGLQ 643
+ F ISPALSG Q
Sbjct: 596 GNNFSISPALSGDQ 609
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225447949|ref|XP_002269016.1| PREDICTED: probable receptor-like protein kinase At1g11050 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2419), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/637 (70%), Positives = 527/637 (82%), Gaps = 8/637 (1%)
Query: 22 TSATSPSSKNDSTTCPMDLNYVLRIPWNKTSCENYEANSTNIRNNKNPCCLSLLSLYGVA 81
++ T+ S ++++ CPMD NYVLRI WN ++C N+ + N+K+ CC +LLSL+ V+
Sbjct: 23 SATTALSQSSNASACPMDFNYVLRISWNSSNCHNFVSQGNTSVNSKSSCCTTLLSLFAVS 82
Query: 82 FAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNKCASIE 141
AQHLKET+ F LP++ TS SCL DFQ+KL++ L++ L S C DP FV + CA ++
Sbjct: 83 LAQHLKETSLFNLPDVSTSQSCLHDFQSKLTSLPLANNLASSCFDPQQFVIGPDICAGVQ 142
Query: 142 SLQDWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNTSHATDCFYFT 201
++ DW +KLG ST LDSSC++DLTDL+ACD+CV AGF+VQS+LI +DGN SH+TDCFYFT
Sbjct: 143 NISDWVAKLGPSTALDSSCRADLTDLTACDACVNAGFEVQSKLIEIDGNKSHSTDCFYFT 202
Query: 202 ILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGVAIFVMFALLG 261
+LYAAGIVNE GPES GA+SC+ + L S SS+K HSAL+FG TGAGVA+ VM LLG
Sbjct: 203 VLYAAGIVNEAGPESTGAMSCVLAVPLNSDEGSSSKSHSALIFGFTGAGVAVLVMSCLLG 262
Query: 262 LYFWWDKKLRKRFY--GSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKN 319
LYFWW++K K+ GSG + SRP++RPNTGSIWFKI DLERATD FSQKN
Sbjct: 263 LYFWWERKWGKKSKRSGSGFFGVDLEDLGGSRPRVRPNTGSIWFKIPDLERATDNFSQKN 322
Query: 320 FIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
FIGRGGFGLVYKG L DG+TVAVKK+IESD Q DA+FCNE+EIISNLKHRNLVPLRGCCV
Sbjct: 323 FIGRGGFGLVYKGTLADGSTVAVKKIIESDIQVDADFCNEIEIISNLKHRNLVPLRGCCV 382
Query: 380 VDGD---NERGSERYLVYDYMPNGNVDDHLFPSFN--DGSGVAKRPLTWPQRKNIILDVA 434
VDG ++R S RYLVYDYMPNGN+DDHLF + +G+G+ K+PLTWPQRK+IILDVA
Sbjct: 383 VDGGEGYDDRASPRYLVYDYMPNGNLDDHLFSKWENGNGNGMGKKPLTWPQRKSIILDVA 442
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY
Sbjct: 443 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 502
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKV 554
LAPEYALYGQLTEKSDVYSFGVV+LEIMCGRKALDLS S SPRA LITDW WS+VKAGK
Sbjct: 503 LAPEYALYGQLTEKSDVYSFGVVVLEIMCGRKALDLS-SRSPRAFLITDWAWSMVKAGKA 561
Query: 555 WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPPL 614
+ALD SL+K+ D + NPKAIMERF+LVGILCAHVMVALRPTISDALKMLEGD+EVP +
Sbjct: 562 EEALDASLVKDGDSSNSNPKAIMERFLLVGILCAHVMVALRPTISDALKMLEGDVEVPAI 621
Query: 615 PDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLR 651
PDRP+PLGHPSF D +TF ISPALSG +LHTGDMLR
Sbjct: 622 PDRPVPLGHPSFLTDGNTFSISPALSGPKLHTGDMLR 658
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528805|ref|XP_003532988.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2370), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/638 (70%), Positives = 526/638 (82%), Gaps = 18/638 (2%)
Query: 29 SKNDSTTCPMDLNYVLRIPWNKTSCENYEAN-STNIRNNKNPCCLSLLSLYGVAFAQHLK 87
S N STTCPMDLNYVLRIPWN ++C N++ + + N CC+SLLSL+G+ A HLK
Sbjct: 102 STNTSTTCPMDLNYVLRIPWNTSACHNFQQTLAAKNGTDANTCCISLLSLFGIGLANHLK 161
Query: 88 ETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNKCASIESLQDWK 147
ET+ F+L NL +S+SC++DFQ+KLS+ SL + LV C DP FV S N CA I+++ DW
Sbjct: 162 ETSQFQLQNLASSLSCIKDFQSKLSSLSLPNNLVDTCFDPLQFVISPNICAGIQTIPDWT 221
Query: 148 SKLGGSTQLDSSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNTSHATDCFYFTILYAAG 207
K+G ST L+++C+SDLTD+S CD C+ AG +V+ +LI++DGN SH+ DCFYF ILYAAG
Sbjct: 222 KKVGQSTPLNTACRSDLTDISLCDVCLQAGLQVKQKLISIDGNASHSIDCFYFAILYAAG 281
Query: 208 IVNEFGPESNGALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGVAIFVMFALLGLYFWWD 267
IVNEFGPESNGA+SCIF +S+ S S KRH ALVFGLTGAGVA+ VM + LG+Y W+D
Sbjct: 282 IVNEFGPESNGAVSCIFSISVYSQGGSGGKRHQALVFGLTGAGVALLVMSSFLGMYSWYD 341
Query: 268 KKLRKR----FYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGR 323
+K R++ F D E SRP+LRPNTGSIWFKI++LE+ATD FS KNFIGR
Sbjct: 342 RKHRRKKLETFNQFDFDPE---EQGGSRPRLRPNTGSIWFKIEELEKATDNFSSKNFIGR 398
Query: 324 GGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383
GGFG+V+KG L DGT VAVK+++ESDFQG+AEFCNEVEIISNLKHRNLVPLRGCCV + D
Sbjct: 399 GGFGMVFKGTLSDGTVVAVKRILESDFQGNAEFCNEVEIISNLKHRNLVPLRGCCVAEED 458
Query: 384 ---NERGS-ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR-PLTWPQRKNIILDVAKGLA 438
+ERGS +RYLVYDYMPNGN++DH+F S + S +K LTWPQRK+IILDVAKGLA
Sbjct: 459 ENCDERGSSQRYLVYDYMPNGNLEDHIFLSSTEDSQKSKGLSLTWPQRKSIILDVAKGLA 518
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
YLHYGVKPAI+HRDIKATNILLD+DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE
Sbjct: 519 YLHYGVKPAIFHRDIKATNILLDSDMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 578
Query: 499 YALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQAL 558
YALYGQLTEKSDVYSFGVV+LEIMCGRKALDLS+SGSPRA LITDW WSLVKAGK+ +AL
Sbjct: 579 YALYGQLTEKSDVYSFGVVVLEIMCGRKALDLSSSGSPRAFLITDWAWSLVKAGKIEEAL 638
Query: 559 DPSLLKEDD--FLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPPLPD 616
D SL+K+ D F S NPK+IMERF+LVGILC+HVMVALRPTI+DALKMLEGDIEVP +PD
Sbjct: 639 DGSLVKDKDESFPSSNPKSIMERFLLVGILCSHVMVALRPTIADALKMLEGDIEVPQIPD 698
Query: 617 RPMPLGHP-SFYGDD--STFGISPALSGLQLHTGDMLR 651
RPMPLGHP SFY +D STF ISPALSG +L TGDMLR
Sbjct: 699 RPMPLGHPSSFYNNDHGSTFSISPALSGPKLQTGDMLR 736
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558471|ref|XP_003547530.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2358), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/647 (69%), Positives = 526/647 (81%), Gaps = 18/647 (2%)
Query: 13 LSLSAFSFTTSATSPSSKNDSTTCPMDLNYVLRIPWNKTSCENYEAN-STNIRNNKNPCC 71
L + FS T+SA ++TTCPMDLNYVLRIPWN ++C N++ + + N CC
Sbjct: 6 LMFALFSCTSSA-------NTTTCPMDLNYVLRIPWNTSACHNFQQTLAAKNGTDANTCC 58
Query: 72 LSLLSLYGVAFAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFV 131
+SLLSL+G+ AQHLKET+ F+LPNL TS+SC++DFQ KLS+ SL L C DP FV
Sbjct: 59 ISLLSLFGIGLAQHLKETSQFQLPNLATSLSCIQDFQLKLSSLSLPSNLADTCFDPLQFV 118
Query: 132 TSRNKCASIESLQDWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNT 191
S N CA I+++ DW KLG ST L+++CKSDLTD+S CD C+ AG + + LI++DGN
Sbjct: 119 ISPNICAGIQTIPDWTKKLGQSTPLNTACKSDLTDISLCDVCLQAGLQAKQVLISIDGNA 178
Query: 192 SHATDCFYFTILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGV 251
SH+ DCFYF ILYAAG+VNEFGPESNGA+SCIF +S+ S S K H ALVFGLTGAG+
Sbjct: 179 SHSIDCFYFAILYAAGVVNEFGPESNGAVSCIFSISVYSQGGSGGKGHQALVFGLTGAGI 238
Query: 252 AIFVMFALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERA 311
A+ VM + LG+Y W+D+K R++ + E Q SRP+LRPNTGSIWFKI++LE+A
Sbjct: 239 ALLVMSSFLGIYAWYDRKHRRKKLET-FQFDFDPEEQGSRPRLRPNTGSIWFKIEELEKA 297
Query: 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
TD FS KNFIGRGGFG+V+KG L DGT V VK+++ESDFQGDAEFCNEVEIISNLKHRNL
Sbjct: 298 TDNFSSKNFIGRGGFGMVFKGTLSDGTVVGVKRILESDFQGDAEFCNEVEIISNLKHRNL 357
Query: 372 VPLRGCCVVDGD---NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
VPLRGCCV + + +ERGS+RYLVYDYMPNGN++DHLF S + S AK LTWPQRK+
Sbjct: 358 VPLRGCCVAEENENYDERGSQRYLVYDYMPNGNLEDHLFLSTD--SQKAKGSLTWPQRKS 415
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
IILDVAKGLAYLHYGVKPAI+HRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV
Sbjct: 416 IILDVAKGLAYLHYGVKPAIFHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 475
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548
AGTHGYLAPEYALYGQLTEKSDVYSFGVV LEIMCGRKALDLS+SGSPRA LITDW WSL
Sbjct: 476 AGTHGYLAPEYALYGQLTEKSDVYSFGVVALEIMCGRKALDLSSSGSPRAFLITDWAWSL 535
Query: 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608
VKAGK+ +ALD L+K+++F S NPK+IMERF+LVGILC+HVMVALRPTI+DALKMLEGD
Sbjct: 536 VKAGKIEEALDAFLVKDENFPSSNPKSIMERFLLVGILCSHVMVALRPTIADALKMLEGD 595
Query: 609 IEVPPLPDRPMPLGHPSFY----GDDSTFGISPALSGLQLHTGDMLR 651
IEVP +PDRPMPLGHPSFY D STF ISPALSG +L TGDMLR
Sbjct: 596 IEVPQIPDRPMPLGHPSFYNNNNNDGSTFSISPALSGPKLQTGDMLR 642
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519892|ref|XP_004166968.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At1g11050-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 910 bits (2352), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/638 (70%), Positives = 512/638 (80%), Gaps = 13/638 (2%)
Query: 21 TTSATSPSSKNDSTTCPMDLNYVLRIPWNKTSCEN--YEANSTNIRNN--KNPCCLSLLS 76
+TSA +P + + CPMDLNY+LRIPWN T C+N ++ + + N+ K PCC +LLS
Sbjct: 18 STSAATPIA---NPICPMDLNYILRIPWNATDCQNPFFQTTAQSAMNDTSKIPCCQTLLS 74
Query: 77 LYGVAFAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNK 136
L+G+A AQHLKET+ F LP+LPTS SCLRD+Q+KLS+ SL D LVS+C DP FV S N
Sbjct: 75 LFGIALAQHLKETSLFNLPDLPTSNSCLRDYQSKLSSLSLPDDLVSHCFDPLQFVISANV 134
Query: 137 CASIESLQDWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNTSHATD 196
CA I++ QDW SKLG ++ LDS CKS+L CD+C+AAG KVQ+ L +DGN SH+ D
Sbjct: 135 CAGIQTTQDWVSKLGQNSPLDSGCKSELVG-PGCDACLAAGLKVQTILTGIDGNKSHSMD 193
Query: 197 CFYFTILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGVAIFVM 256
CFYF +LYAAGIVNE GPE + AL CIF L L + K S +HSALV+GLT A + I V+
Sbjct: 194 CFYFAVLYAAGIVNESGPEGDPALDCIFNLPL-NIEKDSKSKHSALVYGLTAAAIGIXVV 252
Query: 257 FALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFS 316
F L+G+ FW+ K +K S L+ L+ Q SRP RPNTGSIWFKIQ+LE+ATD FS
Sbjct: 253 FVLMGIGFWF-FKWKKLAEKSSLECDVELDEQXSRPHARPNTGSIWFKIQELEKATDNFS 311
Query: 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRG 376
KNFIGRGGFGLVYKG L DG+ VAVKKVIESDFQG+AEFCNEVEIIS+LKHRNLVPLRG
Sbjct: 312 SKNFIGRGGFGLVYKGTLPDGSMVAVKKVIESDFQGNAEFCNEVEIISHLKHRNLVPLRG 371
Query: 377 CCVVDGDN---ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
CCV+DGD+ ER SERYLVYDYMPNGN+DD+LFP D G K+ LTWPQRKNIILDV
Sbjct: 372 CCVIDGDDGYDERVSERYLVYDYMPNGNLDDYLFPIPFDQVGTVKKSLTWPQRKNIILDV 431
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG
Sbjct: 432 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 491
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553
YLAPEYALYGQLTEKSDVYSFGVV+LEIMCGRKALD S S SPRA LITDW WSLVKAGK
Sbjct: 492 YLAPEYALYGQLTEKSDVYSFGVVVLEIMCGRKALDFSLSSSPRAFLITDWAWSLVKAGK 551
Query: 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPP 613
+ +DPSLLK+ D + NP+AIMERF+ VGILC+HVMVALRPTI +ALKMLEGDIEVP
Sbjct: 552 IGDTVDPSLLKDGDSSNSNPRAIMERFIAVGILCSHVMVALRPTIMEALKMLEGDIEVPQ 611
Query: 614 LPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLR 651
+ DRP+P GHPSF GD S F ISP LSG QLH GDMLR
Sbjct: 612 ISDRPVPYGHPSFVGDGSNFSISPTLSGHQLHNGDMLR 649
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457103|ref|XP_004146288.1| PREDICTED: probable receptor-like protein kinase At1g11050-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 910 bits (2351), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/653 (69%), Positives = 516/653 (79%), Gaps = 12/653 (1%)
Query: 8 QIVSLLSLSAFSFTTSATSPSSKND--STTCPMDLNYVLRIPWNKTSCEN--YEANSTNI 63
Q++ +LS S TS S+ + CPMDLNY+LRIPWN T C+N ++ + +
Sbjct: 77 QMIKILSTFLLLCLLSITSTSAATPIANPICPMDLNYILRIPWNATDCQNPFFQTTAQSA 136
Query: 64 RNN--KNPCCLSLLSLYGVAFAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLV 121
N+ K PCC +LLSL+G+A AQHLKET+ F LP+LPTS SCLRD+Q+KLS+ SL D LV
Sbjct: 137 MNDTSKIPCCQTLLSLFGIALAQHLKETSLFNLPDLPTSNSCLRDYQSKLSSLSLPDDLV 196
Query: 122 SYCLDPFHFVTSRNKCASIESLQDWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFKVQ 181
S+C DP FV S N CA I++ QDW SKLG ++ LDS CKS+L CD+C+AAG KVQ
Sbjct: 197 SHCFDPLQFVISANVCAGIQTTQDWVSKLGQNSPLDSGCKSELVG-PGCDACLAAGLKVQ 255
Query: 182 SQLIAVDGNTSHATDCFYFTILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHSA 241
+ L +DGN SH+ DCFYF +LYAAGIVNE GPE + AL CIF L L + K S +HSA
Sbjct: 256 TILTGIDGNKSHSMDCFYFAVLYAAGIVNESGPEGDPALDCIFNLPL-NIEKDSKSKHSA 314
Query: 242 LVFGLTGAGVAIFVMFALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSI 301
LV+GLT A + I V+F L+G+ FW+ K +K S L+ L+ Q SRP RPNTGSI
Sbjct: 315 LVYGLTAAAIGILVVFVLMGIGFWF-FKWKKLAEKSSLECDVELDEQGSRPHARPNTGSI 373
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVE 361
WFKIQ+LE+ATD FS KNFIGRGGFGLVYKG L DG+ VAVKKVIESDFQG+AEFCNEVE
Sbjct: 374 WFKIQELEKATDNFSSKNFIGRGGFGLVYKGTLPDGSMVAVKKVIESDFQGNAEFCNEVE 433
Query: 362 IISNLKHRNLVPLRGCCVVDGDN---ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
IIS+LKHRNLVPLRGCCV+DGD+ ER SERYLVYDYMPNGN+DD+LFP D G K
Sbjct: 434 IISHLKHRNLVPLRGCCVIDGDDGYDERVSERYLVYDYMPNGNLDDYLFPIPFDQVGTVK 493
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 478
+ LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR
Sbjct: 494 KSLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 553
Query: 479 EGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538
EGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVV+LEIMCGRKALD S S SPRA
Sbjct: 554 EGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVVLEIMCGRKALDFSLSSSPRA 613
Query: 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598
LITDW WSLVKAGK+ +DPSLLK+ D + NP+AIMERF+ VGILC+HVMVALRPTI
Sbjct: 614 FLITDWAWSLVKAGKIGDTVDPSLLKDGDSSNSNPRAIMERFIAVGILCSHVMVALRPTI 673
Query: 599 SDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLR 651
+ALKMLEGDIEVP + DRP+P GHPSF GD S F ISP LSG QLH GDMLR
Sbjct: 674 MEALKMLEGDIEVPQISDRPVPYGHPSFVGDGSNFSISPTLSGHQLHNGDMLR 726
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357445489|ref|XP_003593022.1| Kinase-like protein [Medicago truncatula] gi|355482070|gb|AES63273.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2335), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/624 (69%), Positives = 513/624 (82%), Gaps = 11/624 (1%)
Query: 35 TCPMDLNYVLRIPWNKTSCENYEANSTNIRNNKNPCCLSLLSLYGVAFAQHLKETTFFRL 94
TCPMDLNYVLRI WN ++C+N+ + S+ + CC S+LSL+G+ FAQHLKET+ F L
Sbjct: 11 TCPMDLNYVLRIHWNSSACQNFNSLSSK---ETSTCCASVLSLFGIGFAQHLKETSQFNL 67
Query: 95 PNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNKCASIESLQDWKSKLGGST 154
+L TS SC++DFQ+KL++ SL + LV+ C DP FV SRN CA IE++ DW K+G ++
Sbjct: 68 QDLQTSNSCMQDFQSKLNSLSLYNNLVNSCFDPLQFVISRNICAGIETVHDWNEKVGQNS 127
Query: 155 QLDSSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNTSHATDCFYFTILYAAGIVNEFGP 214
L+++CK DLT LS CD+CVAAG +V+ +L++V GN S + CFYF ILYAAGIVNEFGP
Sbjct: 128 SLNTACKPDLTHLSQCDACVAAGLQVKQKLVSVSGNDSQSLSCFYFAILYAAGIVNEFGP 187
Query: 215 ESNGALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGVAIFVMFALLGLYFWWDKKLRKRF 274
ESNGA++C F L + S + S +K H LVFGLTGAGVA+FVM +LLGLY W D+K ++
Sbjct: 188 ESNGAVTCAFSLPVYSQVGSGSKGHQGLVFGLTGAGVALFVMCSLLGLYVWCDRKRMRKR 247
Query: 275 YGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGIL 334
E Q SR +LRPNTGSIW+KIQ+LE+ATD FS KNFIGRGGFGLV+KG L
Sbjct: 248 KLETFQFDFDPEEQGSRRRLRPNTGSIWYKIQELEKATDNFSSKNFIGRGGFGLVFKGTL 307
Query: 335 QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN---ERGSERY 391
DG+ VAVK+V+ESDFQGD EFCNEVEIISNLKHRNL+PLRGCCVVD + ++GS+RY
Sbjct: 308 ADGSVVAVKRVLESDFQGDVEFCNEVEIISNLKHRNLLPLRGCCVVDENENYGDKGSQRY 367
Query: 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451
LVYDYMPNGN++DHLF S + A + L+WP RKNIILDV KGLAYLHYGVKPAIYHR
Sbjct: 368 LVYDYMPNGNLEDHLFVSKDPQK--ANKSLSWPLRKNIILDVGKGLAYLHYGVKPAIYHR 425
Query: 452 DIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDV 511
DIKATNILLD DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDV
Sbjct: 426 DIKATNILLDEDMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDV 485
Query: 512 YSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSL 571
YSFGVV+LEIMCGRKALDLS+SGSPRA LITDW WSLVK+GK+ +ALD SLLK+D+ S
Sbjct: 486 YSFGVVVLEIMCGRKALDLSSSGSPRAFLITDWAWSLVKSGKIDEALDASLLKDDNTASA 545
Query: 572 NPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGDD- 630
NPK+IMERF+LVGILC+HVMVALRPTISDALKMLEGDIEVP +PDRPMPLGHP+FY +D
Sbjct: 546 NPKSIMERFLLVGILCSHVMVALRPTISDALKMLEGDIEVPQIPDRPMPLGHPAFYNNDG 605
Query: 631 --STFGISPALSGLQLHTGDMLRR 652
+TF ISPALSGL+L TGDMLR+
Sbjct: 606 NGNTFSISPALSGLKLPTGDMLRK 629
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486052|ref|XP_002269065.2| PREDICTED: probable receptor-like protein kinase At1g11050-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2318), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/626 (69%), Positives = 512/626 (81%), Gaps = 18/626 (2%)
Query: 38 MDLNYVLRIPWNKTSCENYEANSTNIRNNKNPCCLSLLSLYGVAFAQHLKETTFFRLPNL 97
MD N+VLRIPWN ++C N+ + + N+K PCC +LLSL+ VA AQHLKET+ FRLP++
Sbjct: 1 MDFNFVLRIPWNSSNCHNFISQGSPSDNSKTPCCTTLLSLFAVALAQHLKETSLFRLPDV 60
Query: 98 PTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHFVTSRNKCASIESLQDWKSKLGGSTQLD 157
TS SC+ DFQ+KL++ L + L S C +P FV N CA ++++ DW +KLG ST LD
Sbjct: 61 STSQSCILDFQSKLTSLLLPNNLASSCFNPQRFVIGPNICAGVQNISDWVAKLGRSTALD 120
Query: 158 SSCKSDLTDLSACDSCVAAGFKVQSQLIAVDGNTSHATDCFYFTILYAAGIVNEFGPESN 217
+C++DL+ L+ACD+CV AGF+VQS+LI +DGN SH+ DCFYFTILYAAG+VNE GPESN
Sbjct: 121 GNCRADLSVLTACDACVKAGFQVQSKLIQIDGNESHSKDCFYFTILYAAGVVNEAGPESN 180
Query: 218 GALSCIFGLSLMSPMKSSNKRHSALVFGLTGAGVAIFVMFALLGLYFWWDKKLRKR---- 273
GA+SC+ + L S + S++K HSALVFGLTG GVA+ VM LLGLYFWW++K +
Sbjct: 181 GAMSCVLAVPLDSHVGSASKSHSALVFGLTGVGVAVLVMSCLLGLYFWWERKWGTKSKRS 240
Query: 274 ---FYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVY 330
F+G L+ L G SRP++RPNTGSIWFKI DLERATD FSQKNFIGRGG GLVY
Sbjct: 241 DSGFFGVDLE---DLGG--SRPRVRPNTGSIWFKIPDLERATDNFSQKNFIGRGGCGLVY 295
Query: 331 KGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD---NERG 387
KG L DG+ VAVKK+IESD Q DA+FCNE+EIISNLKH CCVVDGD ++R
Sbjct: 296 KGTLADGSNVAVKKIIESDIQVDADFCNEIEIISNLKHXXXXXXXXCCVVDGDESYDDRA 355
Query: 388 SERYLVYDYMPNGNVDDHLFPSFN--DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK 445
S+RYLVYDYMPNGN+DDHLF + +G+G+ K+PLTWPQRK+IILDVAKGLAYLHYGVK
Sbjct: 356 SQRYLVYDYMPNGNLDDHLFSKWENGNGNGMGKKPLTWPQRKSIILDVAKGLAYLHYGVK 415
Query: 446 PAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL 505
PAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL
Sbjct: 416 PAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL 475
Query: 506 TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKE 565
TEKSDVYSFGVV+LEIMCGRKALDLS S SP A LITDW WS+VKAGK+ +ALD SLLK+
Sbjct: 476 TEKSDVYSFGVVVLEIMCGRKALDLS-SRSPGAFLITDWAWSMVKAGKIEEALDASLLKD 534
Query: 566 DDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPPLPDRPMPLGHPS 625
+D + NPK IMERF+LVGILCAHVMVALRPTISDALKMLEGD+EVP +PDRP+PLGHPS
Sbjct: 535 EDSSNSNPKVIMERFLLVGILCAHVMVALRPTISDALKMLEGDVEVPAIPDRPVPLGHPS 594
Query: 626 FYGDDSTFGISPALSGLQLHTGDMLR 651
F+ D +TF ISPALSG QLH+GDMLR
Sbjct: 595 FFTDGNTFSISPALSGPQLHSGDMLR 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 683 | ||||||
| TAIR|locus:2197414 | 625 | AT1G11050 [Arabidopsis thalian | 0.838 | 0.916 | 0.693 | 3.6e-215 | |
| TAIR|locus:2066390 | 617 | RKF3 "receptor-like kinase in | 0.768 | 0.850 | 0.380 | 1.5e-92 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.445 | 0.282 | 0.442 | 7.5e-64 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.456 | 0.321 | 0.437 | 5.5e-63 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.434 | 0.424 | 0.437 | 4.8e-62 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.477 | 0.5 | 0.411 | 1.6e-61 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.434 | 0.286 | 0.436 | 5.4e-61 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.420 | 0.608 | 0.438 | 7.1e-61 | |
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.477 | 0.346 | 0.391 | 1.8e-60 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.462 | 0.488 | 0.412 | 9.9e-60 |
| TAIR|locus:2197414 AT1G11050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2079 (736.9 bits), Expect = 3.6e-215, P = 3.6e-215
Identities = 408/588 (69%), Positives = 465/588 (79%)
Query: 65 NNKNPCCLSLLSLYGVAFAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYC 124
++KN CC SLL+L G+ A LK+T+ FRLPNL TS+SCL + QTKLS+ SLS L S C
Sbjct: 52 DSKNSCCQSLLTLIGIPLAHRLKQTSNFRLPNLATSISCLNNLQTKLSSLSLSSNLTSLC 111
Query: 125 LDPFHFVTSRNKCASIESLQDWKSKLGGSTQLDSSCKSDLTDLSACDSCVAAGFKVQSQL 184
DP FV + CA I++ QDW S+LG ST LDS+C S LTDL+ CD+CVAAGF+VQ QL
Sbjct: 112 FDPNQFVINNETCAGIQTTQDWVSRLGPSTALDSACSSGLTDLTRCDACVAAGFRVQKQL 171
Query: 185 IAVDGNTSHATDCFYFTILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHS-ALV 243
I +DGN+SH C++F + YAAGIVN+ GPES+ ALSC+F LSL SP+ S KRH+ AL
Sbjct: 172 ITLDGNSSHGVYCYHFVVTYAAGIVNKKGPESDDALSCLFSLSLRSPLNSKKKRHTVALA 231
Query: 244 FGLTGAGVAIFVMFALLGLYFWWDKKLRKRFYXXXXXXXXXXXXXXXRPKLRPNTGSIWF 303
G+TGA V+ L+ LYF RF RPK RPNTGSIWF
Sbjct: 232 LGITGAIFGALVIAGLICLYF--------RFGKAVKGGEVGWEDQGSRPKWRPNTGSIWF 283
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEII 363
KI++LE+AT+ FSQKNFIGRGGFG VYKG+L DG+ +AVKKVIES+FQGDAEF NEVEII
Sbjct: 284 KIEELEKATNNFSQKNFIGRGGFGFVYKGVLPDGSVIAVKKVIESEFQGDAEFRNEVEII 343
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTW 423
SNLKHRNLVPLRGC +VD D+E S+RYLVYDYM NGN+DDHLFP G K PL+W
Sbjct: 344 SNLKHRNLVPLRGCSMVDDDSE--SQRYLVYDYMSNGNLDDHLFPR---GE-TTKMPLSW 397
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
PQRK+IILDVAKGLAYLHYGVKPAIYHRDIK TNILLD DMRARVADFGLAKQSREG+SH
Sbjct: 398 PQRKSIILDVAKGLAYLHYGVKPAIYHRDIKGTNILLDVDMRARVADFGLAKQSREGESH 457
Query: 484 LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543
LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP LITD
Sbjct: 458 LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPNTFLITD 517
Query: 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
W WSLVKAGK +AL+ SLL+E+ NPK IMERF+ VGILCAHV+VALRPTI DALK
Sbjct: 518 WAWSLVKAGKTEEALEQSLLREEGSGLSNPKGIMERFLQVGILCAHVLVALRPTILDALK 577
Query: 604 MLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLR 651
MLEGDIEVPP+PDRP+PL HPS+ D + F ISPALSGLQ+H+GDMLR
Sbjct: 578 MLEGDIEVPPIPDRPVPLAHPSYRMDGNGFTISPALSGLQIHSGDMLR 625
|
|
| TAIR|locus:2066390 RKF3 "receptor-like kinase in in flowers 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.5e-92, P = 1.5e-92
Identities = 211/555 (38%), Positives = 303/555 (54%)
Query: 71 CLSLLSLYGVAFAQHLKETTFFRLPNLPTSVSCLRDFQTKLSAFSLSDKLVSYCLDPFHF 130
C LL + ++ HL++T F LP ++ SC Q+ ++ F + S C F
Sbjct: 46 CQYLLQGLRLLYSHHLRQTGSF-LPPPESAASCWAALQSSVAGFLPRFDVRSTC--GFQT 102
Query: 131 VTSRNKCASIESLQDWKSKLGGSTQLDSS--CKSDLTDLSACDSCVAAGFKVQSQLIAVD 188
C I + ++S + S+ ++ C + L + C SC + Q L
Sbjct: 103 PWISQGCMDITTRSQFESLIPNSSLATTAMRCNTSLESNTPCASCTQSLSAFQPYLSGPS 162
Query: 189 -GNTSHATDCFYFTILYAAGIVNEFGPESNGALSCIFGLSLMSPMKSSNKRHSALVFGLT 247
GN S DC F +YAA N GP G C+F L L SP S + LV +
Sbjct: 163 LGNVS---DCASFPSIYAAAFANSLGPTDKGTAKCLFQLDLASPTSSGANKVKVLVSSFS 219
Query: 248 GAGVAIFVMFALLGLYFWWDKKLRKRFYXXXXXXXXXXXXXXXRPKLRPNTGSIWFKIQD 307
V + ++ +FW+ ++ + + + +T + F +
Sbjct: 220 ---VLLVASVLVITAWFWYCRRKKSKLLKPRDTSLEAGTQSRL-DSMSESTTLVKFSFDE 275
Query: 308 LERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK 367
+++AT+ FS+ N IGRGG+G V+KG L DGT VA K+ GDA F +EVE+I++++
Sbjct: 276 IKKATNNFSRHNIIGRGGYGNVFKGALPDGTQVAFKRFKNCSAGGDANFAHEVEVIASIR 335
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H NL+ LRG C E G +R +V D + NG++ DHLF G + L WP R+
Sbjct: 336 HVNLLALRGYCTATTPYE-GHQRIIVCDLVSNGSLHDHLF-------GDLEAQLAWPLRQ 387
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
I L +A+GLAYLHYG +P+I HRDIKA+NILLD A+VADFGLAK + EG +H++TR
Sbjct: 388 RIALGMARGLAYLHYGAQPSIIHRDIKASNILLDERFEAKVADFGLAKFNPEGMTHMSTR 447
Query: 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547
VAGT GY+APEYALYGQLTEKSDVYSFGVV+LE++ RKA+ G P + + DW WS
Sbjct: 448 VAGTMGYVAPEYALYGQLTEKSDVYSFGVVLLELLSRRKAIVTDEEGQPVS--VADWAWS 505
Query: 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607
LV+ G Q LD + ED P ++E++VL+ +LC+H + RPT+ +KMLE
Sbjct: 506 LVREG---QTLD---VVEDGMPEKGPPEVLEKYVLIAVLCSHPQLHARPTMDQVVKMLES 559
Query: 608 -DIEVPPLPDRPMPL 621
+ V +P RP+PL
Sbjct: 560 NEFTVIAIPQRPIPL 574
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 644 (231.8 bits), Expect = 7.5e-64, Sum P(2) = 7.5e-64
Identities = 147/332 (44%), Positives = 200/332 (60%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
F ++ L+ ATD F+ N IG GGFG VYKG L +GT +AVKK+ QG+ EF NE+ I
Sbjct: 665 FSLRQLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGI 724
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
I+ L+H NLV L GCCV E+ ++ LVY+Y+ N + D LF SG+ L
Sbjct: 725 IACLQHPNLVKLYGCCV-----EK-TQLLLVYEYLENNCLADALFGR----SGLK---LD 771
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
W R I L +A+GLA+LH I HRDIK TNILLD D+ ++++DFGLA+ + QS
Sbjct: 772 WRTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQS 831
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL-I 541
H+TTRVAGT GY+APEYA+ G LTEK+DVYSFGVV +EI+ G+ + + C+ +
Sbjct: 832 HITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNE--CCVGL 889
Query: 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601
DW + L K G + LDP L D + ER + V +LC+ LRPT+S+
Sbjct: 890 LDWAFVLQKKGAFDEILDPKLEGVFDVMEA------ERMIKVSLLCSSKSPTLRPTMSEV 943
Query: 602 LKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTF 633
+KMLEG+ E+ + + P YGD+ F
Sbjct: 944 VKMLEGETEIEEI------ISDPGAYGDELRF 969
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 5.5e-63, P = 5.5e-63
Identities = 150/343 (43%), Positives = 203/343 (59%)
Query: 292 PKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ 351
P LR TGS F ++ L+ AT+ F N IG GGFG VYKG L DGT +AVKK+ Q
Sbjct: 621 PDLR--TGS--FSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQ 676
Query: 352 GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
G+ EF NE+ +I+ L+H NLV L GCCV E+ ++ LVY+Y+ N + D LF
Sbjct: 677 GNKEFVNEIGMIACLQHPNLVKLYGCCV-----EK-NQLLLVYEYLENNCLSDALFA--- 727
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471
G K L W R I L +A+GLA+LH I HRDIK TN+LLD D+ ++++DF
Sbjct: 728 -GRSCLK--LEWGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDF 784
Query: 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531
GLA+ + QSH+TTRVAGT GY+APEYA+ G LTEK+DVYSFGVV +EI+ G+ +
Sbjct: 785 GLARLHEDNQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKS--NAK 842
Query: 532 TSGSPRACL-ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHV 590
+ C+ + DW + L K G + + LDP L D + ER + V +LCA+
Sbjct: 843 YTPDDECCVGLLDWAFVLQKKGDIAEILDPRLEGMFDVMEA------ERMIKVSLLCANK 896
Query: 591 MVALRPTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTF 633
LRP +S +KMLEG+ E+ + + P Y D+ F
Sbjct: 897 SSTLRPNMSQVVKMLEGETEIEQI------ISDPGVYSDNLHF 933
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 4.8e-62, Sum P(3) = 4.8e-62
Identities = 141/322 (43%), Positives = 187/322 (58%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
F ++L AT FS+ +G+GGFG V+KGIL +G +AVK + QG+ EF EVEI
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVEI 383
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
IS + HR+LV L G C + G +R LVY+++PN ++ HL + SG +
Sbjct: 384 ISRVHHRHLVSLVGYC-----SNAGGQRLLVYEFLPNDTLEFHL----HGKSGTV---MD 431
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
WP R I L AKGLAYLH P I HRDIKA+NILLD + A+VADFGLAK S++ +
Sbjct: 432 WPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNT 491
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542
H++TRV GT GYLAPEYA G+LTEKSDV+SFGV++LE++ GR +DLS G L+
Sbjct: 492 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLS--GDMEDSLV- 548
Query: 543 DWVWSL----VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598
DW L + G+ + +DP L E + P M R V RP +
Sbjct: 549 DWARPLCMRVAQDGEYGELVDPFL--EHQY---EPYE-MARMVACAAAAVRHSGRRRPKM 602
Query: 599 SDALKMLEGDIEVPPLPDRPMP 620
S ++ LEGD + L D P
Sbjct: 603 SQIVRTLEGDASLDDLDDGVKP 624
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 1.6e-61, Sum P(2) = 1.6e-61
Identities = 144/350 (41%), Positives = 201/350 (57%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
F ++L RAT+ FS+ N +G+GGFG V+KGIL G VAVK++ QG+ EF EVEI
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP-L 421
IS + HR+LV L G C+ G +R LVY+++PN N++ HL G G RP +
Sbjct: 328 ISRVHHRHLVSLIGYCMA------GVQRLLVYEFVPNNNLEFHLH-----GKG---RPTM 373
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
W R I L AKGL+YLH P I HRDIKA+NIL+D A+VADFGLAK + +
Sbjct: 374 EWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTN 433
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541
+H++TRV GT GYLAPEYA G+LTEKSDV+SFGVV+LE++ GR+ +D + + +
Sbjct: 434 THVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS--L 491
Query: 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601
DW L+ + D L + + + M R V C RP +S
Sbjct: 492 VDWARPLLNRAS--EEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQI 549
Query: 602 LKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLR 651
++ LEG++ + L + P GH + Y S++G S Q + DM++
Sbjct: 550 VRALEGNVSLSDLNEGMRP-GHSNVY---SSYGGSTDYDTSQ-YNDDMIK 594
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 631 (227.2 bits), Expect = 5.4e-61, P = 5.4e-61
Identities = 141/323 (43%), Positives = 198/323 (61%)
Query: 298 TGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFC 357
TGS F ++ ++RAT+ F +N IG GGFG VYKG+L DG T+AVK++ QG+ EF
Sbjct: 652 TGS--FTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFV 709
Query: 358 NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA 417
E+ +IS L+H NLV L GCC+ G E LVY+Y+ N ++ LF G+
Sbjct: 710 TEIGMISALQHPNLVKLYGCCI------EGKELLLVYEYLENNSLARALF-----GTEKQ 758
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
+ L W R + + +AKGLAYLH + I HRDIKATN+LLD + A+++DFGLAK
Sbjct: 759 RLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLD 818
Query: 478 REGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537
E +H++TR+AGT GY+APEYA+ G LT+K+DVYSFGVV LEI+ G+ +T+ P+
Sbjct: 819 EEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKS----NTNYRPK 874
Query: 538 ACLI--TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR 595
I DW + L + G + + +DP L S + K M R + + +LC + LR
Sbjct: 875 EEFIYLLDWAYVLQEQGSLLELVDPDL-----GTSFSKKEAM-RMLNIALLCTNPSPTLR 928
Query: 596 PTISDALKMLEGDIEV-PPLPDR 617
P +S + ML+G I+V PPL R
Sbjct: 929 PPMSSVVSMLQGKIKVQPPLVKR 951
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 7.1e-61, P = 7.1e-61
Identities = 135/308 (43%), Positives = 192/308 (62%)
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVE 361
W+ +++LE AT+ ++N IG GG+G+VY+GIL DGT VAVK ++ + Q + EF EVE
Sbjct: 141 WYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVE 200
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
+I ++H+NLV L G CV G+ R LVYD++ NGN++ + D S PL
Sbjct: 201 VIGRVRHKNLVRLLGYCV------EGAYRMLVYDFVDNGNLEQWIHGDVGDVS-----PL 249
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
TW R NIIL +AKGLAYLH G++P + HRDIK++NILLD A+V+DFGLAK
Sbjct: 250 TWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSES 309
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLST-SGSPRACL 540
S++TTRV GT GY+APEYA G L EKSD+YSFG++I+EI+ GR +D S G
Sbjct: 310 SYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETN--- 366
Query: 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600
+ DW+ S+V + + +DP + + + KA+ +R +LV + C RP +
Sbjct: 367 LVDWLKSMVGNRRSEEVVDPKIPEPP-----SSKAL-KRVLLVALRCVDPDANKRPKMGH 420
Query: 601 ALKMLEGD 608
+ MLE +
Sbjct: 421 IIHMLEAE 428
|
|
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 578 (208.5 bits), Expect = 1.8e-60, Sum P(3) = 1.8e-60
Identities = 139/355 (39%), Positives = 202/355 (56%)
Query: 299 GSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD--AEF 356
G++ IQ L T+ FS N +G GGFG+VYKG L DGT +AVK++ G AEF
Sbjct: 572 GNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRMENGVIAGKGFAEF 631
Query: 357 CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGV 416
+E+ +++ ++HR+LV L G C+ D G+E+ LVY+YMP G + HLF +G
Sbjct: 632 KSEIAVLTKVRHRHLVTLLGYCL---D---GNEKLLVYEYMPQGTLSRHLFEWSEEGL-- 683
Query: 417 AKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476
+PL W QR + LDVA+G+ YLH + HRD+K +NILL DMRA+VADFGL +
Sbjct: 684 --KPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRL 741
Query: 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536
+ EG+ + TR+AGT GYLAPEYA+ G++T K DVYSFGV+++E++ GRK+LD S P
Sbjct: 742 APEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDES---QP 798
Query: 537 RACL-ITDWVWSLV--KAGKVWQALDPSL-LKEDDFLSLNPKAIMERFVLVGILCAHVMV 592
+ + W + K +A+D ++ L E+ S++ + E L G CA
Sbjct: 799 EESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVH--TVAE---LAGHCCAREPY 853
Query: 593 ALRPTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTG 647
RP + A+ +L +E+ +P YG D + AL Q + G
Sbjct: 854 Q-RPDMGHAVNILSSLVELW----KPSDQNPEDIYGIDLDMSLPQALKKWQAYEG 903
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 9.9e-60, Sum P(2) = 9.9e-60
Identities = 139/337 (41%), Positives = 194/337 (57%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
F ++L RAT+ FS+ N +G+GGFG V+KG+L G VAVK++ QG+ EF EVEI
Sbjct: 263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEI 322
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP-L 421
IS + HR+LV L G C+ G++R LVY+++PN N++ HL G G RP +
Sbjct: 323 ISRVHHRHLVSLVGYCIA------GAKRLLVYEFVPNNNLELHLH-----GEG---RPTM 368
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
W R I L AKGL+YLH P I HRDIKA+NIL+D A+VADFGLAK + +
Sbjct: 369 EWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTN 428
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541
+H++TRV GT GYLAPEYA G+LTEKSDV+SFGVV+LE++ GR+ +D + + +
Sbjct: 429 THVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS--L 486
Query: 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601
DW L+ + D L + + + M R V C RP +S
Sbjct: 487 VDWARPLLNRAS--EQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQI 544
Query: 602 LKMLEGDIEVPPLPD--RPMPLGHPSFYGDDSTFGIS 636
++ LEG++ + L + RP S YG + + S
Sbjct: 545 VRALEGNVSLSDLNEGMRPGQSNVYSSYGGSTDYDSS 581
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O04086 | Y1105_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6751 | 0.8916 | 0.9744 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_II002215 | hypothetical protein (652 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 683 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 6e-49
Identities = 76/209 (36%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVI--ESDFQGDAEFCNEVEIISNLKHRNLVPLRGC 377
+G G FG VYK + G VAVK + + D E+ I+ L H N+V L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
E YLV +Y G++ D+L PL+ + K I L + +GL
Sbjct: 67 F------EDKDHLYLVMEYCEGGDLFDYL---------SRGGPLSEDEAKKIALQILRGL 111
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
YLH I HRD+K NILLD + ++ADFGLAK+ + S LTT V GT Y+AP
Sbjct: 112 EYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAP 167
Query: 498 EYALYGQL-TEKSDVYSFGVVILEIMCGR 525
E L G K DV+S GV++ E++ G+
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 315 FSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRNLV 372
+ +G G FG VY + G VA+K + + + D E E++I+ LKH N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L + YLV +Y G++ D L + L+ + + +
Sbjct: 61 RLYDVFEDEDK------LYLVMEYCEGGDLFDLL---------KKRGRLSEDEARFYLRQ 105
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ L YLH I HRD+K NILLD D ++ADFGLA+Q G+ LTT V GT
Sbjct: 106 ILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFV-GTP 160
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
Y+APE L + D++S GV++ E++ G+
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 4e-47
Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 321 IGRGGFGLVYKGILQDG----TTVAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVPLR 375
+G G FG VYKG L+ T VAVK + E + + +F E ++ L H N+V L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C + YLV +YM G++ D+L S K L+ + + +AK
Sbjct: 63 GVCTEEEPL------YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG-- 493
G+ YL HRD+ A N L+ D+ +++DFGL++ + + T G
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKL 169
Query: 494 ---YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
++APE G T KSDV+SFGV++ EI
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 75/205 (36%), Positives = 108/205 (52%), Gaps = 22/205 (10%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRNLVPLRGCC 378
+G GGFG VY + G VA+K + + D E E+EI+ L H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
E + YLV +Y G++ D L + + L+ + I+L + +GL
Sbjct: 61 ------EDENHLYLVMEYCEGGSLKDLLKEN--------EGKLSEDEILRILLQILEGLE 106
Query: 439 YLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
YLH I HRD+K NILLD+D + ++ADFGL+K +S L T V GT Y+AP
Sbjct: 107 YLH--SNG-IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAP 162
Query: 498 EYAL-YGQLTEKSDVYSFGVVILEI 521
E L G +EKSD++S GV++ E+
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 9e-46
Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 314 KFSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKV-IESDFQGDAEFCNEVEIISNLK 367
+K +G G FG VYKG L+ VAVK + ++ Q EF E I+ L
Sbjct: 2 TLGKK--LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N+V L G C + Y+V +YM G++ +L + L+
Sbjct: 60 HPNVVKLLGVCTEEE------PLYIVMEYMEGGDLLSYL--------RKNRPKLSLSDLL 105
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+ L +A+G+ YL K I HRD+ A N L+ ++ +++DFGL SR+ R
Sbjct: 106 SFALQIARGMEYLE--SKNFI-HRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYR 159
Query: 488 VAGTHG---YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
G ++APE G+ T KSDV+SFGV++ EI
Sbjct: 160 KRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 314 KFSQKNFIGRGGFGLVYKGILQDG-----TTVAVKKV-IESDFQGDAEFCNEVEIISNLK 367
+K +G G FG VYKG L+ VAVK + ++ Q EF E I+ L
Sbjct: 2 TLGKK--LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N+V L G C + +V +YMP G++ D+L + L+
Sbjct: 60 HPNIVKLLGVCTEEE------PLMIVMEYMPGGDLLDYL-------RKNRPKELSLSDLL 106
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+ L +A+G+ YL K I HRD+ A N L+ ++ +++DFGL SR+ +
Sbjct: 107 SFALQIARGMEYLE--SKNFI-HRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYK 160
Query: 488 VAGTHG---YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
V G ++APE G+ T KSDV+SFGV++ EI
Sbjct: 161 VKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 72/215 (33%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 321 IGRGGFGLVYKGIL-----QDGTTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG VYKG L T VAVK + E + + EF E I+ L H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G C +G Y+V +YMP G++ D L LT + L +A
Sbjct: 67 LGVCT------QGEPLYIVTEYMPGGDLLDFL--------RKHGEKLTLKDLLQMALQIA 112
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
KG+ YL K + HRD+ A N L+ ++ +++DFGL++ E + G
Sbjct: 113 KGMEYLE--SKNFV-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGK 165
Query: 495 L-----APEYALYGQLTEKSDVYSFGVVILEIMCG 524
L APE G+ T KSDV+SFGV++ EI
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-38
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 319 NFIGRGGFGLVYKGILQD-GTTVAVKKVI--ESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+GRG FG VY + +D G +AVK V + E+ I+S+L+H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHL--FPSFNDGSGVAKRPLTWPQRKNIILDV 433
G +E + + +Y+ G++ L F + P + +
Sbjct: 66 GSER----DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-----------PVIRKYTRQI 110
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR-VAGTH 492
+GLAYLH I HRDIK NIL+D+D ++ADFG AK+ + ++ T V GT
Sbjct: 111 LEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
++APE + +D++S G ++E+ G+
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 77/259 (29%), Positives = 117/259 (45%), Gaps = 34/259 (13%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
F IG+GGFG VYK + G VA+K + + + NE++I+ KH N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
G + E ++V ++ G++ D L S N + LT Q + +
Sbjct: 61 KYYGSYLKKD------ELWIVMEFCSGGSLKD-LLKSTN-------QTLTESQIAYVCKE 106
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-SREGQSHLTTRVAGT 491
+ KGL YLH I HRDIKA NILL +D ++ DFGL+ Q S + + GT
Sbjct: 107 LLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGT 160
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-STSGSPRACLI 541
++APE K+D++S G+ +E+ G+ KAL +T+G P L
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG--LR 218
Query: 542 TDWVWSLVKAGKVWQALDP 560
WS + + L
Sbjct: 219 NPEKWSDEFKDFLKKCLQK 237
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRN 370
+ + IGRG FG+VYKG+ L+ G VA+K++ + +A E++++ NLKH N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR--PLTWPQRKN 428
+V G E Y++ +Y NG++ + K+ P
Sbjct: 61 IVKYIGSI------ETSDSLYIILEYAENGSL-----------RQIIKKFGPFPESLVAV 103
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+ V +GLAYLH + + HRDIKA NIL D ++ADFG+A + + S V
Sbjct: 104 YVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASV 159
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT ++APE + SD++S G ++E++ G
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 72/202 (35%), Positives = 109/202 (53%), Gaps = 24/202 (11%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRNLVPLRGCCV 379
IG+G FG V G + G VAVK + D A+ F E +++ L+H NLV L G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCL--KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
+G+ Y+V +YM G++ D+L + G V +T Q+ LDV +G+ Y
Sbjct: 71 ------QGNPLYIVTEYMAKGSLVDYLR---SRGRAV----ITLAQQLGFALDVCEGMEY 117
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEY 499
L + HRD+ A N+L+ D+ A+V+DFGLAK++ +GQ V T APE
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEA 170
Query: 500 ALYGQLTEKSDVYSFGVVILEI 521
+ + KSDV+SFG+++ EI
Sbjct: 171 LREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 85/297 (28%), Positives = 126/297 (42%), Gaps = 73/297 (24%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEF----CNEVEIISNLKHRNLVPLR 375
IG G +G VYK + G VA+KK+ + F E++++ L+H N+V L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP---LTWPQRKNIILD 432
+GS Y+V++YM + D +G+ P T Q K +
Sbjct: 65 EIVT---SKGKGS-IYMVFEYMDH------------DLTGLLDSPEVKFTESQIKCYMKQ 108
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-KQSREGQSHLTTRVAGT 491
+ +GL YLH I HRDIK +NIL++ D ++ADFGLA ++ + T RV T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 492 HGYLAPEYAL----YGQLTEKSDVYSFGVVILE------IMCGRKALD-----LSTSGSP 536
Y PE L YG + D++S G ++ E I G L+ GSP
Sbjct: 165 LWYRPPELLLGATRYG---PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 537 RACLITDWVWSLVKAGKVWQALDP-----SLLKE--------------DDFLSLNPK 574
TD W V ++ L P L+E D L+L+PK
Sbjct: 222 -----TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPK 273
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 30/223 (13%)
Query: 314 KFSQKNFIGRGGFGLVYKG-ILQDGTTVAVKKV-IESDFQGDAEFC-NEVEIISNLKHRN 370
K+ IG+G FG VY DG +K++ + + + + E NEV+I+ L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
++ + +V +Y G++ + +P Q +
Sbjct: 61 IIKYYES-FEEKGK-----LCIVMEYADGGDLSQKI-----KKQKKEGKPFPEEQILDWF 109
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ + L YLH I HRDIK NI L ++ ++ DFG++K T V G
Sbjct: 110 VQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-G 165
Query: 491 THGYLAPE------YALYGQLTEKSDVYSFGVVILEIMCGRKA 527
T YL+PE Y KSD++S G V+ E+ +
Sbjct: 166 TPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 321 IGRGGFGLVYKGIL------QDGTTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVP 373
+G G FG V+ G D VAVK + E + +F E E+++N +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF---PSFN--DGSGVAKRPLTWPQRKN 428
G C G +V++YM +G+++ L P LT Q
Sbjct: 73 FYGVCT------EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 429 IILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
I + +A G+ YL H+ HRD+ N L+ D+ ++ DFG+ SR+ +
Sbjct: 127 IAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGM---SRDVYTTDY 177
Query: 486 TRVAGTH----GYLAPEYALYGQLTEKSDVYSFGVVILEI 521
RV G ++ PE +Y + T +SDV+SFGVV+ EI
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 71/208 (34%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G G FG V+ G T VAVK + +A F E +I+ L+H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVC-- 70
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
Y+V +YM G++ D L G G L PQ ++ +A+G+AYL
Sbjct: 71 ----SEEEPIYIVTEYMSKGSLLDFL----KSGEGKK---LRLPQLVDMAAQIAEGMAYL 119
Query: 441 ---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH---GY 494
+Y HRD+ A NIL+ ++ ++ADFGLA+ + T R G +
Sbjct: 120 ESRNY------IHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAR-EGAKFPIKW 170
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIM 522
APE A YG+ T KSDV+SFG+++ EI+
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 9e-27
Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 320 FIGRGGFGLVYKGILQDGTTVAVKKV---IESDFQGDAEFCNEVEIISNLKH-RNLVPLR 375
+G G FG VY +D VA+K + +ES + F E++I+++L H N+V L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
+G YLV +Y+ G+++D L K PL+ + I+ +
Sbjct: 65 DFFQDEGSL------YLVMEYVDGGSLEDLL------KKIGRKGPLSESEALFILAQILS 112
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQSREGQSHLTTR-----VA 489
L YLH I HRDIK NILLD D ++ DFGLAK + S +
Sbjct: 113 ALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 490 GTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536
GT GY+APE L + SD++S G+ + E++ G + + S
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 72/245 (29%), Positives = 109/245 (44%), Gaps = 30/245 (12%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
I + + IG G G VYK G VA+KK+ Q NE+ I
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILI 68
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+ + KH N+V +V E ++V +YM G++ D + +F +
Sbjct: 69 MKDCKHPNIVDYYDSYLVGD------ELWVVMEYMDGGSLTDIITQNFVR--------MN 114
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
PQ + +V +GL YLH + HRDIK+ NILL D ++ADFG A Q + +S
Sbjct: 115 EPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-ST 532
+ V GT ++APE K D++S G++ +E+ G +AL L +T
Sbjct: 172 KRNSVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT 230
Query: 533 SGSPR 537
G P
Sbjct: 231 KGIPP 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 25/219 (11%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL 366
+++R + + +K +G G FG V++G+ + T VAVK ++ +F E +I+ L
Sbjct: 2 EIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKT-LKPGTMDPKDFLAEAQIMKKL 58
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H L+ L C Y+V + M G++ ++L G A R L PQ
Sbjct: 59 RHPKLIQLYAVCT------LEEPIYIVTELMKYGSLLEYL-------QGGAGRALKLPQL 105
Query: 427 KNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
++ VA G+AYL +Y HRD+ A N+L+ + +VADFGLA+ +E
Sbjct: 106 IDMAAQVASGMAYLEAQNY------IHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159
Query: 484 LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ APE ALY + + KSDV+SFG+++ EI+
Sbjct: 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPLRGCC 378
+G G +G VYK I + G VA+K V +E D Q E E+ I+ +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+ D ++V +Y G S +D + + LT + I+ KGL
Sbjct: 68 FKNTD------LWIVMEYCGAG--------SVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
YLH HRDIKA NILL+ + +A++ADFG++ Q + + T V GT ++APE
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPE 169
Query: 499 YALYGQLTEKSDVYSFGVVILEIMCGR 525
K+D++S G+ +E+ G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 70/245 (28%), Positives = 120/245 (48%), Gaps = 31/245 (12%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH 368
ER ++F+ + +G G FG V++G+ ++ VA+K + D +F EV+ + L+H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
++L+ L C G Y++ + M G++ L G + L +
Sbjct: 62 KHLISLFAVC------SVGEPVYIITELMEKGSLLAFL----RSPEG---QVLPVASLID 108
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+ VA+G+AYL + HRD+ A NIL+ D+ +VADFGLA+ +E +L++
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDK 164
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI----------MCGRKALDLSTSG---- 534
+ + APE A +G + KSDV+SFG+++ E+ M + D T+G
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP 224
Query: 535 SPRAC 539
P C
Sbjct: 225 CPAKC 229
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVPLRGCCV 379
IG+G FG VYKG+L+ T VAVK + +F E EI+ H N+V L G CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
+ Y+V + +P G++ L N LT + + LD A G+ Y
Sbjct: 63 ------QKQPIYIVMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEY 108
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH----GYL 495
L K I HRD+ A N L+ + +++DFG+ SRE + + T G +
Sbjct: 109 LE--SKNCI-HRDLAARNCLVGENNVLKISDFGM---SREEEGGIYTVSDGLKQIPIKWT 162
Query: 496 APEYALYGQLTEKSDVYSFGVVILEI 521
APE YG+ T +SDV+S+G+++ E
Sbjct: 163 APEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 79/227 (34%), Positives = 116/227 (51%), Gaps = 43/227 (18%)
Query: 319 NFIGRGGFGLVYKG----ILQDGT---TVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRN 370
NF+G G FG VY+G IL G+ VAVK + + + Q EF E ++SN H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP---LTWPQRK 427
+V L G C+ NE +Y++ + M G++ S+ + V + LT +
Sbjct: 61 IVKLLGVCL---LNE---PQYIIMELMEGGDL-----LSYLRDARVERFGPPLLTLKELL 109
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILL-----DADMRARVADFGLAKQ------ 476
+I LDVAKG YL + HRD+ A N L+ DAD ++ DFGLA+
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 477 -SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+EG+ L R ++APE L G+ T +SDV+SFGV++ EI+
Sbjct: 167 YRKEGEGLLPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-----DAEFCNEVEIISNLKH 368
F N IG+G FG+V+K + + D A+K++ D E +E +++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQI---DLSKMNRREREEAIDEARVLAKLDS 58
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
++ + G + +V +Y NG++ L RPL Q
Sbjct: 59 SYIIRYYESFLDKG------KLNIVMEYAENGDLHKLL-------KMQRGRPLPEDQVWR 105
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+ + GLA+LH I HRDIK+ N+ LDA ++ D G+AK ++ +
Sbjct: 106 FFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTI 161
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535
GT YL+PE EKSDV++ GVV+ E G+ D + G+
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 36/228 (15%)
Query: 314 KFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIES-DFQGDAEFCNEVEIISNL 366
+F ++ +G G FG VYKG L T+VA+K + E+ + + EF E E++S+L
Sbjct: 8 RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF-------PSFNDGSGVAKR 419
+H N+V L G C + ++++Y+ +G++ + L G K
Sbjct: 66 QHPNIVCLLGVCTKEQPT------CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 420 PLTWPQRKNIILDVAKGLAYL--HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
L +I + +A G+ YL H+ V HRD+ A N L+ + +++DFGL S
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGL---S 171
Query: 478 REGQSHLTTRVAGTH----GYLAPEYALYGQLTEKSDVYSFGVVILEI 521
R+ S RV ++ PE LYG+ T +SD++SFGVV+ EI
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 314 KFSQKNFIGRGGFGLVYKG---ILQDGTT--VAVKKV-IESDFQGDAEFCNEVEIISNLK 367
KF ++ +G G FG V L D T VAVK + + Q ++F E+EI+ L
Sbjct: 7 KFIKQ--LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N+V +G C G G L+ +Y+P+G++ D+L + KR L +
Sbjct: 65 HENIVKYKGVCEKPG----GRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSS-- 116
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+ KG+ YL HRD+ A NIL++++ +++DFGLAK E + + +
Sbjct: 117 ----QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169
Query: 488 VAGTHG--YLAPEYALYGQLTEKSDVYSFGVVILEI 521
G + APE + + SDV+SFGV + E+
Sbjct: 170 EPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 70/201 (34%), Positives = 100/201 (49%), Gaps = 24/201 (11%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
IG G FG V +G G VAVK I+ D A F E +++ L H+NLV L G +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVK-NIKCDVTAQA-FLEETAVMTKLHHKNLVRLLGVILH 70
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
+G Y+V + M GN+ +F G A + Q LDVA+G+ YL
Sbjct: 71 NG-------LYIVMELMSKGNL-----VNFLRTRGRALVSV--IQLLQFSLDVAEGMEYL 116
Query: 441 HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA 500
+ HRD+ A NIL+ D A+V+DFGLA+ G + V T APE
Sbjct: 117 E---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEAL 169
Query: 501 LYGQLTEKSDVYSFGVVILEI 521
+ + + KSDV+S+GV++ E+
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK---KVI--ESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG VYKG+ + +G V + KV+ E+ + + E +E +++++ H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G C+ S+ L+ MP G + D++ + + ++ L W + +A
Sbjct: 75 LGICL-------SSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWC------VQIA 119
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH-- 492
KG++YL + + HRD+ A N+L+ ++ DFGLAK + G
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVP 174
Query: 493 -GYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
++A E L+ T KSDV+S+GV + E+M
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVP 373
Q+ IG G FGLV+ G + VA+K + E + +F E +++ L H LV
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQ 63
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G C S LV+++M +G + D+L G + L + LDV
Sbjct: 64 LYGVCT------ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLL------GMCLDV 109
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
+G+AYL + HRD+ A N L+ + +V+DFG+ + + Q +T
Sbjct: 110 CEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEI 521
+ +PE + + + KSDV+SFGV++ E+
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRN 370
+ F+ IG+G FG VYK I + VA+K + +E + E++ +S +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+ G + +GS+ +++ +Y G+ D L P L I+
Sbjct: 61 ITKYYGSFL------KGSKLWIIMEYCGGGSCLDLLKPG----------KLDETYIAFIL 104
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+V GL YLH K HRDIKA NILL + ++ADFG++ Q S T V G
Sbjct: 105 REVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-G 160
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
T ++APE EK+D++S G+ +E+ G
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G G FG V+ G T VAVK + ++ F E +I+ L+H LV L VV
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYA--VV 70
Query: 381 DGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
SE Y+V +YM G++ D L DG G R L P ++ VA G+A
Sbjct: 71 -------SEEPIYIVTEYMSKGSLLDFL----KDGEG---RALKLPNLVDMAAQVAAGMA 116
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
Y+ + HRD+++ NIL+ + ++ADFGLA+ + + + APE
Sbjct: 117 YIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 499 YALYGQLTEKSDVYSFGVVILEIM 522
ALYG+ T KSDV+SFG+++ E++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 320 FIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC-----NEVEIISNLKHRNLVP 373
+G G FG VY+G+ L DG AVK+V +D + E+ ++S L+H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 374 LRGCCVVDGDNERGSER-YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
G ER + Y+ + +P G++ L + P +
Sbjct: 67 YLG-------TEREEDNLYIFLELVPGGSLAK-LLKKYG--------SFPEPVIRLYTRQ 110
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ GL YLH HRDIK NIL+D + ++ADFG+AKQ E S + G+
Sbjct: 111 ILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKS-FKGSP 165
Query: 493 GYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
++APE G +D++S G +LE+ G+
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 33/213 (15%)
Query: 321 IGRGGFGLVYKGILQ----DGTTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
IG G FG V +G L+ VA+K K SD Q +F E I+ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ-RLDFLTEASIMGQFDHPNIIRL 70
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G VV + ++ +YM NG++D L NDG T Q ++ +A
Sbjct: 71 EG--VV----TKSRPVMIITEYMENGSLDKFL--RENDGK------FTVGQLVGMLRGIA 116
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR-----VA 489
G+ YL + HRD+ A NIL+++++ +V+DFGL+++ + ++ TT+ +
Sbjct: 117 SGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
T APE Y + T SDV+SFG+V+ E+M
Sbjct: 174 WT----APEAIAYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKV-IESDFQGDAEFCNEVEIIS 364
DLER +G+G G+VYK + G A+KK+ ++ D + + E++ +
Sbjct: 2 DLER-------VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLR 54
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
+ + +V G +G E +V +YM G++ D + K+ P
Sbjct: 55 SCESPYVVKCYGAFYKEG------EISIVLEYMDGGSLAD-----------LLKKVGKIP 97
Query: 425 QR--KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
+ I + KGL YLH I HRDIK +N+L+++ ++ADFG++K
Sbjct: 98 EPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155
Query: 483 HLTTRVAGTHGYLAPEY---ALYGQLTEKSDVYSFGVVILEIMCGR 525
T V GT Y++PE Y +D++S G+ +LE G+
Sbjct: 156 QCNTFV-GTVTYMSPERIQGESYSY---AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 72/233 (30%), Positives = 113/233 (48%), Gaps = 30/233 (12%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISN 365
++ER TD + K+ +G G +G VY+G+ + TVAVK + E + + EF E ++
Sbjct: 2 EMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 58
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
+KH NLV L G C R Y++ ++M GN+ D+L + V L +
Sbjct: 59 IKHPNLVQLLGVCT------REPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLY-- 108
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ ++ + YL K HRD+ A N L+ + +VADFGL++
Sbjct: 109 ---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTY 159
Query: 486 TRVAGTH---GYLAPEYALYGQLTEKSDVYSFGVVILEI----MCGRKALDLS 531
T AG + APE Y + + KSDV++FGV++ EI M +DLS
Sbjct: 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 94/318 (29%), Positives = 136/318 (42%), Gaps = 49/318 (15%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC--NEVEIISNLKHRN 370
+ K +G G FG VYK ++ G VA+KK++ + + E++I+ LKH N
Sbjct: 11 EILGK--LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 371 LVPLRGCCVVDGDNERGS--ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP---LTWPQ 425
+VPL V D + Y+V YM DH D SG+ + P LT Q
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYM------DH------DLSGLLENPSVKLTESQ 116
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-------KQSR 478
K +L + +G+ YLH + I HRDIKA NIL+D ++ADFGLA +
Sbjct: 117 IKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 479 EGQSHLTTRVAG---THGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSG 534
G T + T Y PE L + T D++ G V E+ R L S
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ-GKSD 232
Query: 535 SPRACLITDWVWSLVKAG-KVWQALDPSLLKEDDFLSLN-PKAIMERFVLVGILCAHVMV 592
+ LI + + W++L P E N P+ + ERF +G ++
Sbjct: 233 IDQLHLIFKLCGTPTEETWPGWRSL-PG--CEGVHSFTNYPRTLEERFGKLGPEGLDLLS 289
Query: 593 AL-------RPTISDALK 603
L R T SDAL+
Sbjct: 290 KLLSLDPYKRLTASDALE 307
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 77/286 (26%), Positives = 117/286 (40%), Gaps = 54/286 (18%)
Query: 321 IGRGGFGLVYK-GILQDGTTVAVKKVIESDFQGDAEFC--NEVEIISNLKHRNLVPLRGC 377
IG G G+V+K + G TVA+KKV +G E++ + +H +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
D GS LV +YMP ++ +RPL Q K+ + + KG+
Sbjct: 66 ---DVFPH-GSGFVLVMEYMP---------SDLSEVLRDEERPLPEAQVKSYMRMLLKGV 112
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
AY+H I HRD+K N+L+ AD ++ADFGLA+ E + L + T Y AP
Sbjct: 113 AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
Query: 498 EYALYGQ--LTEKSDVYSFGVVILEIMCGRK-----------ALDLSTSGSPRACLITDW 544
E LYG D+++ G + E++ G A+ T G+P W
Sbjct: 170 EL-LYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE---ETW 225
Query: 545 --VWSLVKAGKV---------WQALDPSLLKE-----DDFLSLNPK 574
+ SL K+ + + P E L +P
Sbjct: 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPS 271
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 22/204 (10%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G+G FG V+ G T VA+K + +A F E +I+ L+H LVPL
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVV-- 70
Query: 381 DGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
SE Y+V ++M G++ D L +G G + L PQ ++ +A G+A
Sbjct: 71 -------SEEPIYIVTEFMGKGSLLDFL----KEGDG---KYLKLPQLVDMAAQIADGMA 116
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
Y+ + HRD++A NIL+ ++ ++ADFGLA+ + + + APE
Sbjct: 117 YIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 499 YALYGQLTEKSDVYSFGVVILEIM 522
ALYG+ T KSDV+SFG+++ E++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 32/231 (13%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G+G FG V+ G T VA+K + +A F E +++ L+H LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVV-- 70
Query: 381 DGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
SE Y+V +YM G++ D L G + L PQ ++ +A G+A
Sbjct: 71 -------SEEPIYIVTEYMSKGSLLDFL-------KGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
Y+ + HRD++A NIL+ ++ +VADFGLA+ + + + APE
Sbjct: 117 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 499 YALYGQLTEKSDVYSFGVVILEI----------MCGRKALDLSTSGSPRAC 539
ALYG+ T KSDV+SFG+++ E+ M R+ LD G C
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRN 370
++ + N IG G FG VY + L G +AVK++ D E +E++++ LKH N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
LV G V R + Y+ +Y G +++ L V +
Sbjct: 61 LVKYYGVEV-----HR-EKVYIFMEYCSGGTLEELLEHGRILDEHVIRV---------YT 105
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV-- 488
L + +GLAYLH I HRDIK NI LD + ++ DFG A + + + + V
Sbjct: 106 LQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162
Query: 489 -AGTHGYLAPEYALYGQLTEK---SDVYSFGVVILEIMCGRK 526
AGT Y+APE G+ +D++S G V+LE+ G++
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 78/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 321 IGRGGFGLVYKGILQD------GTTVAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVP 373
+G+G FG+VY+G+ + T VA+K V E+ + EF NE ++ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL---FPSFNDGSGVAKRPLTWPQRKNII 430
L G G +V + M G++ +L P + G+ P T + +
Sbjct: 74 LLGVV------STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG--PPTLQKFIQMA 125
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-------SREGQSH 483
++A G+AYL HRD+ A N ++ D+ ++ DFG+ + + G+
Sbjct: 126 AEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 484 LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS-PRACLIT 542
L R ++APE G T KSDV+SFGVV+ E+ +T P L
Sbjct: 183 LPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEM---------ATLAEQPYQGLSN 227
Query: 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602
+ V V G LD D L L M C +RPT + +
Sbjct: 228 EEVLKFVIDGGH---LDLPENCPDKLLEL-----MRM-------CWQYNPKMRPTFLEIV 272
Query: 603 KMLE 606
L+
Sbjct: 273 SSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 27/211 (12%)
Query: 321 IGRGGFGLVYK-GILQDGTTVAVK---KVIESDFQGDAEFCNEVEIISNLKHRNLVPLRG 376
+G+G FG V G A+K K + E I+S + H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHL--FPSFNDGSGVAKRPLTWPQRKNIILDVA 434
+ YLV +Y P G + HL F++ A+ ++
Sbjct: 60 YAFQTEEK-----LYLVLEYAPGGELFSHLSKEGRFSEE--RARF---------YAAEIV 103
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
L YLH I +RD+K NILLDAD ++ DFGLAK+ S T GT Y
Sbjct: 104 LALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEY 159
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
LAPE L + D +S GV++ E++ G+
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 32/223 (14%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNLKHR 369
+ IG+G FG V K DG + K+ I+ + E +EV I+ LKH
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKE-IDYGNMTEKEKQQLVSEVNILRELKHP 59
Query: 370 NLVPLRGCCVVDGDNERGSER-YLVYDYMPNGNVDDHLFPSFNDGSGVAKR------PLT 422
N+V D +R ++ Y+V +Y G D + + ++ +
Sbjct: 60 NIVRY-----YDRIIDRSNQTLYIVMEYCEGG-----------DLAQLIQKCKKERKYIE 103
Query: 423 WPQRKNIILDVAKGLAYLHYGV--KPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
I+ + L H + HRD+K NI LDA+ ++ DFGLAK
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC 523
S T V GT Y++PE + EKSD++S G +I E +C
Sbjct: 164 SSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE-LC 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-22
Identities = 74/252 (29%), Positives = 115/252 (45%), Gaps = 48/252 (19%)
Query: 321 IGRGGFGLVY----KGIL--QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG V+ +L QD VAVK + E+ +F E E+++ L+H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFND------GSGVAKRPLTWPQRKN 428
G C G +V++YM +G+++ L D G VA LT Q
Sbjct: 73 YGVCT------EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 429 IILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
I +A G+ YL H+ HRD+ N L+ + ++ DFG+ SR+ S
Sbjct: 127 IASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGM---SRDIYSTDY 177
Query: 486 TRVAGTH----GYLAPEYALYGQLTEKSDVYSFGVVILEI----------MCGRKALDLS 531
RV G ++ PE LY + T +SD++SFGVV+ EI + +A++
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 532 TSG----SPRAC 539
T G PR C
Sbjct: 238 TQGRELERPRTC 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN-----EVEIISNLK 367
++ + +G G + +VYK + G VA+KK+ + + + N E++++ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N++ L S LV+++M + L D S V LT K
Sbjct: 61 HPNIIGLLDVFGHK------SNINLVFEFM-----ETDLEKVIKDKSIV----LTPADIK 105
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+ +L +GL YLH I HRD+K N+L+ +D ++ADFGLA+ +T +
Sbjct: 106 SYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162
Query: 488 VAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIM 522
V T Y APE L+G D++S G + E++
Sbjct: 163 VV-TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 5e-21
Identities = 70/223 (31%), Positives = 111/223 (49%), Gaps = 34/223 (15%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL 366
++ R T K +K +G G FG V+ G T VA+K + + +A F E ++ L
Sbjct: 2 EVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQL 58
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H LV L VV + Y++ +YM NG++ D L +G LT +
Sbjct: 59 QHPRLVRLYA--VVTQE-----PIYIITEYMENGSLVDFLKTP--EGI-----KLTINKL 104
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK-------QSRE 479
++ +A+G+A++ K I HRD++A NIL+ + ++ADFGLA+ +RE
Sbjct: 105 IDMAAQIAEGMAFIE--RKNYI-HRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161
Query: 480 GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
G + APE YG T KSDV+SFG+++ EI+
Sbjct: 162 GAKFPIK-------WTAPEAINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD--AEFCNEVEIISNLKH---RNLVPL 374
IGRG +G VY+G + G VA+K +I D D ++ EV ++S L+ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G + G +++ +Y G+V + P+ II +V
Sbjct: 68 YGSYLK------GPRLWIIMEYAEGGSVRTLMKAG----------PIAEKYISVIIREVL 111
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
L Y+H K + HRDIKA NIL+ ++ DFG+A + S +T V GT +
Sbjct: 112 VALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYW 167
Query: 495 LAPEYALYGQLTE-KSDVYSFGVVILEIMCG 524
+APE G+ + K+D++S G+ I E+ G
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 320 FIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN---EVEIISNLKHRNLVPLR 375
IG G +G+VYK G VA+KK+ F+ + E++++ L H N++ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKL-RFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
V + YLV+++M D +R L K+ + + +
Sbjct: 65 D--VF----RHKGDLYLVFEFM------DTDLYKLIKDR---QRGLPESLIKSYLYQLLQ 109
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
GLA+ H I HRD+K N+L++ + ++ADFGLA+ T V T Y
Sbjct: 110 GLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYR 165
Query: 496 APEYALYG--QLTEKSDVYSFGVVILEIMCGR 525
APE L G + D++S G + E++ R
Sbjct: 166 APE-LLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 321 IGRGGFGLVYKGILQ--DGT--TVAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVPLR 375
+G G FG V KG+ G VAVK + + EF E +++ L H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C G LV + P G + +L +R + K + VA
Sbjct: 63 GVCK-------GEPLMLVMELAPLGPLLKYL---------KKRREIPVSDLKELAHQVAM 106
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG-- 493
G+AYL HRD+ A N+LL +A+++DFG+++ G + A T G
Sbjct: 107 GMAYLE-SKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR---ATTAGRW 160
Query: 494 ---YLAPEYALYGQLTEKSDVYSFGVVILE 520
+ APE YG+ + KSDV+S+GV + E
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 68/221 (30%), Positives = 89/221 (40%), Gaps = 34/221 (15%)
Query: 315 FSQKNFIGRGGFGLVYKGILQD-GTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKH 368
F IG+G FG V +D A+K K +E NE I+ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK--GSVRNVLNERRILQELNH 59
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
LV L D +N YLV D + G++ HL K + Q K
Sbjct: 60 PFLVNLWYS-FQDEEN-----MYLVVDLLLGGDLRYHL---------SQKVKFSEEQVKF 104
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
I ++ L YLH I HRDIK NILLD + DF +A + LTT
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTST 159
Query: 489 AGTHGYLAPE---YALYGQLTEKSDVYSFGVVILEIMCGRK 526
+GT GY+APE Y D +S GV E + G++
Sbjct: 160 SGTPGYMAPEVLCRQGYSVA---VDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 321 IGRGGFGLVYKGIL-QDGTT---VAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG V +G L QD + VAVK K+ + EF +E + + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK--NIILD 432
G C ++ + ++ +M +G++ L S + P P + ++D
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-----YSRLGGLPEKLPLQTLLKFMVD 121
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+A G+ YL HRD+ A N +L DM VADFGL+K+ G + R+A
Sbjct: 122 IALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 493 -GYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
++A E T KSDV++FGV + EI
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 36/222 (16%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV--------IESDFQGD--AEFCNEVEIISNLKHR 369
IG+G +G VY + + G +AVK+V Q D +E+E + +L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 370 NLVPLRGCCVVDGDNERGSERYLVY-DYMPNGNVDDHLFPSFNDGSGVAKR-PLTWPQRK 427
N+V G E E ++ +Y+P G++ GS + +
Sbjct: 69 NIVQYLGF-------ETTEEYLSIFLEYVPGGSI----------GSCLRTYGRFEEQLVR 111
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL-TT 486
V +GLAYLH I HRD+KA N+L+DAD +++DFG++K+S + +
Sbjct: 112 FFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168
Query: 487 RVAGTHGYLAPEY-ALYGQ-LTEKSDVYSFGVVILEIMCGRK 526
+ G+ ++APE Y Q + K D++S G V+LE+ GR+
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 74/253 (29%), Positives = 111/253 (43%), Gaps = 54/253 (21%)
Query: 321 IGRGGFGLVYKGIL--QDGTT----VAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVP 373
+G G FG VY+G+ +DG VAVK + ES + D ++F E I+S H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G R+++ + M G++ F N LT DV
Sbjct: 74 LIGVSF------ERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 434 AKGLAYL---HYGVKPAIYHRDIKATNILLD---ADMRARVADFGLAKQ-------SREG 480
AKG YL H+ HRDI A N LL A++ADFG+A+ + G
Sbjct: 126 AKGCKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC----------GRKALDL 530
++ L + ++ PE L G T K+DV+SFGV++ EI ++ ++
Sbjct: 180 RAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 531 STSG----SPRAC 539
T G P+ C
Sbjct: 234 VTGGGRLDPPKGC 246
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 318 KNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNLKHRNLV 372
IG G +G+V + + G VA+KK I + F D E++++ +L+H N++
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKK-ISNVFD-DLIDAKRILREIKLLRHLRHENII 62
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH-LFPSFNDGSGVAKRPLTWPQRKNIIL 431
L + E ++ Y+V + M D H + S +PLT + +
Sbjct: 63 GLLDI-LRPPSPEDFNDVYIVTELME---TDLHKVIKS--------PQPLTDDHIQYFLY 110
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ---SREGQSHLTTRV 488
+ +GL YLH + HRD+K +NIL++++ ++ DFGLA+ + + LT V
Sbjct: 111 QILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 489 AGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKAL 528
T Y APE L + T+ D++S G + E++ RK L
Sbjct: 168 V-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 321 IGRGGFGLVYK---GILQDGT--TVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G+G FG V LQD T VAVKK+ S + +F E+EI+ +L+H N+V +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C G LV +Y+P G++ D+L + ++ L + + + K
Sbjct: 72 GVCYSAGRRNLR----LVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQ------ICK 119
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG-- 493
G+ YL G K + HRD+ NIL++++ R ++ DFGL K + + + R G
Sbjct: 120 GMEYL--GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEI 521
+ APE + + SDV+SFGVV+ E+
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 68/201 (33%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
IG+G FG V G + G VAVK I++D A F E +++ L+H NLV L G V
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVK-CIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIV- 69
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
E Y+V +YM G++ D+L + L LDV + + YL
Sbjct: 70 ----EEKGGLYIVTEYMAKGSLVDYL-------RSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 441 HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA 500
HRD+ A N+L+ D A+V+DFGL K++ Q V T APE
Sbjct: 119 EAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 171
Query: 501 LYGQLTEKSDVYSFGVVILEI 521
+ + KSDV+SFG+++ EI
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 42/228 (18%)
Query: 321 IGRGGFGLVYK----GIL--QDGTTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVP 373
IG+G FG V++ G+L + T VAVK + E + A+F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-------FPSFNDGSGVAKR------P 420
L G C V G L+++YM G++++ L S + + A++ P
Sbjct: 73 LLGVCAV------GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 421 LTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
L+ ++ I VA G+AYL + HRD+ N L+ +M ++ADFGL S
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGL---S 177
Query: 478 REGQSHLTTRVAGTHG----YLAPEYALYGQLTEKSDVYSFGVVILEI 521
R S + + ++ PE Y + T +SDV+++GVV+ EI
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 41/224 (18%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN-----------EVEIISNLKH 368
IG G FG VY G+ G +AVK+V A + E+ ++ L+H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELP--SVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVY--DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
N+V G + +L +Y+P G+V L + G + L
Sbjct: 66 ENIVQYLGSSL--------DADHLNIFLEYVPGGSVAALL-----NNYGAFEETLV---- 108
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+N + + KGL YLH I HRDIK NIL+D +++DFG++K+ T
Sbjct: 109 RNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 487 RVA-----GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
A G+ ++APE T K+D++S G +++E++ G+
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 5e-20
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 315 FSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESD---FQGDAEFCNEVEIISNLKHR 369
+ + +G G +G+VYK + G VA+KK+ ++++ A E+ ++ LKH
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 370 NLVPLRGCCVVDGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
N+V L +ER YLV++Y D + D PL+ K
Sbjct: 59 NIVKLLDVIH--------TERKLYLVFEYC------DMDLKKYLD---KRPGPLSPNLIK 101
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+I+ + +GLAY H I HRD+K NIL++ D ++ADFGLA+ T
Sbjct: 102 SIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158
Query: 488 VAGTHGYLAPEYALYGQLTEKS--DVYSFGVVILEIMCGRKAL 528
V T Y APE L G + D++S G + E M K L
Sbjct: 159 VV-TLWYRAPE-ILLGSKHYSTAVDIWSVGCIFAE-MITGKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G G FG+V+ G + VA+K + E D +F E +++ L H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCT- 69
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL----DVAKG 436
+ ++V +YM NG + ++L R +L DV +
Sbjct: 70 -----KQRPIFIVTEYMANGCLLNYL------------RERKGKLGTEWLLDMCSDVCEA 112
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH---G 493
+ YL HRD+ A N L+ D +V+DFGLA+ + Q T GT
Sbjct: 113 MEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVK 166
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK 526
+ PE Y + + KSDV+SFGV++ E+ K
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 320 FIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE--FCNEVEIISNLKHRNLVPLRGC 377
+G+G FG V+KG L+D T VAVK E D + + F +E I+ H N+V L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
C + Y+V + +P G+ F SF K L Q LD A G+
Sbjct: 61 CT------QRQPIYIVMELVPGGD-----FLSFLRKK---KDELKTKQLVKFALDAAAGM 106
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
AYL K I HRD+ A N L+ + +++DFG+++Q +G + + AP
Sbjct: 107 AYLE--SKNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP 163
Query: 498 EYALYGQLTEKSDVYSFGVVILE 520
E YG+ + +SDV+S+G+++ E
Sbjct: 164 EALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 52/234 (22%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVK-----KVIESDFQGDAEFCNEVEIISNLK-HRNLVP 373
IG G F V + A+K ++I+ E E+++ L H ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV--KIEKEVLTRLNGHPGIIK 66
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL--FPSFNDGSGVAKRPLTWPQRKNIIL 431
L D E Y V +Y PNG + ++ + S ++ +
Sbjct: 67 LYYTF---QDEEN---LYFVLEYAPNGELLQYIRKYGSLDE-----------KCTRFYAA 109
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK---------------- 475
++ L YLH I HRD+K NILLD DM ++ DFG AK
Sbjct: 110 EILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 476 ----QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
Q + + + V GT Y++PE + SD+++ G +I +++ G+
Sbjct: 167 NIDSQIEKNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 73/246 (29%), Positives = 111/246 (45%), Gaps = 47/246 (19%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK---HRNLVPLRG 376
+G G FG VY + G VA+KK+ + F E N E+ S K H N+V L+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKK-FYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
V +N+ E Y V++YM GN L+ D G +P + ++II + +G
Sbjct: 66 ---VFREND---ELYFVFEYM-EGN----LYQLMKDRKG---KPFSESVIRSIIYQILQG 111
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
LA++H K +HRD+K N+L+ ++ADFGLA++ R + T V T Y A
Sbjct: 112 LAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS-RPPYTDYV-STRWYRA 166
Query: 497 PEYAL----YGQLTEKSDVYSFGVVILEI------MCGRKALD-----LSTSGSPRACLI 541
PE L Y D+++ G ++ E+ G +D S G+P
Sbjct: 167 PEILLRSTSYSS---PVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP----- 218
Query: 542 TDWVWS 547
T W
Sbjct: 219 TKQDWP 224
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 318 KNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
K +G G FG V+ QD VAVK + ++ +F E E+++NL+H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFND----GSGVAKRPLTWPQRK 427
V G CV G +V++YM +G+++ L D G LT Q
Sbjct: 70 VKFYGVCV------EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+I +A G+ YL HRD+ N L+ ++ ++ DFG+ SR+ S R
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGM---SRDVYSTDYYR 177
Query: 488 VAGTH----GYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
V G ++ PE +Y + T +SDV+S GVV+ EI
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEF-CNEVEIISNLKHRN 370
+ + IG G +G VYK + G VA+K VI+ + D E E+ ++ +H N
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V G + R + ++V +Y G++ D V + PL+ Q +
Sbjct: 62 IVAYFGSYL------RRDKLWIVMEYCGGGSLQDIY--------QVTRGPLSELQIAYVC 107
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA- 489
+ KGLAYLH K HRDIK NILL D ++ADFG++ Q LT +A
Sbjct: 108 RETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQ-------LTATIAK 157
Query: 490 -----GTHGYLAPEYA---LYGQLTEKSDVYSFGVVILE 520
GT ++APE A G K D+++ G+ +E
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 5e-19
Identities = 74/236 (31%), Positives = 116/236 (49%), Gaps = 57/236 (24%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQG--DAE--FCNEVEIISNLK- 367
K+ +G+G +G+V+K I + VA+KK+ ++ F+ DA+ F E+ + L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTF-REIMFLQELGD 65
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N+V L V+ +N++ + YLV++YM D H V R
Sbjct: 66 HPNIVKLLN--VIKAENDK--DIYLVFEYM---ETDLH---------AVI--------RA 101
Query: 428 NIILDVAK---------GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--- 475
NI+ DV K L Y+H G + HRD+K +NILL++D R ++ADFGLA+
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158
Query: 476 --QSREGQSHLTTRVAGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILEIMCGR 525
+ LT VA T Y APE L Y T+ D++S G ++ E++ G+
Sbjct: 159 ELEENPENPVLTDYVA-TRWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 43/222 (19%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN--------EVEIISNLKHRNL 371
IG G +VY I L + VA+K++ D E C EV+ +S H N+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-------DLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDD---HLFP-SFNDGSGVAKRPLTWPQRK 427
V VV G E +LV Y+ G++ D +P D + +A
Sbjct: 62 VKYYTSFVV------GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA---------- 105
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL-AKQSREGQSHLTT 486
++ +V KGL YLH HRDIKA NILL D ++ADFG+ A + G
Sbjct: 106 TVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
Query: 487 R--VAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGR 525
R GT ++APE K+D++SFG+ +E+ G
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL 366
++ R + K +K +G G FG V+ G + T VAVK + A F E ++ L
Sbjct: 2 EIPRESIKLVKK--LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTL 58
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H LV L + Y++ +YM G++ D F ++G V P+
Sbjct: 59 QHDKLVRLYAVVT------KEEPIYIITEYMAKGSLLD--FLKSDEGGKV-----LLPKL 105
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ +A+G+AY+ + HRD++A N+L+ + ++ADFGLA+ + +
Sbjct: 106 IDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ APE +G T KSDV+SFG+++ EI+
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 7e-19
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G G FG+V G + VA+K + E D EF E +++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT- 69
Query: 381 DGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+R Y+V +YM NG + ++L + Q + DV +G+A
Sbjct: 70 -------KQRPIYIVTEYMSNGCLLNYLREH--------GKRFQPSQLLEMCKDVCEGMA 114
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH---GYL 495
YL HRD+ A N L+D +V+DFGL++ + + T G+ +
Sbjct: 115 YLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWS 168
Query: 496 APEYALYGQLTEKSDVYSFGVVILEI 521
PE LY + + KSDV++FGV++ E+
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNLKHRNLVPLRGC 377
+G G FG VYK ++ A K+I + + E F E++I+S KH N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
+ +++ ++ G +D + +R LT PQ + + + + L
Sbjct: 71 YFYENK------LWILIEFCDGGALDSIMLE--------LERGLTEPQIRYVCRQMLEAL 116
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL-AKQSREGQSHLTTRVAGTHGYLA 496
+LH + HRD+KA NILL D ++ADFG+ AK Q T GT ++A
Sbjct: 117 NFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMA 171
Query: 497 PEYALYGQLTE-----KSDVYSFGVVILEI 521
PE + K+D++S G+ ++E+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 89/335 (26%), Positives = 139/335 (41%), Gaps = 70/335 (20%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIES-DFQGDAEFCNEVE 361
E + +K + +G+G FG+VY+G +D T VAVK V ES + EF NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
++ ++V L G VV +G +V + M +G++ +L + RP
Sbjct: 62 VMKGFTCHHVVRLLG--VV----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115
Query: 422 TWPQRKNII---LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 478
P + +I ++A G+AYL+ HRD+ A N ++ D ++ DFG+ +
Sbjct: 116 --PTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170
Query: 479 E-------GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531
E G+ L R ++APE G T SD++SFGVV+ EI S
Sbjct: 171 ETDYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEIT--------S 216
Query: 532 TSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVM 591
+ P L + V V G LD P ER + +C
Sbjct: 217 LAEQPYQGLSNEQVLKFVMDGG---YLD------------QPDNCPERVTDLMRMCWQFN 261
Query: 592 VALRPTISDALKMLEGDIEVPPLPDRPMPLGHPSF 626
+RPT + + +L+ D+ HPSF
Sbjct: 262 PKMRPTFLEIVNLLKDDL-------------HPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 23/221 (10%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKG-ILQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNL 366
R+ +F + N IG G +G+VY+ G VA+KKV ++++ G E+ ++ NL
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N+V L+ VV G +LV +Y + S D P + Q
Sbjct: 64 RHPNIVELKE--VVVGK--HLDSIFLVMEYC------EQDLASLLDN---MPTPFSESQV 110
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
K ++L + +GL YLH + I HRD+K +N+LL ++ADFGLA+ +T
Sbjct: 111 KCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167
Query: 487 RVAGTHGYLAPEYALYGQL--TEKSDVYSFGVVILEIMCGR 525
+V T Y APE L G T D+++ G ++ E++ +
Sbjct: 168 KVV-TLWYRAPEL-LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 32/227 (14%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK---KVIE--SDFQGDAEF 356
K +L + +G G FG V+KGI + +G ++ + K I+ S Q E
Sbjct: 4 LKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56
Query: 357 CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGV 416
+ + + +L H +V L G C G+ LV P G++ DH+ + S
Sbjct: 57 TDHMLAMGSLDHAYIVRLLGIC-------PGASLQLVTQLSPLGSLLDHV--RQHRDSLD 107
Query: 417 AKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK- 475
+R L W + +AKG+ YL + + HR++ A NILL +D ++ADFG+A
Sbjct: 108 PQRLLNW------CVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158
Query: 476 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ + + + ++A E L+G+ T +SDV+S+GV + E+M
Sbjct: 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 29/221 (13%)
Query: 318 KNFIGRGGFGLVYKG------ILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
K +G G FG V+ +D VAVK + + +F E E+++NL+H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGV-------AKRPLTWP 424
V G C DGD +V++YM +G+++ L D + AK L
Sbjct: 70 VKFYGVCG-DGD-----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
Q +I +A G+ YL HRD+ N L+ A++ ++ DFG+ SR+ S
Sbjct: 124 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM---SRDVYSTD 177
Query: 485 TTRVAGTH----GYLAPEYALYGQLTEKSDVYSFGVVILEI 521
RV G ++ PE +Y + T +SDV+SFGV++ EI
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 79/262 (30%), Positives = 126/262 (48%), Gaps = 43/262 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQGD-AEFCNEVEIISN 365
D+ + +G G FG V K +TVAVK + + + D ++ +E+E++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 366 L-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL---FPSFNDGSGVAKRP- 420
+ KH+N++ L G C +G Y+V +Y +GN+ D L P S RP
Sbjct: 72 IGKHKNIINLLGVCTQEG------PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 421 ---LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
LT + VA+G+ +L K I HRD+ A N+L+ D ++ADFGLA+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 478 REGQSHLTTRVAGTHGYL-----APEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLS 531
+ T T+G L APE AL+ ++ T +SDV+SFGV++ EI +
Sbjct: 183 HHIDYYRKT----TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIF--------T 229
Query: 532 TSGSPRACLITDWVWSLVKAGK 553
GSP + + ++ L+K G
Sbjct: 230 LGGSPYPGIPVEELFKLLKEGY 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 78/264 (29%), Positives = 121/264 (45%), Gaps = 49/264 (18%)
Query: 318 KNFIGRGGFGLVYKGILQ-DGT--TVAVKKVIESDFQGD-AEFCNEVEIISNL-KHRNLV 372
++ IG G FG V + +++ DG A+K + E + D +F E+E++ L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF--------PSFNDGSGVAKRPLTWP 424
L G C E Y+ +Y P GN+ D L P+F G A LT
Sbjct: 67 NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-TLTSQ 119
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS----REG 480
Q DVA G+ YL + HRD+ A N+L+ ++ +++ADFGL++ ++
Sbjct: 120 QLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKT 176
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-------CGRKALDLSTS 533
L R ++A E Y T KSDV+SFGV++ EI+ CG +L
Sbjct: 177 MGRLPVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230
Query: 534 -------GSPRACLITDWVWSLVK 550
PR C D V+ L++
Sbjct: 231 LPQGYRMEKPRNC--DDEVYELMR 252
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVKKV-IESDFQGDAEFCN----EVEIISNLKHRNLVPL 374
+G+G FG VY D G +AVK+V + D + N E++++ NL+H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
GC D + +YMP G+V D L A LT + +
Sbjct: 70 YGCLRDDE------TLSIFMEYMPGGSVKDQL---------KAYGALTETVTRKYTRQIL 114
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT--TRVAGTH 492
+G+ YLH I HRDIK NIL D+ ++ DFG +K+ + S T V GT
Sbjct: 115 EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 493 GYLAPEYAL---YGQLTEKSDVYSFGVVILEIM 522
+++PE YG+ K+DV+S G ++E++
Sbjct: 172 YWMSPEVISGEGYGR---KADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 321 IGRGGFGLVYKGIL------QDGT--TVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNL 371
+G G FG V L DGT VAVK + E Q + + E+ I+ L H N+
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
V +GCC G L+ +Y+P G++ D+L K L Q
Sbjct: 69 VKYKGCCSEQGGKGL----QLIMEYVPLGSLRDYL----------PKHKLNLAQLLLFAQ 114
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
+ +G+AYLH HRD+ A N+LLD D ++ DFGLAK EG + R G
Sbjct: 115 QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 492 HG--YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ A E + + SDV+SFGV + E++
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL 366
++ R + K +K +G G FG V+ T VAVK + +A F E ++ L
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTL 58
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H LV L + Y++ ++M G++ D F ++GS K+PL P+
Sbjct: 59 QHDKLVKLHAVVTKE-------PIYIITEFMAKGSLLD--FLKSDEGS---KQPL--PKL 104
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ +A+G+A++ + HRD++A NIL+ A + ++ADFGLA+ + +
Sbjct: 105 IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ APE +G T KSDV+SFG++++EI+
Sbjct: 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEF---CNEVEIISNLKHRNLVPLRG 376
IG G FG VY ++ VA+KK+ S Q + ++ EV + L+H N + +G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
C + R +LV +Y S +D V K+PL + I +G
Sbjct: 83 CYL------REHTAWLVMEY---------CLGSASDILEVHKKPLQEVEIAAICHGALQG 127
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
LAYLH + HRDIKA NILL ++ADFG A S + GT ++A
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMA 179
Query: 497 PEYALY---GQLTEKSDVYSFGVVILEI 521
PE L GQ K DV+S G+ +E+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 29/220 (13%)
Query: 318 KNFIGRGGFGLVYKG-ILQDGTTV--AVKKVIESDFQGD-AEFCNEVEIISNL-KHRNLV 372
++ IG G FG V K I +DG + A+K++ E + D +F E+E++ L H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF--------PSFNDGSGVAKRPLTWP 424
L G C E YL +Y P+GN+ D L P+F + A L+
Sbjct: 72 NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQ 124
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
Q + DVA+G+ YL + HRD+ A NIL+ + A++ADFGL++ GQ
Sbjct: 125 QLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177
Query: 485 TTRVAGTHG--YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ G ++A E Y T SDV+S+GV++ EI+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 321 IGRGGFGLVY----KGILQDG--TTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVP 373
+GRG FG V+ KGI ++G T V VK + ++ + +EF E+++ L H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G C Y++ +Y G++ L + + + PL+ Q+ + +
Sbjct: 73 LLGLC------REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
A G+ +L HRD+ A N L+ + +V+ L+K + +
Sbjct: 127 ALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEI 521
+LAPE + KSDV+SFGV++ E+
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 9e-18
Identities = 72/255 (28%), Positives = 128/255 (50%), Gaps = 45/255 (17%)
Query: 321 IGRGGFGLVYK----GILQD----GTTVAVKKVIESDFQGD-AEFCNEVEIISNL-KHRN 370
+G G FG V + GI + TVAVK + ++ D A+ +E+E++ + KH+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL------FPSFN-DGSGVAKRPLTW 423
++ L G C +G Y++ +Y GN+ + L P + D + V + L++
Sbjct: 80 IINLLGVCTQEG------PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
+ VA+G+ YL + I HRD+ A N+L+ D ++ADFGLA+ G
Sbjct: 134 KDLVSCAYQVARGMEYLE--SRRCI-HRDLAARNVLVTEDNVMKIADFGLAR----GVHD 186
Query: 484 LTTRVAGTHG-----YLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537
+ ++G ++APE AL+ ++ T +SDV+SFG+++ EI + GSP
Sbjct: 187 IDYYKKTSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEI--------FTLGGSPY 237
Query: 538 ACLITDWVWSLVKAG 552
+ + ++ L++ G
Sbjct: 238 PGIPVEELFKLLREG 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRNLVPLRGCCV 379
+G G FG VYK ++ +A KVIE+ + + E + E+EI++ H +V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
DG + +++ ++ P G VD + R LT PQ + I + + L Y
Sbjct: 80 WDG------KLWIMIEFCPGGAVDAIMLE--------LDRGLTEPQIQVICRQMLEALQY 125
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGL-AKQSREGQSHLTTRVAGTHGYLAPE 498
LH I HRD+KA N+LL D ++ADFG+ AK + Q GT ++APE
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPE 180
Query: 499 YALYGQLTE-----KSDVYSFGVVILEI 521
+ + + K+D++S G+ ++E+
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 316 SQKNFIGRGGFGLVYKGILQ----DGTTVAVKKV----IESDFQGDAEFCNEVEIISNLK 367
+++ IG G FG V++GIL+ VA+K + E Q +F +E I+
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ---DFLSEASIMGQFS 64
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N++ L G VV + ++ +YM NG +D +L +DG + Q
Sbjct: 65 HHNIIRLEG--VV----TKFKPAMIITEYMENGALDKYL--RDHDGE------FSSYQLV 110
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
++ +A G+ YL HRD+ A NIL+++++ +V+DFGL++ + T
Sbjct: 111 GMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167
Query: 488 VAGTHG--YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
G + APE Y + T SDV+SFG+V+ E+M
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLV 372
F++ IG+G FG VYKGI V K+I+ + D + E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
G + +G++ +++ +Y+ G+ D L P PL I+ +
Sbjct: 66 RYYGSYL------KGTKLWIIMEYLGGGSALDLLKPG----------PLEETYIATILRE 109
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ KGL YLH K HRDIKA N+LL ++ADFG+A Q + Q T V GT
Sbjct: 110 ILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTP 165
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
++APE K+D++S G+ +E+ G
Sbjct: 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 35/229 (15%)
Query: 308 LERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL 366
L T F IG G +G VYK + G VA+K +++ + E E I+
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 367 -KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
H N+ G + + +LV + G+V D + K +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-----------LVKGLRKKGK 108
Query: 426 RKN------IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479
R I+ + +GLAYLH + + HRDIK NILL + ++ DFG++ Q
Sbjct: 109 RLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165
Query: 480 GQSHLTTRVAGTHGYLAPEY--------ALYGQLTEKSDVYSFGVVILE 520
T + GT ++APE A Y +SDV+S G+ +E
Sbjct: 166 TLGRRNTFI-GTPYWMAPEVIACDEQPDASYDA---RSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 77/268 (28%), Positives = 131/268 (48%), Gaps = 47/268 (17%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYK----GILQD----GTTVAVKKVIESDFQGD-AEFCNE 359
E + DK + +G G FG V GI +D TVAVK + + + D ++ +E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 360 VEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFP--------SF 410
+E++ + KH+N++ L G C DG Y++ +Y GN+ ++L S+
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDG------PLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 411 NDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470
D + V +T+ + VA+G+ YL HRD+ A N+L+ + ++AD
Sbjct: 125 -DIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIAD 180
Query: 471 FGLAKQSREGQSHLTTRVAGTHG-----YLAPEYALYGQL-TEKSDVYSFGVVILEIMCG 524
FGLA+ + T T+G ++APE AL+ ++ T +SDV+SFGV++ EI
Sbjct: 181 FGLARDVNNIDYYKKT----TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEI--- 232
Query: 525 RKALDLSTSGSPRACLITDWVWSLVKAG 552
+ GSP + + ++ L+K G
Sbjct: 233 -----FTLGGSPYPGIPVEELFKLLKEG 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 321 IGRGGFGLVYKG-ILQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPLRGCC 378
+G G G+V K G +AVK + +E + + E++I+ +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+GD + +YM G++D L + + I + V KGL
Sbjct: 69 YNNGD------ISICMEYMDGGSLDKIL--------KEVQGRIPERILGKIAVAVLKGLT 114
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA----GTHGY 494
YLH K I HRD+K +NIL+++ + ++ DFG++ Q L +A GT Y
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQ-------LVNSLAKTFVGTSSY 165
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+APE + KSD++S G+ ++E+ GR
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 79/267 (29%), Positives = 123/267 (46%), Gaps = 47/267 (17%)
Query: 319 NFIGRGGFGLVYKGILQ-DG--TTVAVKKVIESDFQGD-AEFCNEVEIISNLKHR-NLVP 373
+ IG G FG V K ++ DG A+K++ E + D +F E+E++ L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF--------PSFNDGSGVAKRPLTWPQ 425
L G C E YL +Y P+GN+ D L P+F + A L+ Q
Sbjct: 61 LLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQ 113
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ DVA+G+ YL + HRD+ A NIL+ + A++ADFGL++ GQ
Sbjct: 114 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV 166
Query: 486 TRVAGTHG--YLAPEYALYGQLTEKSDVYSFGVVILEIM-------CGRKALDLSTS--- 533
+ G ++A E Y T SDV+S+GV++ EI+ CG +L
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226
Query: 534 ----GSPRACLITDWVWSLVKAGKVWQ 556
P C D V+ L++ + W+
Sbjct: 227 GYRLEKPLNC--DDEVYDLMR--QCWR 249
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 319 NFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLK------HRN 370
IG G +G VYK L G VA+KKV + +G + + I+ LK H N
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPL--STLREIALLKQLESFEHPN 62
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L C +R + LV++++ + D + S G+ K+++
Sbjct: 63 IVRLLDVCHGP-RTDRELKLTLVFEHV---DQDLATYLSKCPKPGLPP-----ETIKDLM 113
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ +G+ +LH I HRD+K NIL+ +D + ++ADFGLA+ + LT+ V
Sbjct: 114 RQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV- 168
Query: 491 THGYLAPEYALYGQLTEKS--DVYSFGVVILEIMCGRKAL 528
T Y APE L Q + + D++S G + E + R+ L
Sbjct: 169 TLWYRAPEVLL--QSSYATPVDMWSVGCIFAE-LFRRRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 38/232 (16%)
Query: 309 ERATDKFSQKNFIGRGGFGLVY----KGILQDG--TTVAVKKVIES-DFQGDAEFCNEVE 361
E A +K + +G+G FG+VY KG+++D T VA+K V E+ + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF---PSFNDGSGVAK 418
++ ++V L G +G ++ + M G++ +L P + A
Sbjct: 62 VMKEFNCHHVVRLLGVV------SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 419 RPLTWPQRKNIIL--DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476
L +K I + ++A G+AYL+ HRD+ A N ++ D ++ DFG+ +
Sbjct: 116 PSL----KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 168
Query: 477 SRE-------GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
E G+ L R +++PE G T SDV+SFGVV+ EI
Sbjct: 169 IYETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD--AEFCNEVEIISNLKHRN 370
+K + + +G G G V K L++ + K I +D D + E+EI + K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V G + +E S + +Y G++D G + ++ L I
Sbjct: 61 IVKYYGAFL----DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIA 111
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
V KGL+YLH I HRDIK +NILL + ++ DFG+ S E + L G
Sbjct: 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV---SGELVNSLAGTFTG 165
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
T Y+APE + SDV+S G+ +LE+ R
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 321 IGRGGFGLVYKGILQ----DGTTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
IG G FG V +G L+ VA+K K ++ Q +F +E I+ H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIHL 70
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G VV + ++ ++M NG +D F NDG T Q ++ +A
Sbjct: 71 EG--VV----TKSRPVMIITEFMENGALDS--FLRQNDGQ------FTVIQLVGMLRGIA 116
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT-TRVAGTH- 492
G+ YL + HRD+ A NIL+++++ +V+DFGL++ + S T T G
Sbjct: 117 AGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 493 --GYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ APE Y + T SDV+S+G+V+ E+M
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 7e-17
Identities = 70/270 (25%), Positives = 114/270 (42%), Gaps = 54/270 (20%)
Query: 277 SGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQD 336
S SSSS S P + + +LER N IG G G VYK I +
Sbjct: 52 SSSSSSSSSSASGSAPSAAKS-------LSELERV-------NRIGSGAGGTVYKVIHRP 97
Query: 337 GTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394
+ KVI + + + C E+EI+ ++ H N+V + E ++
Sbjct: 98 TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM------FDHNGEIQVLL 151
Query: 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454
++M G+++ + VA++ L+ G+AYLH + I HRDIK
Sbjct: 152 EFMDGGSLEGTHIADEQFLADVARQILS-------------GIAYLH---RRHIVHRDIK 195
Query: 455 ATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE----------YALYGQ 504
+N+L+++ ++ADFG+++ + + V GT Y++PE Y Y
Sbjct: 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYA- 253
Query: 505 LTEKSDVYSFGVVILEIMCGRKALDLSTSG 534
D++S GV ILE GR + G
Sbjct: 254 ----GDIWSLGVSILEFYLGRFPFGVGRQG 279
|
Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-17
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLV 372
F++ IG+G FG V+KGI V K+I+ + D + E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
G + D ++ +++ +Y+ G+ D L P PL Q I+ +
Sbjct: 66 KYYGSYLKD------TKLWIIMEYLGGGSALDLLEPG----------PLDETQIATILRE 109
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ KGL YLH K HRDIKA N+LL ++ADFG+A Q + Q T V GT
Sbjct: 110 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTP 165
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
++APE K+D++S G+ +E+ G
Sbjct: 166 FWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
K+++ IG+G G VY I + G VA+K++ NE+ ++ KH N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
+V G E ++V +Y+ G++ D + + D +A + +
Sbjct: 80 NYLDSYLV------GDELWVVMEYLAGGSLTDVVTETCMDEGQIAA----------VCRE 123
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ L +LH + HRDIK+ NILL D ++ DFG Q QS +T V GT
Sbjct: 124 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-STSGSP 536
++APE K D++S G++ +E++ G +AL L +T+G+P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGILQDGTT---VAVKKV-IESDFQGDAEF----CNEVE 361
R+ D++ + N I G +G+VY+ +D T VA+KK+ +E + +G F E+
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEG---FPITSLREIN 56
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
I+ L+H N+V ++ VV G N + Y+V +Y+ +H S + K+P
Sbjct: 57 ILLKLQHPNIVTVKE--VVVGSNLD--KIYMVMEYV------EHDLKSLME---TMKQPF 103
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
+ K ++L + G+A+LH I HRD+K +N+LL+ ++ DFGLA++
Sbjct: 104 LQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 482 SHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIM 522
T V T Y APE L + + D++S G + E++
Sbjct: 161 KPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIES-----DFQGDAEFCNEVEIISNLKHRNLVP 373
IG+G FG VY G L D + ++S D + +F E I+ + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII--- 430
L G C+ +E GS +V YM +G++ + + + P K++I
Sbjct: 61 LLGICL---PSE-GSP-LVVLPYMKHGDLRNFI-----------RSETHNPTVKDLIGFG 104
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ--SREGQS-HLTTR 487
L VAKG+ YL HRD+ A N +LD +VADFGLA+ +E S H T
Sbjct: 105 LQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
++A E + T KSDV+SFGV++ E+M
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCN----EVEIISNLKHRNLVPLR 375
+G G +G+V K + G VA+KK ES+ D + EV+++ L+H N+V L+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G YLV++Y+ + + L S A R W + +
Sbjct: 67 EAFRRKG------RLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--------QLLQ 111
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG-QSHLTTRVAGTHGY 494
+AY H I HRDIK NIL+ ++ DFG A+ R S LT VA T Y
Sbjct: 112 AIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWY 167
Query: 495 LAPEYAL----YGQLTEKSDVYSFGVVILEIMCGR 525
APE + YG+ DV++ G ++ E++ G
Sbjct: 168 RAPELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 70/210 (33%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 321 IGRGGFGLVYKGILQDGTT---VAVKKVIESDFQGDAEF---CNEVEIISNLKHRNLVPL 374
IG G FG VY + T VAVKK+ S Q + ++ EV+ + LKH N +
Sbjct: 29 IGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
+GC + + +LV +Y S +D V K+PL + I
Sbjct: 87 KGCYLKE------HTAWLVMEY---------CLGSASDLLEVHKKPLQEVEIAAITHGAL 131
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
+GLAYLH + HRDIKA NILL + ++ADFG A +S S + GT +
Sbjct: 132 QGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYW 183
Query: 495 LAPEYALY---GQLTEKSDVYSFGVVILEI 521
+APE L GQ K DV+S G+ +E+
Sbjct: 184 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 56/189 (29%), Positives = 98/189 (51%), Gaps = 18/189 (9%)
Query: 337 GTTVAVKKVI-ESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395
G VAVK + ES A+ E+EI+ NL H N+V +G C DG N L+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK----LIME 88
Query: 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455
++P+G++ ++L P K + Q+ + + KG+ YL G + + HRD+ A
Sbjct: 89 FLPSGSLKEYL-PR-------NKNKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAA 137
Query: 456 TNILLDADMRARVADFGLAKQSREGQSHLTTR--VAGTHGYLAPEYALYGQLTEKSDVYS 513
N+L++++ + ++ DFGL K + + T + + + APE + + SDV+S
Sbjct: 138 RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWS 197
Query: 514 FGVVILEIM 522
FGV + E++
Sbjct: 198 FGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 75/235 (31%), Positives = 110/235 (46%), Gaps = 38/235 (16%)
Query: 296 PNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTT---VAVKKVIESDFQG 352
P ++FK +D E+ F+ IG G FG VY +D T VA+KK+ S Q
Sbjct: 12 PEIAELFFK-EDPEKL---FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQS 65
Query: 353 DAEF---CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPS 409
+ ++ EV+ + +KH N + +GC + R +LV +Y S
Sbjct: 66 NEKWQDIIKEVKFLQRIKHPNSIEYKGCYL------REHTAWLVMEY---------CLGS 110
Query: 410 FNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469
+D V K+PL + I +GLAYLH + HRDIKA NILL + ++A
Sbjct: 111 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLA 167
Query: 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEI 521
DFG A + S + GT ++APE L GQ K DV+S G+ +E+
Sbjct: 168 DFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 39/230 (16%)
Query: 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVI---------ESDFQGDAEFCNEVEIISN 365
+++ +G+G +G VY G+ G +AVK+V E +++ E EV+++ +
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQE---EVDLLKS 58
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR--PLTW 423
LKH N+V G C+ D + + +++P G++ S + R PL
Sbjct: 59 LKHVNIVQYLGTCLDD------NTISIFMEFVPGGSI-----------SSILNRFGPLPE 101
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-----SR 478
P + G+AYLH + HRDIK N++L + ++ DFG A++
Sbjct: 102 PVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 479 EGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528
S++ + GT ++APE KSD++S G + E+ G+ L
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLV 372
F++ IG+G FG V+KGI V K+I+ + D + E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
G + +G++ +++ +Y+ G+ D L P Q ++ +
Sbjct: 66 KYYGSYL------KGTKLWIIMEYLGGGSALDLLRAG----------PFDEFQIATMLKE 109
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ KGL YLH K HRDIKA N+LL ++ADFG+A Q + Q T V GT
Sbjct: 110 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTP 165
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
++APE K+D++S G+ +E+ G
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISN 365
+ E D+ ++ +G+G +G+VY L +A+K++ E D + E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVY-DYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
LKHRN+V G +G + ++ + +P G++ L + G
Sbjct: 62 LKHRNIVQYLGSDSENG-------FFKIFMEQVPGGSLSALLRSKW--GPLKDNEQTIIF 112
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQSREGQSH 483
K I+ +GL YLH I HRDIK N+L++ +++DFG +K+ G +
Sbjct: 113 YTKQIL----EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGINP 164
Query: 484 LTTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGR 525
T GT Y+APE G +D++S G I+E+ G+
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 73/233 (31%), Positives = 110/233 (47%), Gaps = 36/233 (15%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKV-IESDFQG-DAEFCNEVEIISN 365
+R DKF IG G +G VYK +D G VA+KKV ++++ +G E++I+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 366 LKHRNLVPLRGCCVVDGDNERGSER------YLVYDYMPNGNVDDHLFPSFNDGSGVAKR 419
L HRN+V L +V + + YLV++YM DH D G+ +
Sbjct: 63 LNHRNIVNL--KEIVTDKQDALDFKKDKGAFYLVFEYM------DH------DLMGLLES 108
Query: 420 PL---TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476
L + K+ + + +GL Y H K HRDIK +NILL+ + ++ADFGLA+
Sbjct: 109 GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 477 SREGQSHLTTRVAGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILEIMCGR 525
+S T T Y PE L YG DV+S G ++ E+ +
Sbjct: 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAI---DVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIE-----SDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG VYKGI + +G TV + I+ + + + EF +E I++++ H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G C+ LV MP+G + D++ D G ++ L W + +A
Sbjct: 75 LGVCL-------SPTIQLVTQLMPHGCLLDYVH-EHKDNIG-SQLLLNW------CVQIA 119
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH-- 492
KG+ YL + + HRD+ A N+L+ + ++ DFGLA+ EG G
Sbjct: 120 KGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPI 175
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
++A E Y + T +SDV+S+GV I E+M
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 37/219 (16%)
Query: 321 IGRGGFGLVY---KGILQDGTTVAVKKVIESDFQGDAEF---CNEVEIISNLKHRNLVPL 374
I +G +G V+ K D A+K + ++D + E +I+S + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDD--HLFPSFNDGSGVAKRPLTWPQRKNIILD 432
N YLV +Y+P G++ S ++ + I +
Sbjct: 59 Y-YSFQGKKN-----LYLVMEYLPGGDLASLLENVGSLDEDVA-----------RIYIAE 101
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-------SREGQSHLT 485
+ L YLH I HRD+K NIL+D++ ++ DFGL+K +
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
R+ GT Y+APE L ++ D +S G ++ E + G
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 85/321 (26%), Positives = 143/321 (44%), Gaps = 60/321 (18%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYK----GILQDG----TTVAVKKVIESDFQGD-AEFCNE 359
E D+ +G G FG V G+ ++ T VAVK + + D ++ +E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 360 VEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
+E++ + KH+N++ L G C DG Y++ +Y GN+ ++L G
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDG------PLYVIVEYASKGNLREYLRARRPPGMEYCY 127
Query: 419 RPLTWPQRKNIILD-------VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471
P P+ + D VA+G+ YL K I HRD+ A N+L+ D ++ADF
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADF 184
Query: 472 GLAKQSREGQSHLTTRVAGTHG-----YLAPEYALYGQL-TEKSDVYSFGVVILEIMCGR 525
GLA+ H+ T+G ++APE AL+ ++ T +SDV+SFGV++ EI
Sbjct: 185 GLARDIH----HIDYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEI---- 235
Query: 526 KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGI 585
+ GSP + + ++ L+K G +D P ++
Sbjct: 236 ----FTLGGSPYPGVPVEELFKLLKEG---HRMD------------KPSNCTNELYMMMR 276
Query: 586 LCAHVMVALRPTISDALKMLE 606
C H + + RPT ++ L+
Sbjct: 277 DCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 321 IGRGGFGLVYKGIL-QDGTT--VAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G G FG V +G L QD + VAVK K+ +F +E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK--NIILDV 433
G C+ ++E ++ +M +G++ L S + P P + + D+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-----RLGDCPQYLPTQMLVKFMTDI 121
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH- 492
A G+ YL + HRD+ A N +L+ +M VADFGL+K+ G + R+A
Sbjct: 122 ASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEI 521
++A E T KSDV+SFGV + EI
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G G FG+V+ G + VA+K + E + +F E +++ L H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT- 69
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
+ Y+V ++M NG + ++L G + + ++ DV +G+ YL
Sbjct: 70 -----QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLL----SMCQDVCEGMEYL 116
Query: 441 HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA 500
+ + HRD+ A N L+ + +V+DFG+ + + + ++ + PE
Sbjct: 117 E---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173
Query: 501 LYGQLTEKSDVYSFGVVILEI 521
+ + + KSDV+SFGV++ E+
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLKHRNLVPLRGC 377
IG G +G+VYK G VA+KK+ ++++ +G + E+ ++ L H N+V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD- 66
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
V+ +N+ YLV++++ + D F D S ++ PL P K+ + + +GL
Sbjct: 67 -VIHTENKL----YLVFEFL---HQD---LKKFMDASPLSGIPL--PLIKSYLFQLLQGL 113
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
A+ H + HRD+K N+L++ + ++ADFGLA+ T V T Y AP
Sbjct: 114 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 498 EYALYGQL-TEKSDVYSFGVVILEIMCGRKAL 528
E L + + D++S G + E M R+AL
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAE-MVTRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 59/278 (21%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVI-ESDFQGDAEF----CNEVEIISNL 366
K+ + IG+G FG V+K + VA+KKV+ E++ +G F E++I+ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLL 68
Query: 367 KHRNLVPLRGCC---VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP--- 420
KH N+V L C + +GS YLV+++ +H D +G+
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGS-FYLVFEFC------EH------DLAGLLSNKNVK 115
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK---QS 477
T + K ++ + GL Y+H I HRD+KA NIL+ D ++ADFGLA+ S
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 478 REGQSHL-TTRVAGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILE------IMCG-- 524
+ + + T RV T Y PE L YG D++ G ++ E IM G
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIMQGNT 228
Query: 525 -RKALDLSTS--GSPRACLITDWVWSLVKAGKVWQALD 559
+ L L + GS IT VW V ++++ ++
Sbjct: 229 EQHQLTLISQLCGS-----ITPEVWPGVDKLELFKKME 261
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 20/212 (9%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIES-DFQGDAE-FCNEVEIISNLKHRNLVPLRGC 377
IGRG +G+V + VA+KK+ + D + DA+ E++++ +L H N++ ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
+ E ++ Y+VY+ M + D H + + L+ + + + +GL
Sbjct: 73 -MPPPHREAFNDVYIVYELM---DTDLHQIIRSS-------QTLSDDHCQYFLYQLLRGL 121
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
Y+H + HRD+K +N+LL+A+ ++ DFGLA+ + E +T V T Y AP
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAP 177
Query: 498 EYAL-YGQLTEKSDVYSFGVVILEIMCGRKAL 528
E L + T DV+S G + E++ GRK L
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRG 376
+G+GGFG V ++ G A KK+ + +G+ NE +I+ + R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
E + LV M G++ H+ V + + + G
Sbjct: 61 AF------ETKDDLCLVMTLMNGGDLKYHI-------YNVGEPGFPEARAIFYAAQIICG 107
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
L +LH + I +RD+K N+LLD R++D GLA + + G+ AGT GY+A
Sbjct: 108 LEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMA 162
Query: 497 PEYALYGQLTEKSDVYSFGVVILEIMCGR 525
PE D ++ G + E++ GR
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRNLVPLRGCCV 379
+G G FG VYK ++ +A KVI++ + + E + E++I+++ H N+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
+ + +++ ++ G VD + +RPLT PQ + + + L Y
Sbjct: 73 YENN------LWILIEFCAGGAVDAVMLE--------LERPLTEPQIRVVCKQTLEALNY 118
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGL-AKQSREGQSHLTTRVAGTHGYLAPE 498
LH + I HRD+KA NIL D ++ADFG+ AK +R Q GT ++APE
Sbjct: 119 LH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPE 173
Query: 499 YALYGQLTE-----KSDVYSFGVVILEI 521
+ + K+DV+S G+ ++E+
Sbjct: 174 VVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 40/213 (18%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRG 376
IGRG FG V+ G L+ D T VAVK E+ D + A+F E I+ H N+V L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSF--NDGSGVAKRPLTWPQRKNIILDVA 434
C + Y+V + + G+ F +F +G + + L ++ + A
Sbjct: 61 VCT------QKQPIYIVMELVQGGD-----FLTFLRTEGPRLKVKELI-----QMVENAA 104
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG- 493
G+ YL K I HRD+ A N L+ +++DFG++++ +G A T G
Sbjct: 105 AGMEYLE--SKHCI-HRDLAARNCLVTEKNVLKISDFGMSREEEDGV------YASTGGM 155
Query: 494 ------YLAPEYALYGQLTEKSDVYSFGVVILE 520
+ APE YG+ + +SDV+SFG+++ E
Sbjct: 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 321 IGRGGFGLVYKGILQDG--TTVAVKKV-----------IESDFQGDAEFCNEVEII-SNL 366
+G G FG VYK ++ +A+K++ E D + +EV II L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG-DIVSEVTIIKEQL 66
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N+V + +N+R Y+V D + + +H F S + W
Sbjct: 67 RHPNIVRYYKTFL---ENDR---LYIVMDLIEGAPLGEH-FNSLKEKKQRFTEERIW--- 116
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
NI + + L YLH + I HRD+ NI+L D + + DFGLAKQ + +S LT+
Sbjct: 117 -NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTS 172
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC 523
V GT Y PE EK+DV++FG ++ + MC
Sbjct: 173 -VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ-MC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 321 IGRGGFGLVYKGILQD---GTTVAVKKV----IESDFQGDA--EFCNEVEIISNLKHRNL 371
+G G F Y+ +D GT +AVK+V S Q + E+ +++ L H ++
Sbjct: 8 LGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
+ + G D L ++M G+V HL + G K + N
Sbjct: 66 IRMLGATCEDSHFN------LFVEWMAGGSVS-HLLSKY----GAFKEAVI----INYTE 110
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQ---SREGQSHLTTR 487
+ +GL+YLH + I HRD+K N+L+D+ R R+ADFG A + G +
Sbjct: 111 QLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 488 VAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGR 525
+ GT ++APE L G+ +S DV+S G VI+E+ +
Sbjct: 168 LLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 71/233 (30%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 296 PNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDA 354
P+ ++FK D E+ FS IG G FG VY +++ VA+KK+ S Q +
Sbjct: 2 PDVAELFFK-DDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 355 EF---CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
++ EV + L+H N + RGC + R +LV +Y S +
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCYL------REHTAWLVMEY---------CLGSAS 102
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471
D V K+PL + + +GLAYLH + HRD+KA NILL ++ DF
Sbjct: 103 DLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEI 521
G A + GT ++APE L GQ K DV+S G+ +E+
Sbjct: 160 GSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 321 IGRGGFGLVYKGILQ----DGTTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
IG G FG V G L+ VA+K K ++ Q +F +E I+ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIHL 70
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G VV + +V +YM NG++D F +DG T Q ++ +A
Sbjct: 71 EG--VV----TKSKPVMIVTEYMENGSLDA--FLRKHDGQ------FTVIQLVGMLRGIA 116
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG- 493
G+ YL HRD+ A NIL+++++ +V+DFGL++ + T G
Sbjct: 117 SGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173
Query: 494 -YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ APE Y + T SDV+S+G+V+ E+M
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 315 FSQKNFIGRGGFGLVYK-GILQDGTTVAVKKV-IESDFQGD-AEFCNEVEIISNLKHRNL 371
F +G+G +G VYK L D A+K+V + S Q + + NE+ I++++ H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 372 VPLRGCCVVDGDNER---GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
+ E G++ +V +Y P G++ + ++ + +
Sbjct: 62 I---------SYKEAFLDGNKLCIVMEYAPFGDLSKAI-----SKRKKKRKLIPEQEIWR 107
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
I + + +GL LH + I HRD+K+ NILL A+ ++ D G++K ++ +
Sbjct: 108 IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQ 161
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT Y+APE + KSD++S G ++ E+
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 321 IGRGGFGLVYKG----ILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLVPL 374
+G G FG+V +G VAVK ++SD D +F E I+ +L H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G VV +V + P G++ D L A + + +A
Sbjct: 62 YG--VV-----LTHPLMMVTELAPLGSLLDRL-------RKDALGHFLISTLCDYAVQIA 107
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT----RVAG 490
G+ YL HRD+ A NILL +D + ++ DFGL + + + H +V
Sbjct: 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP- 163
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
+ APE + SDV+ FGV + E+
Sbjct: 164 -FAWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 94/349 (26%), Positives = 153/349 (43%), Gaps = 73/349 (20%)
Query: 321 IGRGGFGLVYK----GILQD----GTTVAVKKVIESDFQGD-AEFCNEVEIISNL-KHRN 370
+G G FG V GI +D TVAVK + + D ++ +E+E++ + KH+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF----PSFN---DGSGVAKRPLTW 423
++ L G C DG Y++ +Y GN+ ++L P + D + + LT+
Sbjct: 80 IINLLGACTQDG------PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
+ VA+G+ YL HRD+ A N+L+ D ++ADFGLA+ +
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 484 LTTRVAGTHG-----YLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537
T T+G ++APE AL+ ++ T +SDV+SFGV++ EI + GSP
Sbjct: 191 KKT----TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEI--------FTLGGSPY 237
Query: 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT 597
+ + ++ L+K G +D P ++ C H + + RPT
Sbjct: 238 PGIPVEELFKLLKEG---HRMD------------KPANCTHELYMIMRECWHAVPSQRPT 282
Query: 598 ISDALKMLEG-----------DIEVPPLPDRPMPLGHPSF--YGDDSTF 633
++ L+ D+ VP P PS GDDS F
Sbjct: 283 FKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCPDSPSSCSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 321 IGRGGFGLVYKGILQD----GTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRNLVPLR 375
IG G FG VY+G+ VAVK E F E I+ H ++V L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL---D 432
G + ++V + P G + +L + ++IL
Sbjct: 74 GVITEN-------PVWIVMELAPLGELRSYL-----------QVNKYSLDLASLILYSYQ 115
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
++ LAYL + HRDI A N+L+ + ++ DFGL++ + + ++
Sbjct: 116 LSTALAYLE-SKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
++APE + + T SDV+ FGV + EI+
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC----NEVEIISNLK 367
++ ++IG G +G+V G VA+KK+ + Q FC E++I+ K
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFK 61
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N++ + + E ++ Y+V + M D + + + L+ +
Sbjct: 62 HENIIGILDI-IRPPSFESFNDVYIVQELMET---DLYKL--------IKTQHLSNDHIQ 109
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH---L 484
+ + +GL Y+H + HRD+K +N+LL+ + ++ DFGLA+ + H L
Sbjct: 110 YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGR 525
T VA T Y APE L + K+ D++S G ++ E++ R
Sbjct: 167 TEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 24/167 (14%)
Query: 320 FIGRGGFGLVYKGILQDGTT---VAVKKVIESDFQGD---AEFCNEVEIISNLKHRNLVP 373
IGRG +G VYK ++G A+KK Q C E+ ++ LKH N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDH-LFPSFNDGSGVAKRPLTWPQRKNIILD 432
L + D YL++DY +H L+ + + K+++
Sbjct: 67 LVEVFLEHAD----KSVYLLFDYA------EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILL--DADMRARV--ADFGLAK 475
+ G+ YLH + HRD+K NIL+ + R V D GLA+
Sbjct: 117 ILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 320 FIGRGGFGLVYKGILQD-GTTVAVKKV------IESDFQGDAEFCNEVEIISNLKHRNLV 372
+G+G FG VY D G +A K+V E+ + A C E++++ NL+H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC-EIQLLKNLQHERIV 67
Query: 373 PLRGCCVVDGDNERGSERYLVY-DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
GC +R + ++ +YMP G+V D L G +T + I+
Sbjct: 68 QYYGCL-----RDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQIL- 116
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE-GQSHLTTR-VA 489
+G++YLH + I HRDIK NIL D+ ++ DFG +K+ + S R V
Sbjct: 117 ---EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
GT +++PE K+DV+S G ++E++
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 61/259 (23%), Positives = 113/259 (43%), Gaps = 48/259 (18%)
Query: 321 IGRGGFGLVYKGI------LQDGTTVAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVP 373
+G G FG V K TTVAVK + E+ + + +E ++ + H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPS-------------------FNDGS 414
L G C DG L+ +Y G++ L S N
Sbjct: 68 LYGACSQDG------PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD- 120
Query: 415 GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
+R LT + +++G+ YL + + HRD+ A N+L+ + +++DFGL+
Sbjct: 121 ---ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 475 KQSREGQSHLT-TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533
+ E S++ ++ ++A E T +SDV+SFGV++ EI ++
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI--------VTLG 226
Query: 534 GSPRACLITDWVWSLVKAG 552
G+P + + +++L+K G
Sbjct: 227 GNPYPGIAPERLFNLLKTG 245
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 23/192 (11%)
Query: 340 VAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMP 398
VAVK + +F EV+I+S L N+ L G C VD ++ +YM
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD------PPLCMIMEYME 102
Query: 399 NGNVDDHLFPS--FNDGSGVAKRPLTWPQRKNIILDVAKGLAYL--HYGVKPAIYHRDIK 454
NG+++ L G + L++ + +A G+ YL V HRD+
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV-----HRDLA 157
Query: 455 ATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH----GYLAPEYALYGQLTEKSD 510
N L+ + ++ADFG+ SR S RV G ++A E L G+ T KSD
Sbjct: 158 TRNCLVGKNYTIKIADFGM---SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214
Query: 511 VYSFGVVILEIM 522
V++FGV + EI+
Sbjct: 215 VWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 314 KFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLK 367
K+ + IG G FG K IL +DG +K++ S E EV ++SN+K
Sbjct: 1 KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK 57
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N+V + + E G+ Y+V DY G+ L+ N GV +P+ +
Sbjct: 58 HPNIVQYQ-----ESFEENGN-LYIVMDYCEGGD----LYKKINAQRGVL-----FPEDQ 102
Query: 428 NIILD----VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
ILD + L ++H I HRDIK+ NI L D ++ DFG+A+
Sbjct: 103 --ILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVE 156
Query: 484 LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK 526
L GT YL+PE KSD+++ G V+ E MC K
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYE-MCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 321 IGRGGFG--LVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRG 376
+G+G FG +Y+ +D + V K+V + + + NE+ I+S L+H N++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
+ D + +Y G + D + G + + W + +
Sbjct: 67 HFMDDN------TLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLW-----YLFQIVSA 113
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
++Y+H K I HRDIK NI L ++ DFG++K S T V GT Y++
Sbjct: 114 VSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMS 169
Query: 497 PEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531
PE + KSD+++ G V+ E++ ++ D +
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 317 QKNFIGRGGFGLVYKGILQD-GTTVAVKKV-IESDFQGDAEFCN----EVEIISNLKHRN 370
+GRG FG VY D G +AVK+V + D Q ++ N E++++ NL+H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V GC + D + ++ S + +YMP G++ D L A LT +
Sbjct: 66 IVQYYGC-LRDPEEKKLS---IFVEYMPGGSIKDQL---------KAYGALTENVTRRYT 112
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--QSREGQSHLTTRV 488
+ +G++YLH + I HRDIK NIL D+ ++ DFG +K Q+ V
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
GT +++PE K+DV+S ++E++
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIE-SDFQGDAEFC-NEVEIISNLKHRNLVPLRGC 377
IG G +G+V I + G VA+KK+ D A+ E++I+ + KH N++ +R
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDD--HLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G + + Y+V D M + D H+ S +PLT + + + +
Sbjct: 73 LRPPGAD--FKDVYVVMDLMES----DLHHIIHS--------DQPLTEEHIRYFLYQLLR 118
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK----QSREGQSHLTTRVAGT 491
GL Y+H + HRD+K +N+L++ D R+ DFG+A+ E + +T VA T
Sbjct: 119 GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-T 174
Query: 492 HGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKAL 528
Y APE L + T D++S G + E M GR+ L
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAE-MLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV---PLRGC 377
IG+G FG VY+ +D + KV+ E + E+ + RN++ L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK-----EIVAKKEVAHTIGERNILVRTLLDES 55
Query: 378 CVVDG---DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
+ G + S+ YLV DYM G + HL +G R K I ++
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFSEDRA------KFYIAELV 106
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
L +LH K I +RD+K NILLDA + DFGL+K + + T GT Y
Sbjct: 107 LALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTTNTFCGTTEY 162
Query: 495 LAPEYALYGQ-LTEKSDVYSFGVVILEIMCG 524
LAPE L + T+ D +S GV++ E+ CG
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-14
Identities = 77/300 (25%), Positives = 137/300 (45%), Gaps = 54/300 (18%)
Query: 317 QKNFIGRGGFGLVYKG-ILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
++N I RG G YKG +++G VK++ + + +E + + L+H N+V L
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C +E+G+ YL+++Y+ N+ + L R L+W +R+ I + +AK
Sbjct: 750 GLC----RSEKGA--YLIHEYIEGKNLSEVL------------RNLSWERRRKIAIGIAK 791
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
L +LH PA+ ++ I++D + + S G T+ + Y+
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYV 845
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK-- 553
APE +TEKSD+Y FG++++E++ G+ D S+V+ +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG----------SIVEWARYC 895
Query: 554 -------VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606
+W +DPS+ + +S+N I+E L + C RP +D LK LE
Sbjct: 896 YSDCHLDMW--IDPSIRGD---VSVNQNEIVEVMNL-ALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 76/308 (24%), Positives = 123/308 (39%), Gaps = 51/308 (16%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKV--IESDFQGDAEFCNEVE 361
+ +DLE +D +G G G V K TV KKV I + + E++
Sbjct: 3 RNEDLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ 55
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR-- 419
I+ + +V G + + + + ++M G++D + K+
Sbjct: 56 IMHECRSPYIVSFYGAFLNENN------ICMCMEFMDCGSLD-----------RIYKKGG 98
Query: 420 PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479
P+ I + V +GL YL+ I HRDIK +NIL+++ + ++ DFG+ S E
Sbjct: 99 PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGV---SGE 153
Query: 480 GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS---TSGSP 536
+ + GT Y++PE G+ T KSDV+S G+ I+E+ G+ S G
Sbjct: 154 LINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
Query: 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP 596
I D + +V+ P L DF + FV C RP
Sbjct: 214 DPMGILDLLQQIVQE-------PPPRLPSSDF-----PEDLRDFV---DACLLKDPTERP 258
Query: 597 TISDALKM 604
T M
Sbjct: 259 TPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 66/232 (28%), Positives = 98/232 (42%), Gaps = 55/232 (23%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHR 369
+K+ + + IG G +G+V+K ++ G VA+KK +ES D E+ ++ LKH
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 370 NLVPL----RGCCVVDGDNERGSERYLVYDYM-----------PNGNVDDHLFPSFNDGS 414
NLV L R R + +LV++Y P G V +HL
Sbjct: 61 NLVNLIEVFR----------RKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLI------- 102
Query: 415 GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
K II + + + H K HRD+K NIL+ + ++ DFG A
Sbjct: 103 ------------KKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFA 147
Query: 475 KQSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCG 524
+ T VA T Y APE L G Q DV++ G V E++ G
Sbjct: 148 RILTGPGDDYTDYVA-TRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCN----EVEIISNLK 367
D++ + +G G +G V G VA+KK+ FQ A E+ ++ ++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQ-SAIHAKRTYRELRLLKHMD 72
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N++ L E + YLV M L + V + L+ +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM-----GADL------NNIVKCQKLSDDHIQ 121
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
++ + +GL Y+H I HRD+K +NI ++ D ++ DFGLA+ + +T
Sbjct: 122 FLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGY 175
Query: 488 VAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
VA T Y APE L + + D++S G ++ E++ G+
Sbjct: 176 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 321 IGRGGFGLVYKGILQD---GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGC 377
IG G G+V I D G VAVKK+ Q NEV I+ + +H N+V +
Sbjct: 27 IGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
+V G E ++V +++ G + D V + Q + L V K L
Sbjct: 85 YLV------GDELWVVMEFLEGGALTDI----------VTHTRMNEEQIATVCLAVLKAL 128
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
++LH + HRDIK+ +ILL +D R +++DFG Q + + V GT ++AP
Sbjct: 129 SFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAP 184
Query: 498 EY---ALYGQLTEKSDVYSFGVVILEIMCG 524
E YG TE D++S G++++E++ G
Sbjct: 185 EVISRLPYG--TE-VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 31/234 (13%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
K+++ IG+G G V+ I + G VA+K++ NE+ ++ LK+ N+V
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
+V G E ++V +Y+ G++ D + + D + +A + +
Sbjct: 80 NFLDSFLV------GDELFVVMEYLAGGSLTDVVTETCMDEAQIAA----------VCRE 123
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ L +LH + HRDIK+ N+LL D ++ DFG Q QS +T V GT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-STSGSP 536
++APE K D++S G++ +E++ G +AL L +T+G+P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 68/254 (26%), Positives = 103/254 (40%), Gaps = 64/254 (25%)
Query: 312 TDKFSQK-NFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----------- 358
++++ QK +G G +G V K G VA+KKV + D
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 359 ---EVEIISNLKHRNLVPLRGCCVVDGDNERGSERY--LVYDYMPNGNVDDHLFPSFNDG 413
E++I++ +KH N++ L V + LV D M L +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYV--------EGDFINLVMDIM-----ASDLKKVVD-- 111
Query: 414 SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473
K LT Q K I+L + GL LH K HRD+ NI +++ ++ADFGL
Sbjct: 112 ---RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGL 165
Query: 474 AK-----------------QSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSF 514
A+ Q RE +T++V T Y APE L G + D++S
Sbjct: 166 ARRYGYPPYSDTLSKDETMQRRE---EMTSKVV-TLWYRAPEL-LMGAEKYHFAVDMWSV 220
Query: 515 GVVILEIMCGRKAL 528
G + E++ G K L
Sbjct: 221 GCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 321 IGRGGFGLV-YKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
IG G G+V + G VAVKK+ Q NEV I+ + +H N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
V G E ++V +++ G + D V + Q + L V K L+
Sbjct: 88 V------GDELWVVMEFLEGGALTDI----------VTHTRMNEEQIAAVCLAVLKALSV 131
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-SREGQSHLTTRVAGTHGYLAPE 498
LH + HRDIK+ +ILL D R +++DFG Q S+E + GT ++APE
Sbjct: 132 LH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE 186
Query: 499 YALYGQLTEKSDVYSFGVVILEIMCG 524
+ D++S G++++E++ G
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 1e-13
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
K+++ IG+G G VY I + G VA+K++ NE+ ++ K+ N+V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
+V G E ++V +Y+ G++ D + + D +A + +
Sbjct: 80 NYLDSYLV------GDELWVVMEYLAGGSLTDVVTETCMDEGQIAA----------VCRE 123
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ L +LH + HRDIK+ NILL D ++ DFG Q QS +T V GT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-STSGSP 536
++APE K D++S G++ +E++ G +AL L +T+G+P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 34/221 (15%)
Query: 321 IGRGGFGLVYKGIL-----QDGTTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G FG +YKG L VA+K + + ++ Q EF E +++ L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF---PSFN-----DGSGVAKRPLTWPQR 426
G + ++++Y+ G++ + L P + D G K L
Sbjct: 73 LGVVTQE------QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 427 KNIILDVAKGLAYL--HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
+I + +A G+ YL H+ V H+D+ A NIL+ + +++D GL SRE S
Sbjct: 127 LHIAIQIAAGMEYLSSHFFV-----HKDLAARNILIGEQLHVKISDLGL---SREIYSAD 178
Query: 485 TTRVAGTH----GYLAPEYALYGQLTEKSDVYSFGVVILEI 521
RV ++ PE +YG+ + SD++SFGVV+ EI
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 31/95 (32%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS-REGQSHLTTRVAG 490
++ GL +LH + I +RD+K N+LLD++ ++ADFG+ K+ G + T+ G
Sbjct: 104 EIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCG 158
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
T Y+APE Y D ++ GV++ E++ G+
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 52/221 (23%)
Query: 321 IGRGGFGLV----YKGILQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKHRNL 371
+G G FG V +K G A+K K+++ Q + NE I+ +++H L
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLK-QVE-HVLNEKRILQSIRHPFL 63
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-----FPSFNDGSGVAKRPLTWPQR 426
V L G D N YLV +Y+P G + HL FP P
Sbjct: 64 VNLYGS-FQDDSN-----LYLVMEYVPGGELFSHLRKSGRFPE--------------PVA 103
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ V L YLH +Y RD+K N+LLD+D ++ DFG AK+ + T
Sbjct: 104 RFYAAQVVLALEYLHS--LDIVY-RDLKPENLLLDSDGYIKITDFGFAKRVKGR----TY 156
Query: 487 RVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCG 524
+ GT YLAPE L YG+ D ++ G++I E++ G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKA---VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 321 IGR----GGFGLVYKGILQDGTTVAVKKV-IESDFQGDAEFC-NEVEIISNLKHRNLVPL 374
IG+ + K T VAVKK+ ++S + D + E+ L+H N++P
Sbjct: 6 IGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG---SGVAKRPLTWPQRKNIIL 431
+VD SE Y+V M G+ +D L F +G +A I+
Sbjct: 65 VTSFIVD------SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA----------FILK 108
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF----GLAKQS-REGQSHLTT 486
DV L Y+H HR +KA++ILL D + ++ + K R+ H
Sbjct: 109 DVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165
Query: 487 RVAGTH-GYLAPEYALYGQL---TEKSDVYSFGVVILEIMCG 524
+ + + +L+PE L L EKSD+YS G+ E+ G
Sbjct: 166 KSSVKNLPWLSPE-VLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
IG G G+V + G VAVKK+ Q NEV I+ + H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
V G E ++V +++ G + D V + Q + L V + L+Y
Sbjct: 90 V------GDELWVVMEFLEGGALTDI----------VTHTRMNEEQIATVCLSVLRALSY 133
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-SREGQSHLTTRVAGTHGYLAPE 498
LH + HRDIK+ +ILL +D R +++DFG Q S+E + GT ++APE
Sbjct: 134 LH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPE 188
Query: 499 YALYGQLTEKSDVYSFGVVILEIMCG 524
+ D++S G++++E++ G
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 315 FSQKNFIGRGGFGLVYKGIL--QDGTTVAVK-KVIESDFQGDA---EFCNEVEIISNLKH 368
F+ +G+G FG V + L +DG+ V K++++D + EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
N++ L G + R ++ +M +G++ L S + + P T P +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-----MSRIGEEPFTLPLQTL 115
Query: 429 I--ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ----- 481
+ ++D+A G+ YL HRD+ A N +L+ +M VADFGL+K+ G
Sbjct: 116 VRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 482 --SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
S L + +LA E T SDV++FGV + EIM
Sbjct: 173 CASKLPVK------WLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLKHRNLVPLRGC 377
IG G +G+VYK G VA+KK+ +E++ +G + E+ ++ L H N+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD- 65
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
VV +N+ YLV++++ D + D L P K+ + + +G+
Sbjct: 66 -VVHSENKL----YLVFEFL------DLDLKKYMDS--SPLTGLDPPLIKSYLYQLLQGI 112
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG------T 491
AY H + HRD+K N+L+D + ++ADFGLA R G T
Sbjct: 113 AYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLA------------RAFGVPVRTYT 157
Query: 492 HG-----YLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKAL 528
H Y APE L Q + D++S G + E M R+ L
Sbjct: 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAE-MVNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV--IE-SDFQGDAEFCNEVEIISNLKHRNLVPLRG 376
IG+G F +VYK I L DG VA+KKV E D + + E++++ L H N++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
+ + +E +V + G++ + F KR + + +
Sbjct: 70 SFIEN------NELNIVLELADAGDLS-RMIKHFKKQ----KRLIPERTIWKYFVQLCSA 118
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
L ++H I HRDIK N+ + A ++ D GL + + + V GT Y++
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 497 PEYALYGQLTEKSDVYSFGVVILEIMC 523
PE KSD++S G ++ E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCN-----EVEIISNL 366
+K+ +G G +G+V K ++ G VA+KK +ES+ D + E+ ++ L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE---DDKMVKKIAMREIRMLKQL 57
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDD-HLFPSFNDGSGVAKRPLTWPQ 425
+H NLV L R YLV++++ + +DD +P+ D S V K
Sbjct: 58 RHENLVNLIEVF------RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK------- 104
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ + +G+ + H I HRDIK NIL+ ++ DFG A+ T
Sbjct: 105 ---YLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
Query: 486 TRVAGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILEIMCG 524
VA T Y APE + YG+ D+++ G ++ E++ G
Sbjct: 159 DYVA-TRWYRAPELLVGDTKYGRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 68/260 (26%), Positives = 117/260 (45%), Gaps = 42/260 (16%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIE-----SDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG VYKGI + DG V + I+ + + + E +E +++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G C+ S LV MP G + D++ N ++ L W + +A
Sbjct: 75 LGICLT-------STVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNW------CVQIA 119
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--QSREGQSHLTTRVAGTH 492
KG++YL + + HRD+ A N+L+ + ++ DFGLA+ E + H
Sbjct: 120 KGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMC----------GRKALDLSTSGS--PRACL 540
++A E L+ + T +SDV+S+GV + E+M R+ DL G P+ +
Sbjct: 177 -WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI 235
Query: 541 ITDWVWSLVKAGKVWQALDP 560
T V+ ++ K W +D
Sbjct: 236 CTIDVYMIMV--KCWM-IDS 252
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 69/261 (26%), Positives = 107/261 (40%), Gaps = 34/261 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLKHR 369
D + + IG G +G VYK G VA+KK +E D +G E+ ++ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 370 NLVPLRGCCVVDGDNERG-SERYLVYDYMPNGNVDDHLFPSFNDGSGVAK-RPLTWPQRK 427
+ +R V + + G YLV++Y+ D F D +G RPL K
Sbjct: 61 IYI-VRLLDVEHVEEKNGKPSLYLVFEYL------DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQSREGQSHLTT 486
+ + + KG+A+ H K + HRD+K N+L+D ++AD GL + T
Sbjct: 114 SFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 487 RVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIM------CGRKALD-----LSTSG 534
+ T Y APE L + D++S G + E+ G L G
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229
Query: 535 SPRACLITDWVWSLVKAGKVW 555
+P T+ VW V + W
Sbjct: 230 TP-----TEQVWPGVSKLRDW 245
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD---AEFCNEVEIISNLKHRNLVPLRG 376
+G G +G V + + G VA+KK + FQ + E+ ++ ++KH N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKK-LYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
D +R + YLV MP F + G + L+ + + ++ + KG
Sbjct: 82 VFTPDLSLDRFHDFYLV---MP--------FMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
L Y+H I HRD+K N+ ++ D ++ DFGLA+Q+ S +T V T Y A
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV-TRWYRA 183
Query: 497 PEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
PE L + T+ D++S G ++ E++ G+
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 39/229 (17%)
Query: 318 KNFIGRGGFGLVY----KGIL---------QDGTTVAVK-KVIESDFQGDA--EFCNEVE 361
K +G G FG V+ +G+ DG V V K++ +D A +F E++
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL--------FPSFNDG 413
I+S LK+ N++ L G CV D ++ +YM NG+++ L F N+
Sbjct: 70 IMSRLKNPNIIRLLGVCVSD------DPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 414 SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473
V+ L + + + +A G+ YL HRD+ N L+ ++ADFG+
Sbjct: 124 PSVSIANLLY-----MAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGM 175
Query: 474 AKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
++ G + + R ++A E L G+ T SDV++FGV + E+
Sbjct: 176 SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA------EFCNEVEIISNLKHRNLVPL 374
IG G FG V G G + A +V+ + + A F EV+ L H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKA--RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G C+ LV ++ P G++ ++L + + +A++ + QR + +VA
Sbjct: 61 LGQCI------ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL--QR--MACEVA 110
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-KQSREGQSHLTTRVAGTHG 493
GL +LH + H D+ N L AD+ ++ D+GLA +Q E A
Sbjct: 111 SGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 494 YLAPEYA-------LYGQLTEKSDVYSFGVVILEI 521
+LAPE L T+KS+++S GV + E+
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIES-DFQGDA-EFCNEVEIISNLKHRNLVPLRGC 377
IG+G +G+V I G VA+KK+ + + DA E++++ L+H ++V ++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
+ E + Y+V++ M + D H ND LT + + + + L
Sbjct: 68 MLPPSRREF-KDIYVVFELMES---DLHQVIKANDD-------LTPEHHQFFLYQLLRAL 116
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS---REGQSHLTTRVAGTHGY 494
Y+H ++HRD+K NIL +AD + ++ DFGLA+ + T VA T Y
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TRWY 172
Query: 495 LAPEY--ALYGQLTEKSDVYSFGVVILEIMCGR---------KALDLSTS--GSP 536
APE + + + T D++S G + E++ G+ LDL T G+P
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 62/234 (26%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
K+++ IG+G G VY + + G VA++++ NE+ ++ K+ N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
+V G E ++V +Y+ G++ D + + D +A + +
Sbjct: 81 NYLDSYLV------GDELWVVMEYLAGGSLTDVVTETCMDEGQIAA----------VCRE 124
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ L +LH + HRDIK+ NILL D ++ DFG Q QS +T V GT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 180
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-STSGSP 536
++APE K D++S G++ +E++ G +AL L +T+G+P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 63/225 (28%), Positives = 111/225 (49%), Gaps = 28/225 (12%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTT----VAVKKVIESDF-QGDAEFCNEVEIISNLK 367
+F + +G G FG VYKG+ + +G VA+K++ E+ + + E +E +++++
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
+ ++ L G C+ S L+ MP G + D++ D G ++ L W
Sbjct: 68 NPHVCRLLGICLT-------STVQLITQLMPFGCLLDYVREH-KDNIG-SQYLLNW---- 114
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--QSREGQSHLT 485
+ +AKG+ YL + + HRD+ A N+L+ ++ DFGLAK + E + H
Sbjct: 115 --CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALD 529
++A E L+ T +SDV+S+GV + E+M G K D
Sbjct: 170 GGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 38/216 (17%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKK-----VIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G GGFG V ++ T A+K ++E+ Q +E EI+ H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFP--SFNDGSGVAKRPLTWPQRKNIILD 432
D + Y++ +Y G + L F++ + I
Sbjct: 59 YRTFK---DKK---YIYMLMEYCLGGELWTILRDRGLFDE-----------YTARFYIAC 101
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
V YLH I +RD+K N+LLD++ ++ DFG AK+ + GQ T GT
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTP 156
Query: 493 GYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGR 525
Y+APE L Y D +S G+++ E++ GR
Sbjct: 157 EYVAPEIILNKGYDFS---VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 320 FIGRGGFGLV----YKGILQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNLK-HRN 370
+G+G +G+V + TVA+KK+ ++ E++++ + + H+N
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKI--TNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+ C+ D D +Y Y D H SG PLT ++ I
Sbjct: 64 IT-----CLYDMDIVFPGNFNELYLYEELMEADLHQIIR----SGQ---PLTDAHFQSFI 111
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK----QSREGQSHLTT 486
+ GL Y+H + HRD+K N+L++AD ++ DFGLA+ E +T
Sbjct: 112 YQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168
Query: 487 RVAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGRK 526
VA T Y APE L Q K+ DV+S G ++ E++ GRK
Sbjct: 169 YVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 29/232 (12%)
Query: 303 FKIQDLERAT----DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD---A 354
F +++ + ++++ +G G +G V I + G VA+KK + FQ +
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK-LSRPFQSEIFAK 59
Query: 355 EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGS 414
E+ ++ +++H N++ L + + YLV YM D
Sbjct: 60 RAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM------------QTDLQ 107
Query: 415 GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
+ PL+ + + ++ + GL Y+H I HRD+K N+ ++ D ++ DFGLA
Sbjct: 108 KIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 475 KQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
R + +T V T Y APE L + + D++S G ++ E++ G+
Sbjct: 165 ---RHADAEMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 30/217 (13%)
Query: 320 FIGRGGFGLVYKGILQD-GTTVAVKKV------IESDFQGDAEFCNEVEIISNLKHRNLV 372
+G+G FG VY D G +AVK+V E+ + +A C E++++ NL H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC-EIQLLKNLLHERIV 67
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
GC + ER ++ ++MP G++ D L G +T + I+
Sbjct: 68 QYYGC--LRDPMERTLSIFM--EHMPGGSIKDQL-----KSYGALTENVTRKYTRQIL-- 116
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR----EGQSHLTTRV 488
+G++YLH + I HRDIK NIL D+ ++ DFG +K+ + G + V
Sbjct: 117 --EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--V 169
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT +++PE K+D++S G ++E++ +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 315 FSQKNFIGRGGFGLVYK-GILQDGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRN 370
F Q +G+GGFG V + G A KK+ + + G++ NE +I+ + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L E LV M G++ H++ G + + + +
Sbjct: 62 VVSLAYA------YETKDALCLVLTLMNGGDLKFHIYHMGEAG---------FEEGRAVF 106
Query: 431 L--DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
++ GL LH + I +RD+K NILLD R++D GLA EGQ+ + RV
Sbjct: 107 YAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV 162
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT GY+APE + T D ++ G ++ E++ G+
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
IG G G+V + G VAVK + Q NEV I+ + +H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
V G E +++ +++ G + D V++ L Q + V + L Y
Sbjct: 89 V------GEELWVLMEFLQGGALTDI----------VSQTRLNEEQIATVCESVLQALCY 132
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEY 499
LH + HRDIK+ +ILL D R +++DFG Q + + V GT ++APE
Sbjct: 133 LH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEV 188
Query: 500 ALYGQLTEKSDVYSFGVVILEIMCG 524
+ D++S G++++E++ G
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 46/137 (33%), Positives = 61/137 (44%), Gaps = 23/137 (16%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKR---PLTWPQRKNIILDVAKGLAYLHYGVKPA 447
YLV +Y+ G+ S + P W K I +V G+ LH +
Sbjct: 73 YLVMEYLNGGDC----------ASLIKTLGGLPEDWA--KQYIAEVVLGVEDLH---QRG 117
Query: 448 IYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE 507
I HRDIK N+L+D ++ DFGL SR G + GT YLAPE L +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGL---SRNGL--ENKKFVGTPDYLAPETILGVGDDK 172
Query: 508 KSDVYSFGVVILEIMCG 524
SD +S G VI E + G
Sbjct: 173 MSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 321 IGRGGFGLV----YKGILQDGTTVAVKK--VIESDFQGDAEFCNE--VEIISNLKHRNLV 372
+GRG FG V YK + A+KK +I D + ++ C + E ++ +H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD-EVESLMCEKRIFETANSERHPFLV 65
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L C + V +Y G++ H + + P+
Sbjct: 66 NLFACFQTE------DHVCFVMEYAAGGDLMMH----------IHTDVFSEPRAVFYAAC 109
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
V GL YLH + I +RD+K N+LLD + ++ADFGL K+ G T+ GT
Sbjct: 110 VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTP 165
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
+LAPE T D + GV+I E++ G
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 18/218 (8%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTT-----VAVKKVIE--SDFQGDAEFCNEVEIISN 365
D+ + + + G FG ++ GIL D V VK V + S+ Q E ++
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYG 64
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
L H+N++P+ C+ DG+ +++Y YM GN+ L G + L+ Q
Sbjct: 65 LSHQNILPILHVCIEDGEPP-----FVLYPYMNWGNLKLFL-QQCRLGEANNPQALSTQQ 118
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH-L 484
++ + +A G++YLH K + H+DI A N ++D +++ ++ D L++ H L
Sbjct: 119 LVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
++A E + + + SDV+SFGV++ E+M
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 45/236 (19%)
Query: 307 DLERATDK-FSQKNFIGRGGFGLVYKGILQDGT-TVAVKKVIESDFQGDAEFCN-EVEII 363
D+ R+ +K + N IG G FG+VY+ I D + VA+KKV++ D ++ N E+ I+
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLIM 113
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYL----------VYDYMPNGNVDDHLFPSFNDG 413
NL H N++ L+ + + +L V+ YM + ++H P F
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF--- 170
Query: 414 SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA-RVADFG 472
K + + LAY+H I HRD+K N+L+D + ++ DFG
Sbjct: 171 -----------LVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216
Query: 473 LAKQSREGQ---SHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCG 524
AK GQ S++ +R Y APE L T D++S G +I E++ G
Sbjct: 217 SAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 321 IGRGGFGLVYKGILQDG---TTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGC 377
+GRG +G VYK +DG A+K++ + A C E+ ++ LKH N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR--KNIILDVAK 435
+ D + +L++DY + D F+ S K+P+ P+ K+++ +
Sbjct: 67 FLSHSDR----KVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDAD----MRARVADFGLAKQSREGQSHLT--TRVA 489
G+ YLH + HRD+K NIL+ + R ++AD G A+ L V
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 490 GTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIM 522
T Y APE L + T+ D+++ G + E++
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 321 IGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQGDA---EFCNEVEIISNLKHRNLVPL 374
+G G FG V KG+ + TVAVK ++++D A E E ++ L + +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G C LV + G ++ L + + V ++ +T ++ V+
Sbjct: 62 IGIC-------EAESWMLVMELAELGPLNKFLQKNKH----VTEKNIT-----ELVHQVS 105
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG- 493
G+ YL + HRD+ A N+LL A+++DFGL+K +++ A THG
Sbjct: 106 MGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK---AKTHGK 159
Query: 494 ----YLAPEYALYGQLTEKSDVYSFGVVILE 520
+ APE Y + + KSDV+SFGV++ E
Sbjct: 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDA---EFCNEVEIISNLK 367
T+++ +G G FGLV Q G VA+KK+++ F E++++ +L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLR 67
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N++ L + E + Y V + + D H + RPL +
Sbjct: 68 HENIISL--SDIFISPLE---DIYFVTELL---GTDLHRL--------LTSRPLEKQFIQ 111
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+ + +GL Y+H + HRD+K +NIL++ + ++ DFGLA R +T
Sbjct: 112 YFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGY 165
Query: 488 VAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGR 525
V+ T Y APE L Q + D++S G + E++ G+
Sbjct: 166 VS-TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV-AG 490
++A GL +LH I +RD+K N++LDA+ ++ADFG+ K++ G TTR G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCG 163
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529
T Y+APE Y + D ++FGV++ E++ G+ D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 29/199 (14%)
Query: 340 VAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYM 397
VAVK ++ D +A +F EV+I+S LK N++ L G CV + ++ +YM
Sbjct: 49 VAVK-ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE------DPLCMITEYM 101
Query: 398 PNGNVDDHLFPSF--------NDGSGVAKRPLT--WPQRKNIILDVAKGLAYLHYGVKPA 447
NG+++ L ND A + ++ L +A G+ YL
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158
Query: 448 IYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH----GYLAPEYALYG 503
HRD+ N L+ ++ ++ADFG+++ G + R+ G ++A E L G
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMG 215
Query: 504 QLTEKSDVYSFGVVILEIM 522
+ T SDV++FGV + EI+
Sbjct: 216 KFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCC 378
+G G G VYK + KVI D + + +E+EI+ ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
V+ R S + ++M G++D + R + I + V KGL
Sbjct: 69 FVE---NRIS---ICTEFMDGGSLDVY-------------RKIPEHVLGRIAVAVVKGLT 109
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
YL + +K I HRD+K +N+L++ + ++ DFG+ S + + + GT+ Y+APE
Sbjct: 110 YL-WSLK--ILHRDVKPSNMLVNTRGQVKLCDFGV---STQLVNSIAKTYVGTNAYMAPE 163
Query: 499 YALYGQLTEKSDVYSFGVVILEIMCGR 525
Q SDV+S G+ +E+ GR
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 66/254 (25%), Positives = 111/254 (43%), Gaps = 58/254 (22%)
Query: 321 IGRGGFGLVYK----GILQDGT--TVAVKKVIESDFQGDAE-FCNEVEIISNL-KHRNLV 372
+G G FG V + G+ + VAVK + + + E +E++I+S+L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL------FPSFNDGSGVAKRPLTWPQR 426
L G C + G ++ +Y G++ + L F + D + +
Sbjct: 103 NLLGACTIGG------PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ------- 149
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR-------E 479
VAKG+A+L K I HRD+ A N+LL ++ DFGLA+ +
Sbjct: 150 ------VAKGMAFLAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200
Query: 480 GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539
G + L + ++APE T +SDV+S+G+++ EI S +P
Sbjct: 201 GNARLPVK------WMAPESIFNCVYTFESDVWSYGILLWEI--------FSLGSNPYPG 246
Query: 540 LITD-WVWSLVKAG 552
+ D + L+K G
Sbjct: 247 MPVDSKFYKLIKEG 260
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 321 IGRGGFGLVYKGILQDG---TTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGC 377
+GRG +G VYK +DG A+K++ + A C E+ ++ LKH N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR--KNIILDVAK 435
+ D + +L++DY + D F+ S K+P+ P+ K+++ +
Sbjct: 67 FLSHADR----KVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDAD----MRARVADFGLAKQSREGQSHLT--TRVA 489
G+ YLH + HRD+K NIL+ + R ++AD G A+ L V
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 490 GTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIM 522
T Y APE L + T+ D+++ G + E++
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 38/91 (41%), Positives = 56/91 (61%), Gaps = 6/91 (6%)
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
GL +LH K I +RD+K N+LLD D ++ADFG+ K++ G+ +T GT Y+
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYI 163
Query: 496 APEYALYGQL-TEKSDVYSFGVVILEIMCGR 525
APE L GQ E D +SFGV++ E++ G+
Sbjct: 164 APE-ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 41/283 (14%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV---IESDFQGDAEFCNEVEIISNLKH 368
+++ + +G G +G V + G VAVKK+ +S + E+ ++ ++KH
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKH 75
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK-RPLTWPQRK 427
N++ L E ++ YLV HL + D + + K + LT +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLV----------THLMGA--DLNNIVKCQKLTDDHVQ 123
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+I + +GL Y+H I HRD+K +N+ ++ D ++ DFGLA+ + + +T
Sbjct: 124 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGY 177
Query: 488 VAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRK-----------ALDLSTSGS 535
VA T Y APE L + + D++S G ++ E++ GR L L G+
Sbjct: 178 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236
Query: 536 PRACLITDWVWSLVKAGKVWQALD--PSLLKEDDFLSLNPKAI 576
P A L+ S A Q+L P + + F+ NP A+
Sbjct: 237 PGAELLKK--ISSESARNYIQSLTQMPKMNFANVFIGANPLAV 277
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 47/229 (20%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEF----CNEVEIISNLK 367
+KF +G G +G+V K ++ VA+KK D + + E E++++ LK
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDY-----------MPNGNVDDHLFPSFNDGSGV 416
N+V L+ + RG + YLV++Y MPNG + +
Sbjct: 59 QENIVELK-----EAFRRRG-KLYLVFEYVEKNMLELLEEMPNGVPPEKV---------- 102
Query: 417 AKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476
++ I + K + + H K I HRDIK N+L+ + ++ DFG A+
Sbjct: 103 ----------RSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARN 149
Query: 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
EG + T T Y +PE L + D++S G ++ E+ G+
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 315 FSQKNFIGRGGFGLVYK-GILQDGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRN 370
F Q +G+GGFG V + G A K++ + + G++ NE +I+ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L E LV M G++ H++ N G +R L +
Sbjct: 62 VVNLAYA------YETKDALCLVLTIMNGGDLKFHIYNMGNPGFE-EERALFYAA----- 109
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
++ GL LH + +RD+K NILLD R++D GLA + EG+S + RV G
Sbjct: 110 -EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-G 163
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
T GY+APE + T D + G +I E++ G+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 22/220 (10%)
Query: 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNLKHRN 370
K+ + +GRG FG+V+ + + + K I + E NE +++ L H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
++ + D +V +Y P G + +++ KR + I+
Sbjct: 61 IIEYYENFLED------KALMIVMEYAPGGTLAEYI----------QKRCNSLLDEDTIL 104
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQSREGQSHLTTRVA 489
+ L LH+ I HRD+K NILLD M ++ DFG++K T V
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VV 162
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529
GT Y++PE +KSD+++ G V+ E+ ++A +
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 321 IGRGGFGLVYKGILQ----DGTTVAVKKVIE--SDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG + +G L+ VA+ + SD Q F E + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVRL 71
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G RG+ +V +YM NG +D F ++G L Q ++ +A
Sbjct: 72 EGVIT------RGNTMMIVTEYMSNGALDS--FLRKHEGQ------LVAGQLMGMLPGLA 117
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
G+ YL + H+ + A +L+++D+ +++ F ++ + + T +
Sbjct: 118 SGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIM 522
APE Y + SDV+SFG+V+ E+M
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 40/224 (17%)
Query: 321 IGRGGFGLVYKGIL------QDGTTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVP 373
+G FG VYKG L + VA+K + + ++ EF +E + S L+H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF---PSFNDGSG----VAKRPLTWPQR 426
L G + +++ Y + ++ + L P + GS K L
Sbjct: 73 LLGVVTKE------QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 427 KNIILDVAKGLAYL--HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE----- 479
+I+ +A G+ +L H+ + H+D+ N+L+ + +++D GL ++
Sbjct: 127 VHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 480 --GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
G S L R +++PE +YG+ + SD++S+GVV+ E+
Sbjct: 182 LMGNSLLPIR------WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 321 IGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQGDA-EFCNEVEIISNLKHRNLVPLRG 376
+G G FG V KG+ + VA+K + + + E E EI+ L + +V + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
C LV + G ++ L K +T ++ V+ G
Sbjct: 63 VC-------EAEALMLVMEMASGGPLNKFL--------SGKKDEITVSNVVELMHQVSMG 107
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH--GY 494
+ YL HRD+ A N+LL A+++DFGL+K S+ R AG +
Sbjct: 108 MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKW 164
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILE 520
APE + + + +SDV+S+G+ + E
Sbjct: 165 YAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 62/233 (26%), Positives = 97/233 (41%), Gaps = 48/233 (20%)
Query: 321 IGRGGFGLVYKGILQD---GTTVAVKKVIESDFQGDA----EFCNEVEIISNLKHRNLVP 373
IG+GG G VY D VA+KK I D + F E +I ++L H +VP
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKK-IREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 374 LRGCCVVDGDNERGSERYLVYDYMP--NGNVDDHLFPSFNDGSGVAKRPL----TWPQRK 427
+ C DGD VY MP G L S ++K L +
Sbjct: 67 VYSICS-DGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSK-ELAEKTSVGAFL 116
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ------ 481
+I + + Y+H + HRD+K NILL + D+G A ++ +
Sbjct: 117 SIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAI-FKKLEEEDLLD 172
Query: 482 ----------SHLTT--RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
S +T ++ GT Y+APE L +E +D+Y+ GV++ +++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 17/220 (7%)
Query: 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH-RNLVP 373
F +G G +G VYKG +A KV++ + E E+ ++ H RN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
G + + +LV ++ G+V D + G+ + + + + I ++
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAY-----ICREI 120
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
+GL++LH + + HRDIK N+LL + ++ DFG++ Q T + GT
Sbjct: 121 LRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 176
Query: 494 YLAPEYALYGQLTE-----KSDVYSFGVVILEIMCGRKAL 528
++APE + + KSD++S G+ +E+ G L
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
GL +LH I +RD+K NILLD D ++ADFG+ K++ G + T GT Y+
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYI 163
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCGR 525
APE L + D +SFGV++ E++ G+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 64/210 (30%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK----KVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
IG+G FG V DG AVK K I + ++ N+KH LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
+ + Y V DY+ G + HL +R P+ + ++A
Sbjct: 63 YSF------QTADKLYFVLDYVNGGELFFHL---------QRERSFPEPRARFYAAEIAS 107
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
L YLH I +RD+K NILLD+ + DFGL K+ E S T+ GT YL
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYL 163
Query: 496 APEYALYGQLTEKS-DVYSFGVVILEIMCG 524
APE L Q +++ D + G V+ E++ G
Sbjct: 164 APE-VLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 66/265 (24%), Positives = 120/265 (45%), Gaps = 33/265 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-----KHRNLVPLR 375
IGRG + V L+ + KV++ + D E + V+ ++ H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
C + S + V +Y+ G++ H+ +R L + +++
Sbjct: 63 SCFQTE------SRLFFVIEYVNGGDLMFHM---------QRQRKLPEEHARFYSAEISL 107
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS-REGQSHLTTRVAGTHGY 494
L YLH + I +RD+K N+LLD++ ++ D+G+ K+ R G + T+ GT Y
Sbjct: 108 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV--KAG 552
+APE D ++ GV++ E+M GR D+ S D+++ ++ K
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222
Query: 553 KVWQALD---PSLLKEDDFLSLNPK 574
++ ++L S+LK FL+ +PK
Sbjct: 223 RIPRSLSVKAASVLKS--FLNKDPK 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH--------RNLV 372
IGRG + V L+ + KV++ + D E +++ + KH LV
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---DIDWVQTEKHVFEQASSNPFLV 59
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L C + S +LV +Y+ G++ H+ +R L + +
Sbjct: 60 GLHSCF------QTTSRLFLVIEYVNGGDLMFHM---------QRQRKLPEEHARFYAAE 104
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS-REGQSHLTTRVAGT 491
+ L +LH + I +RD+K N+LLDAD ++ D+G+ K+ G + T+ GT
Sbjct: 105 ICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGT 159
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLST 532
Y+APE + D ++ GV++ E+M GR D+ T
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 36/234 (15%)
Query: 313 DKFSQKNFIGRGGFGLVY----KGILQ-------------DGTTVAVKKVIESDFQGDA- 354
+ + K +G G FG V+ +G+ + VAVK ++ D +A
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDANKNAR 63
Query: 355 -EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDD----HLFPS 409
+F E++I+S LK N++ L C+ ++ +YM NG+++ H
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITS------DPLCMITEYMENGDLNQFLSRHEPQ- 116
Query: 410 FNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469
+++ + +A G+ YL HRD+ N L+ + ++A
Sbjct: 117 -EAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIA 172
Query: 470 DFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
DFG+++ G + + R +++ E L G+ T SDV++FGV + EI+
Sbjct: 173 DFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 40/134 (29%), Positives = 68/134 (50%), Gaps = 12/134 (8%)
Query: 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451
LV M G++ H++ V +R L + + + G+ +LH I +R
Sbjct: 70 LVMSLMNGGDLKYHIY-------NVGERGLEMERVIHYSAQITCGILHLH---SMDIVYR 119
Query: 452 DIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDV 511
D+K N+LLD R++D GLA + ++G++ T+ AGT+GY+APE + D
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPVDW 177
Query: 512 YSFGVVILEIMCGR 525
++ G I E++ GR
Sbjct: 178 FAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
GL +LH I +RD+K N++LD D ++ADFG+ K++ G + +T GT Y+
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCGR 525
APE + T D +SFGV++ E++ G+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRG 376
+G G +G V + VAVKK + FQ E+ ++ ++KH N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKK-LSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK-RPLTWPQRKNIILDVAK 435
E +E YLV + M D + + K + L+ + +I + +
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGA------------DLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
GL Y+H I HRD+K +N+ ++ D R+ DFGLA+Q+ + +T VA T Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVA-TRWYR 182
Query: 496 APEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
APE L + + D++S G ++ E++ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 18/231 (7%)
Query: 305 IQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEII 363
++ L TD + IG+G +G VYK +DG+ AVK +++ D E E I+
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNIL 72
Query: 364 SNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+L H N+V G D G + +LV + G+V + + G + + L
Sbjct: 73 QSLPNHPNVVKFYGM-FYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLD 126
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
I+ GL +LH I HRD+K NILL + ++ DFG++ Q +
Sbjct: 127 EAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKS-----DVYSFGVVILEIMCGRKAL 528
T V GT ++APE Q + S DV+S G+ +E+ G L
Sbjct: 184 RRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNLKHRNLVPLRGC 377
IG G FG +Y + + V K I+ E EV +++ +KH N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGV---AKRPLTWPQRKNIILDVA 434
+G ++V +Y G+ L N GV + L+W + ++
Sbjct: 68 FQENG------RLFIVMEYCDGGD----LMKRINRQRGVLFSEDQILSW------FVQIS 111
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQSREGQSHLTTRVAGTHG 493
GL ++H I HRDIK+ NI L + M A++ DFG+A+Q + L GT
Sbjct: 112 LGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPY 167
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEI 521
YL+PE K+D++S G V+ E+
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 321 IGRGGFGLVYKG--ILQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLK---HRNLVP 373
IG G +G V+K + G VA+K+V +++ +G EV ++ +L+ H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR-KNIILD 432
L C V +R ++ LV+++ VD L + P + K+++
Sbjct: 69 LFDVCTVS-RTDRETKLTLVFEH-----VDQDLTTYLDK----VPEPGVPTETIKDMMFQ 118
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ +GL +LH + HRD+K NIL+ + + ++ADFGLA+ T V T
Sbjct: 119 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTL 173
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528
Y APE L D++S G + E M RK L
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 42/141 (29%), Positives = 74/141 (52%), Gaps = 17/141 (12%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450
Y V +Y+ G++ H+ V K PQ +++ GL +LH + I +
Sbjct: 77 YFVMEYVNGGDLMYHI-------QQVGK--FKEPQAVFYAAEISVGLFFLH---RRGIIY 124
Query: 451 RDIKATNILLDADMRARVADFGLAKQSR-EGQSHLTTRV-AGTHGYLAPEYALYGQLTEK 508
RD+K N++LD++ ++ADFG+ K+ +G +TTR GT Y+APE Y +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 509 SDVYSFGVVILEIMCGRKALD 529
D +++GV++ E++ G+ D
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRG 376
+G+GGFG V ++ G A KK+ + +G E I++ + R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
+ ++ LV M G++ H++ + G + P+ + G
Sbjct: 60 YAF-----QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE-----PRACFYTAQIISG 109
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
L +LH + I +RD+K N+LLD D R++D GLA + ++GQS T AGT G++A
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMA 165
Query: 497 PEYALYGQLTEKSDVYSFGVVILEIMCGR 525
PE + D ++ GV + E++ R
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVK----KVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
IG+G FG V + DG AVK K++ + + ++ N+KH LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
+ + Y V D++ G + HL +R P+ + ++A
Sbjct: 63 YSF------QTTEKLYFVLDFVNGGELFFHL---------QRERSFPEPRARFYAAEIAS 107
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
L YLH I +RD+K NILLD+ + DFGL K+ QS TT GT YL
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYL 163
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCG 524
APE D + G V+ E++ G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLV 372
F Q +G G + VYKG + G VA+K++ ++++ + E+ ++ LKH N+V
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L V+ +N+ LV++YM D + D GV + L K+
Sbjct: 62 RLHD--VIHTENKL----MLVFEYM------DKDLKKYMDTHGV-RGALDPNTVKSFTYQ 108
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ KG+A+ H + + HRD+K N+L++ ++ADFGLA+ + + V T
Sbjct: 109 LLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TL 164
Query: 493 GYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGR 525
Y AP+ L + S D++S G ++ E++ GR
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 21/158 (13%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVKKV-IESDFQGDAEFC-NEVEIISNLKHRNLVPLRGC 377
IG G +G V+K ++ VA+K+V ++ D +G E+ ++ LKH+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
V+ D + LV++Y D L F+ +G + K+ + + KGL
Sbjct: 67 -VLHSDKKL----TLVFEY-----CDQDLKKYFDSCNGDIDPEIV----KSFMFQLLKGL 112
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475
A+ H + HRD+K N+L++ + ++ADFGLA+
Sbjct: 113 AFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKV-IESDFQGDAEFCN---EVEIISNLKHRNLVPLR 375
+G+G +G VYK + + G T+A+K++ +E D +++F E++I+ +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G ++G Y+ +YM G++D G GVA + + I V K
Sbjct: 66 GAFFIEG------AVYMCMEYMDAGSLD-----KLYAG-GVATEGIPEDVLRRITYAVVK 113
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
GL +L I HRD+K TN+L++ + + ++ DFG++ + L G Y+
Sbjct: 114 GLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYM 168
Query: 496 APEYALYGQLTE------KSDVYSFGVVILEIMCGR 525
APE G + +SDV+S G+ ILE+ GR
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/209 (29%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVK----KVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
IG+G FG V + DG+ AVK K I + + ++ NLKH LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
+ + Y V DY+ G + HL +R P+ + +VA
Sbjct: 63 YSF------QTAEKLYFVLDYVNGGELFFHL---------QRERCFLEPRARFYAAEVAS 107
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
+ YLH I +RD+K NILLD+ + DFGL K+ E + T+ GT YL
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTSTFCGTPEYL 163
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCG 524
APE D + G V+ E++ G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 315 FSQKNFIGRGGFGLVYK-GILQDGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRN 370
F +G+GGFG V + G A KK+ + + G+A NE +I+ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L E LV M G++ H++ N G + + + +
Sbjct: 62 VVSLAYA------YETKDALCLVLTLMNGGDLKFHIYNMGNPG---------FDEERAVF 106
Query: 431 L--DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
++ GL LH + I +RD+K NILLD R++D GLA + EG++ + RV
Sbjct: 107 YAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV 162
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT GY+APE + T D + G +I E++ G+
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 35/94 (37%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
++ L YLH G I +RD+K N++LD D ++ DFGL K+ + + T GT
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGT 158
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
YLAPE D + GVV+ E+MCGR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEV-------EIISNLKHRNLVP 373
IGRG + V L+ + KVI+ + D E + V E SN H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLVG 60
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L C + S + V +++ G++ H+ +R L + ++
Sbjct: 61 LHSCF------QTESRLFFVIEFVSGGDLMFHM---------QRQRKLPEEHARFYSAEI 105
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS-REGQSHLTTRVAGTH 492
+ L +LH I +RD+K N+LLDA+ ++ D+G+ K+ R G T+ GT
Sbjct: 106 SLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTP 160
Query: 493 GYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGRKALDLSTS 533
Y+APE L G+ S D ++ GV++ E+M GR D+
Sbjct: 161 NYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 37/99 (37%), Positives = 50/99 (50%), Gaps = 14/99 (14%)
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH--LTTRVA 489
++ L YLH + +RD+K N++LD D ++ DFGL K EG S
Sbjct: 103 EIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 156
Query: 490 GTHGYLAPEY---ALYGQLTEKSDVYSFGVVILEIMCGR 525
GT YLAPE YG+ D + GVV+ E+MCGR
Sbjct: 157 GTPEYLAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 72/239 (30%), Positives = 109/239 (45%), Gaps = 43/239 (17%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNLKHRNLV--- 372
IG G FG+V+ +DG VA+KK+ FQ + C E++++ KH N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQ-NLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 373 -----PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
P E Y+V + M D H V+ +PL+ K
Sbjct: 66 DILQPPHIDPF---------EEIYVVTELM---QSDLHKII-------VSPQPLSSDHVK 106
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS-HLTT 486
+ + +GL YLH I HRDIK N+L++++ ++ DFGLA+ +S H+T
Sbjct: 107 VFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ 163
Query: 487 RVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543
V T Y APE L G T D++S G + E + GR+ L + S + LITD
Sbjct: 164 EVV-TQYYRAPEI-LMGSRHYTSAVDIWSVGCIFAE-LLGRRILFQAQSPIQQLDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNL 366
E D F + + +G G G+V+K + + +K+I + + + E++++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+V G DG E + ++M G++D V K+ P++
Sbjct: 61 NSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQ-----------VLKKAGRIPEQ 103
Query: 427 --KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
+ + V KGL YL K I HRD+K +NIL+++ ++ DFG++ Q + +
Sbjct: 104 ILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT Y++PE + +SD++S G+ ++E+ GR
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 315 FSQKNFIGRGGFGLVYK-GILQDGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRN 370
F +G+GGFG V + G A KK+ + + G+A NE I+ + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L E LV M G++ H++ N G + +++ I
Sbjct: 62 VVSLAYA------YETKDALCLVLTIMNGGDLKFHIYNMGNPG---------FDEQRAIF 106
Query: 431 L--DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
++ GL L + I +RD+K NILLD R++D GLA Q EG++ + RV
Sbjct: 107 YAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV 162
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT GY+APE + T D + G +I E++ G+
Sbjct: 163 -GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESD--FQGDAEFCNEVE--IISNLKHRNLVPLRG 376
+G+G FG V L++ + KV++ D Q D C E I+S ++ +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
CC D + V +++ G++ H+ S R + + ++
Sbjct: 63 CCFQTPD-----RLFFVMEFVNGGDLMFHIQKS---------RRFDEARARFYAAEITSA 108
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS-REGQSHLTTRVAGTHGYL 495
L +LH I +RD+K N+LLD + ++ADFG+ K+ G+ T+ GT Y+
Sbjct: 109 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYI 163
Query: 496 APEY---ALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545
APE LYG D ++ GV++ E++CG + ++ D V
Sbjct: 164 APEILQEMLYGPSV---DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 321 IGRGGFG---LVYKGILQDGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPL 374
+G+G FG LV K D + KV++ + E +I++ + H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL-TWPQRKNIILDV 433
+G + YL+ D++ G++ L +K + T K + ++
Sbjct: 64 HYAFQTEG------KLYLILDFLRGGDLFTRL----------SKEVMFTEEDVKFYLAEL 107
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
A L +LH I +RD+K NILLD + ++ DFGL+K+S + + GT
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVE 163
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
Y+APE T+ +D +SFGV++ E++ G
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH--LTT 486
I + V +GL YL K I HRD+K +NIL+++ ++ DFG++ GQ +
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMAN 156
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT Y++PE T +SD++S G+ ++E+ GR
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 17/220 (7%)
Query: 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH-RNLVP 373
F +G G +G VYKG +A KV++ + E E+ ++ H RN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
G + + +LV ++ G+V D G+ + + + + R ++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD--LVKNTKGNALKEDWIAYICR-----EI 130
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
+GLA+LH + HRDIK N+LL + ++ DFG++ Q T + GT
Sbjct: 131 LRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 186
Query: 494 YLAPEYALYGQLTE-----KSDVYSFGVVILEIMCGRKAL 528
++APE + + +SD++S G+ +E+ G L
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
++ L YLH + +RDIK N++LD D ++ DFGL K+ + + T GT
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 158
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
YLAPE D + GVV+ E+MCGR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCV 379
IG+G +G V+K + + + A K+++ D E E I+ L H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM-Y 84
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR--PLTWPQRKNIILDVAKGL 437
D + G + +LV + G+V D + G KR + P I+ + GL
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLV-------KGFLKRGERMEEPIIAYILHEALMGL 137
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
+LH HRD+K NILL + ++ DFG++ Q + T V GT ++AP
Sbjct: 138 QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAP 193
Query: 498 EY-ALYGQL----TEKSDVYSFGVVILEI 521
E A QL + DV+S G+ +E+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNL 366
E D F + + +G G G+V K + + +K+I + + + E++++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+V G DG E + ++M G++D V K P+
Sbjct: 61 NSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQ-----------VLKEAKRIPEE 103
Query: 427 --KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
+ + V +GLAYL K I HRD+K +NIL+++ ++ DFG++ Q + +
Sbjct: 104 ILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 158
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT Y++PE + +SD++S G+ ++E+ GR
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ-----GDAEFCN 358
KI L + F IGRG FG V + V K++ S F+ A F
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL-SKFEMIKRSDSAFFWE 92
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
E +I+++ +V L D Y+V +YMP G++ + L +++
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDK----YLYMVMEYMPGGDLVN-LMSNYD------- 138
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-KQS 477
P W + +V L +H HRD+K N+LLD ++ADFG K
Sbjct: 139 IPEKWARF--YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193
Query: 478 REGQSHLTTRVAGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILEIMCG 524
G T V GT Y++PE G + D +S GV + E++ G
Sbjct: 194 ANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 321 IGRGGFGLVYKGI---LQDGT----TVAVKKVIESDFQGDAE-FCNEVEIISNLKHRNLV 372
+G+G F ++KGI + D T + KV++ + +E F ++S L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
G CV ++ +V +Y+ G++D +L + N ++W L+
Sbjct: 63 LNYGVCVCGDES------IMVQEYVKFGSLDTYLKKNKN------LINISWK------LE 104
Query: 433 VAKGLAY-LHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS-------HL 484
VAK LA+ LH+ + H ++ A N+LL + + + K S G S L
Sbjct: 105 VAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL 164
Query: 485 TTRVAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCG 524
R+ ++ PE Q L+ +D +SFG + EI G
Sbjct: 165 LERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
++ L YLH + + +RD+K N++LD D ++ DFGL K+ + + + T GT
Sbjct: 103 EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGT 159
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
YLAPE D + GVV+ E+MCGR
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD---GTTVAVKKV-IESDFQG-DAEFCNEVEIISNLK 367
D++ + IG G +G+VYK +D T+A+KK+ +E + +G + E+ ++ ++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N+V L+ VV + YLV++Y+ D L + AK P K
Sbjct: 60 HGNIVRLQD--VVHSEKRL----YLVFEYL-----DLDLKKHMDSSPDFAKNPRLI---K 105
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA-RVADFGLAKQSREGQSHLTT 486
+ + +G+AY H + HRD+K N+L+D A ++ADFGLA+ T
Sbjct: 106 TYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 487 RVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKAL 528
V T Y APE L + D++S G + E M +K L
Sbjct: 163 EVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAE-MVNQKPL 203
|
Length = 294 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 23/230 (10%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLK---HRNLVPL 374
IG G +G VYK G VA+K V ++++ G EV ++ L+ H N+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
C +R ++ LV+++ VD L V L K+++
Sbjct: 68 MDVCAT-SRTDRETKVTLVFEH-----VDQDLRTYL---DKVPPPGLPAETIKDLMRQFL 118
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT-TRVAGTHG 493
+GL +LH I HRD+K NIL+ + + ++ADFGLA R + T V T
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA---RIYSCQMALTPVVVTLW 172
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543
Y APE L D++S G + E M RK L S + + I D
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKPLFCGNSEADQLGKIFD 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 321 IGRGGFGLVYKGILQDG---TTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPLRG 376
IG G FG V G + G V VK++ + + Q +F E + +L+H NL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
C + LV ++ P G++ +L S + P T + + ++A G
Sbjct: 63 QCT------EVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQR---MACEIALG 112
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT-RVAGTHGYL 495
L +LH K H D+ N LL AD+ ++ D+GL+ + ++T ++ ++
Sbjct: 113 LLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169
Query: 496 APEYA--LYGQL-----TEKSDVYSFGVVILEI 521
APE ++G L T++S+V+S GV I E+
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 41/215 (19%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK----HRNLVPLR 375
IG G F V K + G A+K + F+ + N EI + L+ H N++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQA-LRRLSPHPNILRL- 63
Query: 376 GCCVVDGDNERGSERYL-------VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
V D + G + +Y+ + KRPL + K+
Sbjct: 64 --IEVLFDRKTGRLALVFELMDMNLYELIKG-----------------RKRPLPEKRVKS 104
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+ + K L ++H + I+HRDIK NIL+ D ++ADFG + + T
Sbjct: 105 YMYQLLKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEY 158
Query: 489 AGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIM 522
T Y APE L G K D+++ G V EI+
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 321 IGRGGFGLV---YKGILQDGTTVAVKKVIESDFQGDAEF---CNEVEIISNLKHRNLVPL 374
IG G G+V Y IL+ VA+KK + FQ E+ ++ + H+N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKK-LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
E + Y+V + M D +L V + L + ++ +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELM-----DANL-------CQVIQMELDHERMSYLLYQML 136
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
G+ +LH I HRD+K +NI++ +D ++ DFGLA+ + G S + T T Y
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYY 191
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
APE L E D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 315 FSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRN 370
F + IGRG F VY+ L DG VA+KKV D + A+ E++++ L H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
++ + D +E +V + G++ + F + W
Sbjct: 64 VIKYYASFIED------NELNIVLELADAGDLS-RMIKHFKKQKRLIPEKTVW----KYF 112
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--QSREGQSHLTTRV 488
+ + L ++H + HRDIK N+ + A ++ D GL + S+ +H +
Sbjct: 113 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SL 166
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
GT Y++PE KSD++S G ++ E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 321 IGRGGFGLVYKGILQD-----GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
IG+G FG V + V KK I + ++ N+KH LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
+ + Y V DY+ G + HL +R P+ + ++A
Sbjct: 63 FSF------QTADKLYFVLDYINGGELFYHL---------QRERCFLEPRARFYAAEIAS 107
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
L YLH I +RD+K NILLD+ + DFGL K++ E T+ GT YL
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTSTFCGTPEYL 163
Query: 496 APEYALYGQLTEKS-DVYSFGVVILEIMCG 524
APE L+ Q +++ D + G V+ E++ G
Sbjct: 164 APE-VLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESD--FQGDAEFCNEVE--IIS-NLKHRNLVPLR 375
+G+G FG V L+ V KV++ D Q D C E I++ KH L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 376 GCCVVDGDNERGSER-YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
C + +R + V +Y+ G++ + S R P+ + +V
Sbjct: 63 CCF-------QTKDRLFFVMEYVNGGDLMFQIQRS---------RKFDEPRSRFYAAEVT 106
Query: 435 KGLAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
L +LH +GV IY RD+K NILLDA+ ++ADFG+ K+ TT GT
Sbjct: 107 LALMFLHRHGV---IY-RDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPD 161
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
Y+APE + D ++ GV++ E+M G+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 32/99 (32%), Positives = 58/99 (58%), Gaps = 6/99 (6%)
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR-EGQSHLTTRVAG 490
++A GL +LH I +RD+K N++LD++ ++ADFG+ K++ +G + T G
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCG 163
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529
T Y+APE Y + D ++FGV++ E++ G+ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 335 QDGTTVAVKKVIESDFQGD---AEFCNEVEIISNLKHRNLVPL--RGCCVVDGDNERGSE 389
G VA+K + + + A F E + + L H N+V L G
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA--------PPG 52
Query: 390 R-YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448
+ V++Y+P + + L DG L + ++L V LA H I
Sbjct: 53 LLFAVFEYVPGRTLREVLA---ADG------ALPAGETGRLMLQVLDALACAH---NQGI 100
Query: 449 YHRDIKATNILL---DADMRARVADFGL------AKQSREGQSHLTTRVAGTHGYLAPEY 499
HRD+K NI++ A+V DFG+ + + TT V GT Y APE
Sbjct: 101 VHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE- 159
Query: 500 ALYGQ-LTEKSDVYSFGVVILEIMCGRKAL 528
L G+ +T SD+Y++G++ LE + G++ +
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ K L YL K + HRD+K +NILLDA ++ DFG++ + + ++ TR AG
Sbjct: 123 IVKALHYLK--EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCA 178
Query: 493 GYLAPEY----ALYGQLTEKSDVYSFGVVILEIMCGR 525
Y+APE + ++DV+S G+ ++E+ G+
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIES-DFQGDAEFCNEVEIISNLKH-RNLVPLRGC 377
+GRG +G+V K + GT +AVK++ + + Q +++I V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVD-DHLFPSFNDGSGVAKRPLTWPQR--KNIILDVA 434
+GD V+ M + D + V + LT P+ I + +
Sbjct: 69 LFREGD---------VWICMEVMDTSLDKFYKK------VYDKGLTIPEDILGKIAVSIV 113
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
K L YLH + + HRD+K +N+L++ + + ++ DFG++ + S T AG Y
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPY 169
Query: 495 LAPEYALYGQLTE-----KSDVYSFGVVILEIMCGR 525
+APE + +L + KSDV+S G+ ++E+ GR
Sbjct: 170 MAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDF----QGDAEFCNEVEIISNLKHRNLVPLRG 376
IGRGGFG VY D + K ++ QG+ NE I+ +L P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
C + + D M G++ HL GV IIL G
Sbjct: 61 CMTYAFHTP--DKLCFILDLMNGGDLHYHL-----SQHGVFSEKEMRFYATEIIL----G 109
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
L ++H + +RD+K NILLD R++D GLA + + H + GTHGY+A
Sbjct: 110 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 163
Query: 497 PEYALYGQLTEKS-DVYSFGVVILEIMCG 524
PE G + S D +S G ++ +++ G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPLRGCC 378
+G G + V+KG + VA+K++ +E + EV ++ +LKH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
D LV++Y+ D L +D + ++ K + + +GLA
Sbjct: 74 HTD------KSLTLVFEYL-----DKDLKQYMDDCGNI----MSMHNVKIFLYQILRGLA 118
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
Y H + + HRD+K N+L++ ++ADFGLA+ + V T Y P+
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 174
Query: 499 YAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLST 532
L + + + D++ G + E+ GR ST
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 321 IGRGGFGLVYKGILQDGTT--------VAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+G G FG V+ ++D + +A+ +VI + + NE ++ + H ++
Sbjct: 9 VGTGTFGRVHL--VRDRISEHYYALKVMAIPEVI--RLKQEQHVHNEKRVLKEVSHPFII 64
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPS--FNDGSGVAKRPLTWPQRKNII 430
L D Y++ +Y+P G + +L S F++ +G+
Sbjct: 65 RLF-WTEHDQRF-----LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS---------- 108
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
++ L YLH I +RD+K NILLD + ++ DFG AK+ R+ T + G
Sbjct: 109 -EIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCG 160
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
T YLAPE + D ++ G++I E++ G
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 63/247 (25%), Positives = 95/247 (38%), Gaps = 72/247 (29%)
Query: 321 IGRGGFG---LVYKGILQDGTTVAVKKVIESDF--QGD-AEFCNEVEIISNLKHRNLVPL 374
IGRG FG LV G A+K + +SD + A E +I+++ +V L
Sbjct: 9 IGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD-- 432
D ++ YLV +YMP G++ + RK++ +
Sbjct: 67 Y-YSFQDEEH-----LYLVMEYMPGGDL------------------MNLLIRKDVFPEET 102
Query: 433 ----VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG-------- 480
+A+ + L K HRDIK NIL+DAD ++ADFGL K+ +
Sbjct: 103 ARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 481 -----------------QSHLTTR---VAGTHGYLAPEYAL---YGQLTEKSDVYSFGVV 517
R GT Y+APE YG D +S GV+
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE---CDWWSLGVI 219
Query: 518 ILEIMCG 524
+ E++ G
Sbjct: 220 LYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 7e-09
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 307 DLERAT--DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCN-EVEII 363
DL R + F IG G +G VYK + +A KVI+ + D E+ ++
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDD--HLFPSFNDGSGVAKRPL 421
+ KH N+V G + R + ++ ++ G++ D H+ PL
Sbjct: 61 KDCKHSNIVAYFGSYL------RRDKLWICMEFCGGGSLQDIYHV-----------TGPL 103
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
+ Q + + +GL YLH K HRDIK NILL + ++ADFG++ Q
Sbjct: 104 SESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATI 160
Query: 482 SHLTTRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEI 521
+ + + GT ++APE A G + D+++ G+ +E+
Sbjct: 161 AKRKSFI-GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
+G G GLV+ + D VAVKK++ +D Q E++II L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 380 VDG--DNERGSER------YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
G E Y+V +YM + L G PL+ + +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQG------PLSEEHARLFMY 121
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAK---QSREGQSHLTTR 487
+ +GL Y+H + HRD+K N+ ++ D+ ++ DFGLA+ + +L+
Sbjct: 122 QLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 488 VAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGR 525
+ T Y +P L T+ D+++ G + E++ G+
Sbjct: 179 LV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
E ++ N+ H +++ ++ V G+ +V +P+ + D + + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV------SGAITCMV---LPHYSSDLYTYLTKRS------ 151
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 478
RPL Q I + +GL YLH I HRD+K NI ++ + + D G A+
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 479 EGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ L +AGT APE + K+D++S G+V+ E++
Sbjct: 209 VAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 321 IGRGGFGLV---YKGILQDGTTVAVKKVIESDFQGDA---EFCNEVEIISNLKHRNLVPL 374
IG G G+V Y +L VA+KK + FQ E+ ++ + H+N++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKK-LSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
E + YLV + M D +L V + L + ++ +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-----DANL-------CQVIQMELDHERMSYLLYQML 129
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
G+ +LH I HRD+K +NI++ +D ++ DFGLA+ + G S + T T Y
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYY 184
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIM 522
APE L E D++S G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 50/226 (22%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLKHRNLVPLRGC 377
IG G +G+VYKG + G VA+KK+ +ES+ +G + E+ ++ L+H N+V L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL-TWPQRKNIILDVAKG 436
+ + S YL+++++ S K+ L + P+ + + ++ K
Sbjct: 68 LMQE------SRLYLIFEFL----------------SMDLKKYLDSLPKGQYMDAELVK- 104
Query: 437 LAYLHYGVKPAIY--------HRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+YL Y + I HRD+K N+L+D ++ADFGLA+ + RV
Sbjct: 105 -SYL-YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRV 157
Query: 489 AGTHG-----YLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKAL 528
TH Y APE L + D++S G + E M +K L
Sbjct: 158 Y-THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAE-MATKKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 45/216 (20%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC---NEVEIISNLKHRNLVPLRG 376
+G G +G VYK L G AVK +I+ + GD +F E+ ++ KH N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK-IIKLE-PGD-DFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDD--HLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
+ + ++ +Y G++ D H+ +G PL+ Q + +
Sbjct: 74 SYLSR------EKLWICMEYCGGGSLQDIYHV-------TG----PLSELQIAYVCRETL 116
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA----- 489
+GLAYLH K HRDIK NILL + ++ADFG+A + +T +A
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAK-------ITATIAKRKSF 166
Query: 490 -GTHGYLAPEYALY---GQLTEKSDVYSFGVVILEI 521
GT ++APE A G + D+++ G+ +E+
Sbjct: 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 45/221 (20%)
Query: 321 IGRGGFGLVYKGILQDGTT--------VAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+G+GG+G V++ G V K I + + A E I+ +KH +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL- 431
L G + YL+ +Y+ G + HL +R+ I +
Sbjct: 64 DLIYAFQTGG------KLYLILEYLSGGELFMHL------------------EREGIFME 99
Query: 432 DVAK--------GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
D A L +LH + I +RD+K NILLDA ++ DFGL K+S +
Sbjct: 100 DTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155
Query: 484 LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
+T GT Y+APE + + D +S G ++ +++ G
Sbjct: 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVK----KVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
IGRGGFG VY D G A+K K I+ QG+ NE I+ +L P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNE-RIMLSLVSTGDCPFI 59
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
C + + D M G++ HL GV IIL
Sbjct: 60 VCMSYAFHTP--DKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIIL---- 108
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
GL ++H + +Y RD+K NILLD R++D GLA + + H + GTHGY+
Sbjct: 109 GLEHMH--NRFVVY-RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 496 APEYALYGQLTEKS-DVYSFGVVILEIMCG 524
APE G + S D +S G ++ +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 14/136 (10%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450
+L+ DY+ G + HL + + + ++ L +LH K I +
Sbjct: 81 HLILDYINGGELFTHL---------SQRERFKEQEVQIYSGEIVLALEHLH---KLGIIY 128
Query: 451 RDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKS- 509
RDIK NILLD++ + DFGL+K+ E + GT Y+AP+ G
Sbjct: 129 RDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKA 188
Query: 510 -DVYSFGVVILEIMCG 524
D +S GV++ E++ G
Sbjct: 189 VDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 321 IGRGGFGLV----YKGILQDGTTVAVKKV----IESDFQGDAEFCNEVEIISNLKHRNLV 372
+G+G +G V ++ DG +KK+ + AE E +++S LKH N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIV 62
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
R + E G Y+V + G+ L+ + G + L Q +
Sbjct: 63 AYRE----SWEGEDG-LLYIVMGFCEGGD----LYHKLKEQKG---KLLPENQVVEWFVQ 110
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+A L YLH + I HRD+K N+ L +V D G+A+ E Q + + + GT
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTP 166
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529
Y++PE KSDV++ G + E+ + A +
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 16/117 (13%)
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471
+G + K PLT + VA+G+ +L + I HRD+ A NILL + ++ DF
Sbjct: 161 EGDELYKEPLTLEDLISYSFQVARGMEFL--ASRKCI-HRDLAARNILLSENNVVKICDF 217
Query: 472 GLAKQ-------SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
GLA+ R+G + L + ++APE T +SDV+SFGV++ EI
Sbjct: 218 GLARDIYKDPDYVRKGDARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPLRGCC 378
+G G + V+KG + VA+K++ +E + EV ++ NLKH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+ LV++Y+ D + D G ++ K + + +GL+
Sbjct: 73 HTE------RCLTLVFEYL------DSDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLS 117
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
Y H K I HRD+K N+L++ ++ADFGLA+ + V T Y P+
Sbjct: 118 YCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 173
Query: 499 YALYGQLTEKS---DVYSFGVVILEIMCGRKALDLST 532
L G TE S D++ G ++ E+ GR ST
Sbjct: 174 -VLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 7/100 (7%)
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
I + K L YL +K I HRD+K +NILLD + ++ DFG++ Q + S TR
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRD 167
Query: 489 AGTHGYLAPEYALYGQLTE---KSDVYSFGVVILEIMCGR 525
AG Y+APE +SDV+S G+ + E+ G+
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 43/144 (29%), Positives = 65/144 (45%), Gaps = 31/144 (21%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK--------GLAYLHY 442
+L+ DY+ G + HL+ QR N D + L +LH
Sbjct: 81 HLILDYVSGGEMFTHLY-----------------QRDNFSEDEVRFYSGEIILALEHLH- 122
Query: 443 GVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY 502
K I +RDIK NILLD++ + DFGL+K+ + T GT Y+APE +
Sbjct: 123 --KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIR 179
Query: 503 GQLTEKS--DVYSFGVVILEIMCG 524
G+ D +S G++I E++ G
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 314 KFSQKNFIGRGGFGLV---YKGILQDGTTVAVKKVIESDFQGDA---EFCNEVEIISNLK 367
++ Q IG G G+V + +L G VAVKK+ FQ E+ ++ +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVN 78
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H+N++ L E + YLV + M D +L V L +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANL-------CQVIHMELDHERMS 126
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
++ + G+ +LH I HRD+K +NI++ +D ++ DFGLA+ + + + T
Sbjct: 127 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTP 181
Query: 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
T Y APE L E D++S G ++ E++ G
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 70/233 (30%), Positives = 97/233 (41%), Gaps = 47/233 (20%)
Query: 321 IGRGGFGLVYKGILQ---DGTTVA-------VKKVIESDFQGDAEFCNEVEIISNLKHRN 370
+G+G F +YKG+L+ D V V KV+ SD + F ++S L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
LV L G CV D E +V +Y+ G +D L + + V L W
Sbjct: 63 LVKLYGVCVRD-------ENIMVEEYVKFGPLDVFLH---REKNNV---SLHW------K 103
Query: 431 LDVAKGLAY-LHYGVKPAIYHRDIKATNILL-DADMRARVADFGLAKQSREGQSHLTTRV 488
LDVAK LA LHY + H ++ NIL+ + F K S G
Sbjct: 104 LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPF--IKLSDPGIP----IT 157
Query: 489 AGTHGY-------LAPEYALYGQ--LTEKSDVYSFGVVILEIMCGRKALDLST 532
+ +APE GQ LT +D +SFG +LEI C LST
Sbjct: 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI-CSNGEEPLST 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 38/181 (20%)
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR-------EGQSHLT 485
VA+G+ +L K I HRD+ A N+LL A++ DFGLA+ +G + L
Sbjct: 221 VAQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545
+ ++APE T +SDV+S+G+++ EI L S P L+
Sbjct: 278 VK------WMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGKSPYP-GILVNSKF 324
Query: 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605
+ +VK G +Q P DF +IM+ +C ++ RPT S +++
Sbjct: 325 YKMVKRG--YQMSRP------DFAPPEIYSIMK-------MCWNLEPTERPTFSQISQLI 369
Query: 606 E 606
+
Sbjct: 370 Q 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 66/247 (26%), Positives = 99/247 (40%), Gaps = 61/247 (24%)
Query: 295 RPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLV----YKG--------ILQDGTTVAV 342
+P+T S W K+ D E +G G FG V +KG L+ + +
Sbjct: 9 KPDTSS-W-KLSDFE-------MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59
Query: 343 KKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNV 402
K+V E I+ L H +V + C D + Y + +++ G +
Sbjct: 60 KQV--------QHVAQEKSILMELSHPFIVNMM-CSFQDEN-----RVYFLLEFVVGGEL 105
Query: 403 DDHL-----FPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATN 457
HL FP ND VAK ++L YLH I +RD+K N
Sbjct: 106 FTHLRKAGRFP--ND---VAKF-----YHAELVL----AFEYLH---SKDIIYRDLKPEN 148
Query: 458 ILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVV 517
+LLD +V DFG AK+ + T + GT YLAPE + D ++ GV+
Sbjct: 149 LLLDNKGHVKVTDFGFAKKVPD----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVL 204
Query: 518 ILEIMCG 524
+ E + G
Sbjct: 205 LYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
G+ +LH I HRD+K +NI++ +D ++ DFGLA+ + G S + T T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 184
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCGR 525
APE L E D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 41/137 (29%), Positives = 61/137 (44%), Gaps = 22/137 (16%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450
L+ DY+ +G+ LF + L+ + K II + + L LH K I H
Sbjct: 85 VLIMDYIKDGD----LFDLLK-----KEGKLSEAEVKKIIRQLVEALNDLH---KHNIIH 132
Query: 451 RDIKATNILLDADM-RARVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEK 508
DIK N+L D R + D+GL K G S GT Y +PE + G +
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSCYD----GTLDYFSPE-KIKGHNYDV 185
Query: 509 S-DVYSFGVVILEIMCG 524
S D ++ GV+ E++ G
Sbjct: 186 SFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 39/139 (28%), Positives = 65/139 (46%), Gaps = 14/139 (10%)
Query: 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA 447
++ +L+ DY+ G + HL+ + T + + I ++ L +LH +
Sbjct: 78 TKLHLILDYVNGGELFTHLYQREH---------FTESEVRVYIAEIVLALDHLH---QLG 125
Query: 448 IYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE 507
I +RDIK NILLD++ + DFGL+K+ + GT Y+APE G
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 508 KS--DVYSFGVVILEIMCG 524
D +S GV+ E++ G
Sbjct: 186 DKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVI---ESDFQGDAEFCNEVEIISNLKHRNLVPLRG 376
IGRG F VY+ L D VA+KKV D + + E++++ L H N++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
+ D +E +V + G++ + F + W + +
Sbjct: 70 SFIED------NELNIVLELADAGDLS-QMIKYFKKQKRLIPERTVW----KYFVQLCSA 118
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--QSREGQSHLTTRVAGTHGY 494
+ ++H + HRDIK N+ + A ++ D GL + S+ +H + GT Y
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTPYY 172
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEI 521
++PE KSD++S G ++ E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 16/111 (14%)
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ- 476
K+ LT VAKG+ +L HRD+ A NILL + ++ DFGLA+
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 477 ------SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
R+G + L + ++APE T +SDV+SFGV++ EI
Sbjct: 230 YKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVK--KVIESDFQGD------AEFCNEVEIISNLKHRNLV 372
+G+G FG VY +++D VA + KV++ G+ + E +++S L H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
++ D ++ +Y ++D L + G +++ Q +
Sbjct: 66 KFHAS-FLERDA-----FCIITEYCEGRDLDCKLEELKHTGKTLSE-----NQVCEWFIQ 114
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ G+ Y+H + I HRD+KA NI L ++ ++ DFG+++ G L T GT
Sbjct: 115 LLLGVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTP 169
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMC 523
Y++PE + KSD++S G ++ E+ C
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 16/111 (14%)
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ- 476
K PLT VA+G+ +L HRD+ A NILL + ++ DFGLA+
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 477 ------SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
R+G + L + ++APE T +SDV+SFGV++ EI
Sbjct: 225 YKDPDYVRKGSARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 63/233 (27%), Positives = 96/233 (41%), Gaps = 35/233 (15%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ----GDAEFCNE 359
KI+ L+ + + IGRG FG V + V K++ S F+ D+ F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL-SKFEMIKRSDSAFFWE 92
Query: 360 VEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR 419
I + V C D Y+V +YMP G++ + L +++
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDD-----KYLYMVMEYMPGGDLVN-LMSNYD-------V 139
Query: 420 PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-KQSR 478
P W K +V L +H + HRD+K N+LLD ++ADFG K
Sbjct: 140 PEKWA--KFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194
Query: 479 EGQSHLTTRVAGTHGYLAPEY-------ALYGQLTEKSDVYSFGVVILEIMCG 524
G T V GT Y++PE YG+ + D +S GV + E++ G
Sbjct: 195 TGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAE---FCNEVEIISNLKHRNLVPLRG 376
+G+GG+G V+ +D G VA+K++ +S E E +I++ K LV L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
D + YL +Y+P G+ F + + GV L+ + + ++ +
Sbjct: 68 YAFQDDEY-----LYLAMEYVPGGD-----FRTLLNNLGV----LSEDHARFYMAEMFEA 113
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLA 496
+ LH + HRD+K N L+DA ++ DFGL+K G V G+ Y+A
Sbjct: 114 VDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMA 166
Query: 497 PEYALYGQLTEKS-DVYSFGVVILEIMCG 524
PE L G+ + + D +S G ++ E +CG
Sbjct: 167 PE-VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 46/203 (22%), Positives = 84/203 (41%), Gaps = 19/203 (9%)
Query: 321 IGRGGFG--LVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCC 378
+G G FG L+ + + D + + + E +++ +KH N+V +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
DG Y+V +Y G+ L G + + + G+
Sbjct: 68 EADG------HLYIVMEYCDGGD----LMQKIKLQRG---KLFPEDTILQWFVQMCLGVQ 114
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
++H + + HRDIK+ NI L + + ++ DFG A+ ++ T V GT Y+ PE
Sbjct: 115 HIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE 170
Query: 499 YALYGQLTEKSDVYSFGVVILEI 521
KSD++S G ++ E+
Sbjct: 171 IWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 321 IGRGGFGLVYKG--ILQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPLRGC 377
+G G + VYKG L D VA+K++ +E + EV ++ +LKH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
+ LV++Y+ D L +D + K + + +GL
Sbjct: 73 IHTE------KSLTLVFEYL-----DKDLKQYLDDCGNS----INMHNVKLFLFQLLRGL 117
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
Y H + + HRD+K N+L++ ++ADFGLA+ + V T Y P
Sbjct: 118 NYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPP 173
Query: 498 EYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLST 532
+ L + + D++ G + E+ GR ST
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 314 KFSQKNFI---GRGGFGLVYKGILQDGT--TVAVKKVIESDF----QGDAEFCNEVEIIS 364
K+ NFI G G FG V ++ VA+K+ +S Q D F +E +I++
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILN 86
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
+ H P C + G + S YLV +++ G F +F +R +P
Sbjct: 87 YINH----PF--CVNLYGSFKDESYLYLVLEFVIGGE-----FFTF------LRRNKRFP 129
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--QSREGQS 482
A+ + Y I +RD+K N+LLD D ++ DFG AK +R
Sbjct: 130 NDVGCFY-AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
T + GT Y+APE L + +D ++ G+ I EI+ G
Sbjct: 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 19/103 (18%)
Query: 437 LAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAK--------------QSREGQ 481
L YLH YG I HRD+K N+L+ + ++ DFGL+K ++ +
Sbjct: 114 LEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
L +V GT Y+APE L + D ++ G+++ E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 16/166 (9%)
Query: 358 NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA 417
NE+ + L H N++ + R YM D L+ D +
Sbjct: 212 NEILALGRLNHENILKIEEIL-----------RSEANTYMITQKYDFDLYSFMYDEAFDW 260
Query: 418 K-RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476
K RPL Q + I+ + + Y+H + HRDIK NI L+ D + + DFG A
Sbjct: 261 KDRPLLK-QTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ + GT +PE E +D++S G+++L+++
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 2/94 (2%)
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV-AGTHGYL 495
LA H K I HRDIK+ NILL ++ ++ DFG +K S R GT Y+
Sbjct: 154 LAVHHVHSKHMI-HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529
APE ++K+D++S GV++ E++ ++ D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 26/74 (35%), Positives = 44/74 (59%), Gaps = 1/74 (1%)
Query: 450 HRDIKATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEK 508
HRD+K+ NI L ++ DFG +KQ + S + + GT YLAPE + ++K
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251
Query: 509 SDVYSFGVVILEIM 522
+D++S GV++ E++
Sbjct: 252 ADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 16/96 (16%)
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR-------EGQSHLT 485
VAKG+++L K I HRD+ A NILL ++ DFGLA+ R +G + L
Sbjct: 223 VAKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
+ ++APE T +SDV+S+G+++ EI
Sbjct: 280 VK------WMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDA-EFCNEVEIISNLKHRN 370
D + + +G G + VYKG + +G VA+K + + +G E ++ LKH N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L LV++Y V L + G L K +
Sbjct: 65 IVLLHDII------HTKETLTLVFEY-----VHTDLCQYMDKHPG----GLHPENVKLFL 109
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ +GL+Y+H + I HRD+K N+L+ ++ADFGLA+ ++ SH +
Sbjct: 110 FQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV 165
Query: 491 THGYLAPEYALYGQLTEKS---DVYSFGVVILEIMCGRKAL 528
T Y P+ L G TE S D++ G + +E++ G A
Sbjct: 166 TLWYRPPD-VLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 42/229 (18%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+ F IGRG FG V L++ V K++ E E + R+++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-----WEMLKRAETACFREERDVL 55
Query: 373 PLRGCCVVDGDN----------ERGSERYLVYDYMPNGNVDDHLFPSFND--GSGVAKRP 420
V+GDN + + YLV DY G++ L F D +A+
Sbjct: 56 -------VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFY 107
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
L I +D L Y+H RDIK NIL+D + R+ADFG + E
Sbjct: 108 LA---EMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMED 155
Query: 481 QSHLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCG 524
+ ++ GT Y++PE G+ + D +S GV + E++ G
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 37/234 (15%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ-----GDAEFCN 358
KI+DL + + IGRG FG V + V K++ S F+ A F
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWE 92
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
E +I++ +V L ++R Y+V +YMP G++ + L +++
Sbjct: 93 ERDIMAFANSPWVVQL----FYAFQDDR--YLYMVMEYMPGGDLVN-LMSNYD------- 138
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-KQS 477
P W + +V L +H HRD+K N+LLD ++ADFG K +
Sbjct: 139 VPEKWA--RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193
Query: 478 REGQSHLTTRVAGTHGYLAPEY-------ALYGQLTEKSDVYSFGVVILEIMCG 524
+EG T V GT Y++PE YG+ + D +S GV + E++ G
Sbjct: 194 KEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFC--NEVEIISNLKHRNLVPLRGC 377
+G G + VYKGI + +G VA+K VI + F E ++ LKH N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHANIVLLH-- 69
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
D + + + + V++YM + D + + G L + + + +GL
Sbjct: 70 ---DIIHTKETLTF-VFEYM---HTDLAQYMIQHPGG------LHPYNVRLFMFQLLRGL 116
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK-QSREGQSHLTTRVAGTHGYLA 496
AY+H I HRD+K N+L+ ++ADFGLA+ +S Q++ + V T Y
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRP 171
Query: 497 PEYALYGQLTEKS---DVYSFGVVILEIMCGRKAL 528
P+ L G T+ S D++ G + +E++ G+ A
Sbjct: 172 PD-VLLGA-TDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 58/251 (23%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN- 370
D F IGRG FG V +D G A+K + ++D E E +++++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-------EKEQVAHIRAERD 53
Query: 371 -LVPLRGCCVVDGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
LV G VV +R YL+ +++P G++ L + K L+ +
Sbjct: 54 ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---------MKKDTLSEEATQ 104
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL-------------- 473
I + + +H + HRDIK N+LLDA +++DFGL
Sbjct: 105 FYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 474 --------------------AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYS 513
A+ ++ + L GT Y+APE + + D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 514 FGVVILEIMCG 524
GV++ E++ G
Sbjct: 222 LGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 51/243 (20%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTT--VAVKKVIESDFQGDAE----FCNEVEIISNL 366
F K+ +GRG FG V ++++ T + KV++ E F E +I+S +
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-I 57
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+ +P D DN YLV +Y P G++ L+ R
Sbjct: 58 SNSPWIPQLQYAFQDKDN-----LYLVMEYQPGGDL------------------LSLLNR 94
Query: 427 KNIILD-------VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479
D +A+ + +H + HRDIK N+L+D ++ADFG A +
Sbjct: 95 YEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154
Query: 480 GQSHLTTRVAGTHGYLAPEY---------ALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530
+ + GT Y+APE YG + D +S GV+ E++ GR
Sbjct: 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHE 211
Query: 531 STS 533
TS
Sbjct: 212 GTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 61/261 (23%), Positives = 93/261 (35%), Gaps = 69/261 (26%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKVIESDFQGDAEFCNEVEIISNLK 367
D F +G G FG+VYK L + +KK E VEI N +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY---------GAVEIWMNER 182
Query: 368 HRNLVPLRGCCV--VDG-----DNERGSERYLVYDYMPNGNVDDHL----FPS------F 410
R P C V G +++ E +LV+ Y + D + FP
Sbjct: 183 VRRACP--NSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLL 240
Query: 411 NDGSGVAKRPLTWPQRKNIIL-----DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465
+ K +R+N I+ + L LH I HRD+K NI+
Sbjct: 241 GKVQDLPKG----LERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSG 293
Query: 466 A-RVADFGLAKQSREGQSHLTTRVAGTHGYLAPE-YALYGQ------------------- 504
+ ++ D G A R G +++ Y APE Y + Q
Sbjct: 294 SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353
Query: 505 --LTEKSDVYSFGVVILEIMC 523
L ++ D+YS G++ L+ M
Sbjct: 354 LNLPDRFDIYSAGLIFLQ-MA 373
|
Length = 566 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 57/199 (28%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 343 KKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNV 402
KKVI G E++I+ + HR ++ L + + V MP
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINL-----IHA----YRWKSTVCMVMPKYKC 170
Query: 403 DDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462
D LF ++ D SG PL Q I + + LAYLH I HRD+K NI LD
Sbjct: 171 D--LF-TYVDRSG----PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDE 220
Query: 463 DMRARVADFGLAKQSREGQSHLTTRVAGTHGYL---APEYALYGQLTEKSDVYSFGVVIL 519
A + DFG A + T + G G L +PE K+D++S G+V+
Sbjct: 221 PENAVLGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278
Query: 520 EIMCGRKAL---DLSTSGS 535
E+ L + +S S
Sbjct: 279 EMSVKNVTLFGKQVKSSSS 297
|
Length = 392 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 1/77 (1%)
Query: 448 IYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE 507
+ +RD+K NILLD + DFGL K + + T GT YLAPE L T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 508 KSDVYSFGVVILEIMCG 524
D ++ GV++ E++ G
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/183 (22%), Positives = 68/183 (37%), Gaps = 62/183 (33%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR--KNIILDVAKGLAYLHYGVKPAI 448
Y V DY+P G++ L R +P+ + I ++ + +H K
Sbjct: 77 YFVMDYIPGGDMMSLLI-----------RMEVFPEVLARFYIAELTLAIESVH---KMGF 122
Query: 449 YHRDIKATNILLDADMRARVADFGLA---------------------------------- 474
HRDIK NIL+D D ++ DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 475 ------------KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ +++ Q L + GT Y+APE L T+ D +S GV++ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 523 CGR 525
G+
Sbjct: 243 VGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 58/247 (23%), Positives = 94/247 (38%), Gaps = 68/247 (27%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEF---CNEVEIISNLKHRNLVPLRG 376
+G+G G V+ L+ G A+K + + + + E EI++ L H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK- 435
+ + LV DY P G LF ++P K + +VA+
Sbjct: 69 ------SFQTETYLCLVMDYCPGGE----LFRLLQ------RQP-----GKCLSEEVARF 107
Query: 436 -------GLAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS---------- 477
L YLH G+ +Y RD+K NILL ++DF L+KQS
Sbjct: 108 YAAEVLLALEYLHLLGI---VY-RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 478 ------REGQSHLTTRVA------------GTHGYLAPEY-ALYGQLTEKSDVYSFGVVI 518
R + + + GT Y+APE + G D ++ G+++
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILL 222
Query: 519 LEIMCGR 525
E++ G
Sbjct: 223 YEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 25/110 (22%), Positives = 52/110 (47%), Gaps = 10/110 (9%)
Query: 419 RPLTWPQRKNIILDVAKGLAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
+ L++ + ++ +D KGL L+ Y KP ++++ + + L+ + + ++ GL K
Sbjct: 117 KDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKIL 173
Query: 478 REGQSHLTTRVAGTHGYLAPEYAL--YGQLTEKSDVYSFGVVILEIMCGR 525
+ Y + + + + T K D+YS GVV+ EI G+
Sbjct: 174 SSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 24/118 (20%)
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-------SREGQSHLT 485
VA+G+ +L HRD+ A N+LL ++ DFGLA+ +G + L
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543
+ ++APE T SDV+S+G+++ EI S G+P +I D
Sbjct: 303 VK------WMAPESIFDNLYTTLSDVWSYGILLWEI--------FSLGGTPYPGMIVD 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 4e-05
Identities = 44/191 (23%), Positives = 82/191 (42%), Gaps = 36/191 (18%)
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
EV ++ LKH+N+V + N+ + Y++ ++ G++ ++ + + +
Sbjct: 62 EVNVMRELKHKNIVRY----IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPA-----IYHRDIKATNILLDADMR-------- 465
+ +I + LAY H +K + HRD+K NI L +R
Sbjct: 118 HAIV-----DITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 466 ---------ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSF 514
A++ DFGL+K G + GT Y +PE L+ +KSD+++
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 515 GVVILEIMCGR 525
G +I E+ G+
Sbjct: 230 GCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 5/80 (6%)
Query: 450 HRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQ 504
HRDIK N+LLD + R+ADFG + + + ++ GT Y++PE G+
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184
Query: 505 LTEKSDVYSFGVVILEIMCG 524
+ D +S GV + E++ G
Sbjct: 185 YGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA------EFCNEVEIISNLKHRNLVPL 374
IG G FG V + T VA +V+ + + +A EF + + L+H N++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVA--RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL--- 431
G CV LV++Y G++ +L W +R + +L
Sbjct: 61 LGQCV------EAIPYLLVFEYCELGDLKSYL------------SQEQWHRRNSQLLLLQ 102
Query: 432 ----DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT- 486
++A G+ ++H K H D+ N L +D+ +V D+G+ SR + ++ T
Sbjct: 103 RMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGP-SRYKEDYIETE 158
Query: 487 -RVAGTHGYLAPEY--ALYGQL-----TEKSDVYSFGVVILEI 521
+LAPE +G L T+ S+V++ GV + E+
Sbjct: 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFC--NEVEIISNLKHRNLVPLRGC 377
+G G + VYKG + G VA+K I + + A F E ++ +LKH N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK-EIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD- 70
Query: 378 CVVDGDNERGSERYLVYDYMPNG---NVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
++ LV++Y+ +DD V + + +
Sbjct: 71 -IIHTK----KTLTLVFEYLDTDLKQYMDDC--GGGLSMHNV----------RLFLFQLL 113
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
+GLAY H + + HRD+K N+L+ ++ADFGLA+ ++ S + T Y
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWY 169
Query: 495 LAPEYALYGQLTEKS---DVYSFGVVILEIMCGR 525
P+ L G TE S D++ G + E+ GR
Sbjct: 170 RPPD-VLLGS-TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 47/204 (23%), Positives = 75/204 (36%), Gaps = 59/204 (28%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450
Y V DY+P G++ L G+ L + I ++ + +H K H
Sbjct: 77 YFVMDYIPGGDMMSLLIRM-----GIFPEDLA----RFYIAELTCAVESVH---KMGFIH 124
Query: 451 RDIKATNILLDADMRARVADFGLA------------------------------------ 474
RDIK NIL+D D ++ DFGL
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 475 ----------KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
+ +R+ Q L + GT Y+APE L T+ D +S GV++ E++ G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 525 RKALDLSTSGSPRACLITDWVWSL 548
+ L+ + + +W SL
Sbjct: 245 QPPF-LAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 16/87 (18%)
Query: 391 YLVYDYMPNGNVDD--HLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448
YLV +Y+ G+V H++ F++ I +VA L YLH + I
Sbjct: 80 YLVMEYLIGGDVKSLLHIYGYFDE-----------EMAVKYISEVALALDYLH---RHGI 125
Query: 449 YHRDIKATNILLDADMRARVADFGLAK 475
HRD+K N+L+ + ++ DFGL+K
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 33/105 (31%), Positives = 46/105 (43%), Gaps = 8/105 (7%)
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG---LAK 475
RPL Q + + + Y+H I HRDIK N+L++ + DFG A+
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 476 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520
S H +AGT APE T D++S G+VI E
Sbjct: 312 GSWSTPFHYG--IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 10/93 (10%)
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
VA G+ +L HRD+ A N+L+ ++ DFGLA+ ++++ G+
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK---GST 301
Query: 493 ----GYLAPEYALYGQLTEKSDVYSFGVVILEI 521
++APE T SDV+SFG+++ EI
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 5/80 (6%)
Query: 450 HRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEY--AL---YGQ 504
HRDIK N+LLD + R+ADFG + + + GT Y++PE A+ G+
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 505 LTEKSDVYSFGVVILEIMCG 524
+ D +S GV + E++ G
Sbjct: 185 YGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 43/179 (24%), Positives = 68/179 (37%), Gaps = 58/179 (32%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR--KNIILDVAKGLAYLHYGVKPAI 448
Y V DY+P G++ L R + + + I ++ + +H K
Sbjct: 77 YFVMDYIPGGDMMSLLI-----------RLGIFEEDLARFYIAELTCAIESVH---KMGF 122
Query: 449 YHRDIKATNILLDADMRARVADFGL---------AKQSREGQSH---------------- 483
HRDIK NIL+D D ++ DFGL +K ++G H
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 484 -----------------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
L + GT Y+APE L T+ D +S GV++ E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 46/168 (27%)
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450
YL+ +++P G++ L + K LT + + I + + +H + H
Sbjct: 77 YLIMEFLPGGDMMTLL---------MKKDTLTEEETQFYIAETVLAIDSIH---QLGFIH 124
Query: 451 RDIKATNILLDADMRARVADFGL----------------------------------AKQ 476
RDIK N+LLD+ +++DFGL A+
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
+ + L GT Y+APE + + D +S GV++ E++ G
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 63/247 (25%)
Query: 321 IGRGGFG---LVYKGILQDGTTVAVKKVIESDFQGDAEFCN---EVEIISNLKHRNLVPL 374
IGRG FG LV K G A+KK+ +S+ + + E +I++ + +V L
Sbjct: 9 IGRGAFGEVRLVQK--KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
D + YL+ +Y+P G++ L + K T + + I +
Sbjct: 67 Y-YSFQDENY-----LYLIMEYLPGGDMMTLL---------MKKDTFTEEETRFYIAETI 111
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK------------------- 475
+ +H K HRDIK N+LLDA +++DFGL
Sbjct: 112 LAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 476 ----------QSREGQSH--------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVV 517
S + ++ L GT Y+APE L ++ D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 518 ILEIMCG 524
+ E++ G
Sbjct: 229 MYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 27/121 (22%), Positives = 43/121 (35%), Gaps = 46/121 (38%)
Query: 450 HRDIKATNILLDADMRARVADFGLAK---------------QSREGQSHLTTR------- 487
HRDIK NIL+D +++DFGL+ Q + ++ + R
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 488 ------------------------VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC 523
GT Y+APE L ++ D +S G ++ E +
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 524 G 524
G
Sbjct: 244 G 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 22/60 (36%), Positives = 34/60 (56%), Gaps = 7/60 (11%)
Query: 418 KRPLTWPQR--KNIILDVAKGLAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
KR ++ KNI+ D+ L Y+H +G I H DIK NI++D + R + D+G+A
Sbjct: 118 KRIKCKNKKLIKNIMKDMLTTLEYIHEHG----ISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 60/219 (27%)
Query: 311 ATDKFSQKNFIGRGGFGLVYKGIL-----------------QDGTTVAVKKV------IE 347
++D F ++ +G G FG+ ++G+ Q V +K+V +
Sbjct: 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVR 202
Query: 348 SDF-------QGDAEF-CNEVEIISNLKHRNLVPLRGCC---------VVDGDNERGSER 390
DF +G AE E + + +K RN + C DG +GS+
Sbjct: 203 QDFLKTGTLAKGSAETGMVEAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQ- 260
Query: 391 YLVYDYMPNGNVDDHL------FPSFNDGSGVAKR--PLTWPQRK---NIILDVAK---- 435
+LV+ + + + D L FP + +A + P PQ K N+I V +
Sbjct: 261 WLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLT 320
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
GL LH + I HRDIK N+L+ D + ++ DFG A
Sbjct: 321 GLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 3/96 (3%)
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
V + + YLH + I HRDIKA NI ++ + DFG A + ++ AGT
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528
APE D++S G+V+ E+ +L
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 52/211 (24%)
Query: 337 GTTVAVKKVIESDFQGDAEFCN---------EVEIISNLKHRNLVPLRGCCVVDGDNERG 387
G V V+++ + E C E+ + H N+VP R + D
Sbjct: 25 GEYVTVRRI-------NLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD------ 71
Query: 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA 447
+E ++V +M G+ D + F DG +++ + + I+ V K L Y+H+
Sbjct: 72 NELWVVTSFMAYGSAKDLICTHFMDG--MSELAIAY-----ILQGVLKALDYIHH---MG 121
Query: 448 IYHRDIKATNILLDADMRARVADF-GLAKQSREGQSHLTTRVAGTHGY----------LA 496
HR +KA++IL+ D + ++ GQ R+ H + L+
Sbjct: 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ-----RLRVVHDFPKYSVKVLPWLS 176
Query: 497 PEYALYGQLT---EKSDVYSFGVVILEIMCG 524
PE L L KSD+YS G+ E+ G
Sbjct: 177 PE-VLQQNLQGYDAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 26/105 (24%), Positives = 37/105 (35%), Gaps = 17/105 (16%)
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475
V RPL + + L L LH K NILL D + G
Sbjct: 9 VRGRPLNEEEIWAVCLQCLGALRELHRQAKSG---------NILLTWD--GLLKLDGSVA 57
Query: 476 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520
+ + ++APE TEK+D+YS G+ + E
Sbjct: 58 F-KTPEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.88 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.83 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.7 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.68 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.38 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.91 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.86 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.78 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.68 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.56 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.52 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.43 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.28 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.23 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.17 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.08 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.41 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 96.33 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.23 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.16 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.84 | |
| PLN02236 | 344 | choline kinase | 95.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.43 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.73 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.73 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.67 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.66 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.22 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.87 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.65 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.31 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.17 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 92.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.75 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 92.11 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.66 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.38 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-63 Score=540.93 Aligned_cols=290 Identities=49% Similarity=0.806 Sum_probs=254.9
Q ss_pred CccceehHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCccccccee
Q 005691 299 GSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCC 378 (683)
Q Consensus 299 ~~~~f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c 378 (683)
....|+++|+++||++|+..++||+||||.||+|.+++|+.||||++.....+...+|.+|++++++++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999988775544255699999999999999999999999
Q ss_pred eecCCCCCCC-eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCc
Q 005691 379 VVDGDNERGS-ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATN 457 (683)
Q Consensus 379 ~~~~~~~~~~-~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsN 457 (683)
. +.. +++||||||+||||+++|+... .. .|+|.+|++||.++|+||+|||+.+.++||||||||+|
T Consensus 141 ~------e~~~~~~LVYEym~nGsL~d~L~~~~------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 141 L------EGGEHRLLVYEYMPNGSLEDHLHGKK------GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred e------cCCceEEEEEEccCCCCHHHHhCCCC------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 8 444 6999999999999999997643 11 89999999999999999999999999999999999999
Q ss_pred eeeccCCcEEEcccCccccccc-CCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 458 ILLDADMRARVADFGLAKQSRE-GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 458 ILLd~~~~~KLaDFGla~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
||||+++++||+|||+|+..+. .....+.. .||.||+||||+..+..+.|+|||||||+|+||+|||++.+...+..+
T Consensus 208 ILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~ 286 (361)
T KOG1187|consen 208 ILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE 286 (361)
T ss_pred eeECCCCCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc
Confidence 9999999999999999977655 32222222 899999999999999999999999999999999999999987653332
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..+++|++..++++++.+++|+.+.+.. +...+.+.++..+|+.|++.+|.+||+|.||+++|+..
T Consensus 287 --~~l~~w~~~~~~~~~~~eiiD~~l~~~~----~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 287 --LSLVEWAKPLLEEGKLREIVDPRLKEGE----YPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred --ccHHHHHHHHHHCcchhheeCCCccCCC----CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 4589999999999999999999997320 23236788999999999999999999999999999654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=409.82 Aligned_cols=252 Identities=35% Similarity=0.554 Sum_probs=205.2
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC-eeEEE
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS-ERYLV 393 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~-~~~LV 393 (683)
..+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.. .. ...+|
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~------~~~~~~iV 118 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS------PPGSLCIV 118 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCCceEEE
Confidence 345599999999999999844449999997754443 4589999999999999999999999972 33 68999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC-ccccCCCCCceeeccCC-cEEEccc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA-IYHRDIKATNILLDADM-RARVADF 471 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~-IiHrDIKpsNILLd~~~-~~KLaDF 471 (683)
||||++|+|.++|+.. .+..++|..+++|+.|||+||.||| +.+ ||||||||+|||++.++ ++||+||
T Consensus 119 tEy~~~GsL~~~l~~~-------~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK-------RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred EEeCCCCcHHHHHhhc-------ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 9999999999999653 2468999999999999999999999 666 99999999999999997 9999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc--cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL--YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|+++...... ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ..-+...+
T Consensus 189 Glsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~ 259 (362)
T KOG0192|consen 189 GLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVV 259 (362)
T ss_pred ccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH
Confidence 9998765432 2334478999999999999 56999999999999999999999999986543 11222222
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..+.. +.+ +.+....+..++..||+.||+.||++.+++.+|+..
T Consensus 260 ~~~~R-----p~~----------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 260 VGGLR-----PPI----------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred hcCCC-----CCC----------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 22221 111 122345677888889999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=394.85 Aligned_cols=253 Identities=31% Similarity=0.489 Sum_probs=212.1
Q ss_pred cccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
+...+.||+|-||.||.|.++....||||.++..... .+.|.+|+++|++|+|+|||+|+|+|. .+..++|||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~------~~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCT------KQEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEe------cCCceEEEE
Confidence 3345679999999999999997779999999886433 567999999999999999999999997 445799999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
|||++|+|.+||... .+..+...+.+.++.|||+|++||+ ++++|||||.++|||++++..+||+|||||
T Consensus 281 E~m~~GsLl~yLr~~-------~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR-------EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred EecccCcHHHHhhhc-------CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccc
Confidence 999999999999541 3467889999999999999999999 999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 475 KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 475 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
|...++.........-...|.|||.+..+.++.|||||||||+||||+| |+.|+..... .+ +.+.+++|-
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~e-v~~~le~Gy 421 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EE-VLELLERGY 421 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HH-HHHHHhccC
Confidence 9666666555555556779999999999999999999999999999999 7777654322 12 233344442
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
-. ..|..+...+.+|+..||+.+|++|||...+...|+..
T Consensus 422 Rl---------------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 422 RL---------------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred cC---------------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 11 23445677888999999999999999999999888853
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=402.83 Aligned_cols=265 Identities=26% Similarity=0.433 Sum_probs=219.5
Q ss_pred cCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
.+....+.||+|.||.||+|+.. +.+.||||.+++.... ...+|++|+++++.++|||||+|+|+|.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~------ 559 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR------ 559 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc------
Confidence 44455677999999999999853 3567999999887655 6788999999999999999999999998
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCC-C---C-CCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGS-G---V-AKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~-~---~-~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
+++..++|+|||..|+|.+||........ . . ...+|+-.+.+.||.|||.|++||- +..+|||||..+|+|+
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhcee
Confidence 67889999999999999999954321110 0 1 1445999999999999999999999 8999999999999999
Q ss_pred ccCCcEEEcccCcccccccCCcccc-ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCc
Q 005691 461 DADMRARVADFGLAKQSREGQSHLT-TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRA 538 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~-~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~ 538 (683)
.+++.+||+||||+|..-..+.+.. .+..-..+|||||.+++++||.+||||||||+||||+| |+.|+.....
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----- 711 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----- 711 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----
Confidence 9999999999999986544443332 23445679999999999999999999999999999998 8888764432
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
+-|.+.+++|++.+ -++.+..++..|++.||+.+|.+||+++||-..|+.-..
T Consensus 712 ----~EVIe~i~~g~lL~---------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 712 ----QEVIECIRAGQLLS---------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----HHHHHHHHcCCccc---------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 34667777887743 334566788999999999999999999999999986443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=417.10 Aligned_cols=270 Identities=26% Similarity=0.451 Sum_probs=220.4
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeec
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~ 381 (683)
++++++. ..|...++||+|+||.||+|+. .+|..||||++...... ...|++++++++|||||+++|+|.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~-- 753 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR-- 753 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE--
Confidence 3444443 4577888999999999999997 57899999998653322 235688999999999999999997
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.....++||||+++|+|.++++ .++|.++.+|+.|+|+||+|||+.++++|+||||||+||++|
T Consensus 754 ----~~~~~~lv~Ey~~~g~L~~~l~------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~ 817 (968)
T PLN00113 754 ----SEKGAYLIHEYIEGKNLSEVLR------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817 (968)
T ss_pred ----cCCCCEEEEeCCCCCcHHHHHh------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC
Confidence 4567899999999999999982 489999999999999999999988788999999999999999
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
.++.+++. ||....... .....||.+|||||++.++.++.|+|||||||++|||+||+.|++...... ..+
T Consensus 818 ~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~---~~~ 888 (968)
T PLN00113 818 GKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH---GSI 888 (968)
T ss_pred CCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC---CcH
Confidence 99988876 666543321 122368899999999999999999999999999999999999996443322 457
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
.+|++.........+.+|+.+..... ...+.+.++.+++.+|++.+|++||||.||+++|+....
T Consensus 889 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 889 VEWARYCYSDCHLDMWIDPSIRGDVS----VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHhcCccchhheeCccccCCCC----ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 78887777666777788887754311 223456688999999999999999999999999997543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=366.12 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=201.2
Q ss_pred cceeeeecCceEEEEEEEc-CCcEEEEEEeecc-CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC-eeEEE
Q 005691 317 QKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS-ERYLV 393 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~-~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~-~~~LV 393 (683)
..+.||+|..|+|||++++ +++.+|+|.+... .....++..+|++++++.+||+||.++|.|.. .. +..++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~------~~~~isI~ 156 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS------NGEEISIC 156 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe------CCceEEee
Confidence 3567999999999999986 6788999998443 33446789999999999999999999999974 33 69999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
||||++|||++++.. .+.+++...-+|+.+|.+||.|||+ +.+||||||||+|||++..|++||+|||.
T Consensus 157 mEYMDgGSLd~~~k~---------~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR---------VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred hhhcCCCCHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccc
Confidence 999999999999832 2468899999999999999999994 38999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++..... .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+.. .+|+--+
T Consensus 226 S~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~------~~~~~Ll----- 291 (364)
T KOG0581|consen 226 SGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY------LDIFELL----- 291 (364)
T ss_pred cHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC------CCHHHHH-----
Confidence 9877654 4456789999999999999999999999999999999999999986542211 1222111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+++ +..+. .+..+...++..++-.|++.||.+||+..|+++
T Consensus 292 -~~Iv~----~ppP~--lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 -CAIVD----EPPPR--LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -HHHhc----CCCCC--CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11122 11110 011135667889999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=391.83 Aligned_cols=269 Identities=26% Similarity=0.435 Sum_probs=219.9
Q ss_pred eehHHHHHHhcCc---------ccceeeeecCceEEEEEEEcC----CcEEEEEEeeccCccC-hHHHHHHHHHHHhccC
Q 005691 303 FKIQDLERATDKF---------SQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQG-DAEFCNEVEIISNLKH 368 (683)
Q Consensus 303 f~~~el~~at~~f---------~~~~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H 368 (683)
++|+|-..|...| .++++||.|.||.||+|+++- ...||||.++....+. ..+|+.|..||.+++|
T Consensus 610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH 689 (996)
T KOG0196|consen 610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 689 (996)
T ss_pred ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence 5566555555444 456899999999999999862 4579999998865443 5679999999999999
Q ss_pred CCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCc
Q 005691 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448 (683)
Q Consensus 369 ~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~I 448 (683)
|||++|.|+.. .....++|.|||+||+|+.||... ...++|.+..-+.++||.|+.||- +.++
T Consensus 690 PNIIrLEGVVT------ks~PvMIiTEyMENGsLDsFLR~~--------DGqftviQLVgMLrGIAsGMkYLs---dm~Y 752 (996)
T KOG0196|consen 690 PNIIRLEGVVT------KSKPVMIITEYMENGSLDSFLRQN--------DGQFTVIQLVGMLRGIASGMKYLS---DMNY 752 (996)
T ss_pred CcEEEEEEEEe------cCceeEEEhhhhhCCcHHHHHhhc--------CCceEeehHHHHHHHHHHHhHHHh---hcCc
Confidence 99999999986 667889999999999999999432 346999999999999999999999 9999
Q ss_pred cccCCCCCceeeccCCcEEEcccCcccccccCCccccccccC--CCcccCccccccCCCCccccEEEcchhHHHHhh-CC
Q 005691 449 YHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG--THGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GR 525 (683)
Q Consensus 449 iHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~G--T~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr 525 (683)
|||||.++|||++.+..+||+||||+|...++.....+...| ...|.|||.+.+.++|.+||||||||+|||.++ |.
T Consensus 753 VHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 753 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred hhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 999999999999999999999999999876654333332223 568999999999999999999999999999887 99
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 526 KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 526 ~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
+|+-.+...+ |.+.+++| .+- ..+.++..-+.+|++.|||.|-.+||+..||+.+|
T Consensus 833 RPYWdmSNQd---------VIkaIe~g---------yRL------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 833 RPYWDMSNQD---------VIKAIEQG---------YRL------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred CcccccchHH---------HHHHHHhc---------cCC------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 9986544311 22223222 111 25567788899999999999999999999999999
Q ss_pred hcCCCCC
Q 005691 606 EGDIEVP 612 (683)
Q Consensus 606 ~~~~~~~ 612 (683)
.+.+..|
T Consensus 889 DklIrnP 895 (996)
T KOG0196|consen 889 DKLIRNP 895 (996)
T ss_pred HHHhcCc
Confidence 8765544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=378.50 Aligned_cols=247 Identities=27% Similarity=0.468 Sum_probs=206.8
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
..|...+.||+|||+.||.++. ..|+.||+|.+.+...+. .+...+||+|.++|+|||||++++|+. +..
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE------Ds~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE------DSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee------cCC
Confidence 5788899999999999999997 789999999997754332 456889999999999999999999996 677
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..|+|.|++++|+|..++ +.++++++.+.+.+..||+.||.||| +.+|||||||-.|++|++++++||
T Consensus 92 nVYivLELC~~~sL~el~---------Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKI 159 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELL---------KRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKI 159 (592)
T ss_pred ceEEEEEecCCccHHHHH---------HhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEe
Confidence 899999999999999998 24678999999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||||.....+... ....+||+.|+|||++....++..+||||+||++|-|+.|++||+... +.+- ...
T Consensus 160 gDFGLAt~le~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vket-y~~ 229 (592)
T KOG0575|consen 160 GDFGLATQLEYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKET-YNK 229 (592)
T ss_pred cccceeeeecCcccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHH-HHH
Confidence 999999988754322 234799999999999999999999999999999999999999997431 1111 222
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
++.... . .|........+++...+++||.+|||+++|+.
T Consensus 230 Ik~~~Y---~-------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 230 IKLNEY---S-------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhcCc---c-------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 222211 1 11223345567788889999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.12 Aligned_cols=252 Identities=29% Similarity=0.427 Sum_probs=203.6
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC-------hHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG-------DAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~-------~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
.+.|...+.||+|+||.|-+|.. ++|+.||||++.+....+ .....+|+++|++|+|||||++++++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~---- 246 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE---- 246 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee----
Confidence 45677788999999999999985 579999999997643222 123569999999999999999999997
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
..+..|+|+|||++|.|.+++-. .+.+.+..-..++.|+..|+.||| +.+|+||||||+||||..+
T Consensus 247 --~~ds~YmVlE~v~GGeLfd~vv~---------nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~ 312 (475)
T KOG0615|consen 247 --VPDSSYMVLEYVEGGELFDKVVA---------NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSND 312 (475)
T ss_pred --cCCceEEEEEEecCccHHHHHHh---------ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccC
Confidence 45677999999999999999843 346777777899999999999999 9999999999999999655
Q ss_pred ---CcEEEcccCcccccccCCccccccccCCCcccCccccccCCC---CccccEEEcchhHHHHhhCCCCCCCCCCCCCC
Q 005691 464 ---MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL---TEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537 (683)
Q Consensus 464 ---~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~---s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~ 537 (683)
..+||+|||+|+...++ ..+...+||+.|.|||++..+.+ ..|+|+||+||+||-+++|.+||.......
T Consensus 313 ~e~~llKItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-- 388 (475)
T KOG0615|consen 313 AEDCLLKITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-- 388 (475)
T ss_pred CcceEEEecccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--
Confidence 78999999999987633 34566899999999999986543 348899999999999999999997543211
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. ..+.+..|+.. +.+....++.++..+++.+++..||++|||+.|+++
T Consensus 389 --s----l~eQI~~G~y~------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 --S----LKEQILKGRYA------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --c----HHHHHhcCccc------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 23334444432 111244567788999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.04 Aligned_cols=271 Identities=30% Similarity=0.378 Sum_probs=202.1
Q ss_pred cccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHh--ccCCCcccccceeeecCCCCCCCeeEE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISN--LKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~--L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
....++||+|+||.||||.+. ++.||||++... ..+.|.+|-+|.+. ++|+||++++|.-...+ ....+.+|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t--~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT--ADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCC--ccccceeE
Confidence 334567999999999999997 599999998653 35568888888765 58999999998753211 13568999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc------CCCccccCCCCCceeeccCCcE
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV------KPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~------~~~IiHrDIKpsNILLd~~~~~ 466 (683)
|+||.++|||.+|| +...++|....+|+..+++||+|||++. +++|+|||||++|||+.+|+++
T Consensus 286 Vt~fh~kGsL~dyL----------~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----------KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred EeeeccCCcHHHHH----------HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 99999999999999 3457999999999999999999999765 6789999999999999999999
Q ss_pred EEcccCcccccccCCcc-ccccccCCCcccCccccccC-CC-----CccccEEEcchhHHHHhhCCCCCCCCCCCCCC--
Q 005691 467 RVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYG-QL-----TEKSDVYSFGVVILEIMCGRKALDLSTSGSPR-- 537 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~-~~-----s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~-- 537 (683)
.|+|||||..+..+... .+...+||.+|||||++.+. .+ -.+.||||+|.|||||++.-..++....++.+
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 99999999988755433 23447899999999998742 12 24799999999999999987766421111100
Q ss_pred ------ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 538 ------ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 538 ------~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
..--.+-.+.++-..+. .|.+.... .....+..+.+.+..||.+||+.|-|+.=|-+.+.+...
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~----RP~~p~~W-----~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQ----RPKIPDAW-----RKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhcc----CCCChhhh-----hcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00001122333322222 23332210 111346678889999999999999999988888876443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=361.80 Aligned_cols=202 Identities=30% Similarity=0.538 Sum_probs=178.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
..+|.....||+|.||+||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|+|||+|+.++. .++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~------~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE------DDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe------cCC
Confidence 356777788999999999999975 5899999999776 3444566889999999999999999999997 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC-----
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD----- 463 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~----- 463 (683)
..+||||||.+|+|.+||+ .++.+++...+.+..|+|.||++|| +++||||||||.||||+..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~---------~~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIR---------RRGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred eEEEEEEeCCCCCHHHHHH---------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCC
Confidence 8999999999999999994 3447999999999999999999999 9999999999999999765
Q ss_pred -CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 464 -MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 464 -~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
-.+||+|||+||....+. .....+|++-|||||+++..+|+.|+|+||.|++|||+++|+.||+..+.
T Consensus 151 ~~~LKIADFGfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CceEEecccchhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 468999999999887543 34568999999999999999999999999999999999999999985443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=361.86 Aligned_cols=267 Identities=25% Similarity=0.364 Sum_probs=204.8
Q ss_pred HhcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccceeeecC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDG 382 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~ 382 (683)
..++|...++||+|+||.||+|.. .++..||||++...... ..+.+.+|+.++.++ +|||||+++|+|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 356788899999999999999974 23568999998754322 245689999999999 89999999998862
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCC-------------------------------------------------
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDG------------------------------------------------- 413 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~------------------------------------------------- 413 (683)
.+...++||||+++|+|.+++.......
T Consensus 83 ---~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 83 ---PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ---CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 3446899999999999999885421100
Q ss_pred ----CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCccc-cccc
Q 005691 414 ----SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL-TTRV 488 (683)
Q Consensus 414 ----~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~-~~~~ 488 (683)
.......++|..+++++.|+++||+||| +.+|+||||||+|||++.++.+||+|||+++......... ....
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence 0001245888899999999999999999 8899999999999999999999999999998654332222 2334
Q ss_pred cCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCcccccccc
Q 005691 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDD 567 (683)
Q Consensus 489 ~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~ 567 (683)
.++..|+|||++....++.++|||||||++|||++ |+.||...... .........+... ..
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~~~~-----~~----- 298 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------EEFCQRLKDGTRM-----RA----- 298 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHHHHhcCCCC-----CC-----
Confidence 56789999999999999999999999999999997 99998643221 1111222222111 01
Q ss_pred ccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 568 FLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 568 ~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+......+..++..|++.||++||||.+|+++|+..
T Consensus 299 -----~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 299 -----PENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred -----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112234577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=391.88 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=210.8
Q ss_pred cCcccceeeeecCceEEEEEEEcC--Cc----EEEEEEeecc-CccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD--GT----TVAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~--g~----~VAVK~l~~~-~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
.+......||+|.||.||+|.+.+ |. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l------ 765 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL------ 765 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec------
Confidence 345556789999999999999753 33 4999999775 4455678999999999999999999999998
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++++|||++|+|..||...+.. ......|+..+.+.|+.|||+|+.||+ ++++|||||.++|+||++...
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~--~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPA--PFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccc--cCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCc
Confidence 567799999999999999999765422 123567899999999999999999999 999999999999999999999
Q ss_pred EEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 466 ARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
+||+||||||..-..+.. ......-...|||||.++.+.++.|+|||||||++|||+| |..|+..... ..+
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-----~~v-- 913 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-----FEV-- 913 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-----HHH--
Confidence 999999999944332222 2222234568999999999999999999999999999999 7788764332 111
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.....+.|++ ..+..+.+.+.+|+..||+.+|++||+...+++.++..
T Consensus 914 -~~~~~~ggRL----------------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 914 -LLDVLEGGRL----------------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred -HHHHHhCCcc----------------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1112334443 14456778889999999999999999999999988764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=346.35 Aligned_cols=269 Identities=24% Similarity=0.365 Sum_probs=202.0
Q ss_pred cCcccceeeeecCceEEEEEEEcC-----------------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccc
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-----------------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPL 374 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L 374 (683)
++|...++||+|+||.||++.+++ +..||+|.+..... ....+|.+|++++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999998643 33699998865432 234579999999999999999999
Q ss_pred cceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCC----------CCCCCCCCccchhhhHHHHHHHHHHHhccc
Q 005691 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGS----------GVAKRPLTWPQRKNIILDVAKGLAYLHYGV 444 (683)
Q Consensus 375 ~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~----------~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~ 444 (683)
+|++. .....++||||+++|+|.+++........ ......++|..+++|+.|++.||.|||
T Consensus 85 ~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--- 155 (304)
T cd05096 85 LGVCV------DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--- 155 (304)
T ss_pred EEEEe------cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence 99997 45678999999999999998843211100 112245889999999999999999999
Q ss_pred CCCccccCCCCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh
Q 005691 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC 523 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt 523 (683)
+.+|+||||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++
T Consensus 156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 88999999999999999999999999999986543322 22334556889999999999999999999999999999997
Q ss_pred C--CCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005691 524 G--RKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601 (683)
Q Consensus 524 G--r~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eV 601 (683)
+ ..|+..... .....++........... ... .+......+.+++..|++.+|++||||.+|
T Consensus 236 ~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~--~~~----------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 236 LCKEQPYGELTD-----EQVIENAGEFFRDQGRQV--YLF----------RPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred ccCCCCCCcCCH-----HHHHHHHHHHhhhccccc--ccc----------CCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 5 455543221 112222222222111000 000 011223467889999999999999999999
Q ss_pred HHHHhc
Q 005691 602 LKMLEG 607 (683)
Q Consensus 602 l~~L~~ 607 (683)
+++|++
T Consensus 299 ~~~l~~ 304 (304)
T cd05096 299 HAFLTE 304 (304)
T ss_pred HHHHhC
Confidence 999873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.11 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=210.3
Q ss_pred cCcccceeeeecCceEEEEEE-EcCCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.+|.+.++||+|.||+|||+. +.+|..||.|++.-.... .......|+.+|++|+|||||+++++-.. ++..-
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~----~~~ev 94 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI----EDNEV 94 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh----ccchh
Confidence 457778899999999999998 568999999998744332 24568899999999999999999985432 12334
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeeccCCcEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd~~~~~K 467 (683)
.+|||||+..|+|...+..-. ..++.+++...++++.|+++||.++|... ++ |+||||||.||+|+++|.+|
T Consensus 95 lnivmE~c~~GDLsqmIk~~K-----~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFK-----KQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHH-----hccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCcee
Confidence 899999999999999884432 24567999999999999999999999421 44 99999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+||||+|.+....+ .....+||+-||+||.+....|+.||||||+||+++||..-++||... ++. -..+
T Consensus 169 LGDfGL~r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~-~L~~ 238 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLL-SLCK 238 (375)
T ss_pred eccchhHhHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHH-HHHH
Confidence 999999998876543 344578999999999999999999999999999999999999999743 121 1233
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.++.|.... .+.+-..+.+..|+-.|+.+||+.||+....+..+..+.
T Consensus 239 KI~qgd~~~--------------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 239 KIEQGDYPP--------------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred HHHcCCCCC--------------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence 444443311 122345667788999999999999999777776666543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.47 Aligned_cols=248 Identities=18% Similarity=0.240 Sum_probs=197.0
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
...||+|++|.||+|.+ +|+.||||++....... .+.|.+|+.++.+++|||||+++|++.... ......++||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~--~~~~~~~lv~ 101 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV--DDLPRLSLIL 101 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc--cCCCceEEEE
Confidence 35799999999999998 58999999987654333 356889999999999999999999986311 1235689999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCCceeeccCCcEEEcccCc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
||+++|+|.+++.. .+.++|..+++++.+++.||.||| + .+++||||||+|||+++++.+||+|||+
T Consensus 102 Ey~~~g~L~~~l~~---------~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 102 EYCTRGYLREVLDK---------EKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred EeCCCCcHHHHHhh---------CCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 99999999999942 346899999999999999999999 5 4788999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
++...... ....||..|+|||++.. ..++.++|||||||++|||++|+.||..... .++.......
T Consensus 170 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~ 237 (283)
T PHA02988 170 EKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINK 237 (283)
T ss_pred Hhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhc
Confidence 98654321 23468899999999975 7899999999999999999999999974321 1111111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. +.+. ......+.+++..||+.||++||||.+|++.|+.
T Consensus 238 ~~~-----~~~~----------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 238 NNS-----LKLP----------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CCC-----CCCC----------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 110 1111 1123467789999999999999999999999974
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.30 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=201.5
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||++.+.++..+|+|.+.... ...++|.+|++++++++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT------QQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc------cCCCEEE
Confidence 4577788999999999999999888899999876432 33567999999999999999999999986 4567899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ...++|..++.++.+++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 77 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g 145 (256)
T cd05114 77 VTEFMENGCLLNYLRQR--------QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFG 145 (256)
T ss_pred EEEcCCCCcHHHHHHhC--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCC
Confidence 99999999999988422 235889999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............++..|+|||++....++.++||||||+++|||++ |+.|+..... .+.+.. ...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~-i~~ 216 (256)
T cd05114 146 MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEM-ISR 216 (256)
T ss_pred CccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH-HHC
Confidence 988654333222233345678999999998899999999999999999999 8988864321 111111 111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+.. ...+. .....+..++..|++.+|.+||+|.+++++|.
T Consensus 217 ~~~--~~~~~-------------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 217 GFR--LYRPK-------------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCC--CCCCC-------------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 211 01111 11235789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.29 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=205.3
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|+..++||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++|+||+++++++. .....+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT------KEEPIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCCcE
Confidence 35788889999999999999998888999999876533 23567999999999999999999998875 456789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++|||+++|+|.+++... ....+++.+++.++.+++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 78 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD-------EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred EEEecCCCCcHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCC
Confidence 999999999999998432 2346889999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++..............++..|+|||++..+.++.++||||||+++|||++ |+.|+..... ... ...+.
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~----~~~~~ 218 (261)
T cd05072 148 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDV----MSALQ 218 (261)
T ss_pred ccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHH----HHHHH
Confidence 9998765443333334456788999999998999999999999999999998 9999854221 111 11111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+... +.. ......+.+++..|++.+|++||++.+++++|+.
T Consensus 219 ~~~~~----~~~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 219 RGYRM----PRM-----------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred cCCCC----CCC-----------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11110 100 1123457789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.85 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+|++. .+..||+|.+..... ...+.|.+|+.++++++||||++++|++. .
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT------R 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe------c
Confidence 356888899999999999999864 356899999876432 22456899999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
+...++||||+++|+|++++... ...++|..++.++.+++.||+||| +.+++||||||+|||++.++.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKH--------EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcE
Confidence 56799999999999999998421 246899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v 545 (683)
|++|||.+...............++..|+|||++.++.++.++||||||+++||+++ |+.||...... + .
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~-~ 217 (266)
T cd05064 147 KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------D-V 217 (266)
T ss_pred EECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------H-H
Confidence 999999876543222222223345678999999999999999999999999999875 99998643221 1 1
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+...++... . .+......+.+++..|++.+|++||++.++.+.|++
T Consensus 218 ~~~~~~~~~~-----~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 218 IKAVEDGFRL-----P----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HHHHHCCCCC-----C----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 1112222110 0 111234467789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=342.10 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=200.4
Q ss_pred cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++...+.||+|.||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|..... +.....
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~----~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR----ENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc----cCeeeE
Confidence 456677899999999999999764 899999998765333356689999999999999999999985421 113689
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-CCcEEEcc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVAD 470 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-~~~~KLaD 470 (683)
+.|||+++|||.+++.... . .|++...+....+|++||+||| +.+||||||||+|||++. ++.+||+|
T Consensus 93 i~mEy~~~GsL~~~~~~~g-------~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYG-------G-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred eeeeccCCCcHHHHHHHcC-------C-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEecc
Confidence 9999999999999994321 2 6999999999999999999999 999999999999999999 79999999
Q ss_pred cCccccccc--CCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 471 FGLAKQSRE--GQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 471 FGla~~~~~--~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
||+++.... ..........||+.|||||++..+.. ..++|||||||+++||+||++|+.... ...++...
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-------~~~~~~~~ 234 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-------EEAEALLL 234 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-------chHHHHHH
Confidence 999987663 12222345789999999999996533 359999999999999999999986420 01122222
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
....+.. |.+ +........++...|++.+|+.|||++++++.-
T Consensus 235 ig~~~~~-----P~i----------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 235 IGREDSL-----PEI----------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HhccCCC-----CCC----------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 2222211 111 112334556778899999999999999998754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.18 Aligned_cols=254 Identities=30% Similarity=0.375 Sum_probs=199.3
Q ss_pred CcccceeeeecCceEEEEEEEcC--C--cE-EEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQD--G--TT-VAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~--g--~~-VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
+....++||+|.||.||+|.+.. + .. ||||..+.. ......+|++|.+++++++|||||+++|++.
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~------ 231 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV------ 231 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc------
Confidence 34445799999999999999753 2 23 899998752 2344678999999999999999999999997
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++|||+++||+|++||... ...++..++++++.++|+||+||| +.++|||||.++|+|++.++.
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~--------~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN--------KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC--------CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCe
Confidence 567799999999999999999432 236999999999999999999999 999999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
+||+||||++....-... ...-.-...|+|||.+..+.|+.|+|||||||++||+++ |..|+...... -
T Consensus 301 vKISDFGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------~ 370 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------E 370 (474)
T ss_pred EEeCccccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------H
Confidence 999999998765411111 111134678999999999999999999999999999999 88887643221 1
Q ss_pred hhhhh-hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLV-KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~-~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+...+ .++.-.. .+......+..+...|+..+|++||||.+|.+.|+...
T Consensus 371 v~~kI~~~~~r~~---------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 371 VKAKIVKNGYRMP---------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HHHHHHhcCccCC---------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 22222 2221110 11122345566777999999999999999999998643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.50 Aligned_cols=265 Identities=25% Similarity=0.416 Sum_probs=210.6
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecC
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDG 382 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~ 382 (683)
.++++...+.+.....||+|.||+||+|.+. ..||||.+...... ..+.|++||..+++-||.||+-+.|||.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~--- 458 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM--- 458 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc---
Confidence 3677777788888899999999999999986 36999999765443 3567999999999999999999999996
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.....+|.-|+++-+|..|||.. +..++..+.++|+.|||+|+.||| .++|||||||..||+|++
T Consensus 459 ----~p~~AIiTqwCeGsSLY~hlHv~--------etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~ 523 (678)
T KOG0193|consen 459 ----NPPLAIITQWCEGSSLYTHLHVQ--------ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHE 523 (678)
T ss_pred ----CCceeeeehhccCchhhhhccch--------hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEcc
Confidence 34459999999999999999754 357999999999999999999999 999999999999999999
Q ss_pred CCcEEEcccCccccccc-CCccccccccCCCcccCcccccc---CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 463 DMRARVADFGLAKQSRE-GQSHLTTRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~-~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
++++||+||||+..... ..........|...|||||++.. .+|+..+||||||+++|||++|..|+. ....++
T Consensus 524 ~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq-- 600 (678)
T KOG0193|consen 524 DLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ-- 600 (678)
T ss_pred CCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh--
Confidence 99999999999864321 11112233457789999999873 578999999999999999999999998 332221
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.+ |.-|+-.-..|.... .......+.+|...||..++++||...+|+.+|+...
T Consensus 601 -Ii-------fmVGrG~l~pd~s~~---------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 601 -II-------FMVGRGYLMPDLSKI---------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred -eE-------EEecccccCccchhh---------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 11 122322222222221 1233445677889999999999999999999998644
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.39 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=202.6
Q ss_pred hcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+|+. .++..||||+++.... ...+.+.+|+.++..+ +|||||+++|+|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 45788889999999999999973 2356899999865432 2345688999999999 8999999999996
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCC--------------------------------------------------
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDG-------------------------------------------------- 413 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------------------------------------------------- 413 (683)
.+...++||||+++|+|.+++.......
T Consensus 110 --~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 110 --VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred --cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 5667899999999999999885321000
Q ss_pred ----------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 414 ----------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 414 ----------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
.......++|..+++|+.||++||+||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence 0001235889999999999999999999 889999999999999999999999999999866
Q ss_pred ccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccc
Q 005691 478 REGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVW 555 (683)
Q Consensus 478 ~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~ 555 (683)
...... ......++..|+|||++....++.++|||||||++|||++ |..||...... .. ..+.+..+...
T Consensus 265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~----~~~~~~~~~~~ 336 (375)
T cd05104 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SK----FYKMIKEGYRM 336 (375)
T ss_pred cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HH----HHHHHHhCccC
Confidence 433221 1223445678999999999999999999999999999998 88887643221 11 12222222110
Q ss_pred cccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 556 QALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 556 e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
. .+ .....++.+++..|++.||++||+|.+|+++|+.
T Consensus 337 ~--~~-------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 L--SP-------------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred C--CC-------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 0 00 1112357789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=336.83 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=198.1
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.|...+.||+|+||.||++.. .+|+.||||++..... .....+.+|++++++++|+|++++.+++. ....
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~------~~~~ 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE------TKDA 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc------cCCe
Confidence 367788999999999999986 4789999999865432 23346889999999999999999999886 5567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 75 ~~lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 75 LCLVLTIMNGGDLKFHIYNM-------GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred EEEEEEecCCCcHHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999887432 1236889999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||........ .+-+....
T Consensus 145 Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~ 217 (285)
T cd05631 145 DLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRV 217 (285)
T ss_pred eCCCcEEcCCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHh
Confidence 9999987543322 2345789999999999999999999999999999999999999975432110 01111111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
..... . .+.+....+..++..|++.||++||+ ++++++
T Consensus 218 ~~~~~----------~------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 218 KEDQE----------E------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hcccc----------c------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11100 0 11122346678899999999999997 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=333.04 Aligned_cols=256 Identities=30% Similarity=0.425 Sum_probs=205.3
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..++|+..+.||+|+||.||+|...+++.||+|.+.... ...+++.+|++++++++|+|++++++++. .....
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT------LEEPI 76 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe------cCCCe
Confidence 346788899999999999999998888899999986543 34567999999999999999999999886 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++... ....++|..+.+++.+++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 77 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGG-------AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eeeeecccCCcHHHHHhcc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECC
Confidence 9999999999999998432 1346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+++...............+..|+|||+.....++.++||||||++++||++ |+.|+..... .-+...+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~~ 217 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---------AEVLQQV 217 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHH
Confidence 99998765332222222334568999999999999999999999999999999 9988863221 0111122
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+.. .. .+......+.+++.+|++.+|.+||+|.++++.|+.
T Consensus 218 ~~~~~-----~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 218 DQGYR-----MP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HcCCC-----CC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11110 00 011223567889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=335.30 Aligned_cols=272 Identities=21% Similarity=0.271 Sum_probs=200.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...+.||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR------RRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe------cCCE
Confidence 46888999999999999999986 578899999875432 23456889999999999999999999986 4568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++++.+..+.. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 75 ~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~ 142 (287)
T cd07848 75 LYLVFEYVEKNMLELLEE---------MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLC 142 (287)
T ss_pred EEEEEecCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEe
Confidence 999999999987765541 1246889999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch--------
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI-------- 541 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l-------- 541 (683)
|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+
T Consensus 143 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 221 (287)
T cd07848 143 DFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL-FTIQKVLGPLP 221 (287)
T ss_pred eccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhCCCC
Confidence 99999876543333334567899999999999889999999999999999999999999643221100 000
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+...............+...................+.+++..|++.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000001111111110111100000000001113346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.97 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+++.. ++..||||++...... ..+.+.+|+++++.+ +|+|||+++|+|.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence 457888999999999999998742 3457999998754332 235688999999999 8999999999986
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCC---------------------------------------------------
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFND--------------------------------------------------- 412 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~--------------------------------------------------- 412 (683)
.....++||||+++|+|.+++......
T Consensus 113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 556789999999999999988532100
Q ss_pred ----------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCc
Q 005691 413 ----------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482 (683)
Q Consensus 413 ----------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~ 482 (683)
........++|.+.++|+.|++.||+||| +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 00011235888899999999999999999 88999999999999999999999999999986543322
Q ss_pred c-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCc
Q 005691 483 H-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDP 560 (683)
Q Consensus 483 ~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~ 560 (683)
. ......++..|||||++..+.++.++|||||||++|||++ |+.||....... -.+.....+. .+
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~~~~-----~~ 334 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVKRGY-----QM 334 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHHccc-----Cc
Confidence 1 1223345678999999999999999999999999999997 999986432211 0111122111 00
Q ss_pred cccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 561 SLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 561 ~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. +......+.+++..|++.+|++|||+.+|+++|++
T Consensus 335 ~~----------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 335 SR----------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred cC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 01113456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.52 Aligned_cols=249 Identities=33% Similarity=0.529 Sum_probs=191.8
Q ss_pred cceeeeecCceEEEEEEEc-----CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 317 QKNFIGRGGFGLVYKGILQ-----DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~-----~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..+.||.|.||.||+|.+. .+..|+||.+..... ...++|.+|++.+++++||||++++|+|. .....
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~------~~~~~ 76 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI------ENEPL 76 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE------SSSSE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc------ccccc
Confidence 4578999999999999987 357899999965332 23578999999999999999999999998 45569
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.++|... ....++|.++++|+.|+++||+||| +.+++|+||+++|||++.++.+||+|
T Consensus 77 ~lv~e~~~~g~L~~~L~~~-------~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~ 146 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK-------NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSD 146 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT-------CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEES
T ss_pred ccccccccccccccccccc-------ccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 9999999999999999543 1357999999999999999999999 78899999999999999999999999
Q ss_pred cCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhh
Q 005691 471 FGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 471 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
||+++....... .......+...|+|||.+....++.|+||||||+++|||++ |+.|+.... ..++....
T Consensus 147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~ 218 (259)
T PF07714_consen 147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKL 218 (259)
T ss_dssp TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccc
Confidence 999987632222 22333457789999999999999999999999999999999 678875331 11222222
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.++...+ .+......+..++..||+.+|++||||.++++.|
T Consensus 219 -~~~~~~~---------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 -KQGQRLP---------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HTTEETT---------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccccce---------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3332211 1111234677899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=333.74 Aligned_cols=267 Identities=26% Similarity=0.385 Sum_probs=202.7
Q ss_pred ccceeeeecCceEEEEEEE-----cCCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 316 SQKNFIGRGGFGLVYKGIL-----QDGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
...+.||+|+||+||++.. .++..||+|.+..... ...+.|.+|++++++++|+||+++.+++... ....
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~ 82 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ----GGKG 82 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----CCce
Confidence 6778999999999988653 3678999999865432 2356789999999999999999999998632 2346
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++. ...++|.+++.++.+++.||.||| +.+|+||||||+|||+++++.+||+
T Consensus 83 ~~lv~e~~~~~~l~~~~~----------~~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLP----------KHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred EEEEecCCCCCCHHHHHH----------HcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEe
Confidence 899999999999999983 235899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 470 DFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 470 DFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|||+++....+... ......++..|+|||+...+.++.++||||||++++||++|+.|+........ ....+...
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~ 226 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPKQG 226 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhccccc
Confidence 99999876543221 12223456779999999988999999999999999999999999764322110 11111111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
......+.+.++...... .+......+.+++..|++++|++||||++|+++|+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 227 QMTVVRLIELLERGMRLP------CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred ccchhhhhhhhhcCCCCC------CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111112222222222111 1122345678899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.40 Aligned_cols=262 Identities=27% Similarity=0.489 Sum_probs=204.5
Q ss_pred cCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++|...+.||+|+||.||+|.... ...||+|.+..... ....+|.+|++++++++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~------ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT------ 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc------
Confidence 367778899999999999998643 25799998865432 22456899999999999999999999986
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCC-------CCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGS-------GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
.....+++|||+++|+|.+++........ ......+++...+.++.|++.||+||| +.+|+||||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Ni 155 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNC 155 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceE
Confidence 45678999999999999999854321110 111256889999999999999999999 88999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCC
Q 005691 459 LLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSP 536 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~ 536 (683)
++++++.+||+|||+++....... .......+++.|+|||++..+.++.++|||||||++|||++ |+.||......
T Consensus 156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-- 233 (283)
T cd05048 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-- 233 (283)
T ss_pred EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 999999999999999986543322 22334567889999999999999999999999999999998 99998643221
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+ ...+..+.... .+......+.+++..|++.||++||++.+|++.|++
T Consensus 234 ---~~----~~~i~~~~~~~---------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 ---EV----IEMIRSRQLLP---------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HH----HHHHHcCCcCC---------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11 12222222111 112234567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.10 Aligned_cols=242 Identities=26% Similarity=0.359 Sum_probs=195.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|+..++||+|+||.||.++.. +++.+|+|.+++.... ..+...+|..+|.+++||.||+|+--+. .+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ------t~ 97 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ------TE 97 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc------cC
Confidence 468999999999999999999865 5888999999775432 3456889999999999999999987665 67
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
..+|||+||+.||.|..+|. +...+++....-.+..|+.||.||| +.+||||||||+|||||++|+++
T Consensus 98 ~kLylVld~~~GGeLf~hL~---------~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~ 165 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQ---------REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIK 165 (357)
T ss_pred CeEEEEEeccCCccHHHHHH---------hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEE
Confidence 88999999999999999993 3457888888889999999999999 99999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+||||++....... .+...+||+.|||||++....|+..+|.||+|+++|||++|.+||...+ ...+...
T Consensus 166 LtDFgL~k~~~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~ 236 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDK 236 (357)
T ss_pred EeccccchhcccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHH
Confidence 999999996544332 3445899999999999999999999999999999999999999997432 2233333
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP 596 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP 596 (683)
.. .+++ .. .+.-...+...++..-++.||++|-
T Consensus 237 I~-~~k~--------~~-------~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 237 IL-KGKL--------PL-------PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred Hh-cCcC--------CC-------CCccCCHHHHHHHHHHhccCHHHhc
Confidence 22 2221 00 1111123445666777899999995
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=342.33 Aligned_cols=264 Identities=28% Similarity=0.345 Sum_probs=202.0
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.+.|+..++||+|.||.|||++. .+|+.||+|++.....+ ...-..+||.||++|+||||++|.|..... ...
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~----~~~ 191 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK----LSG 191 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec----CCc
Confidence 45677788999999999999994 57999999999765422 233467899999999999999999998743 356
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..|||+|||++ +|..++.. ..-.++..++..++.|++.||.|+| ..+|+|||||.+|||||++|.+||
T Consensus 192 siYlVFeYMdh-DL~GLl~~--------p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSS--------PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred eEEEEEecccc-hhhhhhcC--------CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEe
Confidence 89999999987 67766632 2347999999999999999999999 999999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||||+++........|..+-|+.|+|||.+.+ ..|+.++|+||.||||.||+.|++.+...++.++ .+-+.+
T Consensus 260 aDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-----l~kIfk 334 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-----LHKIFK 334 (560)
T ss_pred ccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-----HHHHHH
Confidence 9999999887776665666667999999999986 5799999999999999999999999875543221 111111
Q ss_pred hh--------hcCccc--ccc------CccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LV--------KAGKVW--QAL------DPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~--------~~g~l~--e~v------D~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+. ...++. ..+ ...+.+.. .......+.+....+..||.+|.|+.++++
T Consensus 335 lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~-------~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 335 LCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETF-------KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HhCCCChhccccccCCcccccCCCCcccchHHHHh-------ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 100110 111 11111110 111234456777777889999999999874
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=332.05 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=209.0
Q ss_pred HHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++..+|...++||+|+||.||+|...++..+|+|.+.........++.+|+++++.++|+|++++++++. ....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~ 76 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS------VGEP 76 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe------cCCC
Confidence 4556788889999999999999999889999999987766656678999999999999999999999986 5567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++... ....++|.+++.++.+++.||.||| +.+|+||||||+||++++++.+||+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~ 146 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSP-------EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVA 146 (261)
T ss_pred eEEEEeecccCCHHHHHhcC-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEc
Confidence 89999999999999999532 2346899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||++......... .....++..|+|||....+.++.++||||||++++||++ |+.|+..... ......
T Consensus 147 d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~~~~~~---- 216 (261)
T cd05148 147 DFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----HEVYDQ---- 216 (261)
T ss_pred cccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHH----
Confidence 99999876443222 223456788999999998899999999999999999998 8888854321 111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
...+.. .. .+......+.+++.+|++.+|++|||+.++++.|++
T Consensus 217 ~~~~~~-----~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 217 ITAGYR-----MP----------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHhCCc-----CC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111100 00 111223467789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.26 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=202.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+|...++||+|+||.||+|... +++.||+|++... ....+++.+|++++++++|+|++++++++. .....+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~ 78 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT------REPPFY 78 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc------CCCCcE
Confidence 45778889999999999999975 4888999987653 334567999999999999999999999986 456789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|.+++... ....++|..++.++.|+++||+||| +.+++||||||+||++++++.+||+||
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 79 IITEFMTYGNLLDYLREC-------NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEEeCCCCcHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCC
Confidence 999999999999998432 2346899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++..............++.+|+|||++.+..++.++||||||+++|||++ |..|+..... .+ .+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~-~~~~~~ 219 (263)
T cd05052 149 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQ-VYELLE 219 (263)
T ss_pred ccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHH
Confidence 9998765433222222344678999999999999999999999999999998 8888753211 11 122222
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+. .+.. +......+.+++..|++.+|++||||.+++++|+.
T Consensus 220 ~~~-----~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 220 KGY-----RMER----------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCC-----CCCC----------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 211 0111 11123467789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.88 Aligned_cols=249 Identities=28% Similarity=0.411 Sum_probs=207.8
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
..|..-.+||+|.-|.||.+.. .+++.||||++........+-..+|+.+|+..+|+|||+++.-+. .+++++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl------v~deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL------VGDELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc------ccceeE
Confidence 4566677899999999999984 578999999998766666667899999999999999999998887 457899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
.|||||++|+|.|.+- ...+++.++..|+.++++||+||| ..+|||||||.+||||+.++.+||+||
T Consensus 347 VVMEym~ggsLTDvVt----------~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT----------KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEEeecCCCchhhhhh----------cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeee
Confidence 9999999999999982 335999999999999999999999 999999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|++..+...+.. ....+||+-|||||++....|.+|.||||||++++||+-|.+||-...+- .-.|.....
T Consensus 414 GFcaqi~~~~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--------rAlyLIa~n 484 (550)
T KOG0578|consen 414 GFCAQISEEQSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATN 484 (550)
T ss_pred eeeeccccccCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--------HHHHHHhhc
Confidence 999888766553 34468999999999999999999999999999999999999998653321 111222223
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
|.. .+. .++.+...+-++..+|++.|+++||++.|+|+
T Consensus 485 g~P------~lk--------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 485 GTP------KLK--------NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCC------CcC--------CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 322 221 22334556777888999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.45 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=200.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++..++|+||+++++++. .+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~------~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ------DDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE------cCC
Confidence 46888999999999999999976 588999999975422 23456889999999999999999999886 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++...+.++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~---------~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNN---------LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEE
Confidence 89999999999999999832 346889999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..
T Consensus 143 ~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------~~~~ 209 (333)
T cd05600 143 TDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---------TWEN 209 (333)
T ss_pred EeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---------HHHH
Confidence 99999986543 2334679999999999999999999999999999999999999996432211 0111
Q ss_pred hhcCcccccc-CccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQAL-DPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~v-D~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.... +.+ .+.... ........+..++..|++.+|.+||++.++++.
T Consensus 210 i~~~~--~~~~~~~~~~-------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 210 LKYWK--ETLQRPVYDD-------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhcc--ccccCCCCCc-------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11100 000 011000 001223456788889999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.05 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=199.7
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCc----EEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGT----TVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~----~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.+|+..+.||+|+||.||+|++. +++ .||+|++..... ...++|.+|+.+++.++|+||++++|+|.
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~------- 79 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL------- 79 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc-------
Confidence 46888999999999999999864 344 389999865432 33567999999999999999999999995
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++|+||+++|+|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+
T Consensus 80 ~~~~~~v~e~~~~g~l~~~l~~~--------~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 80 TSTVQLITQLMPFGCLLDYVREH--------KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred CCCceeeeecCCCCCHHHHHHhc--------cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcE
Confidence 23578999999999999998432 235889999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccc-cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++......... .....++..|+|||++....++.++|||||||++|||++ |+.|++.... .++
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~ 220 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEI 220 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 999999998765433322 222345678999999999999999999999999999998 9999864221 111
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
......+.. +. .+......+..++..|++.+|++||++.+++..|...
T Consensus 221 -~~~~~~~~~-------~~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 221 -SSILEKGER-------LP--------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -HHHHhCCCC-------CC--------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111222111 00 0011223567899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=336.40 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=197.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++||||+++++++. .+.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~ 91 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ------DEN 91 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE------cCC
Confidence 57888999999999999999975 58899999987542 223456889999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 159 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRK---------AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKV 159 (329)
T ss_pred EEEEEEcCCCCChHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEE
Confidence 89999999999999999832 346788888999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..+.
T Consensus 160 ~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~-~~~~ 226 (329)
T PTZ00263 160 TDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FR-IYEK 226 (329)
T ss_pred eeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HH-HHHH
Confidence 9999998654322 235799999999999999999999999999999999999999863211 01 1122
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
...++.. + +.....++.+++..|++.||.+||+ +.+++.
T Consensus 227 i~~~~~~------~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 227 ILAGRLK------F----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HhcCCcC------C----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2222210 0 0112235678899999999999997 677764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.03 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=202.0
Q ss_pred cCcccceeeeecCceEEEEEEEcC----CcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||+|.+.. ...||||.+...... ...+|.+|+.++++++|+||+++++++. .+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT------KS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe------cC
Confidence 578889999999999999999752 457999988654322 2457899999999999999999999886 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++... ...++|..+++++.+++.||+||| +.+|+||||||+|||+++++.+|
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~ 146 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREN--------DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCK 146 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEE
Confidence 6789999999999999998432 236899999999999999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhh
Q 005691 468 VADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 468 LaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v 545 (683)
|+|||+++....... ..+....++..|+|||++.+..++.++||||||++++|+++ |+.|+..... .. .
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~----~ 217 (266)
T cd05033 147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QD----V 217 (266)
T ss_pred ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HH----H
Confidence 999999987752222 22223345678999999999999999999999999999998 9988853221 11 1
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
......+... + .+....+.+.+++..|++.+|++||++.+|+++|+.
T Consensus 218 ~~~~~~~~~~----~-----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 218 IKAVEDGYRL----P-----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred HHHHHcCCCC----C-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1112121110 0 011223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=324.90 Aligned_cols=270 Identities=23% Similarity=0.285 Sum_probs=201.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+...++|+|+||+|||.+.+ .|+.||||++.+..... .+-.++|+++|++++|+|||.|+.+|. ....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr------rkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR------RKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH------hcce
Confidence 46777889999999999999976 49999999997754322 345789999999999999999999997 6778
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.+||+||++..-|++.= .....++.....+++.|+++|+.|+| +.++|||||||+||||..++.+||+
T Consensus 76 lhLVFE~~dhTvL~eLe---------~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLC 143 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELE---------RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLC 143 (396)
T ss_pred eEEEeeecchHHHHHHH---------hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEec
Confidence 99999999886665543 12346888899999999999999999 9999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh---
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV--- 545 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v--- 545 (683)
|||+||..... ....|..+.|..|+|||.+.+ .+|...+|||+.||++.||++|.+-+....+-++- ..+..-.
T Consensus 144 DFGFAR~L~~p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL-y~I~ktLG~L 221 (396)
T KOG0593|consen 144 DFGFARTLSAP-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL-YLIRKTLGNL 221 (396)
T ss_pred cchhhHhhcCC-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH-HHHHHHHccc
Confidence 99999988742 234556778999999999987 78999999999999999999999877543332210 0000000
Q ss_pred ----hhhhhc-CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 ----WSLVKA-GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ----~~~~~~-g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.... ....-+.-|.....+ .+.........-++.++..|++.||++|++-+|++.
T Consensus 222 ~prhq~iF~~N~~F~Gv~lP~~~~~e-pLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHGVRLPEPEHPE-PLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CHHHHHHhccCCceeeeecCCCCCcc-chhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 011111 111111111111000 000011123446788999999999999999999863
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.93 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=201.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-----CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-----DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-----~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+.|...+.||+|+||.||++... ++..||+|++........+.|.+|++++++++|+|++++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA----GR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC----CC
Confidence 46777889999999999999853 5789999998766555566899999999999999999999987532 33
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ...++|..++.++.+++.||+||| +.+|+||||||+||++++++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~--------~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKH--------RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVK 148 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhc--------CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEE
Confidence 5689999999999999998421 236899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 468 VADFGLAKQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|+|||+++......... .....++..|+|||++.++.++.++|||||||+++||++|..+....... +
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---------~- 218 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---------F- 218 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---------h-
Confidence 99999998765433221 12233455699999999889999999999999999999998765322110 0
Q ss_pred hhhhhcCc--------cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGK--------VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~--------l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+...... +.+.+...... ..+......+.+++..|++.+|++||||.+|+++|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 219 MRMMGNDKQGQMIVYHLIELLKNNGRL------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hhhcccccccccchHHHHHHHhcCCcC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 00000000 00111100000 0111234567889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.39 Aligned_cols=261 Identities=26% Similarity=0.370 Sum_probs=204.6
Q ss_pred hcCcccceeeeecCceEEEEEE-EcCCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.+.|...+.||.|.-++||+|+ .+.++.||||++.-..... .+++.+|+..++.++||||++++..++ .+.+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv------v~~~ 98 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV------VDSE 98 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE------ecce
Confidence 3578888999999999999999 4568999999997654444 478999999999999999999998888 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
+|+||.||.+||+.+.+.... ...+++..+..|.+++.+||.||| +.|.||||||+.|||||.+|.+||+
T Consensus 99 LWvVmpfMa~GS~ldIik~~~-------~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLa 168 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYY-------PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLA 168 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHc-------cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEc
Confidence 999999999999999996554 235889999999999999999999 9999999999999999999999999
Q ss_pred ccCcccccccCCccc---cccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 470 DFGLAKQSREGQSHL---TTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 470 DFGla~~~~~~~~~~---~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
|||..-...+..... ....+||+.|||||+++. ..|+.|+||||||++.+||.+|..||....+.. .++.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vLl~-- 243 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VLLL-- 243 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HHHH--
Confidence 999765443322221 145689999999999653 568999999999999999999999998655422 1111
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
--.|...-..-..+..+ ........+.+++..|++.||.+|||++++++
T Consensus 244 ----tLqn~pp~~~t~~~~~d------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 244 ----TLQNDPPTLLTSGLDKD------EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ----HhcCCCCCcccccCChH------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11222211111111111 11223346778889999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.18 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=201.0
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||+|...++..+|||.+.... ...++|.+|+.++.+++||||+++++++. .....++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT------KQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc------cCCCcEE
Confidence 3567778999999999999998877789999886543 33567999999999999999999999986 4456899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ...++|..+++++.+++.||+||| +.+++|+||||+||++++++.+||+|||
T Consensus 77 v~e~~~~~~l~~~i~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g 145 (256)
T cd05113 77 VTEYMSNGCLLNYLREH--------GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFG 145 (256)
T ss_pred EEEcCCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCc
Confidence 99999999999998421 236899999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............++..|+|||+...+.++.++||||||+++|||++ |+.|+...... +. ......
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~-~~~~~~ 216 (256)
T cd05113 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ET-VEKVSQ 216 (256)
T ss_pred cceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HH-HHHHhc
Confidence 988664433222223346778999999998899999999999999999999 99988643221 11 111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+... . .+....+.+.+++..|++.+|++||++.++++.|+
T Consensus 217 ~~~~-----~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 217 GLRL-----Y----------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCC-----C----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1110 0 00112346788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.04 Aligned_cols=253 Identities=29% Similarity=0.449 Sum_probs=202.2
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|+..++||+|+||.||+|...++..||+|.+..... ..+.|.+|+.++++++|+|++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-------~~~~~l 77 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-------EEPIYI 77 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-------CCCcEE
Confidence 46778889999999999999988888999999875433 3567999999999999999999998873 345799
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
+|||+++++|.+++... ....++|.+++.++.+++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 78 VTEYMSKGSLLDFLKDG-------EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred EEEecCCCcHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCce
Confidence 99999999999998532 1245899999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............++..|+|||+.....++.++||||||++++||++ |+.||..... . +.... +..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~---~~~~~-~~~ 218 (260)
T cd05070 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----R---EVLEQ-VER 218 (260)
T ss_pred eeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H---HHHHH-HHc
Confidence 998765433222223346678999999998899999999999999999999 8888854221 1 11111 111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. .. .+......+.+++..|++.+|.+|||+.+++++|+.
T Consensus 219 ~~~-----~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYR-----MP----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCC-----CC----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 100 00 011223467889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.71 Aligned_cols=262 Identities=25% Similarity=0.359 Sum_probs=200.5
Q ss_pred ccceeeeecCceEEEEEEEcCCc---EEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 316 SQKNFIGRGGFGLVYKGILQDGT---TVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~~g~---~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
...++||+|+||.||+|+..+.. .||+|.+.... ....+.|.+|+++++.++|+||++++++|............
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999976433 58999876532 22345789999999999999999999998643322233467
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++++||+++|+|.+++..... ......++|...+.++.|++.||+||| +.+|+||||||+|||+++++.+||+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRL---GDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcc---cCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECC
Confidence 999999999999988743221 112346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccc-cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhh
Q 005691 471 FGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 471 FGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
||+++......... .....++..|+|||+.....++.++||||||+++|||++ |+.||..... ...+..
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------~~~~~~ 226 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---------SEIYDY 226 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHH
Confidence 99998765433211 222346778999999999999999999999999999999 7888753211 112222
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
...+.... .+......+.+++..|++.+|++|||+.++++.|+.
T Consensus 227 ~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 227 LRQGNRLK---------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHcCCCCC---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 33322111 011223457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.75 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=198.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCc----EEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGT----TVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~----~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||.||+|++. +++ .+++|++...... ...++..|+.++++++|+||++++|++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------- 79 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------- 79 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-------
Confidence 35677789999999999999964 344 4777777543322 2356888899999999999999999874
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
+...++++||+++|+|.+++... ...++|..++.|+.|++.||+||| +.+++||||||+|||+++++.+
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQH--------RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcE
Confidence 34578999999999999999432 346899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++....... ...+...++..|+|||++.++.++.++||||||+++||+++ |+.|+..... ..+
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~--- 220 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEV--- 220 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHH---
Confidence 9999999987644332 22344567889999999999999999999999999999998 9988864321 111
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
...+..+.... .+. .....+..++..|++.+|++|||+.|++++|+...
T Consensus 221 -~~~~~~~~~~~--~~~-------------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 221 -PDLLEKGERLA--QPQ-------------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -HHHHHCCCcCC--CCC-------------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11222222111 111 11234567888999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.26 Aligned_cols=265 Identities=24% Similarity=0.406 Sum_probs=203.3
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDG 382 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~ 382 (683)
..+++|+..+.||+|+||.||+|... ++..||||++..... ....+|.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--- 79 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 35678999999999999999999853 256799998865332 23456899999999999999999999986
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCC-CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDG-SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.+...++||||+++|+|.+++....... .......++|..++.++.+++.||+||| +.+++||||||+||+++
T Consensus 80 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~ 153 (277)
T cd05062 80 ---QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA 153 (277)
T ss_pred ---CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEc
Confidence 5567899999999999999985422110 0111245788899999999999999999 88999999999999999
Q ss_pred cCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCcc
Q 005691 462 ADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRAC 539 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~ 539 (683)
+++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ |..|+..... .
T Consensus 154 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~ 228 (277)
T cd05062 154 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----E 228 (277)
T ss_pred CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H
Confidence 9999999999998765432221 1222345788999999999999999999999999999999 6888753321 1
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
. ..+....+...+ + +......+..++..|++.+|++|||+.|++++|++
T Consensus 229 ---~-~~~~~~~~~~~~-----~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 ---Q-VLRFVMEGGLLD-----K----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---H-HHHHHHcCCcCC-----C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 111111221111 0 11123467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=328.18 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=205.0
Q ss_pred cCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++|...+.||+|+||.||+|...+ +..||||.+...... ..+.|.+|++++++++|+|++++++++.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT------ 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe------
Confidence 467778899999999999998643 478999998765443 3567999999999999999999999987
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCC-----CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDG-----SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-----~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.+...++||||+++|+|.+++....... .......++|.....++.+++.||.||| +.+++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLV 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEE
Confidence 4567999999999999999985432110 0122356899999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCc
Q 005691 461 DADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRA 538 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~ 538 (683)
+.++.+||+|||+++....... .......+++.|+|||++..+.++.++||||||+++|||++ |+.||.....
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----- 230 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----- 230 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999976533221 12234456789999999999999999999999999999999 9999854322
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.... .....+.... .+......+.+++..|++.||++||++.||+++|+
T Consensus 231 ~~~~----~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 EEVI----ECITQGRLLQ---------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHH----HHHHcCCcCC---------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 1122222211 01112346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.20 Aligned_cols=264 Identities=26% Similarity=0.440 Sum_probs=207.1
Q ss_pred cCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.+|...+.||+|+||.||+|+.. ++..+++|++........+.+.+|++++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG------D 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc------c
Confidence 45777889999999999999843 35568999887655555567999999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCC-------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFND-------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~-------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
+...++||||+++++|.+++...... ........++|..+++++.+++.||+||| +.+|+||||||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 155 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCL 155 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEE
Confidence 56789999999999999998543210 00112345899999999999999999999 889999999999999
Q ss_pred eccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCC
Q 005691 460 LDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPR 537 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~ 537 (683)
++.++.+||+|||+++....... .......++..|+|||++....++.++||||||+++|||++ |+.|+......
T Consensus 156 ~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--- 232 (291)
T cd05094 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--- 232 (291)
T ss_pred EccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999976543322 22334557889999999999999999999999999999999 99998543221
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+ .++....+...+. +......+.+++.+|++.+|++||||.+|+++|+...
T Consensus 233 -----~-~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 233 -----E-VIECITQGRVLER---------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred -----H-HHHHHhCCCCCCC---------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 1222223322111 0112345778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.06 Aligned_cols=251 Identities=28% Similarity=0.427 Sum_probs=199.8
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+|...+.||+|+||.||+|...++..+|+|.+..... ..++|.+|++++++++|+||+++++++. .....++|
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~~lv 77 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCT------KQRPIFIV 77 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEc------CCCceEEE
Confidence 4677788999999999999988778899998765432 3457899999999999999999999885 45678999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++++|.+++... ...++|..++.|+.+++.||+||| +.+|+||||||+||++++++.+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 78 TEYMANGCLLNYLRER--------KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred EecCCCCCHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCccc
Confidence 9999999999998422 236899999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
++..............++..|+|||++....++.++||||||+++||+++ |+.|++.....+ . ......+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~----~~~~~~~ 217 (256)
T cd05059 147 ARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----V----VESVSAG 217 (256)
T ss_pred ceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----H----HHHHHcC
Confidence 98664332222222334568999999999999999999999999999999 788886432211 1 1111111
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
. ... .+......+.+++..|++.+|++||||.+|+++|.
T Consensus 218 ~-----~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 218 Y-----RLY----------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred C-----cCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 0 000 11112446789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=336.73 Aligned_cols=241 Identities=23% Similarity=0.327 Sum_probs=192.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
+.||+|+||.||+++.. +|+.||+|++..... .....+.+|++++++++||||+++.+++. .+...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~------~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ------THDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE------cCCEEEEEE
Confidence 36999999999999864 688999999875422 22346788999999999999999999886 567899999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 75 e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a 142 (323)
T cd05571 75 EYANGGELFFHLSR---------ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred eCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCC
Confidence 99999999988832 346899999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcc
Q 005691 475 KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKV 554 (683)
Q Consensus 475 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l 554 (683)
+...... .......||+.|+|||.+....++.++|||||||++|||++|+.||..... ..+ ......+..
T Consensus 143 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~----~~~~~~~~~ 212 (323)
T cd05571 143 KEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKL----FELILMEEI 212 (323)
T ss_pred cccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHH----HHHHHcCCC
Confidence 7543221 123346799999999999999999999999999999999999999863211 111 111111111
Q ss_pred ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 555 WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 555 ~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
.+ +......+.+++..|++.||++|| ++.++++
T Consensus 213 ------~~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 ------RF----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ------CC----------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11 112234567888999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=336.07 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=194.1
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+++.. +++.||+|.+..... ...+.+..|+.++.++ +||||+++++++. .....++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~------~~~~~~lv 74 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ------TESRLFFV 74 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE------eCCEEEEE
Confidence 36999999999999975 578999999876422 2234577899988877 8999999999986 55789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++. ....+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~E~~~~~~L~~~~~---------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~ 142 (329)
T cd05618 75 IEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142 (329)
T ss_pred EeCCCCCCHHHHHH---------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCc
Confidence 99999999988873 2346899999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||...............+.++....+.
T Consensus 143 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 221 (329)
T cd05618 143 CKEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 221 (329)
T ss_pred cccccCCCC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC
Confidence 875432211 2334679999999999999999999999999999999999999996432221111222334444333322
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC------HHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT------ISDAL 602 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt------m~eVl 602 (683)
. .+ +......+..++..|++.||++||+ +.+++
T Consensus 222 ~------~~----------p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05618 222 I------RI----------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 260 (329)
T ss_pred C------CC----------CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh
Confidence 1 01 1122345678899999999999998 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.46 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=191.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 321 LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
||+|+||.||+++.. +++.||+|++.... ......+.+|++++.+++||||+++++++. .....++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ------SPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe------cCCeEEEEEcC
Confidence 699999999999975 57899999987532 233456889999999999999999999886 55789999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 75 ~~~g~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 75 INGGELFHHLQR---------EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred CCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 999999999842 246889999999999999999999 89999999999999999999999999999986
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .+..
T Consensus 143 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~-~~~~-- 210 (312)
T cd05585 143 NMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKIL-QEPL-- 210 (312)
T ss_pred CccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHH-cCCC--
Confidence 43322 22345679999999999999999999999999999999999999986321 111111111 1111
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.+ +......+.+++..|++.||++||+..++.+.|.
T Consensus 211 ----~~----------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 ----RF----------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ----CC----------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 01 1112345678889999999999986544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.22 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=197.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||++... +|+.||+|++..... ...+.+.+|++++++++||||+++++++. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH------DQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc------cCC
Confidence 46888899999999999999975 688999999865322 23456889999999999999999998876 556
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. .+.+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl 142 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKL 142 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEE
Confidence 89999999999999999832 346889999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....
T Consensus 143 ~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~-~~~~ 209 (291)
T cd05612 143 TDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FG-IYEK 209 (291)
T ss_pred EecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHHH
Confidence 999999865432 2235689999999999988899999999999999999999999864321 11 1111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~~ 604 (683)
...+.. .+. ......+.+++..|++.||.+||+ +.++++.
T Consensus 210 i~~~~~------~~~----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 ILAGKL------EFP----------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHhCCc------CCC----------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 222211 010 111235678899999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=324.20 Aligned_cols=254 Identities=29% Similarity=0.435 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|...++||+|+||.||+|+..++..||+|++.... ...++|.+|++++++++|+||+++++++. ....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-------~~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-------EEPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-------CCCcE
Confidence 35688899999999999999998877789999986533 34567999999999999999999998763 34579
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++... ....++|..++.++.+++.||+||| +.+|+||||||+||++++++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE-------MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred EEEEcCCCCcHHHHHhhc-------cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccC
Confidence 999999999999998432 1246889999999999999999999 899999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++..............++..|+|||+...+.++.++||||||+++|||++ |+.||..... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---------~~~~~~~~ 217 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVE 217 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---------HHHHHHHh
Confidence 9998665433322233456788999999999999999999999999999999 7878753321 01111111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+.. .. ...+....+.+++..|++.+|++||++.+++++|+.
T Consensus 218 ~~~~-----~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 218 RGYR-----MP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred cCCC-----CC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1110 00 112234567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.03 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=212.8
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.......++||+|-||.|.......+..||||+++...... ..+|.+|+++|.+++|||||+|+|+|. .++.+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~------~DePi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV------QDDPL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee------cCCch
Confidence 34566678999999999999999888999999998865554 478999999999999999999999998 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
.+|+|||+||+|..||..+.. +.+.-..-.+|+.|||.|++||. +.+++||||.++|+|+|.++++||+|
T Consensus 611 cmI~EYmEnGDLnqFl~ahea-------pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHEL-------PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccC-------cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecC
Confidence 999999999999999954421 22455566789999999999999 99999999999999999999999999
Q ss_pred cCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh--CCCCCCCCCCCCCCccchhhhhhh
Q 005691 471 FGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC--GRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 471 FGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt--Gr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
||++|.+-.++.+ ...+.+-...|||||.+..+++|.+||||+|||++||+++ ..+|+...+.+ .+++-+..
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vven~~~ 755 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVVENAGE 755 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHHHhhhh
Confidence 9999977655544 4456677889999999999999999999999999999865 66787654432 12233333
Q ss_pred hhhcCcc-ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 548 LVKAGKV-WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 548 ~~~~g~l-~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+...+.. .-+. .+.-+...+.++++.||..+-++||+.+++...|..+.
T Consensus 756 ~~~~~~~~~~l~-------------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 756 FFRDQGRQVVLS-------------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hcCCCCcceecc-------------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 3322211 1111 22234557789999999999999999999999998653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.19 Aligned_cols=198 Identities=24% Similarity=0.393 Sum_probs=171.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
-++|+..+.||+|+||.||+++.. +|..+|+|.+..... ...+.+.+|++++++++|+||+++++++. .+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY------SDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE------ECCE
Confidence 367889999999999999999976 578899998865422 22456999999999999999999999987 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCceeeccCCcEEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNILLd~~~~~KL 468 (683)
.++||||+++|+|.+++.. ...+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl 145 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKE---------AKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKL 145 (331)
T ss_pred EEEEeecCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEE
Confidence 9999999999999999832 246889999999999999999999 54 6999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
+|||+++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 146 ~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 146 CDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999998765432 22345789999999999999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=337.41 Aligned_cols=272 Identities=23% Similarity=0.338 Sum_probs=196.2
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...++||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++..... ......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR-REFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCC-CCCceE
Confidence 4778899999999999999965 68999999986532 2234568899999999999999999998864321 123468
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++ ++|.+++. ....+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 80 ~lv~e~~~-~~L~~~l~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 80 YVVFELME-SDLHQVIK---------ANDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred EEEEecCC-CCHHHHHH---------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEcc
Confidence 99999995 68888873 2346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCc--cccccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 471 FGLAKQSREGQS--HLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 471 FGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+++....... .......||..|+|||++.. ..++.++|||||||++|||++|+.||....... ...++.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-----~~~~~~ 221 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-----QLDLIT 221 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-----HHHHHH
Confidence 999986532211 12234679999999999875 678999999999999999999999986432110 000110
Q ss_pred -----------hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 -----------SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 -----------~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+......+.++....................+.+++..|++.||++|||++|+++.
T Consensus 222 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 222 DLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1111111111110000000000000000112356789999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=327.02 Aligned_cols=262 Identities=24% Similarity=0.416 Sum_probs=201.6
Q ss_pred cCcccceeeeecCceEEEEEEE-----cCCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-----QDGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-----~~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|+..+.||+|+||.||+|+. .++..||+|++..... +...+|.+|++++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT------Q 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe------c
Confidence 4577788999999999999985 2467899999875332 23357899999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCC--------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFND--------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~--------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
+...++||||+++|+|.+++...... ........+++.+.+.++.+++.||+||| +.+|+||||||+||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~ni 155 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNI 155 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceE
Confidence 56789999999999999988432110 00112345889999999999999999999 88999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCC
Q 005691 459 LLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSP 536 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~ 536 (683)
|+++++.+||+|||+++....... .......++..|+|||++.++.++.++||||||++++||++ |..||.....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05090 156 LIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--- 232 (283)
T ss_pred EEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 999999999999999986543321 22233446788999999998899999999999999999999 8888753221
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+.+....+.... . +.....++..++..|++.+|++||++.+|.++|..
T Consensus 233 ------~~~~~~~~~~~~~~-----~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ------QEVIEMVRKRQLLP-----C----------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------HHHHHHHHcCCcCC-----C----------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11112222221110 0 11123466788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=322.38 Aligned_cols=263 Identities=26% Similarity=0.379 Sum_probs=202.6
Q ss_pred cccceeeeecCceEEEEEEEcC----CcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 315 FSQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
|...+.||+|+||.||+|.+.. +..||+|++..... ...+++.+|++.++.++|+|+++++|++..........
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999999753 36799999875332 22457999999999999999999999987543322334
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++++||+++|+|.+++...... .....+++...+.++.|++.||+||| +.+|+||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG---GLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc---CCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEE
Confidence 579999999999999998543211 12346899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccc-cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 469 ADFGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 469 aDFGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
+|||+++......... .....++..|+|||++....++.++||||||+++|||++ |..|+..... ..+.++
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~~~~~~-- 227 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----HEIYDY-- 227 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH--
Confidence 9999998765433222 222345778999999988899999999999999999999 8888753221 111111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
...+.... .+......+.+++..|++.||.+|||+.+|++.|+.
T Consensus 228 --~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 228 --LRHGNRLK---------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred --HHcCCCCC---------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11111110 111234567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=320.05 Aligned_cols=246 Identities=30% Similarity=0.447 Sum_probs=196.9
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecC
Q 005691 320 FIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMP 398 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~ 398 (683)
+||+|+||.||+|...+++.+|+|++....... ...|.+|++++++++|+||+++++++. .....++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT------QRQPIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe------cCCccEEEEECCC
Confidence 699999999999998889999999886543322 346889999999999999999999986 4567899999999
Q ss_pred CCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccc
Q 005691 399 NGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 478 (683)
Q Consensus 399 ~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~ 478 (683)
+|+|.+++... ...++|..++.++.+++.||.||| +.+++||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~L~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 76 GGDFLSFLRKK--------KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred CCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecc
Confidence 99999988321 235889999999999999999999 8899999999999999999999999999987654
Q ss_pred cCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccccc
Q 005691 479 EGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVWQA 557 (683)
Q Consensus 479 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~ 557 (683)
...........++..|+|||++..+.++.++||||||+++||+++ |+.||..... .........+..
T Consensus 145 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---------~~~~~~~~~~~~--- 212 (250)
T cd05085 145 DGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---------QQAREQVEKGYR--- 212 (250)
T ss_pred ccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---------HHHHHHHHcCCC---
Confidence 333222223345678999999999999999999999999999998 9989863321 111111211110
Q ss_pred cCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 558 LDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 558 vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.. .+......+.+++..|++.+|++||++.+++++|.
T Consensus 213 --~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 --MS----------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00 01123456788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.55 Aligned_cols=266 Identities=27% Similarity=0.377 Sum_probs=204.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+|+.. .++.||+|++...... ..+.+..|++++.++ +|+||++++++|..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~--- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK--- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec---
Confidence 457888999999999999999743 2478999998654322 234678899999999 89999999998863
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCC--------------------------------------------------
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDG-------------------------------------------------- 413 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------------------------------------------------- 413 (683)
.+...+++|||+++|+|.+++.......
T Consensus 83 --~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 83 --PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred --CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 3457899999999999998884321100
Q ss_pred --CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCccc-cccccC
Q 005691 414 --SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL-TTRVAG 490 (683)
Q Consensus 414 --~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~-~~~~~G 490 (683)
.......++|..+.+++.+|+.||+||| +.+|+||||||+|||++.++.+||+|||+++......... .....+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 0001236899999999999999999999 8899999999999999999999999999998764433322 233456
Q ss_pred CCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCcccccccccc
Q 005691 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFL 569 (683)
Q Consensus 491 T~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~ 569 (683)
+..|+|||++.+..++.++|||||||+++|+++ |+.||...... +........+... .
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~-----~-------- 296 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRM-----R-------- 296 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCC-----C--------
Confidence 788999999999999999999999999999998 99998642211 1111222222110 0
Q ss_pred CCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 570 SLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 570 ~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+......+.+++..|++.+|++||++.||+++|+..
T Consensus 297 --~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 297 --APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred --CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0112234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=329.76 Aligned_cols=269 Identities=24% Similarity=0.294 Sum_probs=195.4
Q ss_pred cCcccceeeeecCceEEEEEEEc--CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhc---cCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ--DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNL---KHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~--~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L---~H~NLV~L~G~c~~~~~~~ 385 (683)
++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.+++.+ +||||++++++|..... .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~-~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT-D 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC-C
Confidence 36888899999999999999863 4678999998654322 234567788887766 69999999999864321 1
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++||||++ ++|.+++... ....+++..++.|+.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKV-------PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCC
Confidence 3456899999996 6888888422 1345899999999999999999999 899999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||+++..... .......||+.|+|||.+....++.++|||||||++|||++|+.||......+ ....+
T Consensus 149 ~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-----~~~~i 221 (290)
T cd07862 149 IKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-----QLGKI 221 (290)
T ss_pred EEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-----HHHHH
Confidence 999999999865433 22344678999999999998899999999999999999999999997543211 11111
Q ss_pred hhhhh---cCcc-------ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVK---AGKV-------WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~---~g~l-------~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..... .... .....+.-..... ....+....+.+++..|++.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE---KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHhCCCChhhchhhhcccchhccCCCCCCHH---HHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 10000 0000 0000000000000 000012345678999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=323.90 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=204.3
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|...++||+|+||.||+|...+++.||+|.+..... ..++|.+|++++++++|+|+++++++.. ....+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------~~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-------QEPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-------cCCcE
Confidence 467888899999999999999998999999999875443 3567999999999999999999998863 34689
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++|||+++|+|.+++... ....+++.+++.++.+++.||+||| +.+++||||||+||+++.++.++|+||
T Consensus 77 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 77 IITEYMENGSLVDFLKTP-------EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred EEEEcCCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccC
Confidence 999999999999988432 2346899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++..............++..|+|||++..+.++.++||||||++++|+++ |+.||...... +.. ..+.
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~-~~~~ 217 (260)
T cd05067 147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVI-QNLE 217 (260)
T ss_pred cceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHH-HHHH
Confidence 9998765333322333456789999999998999999999999999999999 99998643211 111 1111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+...+ . +......+.+++..|++.+|++|||+++++++|+.
T Consensus 218 ~~~~~~-----~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 218 RGYRMP-----R----------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred cCCCCC-----C----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111000 0 01123467889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.04 Aligned_cols=252 Identities=23% Similarity=0.275 Sum_probs=196.3
Q ss_pred CcccceeeeecCceEEEEEEE----cCCcEEEEEEeeccCc----cChHHHHHHHHHHHhc-cCCCcccccceeeecCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDF----QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~ 384 (683)
+|...+.||+|+||.||+++. .+++.||+|.+..... ...+.+..|++++..+ +|+||+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ----- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence 477889999999999999885 3588999999865321 2234588899999999 5999999998876
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....++||||+++|+|.+++.. +..+++...+.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 76 -~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 76 -TEAKLHLILDYVSGGEMFTHLYQ---------RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEG 142 (332)
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCC
Confidence 55678999999999999999842 346889999999999999999999 88999999999999999999
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
.+||+|||+++..............||..|+|||++.+. .++.++|||||||++|||++|+.||........ . .
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~-~ 217 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----Q-S 217 (332)
T ss_pred CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----H-H
Confidence 999999999987644433334456799999999998764 478999999999999999999999964332111 1 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALKM 604 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~~ 604 (683)
.+...... .++.+.. .....+.+++..|++.||++|| ++.++++.
T Consensus 218 ~~~~~~~~------~~~~~~~----------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 218 EVSRRILK------CDPPFPS----------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHhc------CCCCCCC----------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111111 1111111 1233566788999999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.07 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=195.8
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+++.. +++.||||.+..... ...+.+..|..++.++ +||||+++++++. .....++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~------~~~~~~lv 74 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ------TESRLFFV 74 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE------cCCEEEEE
Confidence 36999999999999975 588999999976432 2234588899999998 7999999999986 55689999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++. ..+.+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~~g~L~~~~~---------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 142 (329)
T cd05588 75 IEFVSGGDLMFHMQ---------RQRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM 142 (329)
T ss_pred EeCCCCCCHHHHHH---------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcc
Confidence 99999999988873 2346999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||+.............++..+....+.
T Consensus 143 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (329)
T cd05588 143 CKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ 221 (329)
T ss_pred ccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC
Confidence 87532211 12334679999999999999999999999999999999999999997533221111122334444333322
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT------ISDALK 603 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt------m~eVl~ 603 (683)
.. + +......+..++..|++.||.+||+ +.++++
T Consensus 222 ~~------~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 IR------I----------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC------C----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 10 1 1112345678899999999999997 667754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.19 Aligned_cols=242 Identities=23% Similarity=0.310 Sum_probs=192.8
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
+.||+|+||.||++... +|+.||||++.... ......+.+|+++++.++||||+++.+++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ------TKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE------cCCEEEEEE
Confidence 36999999999999965 68999999997542 223456889999999999999999999886 567899999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
||+++|+|.+++.. ...+++.+.+.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 75 Ey~~~g~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~ 142 (328)
T cd05593 75 EYVNGGELFFHLSR---------ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLC 142 (328)
T ss_pred eCCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCC
Confidence 99999999988832 346899999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcc
Q 005691 475 KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKV 554 (683)
Q Consensus 475 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l 554 (683)
+...... .......||+.|+|||++....++.++|||||||++|||++|+.||...... ... .....+.
T Consensus 143 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~-~~~~~~~- 211 (328)
T cd05593 143 KEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLF-ELILMED- 211 (328)
T ss_pred ccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHH-HHhccCC-
Confidence 7543221 1233467999999999999999999999999999999999999998642210 111 1111111
Q ss_pred ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005691 555 WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALKM 604 (683)
Q Consensus 555 ~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~~ 604 (683)
..+ +......+..++..|++.||++|| ++.++++.
T Consensus 212 -----~~~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 -----IKF----------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----ccC----------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111 112234567888999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=337.45 Aligned_cols=245 Identities=23% Similarity=0.290 Sum_probs=197.3
Q ss_pred cCcccceeeeecCceEEEEEEEcC--CcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD--GTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~--g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||+|+..+ +..||+|++.... ....+.+.+|+++++.++|||||++++++. .+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~------~~ 103 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK------DE 103 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE------eC
Confidence 568889999999999999998653 3689999986532 223456889999999999999999999987 55
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++++|
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRR---------NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEE
Confidence 689999999999999999832 346889999999999999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 172 L~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---------~~~~~ 238 (340)
T PTZ00426 172 MTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---------LLIYQ 238 (340)
T ss_pred EecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---------HHHHH
Confidence 9999999865432 2345799999999999988899999999999999999999999964321 11122
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~~ 604 (683)
....+.. .+ +......+..++..|++.+|++|+ ++.++++.
T Consensus 239 ~i~~~~~------~~----------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 KILEGII------YF----------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHhcCCC------CC----------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2222211 00 111123456788999999999995 89888764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.79 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=199.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++.. +|+.||||++..... .....+.+|++++..++|+||+++++++. .+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ------DEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee------cCC
Confidence 46888999999999999999976 689999999875422 33456889999999999999999999886 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL 142 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIR---------KDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKL 142 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEe
Confidence 89999999999999999842 246889999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCC----------------------------ccccccccCCCcccCccccccCCCCccccEEEcchhHHH
Q 005691 469 ADFGLAKQSREGQ----------------------------SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520 (683)
Q Consensus 469 aDFGla~~~~~~~----------------------------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlE 520 (683)
+|||+++...... ........||+.|+|||++....++.++|||||||++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 222 (350)
T cd05573 143 ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222 (350)
T ss_pred ecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhh
Confidence 9999998664432 112334579999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCCCCCCccchhhhhhhhhhc-CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-H
Q 005691 521 IMCGRKALDLSTSGSPRACLITDWVWSLVKA-GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-I 598 (683)
Q Consensus 521 LltGr~p~~~~~~~~~~~~~l~~~v~~~~~~-g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-m 598 (683)
|++|+.||...... ......... ..+ .+... ......+..++..|++ +|.+||+ +
T Consensus 223 ll~g~~Pf~~~~~~--------~~~~~i~~~~~~~------~~p~~--------~~~~~~~~~li~~ll~-dp~~R~~s~ 279 (350)
T cd05573 223 MLYGFPPFYSDTLQ--------ETYNKIINWKESL------RFPPD--------PPVSPEAIDLICRLLC-DPEDRLGSF 279 (350)
T ss_pred hccCCCCCCCCCHH--------HHHHHHhccCCcc------cCCCC--------CCCCHHHHHHHHHHcc-ChhhcCCCH
Confidence 99999998643211 111111110 000 00000 0123456677788997 9999999 9
Q ss_pred HHHHHH
Q 005691 599 SDALKM 604 (683)
Q Consensus 599 ~eVl~~ 604 (683)
.++++.
T Consensus 280 ~~ll~h 285 (350)
T cd05573 280 EEIKSH 285 (350)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.20 Aligned_cols=269 Identities=23% Similarity=0.355 Sum_probs=204.0
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-----------------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCccc
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-----------------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVP 373 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-----------------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~ 373 (683)
.++|...+.||+|+||.||++...+ +..||+|++..... ...+++.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578888999999999999998643 24689999875432 33567899999999999999999
Q ss_pred ccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCC--CCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcccc
Q 005691 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGS--GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451 (683)
Q Consensus 374 L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~--~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHr 451 (683)
+++++. .+...++++||+++++|.+++........ ......+++..++.++.+++.||+||| +.+|+||
T Consensus 84 ~~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~ 154 (296)
T cd05051 84 LLGVCT------VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHR 154 (296)
T ss_pred EEEEEe------cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccc
Confidence 999986 44678999999999999999854321100 012346899999999999999999999 8899999
Q ss_pred CCCCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh--CCCCC
Q 005691 452 DIKATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC--GRKAL 528 (683)
Q Consensus 452 DIKpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt--Gr~p~ 528 (683)
||||+||+++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ |..|+
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 155 DLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred ccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999986543322 22334567889999999998899999999999999999998 56666
Q ss_pred CCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 529 DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 529 ~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
..... ..+...+...++.+......+ .+......+.+++..|++.+|++||||.+|++.|+
T Consensus 235 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 235 EHLTD-----QQVIENAGHFFRDDGRQIYLP------------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCcCh-----HHHHHHHHhccccccccccCC------------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 43221 111122222221111111100 01112346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=337.92 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=189.8
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+|...++||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|+||+++++++. .....+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~~ 148 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD------HNGEIQ 148 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec------cCCeEE
Confidence 4455678999999999999965 6899999998654322 2456899999999999999999999986 567899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+.. .+.+.....|+.||+.||+||| +.+|+||||||+|||+++++.+||+||
T Consensus 149 lv~e~~~~~~L~~~~-------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~Df 212 (353)
T PLN00034 149 VLLEFMDGGSLEGTH-------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212 (353)
T ss_pred EEEecCCCCcccccc-------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence 999999999987543 3456677889999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+++....... ......||..|+|||++.. ...+.++|||||||++|||++|+.||...... +|..
T Consensus 213 G~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~ 283 (353)
T PLN00034 213 GVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--------DWAS 283 (353)
T ss_pred ccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------cHHH
Confidence 99987643321 1234579999999998743 23456899999999999999999999732211 2211
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
...... .. ..+. .+......+.+++..|++.||++|||+.|+++.
T Consensus 284 ~~~~~~-~~--~~~~----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 284 LMCAIC-MS--QPPE----------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHh-cc--CCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111000 00 0000 111223467789999999999999999999864
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.68 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=191.1
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
+.||+|+||.||+++.. +|+.||+|++..... .....+.+|++++++++||||+++++++. .....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~------~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ------THDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe------cCCEEEEEE
Confidence 36999999999999964 689999999875422 22346788999999999999999999886 456899999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
||+++|+|.+++.. ...+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 75 E~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 142 (323)
T cd05595 75 EYANGGELFFHLSR---------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 142 (323)
T ss_pred eCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHh
Confidence 99999999888732 346899999999999999999999 889999999999999999999999999998
Q ss_pred cccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcc
Q 005691 475 KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKV 554 (683)
Q Consensus 475 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l 554 (683)
+...... .......||+.|+|||++.++.++.++|||||||++|||++|+.||...... .+ ......+..
T Consensus 143 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~----~~~~~~~~~ 212 (323)
T cd05595 143 KEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RL----FELILMEEI 212 (323)
T ss_pred ccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HH----HHHHhcCCC
Confidence 7542221 1223467999999999999999999999999999999999999998643211 01 111111110
Q ss_pred ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 555 WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 555 ~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
.+ +......+.+++..|++.||++|| ++.++++
T Consensus 213 ------~~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 ------RF----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ------CC----------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 01 111234566888899999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=347.12 Aligned_cols=266 Identities=23% Similarity=0.352 Sum_probs=204.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhcc-CCCcccccceeeecC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLK-HRNLVPLRGCCVVDG 382 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~ 382 (683)
..++|...++||+|+||.||+|+.. .+..||||++...... ..+.|.+|+++++++. |||||+++|+|.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--- 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--- 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence 3568888899999999999999853 1347999998654332 2456999999999996 999999999996
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCC-------------------------------------------------
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDG------------------------------------------------- 413 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~------------------------------------------------- 413 (683)
.....++||||+++|+|.++|+......
T Consensus 112 ---~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 112 ---KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ---cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 5567999999999999999885431100
Q ss_pred --------------------------------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCC
Q 005691 414 --------------------------------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455 (683)
Q Consensus 414 --------------------------------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKp 455 (683)
.......++|..+++++.|+++||+||| +.+|+||||||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp 265 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAA 265 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCh
Confidence 0001235888999999999999999999 88999999999
Q ss_pred CceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCC
Q 005691 456 TNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTS 533 (683)
Q Consensus 456 sNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~ 533 (683)
+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.|+.....
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999999999865433222 2233457789999999999999999999999999999997 8888864321
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
. +..+.....+... . .+......+.+++..|++.+|++|||+.+|+++|+..
T Consensus 346 ~--------~~~~~~~~~~~~~-----~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 346 D--------STFYNKIKSGYRM-----A----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred h--------HHHHHHHhcCCCC-----C----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 1111222222110 0 1112344678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.85 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=201.2
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|.....||+|+||.||++...++..+|+|++.... ...+.+.+|++++++++|+|++++++++. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------~~~~~~ 77 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-------EEPIYI 77 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-------CCCcEE
Confidence 4577888999999999999998877789999876533 33567899999999999999999998873 345799
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ....++|..+..++.+++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG-------DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred EEEcCCCCCHHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCc
Confidence 99999999999998432 1235889999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............++..|+|||+...+.++.++||||||+++|||++ |+.|+...... .. ......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~----~~~~~~ 218 (260)
T cd05069 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EV----LEQVER 218 (260)
T ss_pred cceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH----HHHHHc
Confidence 998764433222223456788999999998999999999999999999999 88888643211 11 111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. +. .+......+..++..|++.+|++||++.+|+++|+.
T Consensus 219 ~~~-----~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 GYR-----MP----------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCC-----CC----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 110 00 011224467788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=327.37 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=202.3
Q ss_pred CcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
+|...+.||+|+||.||+|+.. ....+++|.+..... ...+++.+|+++++.++||||+++++.+. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS------Q 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe------c
Confidence 4677889999999999999853 235788888765432 22456899999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCC---------------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcccc
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFND---------------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~---------------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHr 451 (683)
....++++||+++|+|.+++...... ........++|..++.++.+++.||+||| +.+|+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~ 151 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHR 151 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehh
Confidence 56789999999999999988532110 00112346899999999999999999999 8999999
Q ss_pred CCCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCC
Q 005691 452 DIKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALD 529 (683)
Q Consensus 452 DIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~ 529 (683)
||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||++++||++ |+.|+.
T Consensus 152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999865433222 1233456788999999988889999999999999999999 998885
Q ss_pred CCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 530 LSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 530 ~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.... ..++...+.+.. .. .+......+.+++..|++.+|++||++.++++.|++.
T Consensus 232 ~~~~---------~~~~~~~~~~~~-----~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 232 GIAP---------ERLFNLLKTGYR-----ME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CCCH---------HHHHHHHhCCCC-----CC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 3221 122232222211 00 0112234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.08 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=198.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++.. +|+.||+|++..... ...+.+..|+.+++.++|+||+++.+++. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~------~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ------DKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe------cCC
Confidence 46888999999999999999965 688999999976432 23456889999999999999999998886 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++... ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~--------~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL 143 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRY--------EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKL 143 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEe
Confidence 799999999999999998422 246899999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccc------cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL------YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
+|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 144 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------- 215 (330)
T cd05601 144 ADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------- 215 (330)
T ss_pred ccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------
Confidence 999999876544433344467999999999986 456789999999999999999999999643211
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...............- .. ......+..++..|++ +|++|||+.+++.
T Consensus 216 ~~~~~i~~~~~~~~~~-----~~--------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 KTYNNIMNFQRFLKFP-----ED--------PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHcCCCccCCC-----CC--------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111111111111100 00 0123345667778887 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=323.44 Aligned_cols=245 Identities=26% Similarity=0.399 Sum_probs=194.4
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 320 FIGRGGFGLVYKGILQ---DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
.||+|+||.||+|.++ ++..+|+|++..... ...+++.+|+.++++++|+||++++|++. ....++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-------AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-------CCCcEEEE
Confidence 5899999999999753 578899998864432 23467999999999999999999999873 34679999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
||+++|+|.+++.. ...+++..+.+++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 75 e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~ 142 (257)
T cd05116 75 ELAELGPLNKFLQK---------NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLS 142 (257)
T ss_pred ecCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccc
Confidence 99999999999832 246889999999999999999999 889999999999999999999999999999
Q ss_pred cccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 475 KQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 475 ~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+......... .....++..|+|||.+..+.++.++||||||+++|||++ |+.||..... ..+. ...+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~-~~i~~ 213 (257)
T cd05116 143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVT-QMIES 213 (257)
T ss_pred cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH-HHHHC
Confidence 8765433221 122345679999999988889999999999999999998 9999864321 1111 12222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+...+ . +......+.+++..|++.||++||+|.+|+++|++
T Consensus 214 ~~~~~-----~----------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 214 GERME-----C----------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCC-----C----------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 21111 1 11123456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.61 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=204.8
Q ss_pred hcCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||.||+|...+ +..||+|.+..... ....++.+|+++++.++|+|+++++|++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----- 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----- 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence 4578888999999999999998653 36899999865432 23456899999999999999999999986
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCC-CCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSG-VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~-~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.+...++||||+++|+|.+++......... .....++|..++.++.+++.||.||| +.+|+||||||+||+++.+
T Consensus 80 -~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 80 -TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAED 155 (277)
T ss_pred -CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCC
Confidence 456789999999999999998543211100 12345889999999999999999999 8999999999999999999
Q ss_pred CcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccch
Q 005691 464 MRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLI 541 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l 541 (683)
+.+||+|||+++....... .......+|..|+|||.+..+.++.++||||||+++||+++ |+.|+..... ..+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~ 230 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEV 230 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----HHH
Confidence 9999999999986543322 22333457889999999998999999999999999999998 8888853221 111
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+....+.... + +......+.+++..|++.+|++|||+.+++..|+.
T Consensus 231 ----~~~~~~~~~~~-----~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 ----LKFVIDGGHLD-----L----------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----HHHHhcCCCCC-----C----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11222221111 1 11124467889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=338.31 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=202.1
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc----Cc-cChHHHHHHHHHHHhcc-CCCcccccceeeecC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES----DF-QGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDG 382 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~----~~-~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~ 382 (683)
...++|...+.||+|+||.|+.|+.. +|..||||.+... .. ...+...+|+.++++++ ||||++++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--- 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--- 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence 44578889999999999999999854 6899999966543 12 23445668999999999 999999999987
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.....++||||+.+|+|.+++.. ...+.+.....++.|++.|++|+| +.+|+||||||+|||||.
T Consensus 91 ---t~~~~~ivmEy~~gGdL~~~i~~---------~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 91 ---TPTKIYIVMEYCSGGDLFDYIVN---------KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDG 155 (370)
T ss_pred ---cCCeEEEEEEecCCccHHHHHHH---------cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecC
Confidence 45669999999999999999943 357888999999999999999999 999999999999999999
Q ss_pred C-CcEEEcccCcccccccCCccccccccCCCcccCccccccCC-CC-ccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 463 D-MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ-LT-EKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 463 ~-~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s-~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
+ +++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....
T Consensus 156 ~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------ 228 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------ 228 (370)
T ss_pred CCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------
Confidence 9 999999999999874 2223445678999999999999866 76 789999999999999999999986322
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHH-HHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAI-MERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~-~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
.... .....+... .+... ...+..++..|+..||..|+|+.+|+
T Consensus 229 --~~l~-~ki~~~~~~----------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 229 --PNLY-RKIRKGEFK----------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --HHHH-HHHhcCCcc----------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1111 112233220 11112 44677889999999999999999998
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=327.22 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=205.4
Q ss_pred cCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV------E 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe------c
Confidence 57888899999999999999852 34568999887655555667999999999999999999999987 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCC----CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFND----GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~----~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
+...++||||+++++|.+++...... ........++|.+++.++.|++.||+||| +.+++||||||+|||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGE 155 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence 56789999999999999988533210 00112345999999999999999999999 889999999999999999
Q ss_pred CCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccc
Q 005691 463 DMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACL 540 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~ 540 (683)
++.+||+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |+.||......
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------ 229 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------ 229 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999986543322 12233446789999999999999999999999999999999 88887543211
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
-.......+.... ... .....+.+++..|++.||.+|||+.+|++.|+.-
T Consensus 230 ---~~~~~i~~~~~~~-----~~~----------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 230 ---EVIECITQGRVLQ-----RPR----------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred ---HHHHHHHcCCcCC-----CCC----------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1112222222211 000 1123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.09 Aligned_cols=239 Identities=29% Similarity=0.492 Sum_probs=196.9
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
+.+-||.|+.|.||.|++. ++.||||+++.. -..+|+-|++|+|+||+.+.|+|. ...-.++||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCt------qsPcyCIiMEf 193 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCT------QSPCYCIIMEF 193 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeec------CCceeEEeeec
Confidence 3567999999999999998 789999987542 135788899999999999999997 55678899999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
++.|-|...|. .++.++-.....+..+||.|+.||| ...|||||||.-||||..+..+||+|||-++.
T Consensus 194 Ca~GqL~~VLk---------a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 194 CAQGQLYEVLK---------AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred cccccHHHHHh---------ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHh
Confidence 99999999993 3457777888899999999999999 89999999999999999999999999999887
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
..+.. ....++||..|||||++...+.++|+||||||||||||+||..|+..-.... .+|-. ..+.+ .
T Consensus 262 ~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------IIwGV-GsNsL-~ 329 (904)
T KOG4721|consen 262 LSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------IIWGV-GSNSL-H 329 (904)
T ss_pred hhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--------eEEec-cCCcc-c
Confidence 65432 2234789999999999999999999999999999999999999987433211 11210 11111 1
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+ ..+..+.+-+..++.+||+..|..||+..+++..|+
T Consensus 330 L-------------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 330 L-------------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred c-------------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 1 133445666778899999999999999999999997
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.61 Aligned_cols=267 Identities=28% Similarity=0.424 Sum_probs=205.0
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
+...++|+..+.||+|+||.||++...+ ...+|+|.+..... +...++.+|++++.++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 86 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT- 86 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-
Confidence 3445678888999999999999998642 36799998865322 2345688999999999 8999999999986
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
.+...+++|||+++|+|.+++....... .......++|..+++++.|++.||.||| +.+|+||||
T Consensus 87 -----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dl 158 (293)
T cd05053 87 -----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDL 158 (293)
T ss_pred -----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCcccccc
Confidence 4567899999999999999985321000 0023457899999999999999999999 889999999
Q ss_pred CCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCC
Q 005691 454 KATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLS 531 (683)
Q Consensus 454 KpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~ 531 (683)
||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++|||||||++|||++ |..|+...
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999999999999876543221 2223345678999999998999999999999999999998 88887532
Q ss_pred CCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 532 TSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 532 ~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.. .-+.+....+...+ .+......+.+++..|++.+|++||||.++++.|+..
T Consensus 239 ~~---------~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 239 PV---------EELFKLLKEGYRME---------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred CH---------HHHHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 21 01122222221100 0112234677899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.06 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=206.7
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-----CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-----g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
.++|...++||+|+||.||+|...+ +..|++|++..... ...+.+.+|+.++++++|+|+++++|++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----- 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----- 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 5678889999999999999999865 68899998865422 224568899999999999999999999863
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.+...++++||+++|+|.+++....... ......++|.+++.++.+++.||+||| +.+++||||||+||++++++.
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGE-ANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence 3467899999999999999985432111 112356999999999999999999999 889999999999999999999
Q ss_pred EEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 466 ARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
+||+|||+++.......+ ......++..|+|||++....++.++||||||+++||+++ |+.|+..... . +
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~---~ 227 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----F---E 227 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----H---H
Confidence 999999999866443332 2233456788999999998889999999999999999999 9999864321 1 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+. ..+..+.. +. .+......+.+++..|++.+|++|||+.+|+++|+.-
T Consensus 228 ~~-~~~~~~~~-------~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 228 MA-AYLKDGYR-------LA--------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HH-HHHHcCCC-------CC--------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11 11111110 00 0011234577899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.91 Aligned_cols=241 Identities=24% Similarity=0.357 Sum_probs=191.1
Q ss_pred eeeeecCceEEEEEEE----cCCcEEEEEEeeccCc----cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 319 NFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDF----QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++||+|+||.||+++. .+++.||||.+..... .....+.+|+++++.++||||+++++++. .+...
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~------~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ------TGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe------cCCeE
Confidence 5799999999999985 3578999999875321 22345789999999999999999999986 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++.. ...+.+.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 143 (323)
T cd05584 76 YLILEYLSGGELFMHLER---------EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTD 143 (323)
T ss_pred EEEEeCCCCchHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEee
Confidence 999999999999998832 345778888899999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++....... ......||+.|+|||++....++.++|||||||++|||++|+.||..... .... ....
T Consensus 144 fg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~-~~~~ 213 (323)
T cd05584 144 FGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTI-DKIL 213 (323)
T ss_pred CcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHH-HHHH
Confidence 999875433222 23346799999999999988899999999999999999999999864221 0111 1111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
.+.. .+ +......+.+++..|++.+|++|| ++.++++
T Consensus 214 ~~~~------~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 214 KGKL------NL----------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred cCCC------CC----------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1211 01 111234567889999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.35 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=197.6
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
...++|...++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~------ 113 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ------ 113 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe------
Confidence 34568999999999999999999975 58899999986532 223345789999999999999999998886
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.+...++||||+++|+|.+++. ...++......++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~----------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMS----------NYDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCC
Confidence 5678999999999999999883 224777788889999999999999 899999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCcccccc----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
+||+|||+++..............||+.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 181 ~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------- 252 (370)
T cd05596 181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------- 252 (370)
T ss_pred EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------
Confidence 9999999998765433323344679999999998864 3478999999999999999999999964321
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL--RPTISDALKM 604 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~--RPtm~eVl~~ 604 (683)
... ......+.. .. .... .......+.+++..|++.+|.+ ||++.+++..
T Consensus 253 ~~~-~~~i~~~~~-~~---~~~~--------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 VGT-YSKIMDHKN-SL---TFPD--------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHH-HHHHHcCCC-cC---CCCC--------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111 111111110 00 0000 0112345667888999999987 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=342.62 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=215.3
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 306 ~el~~at~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
++++-...+....++||-|.||.||.|+++. .-.||||.+++..+. .++|++|..+|+.++|||||+|+|+|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT----- 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT----- 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhc-----
Confidence 4555555667778999999999999999864 568999999775544 678999999999999999999999997
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....|+|.|||.+|+|.+||.... +..++--..+.++.||+.|++||. ...+|||||.++|+|+.++.
T Consensus 334 -~EpPFYIiTEfM~yGNLLdYLRecn-------r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnh 402 (1157)
T KOG4278|consen 334 -HEPPFYIITEFMCYGNLLDYLRECN-------RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENH 402 (1157)
T ss_pred -cCCCeEEEEecccCccHHHHHHHhc-------hhhcchhHHHHHHHHHHHHHHHHH---Hhhhhhhhhhhhhccccccc
Confidence 5667999999999999999995432 345666778899999999999999 89999999999999999999
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
.+||+||||+|+...+.........-.+.|.|||-+.+..++.|+|||+|||+||||.| |..|+... .+ .
T Consensus 403 iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--------dl-S 473 (1157)
T KOG4278|consen 403 IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DL-S 473 (1157)
T ss_pred eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--------cH-H
Confidence 99999999999887655433333444678999999999999999999999999999987 77776421 12 3
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
-|+.+++.|-- + ..++.+...+.+++..||+.+|.+||+..|+-+.||.
T Consensus 474 qVY~LLEkgyR-------M--------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 474 QVYGLLEKGYR-------M--------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HHHHHHhcccc-------c--------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 35555555421 1 1445667789999999999999999999998777654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.23 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=206.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+++|...+.||+|+||.||+|... +|+.||+|.++.... ...+.+.+|++++++++|+|++++++++. ..
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~------~~ 74 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI------EN 74 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee------cC
Confidence 367889999999999999999986 789999998864322 22457899999999999999999999987 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.... .....+++.+++.++.+++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVK 146 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhc-----ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEE
Confidence 67899999999999999884321 12346899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++........ .....|+..|+|||++.+..++.++|||||||++|||++|+.|+..... .+.++..
T Consensus 147 l~d~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~- 218 (267)
T cd08224 147 LGDLGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCK- 218 (267)
T ss_pred EeccceeeeccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHh-
Confidence 9999998865433221 2334688999999999988899999999999999999999999853221 1111111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
....+.... .........+.+++..|++.+|++|||+.+|+++|++
T Consensus 219 ~~~~~~~~~--------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 219 KIEKCDYPP--------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred hhhcCCCCC--------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 111111100 0111234567789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=314.61 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=201.2
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+|+.. +++.|++|.+.... ....+++.+|++++++++|+|++++++++. .....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL------DKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec------cCCEE
Confidence 4777889999999999999975 68899999986532 233567899999999999999999999987 45789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++... ....+++..+++++.+++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~d 144 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQ-------RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGD 144 (256)
T ss_pred EEEEEeCCCCcHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcc
Confidence 9999999999999998532 1346889999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++........ .....|+..|+|||+...+.++.++||||||++++||++|+.|+..... ........
T Consensus 145 f~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~ 214 (256)
T cd08529 145 LGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---------GALILKII 214 (256)
T ss_pred cccceeccCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHH
Confidence 9998876543222 2335688999999999999999999999999999999999999864321 11111111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+... .+ +......+.+++..|++.+|++||+|.++++.
T Consensus 215 ~~~~~-----~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RGVFP-----PV----------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCCC-----CC----------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11110 01 11223467889999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.44 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=192.8
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeec
Q 005691 320 FIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYM 397 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~ 397 (683)
.||+|+||.||+|+.. +++.||+|.+..... .....|.+|++++++++|+||+++++++. .....++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~lv~e~~ 75 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT------QKQPIYIVMELV 75 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCCeEEEEeec
Confidence 6999999999999975 688999998764322 23456999999999999999999999986 456789999999
Q ss_pred CCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 398 PNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 398 ~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
++++|.+++.. ....++|..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~L~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 76 QGGDFLTFLRT--------EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred cCCcHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccc
Confidence 99999999832 1235889999999999999999999 889999999999999999999999999998765
Q ss_pred ccCCcccc-ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccc
Q 005691 478 REGQSHLT-TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVW 555 (683)
Q Consensus 478 ~~~~~~~~-~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~ 555 (683)
........ ....++..|+|||++..+.++.++||||||+++||+++ |..|+...... ........+..
T Consensus 145 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---------~~~~~~~~~~~- 214 (252)
T cd05084 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---------QTREAIEQGVR- 214 (252)
T ss_pred ccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---------HHHHHHHcCCC-
Confidence 43211111 11223567999999999999999999999999999998 88887532210 11111111100
Q ss_pred cccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 556 QALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 556 e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
. . .+......+.+++..|++.+|++|||+.+|.++|.
T Consensus 215 ----~----~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 ----L----P------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----C----C------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0 0 01112346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=321.55 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=197.7
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
+|+..++||+|+||.||++... +++.||||++...... ....+.+|++++++++|+||+++++++. .+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE------TKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec------CCCe
Confidence 4777889999999999999964 6889999998654322 2345788999999999999999999886 4568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~ 144 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNM-------GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred EEEEEeccCCCcHHHHHHhc-------CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEe
Confidence 99999999999999888432 1246899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+++....... .....||..|+|||++....++.++|||||||++||+++|+.||....... ....+....
T Consensus 145 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~ 217 (285)
T cd05605 145 DLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRV 217 (285)
T ss_pred eCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHh
Confidence 9999987543322 223468999999999998899999999999999999999999997432211 101111111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
..+. .. .+......+.+++..|++.||++|| ++.++++
T Consensus 218 ~~~~------~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 218 KEDQ------EE----------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hhcc------cc----------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1110 00 1112344667899999999999999 7888855
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.03 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=199.7
Q ss_pred CcccceeeeecCceEEEEEEEc-C-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-D-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.|...+.||+|+||.||++... + ++.||+|++..........+.+|+++++.++|||||++++++. .++..+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~------~~~~~~ 141 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK------SDDKLL 141 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE------ECCEEE
Confidence 3788899999999999999854 3 5778888775544444456889999999999999999999987 557899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
|||||+++|+|.++|.... .....+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 142 lv~E~~~gg~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRL-----KEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEEECCCCCCHHHHHHHHH-----hccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeC
Confidence 9999999999999885322 12346888899999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++....... .......||++|+|||++....++.++|||||||++|||++|+.||..... .+.... ..
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~-~~ 284 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQ-VL 284 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HH
Confidence 99987654322 224456799999999999999999999999999999999999999863211 111111 11
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.. ++ .+......+.+++..|++.+|++||++.+++.
T Consensus 285 ~~~~----~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 285 YGKY----DP-----------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred hCCC----CC-----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111 00 01112345678899999999999999999864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.60 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=204.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|||++++++++. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI------EDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE------ECC
Confidence 57888999999999999999964 689999998764332 22346889999999999999999999986 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++|+||+++|+|.+++.... .....+++...+.++.+++.||+||| +.+++||||||+||+++.++.++|
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l 147 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFK-----KQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhh-----hccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEE
Confidence 7899999999999998873221 12345788899999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ....+...
T Consensus 148 ~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~- 219 (267)
T cd08228 148 GDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQK- 219 (267)
T ss_pred CccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHH-
Confidence 99999887643322 12234688999999999988899999999999999999999999853221 11122211
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..... .+.+ ........+.+++..|++.+|++||++.+|++.|++.
T Consensus 220 ~~~~~-----~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 220 IEQCD-----YPPL---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HhcCC-----CCCC---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11111 1111 1122345678889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.22 Aligned_cols=260 Identities=24% Similarity=0.368 Sum_probs=201.6
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~ 386 (683)
+.+++.|+..+.||+|+||.||+|... +++.||+|++.... ....++..|+.++.++ +|+|++++++++........
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356788888999999999999999975 57889999886543 4456789999999998 79999999999875433223
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++... ....++|..+..++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-------~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~ 150 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT-------KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV 150 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCE
Confidence 45689999999999999998432 1246889999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
||+|||+++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......
T Consensus 151 ~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------ 223 (272)
T cd06637 151 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ 223 (272)
T ss_pred EEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------
Confidence 9999999986543222 223467899999999986 3467889999999999999999999986322110
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+ .... ... .+.+. .......+..++..|++.+|.+|||+.+|++
T Consensus 224 -~~-~~~~-~~~-----~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 -AL-FLIP-RNP-----APRLK---------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HH-HHHh-cCC-----CCCCC---------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 01 0001 110 11111 1112345678899999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.13 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=200.5
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-C---cEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-G---TTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-g---~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+|++.. + ..+|+|++.... ....+++.+|++++++++|+|++++.+++. .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT------K 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc------c
Confidence 3578888999999999999999752 3 379999886542 223457999999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++++|.+++.. ....++|.+++.++.+++.||+||| +.+++||||||+||++++++.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~ 146 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRD--------HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLEC 146 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcE
Confidence 5678999999999999999842 1246899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 467 RVADFGLAKQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
||+|||++.......... ......+..|+|||++..+.++.++||||||+++||+++ |+.|+..... .+
T Consensus 147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~ 218 (268)
T cd05063 147 KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HE 218 (268)
T ss_pred EECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HH
Confidence 999999987664332221 112234567999999998899999999999999999998 9999853221 11
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+... +..+.. .+ ...+....+.+++..|++.+|++||+|.+|+++|++
T Consensus 219 ~~~~-i~~~~~----~~-----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 219 VMKA-INDGFR----LP-----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred HHHH-HhcCCC----CC-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 2111 111110 00 111223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=333.77 Aligned_cols=200 Identities=29% Similarity=0.439 Sum_probs=171.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...++||+|+||.||+++.. +|+.||||++.... ......+.+|++++..++|+||+++++++. .+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~------~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ------DEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE------cCC
Confidence 47888999999999999999975 58999999997542 222345788999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 142 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMK---------KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKL 142 (364)
T ss_pred eEEEEECCCCCcHHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEE
Confidence 89999999999999999832 246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCcc-------------------------------------ccccccCCCcccCccccccCCCCccccE
Q 005691 469 ADFGLAKQSREGQSH-------------------------------------LTTRVAGTHGYLAPEYALYGQLTEKSDV 511 (683)
Q Consensus 469 aDFGla~~~~~~~~~-------------------------------------~~~~~~GT~~Y~APE~~~~~~~s~ksDV 511 (683)
+|||+++........ ......||+.|+|||++....++.++||
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 222 (364)
T cd05599 143 SDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222 (364)
T ss_pred eecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence 999998754321100 0112469999999999999999999999
Q ss_pred EEcchhHHHHhhCCCCCCC
Q 005691 512 YSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 512 wSfGvlLlELltGr~p~~~ 530 (683)
|||||+++||++|+.||..
T Consensus 223 wSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred ecchhHHHHhhcCCCCCCC
Confidence 9999999999999999964
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.92 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=201.5
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
|++.+++++....+||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||++++|++.
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 75 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS------ 75 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec------
Confidence 45667888888899999999999999965 57789999987766556678999999999999999999999987
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCC--CccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL--TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA- 462 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L--~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~- 462 (683)
.+...++|+||+++++|.+++.... ..+ ++..+..++.|++.||+||| +.+|+||||||+||+++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 76 ENGFFKIFMEQVPGGSLSALLRSKW--------GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTY 144 (268)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhc--------ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCC
Confidence 5578999999999999999985321 234 77888899999999999999 889999999999999986
Q ss_pred CCcEEEcccCcccccccCCccccccccCCCcccCccccccCC--CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 463 DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
++.+||+|||++........ ......|+..|+|||++..+. ++.++||||||+++|||++|+.|+.......
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----- 218 (268)
T cd06624 145 SGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----- 218 (268)
T ss_pred CCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----
Confidence 67999999999876543222 223346899999999987644 7899999999999999999999986432211
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...|...... ..+.+ +....+.+..++..|++.+|.+|||+.++++
T Consensus 219 ~~~~~~~~~~-------~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 219 AAMFKVGMFK-------IHPEI----------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhHhhhhhhc-------cCCCC----------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111100000 01111 1122345678899999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.83 Aligned_cols=242 Identities=22% Similarity=0.309 Sum_probs=191.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
+.||+|+||.||++... +|+.||+|.+.... ......+.+|++++..++|+||+++.+++. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~------~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ------THDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE------cCCEEEEEE
Confidence 36999999999999864 68899999987542 222456788999999999999999998886 556899999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCCceeeccCCcEEEcccCc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
||+++|+|.+++. ....+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+
T Consensus 75 E~~~~~~L~~~l~---------~~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~ 142 (325)
T cd05594 75 EYANGGELFFHLS---------RERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGL 142 (325)
T ss_pred eCCCCCcHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCC
Confidence 9999999998883 2346899999999999999999999 6 7999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++....... ......||+.|+|||++.++.++.++|||||||++|||++|+.||...... .. ......+.
T Consensus 143 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~-~~~i~~~~ 212 (325)
T cd05594 143 CKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KL-FELILMEE 212 (325)
T ss_pred CeecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HH-HHHHhcCC
Confidence 875432222 223457999999999999999999999999999999999999998642210 01 11111111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALKM 604 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~~ 604 (683)
. .+. ......+.+++..|++.||++|| ++.++++.
T Consensus 213 ~------~~p----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 I------RFP----------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C------CCC----------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 111 11233567788999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.76 Aligned_cols=200 Identities=25% Similarity=0.391 Sum_probs=171.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|+..++||+|+||.||++... ++..+|+|.+..... ...+.+.+|++++++++|+||+++++++. ..+.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY------SDGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE------ECCE
Confidence 368889999999999999999976 578889988765422 22456899999999999999999999997 4568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++.. ...+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+
T Consensus 78 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKK---------AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEEecCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEe
Confidence 9999999999999999832 2358888899999999999999993 2479999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
|||+++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 147 Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 147 DFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred eCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99998765332 123356899999999999889999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.02 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=204.7
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||.||+++. .+++.+|||++...... ...++.+|+.+++.++|+||+++++++. .++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI------EDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE------eCC
Confidence 4677788999999999999995 47899999988653322 2357899999999999999999999987 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..+++|||+++++|.+++.... .....++|..++.++.+++.||+||| +.+++|+||||+||+++.++.+||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l 147 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFK-----KQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKL 147 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhh-----ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence 8999999999999999884211 12346899999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... ......|+..|+|||++....++.++||||||+++|||++|..|+...... ...+...
T Consensus 148 ~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~- 219 (267)
T cd08229 148 GDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK- 219 (267)
T ss_pred CcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhh-
Confidence 99999886643322 123356899999999999889999999999999999999999998532211 1111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. +...+.+ ......+.+..++..|++.+|++||||.+|+++++.
T Consensus 220 ~~-----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 220 IE-----QCDYPPL---------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred hh-----cCCCCCC---------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11 1111111 112234567788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=316.22 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|...++||+|+||.||++...++..+|+|.+.... ...+.|.+|++++++++|+|++++.+++. . ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~-~~~~ 76 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------K-EPIY 76 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc------C-CCeE
Confidence 46788899999999999999998888889999876532 23467999999999999999999999875 2 5689
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++|||+++|+|.+++... ....++|..++.++.+++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 77 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 77 IITEFMAKGSLLDFLKSD-------EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred EEEEeCCCCcHHHHHHhC-------CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCC
Confidence 999999999999998432 1346889999999999999999999 789999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++..............++..|+|||++..+.++.++||||||++++|+++ |+.|+..... ..+ .....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~----~~~~~ 217 (260)
T cd05073 147 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEV----IRALE 217 (260)
T ss_pred cceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHH----HHHHh
Confidence 9998765433333333456788999999998899999999999999999999 8988864321 111 11112
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+...+ .+......+..++..|++.+|++||++.+++++|+.
T Consensus 218 ~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RGYRMP---------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCCC---------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 221110 011223457788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.97 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=198.8
Q ss_pred cCcccceeeeecCceEEEEEEEcC---------------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccc
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD---------------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRG 376 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~---------------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G 376 (683)
++|...+.||+|+||.||+++..+ ...||+|++..... .....|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987642 22589998865422 23456999999999999999999999
Q ss_pred eeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCC---CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG---SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 377 ~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~---~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
++. .....++||||+++++|.+++....... .......++|..++.++.+++.||+||| +.+++||||
T Consensus 85 ~~~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dl 155 (295)
T cd05097 85 VCV------SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDL 155 (295)
T ss_pred EEc------CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeecccc
Confidence 996 4567899999999999999884321100 0011234789999999999999999999 889999999
Q ss_pred CCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh--CCCCCCC
Q 005691 454 KATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC--GRKALDL 530 (683)
Q Consensus 454 KpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt--Gr~p~~~ 530 (683)
||+||++++++.+||+|||+++....... .......++..|+|||+...+.++.++|||||||+++||++ |..|+..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999976543322 12233456789999999999999999999999999999998 4455543
Q ss_pred CCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 531 STSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 531 ~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
... ......+.+.+......... . .+......+.+++..|++.+|++||+|.+|+++|+
T Consensus 236 ~~~-----~~~~~~~~~~~~~~~~~~~~------~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSD-----EQVIENTGEFFRNQGRQIYL------S------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cCh-----HHHHHHHHHhhhhccccccC------C------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 221 11111111111111000000 0 01112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.14 Aligned_cols=252 Identities=28% Similarity=0.467 Sum_probs=200.2
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
.+|...+.||+|+||.||+|...++..+|+|++.... ....+|.+|++++++++|+|++++++++. .....++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT------ERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc------cCCceEE
Confidence 3567788999999999999998778899999886433 33567999999999999999999999886 4567899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++++|.+++... ...++|..++.++.+++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 77 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQ--------RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred EEEcCCCCcHHHHHHhC--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCc
Confidence 99999999999988421 235889999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............++.+|+|||++..+.++.++||||||+++||+++ |+.|+..... ....... ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~ 216 (256)
T cd05112 146 MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETI-NA 216 (256)
T ss_pred ceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHH-hC
Confidence 987654332221222335678999999998999999999999999999998 9998864221 1112111 11
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+. ...++.+ ....+.+++.+|++.+|++||||.+|+++|.
T Consensus 217 ~~--~~~~~~~-------------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 217 GF--RLYKPRL-------------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CC--CCCCCCC-------------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 10 1111111 1346788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.28 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=200.6
Q ss_pred CcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
+|...+.||+|+||.||+|...+ ++.||+|++....... .+.|.+|+.++..++|+||+++++++. .
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~------~ 79 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT------K 79 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence 45667789999999999998642 5789999987543322 356889999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCC-------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFND-------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~-------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
....++++||+++++|.+++...... ........+++..+++++.|++.||.||| +.+|+||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheE
Confidence 56789999999999999998432100 01112345889999999999999999999 889999999999999
Q ss_pred eccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCC
Q 005691 460 LDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPR 537 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~ 537 (683)
+++++.+||+|||+++....... .......+++.|+|||++..+.++.++||||||+++|||++ |..|+.....
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---- 232 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---- 232 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 99999999999999886543322 22233456789999999999999999999999999999998 7777753211
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.++ ......+.... .+.+....+..++..|++.+|++||++.+|++.|+.
T Consensus 233 ----~~~-~~~i~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 ----QDV-IEMIRNRQVLP---------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----HHH-HHHHHcCCcCC---------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 112 12222222110 111234457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.74 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=204.7
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..++|...++||+|+||.||++..++++.||||.+.... ...+++.+|++++++++|+|++++++++. .....
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS------EEEPI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee------cCCce
Confidence 356888899999999999999998888899999887543 34567999999999999999999999886 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++... ....++|..++.++.+++.||.||| +.+++|+||||+||++++++.+||+|
T Consensus 77 ~~v~e~~~~~~L~~~i~~~-------~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSG-------EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred EEEEeccCCCCHHHHHhcc-------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECc
Confidence 9999999999999998432 1246899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+++..............++..|+|||.+.+..++.++||||||++++|+++ |+.||..... . ......
T Consensus 147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~----~~~~~~ 217 (261)
T cd05034 147 FGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----R----EVLEQV 217 (261)
T ss_pred cccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----H----HHHHHH
Confidence 99998765432222223345678999999998899999999999999999999 9999853221 0 011111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+. ... .+.+....+.+++..|++.+|++||++.++++.|+.
T Consensus 218 ~~~~-----~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 ERGY-----RMP----------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcCC-----CCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1110 000 011123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.31 Aligned_cols=200 Identities=27% Similarity=0.396 Sum_probs=170.3
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
+|...+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|++++++++|+|||++++++. ....
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~------~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ------DKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe------cCCE
Confidence 5788899999999999999864 578999999976432 22456889999999999999999999987 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++.. ...+++.....++.|++.||.||| +.+|+||||||+|||++.++++||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---------~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~ 143 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIR---------MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLT 143 (381)
T ss_pred EEEEEecCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEe
Confidence 9999999999999999842 246888888999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCc----------------------------------------------cccccccCCCcccCccccccC
Q 005691 470 DFGLAKQSREGQS----------------------------------------------HLTTRVAGTHGYLAPEYALYG 503 (683)
Q Consensus 470 DFGla~~~~~~~~----------------------------------------------~~~~~~~GT~~Y~APE~~~~~ 503 (683)
|||+++....... .......||..|+|||++...
T Consensus 144 DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (381)
T cd05626 144 DFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223 (381)
T ss_pred eCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC
Confidence 9999864321000 011235799999999999988
Q ss_pred CCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 504 QLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 504 ~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
.++.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 224 GYTQLCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred CCCCccceeehhhHHHHHHhCCCCCcCC
Confidence 8999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.60 Aligned_cols=247 Identities=29% Similarity=0.462 Sum_probs=196.4
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+|+... +..+|+|.+...... ..+++.+|+++++++.|+|+|++++++. +...++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-------~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-------GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-------CCceEEE
Confidence 369999999999998532 268999998765443 3567999999999999999999999873 4568999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...++|..++.++.|++.||+||| ..+++||||||+|||++.++.+||+|||+
T Consensus 74 ~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 74 MELAPLGPLLKYLKK---------RREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred EEeCCCCcHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccc
Confidence 999999999999942 236899999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCcccc--ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 474 AKQSREGQSHLT--TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 474 a~~~~~~~~~~~--~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
++.......... ....++..|+|||....+.++.++||||||+++||+++ |+.||..... ..+..+ ..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~----~~ 212 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAM----LE 212 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHH----HH
Confidence 987654433222 12234578999999999999999999999999999998 9999864322 111122 22
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+.... .+......+.+++..|++.+|++||++.+|+++|++.
T Consensus 213 ~~~~~~---------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 213 SGERLP---------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCcCC---------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 221100 1112234667899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=333.27 Aligned_cols=200 Identities=26% Similarity=0.415 Sum_probs=172.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||+||++... +++.||||++..... .....+.+|+.++.+++|+||+++++.+. ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~------~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ------DKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe------cCC
Confidence 47888999999999999999865 588999999875322 22346888999999999999999999886 566
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL 142 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMK---------KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKL 142 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEE
Confidence 89999999999999999832 346899999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCc----------------------------------cccccccCCCcccCccccccCCCCccccEEEc
Q 005691 469 ADFGLAKQSREGQS----------------------------------HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSF 514 (683)
Q Consensus 469 aDFGla~~~~~~~~----------------------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSf 514 (683)
+|||+++....... .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSl 222 (363)
T cd05628 143 SDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (363)
T ss_pred eeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhh
Confidence 99999875432110 01124579999999999999999999999999
Q ss_pred chhHHHHhhCCCCCCC
Q 005691 515 GVVILEIMCGRKALDL 530 (683)
Q Consensus 515 GvlLlELltGr~p~~~ 530 (683)
||++|||++|+.||..
T Consensus 223 Gvil~ell~G~~Pf~~ 238 (363)
T cd05628 223 GVIMYEMLIGYPPFCS 238 (363)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.94 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=195.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|+||+++++++. .....
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH------TERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc------CCCeE
Confidence 46888899999999999999975 688999999865432 23456889999999999999999999986 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++ +|.+++... ...+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|
T Consensus 79 ~lv~e~~~~-~l~~~l~~~--------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 79 TLVFEYLDS-DLKQYLDNC--------GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred EEEEeCCCc-CHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECc
Confidence 999999985 888887321 235788899999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh-
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL- 548 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~- 548 (683)
||+++....... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ......+.
T Consensus 147 fG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~ 220 (288)
T cd07871 147 FGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-----ELHLIFRLL 220 (288)
T ss_pred CcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHh
Confidence 999976543222 1233568999999998875 568999999999999999999999986432211 00011110
Q ss_pred -------hh----cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 -------VK----AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 -------~~----~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
|. .....+...+........ ...........+++..|++.||.+|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLI--NHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCCChHHhhccccchhhhccccCccCCCchH--HhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 000111111111000000 000012345678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.46 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=192.8
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 321 LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
||+|+||+||++... +|+.||+|++...... ..+.+..|++++++++|+|++++.+++. .....++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~------~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ------TKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc------CCCeEEEEEeC
Confidence 699999999999865 6889999998654322 2356788999999999999999998876 45679999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++|+|.+++.... .....+++..++.++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++.
T Consensus 75 ~~~g~L~~~~~~~~-----~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 75 MNGGDLRYHIYNVD-----EENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVE 146 (280)
T ss_pred CCCCCHHHHHHhcc-----ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence 99999998874321 12356899999999999999999999 88999999999999999999999999999976
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
...... ......||+.|+|||++.++.++.++||||||+++|||++|+.||........ .... ....
T Consensus 147 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~-~~~~------- 213 (280)
T cd05608 147 LKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKEL-KQRI------- 213 (280)
T ss_pred cCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHH-HHhh-------
Confidence 654332 23345789999999999999999999999999999999999999864322110 0000 0000
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
...... .+......+.+++..|++.||++|| +++++++
T Consensus 214 -~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 214 -LNDSVT--------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred -cccCCC--------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 000000 1112344667888999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.78 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=190.0
Q ss_pred eeeecCceEEEEEEEcC---CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEe
Q 005691 320 FIGRGGFGLVYKGILQD---GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~---g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
.||+|+||.||+|...+ +..+|+|++..... .....|.+|+.++++++|+|+++++|++. .....++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~~lv~e 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT------EVTPYLLVME 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc------CCCCcEEEEE
Confidence 58999999999998653 35799998865433 22356899999999999999999999986 4566899999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
|+++|+|.+++..... .....+++..++.++.|++.||+||| +.+++||||||+||+++.++++||+|||+++
T Consensus 76 ~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 76 FCPLGDLKGYLRSCRK----AELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred CCCCCcHHHHHHHhhh----cccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccc
Confidence 9999999999854321 11235677888899999999999999 8899999999999999999999999999997
Q ss_pred ccccCCccc-cccccCCCcccCccccccC-------CCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 476 QSREGQSHL-TTRVAGTHGYLAPEYALYG-------QLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 476 ~~~~~~~~~-~~~~~GT~~Y~APE~~~~~-------~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
......... .....|+..|+|||++... .++.++||||||+++|||++ |+.||....... ...+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~-- 221 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTY-- 221 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHH--
Confidence 644332221 2345678899999988632 35789999999999999996 999986433211 1111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
...+......++.+... ..+.+.+++..|+ .+|++|||+.+|++.|+
T Consensus 222 --~~~~~~~~~~~~~~~~~----------~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 --TVREQQLKLPKPRLKLP----------LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred --HhhcccCCCCCCccCCC----------CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111112222322211 1234566778898 58999999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.26 Aligned_cols=261 Identities=29% Similarity=0.409 Sum_probs=200.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
.+++|...+.||+|+||.||+|.+.+ +..||+|.+..... .....|.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 79 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF---- 79 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc----
Confidence 35788999999999999999999753 56788988764332 23456999999999999999999999886
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.....++||||+++|+|.+++...... ......++|..+++++.+|+.||+||| +.+++||||||+||+++.+
T Consensus 80 --~~~~~~lv~e~~~g~~L~~~i~~~~~~--~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~ 152 (277)
T cd05036 80 --ERLPRFILLELMAGGDLKSFLRENRPR--PERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCK 152 (277)
T ss_pred --cCCCcEEEEecCCCCCHHHHHHHhCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEecc
Confidence 445689999999999999998543211 112246899999999999999999999 8899999999999999875
Q ss_pred C---cEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCc
Q 005691 464 M---RARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRA 538 (683)
Q Consensus 464 ~---~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~ 538 (683)
+ .+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||......
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---- 228 (277)
T cd05036 153 GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---- 228 (277)
T ss_pred CCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 4 6999999999876322211 1222334578999999999999999999999999999997 99888643221
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
... .....+... . .+......+.+++..|++.+|++||++.+|++.|+
T Consensus 229 ----~~~-~~~~~~~~~---------~------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 ----EVM-EFVTGGGRL---------D------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ----HHH-HHHHcCCcC---------C------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111 111111000 0 01122346778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=315.08 Aligned_cols=249 Identities=32% Similarity=0.465 Sum_probs=202.0
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||+|... |+.||||++..... ..+++.+|+.++++++|+|++++++++. .....++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~~~ 77 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL------QGNPLYI 77 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc------CCCCeEE
Confidence 46778899999999999999876 88999999876544 4667999999999999999999999986 4567899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++++|.+++... ....++|..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR-------GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred EEEecCCCcHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccc
Confidence 99999999999998422 1236899999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++....... ...++..|+|||++..+.++.++||||||++++|+++ |+.|+..... .........
T Consensus 148 ~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~ 214 (256)
T cd05039 148 LAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPHVEK 214 (256)
T ss_pred cccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHhc
Confidence 9987643222 2345678999999998999999999999999999997 9988853321 111111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+...+ .+......+.+++..|++.+|++|||+.+++++|++
T Consensus 215 ~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 215 GYRME---------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCC---------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11000 111223567789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=333.55 Aligned_cols=204 Identities=25% Similarity=0.344 Sum_probs=173.3
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
+....++|...++||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~---- 113 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ---- 113 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence 3344578999999999999999999976 57899999986532 222445889999999999999999999886
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.+...++||||+++|+|.+++. ...+++.....++.|++.||+||| +.+|+||||||+|||++++
T Consensus 114 --~~~~~~lv~Ey~~gg~L~~~l~----------~~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~ 178 (370)
T cd05621 114 --DDKYLYMVMEYMPGGDLVNLMS----------NYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKH 178 (370)
T ss_pred --cCCEEEEEEcCCCCCcHHHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCC
Confidence 5678999999999999999883 235788888999999999999999 8999999999999999999
Q ss_pred CcEEEcccCcccccccCCccccccccCCCcccCccccccC----CCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 464 MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG----QLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
+.+||+|||+++..............||+.|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 179 GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred CCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999999999987654333233456799999999998753 378999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.55 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=198.5
Q ss_pred cCcccceeeeecCceEEEEEEEcC-Cc--EEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GT--TVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~--~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|+..+.||+|+||.||+|+..+ +. .+++|.++... ....+.|.+|++++.++ +||||+++++++. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~------~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE------NR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc------cC
Confidence 578888999999999999999754 33 47888876432 23345789999999999 7999999999986 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
...++|+||+++|+|.+++....... .......+++..++.|+.|++.||+||| +.+|+||||||+|||+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill 152 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLV 152 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEE
Confidence 67899999999999999985432110 0012245889999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCcc
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRAC 539 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~ 539 (683)
++++.+||+|||++....... .......+..|+|||+.....++.++|||||||+++||++ |+.||.....
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------ 224 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------ 224 (297)
T ss_pred CCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999986432211 1111223567999999998899999999999999999998 9999864321
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.++ ......+. .+.. +......+.+++..|++.+|.+|||+.+++++|+...
T Consensus 225 --~~~-~~~~~~~~-----~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 225 --AEL-YEKLPQGY-----RMEK----------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred --HHH-HHHHhcCC-----CCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 11111111 0001 1112345678999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=337.65 Aligned_cols=192 Identities=24% Similarity=0.289 Sum_probs=166.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|...+.||+|+||.||+++.. +++.||+|+.. ...+.+|++++++++|||||++++++. .+...+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~------~~~~~~ 159 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT------YNKFTC 159 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE------ECCeeE
Confidence 57999999999999999999964 68899999643 234788999999999999999999986 456789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|+|++. ++|.+++. ....+++..++.|+.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 160 lv~e~~~-~~L~~~l~---------~~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 160 LILPRYK-TDLYCYLA---------AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEEecCC-CCHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 9999985 68887772 2346889999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCC
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~ 529 (683)
|+|+..............||+.|+|||++....++.++|||||||++|||++|+.|+-
T Consensus 227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred CcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9997644333233345679999999999999999999999999999999999998864
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.05 Aligned_cols=238 Identities=24% Similarity=0.336 Sum_probs=189.4
Q ss_pred eeeeecCceEEEEEEE----cCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 319 NFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l----~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++|+||+++++++. .+...++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ------TEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE------cCCEEEE
Confidence 5799999999999875 3588999999976432 22345788999999999999999999986 5568999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++.. ...+++...+.++.|++.||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 76 v~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg 143 (318)
T cd05582 76 ILDFLRGGDLFTRLSK---------EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG 143 (318)
T ss_pred EEcCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeecc
Confidence 9999999999998832 346899999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
+++...... .......||..|+|||.+....++.++|||||||++|||++|+.||..... .+...... .+
T Consensus 144 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~-~~ 213 (318)
T cd05582 144 LSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMIL-KA 213 (318)
T ss_pred CCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHH-cC
Confidence 988654332 223346799999999999988899999999999999999999999864321 01111111 11
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~e 600 (683)
.. .+ +......+..++..|++.||++||++.+
T Consensus 214 ~~------~~----------p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 KL------GM----------PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC------CC----------CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 01 1112335667889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=350.81 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=205.1
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.+...++|...++||+|+||+||+++. .+|+.||||++..... .....+.+|+.++..++|+|++++...+......
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344457999999999999999999985 4789999999865432 2345688999999999999999988776533211
Q ss_pred --CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 385 --ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 385 --~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
......++||||+++|+|.+++.... .....+++.....|+.|++.||.||| +.+|+||||||+|||++.
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~-----~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~ 178 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRA-----KTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCS 178 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhh-----ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeC
Confidence 11224689999999999999985322 12346888999999999999999999 899999999999999999
Q ss_pred CCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 463 DMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
++.+||+|||+++....... .......||+.|+|||++....++.++|||||||++|||++|+.||.... .
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~ 250 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------M 250 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------H
Confidence 99999999999987643322 22345679999999999999999999999999999999999999986321 1
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+.... ...+.. ++ + +......+..++..|++.+|.+||++.+++++
T Consensus 251 ~~~~~~-~~~~~~----~~-~----------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHK-TLAGRY----DP-L----------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHH-HhcCCC----CC-C----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 112211 111211 11 1 11223467789999999999999999999764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.22 Aligned_cols=255 Identities=31% Similarity=0.463 Sum_probs=202.1
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||++...+ +..|++|.+....... .+.+.+|++++..++|+|++++++++. .+...++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT------EEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec------CCCceEEE
Confidence 369999999999999764 7889999987654433 567999999999999999999999986 46789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++++|.+++..............++|..+++++.+++.||+||| +.+|+||||||+||++++++.+||+|||.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccc
Confidence 999999999999854211000011367999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 474 AKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 474 a~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
++....... .......++..|+|||.+....++.++||||+|++++||++ |+.|+..... ...++....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~ 222 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------EEVLEYLRK 222 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHHc
Confidence 987654332 22334567899999999998899999999999999999999 6888865421 111222222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+... . .+......+..++..|++.+|.+|||+.|+++.|+
T Consensus 223 ~~~~-----~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRL-----P----------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCC-----C----------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1110 0 11122456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=323.53 Aligned_cols=267 Identities=27% Similarity=0.430 Sum_probs=203.2
Q ss_pred HHhcCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDG 382 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~ 382 (683)
..+++|+..++||+|+||.||+|...+ +..||+|.+..... .....+.+|+.++++++|+|++++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--- 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--- 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 456789999999999999999997542 45799998764332 22346889999999999999999999986
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCC-CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDG-SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.....++||||+++|+|.+++....... .......+++..+++++.|++.||.||| +.+|+||||||+|||++
T Consensus 80 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~ 153 (288)
T cd05061 80 ---KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVA 153 (288)
T ss_pred ---CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEc
Confidence 4567899999999999999995422110 1112345677788899999999999999 89999999999999999
Q ss_pred cCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCcc
Q 005691 462 ADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRAC 539 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~ 539 (683)
+++.+||+|||+++........ ......++..|+|||++..+.++.++|||||||+++||++ |..|+.....
T Consensus 154 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------ 227 (288)
T cd05061 154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------ 227 (288)
T ss_pred CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 9999999999999865432221 1222345778999999999999999999999999999999 6778753211
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.++.. ....+...+ . +......+.+++..|++.+|++||||.++++.|+...
T Consensus 228 --~~~~~-~~~~~~~~~-----~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 228 --EQVLK-FVMDGGYLD-----Q----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred --HHHHH-HHHcCCCCC-----C----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111 111111100 0 1112346788999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=321.48 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=202.2
Q ss_pred cCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
+++...++||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~ 78 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT------E 78 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe------c
Confidence 45677889999999999999742 35689999887665555678999999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCC------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFND------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
+...+++|||+++|+|.+++...... ........++|..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~ 155 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLV 155 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEE
Confidence 56789999999999999998543211 01112246899999999999999999999 8999999999999999
Q ss_pred ccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCc
Q 005691 461 DADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRA 538 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~ 538 (683)
++++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---- 231 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---- 231 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----
Confidence 9999999999999875543221 12233445788999999999999999999999999999998 88887532211
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.... ...+...+ .+......+.+++..|++.+|++||++.+|++.|+.
T Consensus 232 ----~~~~~-~~~~~~~~---------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 232 ----EAIEC-ITQGRELE---------------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HHHHH-HHcCccCC---------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111 11111100 011123456789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=327.02 Aligned_cols=244 Identities=26% Similarity=0.343 Sum_probs=190.5
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHH---HhccCCCcccccceeeecCCCCCC
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEII---SNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL---~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
|...+.||+|+||.||+|... +|+.||||++.... ....+.+..|++++ +.++||||+++++++. .+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~------~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ------TE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE------cC
Confidence 566789999999999999865 68999999997542 22234566776665 5668999999999986 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|..++. ...+++...+.++.+++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 75 ~~~~lv~E~~~~~~L~~~~~----------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHIH----------TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred CEEEEEEcCCCCCcHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEE
Confidence 78999999999999988872 246899999999999999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....
T Consensus 142 L~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~ 212 (324)
T cd05589 142 IADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDS 212 (324)
T ss_pred eCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 99999987543222 1233467999999999999999999999999999999999999998643211 11111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
+..+.. .. +......+.+++..|++.||.+||+ +.++++
T Consensus 213 -i~~~~~------~~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 213 -IVNDEV------RY----------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -HHhCCC------CC----------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 111111 01 1112345678899999999999994 566554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.88 Aligned_cols=267 Identities=24% Similarity=0.366 Sum_probs=202.4
Q ss_pred CcccceeeeecCceEEEEEEEc-----CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-----DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-----~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.|...+.||+|+||.||++++. ++..||||.+...... ..++|.+|+++++.++|+||+++++++... .+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~----~~ 80 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP----GG 80 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC----CC
Confidence 4566788999999999999864 3678999998765443 356799999999999999999999988632 24
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++... ...++|..++.++.+++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRH--------RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVK 149 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhC--------ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEE
Confidence 5789999999999999999432 235999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 468 VADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 468 LaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|+|||++......... ......++..|+|||+.....++.++||||||++++||++|+.|+........ .++
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~------~~~ 223 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL------RMI 223 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhc------ccc
Confidence 9999999876533221 12223456779999999988999999999999999999999998764322110 000
Q ss_pred hh---hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WS---LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~---~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. ......+.+.+....... .+......+.+++.+|++.+|++||||.||+++|+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 224 GIAQGQMIVTRLLELLKEGERLP------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred ccccccccHHHHHHHHHcCCcCC------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 00 000000011111111000 111223567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=316.57 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=193.6
Q ss_pred eeeecCceEEEEEEEc---CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEe
Q 005691 320 FIGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
.||+|+||.||+|++. ++..||+|.+...... ..++|.+|++++++++|+||++++|++. ....++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-------~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-------AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-------CCCeEEEEE
Confidence 3899999999999864 3557999988654332 2456999999999999999999999873 346899999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
|+++|+|.+++.. ....+++..+++++.+++.||+||| +.+++||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 75 MASGGPLNKFLSG--------KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred eCCCCCHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccc
Confidence 9999999999842 1346899999999999999999999 8899999999999999999999999999998
Q ss_pred ccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 476 QSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 476 ~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
......... .+...++..|+|||++....++.++||||||+++||+++ |+.|+..... .+ +...+..+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~-~~~~~~~~ 214 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PE-VMSFIEQG 214 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HH-HHHHHHCC
Confidence 654433221 122234678999999988889999999999999999996 9999864321 11 12222222
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
...+ . +......+.+++..|++.+|++||++.+|.+.|+.
T Consensus 215 ~~~~-----~----------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 215 KRLD-----C----------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCC-----C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 2110 0 01123456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.82 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=186.8
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+.||+|+||.||+|+.. +++.||||.+.... ....+.+..|..++..+ +||||+++++++. .+...++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~------~~~~~~lv 74 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ------TKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE------cCCEEEEE
Confidence 36999999999999975 57889999987532 22334566777777654 8999999999886 55689999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~gg~L~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~ 142 (316)
T cd05592 75 MEYLNGGDLMFHIQS---------SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGM 142 (316)
T ss_pred EcCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcC
Confidence 999999999988832 246888899999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..... ....
T Consensus 143 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i-~~~~ 212 (316)
T cd05592 143 CKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSI-LNDR 212 (316)
T ss_pred CeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HcCC
Confidence 98653322 223446799999999999999999999999999999999999999864321 0111111 1110
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
+.+ +......+..++..|++.+|++||++.+.+
T Consensus 213 ------~~~----------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 213 ------PHF----------PRWISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred ------CCC----------CCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 111 111223456788899999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=318.50 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=197.3
Q ss_pred CcccceeeeecCceEEEEEEEcC-C---cEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQD-G---TTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~-g---~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.|...+.||+|+||.||+|.... + ..||||.+.... .....+|..|+.+++.++|||++++++++. .+.
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~------~~~ 78 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT------KSR 78 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC------CCC
Confidence 46778899999999999999753 3 369999986542 223457999999999999999999999986 556
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl 147 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQN--------DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKV 147 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEE
Confidence 789999999999999998321 246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccc--ccccc--CCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 469 ADFGLAKQSREGQSHL--TTRVA--GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 469 aDFGla~~~~~~~~~~--~~~~~--GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
+|||+++......... ..... .+..|+|||++..+.++.++||||||+++||+++ |+.||..... ..+..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~ 222 (269)
T cd05065 148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVIN 222 (269)
T ss_pred CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHH
Confidence 9999988654332211 11112 2457999999999999999999999999999886 9999864321 11112
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
++ ..+. .+. .+.+....+.+++..|++.+|.+||+|.+|+.+|+.
T Consensus 223 ~i----~~~~-------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 223 AI----EQDY-------RLP--------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred HH----HcCC-------cCC--------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 21 1110 000 111223456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.35 Aligned_cols=264 Identities=24% Similarity=0.380 Sum_probs=201.4
Q ss_pred cCcccceeeeecCceEEEEEEE-----cCCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-----QDGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-----~~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
+.|...+.||+|+||.||++.+ .++..||+|.+.... ....+.+.+|++++++++|+|++++.+++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED----G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC----C
Confidence 3567788999999999999984 357889999986543 23345799999999999999999999998632 2
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++++|.+++... ...++|..++.++.+++.||+||| +.+|+||||||+||++++++.+
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 148 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRN--------KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 148 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCE
Confidence 35689999999999999998321 235899999999999999999999 8999999999999999999999
Q ss_pred EEcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCC-------CC
Q 005691 467 RVADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS-------PR 537 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~-------~~ 537 (683)
||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++|+.|........ ..
T Consensus 149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd05079 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228 (284)
T ss_pred EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence 99999999876543221 2233557788999999998899999999999999999999887643211100 00
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.... .........+.... .+......+.+++..|++.+|++|||+.++++.|+.
T Consensus 229 ~~~~-~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 229 QMTV-TRLVRVLEEGKRLP---------------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred cccH-HHHHHHHHcCccCC---------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0001 11111111111100 111234578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=316.98 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=198.7
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|...+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++|+||+++++++. .+...+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~------~~~~~~ 82 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL------SREKLW 82 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE------eCCEEE
Confidence 4688889999999999999996 468899999987655445567889999999999999999999987 456889
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|+||+++++|.+++.. ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 83 iv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV---------TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcC
Confidence 99999999999998832 246889999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|+++....... ......|+..|+|||.+. ...++.++|||||||+++||++|+.|+........ ...
T Consensus 151 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~~~----- 220 (267)
T cd06646 151 GVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFL----- 220 (267)
T ss_pred ccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----hee-----
Confidence 99986543221 122346889999999874 45578899999999999999999999853322110 000
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
+..... ..+.... .......+.+++..|++.+|++|||++++++.|
T Consensus 221 ~~~~~~---~~~~~~~--------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 221 MSKSNF---QPPKLKD--------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred eecCCC---CCCCCcc--------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 0011110 112234677889999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=327.23 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=191.0
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+|+.. +++.||||.+.... ....+.+..|.+++..+ +||||+++++++. .....++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~------~~~~~~lv 74 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ------TKDRLFFV 74 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE------cCCeEEEE
Confidence 36999999999999975 47899999987542 22334578899999876 7999999999986 55679999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++..+..++.+++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~E~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~ 142 (321)
T cd05591 75 MEYVNGGDLMFQIQR---------SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGM 142 (321)
T ss_pred EeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeeccc
Confidence 999999999988832 346889999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++....... ......||..|+|||++....++.++|||||||++|||++|+.||...... +.... ...+.
T Consensus 143 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~-i~~~~ 212 (321)
T cd05591 143 CKEGILNGV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFES-ILHDD 212 (321)
T ss_pred ceecccCCc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHH-HHcCC
Confidence 875432222 233467999999999999989999999999999999999999999743221 11111 11111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-------TISDALKM 604 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-------tm~eVl~~ 604 (683)
. .. +......+..++..|++.||++|| ++.++++.
T Consensus 213 ~---~~-------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 V---LY-------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C---CC-------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 00 111223567888999999999999 77887643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=323.88 Aligned_cols=201 Identities=25% Similarity=0.390 Sum_probs=168.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|+++++.++|+||+++++++. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH------TKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe------cCCe
Confidence 467889999999999999999976 6889999998654332 2346789999999999999999999986 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++ ++|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDK--------HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEEECCC-cCHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence 999999996 577777632 1245888899999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
|||+++...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 146 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 146 DFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999987543222 12234568999999998865 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.44 Aligned_cols=268 Identities=22% Similarity=0.363 Sum_probs=200.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-----------------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccc
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-----------------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPL 374 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-----------------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L 374 (683)
++|+..++||+|+||.||++... ++..||+|++..... ....+|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 234689999875432 234679999999999999999999
Q ss_pred cceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCC--CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccC
Q 005691 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG--SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRD 452 (683)
Q Consensus 375 ~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~--~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrD 452 (683)
++++. .....++||||+++|+|.+++....... .......++|.+.+.++.+++.||+||| +.+|+|||
T Consensus 85 ~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~d 155 (296)
T cd05095 85 LAVCI------TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRD 155 (296)
T ss_pred EEEEe------cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeeccc
Confidence 99987 4567899999999999999985432111 0122345888999999999999999999 88999999
Q ss_pred CCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh--CCCCCC
Q 005691 453 IKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC--GRKALD 529 (683)
Q Consensus 453 IKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt--Gr~p~~ 529 (683)
|||+|||++.++.+||+|||+++........ ...+..++..|+|||....+.++.++|||||||++|||++ |..|+.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999865433221 2233445678999999988999999999999999999998 666765
Q ss_pred CCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 530 LSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 530 ~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
..... ............... ....+ .+..+...+.+++.+|++.||++||+|.+|++.|+
T Consensus 236 ~~~~~-----~~~~~~~~~~~~~~~-~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 236 QLSDE-----QVIENTGEFFRDQGR-QVYLP-----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccChH-----HHHHHHHHHHhhccc-cccCC-----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 32211 111111111111100 00000 01112356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=317.20 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=200.4
Q ss_pred cCcccceeeeecCceEEEEEEEcCC----cEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDG----TTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g----~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...++||+|+||.||+|+..+. ..||||+..... .+..+.+.+|+.++++++|+|++++++++. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-------~ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-------E 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc-------C
Confidence 4577888999999999999986532 468999876544 334567999999999999999999999884 3
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ...++|..++.++.+++.||+||| +.+++||||||+||+++.++.+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVN--------KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeE
Confidence 4578999999999999998321 235899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+++..........+...++..|+|||++....++.++||||||++++|+++ |+.||......+ ...+
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~-- 220 (270)
T cd05056 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----VIGR-- 220 (270)
T ss_pred EccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHH--
Confidence 99999998765443333333445678999999988889999999999999999986 999986433211 1111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
...+.... . +......+.+++..|+..+|++|||+.++++.|++.
T Consensus 221 --~~~~~~~~-----~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 221 --IENGERLP-----M----------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred --HHcCCcCC-----C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111100 0 112234677889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=336.57 Aligned_cols=246 Identities=29% Similarity=0.383 Sum_probs=206.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...+.||+|.||+||||+.+ +.+.||+|.+.+.... ..+.+.+|++|+++++|||||.++.++. ...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE------t~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE------TSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc------ccce
Confidence 56777889999999999999965 5788999988664332 2456889999999999999999999986 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++|.||+.+ +|..+|.. ...|+++....|+.++..||.||| +.+|+|||+||.||||+.++.+|++
T Consensus 76 ~~vVte~a~g-~L~~il~~---------d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klc 142 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQ---------DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLC 142 (808)
T ss_pred EEEEehhhhh-hHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeec
Confidence 9999999977 99999932 357999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+||.... .+++.+.+.||+-|||||.+.++.|+..+|.||+||++||+++|++||-. ..+.+.+....
T Consensus 143 dFg~Ar~m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------~si~~Lv~~I~ 213 (808)
T KOG0597|consen 143 DFGLARAMST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------RSITQLVKSIL 213 (808)
T ss_pred hhhhhhhccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------HHHHHHHHHHh
Confidence 9999998765 45567789999999999999999999999999999999999999999853 22333333322
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+. - ..+......+..+...-++.||..|-|-.+++.
T Consensus 214 ~d~--------v---------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KDP--------V---------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCC--------C---------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 221 1 133355667888888899999999999998864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=323.48 Aligned_cols=264 Identities=27% Similarity=0.437 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc--------CCcEEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ--------DGTTVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
.++|...+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+.+++.+ +|+||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-- 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence 457778899999999999999741 34579999886532 23346789999999999 8999999999986
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCC-------CCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGS-------GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~-------~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.....++||||+++|+|.+++........ ......++|.+++.++.|++.||.||| +.+|+|||||
T Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlk 164 (304)
T cd05101 92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLA 164 (304)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccc
Confidence 45678999999999999999854321100 012346889999999999999999999 8899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+|||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |..|+....
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876543322 2233456788999999998889999999999999999998 777775321
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..++ .+....+.... .+......+..++..|++.+|.+||||.+|++.|++.
T Consensus 245 --------~~~~-~~~~~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 245 --------VEEL-FKLLKEGHRMD---------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred --------HHHH-HHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1112 22222221100 0112234677889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.98 Aligned_cols=200 Identities=24% Similarity=0.384 Sum_probs=170.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|||||++++++. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~------~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ------DAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE------cCC
Confidence 46888899999999999999864 68899999986532 222456889999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. .+.+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~---------~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl 142 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIK---------YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKL 142 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEE
Confidence 89999999999999999832 246888888999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCc----------------------------------------------cccccccCCCcccCcccccc
Q 005691 469 ADFGLAKQSREGQS----------------------------------------------HLTTRVAGTHGYLAPEYALY 502 (683)
Q Consensus 469 aDFGla~~~~~~~~----------------------------------------------~~~~~~~GT~~Y~APE~~~~ 502 (683)
+|||+++....... .......||++|+|||++.+
T Consensus 143 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (377)
T cd05629 143 SDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222 (377)
T ss_pred eecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc
Confidence 99999963321000 00112469999999999999
Q ss_pred CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 503 GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 503 ~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
..++.++|||||||++|||++|+.||..
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 223 QGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred CCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 9999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.00 Aligned_cols=265 Identities=25% Similarity=0.383 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccCh-HHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGD-AEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~-~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...++||.|.||.||+|+- .+|..||||++++.-..-+ --=++||..|++|. |||||+|..++.. ...
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d-----~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD-----NDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc-----cCc
Confidence 45778888999999999999995 4689999999977544322 22468999999998 9999999999873 222
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
.+++|||||+. +|.+.+.+ +++.++...++.|+.||.+||+|+| +.|+.|||+||+|||+..+..+||
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~--------R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKi 151 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKD--------RNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKI 151 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhh--------cCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEe
Confidence 89999999964 88888732 2568999999999999999999999 999999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccc-cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+||..... ...|.++.|..|+|||++. .+.|+.+.|||++|||++||.+-++-|....+.+ .+++
T Consensus 152 aDFGLARev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--------qi~K 221 (538)
T KOG0661|consen 152 ADFGLAREVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--------QIYK 221 (538)
T ss_pred cccccccccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--------HHHH
Confidence 999999976543 2345678899999999876 6789999999999999999999998886433321 1222
Q ss_pred hhh-----------cC-ccccccC---ccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 548 LVK-----------AG-KVWQALD---PSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 548 ~~~-----------~g-~l~e~vD---~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
..+ +| .+...+. |...+. +....-+. ....+++++..|++.||.+|||+.|.+++-
T Consensus 222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~-~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPS-PLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHhCCCccccchhHHHHHHHhccCCCcCCCC-ChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111 11 0000111 111110 00001111 456788999999999999999999998764
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=319.06 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=199.8
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCc----EEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGT----TVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~----~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...++||+|+||+||+|.. .+|+ .||+|.+...... ..+++.+|+.++..++|+|+++++|++.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------- 79 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL------- 79 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc-------
Confidence 5678889999999999999985 3454 4899988654332 3457899999999999999999999985
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++++||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~~--------~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~ 148 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVREN--------KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHV 148 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcE
Confidence 24578999999999999998432 246899999999999999999999 8999999999999999999999
Q ss_pred EEcccCcccccccCCccc-cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++......... .....++..|+|||...+..++.++||||||+++|||++ |..|++.... ..+..+
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~ 223 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDL 223 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH
Confidence 999999998765433221 222345678999999999999999999999999999998 8888864221 112111
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+..+.... .+......+..++..|++.||+.||++.++++.|+...
T Consensus 224 ----~~~~~~~~---------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 224 ----LEKGERLP---------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ----HHCCCcCC---------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 22221100 00112345678899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.80 Aligned_cols=249 Identities=31% Similarity=0.420 Sum_probs=197.9
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||++... |..||+|.+.... ..+.|.+|+.++++++|+|+++++|++.. .+...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE-----EKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEc-----CCCceEE
Confidence 46788899999999999999876 7889999875432 34579999999999999999999998753 3456899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
|+||+++|+|.+++... ....++|..+++++.+++.||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg 147 (256)
T cd05082 78 VTEYMAKGSLVDYLRSR-------GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFG 147 (256)
T ss_pred EEECCCCCcHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCc
Confidence 99999999999998432 1235889999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++...... ....++..|+|||++....++.++||||||+++|||++ |+.|+.... +.+.... ...
T Consensus 148 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~-~~~ 214 (256)
T cd05082 148 LTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPR-VEK 214 (256)
T ss_pred cceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-Hhc
Confidence 987643322 22345678999999998899999999999999999998 888875321 1112111 111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. +.+ +......+..++..|++.+|++|||+.++++.|+.
T Consensus 215 ~~~-----~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 215 GYK-----MDA----------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCC-----CCC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 111 001 11123456788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=325.93 Aligned_cols=241 Identities=22% Similarity=0.331 Sum_probs=190.5
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+|...+.||+|+||.||+|+.. +++.||||.+..... ...+.+..|..++..+ +|++|+++.+++. ..+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~------~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ------TMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe------cCC
Confidence 4778899999999999999976 577999999876432 2234567788888877 5889999998886 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEE
Confidence 89999999999999988832 246889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... ......||+.|+|||++....++.++|||||||++|||++|+.||..... ..+ . ..
T Consensus 143 ~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~---~-~~ 212 (323)
T cd05616 143 ADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DEL---F-QS 212 (323)
T ss_pred ccCCCceecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHH---H-HH
Confidence 99999975432221 23346799999999999999999999999999999999999999964321 111 1 11
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
+..+.. . .+......+..++..|++.+|.+|++.
T Consensus 213 i~~~~~------~----------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 213 IMEHNV------A----------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhCCC------C----------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111111 0 111223466789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=334.31 Aligned_cols=272 Identities=23% Similarity=0.306 Sum_probs=196.8
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..++||+|+||.||++... +|+.||||++.... ....+.+.+|+++++.++|+||+++++++..... ......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI-DPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc-cccceE
Confidence 4778899999999999999964 78999999986532 2234568899999999999999999999863221 112368
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++|+||+. ++|.+++. ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~~~---------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 80 YVVTELMQ-SDLHKIIV---------SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred EEEeeccc-cCHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecc
Confidence 99999997 57777662 2346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+++..........+...+|..|+|||++.+. .++.++|||||||+++||++|+.||........ ..-+....
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----~~~i~~~~ 221 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ-----LDLITDLL 221 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHHHc
Confidence 999987654433334445689999999998764 579999999999999999999999964332110 00000000
Q ss_pred hcCcc----------ccccCccccccccc--cCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 550 KAGKV----------WQALDPSLLKEDDF--LSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 550 ~~g~l----------~e~vD~~l~~~~~~--~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..... ...+.......... ......+..+.+.+++..|++.||++|||+.|+++.
T Consensus 222 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 222 GTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 00000000000000 000001123467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=326.60 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=201.6
Q ss_pred hcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||++... ++..||||++..... ...+.+.+|+++++++ +|+||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---- 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT---- 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence 357888999999999999999742 345799998865432 2245689999999999 7999999999986
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.....++||||+++|+|.+++.... ...++|.+++.++.+++.||+||| +.+|+|+||||+|||++.+
T Consensus 110 --~~~~~~lv~e~~~~~~L~~~i~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 110 --IGGPILVITEYCCYGDLLNFLRRKR-------ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHG 177 (302)
T ss_pred --cCCceEEEEEcCCCCcHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCC
Confidence 4567899999999999999984321 234899999999999999999999 8899999999999999999
Q ss_pred CcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccch
Q 005691 464 MRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLI 541 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l 541 (683)
+.+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ |+.|+....... .+
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~ 253 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KF 253 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HH
Confidence 99999999999866443221 1223446788999999999999999999999999999998 999886432210 11
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+....+.. + . .+.....++.+++..|++.+|++|||+.||++.|+.
T Consensus 254 ----~~~~~~~~~-----~----~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 254 ----YKLIKEGYR-----M----A------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ----HHHHHcCCc-----C----C------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 111111110 0 0 011123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.39 Aligned_cols=236 Identities=23% Similarity=0.357 Sum_probs=187.9
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+++.. +++.||||++.... ....+.+..|..++..+ +||||+++++++. .....++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~------~~~~~~iv 74 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ------TPDRLFFV 74 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE------cCCEEEEE
Confidence 36999999999999975 58899999987532 22345678899999877 6999999999986 56789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~Ey~~~g~L~~~i~~---------~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~ 142 (320)
T cd05590 75 MEFVNGGDLMFHIQK---------SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM 142 (320)
T ss_pred EcCCCCchHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCC
Confidence 999999999988832 346889999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||+.|+|||++....++.++|||||||++|||++|+.||..... .+. ...+..+.
T Consensus 143 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~-~~~i~~~~ 212 (320)
T cd05590 143 CKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDL-FEAILNDE 212 (320)
T ss_pred CeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHH-HHHHhcCC
Confidence 87543222 123346799999999999999999999999999999999999999964321 111 11111211
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
. .. +......+.+++..|++.||++||++
T Consensus 213 ~---~~-------------~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 V---VY-------------PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C---CC-------------CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 00 11123456788899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=315.18 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=198.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-----ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-----GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||.||++... +++.||+|.+...... ..+.+.+|++++++++|+||+++++++. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR------D 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc------c
Confidence 57888999999999999999864 6899999998654221 2346889999999999999999999986 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++|+||+++++|.+++.. ...+++....+++.+++.||.||| +.+|+||||||+||++++++.+
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKA---------YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHH---------hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 5689999999999999998832 246888999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCcccc--ccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSHLT--TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~--~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++.......... ....|+..|+|||++.+..++.++||||||+++|||++|+.||...... .-
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~ 215 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AA 215 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HH
Confidence 9999999976543222111 3456888999999999989999999999999999999999998642210 00
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
......... .+.+ +......+..++..|++.+|.+|||+.++++.
T Consensus 216 ~~~~~~~~~-----~~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 IFKIATQPT-----NPQL----------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHhccCC-----CCCC----------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111110 0111 11223456788899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.84 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=170.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.+|...+.||+|+||.||+++.. +++.||||.+..... .....+.+|++++++++|+||+++++.+. .+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~------~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ------DKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE------cCC
Confidence 36888999999999999999965 588999999865322 23456889999999999999999999886 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~---------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIR---------LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEE
Confidence 89999999999999999832 245788888899999999999999 899999999999999999999999
Q ss_pred cccCcccccccC------------------------------------------CccccccccCCCcccCccccccCCCC
Q 005691 469 ADFGLAKQSREG------------------------------------------QSHLTTRVAGTHGYLAPEYALYGQLT 506 (683)
Q Consensus 469 aDFGla~~~~~~------------------------------------------~~~~~~~~~GT~~Y~APE~~~~~~~s 506 (683)
+|||+|..+... .........||+.|||||++....++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 999997532100 00011235799999999999999999
Q ss_pred ccccEEEcchhHHHHhhCCCCCCCC
Q 005691 507 EKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 507 ~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
.++|||||||++|||++|+.||...
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCC
Confidence 9999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.03 Aligned_cols=250 Identities=30% Similarity=0.432 Sum_probs=190.8
Q ss_pred eeeeecCceEEEEEEEcC----CcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQD----GTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+|+..+ +..||+|++.... ....+.+.+|+.+++.++|||++++++++.. .+...++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP-----SEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec-----CCCCcEEE
Confidence 368999999999998642 4579999875432 2334678899999999999999999998763 23457899
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
+||+++|+|.+++... ...+++..++.++.+++.||+||| +.+++||||||+|||+++++.+||+|||+
T Consensus 76 ~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 76 LPYMKHGDLRNFIRSE--------THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred EecCCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccc
Confidence 9999999999998422 234677888999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCc---cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCC-CCCCCCCCCCCCccchhhhhhhhh
Q 005691 474 AKQSREGQS---HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR-KALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 474 a~~~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr-~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
++....... .......++..|+|||++....++.++||||||+++|||++|. .|+..... . +.....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~---~~~~~~- 215 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----F---DITVYL- 215 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----H---HHHHHH-
Confidence 976543221 1122345678899999999889999999999999999999965 45532211 1 111111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..+... . .+......+.+++..|++.+|++||++.+|++.|+..
T Consensus 216 ~~~~~~-----~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 216 LQGRRL-----L----------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred hcCCCC-----C----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111100 0 0111234677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.13 Aligned_cols=266 Identities=26% Similarity=0.364 Sum_probs=201.3
Q ss_pred hcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +|+||++++++|..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK--- 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence 35788899999999999999973 35788999998654322 245688999999999 78999999998863
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCC--------------------------------------------------
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDG-------------------------------------------------- 413 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------------------------------------------------- 413 (683)
.+...++||||+++|+|.+++.......
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 83 --PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred --CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 3456799999999999999885421000
Q ss_pred --------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCcc-c
Q 005691 414 --------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH-L 484 (683)
Q Consensus 414 --------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~ 484 (683)
.......++|..+.+++.|+++||+||| +.+|+||||||+|||+++++++||+|||+++........ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 0001235788999999999999999999 899999999999999999999999999999865432221 1
Q ss_pred cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCcccc
Q 005691 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLL 563 (683)
Q Consensus 485 ~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~ 563 (683)
.....++..|+|||++....++.++||||||+++|||++ |..|+...... .........+.... .
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-----~- 303 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRMR-----A- 303 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHHHHhccCCCC-----C-
Confidence 223446778999999998999999999999999999997 88887542211 01111122221110 0
Q ss_pred ccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 564 KEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 564 ~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+......+.+++..|++.+|++|||+.+|++.|+..
T Consensus 304 ---------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 304 ---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011123567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=341.27 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=204.4
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccC-hHHHHHHHHHHHhcc-CCCcccccceeee
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQG-DAEFCNEVEIISNLK-HRNLVPLRGCCVV 380 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~ 380 (683)
+...++|...++||+|+||.||+|++. .+..||||++....... .+.+.+|++++.++. |+|||+++|+|.
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~- 111 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT- 111 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc-
Confidence 344456778889999999999999864 24689999997643332 346889999999997 999999999997
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCC-----------------------------------------------
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG----------------------------------------------- 413 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~----------------------------------------------- 413 (683)
.....++|+||+++|+|.++++......
T Consensus 112 -----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 112 -----KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred -----cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 4567899999999999999986432100
Q ss_pred ------------------------------------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcccc
Q 005691 414 ------------------------------------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451 (683)
Q Consensus 414 ------------------------------------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHr 451 (683)
.......++|...++|+.+++.||+||| +.+|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcc
Confidence 0011235788888999999999999999 8899999
Q ss_pred CCCCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCC
Q 005691 452 DIKATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALD 529 (683)
Q Consensus 452 DIKpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~ 529 (683)
||||+|||+++++.+||+|||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.|+.
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999986543222 12223457889999999998899999999999999999998 888875
Q ss_pred CCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 530 LSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 530 ~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..... +........+.. +. .+......+.+++..|++.+|.+||++++|++.|+..
T Consensus 344 ~~~~~--------~~~~~~~~~~~~-----~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 344 ELPMN--------EQFYNAIKRGYR-----MA----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCch--------HHHHHHHHcCCC-----CC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 43211 111121222210 00 0111234677888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.27 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=202.8
Q ss_pred cCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++|.....||+|+||.||+|+.. +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR------ 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC------
Confidence 57888889999999999999964 3467999987654433 3467999999999999999999999986
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++||||+++|+|.+++..............++|..++.++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCc
Confidence 45678999999999999999854332111112336899999999999999999999 889999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
+||+|||+++..............++..|+|||.+..+.++.++||||||++++||++ |..||...... .
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~- 226 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------E- 226 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------H-
Confidence 9999999987543332222333456788999999998889999999999999999999 77787532210 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+......+...... +......+.+++..|++.+|++||++.+++.+|+
T Consensus 227 ~~~~~~~~~~~~~~--------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 VLNRLQAGKLELPV--------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHcCCcCCCC--------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11112222221100 1112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.38 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=191.0
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||++... +++.||+|++..... ...+.+.+|+.++.++ +|+||+++++++. .....++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~------~~~~~~lv 74 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ------TTSRLFLV 74 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE------eCCEEEEE
Confidence 36999999999999975 578999999976432 2234588999999888 6999999999886 55689999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++. ..+.+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~~~---------~~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (327)
T cd05617 75 IEYVNGGDLMFHMQ---------RQRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGM 142 (327)
T ss_pred EeCCCCCcHHHHHH---------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEecccc
Confidence 99999999998873 2346999999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+....... ....++..+....+.
T Consensus 143 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 219 (327)
T cd05617 143 CKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEKP 219 (327)
T ss_pred ceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHHHhCC
Confidence 87532221 123346799999999999999999999999999999999999999965332211 122234444333221
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
.. + +......+.+++..|++.||++||++
T Consensus 220 ~~------~----------p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 220 IR------I----------PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CC------C----------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 10 0 11123356788899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=320.41 Aligned_cols=263 Identities=27% Similarity=0.451 Sum_probs=202.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|+..+.||+|+||.||++... ++..||+|++..... ....+|.+|+.++++++|+|++++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----- 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA----- 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence 467888999999999999999864 467899998865432 23456999999999999999999999986
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCC-------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcccc
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDG-------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHr 451 (683)
.+...++||||+++|+|.+++....... .......+++..++.++.+++.||+||| +.+++||
T Consensus 79 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~ 154 (288)
T cd05050 79 -VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHR 154 (288)
T ss_pred -CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 4567899999999999999985321100 0112245889999999999999999999 8899999
Q ss_pred CCCCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCC
Q 005691 452 DIKATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALD 529 (683)
Q Consensus 452 DIKpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~ 529 (683)
||||+||++++++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..|+.
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876533221 11222345678999999998999999999999999999998 887874
Q ss_pred CCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 530 LSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 530 ~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.... .++. .....+.... .+.....++.+++.+|++.+|++|||+.|+++.|+.
T Consensus 235 ~~~~--------~~~~-~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 235 GMAH--------EEVI-YYVRDGNVLS---------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCH--------HHHH-HHHhcCCCCC---------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 3211 1111 1222222211 011223467889999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=323.56 Aligned_cols=261 Identities=29% Similarity=0.408 Sum_probs=197.7
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCc--EEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGT--TVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~--~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|+..+.||+|+||.||+|... ++. .+|+|++.... .....++.+|++++.++ +|+||+++++++. .+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~------~~ 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE------HR 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC------CC
Confidence 57888899999999999999975 444 45777765432 22345788999999999 8999999999986 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
...++|+||+++|+|.+++....... .......+++.+++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEe
Confidence 67999999999999999985432110 0112346899999999999999999999 8999999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCcc
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRAC 539 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~ 539 (683)
+.++.+||+|||+++...... ......++..|+|||++....++.++|||||||+++||+| |..||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----- 230 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----- 230 (303)
T ss_pred cCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----
Confidence 999999999999986432111 1122234678999999988889999999999999999998 99998532211
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+... ....+.. . . .+......+.+++..|++.+|++||++.+++++|+..
T Consensus 231 ---~~~~-~~~~~~~-------~--~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 231 ---ELYE-KLPQGYR-------L--E------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred ---HHHH-HHhcCCc-------C--C------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 1111100 0 0 0011233567899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=315.82 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=199.4
Q ss_pred cCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||+|+.. ++..+|+|.+..... ...+.|.+|+.++++++||||+++++++. .+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT------KS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe------cC
Confidence 46778899999999999999864 234799998865332 22457899999999999999999999986 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ...+++.+++.|+.+++.||+||| +.+++||||||+|||++.++.+|
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKH--------DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEE
Confidence 6789999999999999998421 246899999999999999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCcccc--ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 468 VADFGLAKQSREGQSHLT--TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~--~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
|+|||+++.......... ....++..|+|||++.++.++.++||||||++++|+++ |+.|+...... .+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~- 220 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIK- 220 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHH-
Confidence 999999987654333222 22334568999999999999999999999999999887 99998643221 1111
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
...++.- . + .+......+.+++..|++.+|.+||+|.+++++|+.
T Consensus 221 ---~~~~~~~--~--~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 221 ---AIEEGYR--L--P-----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---HHhCCCc--C--C-----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 1111110 0 0 011123456789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.11 Aligned_cols=240 Identities=23% Similarity=0.355 Sum_probs=188.3
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++. .....++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~------~~~~~~lv 74 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ------TKENLFFV 74 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE------eCCEEEEE
Confidence 36999999999999976 47899999987642 22344577788888764 9999999999986 45679999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++.+...++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~ey~~~g~L~~~l~~---------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05619 75 MEYLNGGDLMFHIQS---------CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGM 142 (316)
T ss_pred EeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCc
Confidence 999999999998832 246889999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... . + ..+....+.
T Consensus 143 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~---~-~~~~i~~~~ 212 (316)
T cd05619 143 CKENMLGDA-KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----E---E-LFQSIRMDN 212 (316)
T ss_pred ceECCCCCC-ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----H---H-HHHHHHhCC
Confidence 875432221 23346799999999999998999999999999999999999999864321 1 1 111111111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS-DAL 602 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~-eVl 602 (683)
+.+. ......+.+++..|++.||++||++. ++.
T Consensus 213 ------~~~~----------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 213 ------PCYP----------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ------CCCC----------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1110 11223566788999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.09 Aligned_cols=237 Identities=27% Similarity=0.345 Sum_probs=185.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHH-HHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVE-IISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~-iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+.||+|+||+||+|+.. +|+.||||++..... ....++..|.. +++.++||||+++++++. .....++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~------~~~~~~lv 74 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ------TADKLYFV 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE------eCCEEEEE
Confidence 36999999999999975 689999999875422 22334555555 567899999999999886 55689999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~~g~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~ 142 (323)
T cd05575 75 LDYVNGGELFFHLQR---------ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142 (323)
T ss_pred EcCCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCC
Confidence 999999999998832 346888999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.... ...+.
T Consensus 143 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~-i~~~~ 212 (323)
T cd05575 143 CKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDN-ILNKP 212 (323)
T ss_pred CcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHH-HHcCC
Confidence 87543222 223446799999999999999999999999999999999999999864221 111111 11111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS 599 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~ 599 (683)
. .+.. .....+.+++..|++.||.+||++.
T Consensus 213 ~------~~~~----------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 L------RLKP----------NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C------CCCC----------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 0111 1234567888999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=321.84 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=201.3
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+|...+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++. .+...+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~------~~~~~~ 93 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL------VGDELW 93 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE------eCCEEE
Confidence 4778888999999999999986 468899999987766566677999999999999999999999987 456899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|.+++. ...+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 94 VVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred EeecccCCCCHHHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999999883 235789999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+++........ .....|++.|+|||++....++.++|||||||++|||++|+.||....... +.......
T Consensus 161 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--------~~~~~~~~ 231 (296)
T cd06654 161 GFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATN 231 (296)
T ss_pred ccchhccccccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--------hHHHHhcC
Confidence 998765433221 223468899999999998889999999999999999999999996432211 11111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+. +.+. .+.+....+.+++..|++.+|++|||+.++++
T Consensus 232 ~~------~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 232 GT------PELQ--------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CC------CCCC--------CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11 0010 11223345678889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.82 Aligned_cols=204 Identities=24% Similarity=0.394 Sum_probs=162.5
Q ss_pred ceeeeecCceEEEEEEEc---CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 318 KNFIGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
..+||+|+||+||+|+.. +++.||+|++.... ....+.+|++++++++||||+++++++... .+...++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH----ADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC----CCcEEEEEE
Confidence 357999999999999965 46789999886532 234578999999999999999999988532 345689999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee----ccCCcEEEcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVAD 470 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL----d~~~~~KLaD 470 (683)
||+++ +|.+++..............+++...+.|+.|++.||.||| +.+|+||||||+|||+ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99864 77776632221111122345888999999999999999999 8899999999999999 4567999999
Q ss_pred cCcccccccCCcc--ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 471 FGLAKQSREGQSH--LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 471 FGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
||+++........ ......||+.|+|||++.+ ..++.++||||+||+++||++|++||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999876433221 2345678999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.34 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=195.1
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+|+..++||+|+||.||+|+. .+++.||+|.+.... .....++.+|++++++++|||++++++++. .....+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~~ 75 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF------VENRIS 75 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE------ECCEEE
Confidence 567788999999999999986 468899999986542 223456899999999999999999999987 456789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|..+. .+++.....++.+++.||.||| +.+|+|+||||+|||++.++.+||+||
T Consensus 76 lv~e~~~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~df 139 (279)
T cd06619 76 ICTEFMDGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDF 139 (279)
T ss_pred EEEecCCCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeC
Confidence 999999999987543 4678888899999999999999 899999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|++...... ......||..|+|||++....++.++||||||+++|||++|+.||......... .....+. +....
T Consensus 140 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~-~~~~~ 214 (279)
T cd06619 140 GVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLL-QCIVD 214 (279)
T ss_pred Ccceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHH-HHHhc
Confidence 999765432 123457899999999999889999999999999999999999998653322110 0000111 00000
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
. ..+.+.. ......+.+++..|++.+|++||++.++++.
T Consensus 215 ~-----~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 215 E-----DPPVLPV---------GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred c-----CCCCCCC---------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 0111111 1123456788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.26 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=199.6
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeee
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~ 380 (683)
+.+++...++|...+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~- 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ- 113 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 4455666789999999999999999999976 57889999986532 122345789999999999999999999886
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.+...++||||+++|+|.+++. ...++...+..++.+++.||+||| +.+|+||||||+|||+
T Consensus 114 -----~~~~~~lv~Ey~~gg~L~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll 175 (371)
T cd05622 114 -----DDRYLYMVMEYMPGGDLVNLMS----------NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLL 175 (371)
T ss_pred -----cCCEEEEEEcCCCCCcHHHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEE
Confidence 5678999999999999999883 234777888899999999999999 8999999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccC----CCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG----QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
+.++.+||+|||+++..............||+.|+|||++... .++.++|||||||++|||++|+.||.....
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--- 252 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--- 252 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---
Confidence 9999999999999987654333333456799999999998753 378999999999999999999999964221
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL--RPTISDALKML 605 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~--RPtm~eVl~~L 605 (683)
.................+ .......+..++..|++.++.+ ||++.++++..
T Consensus 253 -----~~~~~~i~~~~~~~~~~~-------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 253 -----VGTYSKIMNHKNSLTFPD-------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----HHHHHHHHcCCCcccCCC-------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111111111111100 1122345567778888744433 78999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.61 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=201.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc--------CCcEEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ--------DGTTVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
.++|...+.||+|+||.||++... ++..+|+|.+.... .....++..|++++.++ +|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-- 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence 367889999999999999999753 23579999887542 22345688999999999 7999999999986
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.....++||||+++|+|.+++....... .......++|.++++++.|++.||+||| +.+++|||||
T Consensus 95 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlk 167 (307)
T cd05098 95 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLA 167 (307)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCccccccc
Confidence 4567899999999999999995432110 0012346899999999999999999999 8899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.|+....
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999999998765432211 1222334578999999998889999999999999999998 888875321
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
. .+. ......+...+ .+......+.+++..|++.+|++||||.+|++.|+..
T Consensus 248 ~--------~~~-~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 248 V--------EEL-FKLLKEGHRMD---------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred H--------HHH-HHHHHcCCCCC---------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1 111 11122221110 1112234667889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.33 Aligned_cols=241 Identities=25% Similarity=0.348 Sum_probs=189.1
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCC-CcccccceeeecCCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHR-NLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~-NLV~L~G~c~~~~~~~~~~ 388 (683)
+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++|+ +|+++.+++. ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~------~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ------TMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE------cCC
Confidence 4778899999999999999976 46789999987532 23345688899999999765 5778887775 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 75 RLYFVMEYVNGGDLMYHIQQ---------VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred EEEEEEcCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEE
Confidence 79999999999999988832 346889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...
T Consensus 143 ~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~---~~~- 212 (324)
T cd05587 143 ADFGMCKENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DEL---FQS- 212 (324)
T ss_pred eecCcceecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHH---HHH-
Confidence 99999875322211 22345799999999999999999999999999999999999999964321 111 111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
...+.. .+ +......+.+++..|++.||.+||+.
T Consensus 213 i~~~~~------~~----------~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 IMEHNV------SY----------PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHcCCC------CC----------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111110 11 11123456788899999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.38 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=169.4
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
+|...++||+|+||.||+|+.. +++.||+|++..... .....+.+|++++++++|+|||++++.+. .+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~------~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ------DKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE------eCCE
Confidence 5888899999999999999964 688999999875432 22356889999999999999999999987 5568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~---------~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~ 143 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIR---------MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLT 143 (382)
T ss_pred EEEEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999998832 235788888899999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCC----------------------------------------------ccccccccCCCcccCccccccC
Q 005691 470 DFGLAKQSREGQ----------------------------------------------SHLTTRVAGTHGYLAPEYALYG 503 (683)
Q Consensus 470 DFGla~~~~~~~----------------------------------------------~~~~~~~~GT~~Y~APE~~~~~ 503 (683)
|||+++...... ........||+.|+|||++.+.
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 223 (382)
T cd05625 144 DFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223 (382)
T ss_pred ECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC
Confidence 999975331000 0011235799999999999999
Q ss_pred CCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 504 QLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 504 ~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
.++.++|||||||++|||++|+.||...
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 224 GYTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.48 Aligned_cols=239 Identities=23% Similarity=0.330 Sum_probs=184.9
Q ss_pred eeeecCceEEEEEEEcC-------------------------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccc
Q 005691 320 FIGRGGFGLVYKGILQD-------------------------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L 374 (683)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+++++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588998865544445678999999999999999999
Q ss_pred cceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 375 ~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
+|+|. .....++||||+++|+|+.++.. ....+++..+++++.|+++||+||| +.+|+|||||
T Consensus 82 ~~~~~------~~~~~~lv~ey~~~g~L~~~l~~--------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlk 144 (274)
T cd05076 82 HGVCV------RGSENIMVEEFVEHGPLDVCLRK--------EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVC 144 (274)
T ss_pred EEEEE------eCCceEEEEecCCCCcHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCC
Confidence 99997 45678999999999999998842 1346889999999999999999999 8899999999
Q ss_pred CCceeeccCC-------cEEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHh-hCC
Q 005691 455 ATNILLDADM-------RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIM-CGR 525 (683)
Q Consensus 455 psNILLd~~~-------~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELl-tGr 525 (683)
|+|||++.++ .+|++|||++...... ....++..|+|||++.. ..++.++||||||+++||++ +|+
T Consensus 145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred cccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999997654 3799999987643221 12357888999998875 56899999999999999994 788
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 526 KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 526 ~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.|+....... ...+ .... ..+.. .....+..++..|++.+|++||||.+|++.|
T Consensus 220 ~p~~~~~~~~-----~~~~----~~~~-------~~~~~----------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 220 VPLKERTPSE-----KERF----YEKK-------HRLPE----------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCccccChHH-----HHHH----HHhc-------cCCCC----------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 8886432211 1111 1110 00100 1123577899999999999999999999987
Q ss_pred h
Q 005691 606 E 606 (683)
Q Consensus 606 ~ 606 (683)
+
T Consensus 274 ~ 274 (274)
T cd05076 274 T 274 (274)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.45 Aligned_cols=241 Identities=23% Similarity=0.357 Sum_probs=191.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+.||+|+||.||+++.. +++.||||++.... ....+.+..|.+++..+ +|+||+++++++. .....++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~------~~~~~~lv 74 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ------TKDRLFFV 74 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE------cCCEEEEE
Confidence 36999999999999976 47899999997642 22345577899999888 7999999999986 56689999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~~~~---------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 142 (318)
T cd05570 75 MEYVNGGDLMFHIQR---------SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGM 142 (318)
T ss_pred EcCCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCC
Confidence 999999999988832 236899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... . .. ......+.
T Consensus 143 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~---~~-~~~i~~~~ 212 (318)
T cd05570 143 CKEGILGGV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----D---EL-FQSILEDE 212 (318)
T ss_pred CeecCcCCC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----H---HH-HHHHHcCC
Confidence 875332221 23345689999999999999999999999999999999999999864221 1 11 11111111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI-----SDALK 603 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm-----~eVl~ 603 (683)
. .+ +......+..++..|++.||.+||++ .++++
T Consensus 213 ~------~~----------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 V------RY----------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred C------CC----------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1 00 11123456788999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.10 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=197.2
Q ss_pred eeeeecCceEEEEEEEcC--C--cEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQD--G--TTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~--g--~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++|+||+++++++. . ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL------T-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc------C-CeEEEE
Confidence 368999999999999753 3 3699999877655 44667999999999999999999999985 3 678999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
+||+++|+|.+++.... ...++|...+.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 74 ~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 74 TELAPLGSLLDRLRKDA-------LGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EEecCCCcHHHHHHhcc-------cccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccc
Confidence 99999999999984321 146899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 474 AKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 474 a~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
++........ ......++.+|+|||++....++.++||||||+++|||++ |+.|+...... +.......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~ 215 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDK 215 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHh
Confidence 9876543222 1223567889999999999999999999999999999999 99998633211 11111111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.+.. +. .+......+..++..|++.+|++||++.+|++.|.
T Consensus 216 ~~~~-------~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 EGER-------LE--------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCc-------CC--------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1100 00 11122346778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.47 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=187.0
Q ss_pred eeeecCceEEEEEEEcC---CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEe
Q 005691 320 FIGRGGFGLVYKGILQD---GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~---g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
.||+|+||.||+|...+ ...+|+|++..... ....+|.+|+++++.++|+||++++|.+. .....++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~------~~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI------ESIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCceEEEEE
Confidence 58999999999998643 34688887754432 22456889999999999999999999986 4567899999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
|+++|+|.+++..... ......++...+.++.|++.||+||| +.+|+||||||+|||+++++++||+|||+++
T Consensus 76 ~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 76 FCPLGDLKNYLRSNRG----MVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred eCCCCcHHHHHHhccc----cccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEecccccc
Confidence 9999999999854321 11234567888899999999999999 8899999999999999999999999999987
Q ss_pred ccccCCcc-ccccccCCCcccCcccccc-------CCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 476 QSREGQSH-LTTRVAGTHGYLAPEYALY-------GQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 476 ~~~~~~~~-~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
........ ......++..|+|||+... ..++.++||||||+++|||++ |+.|+....+. +-..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~ 220 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLK 220 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHH
Confidence 54332211 1233456788999998742 456889999999999999999 77787533211 1111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.....+. ....++.+.. .....+.++...|+ .+|++|||+++|+++|.
T Consensus 221 ~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 221 QVVREQD-IKLPKPQLDL----------KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHhhccC-ccCCCCcccc----------cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1122221 1222222211 12334556777787 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=320.60 Aligned_cols=237 Identities=27% Similarity=0.359 Sum_probs=184.1
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHH-HHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVE-IISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~-iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+++.. +|+.||+|.+..... ....++..|.. +++.++|+||+++++++. .....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~------~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ------TAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE------cCCEEEEE
Confidence 36999999999999975 588999999865322 22334555654 578899999999998886 56789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 142 (321)
T cd05603 75 LDYVNGGELFFHLQR---------ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142 (321)
T ss_pred EcCCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCC
Confidence 999999999888732 346788888899999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||+.|+|||.+....++.++|||||||++|||++|+.||..... ...... +..+.
T Consensus 143 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~-i~~~~ 212 (321)
T cd05603 143 CKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDN-ILHKP 212 (321)
T ss_pred CccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHH-HhcCC
Confidence 87542222 223446799999999999988999999999999999999999999864221 111111 11111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS 599 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~ 599 (683)
. .+ +......+.+++..|++.+|.+||+..
T Consensus 213 ~------~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 L------QL----------PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C------CC----------CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 01 011234567899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.79 Aligned_cols=249 Identities=28% Similarity=0.415 Sum_probs=200.8
Q ss_pred cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|+..+.||+|+||.||+|+..+ ++.+++|.+..... .+++.+|++++++++|+|+++++|++. .....+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~------~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF------KNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee------cCCcEE
Confidence 578888999999999999999865 78999999865432 678999999999999999999999987 457799
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+++||+++++|.+++.. ....++|..++.++.+++.||.||| +.+|+||||+|+||++++++.+||+||
T Consensus 75 l~~e~~~~~~L~~~l~~--------~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 75 IVMEYCGAGSVSDIMKI--------TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred EEEecCCCCcHHHHHHh--------CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEccc
Confidence 99999999999999832 2357899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|++........ ......|+..|+|||++.+..++.++||||||+++|||++|+.|+........ . .....
T Consensus 144 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~-----~~~~~ 213 (256)
T cd06612 144 GVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----I-----FMIPN 213 (256)
T ss_pred ccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----h-----hhhcc
Confidence 99987654321 22335588999999999988999999999999999999999999874332110 0 00000
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. ..+.+. .+......+.+++..|++.+|++|||+.||++
T Consensus 214 ~-----~~~~~~--------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 K-----PPPTLS--------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C-----CCCCCC--------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 001110 11122346778899999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.87 Aligned_cols=267 Identities=25% Similarity=0.337 Sum_probs=201.3
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...++||+|.||.||||+. ..|+.||||+++.....+ .....+|++.|+.++|+||+.|+.++. ..+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~------~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP------HKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc------CCCc
Confidence 3567778999999999999995 469999999998764332 446889999999999999999999986 5677
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.-||+|||+. +|+..+.+. ...|+-.+...++.++.+||+||| ...|+||||||.|+|++++|.+||+
T Consensus 76 l~lVfEfm~t-dLe~vIkd~--------~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiA 143 (318)
T KOG0659|consen 76 LSLVFEFMPT-DLEVVIKDK--------NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIA 143 (318)
T ss_pred eEEEEEeccc-cHHHHhccc--------ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEee
Confidence 8999999975 888888432 357888999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||+|+.+.......+.. +-|..|+|||.+.+ .+|+..+||||.||++.||+-|.+-|...++-++ ...+.+.
T Consensus 144 DFGLAr~f~~p~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ-----L~~If~~ 217 (318)
T KOG0659|consen 144 DFGLARFFGSPNRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ-----LSKIFRA 217 (318)
T ss_pred cccchhccCCCCcccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH-----HHHHHHH
Confidence 999999887554433333 56899999998875 5799999999999999999999977654332211 0111111
Q ss_pred hhcCccccccCccccccccc-----------cCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 549 VKAGKVWQALDPSLLKEDDF-----------LSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~-----------~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+ |...+-.-|.+..-.++ ....+ .+....+++...++..||.+|+|++|++++=-
T Consensus 218 L--GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 218 L--GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred c--CCCCcccCccccccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 1 11111111111100000 00011 12345588889999999999999999987654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=347.56 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=208.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCC-cEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccc-eeeecCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDG-TTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRG-CCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g-~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G-~c~~~~~~~~~ 387 (683)
...+..+++.|.+|||+.||.+....+ ..+|+||+...+....+..++||++|++|+ |+|||.+++ ...........
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 445677889999999999999998766 999999998888888888999999999997 999999999 44333233235
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
.+.+|.||||++|+|-|++.... ...|++.+.++|+.++++|+++||. ++++|||||||.+||||+.+++.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rl-------q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRL-------QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHH-------hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEE
Confidence 78999999999999999994332 2349999999999999999999994 588999999999999999999999
Q ss_pred EcccCcccccccCC--ccc------cccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 468 VADFGLAKQSREGQ--SHL------TTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 468 LaDFGla~~~~~~~--~~~------~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
|+|||.|.-..... ... .-...-|+-|+|||.+. +...++|+|||+|||+||-|+....||+....
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--- 263 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--- 263 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---
Confidence 99999986432111 000 01134689999999875 56789999999999999999999999974311
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+++....- ........++..|+..|+++||.+||++-||+..+-.
T Consensus 264 ------------------laIlng~Y~~------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 264 ------------------LAILNGNYSF------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ------------------eeEEeccccC------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 0111111110 1123457788999999999999999999999887754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.84 Aligned_cols=268 Identities=25% Similarity=0.361 Sum_probs=206.6
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
+..+++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 556777888999999999999999999999974 68899999886532 2345688999999999 89999999999874
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.+. ..+...++|+||+++|+|.+++.... .....++|..++.++.+++.||.||| +.+|+||||||+||++
T Consensus 91 ~~~-~~~~~~~lv~ey~~~~sL~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili 161 (291)
T cd06639 91 ADK-LVGGQLWLVLELCNGGSVTELVKGLL-----ICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILL 161 (291)
T ss_pred ccc-cCCCeeEEEEEECCCCcHHHHHHHhh-----hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEE
Confidence 322 13457899999999999999874321 12346899999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCC-----CCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ-----LTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-----~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
+.++.+||+|||+++........ .....|+..|+|||++..++ ++.++|||||||++|||++|+.|+.......
T Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 162 TTEGGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred cCCCCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 99999999999998865432221 22356889999999876443 6899999999999999999999986432210
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+ .+ +..+......+ +.+....+.+++..|++.+|++||++.++++
T Consensus 241 ----~~----~~-~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 ----TL----FK-IPRNPPPTLLH-------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ----HH----HH-HhcCCCCCCCc-------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 11 11111111111 1122345788999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.92 Aligned_cols=239 Identities=23% Similarity=0.337 Sum_probs=185.2
Q ss_pred eeeecCceEEEEEEEcC-------------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 320 FIGRGGFGLVYKGILQD-------------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~-------------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.||+|+||.||+|++.+ ...|++|.+..........|.+|+.+++.++||||++++|++. .
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~------~ 75 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV------R 75 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence 68999999999998642 2258888876654444567889999999999999999999987 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc-
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR- 465 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~- 465 (683)
....++||||+++|+|+.++.. ....+++..+++|+.|+++||+||| +.+|+||||||+|||++.++.
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~ 144 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHR--------KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGID 144 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCcc
Confidence 5678999999999999988742 1246899999999999999999999 899999999999999987664
Q ss_pred ------EEEcccCcccccccCCccccccccCCCcccCccccc-cCCCCccccEEEcchhHHHHh-hCCCCCCCCCCCCCC
Q 005691 466 ------ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIM-CGRKALDLSTSGSPR 537 (683)
Q Consensus 466 ------~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGvlLlELl-tGr~p~~~~~~~~~~ 537 (683)
+|++|||++...... ....++..|+|||++. ...++.++|||||||++|||+ +|+.|+......
T Consensus 145 ~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--- 216 (262)
T cd05077 145 GECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--- 216 (262)
T ss_pred CCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---
Confidence 899999998654322 2245788999999887 467899999999999999998 577776532110
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+. .... .+.. .+ . . .....+..++..|++.||++||++.++++.|+
T Consensus 217 -----~~-~~~~-~~~~------~~--~------~--~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 217 -----EK-ERFY-EGQC------ML--V------T--PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----HH-HHHH-hcCc------cC--C------C--CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 0111 1110 00 0 0 01235678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.06 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=187.2
Q ss_pred eeeecCceEEEEEEEcCCc---EEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEe
Q 005691 320 FIGRGGFGLVYKGILQDGT---TVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g~---~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
.||+|+||.||+|...++. .+++|.+.... ....+.|.+|+.+++.++||||++++++|. .....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~------~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV------EAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec------CCCccEEEEe
Confidence 5999999999999865443 45666665433 233567999999999999999999999987 4567899999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
|+++|+|.+++.... .....+++...+.++.|+++||+||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~ 147 (268)
T cd05086 76 YCELGDLKSYLSQEQ-----WHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGP 147 (268)
T ss_pred cCCCCcHHHHHHhhh-----cccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEeccccccc
Confidence 999999999985421 11234667777899999999999999 8899999999999999999999999999986
Q ss_pred ccccCC-ccccccccCCCcccCcccccc-------CCCCccccEEEcchhHHHHhhC-CCCCCCCCCCCCCccchhhhhh
Q 005691 476 QSREGQ-SHLTTRVAGTHGYLAPEYALY-------GQLTEKSDVYSFGVVILEIMCG-RKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 476 ~~~~~~-~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSfGvlLlELltG-r~p~~~~~~~~~~~~~l~~~v~ 546 (683)
...... ........|+..|+|||++.. ..++.++||||||+++|||+++ ..|+..... .+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~ 219 (268)
T cd05086 148 SRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLN 219 (268)
T ss_pred ccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 432211 112234568899999998753 2457899999999999999975 566643221 11222
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
..+. +......++.+... ...++.+++..|+ .+|++||+|.+|+++|.
T Consensus 220 ~~~~-~~~~~~~~~~~~~~----------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 220 HVIK-DQQVKLFKPQLELP----------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHh-hcccccCCCccCCC----------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222 22233444444322 2235566778898 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.79 Aligned_cols=255 Identities=28% Similarity=0.409 Sum_probs=192.5
Q ss_pred eeeeecCceEEEEEEEcC-Cc--EEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQD-GT--TVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~-g~--~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+|++.+ +. .+++|.+.... ....+.+.+|++++.++ +|||++++++++. .....++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~------~~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE------HRGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe------cCCCceEE
Confidence 368999999999999764 43 46888876432 23345788999999999 8999999999986 45568999
Q ss_pred EeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 394 YDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
|||+++|+|.+++....... .......+++.+++.++.+++.||+||| +.+++||||||+|||+++++.+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeE
Confidence 99999999999985432100 0112245889999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v 545 (683)
||+|||+++...... .......+..|+|||++....++.++||||||++++||++ |+.||...... +.
T Consensus 152 kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~- 220 (270)
T cd05047 152 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------EL- 220 (270)
T ss_pred EECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HH-
Confidence 999999986432111 1111234668999999998899999999999999999997 99998542211 11
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
......+...+ . +......+.+++..|++.+|.+|||+.+++..|+..
T Consensus 221 ~~~~~~~~~~~-----~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 221 YEKLPQGYRLE-----K----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHhCCCCCC-----C----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11111111000 0 011234567899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.34 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=191.3
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 321 LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
||+|+||.||+++.. +|+.+|+|++..... .....+..|++++++++||||+++.+++. .+...++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~------~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE------SKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe------cCCeEEEEEec
Confidence 699999999999865 589999999865322 12344667999999999999999998886 55689999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++|+|.+++... ....++|..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 75 ~~g~~L~~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~ 144 (277)
T cd05607 75 MNGGDLKYHIYNV-------GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVE 144 (277)
T ss_pred CCCCCHHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeee
Confidence 9999999887432 1345889999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
..... ......||..|+|||++..+.++.++|||||||++|||++|+.||....... ...+...... .+.
T Consensus 145 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~-~~~--- 214 (277)
T cd05607 145 LKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTL-EDE--- 214 (277)
T ss_pred cCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhh-ccc---
Confidence 64332 2234568999999999999899999999999999999999999986432211 1111111111 110
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
+.. ........+.+++..|++.||++||++.|+++.+
T Consensus 215 -~~~-----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 215 -VKF-----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -ccc-----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 000 0011234567889999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.75 Aligned_cols=201 Identities=26% Similarity=0.377 Sum_probs=171.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.|.+|+.++..++|+||+++++++. .+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ------DEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe------cCC
Confidence 46888999999999999999975 58899999986532 222445889999999999999999999886 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~--------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl 143 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSK--------FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRL 143 (331)
T ss_pred eEEEEEecCCCCcHHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEE
Confidence 89999999999999999832 1246888899999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
+|||+++..............||+.|+|||++.. +.++.++|||||||++|||++|+.||..
T Consensus 144 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 144 ADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 9999987665443333334579999999999863 5678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.28 Aligned_cols=204 Identities=24% Similarity=0.338 Sum_probs=170.8
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
...++|...+.||+|+||.||+++.. .++.||||++..... .....+.+|+.+++.++|+||+++++++........
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 588999999865422 224568889999999999999999999865433334
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCE
Confidence 4568999999975 5655551 25788889999999999999999 8999999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 159 KILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred EEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999865332 223345789999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.55 Aligned_cols=240 Identities=22% Similarity=0.295 Sum_probs=188.3
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+|+.. +|+.||+|.+.... ....+.+..|..++..+ +|+||+++++++. .....++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~------~~~~~~lv 74 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ------TKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE------eCCEEEEE
Confidence 36999999999999976 58899999987642 22344577788888765 8999999999986 55789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~E~~~~g~L~~~i~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~ 142 (316)
T cd05620 75 MEFLNGGDLMFHIQD---------KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGM 142 (316)
T ss_pred ECCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCC
Confidence 999999999988832 246888999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||..... . -..+....+.
T Consensus 143 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~----~~~~~~~~~~ 212 (316)
T cd05620 143 CKENVFGDN-RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----D----ELFESIRVDT 212 (316)
T ss_pred CeecccCCC-ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----H----HHHHHHHhCC
Confidence 875432221 23446799999999999999999999999999999999999999964221 0 1111111111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS-DAL 602 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~-eVl 602 (683)
+.+. ......+..++..|++.||++||++. ++.
T Consensus 213 ------~~~~----------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 ------PHYP----------RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ------CCCC----------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111 11233566788999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=343.59 Aligned_cols=251 Identities=29% Similarity=0.433 Sum_probs=204.9
Q ss_pred cceeeeecCceEEEEEEE-cCCc----EEEEEEeecc-CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 317 QKNFIGRGGFGLVYKGIL-QDGT----TVAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l-~~g~----~VAVK~l~~~-~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..++||+|+||+||||.+ ++|+ +||+|.+... ..+...+++.|.-+|++|+||||++|+|+|. ....
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~-------~s~~ 772 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCM-------LSTL 772 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcc-------cchH
Confidence 356899999999999984 4554 6899988764 4455788999999999999999999999996 3458
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
.||.+|||.|+|.||++.+ +..+.-...+.|..|||+|+.||| +.+++||||.++|||+..-..+||.|
T Consensus 773 qlvtq~mP~G~LlDyvr~h--------r~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitd 841 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREH--------RDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITD 841 (1177)
T ss_pred HHHHHhcccchHHHHHHHh--------hccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEe
Confidence 9999999999999999543 456777888999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCcccc-ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhh
Q 005691 471 FGLAKQSREGQSHLT-TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 471 FGla~~~~~~~~~~~-~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
||+|+....+....+ ....-.+.|||=|.+....|+.++|||||||.+||++| |.+|++.... +-+..+
T Consensus 842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------~eI~dl 912 (1177)
T KOG1025|consen 842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------EEIPDL 912 (1177)
T ss_pred cchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------HHhhHH
Confidence 999999876554433 33344678999999999999999999999999999998 8899874332 223333
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
++.|.- | ..+.-+...+..++..||..|+..||+++++...+.+..
T Consensus 913 le~geR-------L--------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 913 LEKGER-------L--------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred Hhcccc-------C--------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 444321 1 123344557788999999999999999999988776543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.44 Aligned_cols=241 Identities=25% Similarity=0.314 Sum_probs=186.9
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHH-HHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVE-IISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~-iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+.||+|+||.||+++.. +|+.||+|++.... .....++..|.. +++.++||||+++++++. .....++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~------~~~~~~lv 74 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ------TTEKLYFV 74 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe------cCCEEEEE
Confidence 36999999999999864 68999999986542 222345566665 467799999999998886 56789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++. ....+++.....++.||+.||+||| +.+|+||||||+|||+++++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~l~---------~~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~ 142 (325)
T cd05604 75 LDFVNGGELFFHLQ---------RERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGL 142 (325)
T ss_pred EcCCCCCCHHHHHH---------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCC
Confidence 99999999988873 2346889999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||..... .+.... ...+.
T Consensus 143 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~-~~~~~ 212 (325)
T cd05604 143 CKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDN-ILHKP 212 (325)
T ss_pred cccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHH-HHcCC
Confidence 87542221 123446799999999999999999999999999999999999999864221 111111 11111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+ .+.. .....+..++..|++.+|.+||++.+.++
T Consensus 213 ~------~~~~----------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 213 L------VLRP----------GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred c------cCCC----------CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 1 0000 12335667889999999999999864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.42 Aligned_cols=238 Identities=24% Similarity=0.374 Sum_probs=187.0
Q ss_pred eeeeecCceEEEEEEEcCCc-----------EEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 319 NFIGRGGFGLVYKGILQDGT-----------TVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~-----------~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+|+++++|++. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~------~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCV------R- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEe------c-
Confidence 36999999999999986533 5788876554333 678999999999999999999999986 3
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC---
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM--- 464 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~--- 464 (683)
...++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHRE--------KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCcccc
Confidence 5679999999999999998432 126889999999999999999999 89999999999999999888
Q ss_pred ----cEEEcccCcccccccCCccccccccCCCcccCccccccC--CCCccccEEEcchhHHHHhhC-CCCCCCCCCCCCC
Q 005691 465 ----RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCG-RKALDLSTSGSPR 537 (683)
Q Consensus 465 ----~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGvlLlELltG-r~p~~~~~~~~~~ 537 (683)
.+||+|||+++.... .....++..|+|||++... .++.++||||||+++|||++| ..|+......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--- 213 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--- 213 (259)
T ss_pred CCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---
Confidence 799999999886543 1224567789999998876 789999999999999999994 6666443211
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.+. ..+.... .... .. ...+.+++..|++.+|.+|||+.+|++.|+
T Consensus 214 -----~~~-~~~~~~~--------~~~~------~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 214 -----EKE-RFYQDQH--------RLPM------PD---CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----hHH-HHHhcCC--------CCCC------CC---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110 0111100 0000 00 146778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.09 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=201.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc--------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ--------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
.++|...+.||+|+||.||++... ....+|+|++..... ....++.+|+++++++ +|+||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 357888899999999999999742 245789998865432 2345688999999999 6999999999986
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.....++||||+++|+|.+++....... .......++|.++++++.|++.||.||| +.+|+|||||
T Consensus 89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlk 161 (314)
T cd05099 89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLA 161 (314)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecccc
Confidence 4567899999999999999985432110 0112346899999999999999999999 8899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+|||+++++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ |+.|+....
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866432221 1222334568999999998999999999999999999999 888875322
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
. ..+......+...+ . +......+.+++..|++.+|++|||+.++++.|+..
T Consensus 242 ~---------~~~~~~~~~~~~~~-----~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 242 V---------EELFKLLREGHRMD-----K----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred H---------HHHHHHHHcCCCCC-----C----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1 11122222221111 0 111233567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.53 Aligned_cols=247 Identities=29% Similarity=0.461 Sum_probs=195.9
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeec
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYM 397 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~ 397 (683)
++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV------QKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe------cCCCeEEEEEcC
Confidence 369999999999999877999999988765443 3567999999999999999999999986 456789999999
Q ss_pred CCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 398 PNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 398 ~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
++++|.+++... ...+++..++.++.+++.||+||| +.+++||||||+||+++.++.+||+|||+++..
T Consensus 75 ~~~~l~~~l~~~--------~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 143 (251)
T cd05041 75 PGGSLLTFLRKK--------KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREE 143 (251)
T ss_pred CCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence 999999998422 235788999999999999999999 889999999999999999999999999999865
Q ss_pred ccCCcccc-ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCccc
Q 005691 478 REGQSHLT-TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKVW 555 (683)
Q Consensus 478 ~~~~~~~~-~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~ 555 (683)
........ ....++..|+|||++.++.++.++||||||++++|+++ |..|+....... . ......+.
T Consensus 144 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~----~~~~~~~~-- 212 (251)
T cd05041 144 EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----T----RERIESGY-- 212 (251)
T ss_pred cCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----H----HHHHhcCC--
Confidence 43222111 22334678999999998999999999999999999999 788875432210 1 11111110
Q ss_pred cccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 556 QALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 556 e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.+ . .+......+.+++..|++.+|.+|||+.||++.|+
T Consensus 213 -----~~--~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 -----RM--P------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -----CC--C------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00 0 11122346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=318.09 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=201.3
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+|...+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++. .+...+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~~~~~ 92 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL------VGDELW 92 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEE
Confidence 5788889999999999999996 479999999997766555677899999999999999999999987 567899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|.+++. ...+++.++..++.+++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 93 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 93 VVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred EeecccCCCCHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcC
Confidence 9999999999999882 235788999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|++......... .....|++.|+|||++....++.++|||||||++||+++|+.||........ .. .....
T Consensus 160 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~-----~~~~~ 230 (297)
T cd06656 160 GFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LY-----LIATN 230 (297)
T ss_pred ccceEccCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---ee-----eeccC
Confidence 998765443322 2334688999999999998899999999999999999999999964332110 00 00011
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+. +.+. .+......+.+++..|++.+|++||++.+|++
T Consensus 231 ~~------~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 231 GT------PELQ--------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CC------CCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 0000 11122345667889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.94 Aligned_cols=204 Identities=24% Similarity=0.397 Sum_probs=162.2
Q ss_pred ceeeeecCceEEEEEEEc---CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 318 KNFIGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
..+||+|+||.||+|+.. ++..||+|++.... ....+.+|++++++++|+||+++++++... .+...++|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH----SDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc----CCCeEEEEE
Confidence 358999999999999975 35789999886532 234688999999999999999999988632 345789999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee----ccCCcEEEcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVAD 470 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL----d~~~~~KLaD 470 (683)
||+++ +|.+++..............+++..++.|+.|++.||.||| +.+|+||||||+|||+ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99875 66666532211111122346888999999999999999999 8899999999999999 5678999999
Q ss_pred cCcccccccCCcc--ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 471 FGLAKQSREGQSH--LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 471 FGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
||+++........ ......||..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999876543221 2234578999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.99 Aligned_cols=272 Identities=24% Similarity=0.275 Sum_probs=194.1
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhc---cCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNL---KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L---~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...+.||+|+||+||+|+.. +|+.||+|.+...... ....+.+|+++++++ +|+||+++++++..... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~-~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT-DRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC-CCC
Confidence 4778889999999999999975 5889999998654322 234567788887766 69999999998863221 234
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++ +|.+++... ....+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+|
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKV-------PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence 568999999984 888877322 1245899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh-
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW- 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~- 546 (683)
|+|||+++...... ......||..|+|||++.+..++.++|||||||+++||++|++||......+.. ..+..+..
T Consensus 149 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~ 225 (288)
T cd07863 149 LADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKIFDLIGL 225 (288)
T ss_pred ECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH-HHHHHHhCC
Confidence 99999998664322 223457899999999999999999999999999999999999998643221100 00000000
Q ss_pred ---hhhhc-Ccc-ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 ---SLVKA-GKV-WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ---~~~~~-g~l-~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+.. ... .....+..... ......+..+.+.+++..|++.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRP---VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCc---hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000 00000000000 00000123446678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=313.40 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=194.7
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
|...++||+|+||+||+|... +++.||+|.+...... ....+.+|++++++++|+|++++.+++. .++..
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~------~~~~~ 75 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE------TKDAL 75 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe------cCCEE
Confidence 666789999999999999874 6889999998654322 2345788999999999999999998886 55689
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++... ....++|..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~D 145 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNM-------GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEEeccCccHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEec
Confidence 9999999999999888432 1236999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||++........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....+ .....
T Consensus 146 fg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~----~~~~~-~~~~~ 218 (285)
T cd05632 146 LGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV----KREEV-DRRVL 218 (285)
T ss_pred CCcceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH-HHhhh
Confidence 999876543221 234578999999999998999999999999999999999999986432110 01111 11111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
.+. ... ..+....+..++..|++.||++||+ +.+++.
T Consensus 219 ~~~------~~~----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 219 ETE------EVY----------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccc------ccc----------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 110 001 1112335577889999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=306.70 Aligned_cols=247 Identities=27% Similarity=0.440 Sum_probs=197.7
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-----cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-----QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...+.||+|+||.||+|+.. +++.|++|.+..... +..+.+.+|++++++++|+|++++++++. .+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER------EE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe------cC
Confidence 4667789999999999999976 789999999865432 23457899999999999999999999986 55
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...+++|||+++++|.+++.. ...+++..+..++.+++.||+||| +.+|+|+||||+||+++.++.+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKK---------YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 689999999999999999832 235889999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCC-CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||++....... ......|+..|+|||++.... ++.++|+||||++++||++|+.||..... ....+
T Consensus 143 l~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~ 212 (258)
T cd06632 143 LADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVF 212 (258)
T ss_pred EccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHH
Confidence 99999987654332 233456889999999988776 89999999999999999999999864321 11122
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.....+... .+ +......+.+++..|++.+|.+||++.++++
T Consensus 213 ~~~~~~~~~-----~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 213 KIGRSKELP-----PI----------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhcccCC-----Cc----------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 211111110 01 1112345677889999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.37 Aligned_cols=269 Identities=24% Similarity=0.330 Sum_probs=205.8
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
+.++.+..++++|+..+.||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.+++++ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445777888999999999999999999999874 57899999875432 2346788999999999 69999999998853
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.. ...+...++||||+++++|.+++.... .....+++..+..++.++++||.||| +.+|+||||||+||++
T Consensus 87 ~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili 157 (286)
T cd06638 87 KD-VKNGDQLWLVLELCNGGSVTDLVKGFL-----KRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILL 157 (286)
T ss_pred cc-cCCCCeEEEEEeecCCCCHHHHHHHhh-----ccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEE
Confidence 22 124567899999999999998874321 12346888999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
+.++.+||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.|+.......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred CCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 9999999999999886643222 2233568999999998753 457889999999999999999999986432211
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+. . ...+......++ ......+..++..|++.+|++|||+.||++.
T Consensus 237 ----~~~----~-~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ----ALF----K-IPRNPPPTLHQP-------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----HHh----h-ccccCCCcccCC-------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 0 001100011111 1112357789999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.82 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=197.0
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||+|.. +++.||+|++.... ..+.+.+|+.++++++|+|++++++++. ....++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~-------~~~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL-------HNGLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEc-------CCCcEE
Confidence 4578889999999999999985 57889999885432 3457899999999999999999999885 234799
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ....+++..+++++.+++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 76 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg 145 (254)
T cd05083 76 VMELMSKGNLVNFLRTR-------GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFG 145 (254)
T ss_pred EEECCCCCCHHHHHHhc-------CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCc
Confidence 99999999999998432 1236889999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++...... .....+..|+|||++..+.++.++||||||++++||++ |+.|+..... .++ ......
T Consensus 146 ~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~-~~~~~~ 212 (254)
T cd05083 146 LARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEV-KECVEK 212 (254)
T ss_pred cceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHH-HHHHhC
Confidence 987643321 12334678999999998999999999999999999998 9988853221 111 111222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+... + .+......+.+++..|++.+|+.||++.++++.|+.+
T Consensus 213 ~~~~---~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 213 GYRM---E------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254 (254)
T ss_pred CCCC---C------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence 2110 0 0112234667899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=323.92 Aligned_cols=247 Identities=28% Similarity=0.404 Sum_probs=201.7
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.|...+.||+|.||.||||... .++.||+|.+.-.. ....++...|+.+|+.++|+||.+++|.+. .+..++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl------~g~~Lw 87 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL------KGTKLW 87 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee------ecccHH
Confidence 4556678999999999999965 58899999986543 333567889999999999999999999998 677899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++|||+.+|++.+.|. ....+++....-|..++..||.||| ..+.+|||||+.|||+.++|.+||+||
T Consensus 88 iiMey~~gGsv~~lL~---------~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~Df 155 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLK---------SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADF 155 (467)
T ss_pred HHHHHhcCcchhhhhc---------cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEec
Confidence 9999999999999983 2335588888889999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|.+-......... ...+||+-|||||++....|+.|+||||||++.+||.+|.+|+....+.. . +. +
T Consensus 156 gVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---v-lf-----l--- 222 (467)
T KOG0201|consen 156 GVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---V-LF-----L--- 222 (467)
T ss_pred ceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---E-EE-----e---
Confidence 9998776554433 56789999999999998899999999999999999999999987554421 0 10 0
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.+.--|.+.+. ....+.+++..|++.||+.||++.++++
T Consensus 223 --Ipk~~PP~L~~~----------~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 223 --IPKSAPPRLDGD----------FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred --ccCCCCCccccc----------cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111112333222 2334667888999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.04 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=197.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCc----EEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGT----TVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~----~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||.||+|+.. +|. .||+|.+...... ...++.+|+.+++.++|+||++++|+|.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~------- 79 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL------- 79 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-------
Confidence 45677789999999999999864 444 4788887654322 2346899999999999999999999985
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++++||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 80 ~~~~~~v~e~~~~g~l~~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~ 148 (303)
T cd05110 80 SPTIQLVTQLMPHGCLLDYVHEH--------KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHV 148 (303)
T ss_pred CCCceeeehhcCCCCHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCce
Confidence 23467999999999999998422 235889999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.|+..... . .
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----~----~ 219 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----R----E 219 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----H----H
Confidence 99999999876533322 2223456789999999998999999999999999999998 8888853211 1 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.......+.... .+......+..++..|+..+|++||+|.+++++|+..
T Consensus 220 ~~~~~~~~~~~~---------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 220 IPDLLEKGERLP---------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHHHHCCCCCC---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112222221100 0011123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=321.50 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=201.8
Q ss_pred cCcccceeeeecCceEEEEEEEc--------CCcEEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeecC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ--------DGTTVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDG 382 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~ 382 (683)
.+|...+.||+|+||.||+++.. ++..||+|.+.... ....+++.+|+++++++ +|+||++++++|.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--- 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence 46788899999999999999742 12368999876432 22346799999999999 8999999999986
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCC
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKp 455 (683)
.....+++|||+++|+|.+++....... .......++|.+++.++.|++.||+||| +.+|+||||||
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp 162 (334)
T cd05100 89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAA 162 (334)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecccccc
Confidence 4567899999999999999985422100 0122346899999999999999999999 89999999999
Q ss_pred CceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCC
Q 005691 456 TNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTS 533 (683)
Q Consensus 456 sNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~ 533 (683)
+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ |+.|+....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~- 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP- 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-
Confidence 9999999999999999999866443221 1222344678999999999999999999999999999998 888875321
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
..++.. .+..+...+ .+......+.+++..|++.+|++||+|.++++.|+...
T Consensus 242 -------~~~~~~-~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 242 -------VEELFK-LLKEGHRMD---------------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -------HHHHHH-HHHcCCCCC---------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 112211 122221111 01112346778999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.63 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=201.2
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+|...+.||.|+||.||+|+. .+|+.||+|++........+.+.+|+.+++.++|+|++++++++. .+...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL------VGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe------cCceEE
Confidence 4688889999999999999985 468999999997665555677899999999999999999999986 567899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|+||+++++|.+++. ...++|.++..++.+++.||+||| +.+++||||||+||+++.++.+||+||
T Consensus 93 lv~e~~~~~~L~~~~~----------~~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 93 VVMEYLAGGSLTDVVT----------ETCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEEecCCCcHHHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccC
Confidence 9999999999999882 235899999999999999999999 899999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+++........ .....|+..|+|||.+....++.++|||||||++||+++|+.||...... .........
T Consensus 160 g~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~~ 230 (296)
T cd06655 160 GFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATN 230 (296)
T ss_pred ccchhccccccc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc
Confidence 998865443221 23356889999999999888999999999999999999999998643221 111111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+ ... +. .+.+....+.+++..|++.+|++|||+.+++.
T Consensus 231 ~-~~~-----~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 231 G-TPE-----LQ--------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred C-Ccc-----cC--------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1 100 10 11122345677889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=316.65 Aligned_cols=268 Identities=28% Similarity=0.385 Sum_probs=204.7
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHh--ccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISN--LKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~--L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+.....+.||+|.||.||+|.++ |+.||||.+...+ ++.+.+|.+|... |||+||..+++.=..+ .+.-.++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~--~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKD--NGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccC--CCceEEE
Confidence 45667789999999999999998 9999999986543 5668889888876 5999999998865433 2356789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc-----CCCccccCCCCCceeeccCCc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV-----KPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~-----~~~IiHrDIKpsNILLd~~~~ 465 (683)
+||.+|.++|||.|||. +..++-...++++..+|.||++||.+. ++.|.|||||+.|||+..++.
T Consensus 285 wLvTdYHe~GSL~DyL~----------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN----------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred EEeeecccCCcHHHHHh----------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 99999999999999992 457999999999999999999999644 788999999999999999999
Q ss_pred EEEcccCcccccccCCcc---ccccccCCCcccCccccccC----CC--CccccEEEcchhHHHHhhC----------CC
Q 005691 466 ARVADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALYG----QL--TEKSDVYSFGVVILEIMCG----------RK 526 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~----~~--s~ksDVwSfGvlLlELltG----------r~ 526 (683)
.-|+|+|||-....+... .....+||.+|||||++... .+ -..+||||||.++||+... +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999999766544322 13446899999999998642 12 2369999999999998653 24
Q ss_pred CCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 527 ALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 527 p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
||....+.++. + +-.++.+-..++...++.+. ...+++..+.+++..||..||..|-|+-.+-+.|.
T Consensus 435 Pyyd~Vp~DPs---~-eeMrkVVCv~~~RP~ipnrW---------~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~ 501 (513)
T KOG2052|consen 435 PYYDVVPSDPS---F-EEMRKVVCVQKLRPNIPNRW---------KSDPALRVMAKLMKECWYANPAARLTALRIKKTLA 501 (513)
T ss_pred CcccCCCCCCC---H-HHHhcceeecccCCCCCccc---------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence 55444443331 1 11111121222222222222 33467888999999999999999999999988887
Q ss_pred cCC
Q 005691 607 GDI 609 (683)
Q Consensus 607 ~~~ 609 (683)
+..
T Consensus 502 ~l~ 504 (513)
T KOG2052|consen 502 KLS 504 (513)
T ss_pred HHh
Confidence 654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.07 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=201.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..++||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++|+||+++++++. .....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL------NENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe------cCCEE
Confidence 46777789999999999999965 58899999886543 233567999999999999999999999997 45789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++.. .+.++|.....++.+++.||.|||+ ..+++||||||+||++++++.++|+|
T Consensus 79 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK---------GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred EEEEecCCCCCHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEcc
Confidence 999999999999988732 2468999999999999999999993 25799999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCC---ccchhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR---ACLITDWVWS 547 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~---~~~l~~~v~~ 547 (683)
||++....... .....|+..|+|||++..+.++.++|||||||++||+++|+.||+........ ...+.++...
T Consensus 148 ~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 148 FGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred CCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 99986543221 23457899999999998889999999999999999999999999754332110 0111122222
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
..... .+.+ ...+....+..++..|++.||++|||+.||+++.
T Consensus 225 ~~~~~------~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 225 IVQEP------PPRL---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred Hhhcc------CCCC---------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11110 0111 1112344677888999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=325.05 Aligned_cols=204 Identities=25% Similarity=0.372 Sum_probs=170.3
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
..++|...+.||+|+||.||+++.. +|..||||++.... .....++.+|+.+++.++||||+++++++.........
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 58899999986532 23345688999999999999999999998644333334
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEE
Confidence 568999999975 4555441 24778888999999999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
|+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 164 l~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 164 ILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred EecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999764332 2234457899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.01 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=189.2
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+|+..+.||+|+||.||+++.. +|+.||+|++.... ....+.+..|.+++..+. |++|+++.+++. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~------~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ------TVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe------cCC
Confidence 4677889999999999999965 68899999987532 223356788999998886 567778888775 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++.+++.|+.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~~---------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQQ---------VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred EEEEEEcCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEE
Confidence 79999999999999998832 246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ...
T Consensus 143 ~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~---~~~- 212 (323)
T cd05615 143 ADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DEL---FQS- 212 (323)
T ss_pred eccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHH---HHH-
Confidence 9999987543222 123345699999999999999999999999999999999999999864321 111 111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
...+.. .. +......+..++..|++.+|.+|++.
T Consensus 213 i~~~~~------~~----------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHNV------SY----------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCC------CC----------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111 00 11123456788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.22 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=196.8
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.|+..+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++|+||+++++++. .+...+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~ 78 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL------KGTKLW 78 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc------cCCceE
Confidence 4556678999999999999865 578899998864432 23456899999999999999999999986 456799
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|.+++. ...+++..+..++.++++||.||| +.+++|+||+|+||++++++.+||+||
T Consensus 79 lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06642 79 IIMEYLGGGSALDLLK----------PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEEccCCCcHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccc
Confidence 9999999999999882 236889999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+++....... ......|+..|+|||++....++.++||||||++++||++|+.|+....... +... ...
T Consensus 146 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~-~~~ 215 (277)
T cd06642 146 GVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFL-IPK 215 (277)
T ss_pred cccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhh-hhc
Confidence 99976543321 1223468899999999998899999999999999999999999986432211 1111 111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+. .+.+. ......+..++..|++.+|++||+|.+|++.
T Consensus 216 ~~-----~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 216 NS-----PPTLE----------GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CC-----CCCCC----------cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11 11111 1223457789999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=317.76 Aligned_cols=270 Identities=22% Similarity=0.348 Sum_probs=198.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..++||+|+||.||+|... +++.||+|++...... ..+.+.+|+++++.++|+|++++++++. .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR------RKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc------cCCe
Confidence 46888899999999999999986 5889999988654322 2456889999999999999999999986 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++++|.++... ...++|..++.++.+++.||+||| +.+|+||||+|+||++++++.+||+
T Consensus 75 ~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~ 142 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKY---------PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLC 142 (286)
T ss_pred EEEEEecCCccHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEE
Confidence 9999999999999887621 235899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||+++...... ...+...++..|+|||++.. ..++.++||||||++++||++|++|+......+. ...+..+...+
T Consensus 143 dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~ 220 (286)
T cd07846 143 DFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNL 220 (286)
T ss_pred eeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCC
Confidence 999988764433 22334568899999999875 4578899999999999999999998864321100 00011100000
Q ss_pred h-------hcCcc-ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 V-------KAGKV-WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~-------~~g~l-~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. ..... .....+......... .........+.+++..|++.+|++||+|.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLE-KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chhhHHHhccchHhhccccccccCcchHH-HhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00000 000001000000000 001123456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=324.60 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=172.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|++++..++|+||+++++.+. ...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~------~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ------DKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE------cCC
Confidence 46888899999999999999975 58899999987532 223456888999999999999999999886 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~---------~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL 142 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMK---------KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKL 142 (360)
T ss_pred EEEEEEeCCCCccHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEE
Confidence 89999999999999999832 346889999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCc----------------------------------cccccccCCCcccCccccccCCCCccccEEEc
Q 005691 469 ADFGLAKQSREGQS----------------------------------HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSF 514 (683)
Q Consensus 469 aDFGla~~~~~~~~----------------------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSf 514 (683)
+|||+++....... .......||+.|+|||++.+..++.++|||||
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSl 222 (360)
T cd05627 143 SDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222 (360)
T ss_pred eeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccc
Confidence 99999875432110 01123579999999999999999999999999
Q ss_pred chhHHHHhhCCCCCCCC
Q 005691 515 GVVILEIMCGRKALDLS 531 (683)
Q Consensus 515 GvlLlELltGr~p~~~~ 531 (683)
||++|||++|+.||...
T Consensus 223 Gvilyel~tG~~Pf~~~ 239 (360)
T cd05627 223 GVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cceeeecccCCCCCCCC
Confidence 99999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.13 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=194.8
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++. .+...++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~------~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY------YENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe------eCCEEEEE
Confidence 456678999999999999976 46788888886655555667999999999999999999999987 45678999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++++|..++.. ....++|..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~e~~~~~~l~~~~~~--------~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 81 IEFCAGGAVDAVMLE--------LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred EEecCCCcHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccc
Confidence 999999999988742 1346899999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
++...... .......||..|+|||++. ...++.++|||||||++|||++|++|+...... +.+...
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~ 220 (282)
T cd06643 150 SAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKI 220 (282)
T ss_pred cccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHH
Confidence 87653322 1223356899999999984 345788999999999999999999998642210 111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
. .+.. +.+. .+......+.+++..|++.+|.+||++.++++.
T Consensus 221 ~-~~~~-----~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 221 A-KSEP-----PTLA--------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred h-hcCC-----CCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1110 1110 011123456788999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.97 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=198.4
Q ss_pred CcccceeeeecCceEEEEEEEcC--CcEEEEEEeeccCc----------cChHHHHHHHHHHHh-ccCCCcccccceeee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQD--GTTVAVKKVIESDF----------QGDAEFCNEVEIISN-LKHRNLVPLRGCCVV 380 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~--g~~VAVK~l~~~~~----------~~~~~f~~Ev~iL~~-L~H~NLV~L~G~c~~ 380 (683)
+|...+.||+|+||.||+|...+ ++.+|+|++..... ....++..|+.++.+ ++|+|++++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 46778899999999999999865 68899998854321 112457788888875 79999999999986
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.+...++||||+++++|.+++.... .....+++..+++++.|++.||.|||+ ..+++|+||||+||++
T Consensus 80 -----~~~~~~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~ 147 (269)
T cd08528 80 -----ENDRLYIVMDLIEGAPLGEHFNSLK-----EKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIML 147 (269)
T ss_pred -----cCCeEEEEEecCCCCcHHHHHHHHH-----hccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEE
Confidence 5678999999999999998874321 123468889999999999999999992 2579999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
+.++.+||+|||++....... ......|+..|+|||++..+.++.++||||||+++|||++|+.|+.....
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------- 218 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------- 218 (269)
T ss_pred CCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------
Confidence 999999999999998755433 23445789999999999998999999999999999999999999863221
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
....... ..+..... ........+.+++.+|++.||++||+|.||..+|+
T Consensus 219 -~~~~~~~-~~~~~~~~--------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 -LSLATKI-VEAVYEPL--------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHHHHHH-hhccCCcC--------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111 11111100 00012345678889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.53 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=198.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..+.||+|+||.||++... ++..+|+|.+..... ...+++.+|++++.+++|+||+++++++. .++..
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY------SDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------eCCEE
Confidence 46888999999999999999965 577888888764322 22356889999999999999999999997 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++.. ...+++..+..++.++++||.|||+ ..+++||||||+|||++.++.+||+|
T Consensus 75 ~lv~ey~~~~~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 75 SICMEHMDGGSLDQVLKK---------AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEEeeccCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEcc
Confidence 999999999999999832 2468899999999999999999993 25899999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++...... .....|+..|+|||.+.+..++.++||||||+++||+++|+.|+....... +..+......
T Consensus 144 fg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~ 215 (308)
T cd06615 144 FGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVS 215 (308)
T ss_pred CCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccc
Confidence 99987553321 233578999999999988889999999999999999999999986432111 1111000000
Q ss_pred cCcc--------------------ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 551 AGKV--------------------WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 551 ~g~l--------------------~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.... .+..+......... .........+.+++.+|++.+|++|||+.+|++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000 00000000000000 00011234577899999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.09 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=200.7
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+|++++++++. .++.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR------RKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE------ECCE
Confidence 36888999999999999999976 57899999886532 233467899999999999999999999997 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++++.+..++. ....+++..++.++.+++.||.||| +.+++||||||+||++++++.+||+
T Consensus 75 ~~iv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~ 142 (288)
T cd07833 75 LYLVFEYVERTLLELLEA---------SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLC 142 (288)
T ss_pred EEEEEecCCCCHHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEE
Confidence 999999999887776552 2345899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh---
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV--- 545 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v--- 545 (683)
|||++...............++..|+|||++... .++.++||||||+++||+++|+.|+......+.. ..+..+.
T Consensus 143 d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~ 221 (288)
T cd07833 143 DFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLGPL 221 (288)
T ss_pred eeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCC
Confidence 9999987765443334456788999999999888 8899999999999999999999998643221100 0000000
Q ss_pred ----hhhhh-cCc-----cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 ----WSLVK-AGK-----VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ----~~~~~-~g~-----l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..+. ... ..+..++..... ..+......+.+++..|++.+|++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 222 PPSHQELFSSNPRFAGVAFPEPSQPESLER-----RYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHhhhcccCccccccccCCCCCcHHHHH-----hcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000 000000000000 011122467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=305.38 Aligned_cols=250 Identities=18% Similarity=0.287 Sum_probs=198.9
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+|...++||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++.+. .+...+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE------ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE------ECCEEE
Confidence 4677889999999999999965 68899999986432 333567889999999999999999999986 557899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++... ....+++...+.++.+++.||.||| +.+|+|+||||+||++++++.++|+||
T Consensus 75 lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~df 144 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQ-------RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDF 144 (255)
T ss_pred EEEeeCCCCcHHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEccc
Confidence 999999999999887321 2345788899999999999999999 899999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+++....... ......|+..|+|||++....++.++||||||++++||++|+.||..... ....... ..
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~-~~ 214 (255)
T cd08219 145 GSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKV-CQ 214 (255)
T ss_pred Ccceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHH-hc
Confidence 99976643222 22345789999999999988999999999999999999999999864221 1111221 12
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.... + +......+.+++..|++.||++|||+.+++..
T Consensus 215 ~~~~~-----~----------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GSYKP-----L----------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCC-----C----------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22111 0 11123356788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=319.63 Aligned_cols=201 Identities=26% Similarity=0.368 Sum_probs=171.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...++||+|+||.||+++.+ +++.+|+|.+.+.. ......+.+|+.++..++|+||+++.+++. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ------DEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe------cCC
Confidence 46888999999999999999976 46789999986432 122345889999999999999999999886 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~--------~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL 143 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKF--------EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRL 143 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEE
Confidence 899999999999999999421 246889999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
+|||+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 144 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred eecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 999999765444333344567999999999986 35688999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=319.66 Aligned_cols=201 Identities=26% Similarity=0.356 Sum_probs=171.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++..++|+||+++++++. ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~------~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ------DEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------cCC
Confidence 47888999999999999999975 57889999986532 122345888999999999999999999986 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++... ...+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~--------~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl 143 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKF--------EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRL 143 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEE
Confidence 899999999999999998421 246888899999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
+|||+++..............||++|+|||++.. +.++.++|||||||++|||++|+.||..
T Consensus 144 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 144 ADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 9999998765443333344679999999999875 5688999999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=308.44 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=196.8
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc------ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...+.||+|+||.||+|...+|+.+|||++...... ....+.+|++++++++|+||+++++++. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL------DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee------cC
Confidence 36677899999999999999888999999988653221 1245889999999999999999999987 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++.. ...+++..+..++.|++.||+||| +.+|+|+||||+||++++++.+|
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 142 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR---------FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIK 142 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEE
Confidence 789999999999999999832 236889999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCC-----ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 468 VADFGLAKQSREGQ-----SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 468 LaDFGla~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
|+|||+++...... ........|+..|+|||++.+..++.++||||||++++|+++|+.||.......
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------- 215 (265)
T cd06631 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------- 215 (265)
T ss_pred eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------
Confidence 99999987653211 112234568999999999998889999999999999999999999986432110
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... ...... ...+.+.. .....+..++..|++.+|++||++.++++
T Consensus 216 ~~~--~~~~~~---~~~~~~~~----------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 AMF--YIGAHR---GLMPRLPD----------SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHH--Hhhhcc---CCCCCCCC----------CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000000 00111111 12345678899999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.74 Aligned_cols=254 Identities=31% Similarity=0.470 Sum_probs=195.8
Q ss_pred eeeeecCceEEEEEEEcC-------CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 319 NFIGRGGFGLVYKGILQD-------GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~-------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+.||+|+||.||+|+..+ ++.+|+|.+..... ....+|.+|+++++.++|+||+++++++. .....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL------LNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec------CCCCe
Confidence 369999999999998653 25799998765432 33567999999999999999999999986 45578
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-----c
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-----R 465 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-----~ 465 (683)
++||||+++|+|.+++...... ......++|.+++.++.+++.||+||| +.+++|+||||+||+++.+. .
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~ 149 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVE--RFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRV 149 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhc--ccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcc
Confidence 9999999999999999543211 112345889999999999999999999 88999999999999999877 8
Q ss_pred EEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 466 ARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ |+.|+..... . +
T Consensus 150 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~---~ 221 (269)
T cd05044 150 VKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----Q---E 221 (269)
T ss_pred eEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----H---H
Confidence 999999999865433221 1223345788999999999999999999999999999998 9999863321 1 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. .....+.. +. .+......+.+++..|++.+|.+||+|.+|+++|++
T Consensus 222 ~~-~~~~~~~~-------~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 222 VL-QHVTAGGR-------LQ--------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HH-HHHhcCCc-------cC--------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111110 00 111234567789999999999999999999999873
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=321.54 Aligned_cols=244 Identities=26% Similarity=0.353 Sum_probs=187.0
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHH-HHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVE-IISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~-iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+.||+|+||.||+++.. +++.||+|.+..... ....++..|.. +++.++|+||+++++++. ..+..++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~------~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ------TADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE------cCCeEEEE
Confidence 36999999999999975 577899999875321 22334455544 567899999999999886 56789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...+.+.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~ 142 (325)
T cd05602 75 LDYINGGELFYHLQR---------ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL 142 (325)
T ss_pred EeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCC
Confidence 999999999998842 235777888889999999999999 89999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...... .+.
T Consensus 143 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~-~~~ 212 (325)
T cd05602 143 CKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNIL-NKP 212 (325)
T ss_pred CcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHH-hCC
Confidence 97543222 123446799999999999999999999999999999999999999964221 11111111 111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
. .+.+ .....+.+++..|++.+|.+||++.+.+..+.
T Consensus 213 ~--~~~~--------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 213 L--QLKP--------------NITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred c--CCCC--------------CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 1 0011 12335677888999999999999876554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.90 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=199.1
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|++|.||+++.. +++.||+|++..... ...+.+.+|++++++++|+|++++++.+.. .....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-----EDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-----CCCEE
Confidence 4778899999999999999965 578899999865432 234568899999999999999999987642 23467
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
+++|||+++++|.+++... ....+++.+++.++.+++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 76 ~lv~e~~~~~~l~~~l~~~-------~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~d 145 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQ-------KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGD 145 (257)
T ss_pred EEEecccCCCcHHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEec
Confidence 8999999999999998432 2346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++....... ......|++.|+|||+..+..++.++||||||++++|+++|+.||+... ...+.....
T Consensus 146 f~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~- 215 (257)
T cd08223 146 LGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRII- 215 (257)
T ss_pred ccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHH-
Confidence 999987643222 2334568999999999999999999999999999999999999986321 112222221
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+.+. .+ +......+.+++..|++.+|++|||+.++++.
T Consensus 216 ~~~~~-----~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 216 EGKLP-----PM----------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred hcCCC-----CC----------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 22211 01 11233467789999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=310.08 Aligned_cols=263 Identities=25% Similarity=0.349 Sum_probs=199.4
Q ss_pred cccceeeeecCceEEEEEEEc----CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
|...+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++|||++++++++..........
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999864 36889999986542 223456889999999999999999999886432211223
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++++||+++|+|.+++...... .....+++...++++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG---EEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEE
Confidence 457899999999999887533211 12235788899999999999999999 789999999999999999999999
Q ss_pred cccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 469 ADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 469 aDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
+|||+++....+... ......++..|++||.+....++.++||||||+++|||++ |+.|+..... ..+..+.
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~~~~~- 228 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEIYNYL- 228 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHHHHHH-
Confidence 999999866433221 1223446678999999998889999999999999999999 8888753221 1111111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+... . .+......+.+++..|++.+|++||++.++++.|++
T Consensus 229 ---~~~~~~-----~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 229 ---IKGNRL-----K----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred ---HcCCcC-----C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111100 0 001123467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.89 Aligned_cols=204 Identities=24% Similarity=0.343 Sum_probs=170.7
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
..++|...+.||+|+||.||+++.. .++.||||++.... ......+.+|+.+++.++|+||+++++++.........
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999965 58899999986532 22345688999999999999999999987644333344
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++ +|.+++. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEE
Confidence 568999999975 6666551 24788889999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
|+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 167 L~DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 167 ILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred EEeCCCccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 9999999865432 2233457899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=313.72 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=196.3
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.|+..++||+|+||.||++... +++.||||++....... .+.+.+|+.++++++|+|++++.+.+. ....
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~------~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE------TKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe------cCCE
Confidence 3667789999999999999865 68899999987543322 345788999999999999999999886 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++... ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~-------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHM-------GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred EEEEEEecCCCcHHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999988432 1235889999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||++........ .....||..|+|||++.+..++.++||||||+++|||++|+.||........ . +-.....
T Consensus 145 Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----~-~~~~~~~ 217 (285)
T cd05630 145 DLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----R-EEVERLV 217 (285)
T ss_pred eccceeecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----H-HHHHhhh
Confidence 9999876543322 1234789999999999999999999999999999999999999975322110 0 0011111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
... ..... ......+.+++..|++.||++||| +.|+++
T Consensus 218 ~~~------~~~~~----------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 218 KEV------QEEYS----------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhh------hhhcC----------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 100 00111 112334678889999999999999 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.75 Aligned_cols=239 Identities=23% Similarity=0.354 Sum_probs=185.5
Q ss_pred eeeecCceEEEEEEEcC--------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 320 FIGRGGFGLVYKGILQD--------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.||+|+||.||+|...+ ...||+|.+........+++.+|+.+++.++|+|++++++++. .+...+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~------~~~~~~ 75 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV------CGDESI 75 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE------eCCCcE
Confidence 69999999999998642 2348888876554444567899999999999999999999997 446689
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc------
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR------ 465 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~------ 465 (683)
+||||+++|+|.+++... ...++|..+++++.|++.||+||| +.+|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~ 144 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKN--------KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNP 144 (258)
T ss_pred EEEecCCCCcHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCC
Confidence 999999999999998432 236899999999999999999999 899999999999999987765
Q ss_pred --EEEcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCC-CCCCCCCCCCCCccch
Q 005691 466 --ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGR-KALDLSTSGSPRACLI 541 (683)
Q Consensus 466 --~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr-~p~~~~~~~~~~~~~l 541 (683)
+|++|||++..... .....++..|+|||++... .++.++||||||+++|||++|. .|+..... .
T Consensus 145 ~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-----~-- 212 (258)
T cd05078 145 PFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-----Q-- 212 (258)
T ss_pred ceEEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-----H--
Confidence 58999998765432 1235678899999999864 5799999999999999999995 44432111 0
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
... ..... + ..+. ......+..++..|++.+|++|||+.++++.|+
T Consensus 213 -~~~-~~~~~-~------~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 -KKL-QFYED-R------HQLP----------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHH-HHHHc-c------ccCC----------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 01111 0 0011 111245778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.50 Aligned_cols=192 Identities=27% Similarity=0.313 Sum_probs=164.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+|...+.||+|+||.||+++.. .++.||||... ...+.+|++++++++|+|||++++++. .+...+
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~------~~~~~~ 236 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV------VGGLTC 236 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE------ECCEEE
Confidence 36888999999999999999976 47889999632 234678999999999999999999987 456789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|||++. ++|.+++.. ....++|.+++.|+.|+++||.||| +.+|+||||||+||||+.++.+||+||
T Consensus 237 lv~e~~~-~~L~~~l~~--------~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DF 304 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGA--------RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDF 304 (461)
T ss_pred EEEEccC-CCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEccc
Confidence 9999995 788887732 1246999999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCC
Q 005691 472 GLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 472 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
|+++....... .......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 305 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 305 GAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 99987643322 2233467999999999999999999999999999999999988765
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.39 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=198.6
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+|+.. +++.|++|.+...... ..+.+.+|++++++++|+||+++++++. .....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV------HREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe------cCCEE
Confidence 4677889999999999999965 6889999998765443 4567999999999999999999999876 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++|+||+++++|.+++.. ...+++..++.|+.++++||+||| +.+|+|+||||+||++++++.+||+|
T Consensus 75 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d 142 (264)
T cd06626 75 YIFMEYCSGGTLEELLEH---------GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGD 142 (264)
T ss_pred EEEEecCCCCcHHHHHhh---------cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcc
Confidence 999999999999999842 235889999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccc---cccCCCcccCccccccCC---CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 471 FGLAKQSREGQSHLTT---RVAGTHGYLAPEYALYGQ---LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 471 FGla~~~~~~~~~~~~---~~~GT~~Y~APE~~~~~~---~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||++............ ...++..|+|||++.... ++.++||||||++++|+++|+.||..... .|
T Consensus 143 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---------~~ 213 (264)
T cd06626 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------EF 213 (264)
T ss_pred cccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---------hH
Confidence 9998876543332221 356889999999998766 88999999999999999999999864321 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
......... ..+.+... ......+..++..|++.+|.+|||+.+++.
T Consensus 214 ~~~~~~~~~----~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 214 QIMFHVGAG----HKPPIPDS--------LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHhcC----CCCCCCcc--------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111100 01111111 112345668889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=309.29 Aligned_cols=248 Identities=28% Similarity=0.405 Sum_probs=199.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+|++++++++. .+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL------KGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE------ECCeE
Confidence 36777889999999999999975 58899999986543 333457899999999999999999999987 45789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++|+||+++++|.+++. ...+++...+.++.|++.||.||| +.+++||||+|+||++++++.++|+|
T Consensus 75 ~~v~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d 141 (274)
T cd06609 75 WIIMEYCGGGSCLDLLK----------PGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLAD 141 (274)
T ss_pred EEEEEeeCCCcHHHHHh----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcc
Confidence 99999999999999983 127899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+...... ..... ..
T Consensus 142 ~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~-~~ 211 (274)
T cd06609 142 FGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFL-IP 211 (274)
T ss_pred cccceeeccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHH-hh
Confidence 999987654322 223456889999999999988999999999999999999999998643221 11111 11
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+. .+.+... .....+..++..|++.+|++|||++++++
T Consensus 212 ~~~-----~~~~~~~---------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 212 KNN-----PPSLEGN---------KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hcC-----CCCCccc---------ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111 1111110 02345678889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.12 Aligned_cols=199 Identities=28% Similarity=0.417 Sum_probs=177.7
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+....||.|+||+|...+.+ +|..+|.|.+.+...-. .+...+|..+|+.+.||.+++|.+.+. +..
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~------d~~ 117 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK------DNS 117 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec------cCC
Confidence 46777889999999999999975 58889999997654333 345789999999999999999999886 678
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|.|..+|+ +.+.++....+-++.+|+.||+||| +..|++|||||+|||||.+|.+||
T Consensus 118 ~lymvmeyv~GGElFS~Lr---------k~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLR---------KSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred eEEEEEeccCCccHHHHHH---------hcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEE
Confidence 8999999999999999994 3457999999999999999999999 999999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
.|||+|+..... +-..+||+.|+|||.+....+...+|.|+|||++|||+.|.+||...++
T Consensus 186 tDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 186 TDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred EeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 999999987543 5568999999999999999999999999999999999999999976543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=312.08 Aligned_cols=270 Identities=24% Similarity=0.292 Sum_probs=197.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++|+|++++++++. .+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR------RKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe------eCCE
Confidence 46888899999999999999976 589999999865432 23456889999999999999999999986 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++++|..++. ....++|..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 75 ~~~v~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~ 142 (286)
T cd07847 75 LHLVFEYCDHTVLNELEK---------NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLC 142 (286)
T ss_pred EEEEEeccCccHHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEEC
Confidence 899999999999888762 1236899999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh----hh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT----DW 544 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~----~~ 544 (683)
|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ..+. .+
T Consensus 143 dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~ 220 (286)
T cd07847 143 DFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL-YLIRKTLGDL 220 (286)
T ss_pred ccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCC
Confidence 9999987654322 1223467889999999875 56789999999999999999999998643321100 0000 00
Q ss_pred hhh---hhhcCcc-ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWS---LVKAGKV-WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~---~~~~g~l-~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+ .+..+.. .....+......... .........+.+++..|++.+|++||++.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IPRHQQIFSTNQFFKGLSIPEPETREPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ChHHhhhcccccccccccCCCcccccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 0000000 000000000000000 000112346778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.02 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=202.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++|+|+++++|++. .+...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~~~~ 75 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL------RRDKL 75 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE------eCCEE
Confidence 367888999999999999999975 57889999987665556678999999999999999999999886 56689
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
+++|||+++++|.+++... ...+++...+.++.|++.||+||| +.+|+|+||||+||++++++.+||+|
T Consensus 76 ~l~~e~~~~~~l~~~~~~~--------~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d 144 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVT--------RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLAD 144 (262)
T ss_pred EEEEeCCCCCcHHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECc
Confidence 9999999999999988322 246889999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC---CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG---QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.|+....... . ...
T Consensus 145 ~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~----~----~~~ 215 (262)
T cd06613 145 FGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR----A----LFL 215 (262)
T ss_pred cccchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----H----HHH
Confidence 999876543221 12335688899999998776 88999999999999999999999986432110 0 000
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...... -.+.+. ........+.+++.+|++.+|.+|||+.+|+.
T Consensus 216 -~~~~~~---~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 -ISKSNF---PPPKLK--------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -HHhccC---CCcccc--------chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111100 011111 11233456789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.80 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=195.7
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---------hHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---------DAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---------~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
+|.....||+|+||.||+|... +++.+|+|.+....... .+.+.+|++++++++|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL---- 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence 3566789999999999999864 58899999886543322 145889999999999999999999987
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.....++|+||+++++|.+++.. ...+++..+..++.+++.||+||| +.+++||||||+||+++++
T Consensus 77 --~~~~~~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~ 142 (267)
T cd06628 77 --DADHLNIFLEYVPGGSVAALLNN---------YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNK 142 (267)
T ss_pred --eCCccEEEEEecCCCCHHHHHHh---------ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCC
Confidence 45678999999999999999832 246888999999999999999999 8899999999999999999
Q ss_pred CcEEEcccCcccccccCCcc-----ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 464 MRARVADFGLAKQSREGQSH-----LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~-----~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
+.+||+|||+++........ ......|+..|+|||++..+.++.++||||||+++|||++|+.||......
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---- 218 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---- 218 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----
Confidence 99999999999876532111 112345889999999999889999999999999999999999998643210
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.-+... .. ...+.+. ....+.+..++..|++.+|.+||++.+|++
T Consensus 219 ----~~~~~~-~~-----~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 ----QAIFKI-GE-----NASPEIP----------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HHHHHH-hc-----cCCCcCC----------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001110 01 1111111 122346678889999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=305.02 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=199.0
Q ss_pred cccceeeeecCceEEEEEEEcC-----CcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 315 FSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~-----g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
|...+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|++++.+++|+|++++++++. ...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT------EEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc------CCC
Confidence 3456789999999999999764 488999998665443 4567999999999999999999999986 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..+++|||+++++|.+++.... ...++|.+++.++.+++.||+||| +.+++||||||+||++++++.+||
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l 144 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNR-------PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKI 144 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhh-------hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEE
Confidence 7999999999999999984321 112899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++..............++..|+|||.+....++.++||||+|++++||++ |+.|+..... . +. .+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~---~~-~~ 215 (258)
T smart00219 145 SDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----E---EV-LE 215 (258)
T ss_pred cccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----H---HH-HH
Confidence 9999998776543332223347889999999988889999999999999999998 7787754211 1 11 11
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
....+.... .+......+.+++..|++.+|++|||+.+++++|
T Consensus 216 ~~~~~~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGYRLP---------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCCCCC---------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 122221110 0111244677899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.22 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=192.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-----cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-----QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.+|...+.||+|+||.||+|... ++..||+|++..... +..+.+.+|++++++++|+||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR----A 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC----C
Confidence 47888999999999999999875 588999998864322 1234588999999999999999999987532 2
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
+...++++||+++++|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~ 145 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKA---------YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNV 145 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCE
Confidence 4578899999999999999832 235889999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc--cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++....... .......++.+|+|||++.+..++.++||||||+++|||++|+.||...... ..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~ 217 (266)
T cd06651 146 KLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AA 217 (266)
T ss_pred EEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HH
Confidence 9999999876543211 1122356899999999999888999999999999999999999998642110 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+....... ..+.+. ....+.+..+ +.|+..+|++||+|.||++
T Consensus 218 ~~~~~~~~-----~~~~~~----------~~~~~~~~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQP-----TNPQLP----------SHISEHARDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCC-----CCCCCc----------hhcCHHHHHH-HHHhcCChhhCcCHHHHhc
Confidence 11111111 111111 1112222233 4788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=319.01 Aligned_cols=269 Identities=20% Similarity=0.319 Sum_probs=194.7
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...+.||+|+||.||+|+.. +++.||+|++...... ....+.+|++++++++|+||+++++++. .+...
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH------TDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe------eCCeE
Confidence 56888899999999999999965 5788999998754332 3446889999999999999999999987 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++ +|.+++... ...+++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~D 147 (309)
T cd07872 80 TLVFEYLDK-DLKQYMDDC--------GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLAD 147 (309)
T ss_pred EEEEeCCCC-CHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECc
Confidence 999999985 777776321 235788999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh-------
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT------- 542 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~------- 542 (683)
||+++....... ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ..+.
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~ 225 (309)
T cd07872 148 FGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-HLIFRLLGTPT 225 (309)
T ss_pred cccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCC
Confidence 999976543222 1223467899999998865 56899999999999999999999999644321100 0000
Q ss_pred hhhhhhhhcCcc-ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKV-WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l-~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...|+.+....- ...-.+..... ... .........+.+++..|++.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 226 EETWPGISSNDEFKNYNFPKYKPQ-PLI-NHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHhhhcchhhhhhhhcCccCCC-chh-hhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000111100000 00000000000 000 000112345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.80 Aligned_cols=240 Identities=28% Similarity=0.347 Sum_probs=183.8
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhc---cCCCcccccceeeecCCCCCCCeeEEE
Q 005691 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNL---KHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 321 LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L---~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
||+|+||+||+|+.. +++.||||++...... ....+..|..++.+. +||||+++++++. .....++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~------~~~~~~lv 74 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ------TDSDLYLV 74 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe------cCCeEEEE
Confidence 799999999999965 5899999998653222 223455677777665 6999999998886 56789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++. ....+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 75 ~e~~~~g~L~~~l~---------~~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~ 142 (330)
T cd05586 75 TDYMSGGELFWHLQ---------KEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGL 142 (330)
T ss_pred EcCCCCChHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCc
Confidence 99999999998883 2346889999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
++....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||..... ....+.+..+
T Consensus 143 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---------~~~~~~i~~~ 212 (330)
T cd05586 143 SKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---------QQMYRNIAFG 212 (330)
T ss_pred CcCCCCCCC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---------HHHHHHHHcC
Confidence 875432221 23346799999999998754 479999999999999999999999864221 1112222222
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT----ISDALK 603 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt----m~eVl~ 603 (683)
.. .+.. ......+.+++..|++.||.+||+ +.++++
T Consensus 213 ~~------~~~~---------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KV------RFPK---------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CC------CCCC---------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11 1111 112335567889999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=308.42 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=197.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|...+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++|+||+++++++. .....+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~------~~~~~~ 82 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL------RRDKLW 82 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE------eCCEEE
Confidence 47777889999999999999864 58899999987655444566889999999999999999999986 457899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|+||+++++|.+++.. ...+++.+.+.++.+++.||.||| +.+|+|+||||+||+++.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 83 ICMEFCGGGSLQDIYHV---------TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEEeccCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcc
Confidence 99999999999998832 346889999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|++....... .......|+..|+|||++. .+.++.++|||||||++|||++|+.|+....+.. .+...
T Consensus 151 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--------~~~~~ 221 (267)
T cd06645 151 GVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLM 221 (267)
T ss_pred eeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--------hHHhh
Confidence 9987654321 1223457899999999874 4568899999999999999999999985332211 01111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. .... ..+..... ....+.+.+++..|++.+|++||++.+|++
T Consensus 222 ~-~~~~---~~~~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 222 T-KSNF---QPPKLKDK--------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred h-ccCC---CCCccccc--------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1 1111 00111100 012235678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=320.67 Aligned_cols=203 Identities=26% Similarity=0.423 Sum_probs=170.1
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
...++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++........
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34678999999999999999999864 67899999986532 2234567899999999999999999998864332223
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++++|++ +++|.+++. ...+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~ 157 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----------CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCEL 157 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCE
Confidence 45679999988 778887762 246899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
||+|||+++..... .....||..|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus 158 kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 158 RILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred EEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999865432 233568999999999876 5789999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.87 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=197.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|+..++||+|+||.||+|... +++.+++|.+........+.+.+|+++++.++|+|++++++++. .....+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~ 85 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY------WDGKLW 85 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE------eCCeEE
Confidence 56778889999999999999976 48899999987665555677899999999999999999999986 456799
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|..++... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 86 lv~e~~~~~~l~~~~~~~--------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~df 154 (292)
T cd06644 86 IMIEFCPGGAVDAIMLEL--------DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADF 154 (292)
T ss_pred EEEecCCCCcHHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccC
Confidence 999999999998877321 246899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|++....... .......++..|+|||++. ...++.++|||||||++|||++|+.|+..... .....
T Consensus 155 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~ 225 (292)
T cd06644 155 GVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLL 225 (292)
T ss_pred ccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHH
Confidence 9987543221 1123356889999999885 34578899999999999999999999854221 01111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.. .... .+.+. .+......+..++..|++.+|++||++.++++
T Consensus 226 ~~-~~~~-----~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 226 KI-AKSE-----PPTLS--------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HH-hcCC-----CccCC--------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 1111 11110 11122346778899999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.78 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=201.4
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..+.||+|+||.||.++.. +++.+++|++.... .....++.+|++++++++|+||+++++++. .....
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM------DDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe------cCCeE
Confidence 4778899999999999988854 58899999986543 333567899999999999999999999997 55789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
+++|||+++|+|.+++... ....+++.++..++.+++.||+||| +.+++||||||+||++++++.+||+|
T Consensus 75 ~~~~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d 144 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQ-------KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGD 144 (256)
T ss_pred EEEEEecCCCcHHHHHHhc-------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECc
Confidence 9999999999999998422 1346889999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++....... ......|+..|+|||+..+..++.++||||||++++||++|+.|+..... .+..... .
T Consensus 145 ~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~-~ 214 (256)
T cd08221 145 FGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKI-V 214 (256)
T ss_pred CcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH-H
Confidence 999987644332 22345689999999999988899999999999999999999999864221 1122221 1
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.+..... .......+..++..|++.+|++||++.++++.+
T Consensus 215 ~~~~~~~---------------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 215 QGNYTPV---------------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCCCCCC---------------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2221110 112234577889999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=335.15 Aligned_cols=272 Identities=24% Similarity=0.324 Sum_probs=192.6
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCC--CCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN--ERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~--~~~ 387 (683)
..++|...++||+|+||.||+|+.. +++.||||++.... ....+|+.+++.++|+|||++++++...... ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999975 58899999885432 2345799999999999999999987533211 122
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RA 466 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~ 466 (683)
...++||||+++ +|.+++.... .....+++...+.++.|++.||+||| +.+|+||||||+|||++.++ .+
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~-----~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYA-----RNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCce
Confidence 346799999985 6666653211 12356899999999999999999999 89999999999999999665 79
Q ss_pred EEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||......+ .+...
T Consensus 211 kL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~----~~~~i- 283 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD----QLVRI- 283 (440)
T ss_pred eeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHH-
Confidence 9999999987654332 223568999999998875 468999999999999999999999996432211 11111
Q ss_pred hhhhhc----------CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKA----------GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~----------g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.... ....+.--+..... +.....+......+.+++..|++.||.+|||+.|+++
T Consensus 284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPK-DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhCCCCHHHHHHhchhhhcccCCccCch-hHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000 00000000000000 0000001112346788999999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=328.69 Aligned_cols=196 Identities=24% Similarity=0.286 Sum_probs=168.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc---CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
..+|...+.||+|+||.||++... .+..||||.+... +.+.+|++++++++|+|||++++++. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~------~~~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR------WKS 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe------eCC
Confidence 457999999999999999999754 3578999987542 34568999999999999999999886 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+. ++|.+++. ....++|..++.|+.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 160 ~~~lv~e~~~-~~l~~~l~---------~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l 226 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVD---------RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVL 226 (392)
T ss_pred EEEEEehhcC-CCHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEE
Confidence 7899999996 67888772 2347999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 469 ADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 469 aDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
+|||+++....... .......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999986654332 2233567999999999999999999999999999999999999998644
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=324.18 Aligned_cols=192 Identities=23% Similarity=0.328 Sum_probs=162.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
...+|...+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++|+||+++++++. .+..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~ 131 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV------SGAI 131 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE------eCCe
Confidence 3467999999999999999999976 4678999864322 2456999999999999999999987 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++|+||+. ++|.+++.. ....++|..++.|+.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~~-~~l~~~l~~--------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTK--------RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred eEEEEEccC-CcHHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEe
Confidence 899999995 688887732 2346899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCC
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
|||+++...... ......||..|+|||++....++.++|||||||++|||+++..++
T Consensus 200 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999997543221 223467999999999999999999999999999999999976654
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.76 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=195.3
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--C--------hHHHHHHHHHHHhccCCCcccccceeeecC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--G--------DAEFCNEVEIISNLKHRNLVPLRGCCVVDG 382 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~--------~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~ 382 (683)
+|...+.||+|+||.||+|+.. +|+.||+|++...... . .+.+.+|+++++.++|+|++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 4667789999999999999864 6889999988542111 1 235788999999999999999999986
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.....++||||+++|+|.+++.. ...+++..+..++.+++.||.||| +.+++||||||+||+++.
T Consensus 79 ---~~~~~~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~ 143 (272)
T cd06629 79 ---TEEYLSIFLEYVPGGSIGSCLRT---------YGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDA 143 (272)
T ss_pred ---cCCceEEEEecCCCCcHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcC
Confidence 55778999999999999999832 246889999999999999999999 789999999999999999
Q ss_pred CCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCC--CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 463 DMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
++.+||+|||+++........ ......|+..|+|||.+.... ++.++||||||+++||+++|+.|+.....
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------ 217 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------ 217 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------
Confidence 999999999999765432211 233456899999999987654 78999999999999999999999853211
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
. ......... .....++..+. .+....+.+++..|++.+|.+||||.+|++.
T Consensus 218 -~-~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 218 -I-AAMFKLGNK-RSAPPIPPDVS----------MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -H-HHHHHhhcc-ccCCcCCcccc----------ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1 111111111 11111111111 1224567788899999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=311.10 Aligned_cols=265 Identities=24% Similarity=0.374 Sum_probs=204.3
Q ss_pred ehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 304 ~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
++.++..+.+.|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+|++++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45666677889999999999999999999974 57889999875533 3345688999999998 799999999998644
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
...+.....+++|||+++|+|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+||+++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~ 155 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-------GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLT 155 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEC
Confidence 33334567899999999999999884321 235788888999999999999999 88999999999999999
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
+++.+||+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........
T Consensus 156 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 156 ENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred CCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 999999999999876543221 123356899999999876 34678899999999999999999999864322110
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+ .. .. ....+.+ ........+.+++..|++.||.+|||+.|+++
T Consensus 235 ----~----~~-~~-----~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 ----L----FL-IP-----RNPPPKL---------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----h----hh-Hh-----hCCCCCC---------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00 00 0001111 11123446788999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=310.06 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=199.6
Q ss_pred cCcccceeeeecCceEEEEEEEcC-Cc----EEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GT----TVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~----~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||.||+|...+ |. .+|+|.+..... ....++.+|++++++++|+|+++++|+|.
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------- 79 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL------- 79 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-------
Confidence 467778899999999999999653 33 589998765543 23457899999999999999999999986
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++|+||+++|+|.+++... ...++|..++.++.|++.||+||| +.+|+||||||+|||+++++.+
T Consensus 80 ~~~~~~v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~ 148 (279)
T cd05057 80 SSQVQLITQLMPLGCLLDYVRNH--------KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHV 148 (279)
T ss_pred cCceEEEEecCCCCcHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeE
Confidence 25789999999999999998432 235899999999999999999999 7999999999999999999999
Q ss_pred EEcccCcccccccCCccc-cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++......... .....++..|+|||....+.++.++||||||++++|+++ |+.|++.... .++
T Consensus 149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~ 220 (279)
T cd05057 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEI 220 (279)
T ss_pred EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHH
Confidence 999999998765433222 122234678999999988899999999999999999999 9999864321 112
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
. .....+... . .+......+..++..|+..+|.+||++.++++.|+..
T Consensus 221 ~-~~~~~~~~~--------~-------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 221 P-DLLEKGERL--------P-------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred H-HHHhCCCCC--------C-------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 112222110 0 0011123567888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.70 Aligned_cols=271 Identities=23% Similarity=0.275 Sum_probs=197.8
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-----ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-----GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-----~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...+.||+|+||.||+|... +|+.||||++...... ....+.+|++++++++|+||+++++++. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG------HK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee------cC
Confidence 4677889999999999999975 6899999999765433 2345778999999999999999999987 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+ +|+|.+++... ...++|..+++++.|+++||.||| +.+|+|+||||+||+++.++.+|
T Consensus 75 ~~~~lv~e~~-~~~L~~~i~~~--------~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 75 SNINLVFEFM-ETDLEKVIKDK--------SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred CEEEEEEccc-CCCHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEE
Confidence 6899999999 99999998321 136999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh----
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT---- 542 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~---- 542 (683)
|+|||+++....... ......++..|+|||++.. ..++.++|||||||+++|+++|.+++......+.. ..+.
T Consensus 143 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~-~~~~~~~~ 220 (298)
T cd07841 143 LADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL-GKIFEALG 220 (298)
T ss_pred EccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH-HHHHHHcC
Confidence 999999987654322 1233456888999998864 46789999999999999999998777543221000 0000
Q ss_pred ---hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc
Q 005691 543 ---DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM--LEG 607 (683)
Q Consensus 543 ---~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~--L~~ 607 (683)
...|... .................. .........+.+++..|++.+|++|||+.||++. +++
T Consensus 221 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 221 TPTEENWPGV--TSLPDYVEFKPFPPTPLK-QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred CCchhhhhhc--ccccccccccccCCcchh-hhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0000000 000000000000000000 0001224577899999999999999999999986 554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.51 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=202.8
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..+.||.|+||.||++... +++.+|+|.+..... ...+.+.+|++++++++|+|++++++++... .+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR----SNQTL 76 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC----CCCEE
Confidence 4677889999999999999864 678999999865432 2245688999999999999999999987532 34568
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc--CCCccccCCCCCceeeccCCcEEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV--KPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~--~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
+++|||+++++|.+++.... .....+++...+.++.+++.||.|||... +.+++|+||||+||++++++.+||
T Consensus 77 ~~~~e~~~~~~L~~~l~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 77 YIVMEYCEGGDLAQLIQKCK-----KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred EEEehhccCCCHHHHHHHHh-----hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 99999999999999984322 12357899999999999999999999554 678999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++........ .....|+..|+|||++....++.++||||||++++||++|+.|+..... . .+. +.
T Consensus 152 ~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~---~~~-~~ 221 (265)
T cd08217 152 GDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----L---QLA-SK 221 (265)
T ss_pred ecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----H---HHH-HH
Confidence 999999876543321 2335689999999999998999999999999999999999999874321 1 111 11
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
...+... .+ +......+.+++..|++.+|++||+|.+|+++
T Consensus 222 ~~~~~~~-----~~----------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 IKEGKFR-----RI----------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HhcCCCC-----CC----------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 2222111 11 11234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.75 Aligned_cols=267 Identities=24% Similarity=0.315 Sum_probs=211.7
Q ss_pred hcCcccceeeeecCceEEEEEE-EcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|.+.+.||+|||.-||.++ +.++..+|+|++.....++.+..++|++.-++++|||+++++.++...... ...+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D-~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD-GKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc-CceeE
Confidence 4689999999999999999998 667899999999888877888899999999999999999999998744321 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
||+++|...|||.+.+... ..++..+++.+.+.|+.+|.+||++||+. .++++||||||.|||+.+.+.++|.|
T Consensus 99 yll~Pyy~~Gsl~d~i~~~-----k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERL-----KIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred EEEeehhccccHHHHHHHH-----hhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence 9999999999999998432 23455799999999999999999999944 45699999999999999999999999
Q ss_pred cCcccccccC---Cccc-----cccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 471 FGLAKQSREG---QSHL-----TTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 471 FGla~~~~~~---~~~~-----~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
||.+...+-. .... -....-|..|+|||.+. +...++++|||||||+||+|+.|..||+.....+
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---- 248 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---- 248 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC----
Confidence 9998765321 1100 11234689999999886 4567899999999999999999999997543311
Q ss_pred chhhhhhhhhhcCcc-ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 540 LITDWVWSLVKAGKV-WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l-~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
|.+ ..+..+.+.-. ...-..+.+.+++.+|+++||.+||++.+++..++.
T Consensus 249 ------------gSlaLAv~n~q~s~P------~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 249 ------------GSLALAVQNAQISIP------NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ------------CeEEEeeeccccccC------CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111 11111122111 111146678899999999999999999999998874
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=305.55 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=198.9
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..++||+|+||.||++... +|+.||+|++.... ....+++.+|++++++++|+||+++.+++. .....
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE------ENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec------CCCeE
Confidence 4778899999999999999864 68899999986542 223457999999999999999999999886 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++... ....+++.++++++.|++.||.||| +.+++|+||+|+||+++.++.+||+|
T Consensus 75 ~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d 144 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQ-------RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGD 144 (256)
T ss_pred EEEEecCCCCcHHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEee
Confidence 9999999999999988422 1235788999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||++........ ......|+..|+|||+...+.++.++||||||++++|+++|+.|+.... ..+.+....
T Consensus 145 ~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~- 214 (256)
T cd08218 145 FGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKII- 214 (256)
T ss_pred ccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHh-
Confidence 999976543322 1223468899999999998899999999999999999999999986321 112222221
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.... .+......+..++..|++.+|++||+|.+|++
T Consensus 215 ~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 215 RGSYPP---------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCCCC---------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111100 11122345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.45 Aligned_cols=197 Identities=22% Similarity=0.323 Sum_probs=162.0
Q ss_pred ceeeeec--CceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 318 KNFIGRG--GFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 318 ~~~LG~G--gfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
.++||+| +||+||+++.. +|+.||+|++...... ..+.+.+|+++++.++||||+++++++. .++..++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~------~~~~~~l 76 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI------ADNELWV 76 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE------ECCEEEE
Confidence 4679999 78999999864 6899999998654322 2345778999999999999999999997 4567999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.++++||+
T Consensus 77 v~e~~~~~~l~~~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~ 146 (327)
T cd08227 77 VTSFMAYGSAKDLICTHF-------MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR 146 (327)
T ss_pred EEeccCCCcHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccc
Confidence 999999999999984321 235899999999999999999999 8899999999999999999999999998
Q ss_pred cccccccCCc-c-----ccccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 473 LAKQSREGQS-H-----LTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 473 la~~~~~~~~-~-----~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
.......... . ......++..|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 6543321111 0 1122356788999999876 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.92 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=201.0
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~ 384 (683)
+-.++|..++.||+|.|++||+++.. .++++|||++.+.- .+..+-...|-++|.+| .||.||+|+-.+.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ----- 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ----- 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee-----
Confidence 33467888899999999999999954 68999999986532 22234467889999999 8999999998886
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
+...+|+|+||++||.|.++|. +.+.|+....+-.+.+|..||+||| +.+||||||||+|||||.||
T Consensus 145 -D~~sLYFvLe~A~nGdll~~i~---------K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 145 -DEESLYFVLEYAPNGDLLDLIK---------KYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred -cccceEEEEEecCCCcHHHHHH---------HhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCC
Confidence 6678999999999999999994 3357888889999999999999999 99999999999999999999
Q ss_pred cEEEcccCcccccccCCcc----------cc--ccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 465 RARVADFGLAKQSREGQSH----------LT--TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~----------~~--~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
++||+|||.|+.+.+.... .. ...+||-.|.+||++..+..+..+|+|+|||+||+|+.|++||...+
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999987543221 11 34789999999999999999999999999999999999999997543
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+ ++ +.+.+. .+|-.+... ..+...+|+..-+-.||.+|+|..||-+.
T Consensus 292 e------yl---iFqkI~------~l~y~fp~~----------fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 292 E------YL---IFQKIQ------ALDYEFPEG----------FPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H------HH---HHHHHH------HhcccCCCC----------CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2 11 111111 112222222 22344566677778999999999998764
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.70 Aligned_cols=257 Identities=29% Similarity=0.427 Sum_probs=202.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..+.||+|+||+||+|... ++..+|+|++..... ...+.+.+|+++++.++|+|++++++.+. .+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV------VGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe------eCCEE
Confidence 46888999999999999999964 678999999865432 24567999999999999999999999886 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++|+||+++++|.+++.... ....+++.....++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~d 145 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSY------PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIAD 145 (267)
T ss_pred EEEEeccCCCcHHHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcc
Confidence 99999999999999984321 1246889999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCcc---ccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 471 FGLAKQSREGQSH---LTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 471 FGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||++......... ......|+..|+|||++... .++.++|||||||+++||++|+.|+....... .+.
T Consensus 146 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~---- 217 (267)
T cd06610 146 FGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLM---- 217 (267)
T ss_pred cchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHH----
Confidence 9998776543322 22345689999999998877 78999999999999999999999986443211 111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..... .+.+... .........+.+++..|++.||++||++.++++
T Consensus 218 ~~~~~~------~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 218 LTLQND------PPSLETG-----ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHhcCC------CCCcCCc-----cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111110 1111111 011233456788999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.18 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=198.5
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+|++++++++. .+...+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~ 78 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL------KGTKLW 78 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------ECCEEE
Confidence 4666778999999999999975 58899999886543 233457899999999999999999999987 567899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++. ...+++.+...++.+++.||+||| +.+++|+||+|+||+++.++.++|+||
T Consensus 79 lv~e~~~~~~L~~~i~----------~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~df 145 (277)
T cd06640 79 IIMEYLGGGSALDLLR----------AGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEecCCCCcHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEccc
Confidence 9999999999999883 235788889999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|++........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+....... ... ....
T Consensus 146 g~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~-~~~~ 215 (277)
T cd06640 146 GVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLF-LIPK 215 (277)
T ss_pred ccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhh-hhhc
Confidence 99976643322 2233568899999999998889999999999999999999999986432211 000 0011
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+. .+. ........+.+++..|++.+|++||++.++++.
T Consensus 216 ~~-----~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 NN-----PPT----------LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CC-----CCC----------CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 10 011 112345567889999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.78 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=194.6
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
...||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+|++++++.+. .++..++||||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~------~~~~~~lv~e~ 100 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL------VGDELWVVMEF 100 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee------cCCeEEEEEeC
Confidence 356999999999999864 58899999987655555667899999999999999999999986 56789999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++++|.+++. ...+++..++.++.+++.||+||| +.+|+||||||+||++++++.+||+|||++..
T Consensus 101 ~~~~~L~~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 101 LEGGALTDIVT----------HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred CCCCcHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 99999999872 235889999999999999999999 88999999999999999999999999999876
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
...... ......|+..|+|||+.....++.++||||||++++|+++|+.|+...... .-. .... .
T Consensus 168 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~-~~~~-----~ 232 (292)
T cd06658 168 VSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAM-RRIR-----D 232 (292)
T ss_pred cccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH-HHHH-----h
Confidence 543222 223356899999999998888999999999999999999999998632210 000 0111 1
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+.+.+... ......+..++..|++.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~--------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 NLPPRVKDS--------HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCCCccccc--------cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111211111 0112345677888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.71 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=200.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..+.||+|+||.||++... +++.||+|++..... ...+++.+|++++++++|+||+++++++. .....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY------NNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee------cCCEE
Confidence 35677789999999999999976 688999999876533 34567999999999999999999999987 45789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCCceeeccCCcEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
++++||+++++|.+++... ...+++....+++.+++.||+||| + .+++|+||||+||++++++.+||+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 75 SICMEYMDGGSLDKILKEV--------QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--------cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEe
Confidence 9999999999999998422 156888899999999999999999 7 899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||.+......... ...++..|+|||++....++.++||||||++++||++|+.|+....... ....+......
T Consensus 144 d~g~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~ 217 (265)
T cd06605 144 DFGVSGQLVNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIV 217 (265)
T ss_pred ecccchhhHHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHh
Confidence 99998765432221 2678899999999999999999999999999999999999986442211 11112221111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... -+.+ ........+.+++..|++.+|++|||+.+++.
T Consensus 218 ~~~------~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 218 NEP------PPRL---------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cCC------CCCC---------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 110 0111 11113446778999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=306.77 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=196.9
Q ss_pred cccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChH--HHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~--~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
|+..+.||+|+||+||+++... ++.+|+|++......... ....|+.++++++|+||+++++++. .....+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ------DDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE------ESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc------cccccc
Confidence 4567899999999999999764 568999999776544322 3456999999999999999999987 467889
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|.+++. ....+++..++.++.++++||+||| +.+|+||||||+||+++++++++|+||
T Consensus 75 ~v~~~~~~~~L~~~l~---------~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Df 142 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQ---------KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDF 142 (260)
T ss_dssp EEEEEETTEBHHHHHH---------HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSG
T ss_pred cccccccccccccccc---------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 9999999999999994 2357899999999999999999999 789999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc-cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|.+.... ..........+|..|+|||.+. ...++.++||||+|++++||++|+.|+......+ ......+..
T Consensus 143 g~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~~- 215 (260)
T PF00069_consen 143 GSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-----QLEIIEKIL- 215 (260)
T ss_dssp TTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-----HHHHHHHHH-
T ss_pred ccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccchh-----hhhhhhhcc-
Confidence 9987642 1222344567899999999998 8889999999999999999999999987431100 000111000
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.... .... .........+.+++..|++.||++||++.++++
T Consensus 216 ~~~~----~~~~--------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 216 KRPL----PSSS--------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTHH----HHHT--------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccc----cccc--------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000 001111257889999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.90 Aligned_cols=270 Identities=22% Similarity=0.288 Sum_probs=193.9
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++.+++|+|++++++++. .+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM------QESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe------eCCeE
Confidence 4777889999999999999975 689999999865322 22457889999999999999999999987 45689
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++ ++|.+++.... ....+++..++.++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 144 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLP------KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLAD 144 (285)
T ss_pred EEEEecCC-CCHHHHHhcCC------CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECc
Confidence 99999997 68888773221 2346899999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh------h
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT------D 543 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~------~ 543 (683)
||+++...... .......+++.|+|||++... .++.++||||||++++||++|+.||............+. .
T Consensus 145 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
T cd07861 145 FGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE 223 (285)
T ss_pred ccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 99987654322 122334578899999988654 578999999999999999999999864321100000000 0
Q ss_pred hhhhhhhc-CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKA-GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~-g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
-.|+.... ......++...... ..........++.+++..|++.||++|||+.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGS---LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhcchhhHHHHhhccccCcch---hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 00000000000000 00000112345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=348.18 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=200.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...++||+|+||.||+|+.. +|+.||||++...... ..++|.+|++++++++||||+++++++. .++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~------d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS------DGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe------eCC
Confidence 57888999999999999999975 5889999998653222 2456999999999999999999999986 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCC--CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDG--SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~--~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
..++||||+++|+|.+++....... .......+++..+++|+.|+++||+||| +.+|+||||||+|||++.++.+
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~v 152 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEV 152 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCE
Confidence 7999999999999999885321110 0112345678888999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc-----------------cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCC
Q 005691 467 RVADFGLAKQSREGQS-----------------HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529 (683)
Q Consensus 467 KLaDFGla~~~~~~~~-----------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~ 529 (683)
||+|||+++....... .......||+.|||||++.+..++.++|||||||+++||++|+.||.
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 9999999986521110 01123579999999999999999999999999999999999999986
Q ss_pred CCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhc
Q 005691 530 LSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-TISDALKMLEG 607 (683)
Q Consensus 530 ~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-tm~eVl~~L~~ 607 (683)
...... + ... ..+ .++.-.. ...+....+.+++..|++.||++|| ++.++++.|+.
T Consensus 233 ~~~~~k-----i---~~~----~~i---~~P~~~~-------p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 233 RKKGRK-----I---SYR----DVI---LSPIEVA-------PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred Ccchhh-----h---hhh----hhc---cChhhcc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 422110 0 000 000 1110000 0112234567889999999999996 56667776654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.12 Aligned_cols=263 Identities=24% Similarity=0.266 Sum_probs=201.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++... .....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE----SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc----CCCeE
Confidence 46888899999999999999985 578899998875433 3356799999999999999999999998632 34568
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++.... .....+++.....|+.+++.||+||| +.+++|+||+|+||++++++.+||+|
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVK-----KRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EEEEEecCCCCHHHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEee
Confidence 99999999999998874221 12346888899999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||++....... .....++..|+|||.+....++.++||||||+++|||++|+.|++...........+..|..
T Consensus 149 fg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 221 (287)
T cd06621 149 FGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---- 221 (287)
T ss_pred ccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----
Confidence 99987554322 12346788999999999999999999999999999999999999754321111011112211
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...... +...... .....+.+.+++..|++.+|++||||.||++
T Consensus 222 ~~~~~~-~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 222 NMPNPE-LKDEPGN--------GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCchh-hccCCCC--------CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111101 1111100 0123456789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=327.57 Aligned_cols=246 Identities=27% Similarity=0.376 Sum_probs=204.9
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
-|..++-||.|+-|.|..|++. +|+.+|||.+.+... ........|+-||+-+.|||+++|+.++. ...+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe------~~~~ 86 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE------NKQH 86 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec------cCce
Confidence 4566778999999999999964 699999999866422 11334778999999999999999999986 6789
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
+|||.||+++|.|.++|. .+++|+..+..+++.||..|+.|+| ..+|+|||+||+|+|||.++++||+
T Consensus 87 lylvlEyv~gGELFdylv---------~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLV---------RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred EEEEEEecCCchhHHHHH---------hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeee
Confidence 999999999999999993 4568999999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCC-ccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT-EKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||||..-.++. .....+|.+.|.+||++++.+|. .++||||.||||+.|+||+.||+..+ + .-....
T Consensus 155 DFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------i-r~LLlK 223 (786)
T KOG0588|consen 155 DFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------I-RVLLLK 223 (786)
T ss_pred ccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------H-HHHHHH
Confidence 999998755543 34457899999999999999885 68999999999999999999998422 2 122334
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
++.|... -+..+..++.+++..++..||+.|-||.||++.
T Consensus 224 V~~G~f~----------------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 224 VQRGVFE----------------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHcCccc----------------CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 5555441 223344566778888999999999999999984
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=314.38 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=195.3
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeec
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYM 397 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~ 397 (683)
..||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++++. .+...++|+||+
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~------~~~~~~iv~e~~ 100 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL------VGEELWVLMEFL 100 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee------eCCeEEEEEecC
Confidence 46999999999999865 68999999987655555677899999999999999999999987 567899999999
Q ss_pred CCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 398 PNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 398 ~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
++++|.+++. ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~~~~L~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 101 QGGALTDIVS----------QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred CCCCHHHHHh----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 9999998772 245889999999999999999999 889999999999999999999999999998765
Q ss_pred ccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccc
Q 005691 478 REGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQA 557 (683)
Q Consensus 478 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~ 557 (683)
..... ......|+..|+|||++....++.++||||||++++||++|+.||...... +-... +....
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~-~~~~~---- 233 (297)
T cd06659 168 SKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKR-LRDSP---- 233 (297)
T ss_pred ccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH-HhccC----
Confidence 43322 223356899999999999889999999999999999999999998642211 01111 11110
Q ss_pred cCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 558 LDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 558 vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+... ........+.+++..|++.+|++||++.++++.
T Consensus 234 -~~~~~--------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 -PPKLK--------NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -CCCcc--------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 001123356788899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.49 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=192.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-----cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-----QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-----~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...++||+|+||.||+|... +|..||||++..... ...+.+.+|++++++++|+||+++++++... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~ 77 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP----M 77 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC----C
Confidence 47888999999999999999975 588999998853221 1134688899999999999999999987521 2
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++++|.+++.. ...+++...++++.+++.||+||| +.+|+|+||||+||+++.++.+
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~ 145 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKS---------YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNV 145 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCE
Confidence 3567899999999999998832 235788889999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc--cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++....... .......|+..|+|||.+....++.++||||||+++|||++|+.|+..... ...
T Consensus 146 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~- 217 (265)
T cd06652 146 KLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAA- 217 (265)
T ss_pred EECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHH-
Confidence 9999999886542211 112335689999999999888899999999999999999999999863211 000
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+..... ..+. .+......+..++..|+. +|++||++++|++
T Consensus 218 ~~~~~~~~-----~~~~----------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 IFKIATQP-----TNPV----------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHhcCC-----CCCC----------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111000 0111 112233455667777774 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.62 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=199.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+|... ++..+|+|.+........+.|..|++++++++|+|++++++++. .+...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 77 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF------YENKL 77 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe------cCCeE
Confidence 457888889999999999999975 68899999987655555667999999999999999999999986 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++.. ....+++...+.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 78 ~lv~e~~~~~~L~~~~~~--------~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 78 WILIEFCDGGALDSIMLE--------LERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEEeeccCCCcHHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEcc
Confidence 999999999999998832 1246899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
||++........ ......||..|+|||++. ...++.++||||||+++|||++|+.|+...... ...
T Consensus 147 ~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~ 217 (280)
T cd06611 147 FGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVL 217 (280)
T ss_pred Cccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHH
Confidence 999876543221 123356899999999875 345678999999999999999999998643211 111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.. +..+.. +.+. .+......+.+++..|++.+|.+||++.+|++.
T Consensus 218 ~~-~~~~~~-----~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 LK-ILKSEP-----PTLD--------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HH-HhcCCC-----CCcC--------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11 111111 1111 011123456788899999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.11 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=203.0
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++++|+..+.||+|+||.||+|... +++.+++|.+..... ..+++.+|+++++++ +|+|++++++++........+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46789999999999999999999975 578899998765433 356799999999999 799999999999754322345
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++.... .....+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR-----KKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh-----hcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEE
Confidence 67899999999999999884321 12357899999999999999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
|+|||++........ ......|+..|+|||++.. ..++.++||||||++++|+++|+.||....... .+
T Consensus 154 l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~- 227 (275)
T cd06608 154 LVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR----AL- 227 (275)
T ss_pred ECCCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH----HH-
Confidence 999999876543222 1233568999999998753 346789999999999999999999986322110 01
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+ ...+. .+.+. .+.+..+.+.+++..|++.||++|||+.++++
T Consensus 228 ---~~-~~~~~-----~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 ---FK-IPRNP-----PPTLK--------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ---HH-hhccC-----CCCCC--------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 11111 11111 11223456778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.23 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=200.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||++... .++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+. .+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE------TKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe------cCC
Confidence 46888899999999999999975 578999999876532 22356889999999999999999999886 556
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++.. ...+++.....++.+++.||+||| +.+++||||||+||+++.++.+||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKN---------IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EEEEEEecCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEE
Confidence 78999999999999999832 246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccC--------------CccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCC
Q 005691 469 ADFGLAKQSREG--------------QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSG 534 (683)
Q Consensus 469 aDFGla~~~~~~--------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~ 534 (683)
+|||+++..... .........|+..|+|||++....++.++||||||+++||+++|+.||.....
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~- 221 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP- 221 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 999998742111 00111234678899999999988999999999999999999999999863211
Q ss_pred CCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 535 SPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 535 ~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.++... ...+.. ..+... ......+..++..|++.+|++||++.++.++|+..
T Consensus 222 -------~~~~~~-~~~~~~---~~~~~~----------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 222 -------EELFGQ-VISDDI---EWPEGD----------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred -------HHHHHH-HHhccc---CCCCcc----------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 111111 111111 111110 01234567899999999999999988888888763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=333.09 Aligned_cols=204 Identities=23% Similarity=0.365 Sum_probs=166.9
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCC------Ccccccce
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHR------NLVPLRGC 377 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~------NLV~L~G~ 377 (683)
.+++...+++|...++||+|+||+||+|+.. .++.||||++.... ....++..|++++..++|. ++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3455566789999999999999999999965 57889999986532 2244567788888887655 47888888
Q ss_pred eeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCC
Q 005691 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKAT 456 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKps 456 (683)
+.. .....++|||++ +++|.+++.. ...+++..+..|+.||+.||.||| . .+||||||||+
T Consensus 200 ~~~-----~~~~~~iv~~~~-g~~l~~~l~~---------~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~ 261 (467)
T PTZ00284 200 FQN-----ETGHMCIVMPKY-GPCLLDWIMK---------HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPE 261 (467)
T ss_pred EEc-----CCceEEEEEecc-CCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHH
Confidence 752 345688999988 6788887732 346899999999999999999999 5 59999999999
Q ss_pred ceeeccCC----------------cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHH
Q 005691 457 NILLDADM----------------RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520 (683)
Q Consensus 457 NILLd~~~----------------~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlE 520 (683)
|||++.++ .+||+|||++.... ...+...||+.|+|||++.+..++.++|||||||++||
T Consensus 262 NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e 337 (467)
T PTZ00284 262 NILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE 337 (467)
T ss_pred HEEEecCCcccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence 99998765 49999999876432 22345689999999999999999999999999999999
Q ss_pred HhhCCCCCCCC
Q 005691 521 IMCGRKALDLS 531 (683)
Q Consensus 521 LltGr~p~~~~ 531 (683)
|++|+.||+..
T Consensus 338 lltG~~pf~~~ 348 (467)
T PTZ00284 338 LYTGKLLYDTH 348 (467)
T ss_pred HHhCCCCCCCC
Confidence 99999999754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.81 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=200.8
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhc-cCCCcccccceeeecCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~ 384 (683)
...++|....+||+|.||.|+.+.++ +++.+|||.+++...- ..+..+.|.+|+... +||.|++|++++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ----- 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ----- 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-----
Confidence 34578999999999999999999976 5789999999876433 235578888888777 5999999999987
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
...+.+.||||+.||++..+.+ ...++.....-++..|+.||.||| +.+||+||||-+|||||.+|
T Consensus 440 -T~~~l~fvmey~~Ggdm~~~~~----------~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eG 505 (694)
T KOG0694|consen 440 -TKEHLFFVMEYVAGGDLMHHIH----------TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEG 505 (694)
T ss_pred -cCCeEEEEEEecCCCcEEEEEe----------cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccC
Confidence 6788999999999999665552 357888999999999999999999 99999999999999999999
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
.+||+||||+|...... ..+...+||+.|||||++....|+..+|.|+|||+||||+.|..||...+++
T Consensus 506 h~kiADFGlcKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------- 574 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------- 574 (694)
T ss_pred cEEecccccccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------
Confidence 99999999998654222 2567799999999999999999999999999999999999999999743321
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
|+.|.-+.++. ..|..+..+.+.|+...+..||++|--+
T Consensus 575 -----------e~FdsI~~d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -----------EVFDSIVNDEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----------HHHHHHhcCCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12222222221 1334455667788888999999999988
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.47 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=203.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..+.||+|++|.||+++.. +++.|+||++..... ....++.+|++.+.+++|+|++++++++. .....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY------KEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------cCCeE
Confidence 46888899999999999999976 489999999876544 34567999999999999999999999987 55789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCCceeeccCCcEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
++||||+++++|.+++.. ...+++..++.++.++++||+||| + .+++||||+|+||+++.++.+||+
T Consensus 75 ~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~ 142 (264)
T cd06623 75 SIVLEYMDGGSLADLLKK---------VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIA 142 (264)
T ss_pred EEEEEecCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEc
Confidence 999999999999999832 256899999999999999999999 7 999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||++......... .....++..|+|||......++.++||||||+++|||++|+.|+........ ..+..+. .
T Consensus 143 df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~---~ 216 (264)
T cd06623 143 DFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--FELMQAI---C 216 (264)
T ss_pred cCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH--HHHHHHH---h
Confidence 99998876543322 2345688999999999999999999999999999999999999865432110 0111111 1
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+.. +.+ ......+.+.+++..|++.+|++||++.++++.
T Consensus 217 -~~~~-----~~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 217 -DGPP-----PSL---------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCCC-----CCC---------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 111 111134577889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.70 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=200.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++|||++++++++. .....+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~------~~~~~~ 92 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL------VGDELW 92 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee------eCCcEE
Confidence 57888899999999999999864 68899999986555555667899999999999999999999987 456799
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|+||+++++|.+++. ...+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 93 lv~e~~~~~~L~~~~~----------~~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 93 VVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred EEEecCCCCcHHHHHh----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccC
Confidence 9999999999999983 235789999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|++......... .....|++.|+|||++..+.++.++||||||+++||+++|+.||........ +......
T Consensus 160 g~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--------~~~~~~~ 230 (293)
T cd06647 160 GFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATN 230 (293)
T ss_pred cceecccccccc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------eeehhcC
Confidence 998765443322 2234688999999999888899999999999999999999999964332110 0111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.. .. ..+......+..++..|++.+|++||++.+++.+
T Consensus 231 ~~~------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTP------EL--------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCC------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 00 0111223456788899999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.53 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=195.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..+.||+|+||.||++... +|..||+|.+.... ......+.+|++++.+++|+||+++++++. .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF------IEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee------cCCeE
Confidence 35777889999999999999976 68999999886532 222457899999999999999999999886 45789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|..++.... ....+++..+..++.+++.||.|||+ +.+|+||||||+||+++.++.+||+|
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGV------ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEEeecCCCCHHHHHHhcc------ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEee
Confidence 99999999999998884321 12468999999999999999999993 35899999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC------CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG------QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+++..... ......|+.+|+|||++... .++.++|||||||++|||++|+.||...... ....-
T Consensus 147 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~ 218 (286)
T cd06622 147 FGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQ 218 (286)
T ss_pred cCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHH
Confidence 9998765322 22334688899999988544 3588999999999999999999998642211 01000
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
......+.. +.+ +.+....+..++..|++.+|++||++.+++.
T Consensus 219 -~~~~~~~~~-----~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 219 -LSAIVDGDP-----PTL----------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -HHHHhhcCC-----CCC----------CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 001111111 111 1123456678899999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.31 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=197.3
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc------ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++|+||+++++++. .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC------E 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec------c
Confidence 477788999999999999985 56899999998643311 2356899999999999999999999986 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-c
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-R 465 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~ 465 (683)
+...++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++||||||+||+++.++ .
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~ 142 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSK---------YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQR 142 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHH---------hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 6789999999999999999832 246889999999999999999999 88999999999999998776 5
Q ss_pred EEEcccCcccccccCCc---cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 466 ARVADFGLAKQSREGQS---HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
+||+|||++........ .......||..|+|||++....++.++||||+|++++||++|+.|+....... ..
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~ 217 (268)
T cd06630 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HL 217 (268)
T ss_pred EEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-----hH
Confidence 99999999876643221 11234568999999999988889999999999999999999999986432211 11
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
........... .+. .+......+.+++..|++.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~-----~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 218 ALIFKIASATT-----APS----------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHhccCC-----CCC----------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111110000 011 11223456778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.47 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=196.7
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccC-ccChHHHHHHHHHHHhcc---CCCcccccceeeecCCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESD-FQGDAEFCNEVEIISNLK---HRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+.++++++ |+|++++++++. .+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~------~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL------KGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee------eCC
Confidence 467778899999999999996 468999999886543 233567889999999997 999999999986 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++. ...++|...+.++.+++.||.||| +.+|+||||+|+||+++.++.++|
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l 142 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMK----------AGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKL 142 (277)
T ss_pred EEEEEEecCCCCcHHHHHH----------ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEE
Confidence 7899999999999999872 236889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||++......... .....|+..|+|||++..+ .++.++|||||||++|||++|+.|+...... .+...
T Consensus 143 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~ 213 (277)
T cd06917 143 CDFGVAALLNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMML 213 (277)
T ss_pred ccCCceeecCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhc
Confidence 999999876544322 2335689999999998754 4689999999999999999999998643221 11100
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.... ..+.+... .....+.+++..|++.||++||++.++++.
T Consensus 214 -~~~~-----~~~~~~~~---------~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 -IPKS-----KPPRLEDN---------GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -cccC-----CCCCCCcc---------cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0010 11111111 123456788899999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.94 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=196.8
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..+.||+|+||.||++... +++.+|||++..... .....+.+|++++++++|+|++++++.+. .+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL------EDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe------cCCEE
Confidence 5778899999999999999864 688999999865432 23457899999999999999999999876 45689
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC-CcEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-~~~KLa 469 (683)
++||||+++++|.+++... ....+++..+++++.++++||+||| +.+|+|+||||+||+++++ +.+||+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~ 144 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKR-------CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIG 144 (256)
T ss_pred EEEEecCCCCCHHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence 9999999999999998432 1345889999999999999999999 8899999999999999865 468999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+++...... ......|+..|+|||.+....++.++||||||+++|||++|+.|++.... ...+....
T Consensus 145 d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~ 214 (256)
T cd08220 145 DFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIM 214 (256)
T ss_pred cCCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHH
Confidence 999998664332 12335689999999999988899999999999999999999999864321 11111111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.... + +......+..++..|++.+|++|||+.|+++
T Consensus 215 -~~~~~~-----~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 215 -SGTFAP-----I----------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -hcCCCC-----C----------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111101 0 1112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.97 Aligned_cols=269 Identities=21% Similarity=0.308 Sum_probs=194.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++. .....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~------~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH------TEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe------cCCeE
Confidence 46888899999999999999875 578999999865432 23456789999999999999999999986 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++ ++|.+++... ...+++.....++.|+++||+||| +.+|+||||||+||++++++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--------~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDC--------GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred EEEEeccc-cCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECc
Confidence 99999997 5888887322 245888999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch-------h
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI-------T 542 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l-------~ 542 (683)
||+++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+ .
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~ 225 (301)
T cd07873 148 FGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-HFIFRILGTPT 225 (301)
T ss_pred CcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCC
Confidence 999876543221 1223457889999998865 45788999999999999999999998643321000 000 0
Q ss_pred hhhhhhhhcC-ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAG-KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g-~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...|+.+... .....-.+..... ............+.+++..|++.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 226 EETWPGILSNEEFKSYNYPKYRAD--CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhchhhhccccccccccCccccc--cHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0011111000 0000000100000 000000112335678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=305.39 Aligned_cols=266 Identities=24% Similarity=0.289 Sum_probs=198.5
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++|+|++++++++. .+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP------HGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe------cCCee
Confidence 4677889999999999999974 689999999876542 22467999999999999999999999986 46789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+ +++|.+++... ...+++.+++.++.++++||+||| +.+++|+||||+||+++.++.+||+|
T Consensus 75 ~~v~e~~-~~~L~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~d 142 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDE--------ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIAD 142 (286)
T ss_pred EEEeccc-CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEee
Confidence 9999999 99999988432 246899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||++...............|+..|+|||++... .++.++||||+|++++||++|++++...... ....++...+
T Consensus 143 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~ 217 (286)
T cd07832 143 FGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-----EQLAIVFRTL 217 (286)
T ss_pred eeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-----HHHHHHHHHc
Confidence 999987654432223345689999999988654 4689999999999999999998777533211 0111111110
Q ss_pred hcC------------ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 550 KAG------------KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 550 ~~g------------~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
... ....+..+.-... ... ....+....+.+++..|++.+|++|||++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 218 GTPNEETWPGLTSLPDYNKITFPESKPI-PLE-EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCChHHHhhccCcchhhcccCCCCCcc-hHH-HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000000000 000 0001223577889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=325.93 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=207.9
Q ss_pred cCcccceeeeecCceEEEEEEEcC---Cc--EEEEEEeecc-CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD---GT--TVAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~---g~--~VAVK~l~~~-~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
+.....++||+|-||.||+|++.+ |. .||||..+.. .....+.|+.|..+|++++|||||+|+|+|.
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------- 461 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------- 461 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-------
Confidence 344456789999999999999653 33 5889988763 4445667999999999999999999999995
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++|||.++-|.|..||.. .+..|+......++.|+..||+||| +.+++||||.++|||+...-.+
T Consensus 462 e~P~WivmEL~~~GELr~yLq~--------nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CV 530 (974)
T KOG4257|consen 462 EQPMWIVMELAPLGELREYLQQ--------NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCV 530 (974)
T ss_pred ccceeEEEecccchhHHHHHHh--------ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCccee
Confidence 4678999999999999999943 2356888888999999999999999 9999999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v 545 (683)
||+|||++|...++.....++..-...|||||.+...+++.+||||-|||.+|||++ |.+||..-...+ |
T Consensus 531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------V 601 (974)
T KOG4257|consen 531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------V 601 (974)
T ss_pred eecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------e
Confidence 999999999998887776667777889999999999999999999999999999987 999997543221 0
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.-.++.|.- + .-+..+...+.-+...||..+|.+||+..++...|+
T Consensus 602 I~~iEnGeR-------l--------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 602 IGHIENGER-------L--------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred EEEecCCCC-------C--------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 111222211 1 234456678889999999999999999998877663
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.18 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=191.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHH-HHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEI-ISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~i-L~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..+.||+|+||.||+++.. +|+.||+|++..... ....++..|+.+ ++.++|+|++++++++. ....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~------~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF------REGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe------cCCc
Confidence 46888899999999999999975 689999999865432 234456667775 56678999999999986 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCceeeccCCcEEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNILLd~~~~~KL 468 (683)
.+++|||++ |+|.+++.... .....+++...+.++.|++.||+||| +. +++||||||+||+++.++.+||
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl 145 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVY-----DKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKL 145 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhc-----cCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEE
Confidence 999999996 68887774322 12356899999999999999999999 65 8999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
+|||+++...... ..+...|+..|+|||.+.. ..++.++|+||||+++|||++|+.|+...... . +.
T Consensus 146 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~ 216 (283)
T cd06617 146 CDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------F-QQ 216 (283)
T ss_pred eeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------H-HH
Confidence 9999998654322 2233568999999998764 45789999999999999999999998632211 0 01
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..... .+ ..+.+. .....+.+..++..|++.+|++||++.++++
T Consensus 217 ~~~~~-~~-----~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 LKQVV-EE-----PSPQLP---------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHH-hc-----CCCCCC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 11 111111 1112345778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=299.72 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=197.6
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+|... +|..+|+|.+..... ...+.+.+|+++++.++|+|++++++.+. .....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~------~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ------ENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec------cCCeE
Confidence 5778899999999999999976 588999999865422 33456889999999999999999999886 55689
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~KLa 469 (683)
++|+||+++++|.+++... ....++|..++.++.+++.||.||| +.+++|+||||+||++++++ .+||+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~ 144 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQ-------RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLG 144 (257)
T ss_pred EEEEecCCCCcHHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEec
Confidence 9999999999999988432 1235899999999999999999999 88999999999999999885 56999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||.+........ ......|++.|+|||+.....++.++||||||++++|+++|+.|+.... ...++....
T Consensus 145 d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~ 215 (257)
T cd08225 145 DFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKIC 215 (257)
T ss_pred ccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHh
Confidence 9999887653322 2233468999999999988889999999999999999999999985321 122333222
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. +.. .+. .......+.+++.+|++.+|++|||+.+|++
T Consensus 216 ~-~~~----~~~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 216 Q-GYF----API-----------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred c-ccC----CCC-----------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1 111 110 0011235678889999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.05 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=197.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||.||++... +++.+|+|.+...... ..+.+.+|+++++.++|+||+++++++. .+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ------TET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee------cCC
Confidence 36888899999999999999976 4899999998765433 3456889999999999999999999986 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~-------~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQ-------PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIML 144 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhC-------CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEE
Confidence 899999999999999988422 1346899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCcc----------------------------ccccccCCCcccCccccccCCCCccccEEEcchhHHH
Q 005691 469 ADFGLAKQSREGQSH----------------------------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520 (683)
Q Consensus 469 aDFGla~~~~~~~~~----------------------------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlE 520 (683)
+|||++......... ......||..|+|||++.+..++.++||||||+++||
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 999998754322110 1113468999999999998899999999999999999
Q ss_pred HhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC---
Q 005691 521 IMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT--- 597 (683)
Q Consensus 521 LltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt--- 597 (683)
|++|+.||....... .+ .... .... ... ........+.+++..|++.+|++|||
T Consensus 225 l~~g~~pf~~~~~~~-------~~-~~~~-~~~~------~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 225 MLYGTTPFKGSNRDE-------TF-SNIL-KKEV------TFP--------GSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred HhhCCCCCCCCchHH-------HH-HHHh-cCCc------cCC--------CccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 999999986432210 01 0111 1110 000 01113456788999999999999999
Q ss_pred -HHHHHH
Q 005691 598 -ISDALK 603 (683)
Q Consensus 598 -m~eVl~ 603 (683)
+.+++.
T Consensus 282 ~~~~ll~ 288 (316)
T cd05574 282 GAAEIKQ 288 (316)
T ss_pred hHHHHHc
Confidence 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=294.78 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=203.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|+..+.||+|-||.||.|+.+ ++-.||+|++.+.. .+-..++.+|++|-+.|+||||.+++|++. +.
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh------d~ 94 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH------DS 94 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee------cc
Confidence 367889999999999999999965 57789999987643 233567999999999999999999999998 67
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...||++||.++|+|...|... ....++......++.|+|.||.|+| .++||||||||+|+|++.++..|
T Consensus 95 ~riyLilEya~~gel~k~L~~~-------~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEG-------RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhc-------ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCee
Confidence 7899999999999999999532 2346788888899999999999999 99999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||-+-..+.+ .....+||+-|.|||...+..++.++|+|++||+.+|++.|.+||...... -..+
T Consensus 165 iAdfGwsV~~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---------etYk 232 (281)
T KOG0580|consen 165 IADFGWSVHAPSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---------ETYK 232 (281)
T ss_pred ccCCCceeecCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---------HHHH
Confidence 9999987654422 234578999999999999999999999999999999999999999754321 1111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+.. .+..+| ..+.....+++..|+..+|.+|.+..||+..
T Consensus 233 rI~k---~~~~~p-------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 233 RIRK---VDLKFP-------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHH---ccccCC-------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111 122223 1223355678899999999999999999753
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=293.99 Aligned_cols=249 Identities=30% Similarity=0.452 Sum_probs=201.3
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
+|...+.||+|++|.||++... +++.+++|++........+++.+|++++++++|+|++++++++. .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL------KKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe------cCCeEEE
Confidence 3667789999999999999986 68899999997765555678999999999999999999999987 4567999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
++||+++++|.+++... ...+++..+..++.+++.||.||| +.+++||||+|+||++++++.+||+|||
T Consensus 75 ~~e~~~~~~L~~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~ 143 (253)
T cd05122 75 VMEFCSGGSLKDLLKST--------NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG 143 (253)
T ss_pred EEecCCCCcHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecc
Confidence 99999999999988321 247899999999999999999999 7999999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
.+........ .....|+..|+|||++....++.++||||||++++||++|+.|+...... ....... ..
T Consensus 144 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~ 212 (253)
T cd05122 144 LSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKIA-TN 212 (253)
T ss_pred cccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHHH-hc
Confidence 9877654432 34467899999999999888999999999999999999999998643211 1111111 11
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.... +. ........+.+++..|++.||++|||+.++++
T Consensus 213 ~~~~-----~~--------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 213 GPPG-----LR--------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCC-----cC--------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1101 10 01111346778999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.81 Aligned_cols=260 Identities=25% Similarity=0.323 Sum_probs=201.0
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--------------ChHHHHHHHHHHHhccCCCcc
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--------------GDAEFCNEVEIISNLKHRNLV 372 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--------------~~~~f~~Ev~iL~~L~H~NLV 372 (683)
-.+..+.|.....||+|.||.|-+|+.. +++.||||.+.+.... ..+....||.+|++++|+|||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3445678999999999999999999954 7999999999653321 124688999999999999999
Q ss_pred cccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccC
Q 005691 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRD 452 (683)
Q Consensus 373 ~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrD 452 (683)
+|+.+.-. ...+..|||+||+..|.+...= .....|+..+.++++.++..||+||| .++|||||
T Consensus 172 ~LiEvLDD----P~s~~~YlVley~s~G~v~w~p---------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRD 235 (576)
T KOG0585|consen 172 KLIEVLDD----PESDKLYLVLEYCSKGEVKWCP---------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRD 235 (576)
T ss_pred EEEEeecC----cccCceEEEEEeccCCccccCC---------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccc
Confidence 99987531 2567899999999999876543 11223999999999999999999999 89999999
Q ss_pred CCCCceeeccCCcEEEcccCcccccccCC----ccccccccCCCcccCccccccCC----CCccccEEEcchhHHHHhhC
Q 005691 453 IKATNILLDADMRARVADFGLAKQSREGQ----SHLTTRVAGTHGYLAPEYALYGQ----LTEKSDVYSFGVVILEIMCG 524 (683)
Q Consensus 453 IKpsNILLd~~~~~KLaDFGla~~~~~~~----~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDVwSfGvlLlELltG 524 (683)
|||+|+||+++|++||+|||.+..+..+. .....+.+||+.|+|||....+. .+.+.||||+||+||.++.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 99999999999999999999987663221 11234578999999999988743 35689999999999999999
Q ss_pred CCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 525 RKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 525 r~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+-||-.... ..+++ .++...|.- ....++.+++-.|++..++.||+.|-+..+|...
T Consensus 316 ~~PF~~~~~------------~~l~~-----KIvn~pL~f------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 316 QLPFFDDFE------------LELFD-----KIVNDPLEF------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred cCCcccchH------------HHHHH-----HHhcCcccC------CCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 999953211 11111 111111111 1122445677889999999999999999999877
Q ss_pred Hh
Q 005691 605 LE 606 (683)
Q Consensus 605 L~ 606 (683)
..
T Consensus 373 pw 374 (576)
T KOG0585|consen 373 PW 374 (576)
T ss_pred ce
Confidence 64
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=305.26 Aligned_cols=200 Identities=24% Similarity=0.412 Sum_probs=167.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|+..+.||+|+||.||+|+.. +++.||||.+...... ....+.+|++++++++|+||+++++++. .....
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH------TKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe------cCCeE
Confidence 57888899999999999999976 6889999998654322 2345788999999999999999999986 55689
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++ +|.+++... ...+++...+.++.+++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 79 ~lv~e~~~~-~L~~~~~~~--------~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 146 (291)
T cd07844 79 TLVFEYLDT-DLKQYMDDC--------GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLAD 146 (291)
T ss_pred EEEEecCCC-CHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECc
Confidence 999999985 898887422 236889999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
||+++....... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 147 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 147 FGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999875432211 1122346889999998875 45889999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=303.86 Aligned_cols=266 Identities=26% Similarity=0.315 Sum_probs=195.8
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
|+..+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|+|++++++++... .....+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~~ 76 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK----GKGSIY 76 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC----CCCcEE
Confidence 556788999999999999976 48899999997653 22345688999999999999999999998732 136899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++ +|.+++... ...+++..++.++.++++||+||| +.+++|+||||+||++++++.+||+||
T Consensus 77 lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~ 144 (287)
T cd07840 77 MVFEYMDH-DLTGLLDSP--------EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADF 144 (287)
T ss_pred EEeccccc-cHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccc
Confidence 99999985 888877321 246899999999999999999999 789999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh-------
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD------- 543 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~------- 543 (683)
|++...........+...++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......... ..+..
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~-~~~~~~~~~~~~ 223 (287)
T cd07840 145 GLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTD 223 (287)
T ss_pred cceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCch
Confidence 9998765543323344567889999997764 46789999999999999999999998643321100 00000
Q ss_pred hhhhhhhc------CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKA------GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~------g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..|..+.. ..........+... ....+...+.+++..|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREF------FKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHH------hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000 00000000000000 00011456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.32 Aligned_cols=270 Identities=24% Similarity=0.317 Sum_probs=197.3
Q ss_pred cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
-.|...+++|.|.||.||+|++.+ ++.||||+....... -..|+++|++++|||||+|+-++...... +.-..-
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~-d~~~ln 98 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTES-DEVYLN 98 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCC-chhHHH
Confidence 356667899999999999999764 689999998553322 23699999999999999999988765432 233456
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC-CcEEEcc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVAD 470 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-~~~KLaD 470 (683)
|||||||. +|.+++.... ..+..++....+-+..|+.+||+||| ..+|+||||||.|+|+|.+ |.+||+|
T Consensus 99 lVleymP~-tL~~~~r~~~-----~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicD 169 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYT-----RANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICD 169 (364)
T ss_pred HHHHhchH-HHHHHHHHHh-----hcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEecc
Confidence 89999987 7887774311 12456888888889999999999999 8999999999999999987 8999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||.|+....++...+ ..-|.-|+|||.+.+ ..|+.+.||||.||++.||+-|++-|......++ ++..+ +.+
T Consensus 170 FGSAK~L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~eIi-k~l 242 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LVEII-KVL 242 (364)
T ss_pred CCcceeeccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HHHHH-HHh
Confidence 999999876655433 334778999998875 6799999999999999999999998875333221 11111 111
Q ss_pred h----------cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 550 K----------AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 550 ~----------~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
. .....+.-.|.+....- ..........+.+++...+++.+|.+|.+..|++..
T Consensus 243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~-~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 243 GTPTREDIKSMNPNYTEFKFPQIKAHPW-HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CCCCHHHHhhcCcccccccCcccccccc-eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 01111222233322210 000112233466788999999999999999998753
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=312.63 Aligned_cols=277 Identities=21% Similarity=0.300 Sum_probs=199.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
+++|...++||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++|+||+++++++.... ......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS-FESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc-ccccce
Confidence 478999999999999999999864 68999999986432 223456889999999999999999999876332 123456
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++|+||+++ +|.+++. ...+++...+.++.|++.||+||| +.+|+||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~~-~l~~~~~----------~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 83 VYIVQELMET-DLYKLIK----------TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEEehhccc-CHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEC
Confidence 8999999975 7766662 246899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCcc--ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 470 DFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 470 DFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|||+++........ ......||..|+|||.+.. ..++.++|||||||+++||++|+.||...... ....+..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-----~~~~~~~ 223 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-----HQLNLIL 223 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH
Confidence 99999865432221 1233568999999998754 56899999999999999999999998542210 0001111
Q ss_pred hhhhcC---ccccccCcccccc---ccccCC-C----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 005691 547 SLVKAG---KVWQALDPSLLKE---DDFLSL-N----PKAIMERFVLVGILCAHVMVALRPTISDALKM--LEGD 608 (683)
Q Consensus 547 ~~~~~g---~l~e~vD~~l~~~---~~~~~~-~----~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~--L~~~ 608 (683)
...... .+..+.+....+. ...... . .......+..++..|++.+|++|||+.++++. |+.-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 111100 0000111000000 000000 0 01123467889999999999999999999986 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=306.25 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=202.7
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
..+++|+..+.||+|+||.||+|..+ +++.|++|++..... ..+.+.+|+++++.++|+|++++++++. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~ 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL------VGD 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE------ECC
Confidence 45677888889999999999999987 688999999876544 4667999999999999999999999987 457
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++|+||+++++|.+++... ...+++..++.++.+++.||+||| +.+|+|+||||+||+++.++.+||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l 157 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKL 157 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHh--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEE
Confidence 899999999999999999421 137999999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||++........ ......++..|+|||++....++.++|||||||++|||++|+.|+...... ......
T Consensus 158 ~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~ 228 (286)
T cd06614 158 ADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLI 228 (286)
T ss_pred Cccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 99998865543221 123345788999999998888999999999999999999999998632211 011111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+.... +. ........+.+++..|++.+|..|||+.+|++.
T Consensus 229 -~~~~~~~-----~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 229 -TTKGIPP-----LK--------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -HhcCCCC-----Cc--------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111100 00 111123467789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.17 Aligned_cols=205 Identities=26% Similarity=0.387 Sum_probs=176.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
..++|+....||+|+||.||.++.+ .|..+|+|++++..... .+..+.|-.+|...+++.||+|+-.+. +
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ------D 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ------D 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec------C
Confidence 3578999999999999999999965 58999999998876544 345788999999999999999987775 6
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
...+||||||+|||++..+|- ....|+.......+.+++-|+.-|| +.++|||||||+|+|||..|++
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~---------~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLM---------RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CCeeEEEEEecCCccHHHHHH---------hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence 788999999999999999993 3457999999999999999999999 9999999999999999999999
Q ss_pred EEcccCccccccc----------------------CCcc-----c-------------------cccccCCCcccCcccc
Q 005691 467 RVADFGLAKQSRE----------------------GQSH-----L-------------------TTRVAGTHGYLAPEYA 500 (683)
Q Consensus 467 KLaDFGla~~~~~----------------------~~~~-----~-------------------~~~~~GT~~Y~APE~~ 500 (683)
||+||||+..... .+.. . ....+||+-|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 9999999843211 0000 0 0124799999999999
Q ss_pred ccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 501 LYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 501 ~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
.+..|+..+|.||+|||+||++.|.+||...++
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999999999986554
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.81 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=196.7
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
-|...+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++|+||+++++++. .+...+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL------KDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE------eCCeEE
Confidence 3566778999999999999864 688999998764332 23456889999999999999999999987 567799
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|.+++. ...+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 79 lv~e~~~~~~l~~~i~----------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~df 145 (277)
T cd06641 79 IIMEYLGGGSALDLLE----------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADF 145 (277)
T ss_pred EEEEeCCCCcHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeec
Confidence 9999999999999882 236889999999999999999999 899999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+++....... ......|+..|+|||++....++.++|||||||+++|+++|+.|+..... ..+... ...
T Consensus 146 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~-~~~ 215 (277)
T cd06641 146 GVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFL-IPK 215 (277)
T ss_pred ccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHH-Hhc
Confidence 99876543221 22334688999999999988899999999999999999999999863221 011111 111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.. +.+.. .....+.+++..|++.+|.+||+|.++++.
T Consensus 216 ~~~-----~~~~~----------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 NNP-----PTLEG----------NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCC-----CCCCc----------ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111 11111 123456788999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=304.40 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=193.2
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|+||+++++++. .+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH------TENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc------cCCcE
Confidence 5788899999999999999875 688999998864322 22356899999999999999999999986 55678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++ ++|.+++... ....+++..++.++.+++.||+||| +.+++||||||+||+++.++.+||+|
T Consensus 75 ~~v~e~~~-~~l~~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~d 143 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDAS-------PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 143 (284)
T ss_pred EEEeeccc-cCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEee
Confidence 99999996 6888887432 2346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCC-CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh-------
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT------- 542 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~------- 542 (683)
||+++....... ......++..|+|||++.+.. ++.++||||||+++|||+||+.||......... ..+.
T Consensus 144 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~ 221 (284)
T cd07860 144 FGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL-FRIFRTLGTPD 221 (284)
T ss_pred ccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCC
Confidence 999876543222 123345788999999887644 688999999999999999999998643211000 0000
Q ss_pred hhhhhhhhc-----CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKA-----GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~-----g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...|..+.. ..........+... .......+.+++..|++.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 222 EVVWPGVTSLPDYKPSFPKWARQDFSKV-------VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhhHHHHHHhhcccccccCHHHH-------cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 001100000 00000000000000 0011235568899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=304.50 Aligned_cols=202 Identities=25% Similarity=0.403 Sum_probs=167.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++++|...+.||+|+||.||+|... +|+.||+|++....... ...+.+|+++++.++|+||+++.+++. .+.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~------~~~ 76 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH------TKE 76 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe------cCC
Confidence 4578999999999999999999864 68899999986543333 346789999999999999999999986 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++|+||++ ++|.+++... ...+.+..+..++.|++.||+||| +.+|+||||||+|||++.++++||
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l 144 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQH--------PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKL 144 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEE
Confidence 7899999996 6776666321 235778888999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
+|||+++....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||+..
T Consensus 145 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 145 ADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred eccccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999976433221 12234578999999998754 5788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.72 Aligned_cols=243 Identities=28% Similarity=0.379 Sum_probs=196.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++. .+.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ------DDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE------cCC
Confidence 46888899999999999999975 589999999865432 23456889999999999999999999986 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++.. ...+++..+..++.+++.||.||| +.+|+||||+|+|||++.++.+||
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~---------~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl 142 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRK---------SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKI 142 (290)
T ss_pred eEEEEEecCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEE
Confidence 89999999999999999832 346889999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++..... .....|++.|+|||.+.....+.++||||||++++||++|+.|+..... ....+.
T Consensus 143 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~ 209 (290)
T cd05580 143 TDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---------IQIYEK 209 (290)
T ss_pred eeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Confidence 999999876543 2345689999999999888899999999999999999999999864321 111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDAL 602 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl 602 (683)
...+.. .+. ......+.+++..|++.+|.+|| ++.+++
T Consensus 210 ~~~~~~------~~~----------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 210 ILEGKV------RFP----------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred HhcCCc------cCC----------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 112211 111 11234667889999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.28 Aligned_cols=247 Identities=25% Similarity=0.349 Sum_probs=197.3
Q ss_pred cccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 315 FSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+|++++++++. .+...++|
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~------~~~~~~~v 94 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL------VGDELWVV 94 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE------cCCeEEEE
Confidence 44456899999999999996 468899999987655555667899999999999999999999886 45788999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
+||+++++|.+++.. ..+++..+..++.+++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 95 ~e~~~~~~L~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~ 161 (285)
T cd06648 95 MEFLEGGALTDIVTH----------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGF 161 (285)
T ss_pred EeccCCCCHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEccccc
Confidence 999999999998831 35889999999999999999999 88999999999999999999999999998
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
+........ ......|+..|+|||......++.++||||||++++||++|+.|+..... ..+.... ..+.
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~-~~~~ 231 (285)
T cd06648 162 CAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRI-RDNL 231 (285)
T ss_pred chhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHH-HhcC
Confidence 876543221 22335689999999999888899999999999999999999999864221 1111111 1111
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.+.. .......+.+++..|++.+|++|||+.++++
T Consensus 232 -----~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 232 -----PPKLKN--------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -----CCCCcc--------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111111 1112346788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=308.17 Aligned_cols=247 Identities=31% Similarity=0.436 Sum_probs=193.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+.|...+.||+|+||.||+|+.. +|+.||+|++....... .+++.+|+++++.++|||++++.++|. ...
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~------~~~ 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL------REH 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE------eCC
Confidence 45778889999999999999975 68999999986543322 346889999999999999999999997 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||++ |+|.+++.. ....+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.+||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~--------~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL 156 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEV--------HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKL 156 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHH--------cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEE
Confidence 7899999997 566666521 1346899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+|||+++..... ....|+..|+|||++. .+.++.++||||||+++|||++|+.|+..... ....
T Consensus 157 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~ 223 (307)
T cd06607 157 ADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSAL 223 (307)
T ss_pred eecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHH
Confidence 999998765432 2346788999999874 46788999999999999999999999853221 0111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.... .+. .+.+ ........+..++..|++.+|++||+|.+|+...
T Consensus 224 ~~~~-~~~-----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 224 YHIA-QND-----SPTL---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHHh-cCC-----CCCC---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1111 110 0111 1122345678899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=314.53 Aligned_cols=275 Identities=24% Similarity=0.335 Sum_probs=197.7
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc--CccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES--DFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~ 386 (683)
..++|...+.||+|+||.||+|... +|+.+|||++... .......+..|+.+++++ +|+||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~----~ 80 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE----N 80 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC----C
Confidence 4568888899999999999999975 5889999998543 223345678899999999 999999999988532 3
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
+...++||||++ ++|..++. ...++|..++.++.|++.||+||| +.+|+||||||+||++++++.+
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~ 146 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIR----------ANILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRV 146 (337)
T ss_pred CceEEEEecccc-cCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcE
Confidence 456899999997 58888772 126889999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc----cccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 467 RVADFGLAKQSREGQS----HLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 467 KLaDFGla~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
||+|||+++....... .......||..|+|||++.. ..++.++||||||+++|||++|+.||......... ..+
T Consensus 147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~-~~~ 225 (337)
T cd07852 147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL-EKI 225 (337)
T ss_pred EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHH
Confidence 9999999986644322 12334678999999998764 56789999999999999999999998643221100 000
Q ss_pred hhh-------hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 542 TDW-------VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 542 ~~~-------v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+ .+..+......+.++...............+....+.+++..|++.+|++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 000000000001111000000000000001124467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.92 Aligned_cols=269 Identities=21% Similarity=0.254 Sum_probs=192.6
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++|+|++++++++. .....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~------~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH------SDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc------cCCce
Confidence 4777889999999999999975 688999999865322 22356788999999999999999999986 55679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++|+||++ ++|.+++... ...+++...+.++.||++||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 75 ~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d 142 (284)
T cd07839 75 TLVFEYCD-QDLKKYFDSC--------NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLAD 142 (284)
T ss_pred EEEEecCC-CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECc
Confidence 99999997 4777776321 246899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch-------h
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI-------T 542 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l-------~ 542 (683)
||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|+.|+............+ .
T Consensus 143 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07839 143 FGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221 (284)
T ss_pred cchhhccCCCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 9999865433221 2334678999999988764 46899999999999999999999864322211000000 0
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.|..+..-.-.... +.......+. .........+.+++..|++.||.+|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 222 EESWPGVSKLPDYKPY-PMYPATTSLV-NVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hHHhHHhhhccccccc-CCCCCcchhh-hhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0111111000000000 0000000000 000112346678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.50 Aligned_cols=244 Identities=33% Similarity=0.457 Sum_probs=198.8
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccCh---HHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGD---AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~---~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.|+....||.|.||.||.++. .+.+.||||++.-...+.. .+..+||..|.+++|||.|.+.||+. ....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL------re~T 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL------REHT 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee------ccch
Confidence 466667899999999999995 4678999999977666654 35889999999999999999999998 6678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.+|||||| -||-.|.|- ..+++|....+..|..|+..||+||| +.+.||||||+.||||.+.|.+||+
T Consensus 101 aWLVMEYC-lGSAsDlle--------VhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLE--------VHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred HHHHHHHH-hccHHHHHH--------HHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeec
Confidence 99999999 457777762 34678999999999999999999999 9999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|||.|....+.. .++||+-|||||++. .|+|+.|+||||+|++-.||.-.++|.-.++... -+..
T Consensus 169 DFGSAsi~~PAn-----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS----ALYH--- 236 (948)
T KOG0577|consen 169 DFGSASIMAPAN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH--- 236 (948)
T ss_pred cccchhhcCchh-----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH----HHHH---
Confidence 999998766544 368999999999886 6899999999999999999999999975433211 0111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..+ -.|.|. ..+....+..++-.|++.-|.+|||..++++
T Consensus 237 --IAQN-----esPtLq---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 237 --IAQN-----ESPTLQ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --HHhc-----CCCCCC---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1111 112222 2344567788889999999999999988764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.80 Aligned_cols=252 Identities=28% Similarity=0.415 Sum_probs=201.3
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++++... .....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE----EKNTL 76 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC----CCCeE
Confidence 4677889999999999999986 688999999866543 3456799999999999999999999998621 12678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++|+||+++++|.+++.. ...++|..++.++.++++||+||| +.+++|+||+|+||+++.++.+||+|
T Consensus 77 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d 144 (260)
T cd06606 77 NIFLEYVSGGSLSSLLKK---------FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLAD 144 (260)
T ss_pred EEEEEecCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcc
Confidence 999999999999999832 237999999999999999999999 79999999999999999999999999
Q ss_pred cCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||.+......... ......++..|+|||.......+.++||||||++++||++|+.|+..... .....+...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~ 217 (260)
T cd06606 145 FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIG 217 (260)
T ss_pred cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhcc
Confidence 9998876554321 12345688999999999988899999999999999999999999875331 111112211
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+.. +.+ +......+.+++..|++.+|.+||++.++++
T Consensus 218 ~~~~~-----~~~----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSGEP-----PEI----------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccCCC-----cCC----------CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111 011 1122346778889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=343.99 Aligned_cols=262 Identities=22% Similarity=0.342 Sum_probs=198.6
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
+.+...++|...++||+|+||+||++... ++..||+|.+..... .....|..|+.++.+|+|||||++++++...
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de-- 84 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK-- 84 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec--
Confidence 33455678999999999999999999975 467889998865332 2245689999999999999999999988632
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc----CCCccccCCCCCcee
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV----KPAIYHRDIKATNIL 459 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~----~~~IiHrDIKpsNIL 459 (683)
.....+|||||+++|+|.++|.... .....+++...+.|+.||+.||.|||... ..+||||||||+|||
T Consensus 85 --~~~~lyIVMEY~~gGSL~~lL~k~~-----~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 85 --ANQKLYILMEFCDAGDLSRNIQKCY-----KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred --CCCEEEEEEeCCCCCcHHHHHHHHh-----hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 3456899999999999999984322 12346999999999999999999999421 146999999999999
Q ss_pred eccC-----------------CcEEEcccCcccccccCCccccccccCCCcccCcccccc--CCCCccccEEEcchhHHH
Q 005691 460 LDAD-----------------MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILE 520 (683)
Q Consensus 460 Ld~~-----------------~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlE 520 (683)
|+.+ ..+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+|||
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 9642 358999999998654322 2334579999999999864 458899999999999999
Q ss_pred HhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005691 521 IMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600 (683)
Q Consensus 521 LltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~e 600 (683)
|++|+.||..... ... +...+..+. .+.. ......+..++..|++.+|.+||++.|
T Consensus 236 LLTGk~PF~~~~~-------~~q-li~~lk~~p-------~lpi---------~~~S~eL~dLI~~~L~~dPeeRPSa~Q 291 (1021)
T PTZ00266 236 LCSGKTPFHKANN-------FSQ-LISELKRGP-------DLPI---------KGKSKELNILIKNLLNLSAKERPSALQ 291 (1021)
T ss_pred HHHCCCCCCcCCc-------HHH-HHHHHhcCC-------CCCc---------CCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence 9999999964221 111 112222211 1100 011345678899999999999999999
Q ss_pred HHH
Q 005691 601 ALK 603 (683)
Q Consensus 601 Vl~ 603 (683)
++.
T Consensus 292 lL~ 294 (1021)
T PTZ00266 292 CLG 294 (1021)
T ss_pred Hhc
Confidence 983
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.78 Aligned_cols=277 Identities=23% Similarity=0.303 Sum_probs=200.4
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCc-cC-hHHHHHHHHHHHhccCCC-cccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDF-QG-DAEFCNEVEIISNLKHRN-LVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~-~~-~~~f~~Ev~iL~~L~H~N-LV~L~G~c~~~~~~~~~ 387 (683)
..+|...++||+|.||+||+|+. .+|+.||+|++.-... ++ -....+|+.++++|+|+| ||+|.+++..+...+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566667899999999999995 4789999999976544 23 334688999999999999 99999999865433344
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++|+||++ -+|..++..... ....++-...+.+..|+.+||+||| +.+|+||||||.|||++++|.+|
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~-----~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lK 160 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPK-----KPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLK 160 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccc-----cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEe
Confidence 57889999995 488888843221 1135666788999999999999999 99999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+|+...-.... .+...+|..|.|||++.+. .|+...||||+||++.||++++.-|....+.++ ..-+.
T Consensus 161 laDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q-----l~~If 234 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ-----LFRIF 234 (323)
T ss_pred eeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH-----HHHHH
Confidence 9999999976533322 4556789999999999876 799999999999999999999988865433111 11111
Q ss_pred hhhhc--Ccccc------ccCcccccc---ccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 SLVKA--GKVWQ------ALDPSLLKE---DDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 ~~~~~--g~l~e------~vD~~l~~~---~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.+.. +..+. -.+...... .+..... ........+++..|++.+|.+|.|+..++.+
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11110 00000 001011000 0000000 0111366788999999999999999999976
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.60 Aligned_cols=247 Identities=27% Similarity=0.298 Sum_probs=198.3
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
+|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|++++++++||||+++++++. .+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ------DEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc------CCCe
Confidence 5788899999999999999976 589999999875432 23567999999999999999999999886 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++|+||+++++|.+++.. ...+++.....|+.++++||.||| +.+++|+||||+||++++++.+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~ 142 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQ---------KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHIT 142 (258)
T ss_pred EEEEEeCCCCCCHHHHHHh---------cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEe
Confidence 9999999999999999832 247889999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||++....... ......|+..|+|||++....++.++||||||+++|||++|+.|+....... .++.....
T Consensus 143 d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~ 214 (258)
T cd05578 143 DFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQ 214 (258)
T ss_pred ecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHh
Confidence 999987664432 2234568889999999998889999999999999999999999987543211 11221111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI--SDAL 602 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm--~eVl 602 (683)
... . +. .+......+.+++..|++.+|.+||+. .|++
T Consensus 215 ~~~--~----~~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 215 ETA--D----VL----------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccc--c----cc----------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 110 0 00 111223567788999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.33 Aligned_cols=248 Identities=22% Similarity=0.362 Sum_probs=205.5
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccCh---HHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGD---AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~---~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
..+|+..+.||+|.||.|-+++. ..|+.||||.+++...... -...+|++||+.|+||||+.++.++. ..
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE------Nk 125 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE------NK 125 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc------CC
Confidence 34677778899999999999985 6799999999977654443 34789999999999999999999986 67
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
+...+||||..+|.|.||+. .++.|++...+.++.||..|+.|+| +.+++|||||.+|||||.|+++|
T Consensus 126 dKIvivMEYaS~GeLYDYiS---------er~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYIS---------ERGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred ceEEEEEEecCCccHHHHHH---------HhccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCee
Confidence 78999999999999999993 3568999999999999999999999 99999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCC-ccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT-EKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+||||+.++..+. ..+..+|++-|.+||++.+.+|. +.+|-||+||+||-|+.|..||+..+. . ..+
T Consensus 194 IADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k---~lv- 262 (668)
T KOG0611|consen 194 IADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----K---RLV- 262 (668)
T ss_pred eeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----H---HHH-
Confidence 99999998876543 34568999999999999988884 789999999999999999999985322 1 122
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
+.+..|...| | +.......++.|++..||++|.|+.+|...-
T Consensus 263 rQIs~GaYrE---P--------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 263 RQISRGAYRE---P--------------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHhhcccccC---C--------------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2233443322 1 1122345678899999999999999998754
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=295.15 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=207.4
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--------hHHHHHHHHHHHhc-cCCCccccccee
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--------DAEFCNEVEIISNL-KHRNLVPLRGCC 378 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--------~~~f~~Ev~iL~~L-~H~NLV~L~G~c 378 (683)
+...++|...++||+|+.++|.+...+ .|++.|+|++....... .++-..|+.||+++ -||||+.|..++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 445578888999999999999988764 68899999986533211 23467899999998 599999999998
Q ss_pred eecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 379 ~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
. .....++|+|.|+.|.|.|+|. ..-.+++...++|..++.+|++||| ...|+||||||+||
T Consensus 93 e------s~sF~FlVFdl~prGELFDyLt---------s~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENI 154 (411)
T KOG0599|consen 93 E------SDAFVFLVFDLMPRGELFDYLT---------SKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENI 154 (411)
T ss_pred c------CcchhhhhhhhcccchHHHHhh---------hheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhhe
Confidence 6 4567899999999999999993 3457899999999999999999999 89999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc------CCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 459 LLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY------GQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
|+|+++++||+|||+|.....+.. ....+||+||+|||.+.. ..|+..+|.|+.||++|.|+.|.+||-...
T Consensus 155 Llddn~~i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 155 LLDDNMNIKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred eeccccceEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 999999999999999998877654 456899999999998862 457889999999999999999999985311
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. -...+++.+|+. .+.+....+..+...+++..|++.||.+|-|.+|+++
T Consensus 233 ------Q---mlMLR~ImeGky------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 233 ------Q---MLMLRMIMEGKY------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ------H---HHHHHHHHhccc------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0 122344445543 2222344566677788999999999999999999874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.19 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=197.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccCh-HHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGD-AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~-~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..+.|++|.||.||+|+.+ +++.||+|+++-.. ..+. -.-++||.+|.+++|||||.+..+.+-. .-+.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~----~~d~ 151 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS----NMDK 151 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc----ccce
Confidence 46777899999999999999965 68899999996532 2221 2367899999999999999998887632 3466
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.|+||||++. +|...+.. ..+++...+...+..|+.+||+||| ..-|+|||||++|+|+...|.+||+
T Consensus 152 iy~VMe~~Eh-DLksl~d~--------m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMET--------MKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeeeHHHHHh-hHHHHHHh--------ccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEec
Confidence 9999999976 77777732 2357888899999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
||||||.+...... .|..+-|..|+|||.+.+ ..|+...|+||+|||+.|++++++-|....+.++ .+-+.++
T Consensus 220 DFGLAR~ygsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-----l~~If~l 293 (419)
T KOG0663|consen 220 DFGLAREYGSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-----LDKIFKL 293 (419)
T ss_pred ccchhhhhcCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-----HHHHHHH
Confidence 99999988765433 455667999999999886 5799999999999999999999998865433221 1111111
Q ss_pred hhcCccccccCcccccccc-----ccC---------CChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDD-----FLS---------LNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~-----~~~---------~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
-|...+.+-|.+..-.. +.. +......+.-..+.-..+..||.+|-|++|.++.
T Consensus 294 --lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 294 --LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred --hCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 12222222222211100 000 0000012334455556678899999999998753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.12 Aligned_cols=203 Identities=25% Similarity=0.365 Sum_probs=169.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
..++|...+.||+|+||.||++... +|+.||+|++.... ....+++.+|+.++++++|+||+++++++.........
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 68999999986432 22345678899999999999999999988644332334
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||++ ++|.+.+. ..+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQ-----------MDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccC-CCHHHHHh-----------hcCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 56899999996 47777762 13788889999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
|+|||+++...... ......+|..|+|||.+.+..++.++|||||||+++||++|+.||..
T Consensus 159 L~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 159 ILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred EccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 99999998654322 12334678999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.49 Aligned_cols=263 Identities=25% Similarity=0.301 Sum_probs=193.2
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
|+..++||+|++|.||+|... +|..||+|++..... ...+.+.+|++++++++|+|++++++++. .+...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~------~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH------SENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec------cCCeEE
Confidence 566789999999999999965 799999999865432 22356889999999999999999999986 557899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++|||++ ++|.+++.... ...++|..+++++.++++||+||| +.+++||||+|+||+++.++.+||+||
T Consensus 75 iv~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df 143 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSP-------LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADF 143 (283)
T ss_pred EEEeccC-cCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeec
Confidence 9999995 68998884221 236899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh-------h
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT-------D 543 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~-------~ 543 (683)
|+++........ .....++..|+|||++..+ .++.++||||||+++|||++|+.||......... ..+. .
T Consensus 144 ~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 221 (283)
T cd07835 144 GLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL-FRIFRTLGTPDE 221 (283)
T ss_pred ccccccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence 999765432221 1223568899999988654 5789999999999999999999998643221000 0000 0
Q ss_pred hhhhhhhc--C---ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKA--G---KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~--g---~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.|..+.. + .......+.+.. ........+.+++..|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDLSK-------VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhhhhhhchhhhhhcccccccchhh-------hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01100000 0 000000000000 01112346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.70 Aligned_cols=271 Identities=21% Similarity=0.332 Sum_probs=195.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++|+||+++++++..........
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999964 68999999986532 122346889999999999999999999986443322345
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++|+||+++ +|..++ ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----------~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----------GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEeccccc-CHHHHH-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 67999999964 665544 235889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++..... .....+|..|+|||.+.. ..++.++|||||||++|||++|+.||....... .+ .-.+.
T Consensus 159 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~----~~-~~~~~ 229 (342)
T cd07879 159 LDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QL-TQILK 229 (342)
T ss_pred eeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HH-HHHHH
Confidence 999998765332 223467889999999876 468999999999999999999999996432100 00 00000
Q ss_pred -----------hhhcCccccccC--ccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 005691 548 -----------LVKAGKVWQALD--PSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM--LEGD 608 (683)
Q Consensus 548 -----------~~~~g~l~e~vD--~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~--L~~~ 608 (683)
.+........++ +..... +.. .........+.+++..|++.||++||++.+++.. +++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK-DFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccc-hHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000000000 000000 000 0000123456789999999999999999999854 6553
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.62 Aligned_cols=268 Identities=24% Similarity=0.312 Sum_probs=195.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..+.||+|+||.||+|... +++.+|+|++...... ....+.+|++++++++||||+++++++... ....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----~~~~ 80 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS----NLDK 80 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec----CCCc
Confidence 46888889999999999999976 5889999998654322 233577899999999999999999998632 2368
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++ ++|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+||++++++.+||+
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETM--------KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred EEEEehhcC-cCHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEe
Confidence 999999997 4888887321 236899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh------
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT------ 542 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~------ 542 (683)
|||+++....... ......++..|+|||++.+. .++.++|+||||++++||++|+.||......... ..+.
T Consensus 149 d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~ 226 (293)
T cd07843 149 DFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTP 226 (293)
T ss_pred ecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCC
Confidence 9999987654322 12334578899999988754 4689999999999999999999998643221100 0000
Q ss_pred -hhhhhhhh------cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 -DWVWSLVK------AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 -~~v~~~~~------~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..|..+. .....+.....+... .........+.+++..|++.+|++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLRKK-----FPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhhcc-----ccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00111110 001111111111111 011112445678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.26 Aligned_cols=207 Identities=26% Similarity=0.397 Sum_probs=167.9
Q ss_pred CcccceeeeecCceEEEEEEEc---CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ---DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++... .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~ 76 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH----AD 76 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC----CC
Confidence 4777889999999999999975 47899999987633 33345688999999999999999999998732 23
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc----C
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA----D 463 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~----~ 463 (683)
...++||||+++ +|.+++..... .....+++...+.|+.|++.||.||| +.+|+||||||+||+++. +
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~ 148 (316)
T cd07842 77 KSVYLLFDYAEH-DLWQIIKFHRQ----AKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPER 148 (316)
T ss_pred ceEEEEEeCCCc-CHHHHHHhhcc----CCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCcc
Confidence 679999999975 56655532211 11236888899999999999999999 889999999999999999 9
Q ss_pred CcEEEcccCcccccccCCc--cccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 464 MRARVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
+.+||+|||+++....... .......+|..|+|||++.+. .++.++||||||++++||++|+.||....
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 9999999999987643322 122345789999999988764 57899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.16 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=195.5
Q ss_pred eeecCceEEEEEEEcC-CcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 321 IGRGGFGLVYKGILQD-GTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 321 LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
||+|+||.||+++..+ |+.+++|.+..... ...+.+.+|++++.+++|+|++++++.+. .+...+++|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ------GKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee------cCcEEEEEEec
Confidence 6899999999999874 89999999865433 33557899999999999999999999876 56789999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++++|.+++.. ...+++..+++++.|+++||+||| +.+++||||+|+||++++++.+||+|||++..
T Consensus 75 ~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 75 LPGGDLASLLEN---------VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred CCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 999999999832 236899999999999999999999 88999999999999999999999999999876
Q ss_pred cccCCc-------cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 477 SREGQS-------HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 477 ~~~~~~-------~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
...... .......++..|+|||.......+.++||||||++++|+++|+.|+..... .......
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~- 213 (265)
T cd05579 143 GLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNI- 213 (265)
T ss_pred cccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-
Confidence 543321 122345688899999999988899999999999999999999999864321 1111111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+... .. ........+..++..|++.+|++|||+.+|.+.|+.
T Consensus 214 ~~~~~~------~~--------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 214 LNGKIE------WP--------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred hcCCcC------CC--------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 111110 00 000013466789999999999999999888887774
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.25 Aligned_cols=277 Identities=26% Similarity=0.319 Sum_probs=198.8
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCC--
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD-- 383 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~-- 383 (683)
+.+.++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|||++++++++....+
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456788999999999999999999986 588999999865432 223467889999999999999999999864321
Q ss_pred --CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 384 --NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 384 --~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.......++|+||+++ +|.+++.. ....++|..++.|+.+++.||+||| +.+|+||||||+||+++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~--------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~ 150 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES--------GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLN 150 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 1123478999999986 66666522 1246899999999999999999999 88999999999999999
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
+++.+||+|||++...............++..|+|||.+.. ..++.++|||||||+++||++|+.|+....... .
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~ 226 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----Q 226 (302)
T ss_pred CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----H
Confidence 99999999999998765443323333456889999998764 457899999999999999999999986432110 0
Q ss_pred hhhhhhhhh-----------hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLV-----------KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~-----------~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+ .-+.+.. .+.......|+.-....... .........+.+++..|++.+|.+||++.+|+.
T Consensus 227 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 227 L-ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred H-HHHHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0011100 00000000110000000000 000112346788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.30 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=200.7
Q ss_pred ceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 318 KNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
.-+||+|.||+||-|+..+ ...+|||.+.....+...-+..|+.+-++|+|+|||+++|.|. +++..-+.||-
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s------enGf~kIFMEq 653 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS------ENGFFKIFMEQ 653 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC------CCCeEEEEeec
Confidence 3479999999999999764 5579999998877776677899999999999999999999986 56678899999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCC--CccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-CCcEEEcccCc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPL--TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGL 473 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L--~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-~~~~KLaDFGl 473 (683)
+|||||.+.|.... .+| ++.+.--...||.+||.||| +..|||||||-.|||++. .|.+||+|||-
T Consensus 654 VPGGSLSsLLrskW--------GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGT 722 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKW--------GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGT 722 (1226)
T ss_pred CCCCcHHHHHHhcc--------CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEeccccc
Confidence 99999999995443 344 56666778899999999999 899999999999999964 68999999998
Q ss_pred ccccccCCccccccccCCCcccCccccccCC--CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
++.... -...+....||..|||||++..|+ |..++|||||||++.||.|||+||.....+.. .+.+-
T Consensus 723 sKRLAg-inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----------AMFkV 791 (1226)
T KOG4279|consen 723 SKRLAG-INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----------AMFKV 791 (1226)
T ss_pred chhhcc-CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----------hhhhh
Confidence 876542 334566788999999999998764 78899999999999999999999975543221 11222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
|-. .+.| .-+.+..++....++.|..++|.+||++.++++
T Consensus 792 Gmy--KvHP----------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 GMY--KVHP----------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cce--ecCC----------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 211 1111 245677788899999999999999999999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.51 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=180.5
Q ss_pred cCcccceeeeecCceEEEEEEEcCC----cEEEEEEeeccCccChH-----------HHHHHHHHHHhccCCCcccccce
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDG----TTVAVKKVIESDFQGDA-----------EFCNEVEIISNLKHRNLVPLRGC 377 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g----~~VAVK~l~~~~~~~~~-----------~f~~Ev~iL~~L~H~NLV~L~G~ 377 (683)
++|...++||+|+||.||+|...++ ..+|+|........... ....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788899999999999999997654 45555543222211111 12223344566789999999997
Q ss_pred eeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCc
Q 005691 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATN 457 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsN 457 (683)
+..... .....++++|++.. ++.+.+. .....++...+.|+.|++.||+||| +.+|+||||||+|
T Consensus 92 ~~~~~~--~~~~~~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~N 156 (294)
T PHA02882 92 GSFKRC--RMYYRFILLEKLVE-NTKEIFK---------RIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPEN 156 (294)
T ss_pred eeEecC--CceEEEEEEehhcc-CHHHHHH---------hhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 753221 11234677776643 4444441 1123567788899999999999999 8899999999999
Q ss_pred eeeccCCcEEEcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 458 ILLDADMRARVADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 458 ILLd~~~~~KLaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
||++.++.+||+|||+|+........ ......||+.|+|||+..+..++.++|||||||+++||++|+.||...
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999876432211 122346999999999999999999999999999999999999999754
Q ss_pred CCCCCC-ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 532 TSGSPR-ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 532 ~~~~~~-~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
...... .....++..+ ...+.+ . .......+.+++..|++.+|++||++.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~--------~---------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 237 GHNGNLIHAAKCDFIKR-LHEGKI--------K---------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred ccchHHHHHhHHHHHHH-hhhhhh--------c---------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 321110 0000111111 111111 0 0112345678889999999999999999999874
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.57 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=191.0
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.++.++. |+||++++|++. .....
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~------~~~~~ 78 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF------REGDC 78 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe------cCCcE
Confidence 4455678999999999999965 589999999865432 23456889999999996 999999999886 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
+++|||++. +|.++..... ......+++....+++.+++.||+|||+ ..+|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVY----EVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred EEEEecccC-CHHHHHHHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEee
Confidence 999999864 5544321100 0123468999999999999999999993 35899999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC---CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG---QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
||+++....... .....|+..|+|||++... .++.++|||||||++|||++|+.||..... ..+-..+
T Consensus 152 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~ 222 (288)
T cd06616 152 FGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQ 222 (288)
T ss_pred cchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhh
Confidence 999976543221 2334689999999998766 689999999999999999999999864321 1011111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.. .+ ..+.+... ........+.+++..|++.+|++|||+.+|++.
T Consensus 223 ~~-~~-----~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 VV-KG-----DPPILSNS------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hc-CC-----CCCcCCCc------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11 11112111 112234567889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.53 Aligned_cols=248 Identities=31% Similarity=0.438 Sum_probs=193.9
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.|...+.||+|+||.||+|+.. ++..||+|++....... ..++.+|++++++++|+|++++++++. .+..
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~ 99 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL------REHT 99 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe------eCCe
Confidence 3667788999999999999964 68899999986543322 346889999999999999999999987 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++ |+|.+.+.. ....++|.++..++.+++.||.||| +.+|+||||+|+||+++.++.+||+
T Consensus 100 ~~lv~e~~~-g~l~~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEV--------HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred EEEEEeCCC-CCHHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEe
Confidence 899999997 577776632 1346899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|||++...... ....|+..|+|||++. .+.++.++|||||||++|||++|+.|+...... ....
T Consensus 168 dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~ 234 (317)
T cd06635 168 DFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALY 234 (317)
T ss_pred cCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHH
Confidence 99998754432 2346889999999974 467899999999999999999999998542210 1111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.....+. +.. ........+.+++..|++.+|.+||++.+|++.+.-
T Consensus 235 ~~~~~~~------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 235 HIAQNES------PTL---------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHhccC------CCC---------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1111111 000 111233457788999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.85 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=193.1
Q ss_pred CcccceeeeecCceEEEEEEE----cCCcEEEEEEeeccCc----cChHHHHHHHHHHHhc-cCCCcccccceeeecCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDF----QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~ 384 (683)
+|+..+.||+|+||.||++.. .+|..||+|++..... ...+.+.+|++++.++ +|+||+++.+++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----- 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----- 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence 467788999999999999986 3689999999875322 2245688999999999 5999999998876
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.+...++||||+++++|.+++.. ...+++.....++.++++||.||| +.+++||||||+|||+++++
T Consensus 76 -~~~~~~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 76 -TDTKLHLILDYINGGELFTHLSQ---------RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 142 (290)
T ss_pred -cCCeEEEEEecCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCC
Confidence 45678999999999999999832 346888888899999999999999 89999999999999999999
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccC--CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
.+||+|||+++..............|+..|+|||++..+ .++.++||||||+++|||++|+.|+...... ....
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~ 218 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQA 218 (290)
T ss_pred CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHH
Confidence 999999999987654433333345689999999998753 4688999999999999999999998643221 1112
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDAL 602 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl 602 (683)
.+.......+ +.. +......+..++..|++.+|++|| ++.+++
T Consensus 219 ~~~~~~~~~~-------~~~----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 219 EISRRILKSE-------PPY----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred HHHHHhhccC-------CCC----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 2222211111 001 111234567888999999999997 555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.76 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=197.9
Q ss_pred CcccceeeeecCceEEEEEEE----cCCcEEEEEEeeccCc----cChHHHHHHHHHHHhc-cCCCcccccceeeecCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDF----QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~ 384 (683)
+|...+.||+|+||.||+++. .+++.||||.+..... ...+.+.+|++++.++ +|+|++++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~----- 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ----- 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence 467788999999999999984 3578899999875321 2245688999999999 5999999998875
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.+...++||||+++|+|.+++.. ...+++.....++.|+++||.||| +.+++||||||+||+++.++
T Consensus 76 -~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 76 -TDTKLHLILDYVNGGELFTHLYQ---------REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEG 142 (288)
T ss_pred -cCCEEEEEEecCCCCcHHHHHhh---------cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCC
Confidence 45678999999999999998832 236888999999999999999999 89999999999999999999
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCC--CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
.+||+|||+++..............|+..|+|||.+.+.. .+.++||||||++++||++|+.|+....... ...
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~ 218 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQS 218 (288)
T ss_pred CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHH
Confidence 9999999999876544333333456899999999987655 7889999999999999999999986322110 111
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+....... ++.. +......+.+++..|++.+|++|||+.+|.+.|+.
T Consensus 219 ~~~~~~~~~-------~~~~----------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 219 EISRRILKS-------KPPF----------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHcc-------CCCC----------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111111110 0111 11122345678899999999999999999888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.26 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=199.9
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..++||+|+||.||+++.. +++.+|+|++..... ....++.+|++++++++|+||+++++++. .....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL------DGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc------cCCEE
Confidence 4778889999999999999854 678999999875432 22456889999999999999999999886 45789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++.... .....+++..++.++.+++.||+||| +.+++|+||+|+||++++++.+||+|
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d 146 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRK-----KKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD 146 (256)
T ss_pred EEEehhcCCCCHHHHHHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEee
Confidence 99999999999999884321 12356899999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++..... ......|+..|+|||++....++.++|+||||+++||+++|+.|+..... ..+ ...+.
T Consensus 147 ~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~----~~~~~ 214 (256)
T cd08530 147 LGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDL----RYKVQ 214 (256)
T ss_pred ccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH----HHHHh
Confidence 9999876544 22234578999999999998999999999999999999999999864321 001 11111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+...+ .+......+..++..|++.+|++||++.++++
T Consensus 215 ~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 215 RGKYPP---------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred cCCCCC---------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 221111 11123456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=298.90 Aligned_cols=273 Identities=23% Similarity=0.254 Sum_probs=194.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++ |+|++++++++...... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~-~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN-GKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC-CCc
Confidence 46888999999999999999975 689999998765322 22456889999999995 69999999998743321 223
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-CCcEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRAR 467 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-~~~~K 467 (683)
..++||||+++ +|.+++..... .....+++...+.++.||+.||.||| +.+|+||||||+||+++. ++.+|
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGR----GPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcc----cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEE
Confidence 47999999985 78888743221 11346899999999999999999999 889999999999999998 89999
Q ss_pred EcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+++....... ..+...+++.|+|||++.. ..++.++||||||+++|||++|+.||...... ....
T Consensus 152 l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~ 222 (295)
T cd07837 152 IADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--------QQLL 222 (295)
T ss_pred EeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHH
Confidence 999999876532211 1223356889999998865 45799999999999999999999998643211 1111
Q ss_pred hhhhc-CccccccCcccc---------c-cccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKA-GKVWQALDPSLL---------K-EDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~-g~l~e~vD~~l~---------~-~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+. +......-+... . ...............+.+++..|+++||.+||++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11100 000000000000 0 000000000123456788999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.36 Aligned_cols=274 Identities=23% Similarity=0.348 Sum_probs=199.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++|+||+++++++.... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG--ADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC--CCCc
Confidence 368888999999999999999965 689999999875422 33456788999999999999999999875432 2345
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+. |+|.+++.. ...+++...+.++.|++.||+||| +.+|+||||||+||++++++.+||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl 148 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHS---------DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRI 148 (334)
T ss_pred eEEEEEehhh-hhHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEe
Confidence 7899999995 688888732 345899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCcc---ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh-
Q 005691 469 ADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD- 543 (683)
Q Consensus 469 aDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~- 543 (683)
+|||+++........ ......|+..|+|||++.. ..++.++||||||+++|||++|+.||........- ..+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~-~~~~~~ 227 (334)
T cd07855 149 GDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL-KLILSV 227 (334)
T ss_pred cccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH-HHHHHH
Confidence 999999765432211 1234578999999998765 56899999999999999999999999643221000 00000
Q ss_pred ------hhhhhhhcCccccccCccccccccccCCC----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 544 ------WVWSLVKAGKVWQALDPSLLKEDDFLSLN----PKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 544 ------~v~~~~~~g~l~e~vD~~l~~~~~~~~~~----~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
-.+.....+.+.+..+. ..... ... .......+..++..|++.+|++|||+.+++..-
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQN-LPRKQ---PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhh-cccCC---CCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000001111111110 00000 000 012245788999999999999999999988743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=290.12 Aligned_cols=247 Identities=30% Similarity=0.500 Sum_probs=199.0
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++. .+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE------TSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE------eCCEE
Confidence 4677889999999999999865 578999999876544 33467999999999999999999999986 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
+++|||+++++|.+++.. ...++|..+..++.+++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 75 ~~v~e~~~~~~L~~~~~~---------~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d 142 (254)
T cd06627 75 YIILEYAENGSLRQIIKK---------FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLAD 142 (254)
T ss_pred EEEEecCCCCcHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 999999999999998832 247899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||++......... .....++..|+|||+.....++.++|||++|++++||++|+.|+..... . .-.+....
T Consensus 143 ~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~---~~~~~~~~ 213 (254)
T cd06627 143 FGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----M---AALFRIVQ 213 (254)
T ss_pred cccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----H---HHHHHHhc
Confidence 9999876543322 2345689999999999888889999999999999999999999864321 0 11111111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.. +.+ +......+..++..|++.+|++|||+.+++.
T Consensus 214 -~~~-----~~~----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 -DDH-----PPL----------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -cCC-----CCC----------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 100 111 1112346678899999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=297.88 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=195.4
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+|+..+.||+|++|.||+|+.. +|+.||||++...... ..+.+.+|++++++++|+|++++++++. .....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH------TENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe------eCCcEE
Confidence 5788899999999999999975 5889999998765433 3456789999999999999999999987 456789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++ +|.+++.... ....++|..+++++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 75 lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~ 144 (284)
T cd07836 75 LVFEYMDK-DLKKYMDTHG------VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADF 144 (284)
T ss_pred EEEecCCc-cHHHHHHhcC------CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeec
Confidence 99999985 8888774321 1346899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh------
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW------ 544 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~------ 544 (683)
|+++....... ......+|..|++||++... .++.++||||||+++||+++|+.|+......+.. ..+.+.
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~ 222 (284)
T cd07836 145 GLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL-LKIFRIMGTPTE 222 (284)
T ss_pred chhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCh
Confidence 99976543221 12234578899999988654 5688999999999999999999998643321100 000000
Q ss_pred -hhhhhhcCccccccCccccccc-cccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 -VWSLVKAGKVWQALDPSLLKED-DFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 -v~~~~~~g~l~e~vD~~l~~~~-~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.|+.+... ........... .............+.+++..|++.||.+||++.++++
T Consensus 223 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 223 STWPGISQL---PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhHHHHhcC---chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01111100 00000000000 0000000112345678899999999999999999884
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=308.05 Aligned_cols=273 Identities=23% Similarity=0.345 Sum_probs=199.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||+||+|+.. +++.||||++... .......+.+|+.+++.++|+||+++++++..... ....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~-~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR-EAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc-cccC
Confidence 457888999999999999999964 6899999998653 22234567889999999999999999998763221 1224
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+. ++|.+++. ....+++.....++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR---------SSQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEE
Confidence 5899999996 68887773 2346899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh---
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW--- 544 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~--- 544 (683)
+|||+++....... ......++..|+|||.+.. ..++.++||||||++++||++|+.||........ ...+...
T Consensus 150 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ-LKLITELLGS 227 (337)
T ss_pred CcCccccccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCC
Confidence 99999987644321 2233567899999998865 5689999999999999999999999864321000 0000000
Q ss_pred ----hhhhhhcCcccccc-------CccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc
Q 005691 545 ----VWSLVKAGKVWQAL-------DPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM--LEG 607 (683)
Q Consensus 545 ----v~~~~~~g~l~e~v-------D~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~--L~~ 607 (683)
.+.....+...+.+ ++.+.. ........+.+++..|++.+|++|||+.++++. |+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-------LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHH-------HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00000011111100 010000 011234567899999999999999999999876 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=301.34 Aligned_cols=208 Identities=28% Similarity=0.403 Sum_probs=167.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCC--CCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD--NER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~--~~~ 386 (683)
.++|...++||+|+||.||++... +++.||||++...... ....+.+|++++++++||||++++++|..... ...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357888999999999999999975 6889999998653322 23456789999999999999999999874332 112
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++ +|.+++.. ....+++.+.+.++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--------KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGIL 158 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcE
Confidence 3567999999975 77776622 1236899999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCc---cccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 467 RVADFGLAKQSREGQS---HLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 467 KLaDFGla~~~~~~~~---~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
||+|||++........ .......++..|+|||++.+. .++.++||||||++++||++|+.|+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999986643221 122334678899999988764 4788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.53 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=204.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...+.+|+|.||.++..+.+ ++..+++|++.-.... ..+...+|+.++++++|||||.+...+. +++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~------~~~~ 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE------EDGQ 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh------cCCc
Confidence 46777889999999999988754 6789999998654332 2346889999999999999999999887 3445
Q ss_pred -eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 390 -RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 390 -~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
.++||+|++||+|.+.+... ++..++..+..+++.|+..|+.||| +.+|+|||||+.||++..+..+||
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~-------k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkL 147 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQ-------KGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKL 147 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHH-------hhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceee
Confidence 89999999999999999432 2456888899999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+|+....... ....+.||+.||.||.+.+.+|..|+|||||||++|||.+-+++|+..+. ...+.+.
T Consensus 148 gDfGlaK~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki 218 (426)
T KOG0589|consen 148 GDFGLAKILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKI 218 (426)
T ss_pred cchhhhhhcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHH
Confidence 99999998876543 34558899999999999999999999999999999999999999975332 1112221
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+. .++| -+......+..++..|++.+|+.||++.+++.+
T Consensus 219 ~~~-----~~~P-----------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 219 NRG-----LYSP-----------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hhc-----cCCC-----------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111 1121 122335567788899999999999999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=294.38 Aligned_cols=236 Identities=25% Similarity=0.309 Sum_probs=188.4
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 321 LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++. .+...++|+||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK------DKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE------cCCccEEEEec
Confidence 699999999999976 488999999875432 23456999999999999999999999886 55679999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++++|.+++.. ...+++..+..++.+++.||+||| +.+++|+||||+||+++.++.+||+|||+++.
T Consensus 75 ~~~~~L~~~l~~---------~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~ 142 (262)
T cd05572 75 CLGGELWTILRD---------RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK 142 (262)
T ss_pred CCCCcHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccc
Confidence 999999999842 235889999999999999999999 89999999999999999999999999999987
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
..... ......|+..|+|||++....++.++|+||||+++|||++|+.|+....... ........ .+..
T Consensus 143 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~-- 211 (262)
T cd05572 143 LKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDIL-KGNG-- 211 (262)
T ss_pred cCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHh-ccCC--
Confidence 65432 2233568899999999988889999999999999999999999987543211 11111111 1000
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT 597 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt 597 (683)
... .+......+..++..|++.+|++||+
T Consensus 212 ------~~~------~~~~~~~~~~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 212 ------KLE------FPNYIDKAAKDLIKQLLRRNPEERLG 240 (262)
T ss_pred ------CCC------CCcccCHHHHHHHHHHccCChhhCcC
Confidence 000 11112346788999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.26 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=199.8
Q ss_pred ceeeeecCceEEEEEEEc--CCc--EEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 318 KNFIGRGGFGLVYKGILQ--DGT--TVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~--~g~--~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
.++||+|.||.|++|.+. .|+ .||||.+...... ...+|+.|+.+|.+|+|+|+++|+|+.. +....+
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl-------~qp~mM 187 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL-------DQPAMM 187 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec-------cchhhH
Confidence 468999999999999975 344 6899999775444 5678999999999999999999999985 467899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
|+|.++.|||.+.|++. .+..|-....-.++.|||.|+.||. .+++|||||.++|+||-..-.+||+|||
T Consensus 188 V~ELaplGSLldrLrka-------~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKA-------KKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred HhhhcccchHHHHHhhc-------cccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeeccc
Confidence 99999999999999652 2446777777899999999999999 9999999999999999999999999999
Q ss_pred cccccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhC-CCCCCCCCCCCCCccchhhhhhhhh
Q 005691 473 LAKQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG-RKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 473 la~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltG-r~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|.|.+..++.+. .....-.+.|.|||.+....++.++|||+|||+||||+|+ ..|+..-.
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----------------- 320 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----------------- 320 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----------------
Confidence 999887654432 2333457789999999999999999999999999999994 45543211
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.-.+.+.+|..-+- ..++.+.+++.++++.||.++|++|||...+++.+
T Consensus 321 -g~qIL~~iD~~erL------pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 321 -GIQILKNIDAGERL------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -HHHHHHhccccccC------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11223334421111 13456788999999999999999999999997433
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=299.78 Aligned_cols=272 Identities=29% Similarity=0.347 Sum_probs=196.2
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCC--CC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN--ER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~--~~ 386 (683)
.++|...++||+|+||.||+|+.. +++.+|||++...... ....+.+|++++++++|+||+++++++...... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999965 6889999998654322 234578999999999999999999987643321 23
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++|+||+.+ +|...+.. ....+++..++.++.|+++||.||| +.+|+||||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--------~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--------PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 4568999999975 56655532 1346999999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc----------cccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 467 RVADFGLAKQSREGQS----------HLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 467 KLaDFGla~~~~~~~~----------~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
||+|||+++....... ...+.+.|+..|+|||++.+ ..++.++||||||++++||++|++||.......
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999976543221 11234567889999998765 458899999999999999999999986433211
Q ss_pred CCccch-------hhhhhhhhhcCcc------ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 536 PRACLI-------TDWVWSLVKAGKV------WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 536 ~~~~~l-------~~~v~~~~~~g~l------~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
.. ..+ ..+.|..+..... .....+.+... .......+.+++..|++.+|++|||+.+++
T Consensus 235 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 235 QL-HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-------FGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred HH-HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-------cccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 00 000 0011111110000 00000111000 011224678899999999999999999987
Q ss_pred H
Q 005691 603 K 603 (683)
Q Consensus 603 ~ 603 (683)
.
T Consensus 307 ~ 307 (311)
T cd07866 307 E 307 (311)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=289.43 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=201.7
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||++... +++.+++|++..... ...+++.+|+++++.++|+|++++++.+. .+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~------~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE------EKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe------cCCEE
Confidence 4777889999999999999975 588999999876543 34567899999999999999999999886 45789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++|+||+++++|.+++.... .....+++..+..++.+++.||.||| +.+++|+||+|+||++++++.+||+|
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d 146 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQK-----KEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGD 146 (258)
T ss_pred EEEEEecCCCcHHHHHHHhh-----ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECC
Confidence 99999999999999884321 12357999999999999999999999 78999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||++....... .......|+..|+|||......++.++||||+|++++||++|+.|++.... ........
T Consensus 147 ~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~- 216 (258)
T cd08215 147 FGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKIL- 216 (258)
T ss_pred ccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHh-
Confidence 99998765433 223335688999999999988999999999999999999999999864321 11111111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.... + +......+..++..|++.+|++|||+.++++
T Consensus 217 ~~~~~~-----~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 217 KGQYPP-----I----------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred cCCCCC-----C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111110 1 1122346778999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=295.82 Aligned_cols=263 Identities=22% Similarity=0.221 Sum_probs=190.9
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCeeE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
|...++||+|+||.||+|... +++.||+|++...... ......+|+.++.++. |+|++++++++... ..+..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~----~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR----KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC----CCCcEE
Confidence 456788999999999999964 6889999998654322 2234567999999995 99999999998632 226789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|+||++ |+|.+++... ...++|..++.++.|++.||+||| +.+|+||||||+||+++. +.+||+||
T Consensus 77 lv~e~~~-~~l~~~l~~~--------~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~df 143 (282)
T cd07831 77 LVFELMD-MNLYELIKGR--------KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADF 143 (282)
T ss_pred EEEecCC-ccHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEec
Confidence 9999997 5777777321 246899999999999999999999 889999999999999999 99999999
Q ss_pred CcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh---
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS--- 547 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~--- 547 (683)
|+++....... .....++..|+|||++.. +.++.++|||||||++|||++|+.||...+.. ....+...
T Consensus 144 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~ 216 (282)
T cd07831 144 GSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLG 216 (282)
T ss_pred ccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcC
Confidence 99986543222 223467899999997654 56789999999999999999999999643321 11111111
Q ss_pred --------hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 --------LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 --------~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
............+...+.. . ..........+.+++..|++.+|++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 217 TPDAEVLKKFRKSRHMNYNFPSKKGTG-L-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHHHHhhcccccccccCccccccc-H-HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111111111111100000 0 0001123567889999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=294.20 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=193.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-----ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-----FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-----~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.+|...+.||+|+||.||+|... +++.||+|++.... .+....+.+|++++++++|+||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~----~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP----E 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC----C
Confidence 47888999999999999999964 58999999875321 12234688999999999999999999987531 3
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
+...++++||+++++|.+++.. ...+++...++++.+++.||.||| +.+++|+||||+||+++.++.+
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~---------~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~ 145 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKA---------YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNV 145 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCE
Confidence 4568899999999999998832 235788899999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCC--ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQ--SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++...... ....+...|+..|+|||++.+..++.++|||||||+++||++|+.||...... ..
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~---- 217 (264)
T cd06653 146 KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AA---- 217 (264)
T ss_pred EECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HH----
Confidence 999999998653211 11123456899999999999888999999999999999999999998643210 00
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.+..... . .+. .+....+.+.+++..|++ +|..||+..+++.
T Consensus 218 ~~~~~~~~-~----~~~----------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQP-T----KPM----------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCC-C----CCC----------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111010 0 011 112233456788889998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=309.47 Aligned_cols=252 Identities=26% Similarity=0.353 Sum_probs=206.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccC---hHHHHHHHHHHHhcc-CCCcccccceeeecCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQG---DAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~ 385 (683)
....|...+.||+|.||.||+++.+. |+.+|+|.+.+....+ .+.+.+|+.+|+++. |||+|.+.+.+.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e------ 106 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE------ 106 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE------
Confidence 34567777899999999999999775 9999999997765544 357999999999998 999999999997
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC--
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-- 463 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-- 463 (683)
.....++|||++.+|.|.+.+... .+++.....++.+++.++.||| +.+|+||||||+|+|+...
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDE 173 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccC
Confidence 556899999999999999998321 3888899999999999999999 8999999999999999543
Q ss_pred --CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 464 --MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 464 --~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
+.+|++|||++..... ......++||+.|+|||++....|+.++||||.||++|.|++|.+||........
T Consensus 174 ~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~----- 246 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI----- 246 (382)
T ss_pred CCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-----
Confidence 5799999999998776 3345668999999999999999999999999999999999999999975443211
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
...+..++. .... .......+..-.++..++..||.+|+|+.++++.
T Consensus 247 ----~~~i~~~~~------~f~~------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 247 ----FLAILRGDF------DFTS------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----HHHHHcCCC------CCCC------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 112223332 1111 1223334566678888999999999999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=329.98 Aligned_cols=269 Identities=27% Similarity=0.428 Sum_probs=210.3
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc----C----CcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccce
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ----D----GTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGC 377 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~----~----g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~ 377 (683)
++...++....+.||+|.||.|++|... . ...||||.++..... ..+.+..|+++|..+ +|+|+|.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555566669999999999999853 1 457999999875444 356799999999999 69999999999
Q ss_pred eeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCC-----CC--CCCCccchhhhHHHHHHHHHHHhcccCCCccc
Q 005691 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGV-----AK--RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~-----~~--~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiH 450 (683)
|. .....++|.||+.+|+|.++|...+...... .. ..|+....+.++.|||.|++||+ +.++||
T Consensus 371 ~t------~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vH 441 (609)
T KOG0200|consen 371 CT------QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVH 441 (609)
T ss_pred ec------cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccc
Confidence 97 4677999999999999999997655100000 01 24888999999999999999999 899999
Q ss_pred cCCCCCceeeccCCcEEEcccCcccccccCCccccccccC--CCcccCccccccCCCCccccEEEcchhHHHHhh-CCCC
Q 005691 451 RDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG--THGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKA 527 (683)
Q Consensus 451 rDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~G--T~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p 527 (683)
|||.++|||+.++..+||+|||+||............-.| ...|||||.+....|+.|||||||||+||||+| |..|
T Consensus 442 RDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 442 RDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 9999999999999999999999999765544443333333 446999999999999999999999999999999 6666
Q ss_pred CCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 528 LDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 528 ~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+..... ..+ +++.+++|.-.+ .|..+..++..++..||+.+|++||+..++++.|+.
T Consensus 522 Yp~~~~-------~~~-l~~~l~~G~r~~---------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 522 YPGIPP-------TEE-LLEFLKEGNRME---------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CCCCCc-------HHH-HHHHHhcCCCCC---------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 643110 111 244555654322 233445677899999999999999999999999987
Q ss_pred C
Q 005691 608 D 608 (683)
Q Consensus 608 ~ 608 (683)
.
T Consensus 579 ~ 579 (609)
T KOG0200|consen 579 H 579 (609)
T ss_pred H
Confidence 3
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=300.86 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=192.7
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeec
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYM 397 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~ 397 (683)
.+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+|++++++++. .++..++||||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL------VGDELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE------eCCEEEEEEecC
Confidence 46999999999999874 68999999986555455667999999999999999999999987 567899999999
Q ss_pred CCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 398 PNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 398 ~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
++++|.+++. ...+++...+.++.+++.||+||| +.+++||||||+||++++++.++|+|||++...
T Consensus 100 ~~~~L~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 100 EGGALTDIVT----------HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CCCcHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 9999998772 235789999999999999999999 889999999999999999999999999998765
Q ss_pred ccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccc
Q 005691 478 REGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQA 557 (683)
Q Consensus 478 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~ 557 (683)
.... .......|+.+|+|||+.....++.++||||||++++||++|+.|+..... . .. ......+
T Consensus 167 ~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~---~~-~~~~~~~----- 231 (292)
T cd06657 167 SKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----L---KA-MKMIRDN----- 231 (292)
T ss_pred cccc-ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H---HH-HHHHHhh-----
Confidence 4322 122335689999999999888899999999999999999999999853211 0 01 0111111
Q ss_pred cCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 558 LDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 558 vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.+.+... ......+..++..|++.+|.+||++.++++
T Consensus 232 ~~~~~~~~--------~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 232 LPPKLKNL--------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCcccCCc--------ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11111100 111234567888999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.64 Aligned_cols=242 Identities=22% Similarity=0.295 Sum_probs=184.3
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHh---ccCCCcccccceeeecCCCCCCCeeEE
Q 005691 320 FIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISN---LKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~---L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
+||+|+||.||++... +++.+|+|.+...... ....+.+|..++.. .+|+|++.+.+++. ..+..++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~------~~~~~~l 74 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH------TPDKLCF 74 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe------cCCeEEE
Confidence 4899999999999975 5889999988654322 12334555544443 47999999998886 4567899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++.. ...++|.....|+.|++.||.||| +.+|+||||||+|||+++++.+||+|||
T Consensus 75 v~e~~~~~~L~~~i~~---------~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg 142 (279)
T cd05633 75 ILDLMNGGDLHYHLSQ---------HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (279)
T ss_pred EEecCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCC
Confidence 9999999999988832 346999999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
++....... .....||..|+|||.... ..++.++|||||||+++||++|+.||........ ........
T Consensus 143 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~- 212 (279)
T cd05633 143 LACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTL- 212 (279)
T ss_pred cceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH------HHHHHHhh-
Confidence 987554322 223468999999998864 4578999999999999999999999964432111 11111100
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALKM 604 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~~ 604 (683)
..+..+. ......+..++..|++.||++|| ++.++++.
T Consensus 213 -----~~~~~~~----------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 -----TVNVELP----------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -----cCCcCCc----------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0111111 12234667888999999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=300.72 Aligned_cols=273 Identities=26% Similarity=0.341 Sum_probs=195.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|+..+.||+|+||.||+|... +|+.||+|++....... ...+.+|+.++++++|+|++++++++... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~ 81 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK----HLD 81 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC----CCC
Confidence 467889999999999999999975 58999999986543221 33567899999999999999999998632 235
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++ +|.+++... ...++|.+++.++.|++.||+||| +.+++||||||+||++++++.+||
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~--------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNM--------PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 68999999974 787777321 246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh-----
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT----- 542 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~----- 542 (683)
+|||+++....... ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+.
T Consensus 150 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~-~~~~~~~~~ 227 (309)
T cd07845 150 ADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL-DLIIQLLGT 227 (309)
T ss_pred CccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCC
Confidence 99999987654322 1223345788999998865 45789999999999999999999998643221100 0000
Q ss_pred --hhhhhhhhcCccccccCccccccccccCC--ChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 543 --DWVWSLVKAGKVWQALDPSLLKEDDFLSL--NPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 543 --~~v~~~~~~g~l~e~vD~~l~~~~~~~~~--~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
...|..+........+. +... ..... ........+..++..|++.||++|||+.++++.-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFT--LPKQ-PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred CChhhchhhhccccccccc--ccCC-CCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 01111111000000000 0000 00000 0001234556789999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.03 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=191.8
Q ss_pred cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCc-cChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDF-QGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...+.||+|+||.||+|+.++ ++.||||++..... ....++..|+.++.+.. |+||++++|++. ....
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~------~~~~ 88 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI------TDSD 88 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee------cCCe
Confidence 567788999999999999999875 89999999876433 23456777888777775 999999999997 5567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCCceeeccCCcEEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKpsNILLd~~~~~KL 468 (683)
.++||||+++ +|.+++.. ....++|..+..|+.+++.||+||| + .+|+||||+|+||++++++.+||
T Consensus 89 ~~~v~e~~~~-~l~~l~~~--------~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL 156 (296)
T cd06618 89 VFICMELMST-CLDKLLKR--------IQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKL 156 (296)
T ss_pred EEEEeeccCc-CHHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEE
Confidence 9999999854 66665522 1237899999999999999999999 5 58999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccC----CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG----QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
+|||++........ .....++..|+|||++... .++.++||||||+++|||++|+.||...... .+.
T Consensus 157 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~ 227 (296)
T cd06618 157 CDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEV 227 (296)
T ss_pred CccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHH
Confidence 99999876543322 2234578899999998754 3789999999999999999999998642111 011
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
........ . +.+.. .....+.+.+++..|++.+|.+||++.+++++-
T Consensus 228 ~~~~~~~~-~-----~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 228 LTKILQEE-P-----PSLPP--------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHHHhcCC-C-----CCCCC--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 11111111 0 00100 011234678899999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.76 Aligned_cols=270 Identities=22% Similarity=0.264 Sum_probs=191.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++|+|++++++++. .+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH------SEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe------cCCe
Confidence 57888999999999999999975 688999998865432 22456889999999999999999999987 5568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-CCcEEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARV 468 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-~~~~KL 468 (683)
.++||||++ ++|.+++... ....+++.....++.+++.||+||| +.+|+||||||+||+++. ++.+||
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl 144 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSS-------PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKL 144 (294)
T ss_pred EEEEEeccc-ccHHHHHHhC-------CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEE
Confidence 999999996 5777776321 1223577788899999999999999 889999999999999985 567999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++...... ...+...+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .....+.+.
T Consensus 145 ~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~-~~~~~~~~~ 222 (294)
T PLN00009 145 ADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL-FKIFRILGT 222 (294)
T ss_pred cccccccccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCC
Confidence 9999997654321 11233467899999998865 45789999999999999999999998643221100 000000000
Q ss_pred ----hhhcC-ccccc--cCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 ----LVKAG-KVWQA--LDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ----~~~~g-~l~e~--vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.|... .+.+. .-+..... ...........++.+++..|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPK--DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCC--CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 00000 00000000 000001112345778999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.63 Aligned_cols=278 Identities=23% Similarity=0.340 Sum_probs=201.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeec--cCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIE--SDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~--~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
....|...+.||+|.||.|.+++.. +|+.||||++.. ......++..+|+.+|+.++|+||+.+...... .....-
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p-~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP-PSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc-cccccc
Confidence 3456666788999999999999965 689999999974 333445678899999999999999999988765 222355
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...|+|+|+| ..+|...+. .++.|+.....-+..|+.+||.|+| +.+|+||||||+|+|++.+...|
T Consensus 99 ~DvYiV~elM-etDL~~iik---------~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---------SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---------cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEE
Confidence 7899999999 568888883 2345888999999999999999999 99999999999999999999999
Q ss_pred EcccCcccccccC-CccccccccCCCcccCccccc-cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh--
Q 005691 468 VADFGLAKQSREG-QSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD-- 543 (683)
Q Consensus 468 LaDFGla~~~~~~-~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~-- 543 (683)
|+|||+||..... .....|..+-|..|.|||.+. ...|+...||||.||++.||++|++-|.....-++- .++.+
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql-~lI~~~l 244 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL-QLILELL 244 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH-HHHHHhc
Confidence 9999999987543 122245567799999999876 568999999999999999999999988643322110 01110
Q ss_pred -----hhhhhhhcCccccccCccccc-cccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 544 -----WVWSLVKAGKVWQALDPSLLK-EDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 544 -----~v~~~~~~g~l~e~vD~~l~~-~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.....+...+....+...-.. ..++....+ ......+++...++..||.+|+|++|.++.
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011111111111111100000 000000011 122355778888999999999999999863
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.23 Aligned_cols=268 Identities=24% Similarity=0.301 Sum_probs=196.1
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
|...+.||+|++|.||++... +++.+++|++...... ....+.+|++++++++|+|++++++++. .+...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR------HKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc------cCCCEE
Confidence 455678999999999999975 6889999998664433 3467889999999999999999999986 457899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+|+||+++ +|.+++.. ....+++..++.++.+++.||.||| +.+|+|+||||+||+++.++.+||+||
T Consensus 75 ~v~e~~~~-~l~~~l~~--------~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 142 (283)
T cd05118 75 LVFEFMDT-DLYKLIKD--------RQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADF 142 (283)
T ss_pred EEEeccCC-CHHHHHHh--------hcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeee
Confidence 99999975 88877732 1247899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch------hhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI------TDW 544 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l------~~~ 544 (683)
|.+....... .......++..|+|||.+... .++.++||||||++++||++|+.||......+...... ..+
T Consensus 143 ~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd05118 143 GLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE 221 (283)
T ss_pred eeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchH
Confidence 9998765443 122335678899999998876 78999999999999999999999885432211000000 000
Q ss_pred hhhhhhcCccccccCcccccccc-ccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDD-FLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~-~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.|..... ..+........... .......+....+.+++..|++.+|.+||++.+++.
T Consensus 222 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 222 VWPKFTS--LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hcccchh--hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0110000 00000000000000 000011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.90 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=188.6
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 321 LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
||+|+||+||++... +|+.+|+|.+..... .....+.+|++++++++|||++++.+.+. ..+..++||||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~------~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE------TKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe------cCCeEEEEEec
Confidence 689999999999864 688999999865432 22445788999999999999999998886 45679999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++++|.+++.... ...+++..++.++.+++.||.||| +.+++||||||+||++++++.+||+|||++..
T Consensus 75 ~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~ 144 (277)
T cd05577 75 MNGGDLKYHIYNVG-------EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVE 144 (277)
T ss_pred CCCCcHHHHHHHcC-------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhh
Confidence 99999999985321 236899999999999999999999 88999999999999999999999999999876
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
..... ......++..|+|||++.++.++.++||||||++++||++|+.||........ . .. +.......
T Consensus 145 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~-~~----~~~~~~~~ 213 (277)
T cd05577 145 LKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----K-EE----LKRRTLEM 213 (277)
T ss_pred hccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----H-HH----HHhccccc
Confidence 54321 22334678899999999988899999999999999999999999864332110 0 00 11110000
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
...+ +......+..++..|++.+|++|| +..+++.
T Consensus 214 --~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 --AVEY----------PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --cccC----------CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0001 111234567888999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.96 Aligned_cols=271 Identities=24% Similarity=0.268 Sum_probs=192.9
Q ss_pred cccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCcc--ChHHHHHHHHHHHhc---cCCCcccccceeeecCCCCCCC
Q 005691 315 FSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQ--GDAEFCNEVEIISNL---KHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L---~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
|+..++||+|+||.||+|+..+ ++.||+|++...... ....+.+|+.++.++ +|+|++++++++..... ....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~-~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT-DREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC-CCCc
Confidence 5667899999999999999864 899999998643222 134577888887766 59999999999874321 1223
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..+++|||+++ +|.+++... ....++|..++.++.++++||.||| +.+++|+||||+||+++.++.+||
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~-------~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKC-------PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eeEEEehhccc-CHHHHHHHc-------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEE
Confidence 48999999974 788877322 1235899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||++........ .....++..|+|||++....++.++||||||++++||++|+.|+......+ .+..+....
T Consensus 149 ~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----~~~~~~~~~ 222 (287)
T cd07838 149 ADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----QLDKIFDVI 222 (287)
T ss_pred eccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----HHHHHHHHc
Confidence 99999987643322 223457889999999999999999999999999999999999886433211 111111000
Q ss_pred hhcCccccccC-----cccccc-ccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALD-----PSLLKE-DDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD-----~~l~~~-~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+....... ...... .........+....+.+++..|++.||.+||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 000000 00000001123456778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=292.46 Aligned_cols=268 Identities=26% Similarity=0.358 Sum_probs=193.9
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCeeE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
|...+.||+|+||.||+|+.. +++.|+||++...... ......+|+..+++++ |+|++++++++. .+...+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~------~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR------ENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh------cCCcEE
Confidence 556788999999999999986 4788999998654322 2334567999999999 999999999986 467899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+ +|+|.+++.... ...++|..++.++.|++.+|.||| +.+++|+||||+||+++.++.+||+||
T Consensus 75 lv~e~~-~~~l~~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~ 143 (283)
T cd07830 75 FVFEYM-EGNLYQLMKDRK-------GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADF 143 (283)
T ss_pred EEEecC-CCCHHHHHHhcc-------cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeec
Confidence 999999 889988874321 246899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc-cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc--------cchh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA--------CLIT 542 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~--------~~l~ 542 (683)
|+++....... .....++..|+|||++. ...++.++||||||++++||++|+.|+......+... ..-.
T Consensus 144 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07830 144 GLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221 (283)
T ss_pred ccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence 99986543322 22346788999999875 4567999999999999999999999885433211000 0000
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.|.............+....... .....+ .....+.+++..|++.+|++|||+.|++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTS--LHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhHhhhhcccccccccccccc--HHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 11111111111110000000000 000000 113567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=300.52 Aligned_cols=263 Identities=23% Similarity=0.251 Sum_probs=189.7
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeecc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++. .....+++|||
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~------~~~~~~~~~e~ 80 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI------VDSELYVVSPL 80 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee------cCCeEEEEEec
Confidence 3456666666777665 6899999998754 2334567999999999999999999999987 55678999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++|+|.+++.... ...+++.....++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.+..
T Consensus 81 ~~~~~l~~~l~~~~-------~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~ 150 (314)
T cd08216 81 MAYGSCEDLLKTHF-------PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVS 150 (314)
T ss_pred cCCCCHHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCcccee
Confidence 99999999984321 235788889999999999999999 88999999999999999999999999998875
Q ss_pred cccCCc------cccccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh---
Q 005691 477 SREGQS------HLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV--- 545 (683)
Q Consensus 477 ~~~~~~------~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v--- 545 (683)
...... .......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .+.+-.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~----~~~~~~~~~ 226 (314)
T cd08216 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKVRGT 226 (314)
T ss_pred eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcc
Confidence 532211 11233567889999999875 358899999999999999999999997532211 000000
Q ss_pred -hhhhhc-------Ccccc----ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 546 -WSLVKA-------GKVWQ----ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 546 -~~~~~~-------g~l~e----~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
...+.. +.... ..++...... ...........+..++..|++.||++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV--DHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CccccccCchhhhcCCcCcccccccccchhhhh--hcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 00000 1111111000 001122334577889999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=323.02 Aligned_cols=205 Identities=20% Similarity=0.316 Sum_probs=158.9
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEcC--CcEEEEEE--------------eec---cCccChHHHHHHHHHHHhccCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQD--GTTVAVKK--------------VIE---SDFQGDAEFCNEVEIISNLKHR 369 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~~--g~~VAVK~--------------l~~---~~~~~~~~f~~Ev~iL~~L~H~ 369 (683)
....++|...+.||+|+||+||++..+. +...++|. +.+ ........+.+|++++++++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3446789999999999999999987542 22222221 111 1111234588999999999999
Q ss_pred CcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcc
Q 005691 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIY 449 (683)
Q Consensus 370 NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~Ii 449 (683)
|||++++++. .....++|+|++. ++|.+++...... ..........+.|+.|++.||.||| +.+||
T Consensus 224 nIv~l~~~~~------~~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIi 289 (501)
T PHA03210 224 NILKIEEILR------SEANTYMITQKYD-FDLYSFMYDEAFD----WKDRPLLKQTRAIMKQLLCAVEYIH---DKKLI 289 (501)
T ss_pred CcCcEeEEEE------ECCeeEEEEeccc-cCHHHHHhhcccc----ccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 9999999987 4567899999985 5676666432111 1122334556789999999999999 88999
Q ss_pred ccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCC
Q 005691 450 HRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527 (683)
Q Consensus 450 HrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p 527 (683)
||||||+|||++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 290 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred cCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 999999999999999999999999987765444344456799999999999999999999999999999999999854
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=293.31 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=197.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|++++.+++ |+||+++++++. .+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~------~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ------DE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc------CC
Confidence 46888899999999999999975 68999999886532 223456889999999998 999999999886 55
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++.. ...++|..++.|+.+++.||.||| +.+++|+||||+||+++.++.++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~ 142 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRK---------YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIK 142 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEE
Confidence 689999999999999999832 237999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCc-------------------cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCC
Q 005691 468 VADFGLAKQSREGQS-------------------HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 468 LaDFGla~~~~~~~~-------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
|+|||++........ .......|+..|+|||......++.++||||||++++|+++|+.|+
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222 (280)
T ss_pred ecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 999999886543221 1122346789999999999888999999999999999999999998
Q ss_pred CCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 005691 529 DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI----SDALK 603 (683)
Q Consensus 529 ~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm----~eVl~ 603 (683)
..... ... ..... .. +.. .+....+.+..++..|++.+|.+||++ .++++
T Consensus 223 ~~~~~-----~~~---~~~~~-~~------~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 223 RGSNE-----YLT---FQKIL-KL------EYS----------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCccH-----HHH---HHHHH-hc------CCC----------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 74321 000 01111 10 000 111224567889999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=292.37 Aligned_cols=245 Identities=25% Similarity=0.298 Sum_probs=188.4
Q ss_pred eeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHH-HhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEII-SNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL-~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+.||+|+||.||+|... +|+.||||.+....... ...+..|..++ ...+|+|++++++++. .+...++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~------~~~~~~lv 75 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ------SKDYLYLV 75 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE------cCCeEEEE
Confidence 46899999999999874 58899999986543221 22345555544 4458999999999986 55689999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
+||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++||||+|+||++++++.+||+|||+
T Consensus 76 ~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 143 (260)
T cd05611 76 MEYLNGGDCASLIKT---------LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL 143 (260)
T ss_pred EeccCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeeccc
Confidence 999999999999832 236888999999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~ 553 (683)
++.... .....|+..|+|||...+..++.++||||||++++||++|+.|+..... .. .+.....+.
T Consensus 144 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~-~~~~~~~~~ 209 (260)
T cd05611 144 SRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DA-VFDNILSRR 209 (260)
T ss_pred ceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HH-HHHHHHhcc
Confidence 876433 2234688999999999888899999999999999999999999864321 01 112222221
Q ss_pred cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 554 l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. ..+.. ...+...+..++..|++.+|++||++.++.+.|..
T Consensus 210 ~~--~~~~~----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 210 IN--WPEEV----------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cC--CCCcc----------cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 10 00000 11123467789999999999999988877776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.62 Aligned_cols=209 Identities=25% Similarity=0.422 Sum_probs=173.6
Q ss_pred ehHHHHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeee
Q 005691 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380 (683)
Q Consensus 304 ~~~el~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~ 380 (683)
...++...+++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++.+++|+||+++.+++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 468899999986532 2234568899999999999999999998864
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
..........++++|++ +++|.+++. ...++|..++.++.|+++||+||| +.+|+||||||+||++
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll 153 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 153 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEE
Confidence 43322334578888886 788888762 235899999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
++++.+||+|||+++..... .....||..|+|||.+.. ..++.++||||||++++||++|+.||..
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 154 NEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999998765332 233567899999998865 5688999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=301.20 Aligned_cols=275 Identities=23% Similarity=0.323 Sum_probs=197.3
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
+....++|...+.||+|+||.||++... +|..||||++.... ....+.+.+|++++++++|+||+++++++..+...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445678999999999999999999854 68999999985432 12234688999999999999999999998644332
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
......++||||+ +++|.+++. ...+++..++.++.|+++||+||| +.+|+||||||+||+++.++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~----------~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~ 155 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK----------HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDC 155 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 2334579999999 678888772 236889999999999999999999 89999999999999999999
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc-----
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA----- 538 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~----- 538 (683)
.+||+|||+++..... .....++..|+|||.+.. ..++.++||||||++++|+++|+.||..........
T Consensus 156 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07880 156 ELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV 231 (343)
T ss_pred CEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999998765432 223467889999998875 468899999999999999999999986432110000
Q ss_pred --cchhhhhhhhhhcCccccccC--ccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 539 --CLITDWVWSLVKAGKVWQALD--PSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 539 --~~l~~~v~~~~~~g~l~e~vD--~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.....|.. .+........+. +..... ... .........+.+++..|++.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 232 TGTPSKEFVQ-KLQSEDAKNYVKKLPRFRKK-DFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred cCCCCHHHHH-hhcchhHHHHHHhccccCcc-hHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000000000000 000000 000 000112335778999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.40 Aligned_cols=250 Identities=21% Similarity=0.245 Sum_probs=189.4
Q ss_pred hHHHHHHhcCcccceee--eecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 305 IQDLERATDKFSQKNFI--GRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 305 ~~el~~at~~f~~~~~L--G~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
..+.....++|...+.+ |+|+||.||+++.. ++..+|+|.+........ |+.....+ +|+|++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~- 79 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT- 79 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe-
Confidence 34555556677776666 99999999999964 578899998765432211 22222222 7999999999987
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.....++||||+++|+|.+++.. ...++|..++.++.|+++||.||| +.+++||||||+||++
T Consensus 80 -----~~~~~~iv~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 80 -----TLKGHVLIMDYIKDGDLFDLLKK---------EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLY 142 (267)
T ss_pred -----cCCeeEEEEEcCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEE
Confidence 45689999999999999999832 237999999999999999999999 8899999999999999
Q ss_pred ccCC-cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 461 DADM-RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 461 d~~~-~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
+.++ .++|+|||+++..... ....|+..|+|||++....++.++||||||++++||++|+.|+....... .
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~ 214 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---L 214 (267)
T ss_pred eCCCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---h
Confidence 9998 9999999998765432 22468899999999999899999999999999999999999997432211 1
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-ISDALK 603 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-m~eVl~ 603 (683)
.+..|.... .... + ........+.+++..|++.+|.+||+ ++++++
T Consensus 215 ~~~~~~~~~--~~~~-----~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQ--QKKL-----P-----------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhh--cccC-----C-----------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 122222111 0000 0 01122346678889999999999996 688873
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.36 Aligned_cols=248 Identities=31% Similarity=0.417 Sum_probs=192.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+.|...+.||+|+||.||+|+.. +++.+|+|++..... ....++.+|+++++.++|+|++++.+++. ...
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL------REH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE------cCC
Confidence 34666778999999999999965 578899999864322 22346889999999999999999999987 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+. |+|.+++.. ....+++.++..++.+++.||.||| +.+++||||||+||+++.++.+||
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~--------~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl 156 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEV--------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 156 (308)
T ss_pred eeEEEEEccC-CCHHHHHHH--------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEE
Confidence 7899999997 677776632 1245889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+|||++...... ....|+..|+|||++. .+.++.++|||||||++|||++|+.|+...... ...
T Consensus 157 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~ 223 (308)
T cd06634 157 GDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SAL 223 (308)
T ss_pred CCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHH
Confidence 999998765432 2346889999999874 456889999999999999999999997542211 111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
.. +..+.. +.. ........+..++..|++.+|++||++.+|++...
T Consensus 224 ~~-~~~~~~-----~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 224 YH-IAQNES-----PAL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HH-HhhcCC-----CCc---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11 111111 111 11122345678899999999999999999986644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.52 Aligned_cols=276 Identities=22% Similarity=0.320 Sum_probs=199.5
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++..... ......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP-EDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc-ccccce
Confidence 4778889999999999999976 48999999987643 3334678999999999999999999999864321 123478
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++ ++|.+++. ....+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~l~---------~~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 80 YIVTELME-TDLHKVIK---------SPQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred EEEecchh-hhHHHHHh---------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 99999998 47888773 2237999999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCc--cccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh--
Q 005691 471 FGLAKQSREGQS--HLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV-- 545 (683)
Q Consensus 471 FGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v-- 545 (683)
||++........ .......+|..|+|||++.+. .++.++||||||++++||++|+.||......... ..+.++.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~ 225 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-NLIVEVLGT 225 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHhcCC
Confidence 999987654431 123345678899999999887 8899999999999999999999998654321100 0000000
Q ss_pred -----hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 546 -----WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 546 -----~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.........+.+...-............+....+.+++..|++.+|++|||+.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000001110000000000000001123467789999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.20 Aligned_cols=241 Identities=22% Similarity=0.308 Sum_probs=184.4
Q ss_pred eeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHH---HhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 320 FIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEII---SNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL---~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
+||+|+||.||++... +++.||+|.+...... ....+..|..++ +...|+|++++.+++. .....++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~------~~~~~~~ 74 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH------TPDKLSF 74 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee------cCCEEEE
Confidence 4899999999999864 5889999998764322 223355555444 4457999999998886 5568999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++. ....++|..++.|+.|+++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 75 v~e~~~g~~L~~~l~---------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg 142 (278)
T cd05606 75 ILDLMNGGDLHYHLS---------QHGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 142 (278)
T ss_pred EEecCCCCcHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCc
Confidence 999999999998883 2346999999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++...... .....|+..|+|||++..+ .++.++|||||||+++||++|+.||........ .........
T Consensus 143 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 213 (278)
T cd05606 143 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTLT 213 (278)
T ss_pred CccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch------HHHHHHhhc
Confidence 987553322 2234689999999998754 689999999999999999999999975432111 011111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
.++.+.. .....+..++..|++.+|++|| ++.++++
T Consensus 214 ------~~~~~~~----------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 214 ------MAVELPD----------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ------cCCCCCC----------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111111 1234677888999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.75 Aligned_cols=197 Identities=24% Similarity=0.326 Sum_probs=159.2
Q ss_pred eeeeec--CceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRG--GFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~G--gfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
..||+| +||+||+++.. +|+.||+|.+...... ..+.+.+|+.+++.++|+||+++++++. .+...++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~------~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT------TGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe------cCCceEEE
Confidence 356666 99999999974 7899999998653322 2356889999999999999999999997 45678999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
+||+++|+|.+++.... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++||+.
T Consensus 78 ~e~~~~~~l~~~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~ 147 (328)
T cd08226 78 SPFMAYGSANSLLKTYF-------PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSH 147 (328)
T ss_pred EecccCCCHHHHHHhhc-------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHH
Confidence 99999999999884321 235888999999999999999999 88999999999999999999999999986
Q ss_pred ccccccCCccc------cccccCCCcccCccccccC--CCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 474 AKQSREGQSHL------TTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 474 a~~~~~~~~~~------~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
+.......... .....++..|+|||++.++ .++.++||||||++++||++|+.||...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred HhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 54332111100 1112356779999998763 4789999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=300.19 Aligned_cols=273 Identities=22% Similarity=0.307 Sum_probs=194.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCC--------
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD-------- 383 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~-------- 383 (683)
.+|...+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++|+||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999975 588999999877666666779999999999999999999987653211
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec-c
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD-A 462 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd-~ 462 (683)
.......++||||++ ++|.+++. ...+++...+.++.|++.||.||| +.+|+||||||+||+++ +
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----------~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~ 150 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----------QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTE 150 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCC
Confidence 011235789999997 58877762 235889999999999999999999 88999999999999997 4
Q ss_pred CCcEEEcccCcccccccCCcc--ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 463 DMRARVADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
++.+||+|||+++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+...
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--- 227 (342)
T cd07854 151 DLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--- 227 (342)
T ss_pred CceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 567899999999765332211 1233467889999998754 5678899999999999999999999964322110
Q ss_pred chhhhhhhh--h---hcCccccccCccccccccccCCCh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 540 LITDWVWSL--V---KAGKVWQALDPSLLKEDDFLSLNP----KAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 540 ~l~~~v~~~--~---~~g~l~e~vD~~l~~~~~~~~~~~----~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
........ . ........+...+........... ......+.+++..|++.||++|||+.++++
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 228 -MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000 0 000000000000000000000000 012346778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=298.52 Aligned_cols=269 Identities=22% Similarity=0.336 Sum_probs=197.1
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
++...+++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++|||++++.+++..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--- 80 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS--- 80 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec---
Confidence 34457889999999999999999999865 78999999886432 2234568899999999999999999998863
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.+...++|+||+ +++|.+++. ...+++.....++.|++.||.||| +.+|+||||||+||+++++
T Consensus 81 --~~~~~~lv~e~~-~~~L~~~~~----------~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 81 --PLEDIYFVTELL-GTDLHRLLT----------SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINEN 144 (328)
T ss_pred --CCCcEEEEeehh-ccCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCC
Confidence 245689999998 568887772 235778888899999999999999 8999999999999999999
Q ss_pred CcEEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch-
Q 005691 464 MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI- 541 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l- 541 (683)
+.+||+|||+++..... .....++..|+|||++.+ ..++.++||||||++++||++|+.||......... ..+
T Consensus 145 ~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~-~~~~ 219 (328)
T cd07856 145 CDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF-SIIT 219 (328)
T ss_pred CCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence 99999999998754321 123457889999998765 56899999999999999999999998643221000 000
Q ss_pred -------hhhhhhhhhcCccccccCccccccccccCCChH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 542 -------TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPK----AIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 542 -------~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~----e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+|..... .+...+.+.. +..... .... .....+.+++..|++.+|++|||+.+++..
T Consensus 220 ~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 220 DLLGTPPDDVINTIC-SENTLRFVQS-LPKREP---VPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhCCCCHHHHHhcc-chhhHHHHhh-ccccCC---CcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111100 1111111100 000000 0111 123567889999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=289.34 Aligned_cols=267 Identities=26% Similarity=0.321 Sum_probs=194.9
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....+.+..|++++++++|+|++++++++. .....+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~------~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH------TERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh------cCCceE
Confidence 455678999999999999976 48999999987653 223467889999999999999999999986 457899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||++ ++|.+++... ...+++..+++++.+++.||+||| +.+|+||||+|+||++++++.+||+||
T Consensus 75 ~v~e~~~-~~l~~~i~~~--------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~ 142 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKR--------PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADF 142 (282)
T ss_pred EEecCcC-cCHHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecC
Confidence 9999998 5899988421 146899999999999999999999 789999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch-------hh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI-------TD 543 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l-------~~ 543 (683)
|+++....... ......++..|+|||++... .++.++||||||++++||++|+.|+......... ..+ ..
T Consensus 143 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 220 (282)
T cd07829 143 GLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL-FKIFQILGTPTE 220 (282)
T ss_pred CcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHHHhCCCcH
Confidence 99987644322 12234567889999998776 8899999999999999999999998643211000 000 00
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..|..+..-...+..-+....... . .........+.+++..|++.+|++||++.+|+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 221 ESWPGVTKLPDYKPTFPKFPPKDL-E-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHhhcccccccccccccCccch-H-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 111111000000000000000000 0 000011346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=297.81 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=192.5
Q ss_pred cCccc-ceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--------------hHHHHHHHHHHHhccCCCcccccc
Q 005691 313 DKFSQ-KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--------------DAEFCNEVEIISNLKHRNLVPLRG 376 (683)
Q Consensus 313 ~~f~~-~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ev~iL~~L~H~NLV~L~G 376 (683)
++|.. .+.||+|+||+||+|+.. +++.||||++....... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 467999999999999965 68999999986543221 125789999999999999999999
Q ss_pred eeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCC
Q 005691 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKAT 456 (683)
Q Consensus 377 ~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKps 456 (683)
++. .+...++||||++ |+|.+++. ....+++.....++.|++.||.||| +.+|+||||||+
T Consensus 88 ~~~------~~~~~~lv~e~~~-~~l~~~l~---------~~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~ 148 (335)
T PTZ00024 88 VYV------EGDFINLVMDIMA-SDLKKVVD---------RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPA 148 (335)
T ss_pred EEe------cCCcEEEEEeccc-cCHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHH
Confidence 987 4568899999997 68888873 2346889999999999999999999 899999999999
Q ss_pred ceeeccCCcEEEcccCcccccccCC-------------ccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHh
Q 005691 457 NILLDADMRARVADFGLAKQSREGQ-------------SHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIM 522 (683)
Q Consensus 457 NILLd~~~~~KLaDFGla~~~~~~~-------------~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELl 522 (683)
||+++.++.+||+|||+++...... ........++..|+|||++.+. .++.++||||||+++|||+
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999987654110 1111223568899999998764 4689999999999999999
Q ss_pred hCCCCCCCCCCCCCCccchhhhhhhhhhcC-----------ccccccCccccccccccCCChHHHHHHHHHHHHHhcccC
Q 005691 523 CGRKALDLSTSGSPRACLITDWVWSLVKAG-----------KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVM 591 (683)
Q Consensus 523 tGr~p~~~~~~~~~~~~~l~~~v~~~~~~g-----------~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~d 591 (683)
+|+.|+......+ ....+....... .......+..... .. .........+.+++..|++.+
T Consensus 229 tg~~p~~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 229 TGKPLFPGENEID-----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKD--LK-TIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred hCCCCCCCCCHHH-----HHHHHHHHhCCCchhhCcchhhcccccccCcCCccc--HH-HhCcCCChHHHHHHHHHcCCC
Confidence 9999986443211 111111111100 0000000000000 00 000112346778999999999
Q ss_pred CCCCCCHHHHHHHH
Q 005691 592 VALRPTISDALKML 605 (683)
Q Consensus 592 P~~RPtm~eVl~~L 605 (683)
|++|||+.|++..-
T Consensus 301 P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 301 PLERISAKEALKHE 314 (335)
T ss_pred chhccCHHHHhcCc
Confidence 99999999999644
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=294.94 Aligned_cols=244 Identities=32% Similarity=0.460 Sum_probs=189.2
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
|...+.||+|+||.||+|+.. +|+.|++|++....... ...+.+|+++++.++|+|++++++++. .....
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~ 96 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL------KEHTA 96 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE------eCCEE
Confidence 555677999999999999964 58899999986543322 246889999999999999999999987 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++ |+|.+++.. ....++|.+++.++.+++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 97 ~lv~e~~~-~~l~~~l~~--------~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~d 164 (313)
T cd06633 97 WLVMEYCL-GSASDLLEV--------HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLAD 164 (313)
T ss_pred EEEEecCC-CCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEee
Confidence 99999996 577776632 2346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
||++..... .....|+..|+|||++. .+.++.++|||||||++|||++|+.|+...... .....
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~~~~ 231 (313)
T cd06633 165 FGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYH 231 (313)
T ss_pred cCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHH
Confidence 999864322 22356889999999974 467889999999999999999999998643211 11111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..... . +.... ......+..++..|++.+|.+||++.++++.
T Consensus 232 ~~~~~-~-----~~~~~---------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 232 IAQND-S-----PTLQS---------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHhcC-C-----CCCCc---------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 1 11100 1112346778899999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.81 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=204.6
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
-|....+||+|.||.|||+.++ .|+.+|||++.. ..+..+..+|+.++.+.+.+++|+++|-+. ....+++
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYF------K~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYF------KHSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhc------cCCceEe
Confidence 4677789999999999999976 599999998754 234678999999999999999999999876 5677999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
|||||--||+.+.+. .++++|.+..+..|+.+..+||+||| ...-||||||+.||||+.+|.+||+|||
T Consensus 106 VMEYCGAGSiSDI~R--------~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFG 174 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMR--------ARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFG 174 (502)
T ss_pred ehhhcCCCcHHHHHH--------HhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhcc
Confidence 999999999999983 24578999999999999999999999 8889999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
.|-.+.+.... ...+.||+-|||||++..-.|..++||||+|+...||.-||+|+....+...- ..+. -
T Consensus 175 VAGQLTDTMAK-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-FMIP--------T- 243 (502)
T KOG0574|consen 175 VAGQLTDTMAK-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-FMIP--------T- 243 (502)
T ss_pred ccchhhhhHHh-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-Eecc--------C-
Confidence 99876554332 34578999999999999999999999999999999999999998754332110 0000 0
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.--|.+ ..+++-...+-..+..|+-.+|++|-|+.++++
T Consensus 244 ----~PPPTF--------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 244 ----KPPPTF--------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ----CCCCCC--------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 001111 234556678889999999999999999988765
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.32 Aligned_cols=273 Identities=21% Similarity=0.310 Sum_probs=196.5
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
...++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+|++++++++........
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 57899999886432 2234567889999999999999999998754322223
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++|+||+ +++|.+++. ...+++..++.++.++++||.||| +.+|+||||||+||++++++.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----------~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----------CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCE
Confidence 34589999998 568888872 246899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh---
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT--- 542 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~--- 542 (683)
||+|||++...... .....+|..|+|||.+.. ..++.++||||||++++|+++|+.||......... ..+.
T Consensus 158 kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~-~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL-KRIMNLV 232 (343)
T ss_pred EEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhc
Confidence 99999999865432 233467889999998865 46789999999999999999999998643211000 0000
Q ss_pred -----hhhhhhhhcCccccccCccc-cccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 -----DWVWSLVKAGKVWQALDPSL-LKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 -----~~v~~~~~~g~l~e~vD~~l-~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+. ..+........+.... ....++. .........+.+++..|++.+|++|||+.+|++
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELL-QKISSESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHH-hhccchhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000000000000000 0000000 000012456789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.68 Aligned_cols=202 Identities=26% Similarity=0.413 Sum_probs=165.0
Q ss_pred CcccceeeeecCceEEEEEEEc-C--CcEEEEEEeeccCc--cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-D--GTTVAVKKVIESDF--QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~--g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...+.||+|+||.||+++.. + +..||+|++..... ...+.+.+|++++.++ +|+||+++++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP--GNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc--ccC
Confidence 4777889999999999999975 3 67899999864322 2245688999999999 5999999999865321 123
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++++||+. ++|.+++. ....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~---------~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~k 145 (332)
T cd07857 79 NELYLYEELME-ADLHQIIR---------SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELK 145 (332)
T ss_pred CcEEEEEeccc-CCHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEE
Confidence 45788899886 68888873 2346899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCcc---ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 468 VADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 468 LaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
|+|||+++........ ......||..|+|||++.+ ..++.++|||||||+++|+++|+.||..
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 9999999865433221 1234578999999998765 4689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=284.84 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=190.7
Q ss_pred CcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccC-----ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESD-----FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~-----~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...++||+|+||.||+++... +..+++|.++... .....++..|+.++++++|||++++++++. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL------ER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh------cC
Confidence 46778899999999999998653 4445555554321 122345778999999999999999999986 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++.... .....++|..++.++.+++.||.||| +.+++|+||||+||++++ +.+|
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELK-----HTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHh-----hcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEe
Confidence 67899999999999998884321 12357999999999999999999999 899999999999999986 5699
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... ......|+..|+|||+.....++.++||||||+++|||++|+.|+.... .......
T Consensus 146 l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~ 216 (260)
T cd08222 146 IGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLR 216 (260)
T ss_pred ecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHH
Confidence 999999876643322 2234568899999999988888999999999999999999999985321 1111111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. ..+. .+.+ +......+..++..|++.+|++||++.++++
T Consensus 217 ~-~~~~-----~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 217 I-VEGP-----TPSL----------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred H-HcCC-----CCCC----------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 1111 1111 1123346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.08 Aligned_cols=270 Identities=22% Similarity=0.295 Sum_probs=218.6
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccce
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGC 377 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~ 377 (683)
.+|+.....++....++-+|.||.||+|.+. +.+.|.||.++....+- ...|+.|--++..+.|||+..+.|+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566666778888889999999999999654 45668888887654443 4568899999999999999999999
Q ss_pred eeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCc
Q 005691 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATN 457 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsN 457 (683)
+++ +....+.+|.++.-|+|..||...+ .......+.++-.+...++.|++.|++||| +.+|||.||.++|
T Consensus 356 ~ie-----~~~~P~V~y~~~~~gNLK~FL~~Cr-~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRN 426 (563)
T KOG1024|consen 356 SIE-----DYATPFVLYPATGVGNLKSFLQICR-GDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARN 426 (563)
T ss_pred Eee-----ccCcceEEEeccCcchHHHHHHHhc-cCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhc
Confidence 986 4567899999999999999996433 111223456778888899999999999999 9999999999999
Q ss_pred eeeccCCcEEEcccCcccccccCCccc-cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCC
Q 005691 458 ILLDADMRARVADFGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGS 535 (683)
Q Consensus 458 ILLd~~~~~KLaDFGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~ 535 (683)
.+||+..++||+|=.++|...+.+.+. .........||+||.+....|+..+|||||||+||||+| |+.|+...++
T Consensus 427 CvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-- 504 (563)
T KOG1024|consen 427 CVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-- 504 (563)
T ss_pred ceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--
Confidence 999999999999999999877766654 344566789999999999999999999999999999998 8888764332
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.-+...+++|.- + ..|-.+..++..|+.-||...|++||+.+|++..|.+
T Consensus 505 -------fEm~~ylkdGyR-------l--------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 505 -------FEMEHYLKDGYR-------L--------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------HHHHHHHhccce-------e--------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 112333444421 1 1344567788999999999999999999999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-34 Score=286.26 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=195.3
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeecc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+++|+..+.||+|.|+.||+... ..|+.+|+|.+... ...+.+++.+|++|-+.|+|||||+|..... +..
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~------~~~ 83 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ------EES 83 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc------ccc
Confidence 46777888999999999999875 46888998877432 3335678999999999999999999998765 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc---CCc
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DMR 465 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---~~~ 465 (683)
..|+|+|+|.++.|..-+- .+...++...--.+.||.++|.|+| ..+|||||+||.|+||-. .--
T Consensus 84 ~~ylvFe~m~G~dl~~eIV---------~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~ 151 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIV---------AREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAA 151 (355)
T ss_pred eeEEEEecccchHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCc
Confidence 8999999999999876551 2234556666678899999999999 999999999999999943 346
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||+|..... ...-...+||++|||||++...+|+..+|||+-||+|+-|+.|+.||..... .-.
T Consensus 152 vKL~~FGvAi~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---------~rl 220 (355)
T KOG0033|consen 152 VKLADFGLAIEVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------HRL 220 (355)
T ss_pred eeecccceEEEeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---------HHH
Confidence 89999999998773 2334557899999999999999999999999999999999999999974221 112
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.++.|... +++. ....+.+....++..++..||++|.|+.|.+.
T Consensus 221 ye~I~~g~yd--~~~~----------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 221 YEQIKAGAYD--YPSP----------EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHhccccC--CCCc----------ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 3333344321 1111 11223344567778899999999999998764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=308.25 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=197.4
Q ss_pred ccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 316 SQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
...+.||+||||.||+|+.+ .|+.||||.+.... ....+....|+++|++++|+|||++++.=......-......+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 34567999999999999954 69999999997754 34466789999999999999999999874322111124678999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec--cCC--cEEEc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD--ADM--RARVA 469 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd--~~~--~~KLa 469 (683)
|||+.+|||...|.... ....|+..+.+.+..++..||.||| +.+|+||||||.||++- ++| ..||+
T Consensus 96 mEyC~gGsL~~~L~~PE------N~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPE------NAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred EeecCCCcHHHHhcCcc------cccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeee
Confidence 99999999999995543 3457999999999999999999999 89999999999999993 334 57999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccc-cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||.||-.+++. ..+.++||..|++||.+. .+.|+..+|.|||||++||.+||..||...... ....+.+|..
T Consensus 167 DfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p----k~~~~~~~~~ 240 (732)
T KOG4250|consen 167 DFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP----KNNKEIMWHI 240 (732)
T ss_pred cccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc----cccchhhhhh
Confidence 999999887665 566789999999999998 488999999999999999999999999754332 1222334443
Q ss_pred hhcC--ccccccCcccccccccc---CCC---hHHHHHHHHHHHHHhcccCCCCCC
Q 005691 549 VKAG--KVWQALDPSLLKEDDFL---SLN---PKAIMERFVLVGILCAHVMVALRP 596 (683)
Q Consensus 549 ~~~g--~l~e~vD~~l~~~~~~~---~~~---~~e~~~~l~~lal~C~~~dP~~RP 596 (683)
.... .+.-.+++...+...+. +.. ......++..+....+..+|++|-
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 3222 12222222222211111 111 112344666666667777787777
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=324.09 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=187.5
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCC-
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN- 384 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~- 384 (683)
..+-..+|++..+||+||||.|||++.+ ||+.+||||+.-.. .+......+|+..|++|+|||+|+++..+++....
T Consensus 474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3566778999999999999999999976 89999999996653 22234578899999999999999987543321100
Q ss_pred --------------------------------------------------------------------------------
Q 005691 385 -------------------------------------------------------------------------------- 384 (683)
Q Consensus 385 -------------------------------------------------------------------------------- 384 (683)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred ----------------------CC--C--------CeeEEEEeecCCCCccccccCCCCCCCCCCCCCC-CccchhhhHH
Q 005691 385 ----------------------ER--G--------SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL-TWPQRKNIIL 431 (683)
Q Consensus 385 ----------------------~~--~--------~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L-~w~~r~~Ia~ 431 (683)
+. . ..+|+=||||+...|.+++.... .. .-...++++.
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---------~~~~~d~~wrLFr 704 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---------FNSQRDEAWRLFR 704 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---------cchhhHHHHHHHH
Confidence 00 0 23466677777777776663221 11 2455679999
Q ss_pred HHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccc------c-----------CCccccccccCCCcc
Q 005691 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR------E-----------GQSHLTTRVAGTHGY 494 (683)
Q Consensus 432 ~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~------~-----------~~~~~~~~~~GT~~Y 494 (683)
+|++||+|+| +.+||||||||.||+||++..+||+|||+|.... + ......|..+||.-|
T Consensus 705 eIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 705 EILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred HHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence 9999999999 8999999999999999999999999999998621 0 011134567899999
Q ss_pred cCccccccC---CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCC
Q 005691 495 LAPEYALYG---QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSL 571 (683)
Q Consensus 495 ~APE~~~~~---~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~ 571 (683)
+|||.+... +|+.|+|+||+|||++||+.- |...-+ + .-+...++.|.+.+- +.+.
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsME---R-----a~iL~~LR~g~iP~~--~~f~-------- 840 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSME---R-----ASILTNLRKGSIPEP--ADFF-------- 840 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHH---H-----HHHHHhcccCCCCCC--cccc--------
Confidence 999998753 599999999999999999854 432111 0 012223344544322 1111
Q ss_pred ChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 572 NPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 572 ~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+..-..++.++++.||.+|||+.|++.
T Consensus 841 --~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 841 --DPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111233467889999999999999999863
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=277.56 Aligned_cols=236 Identities=25% Similarity=0.338 Sum_probs=189.5
Q ss_pred eeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 321 LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
||+|+||.||++... +++.+|+|.+...... ..+.+..|++++++++|+|++++++.+. .+...++||||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ------TEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee------cCCeeEEEEec
Confidence 699999999999976 5889999998765432 3457899999999999999999998886 56789999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
+++++|.+++.. ...+++.....++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 75 ~~~~~L~~~l~~---------~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 142 (250)
T cd05123 75 APGGELFSHLSK---------EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKE 142 (250)
T ss_pred CCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCccee
Confidence 999999999832 236899999999999999999999 89999999999999999999999999999877
Q ss_pred cccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 477 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
..... .......++..|+|||.......+.++|+||||+++||+++|+.|+..... ........ .+..
T Consensus 143 ~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~-- 210 (250)
T cd05123 143 LSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKIL-KDPL-- 210 (250)
T ss_pred cccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHh-cCCC--
Confidence 64432 123446789999999999888899999999999999999999999864321 01111111 1110
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~e 600 (683)
.+ +......+.+++..|+..||++||++.+
T Consensus 211 ----~~----------~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 ----RF----------PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ----CC----------CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11 1111345678999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=304.30 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=166.6
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CC-----CcccccceeeecCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HR-----NLVPLRGCCVVDGDNER 386 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~-----NLV~L~G~c~~~~~~~~ 386 (683)
+|.+.+.||+|.||.|.|+... +++.||||+++... .-..+-..|+.+|..|+ |. |+|+++.|+. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~------f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY------F 259 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc------c
Confidence 7889999999999999999965 58999999986633 33456678999999997 43 8999999997 6
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC--C
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD--M 464 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~--~ 464 (683)
.++.+||+|.+. -+|.++|... +-..|+....+.|+.||+.||.+|| +.+|||+||||+||||.+- -
T Consensus 260 r~HlciVfELL~-~NLYellK~n-------~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~ 328 (586)
T KOG0667|consen 260 RNHLCIVFELLS-TNLYELLKNN-------KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRS 328 (586)
T ss_pred ccceeeeehhhh-hhHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcC
Confidence 788999999995 5999999543 2456999999999999999999999 8999999999999999654 4
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
.+||+|||.+......- . ...-+.-|+|||++.+.+|+.+.||||||||+.||++|.+-|...
T Consensus 329 ~vKVIDFGSSc~~~q~v---y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRV---Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ceeEEecccccccCCcc---e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 79999999998654322 1 355678899999999999999999999999999999998777543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=292.82 Aligned_cols=247 Identities=20% Similarity=0.328 Sum_probs=204.5
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
-|..++.||+|.|..|-.+++ -.|..||||++.+..... ...+..||+-|+.++|||||+|+.+.- ....+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD------TQTKl 92 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID------TQTKL 92 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc------ccceE
Confidence 355566899999999988874 369999999997765443 345888999999999999999998864 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-CCcEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-~~~~KLa 469 (683)
|||.|.-++|+|.||+-. ....+.+....+++.||..|+.|+| +..+|||||||+||.+-+ -|-+||.
T Consensus 93 yLiLELGD~GDl~DyImK--------He~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLT 161 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMK--------HEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLT 161 (864)
T ss_pred EEEEEecCCchHHHHHHh--------hhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEee
Confidence 999999999999999943 3457889999999999999999999 999999999999998854 5789999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCC-ccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT-EKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||++..+.+++. .+..+|++.|-|||++.+..|+ +++||||+||+||.|++|+.||+..++.+
T Consensus 162 DFGFSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------------- 226 (864)
T KOG4717|consen 162 DFGFSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------------- 226 (864)
T ss_pred eccccccCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-------------
Confidence 9999988877654 3456899999999999999886 68999999999999999999998654322
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+..++|-.. .-+..+..+|..++..++..||.+|.+.++|+..
T Consensus 227 ----TLTmImDCKY--------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 227 ----TLTMIMDCKY--------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----hhhhhhcccc--------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1222333322 1345567789999999999999999999998753
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-33 Score=303.09 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=196.9
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEE-EEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTV-AVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~V-AVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+-|.+...||.|+||.|||++.++.... |.|.+...+....++|+-|++||+..+||+||+|++.+. ..+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy------~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY------FENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh------ccCceE
Confidence 3455566799999999999998765544 556665556666778999999999999999999999876 456799
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++.|||.||-++..+.. -.+.|+..++.-++.+++.||.||| +.+|||||||+.|||++-+|.++|+||
T Consensus 106 iliEFC~GGAVDaimlE--------L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLE--------LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred EEEeecCCchHhHHHHH--------hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecc
Confidence 99999999999988742 2468999999999999999999999 999999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|.+-..... ........||+.|||||+++ ..+|+.++||||||++|.||..+.+|....++ .....
T Consensus 175 GVSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--------MRVll 245 (1187)
T KOG0579|consen 175 GVSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLL 245 (1187)
T ss_pred cccccchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--------HHHHH
Confidence 976432111 11223478999999999886 46789999999999999999999999764332 11111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..+.. -|.|. .+......+-.+...|+..||..||+++++++
T Consensus 246 KiaKSe------PPTLl--------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 246 KIAKSE------PPTLL--------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHhhcC------CCccc--------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111111 12221 23334557788889999999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-33 Score=293.01 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=176.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+.|+.-.+||+||||.||-.+.+ .|+.+|.|++.+. ..++..-.++|-.||.+++.+.||.|--.+. ..+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe------Tkd 258 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE------TKD 258 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec------CCC
Confidence 56777789999999999999865 6999999998553 3445666889999999999999998854443 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
.+.||+..|.||+|.-||+... .+.+++...+-.+.+|+.||++|| +.+||.||+||+|||||+.|+++|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g-------~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHG-------NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred ceEEEEEeecCCceeEEeeccC-------CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEe
Confidence 8999999999999999997654 357899999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
+|.|||..+.+++.+. ..+||.||||||++..+.|+...|.||+||+||||+.|+.||...
T Consensus 329 SDLGLAvei~~g~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred eccceEEecCCCCccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 9999999887776543 238999999999999999999999999999999999999999743
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-33 Score=304.86 Aligned_cols=245 Identities=26% Similarity=0.398 Sum_probs=193.1
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEee--cc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVI--ES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~--~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
..+||+|.|-+||||... +|.+||--.++ +. +....+.|..|+.+|+.|+|+|||+++..+... .....-+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~----~n~~in~ 120 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT----DNKTINF 120 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC----CCceeee
Confidence 347999999999999975 47777743332 21 222346799999999999999999999988743 3467889
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC-CcEEEccc
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADF 471 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-~~~KLaDF 471 (683)
|.|.|..|+|..|+. +.+.++....++|++||.+||.|||.. .++|||||||-.||+|+.+ |.+||+|.
T Consensus 121 iTEL~TSGtLr~Y~k---------k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 121 ITELFTSGTLREYRK---------KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred eeecccCCcHHHHHH---------HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence 999999999999993 345677888999999999999999965 8999999999999999865 89999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|||....... ...+.||+.|||||... ..|.+.+||||||+.++||+|+..|+..-.. ..-+++.+..
T Consensus 191 GLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--------~AQIYKKV~S 258 (632)
T KOG0584|consen 191 GLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--------PAQIYKKVTS 258 (632)
T ss_pred hHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--------HHHHHHHHHc
Confidence 9998865432 23389999999999776 7899999999999999999999999864332 1234555555
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
|.--+.+..- . ..++.+++..|+.. .++|||+.|+++
T Consensus 259 GiKP~sl~kV----------~----dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 259 GIKPAALSKV----------K----DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCCHHHhhcc----------C----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 5432222111 1 12456788899999 999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=301.37 Aligned_cols=216 Identities=21% Similarity=0.324 Sum_probs=161.1
Q ss_pred HhcCcccceeeeecCceEEEEEEE-----------------cCCcEEEEEEeeccCccChHH--------------HHHH
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL-----------------QDGTTVAVKKVIESDFQGDAE--------------FCNE 359 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l-----------------~~g~~VAVK~l~~~~~~~~~~--------------f~~E 359 (683)
.+++|+..++||+|+||+||+|.+ .+++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999974 235689999986543322233 3447
Q ss_pred HHHHHhccCCCc-----ccccceeeecCC--CCCCCeeEEEEeecCCCCccccccCCCCCC---------------CCCC
Q 005691 360 VEIISNLKHRNL-----VPLRGCCVVDGD--NERGSERYLVYDYMPNGNVDDHLFPSFNDG---------------SGVA 417 (683)
Q Consensus 360 v~iL~~L~H~NL-----V~L~G~c~~~~~--~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~---------------~~~~ 417 (683)
+.++.+++|.|+ ++++|+|..... .....+.+|||||+++|+|.++|+...... ....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877665 778888864321 113456899999999999999996532110 0112
Q ss_pred CCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCc
Q 005691 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497 (683)
Q Consensus 418 ~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~AP 497 (683)
...++|..++.|+.+++.||.||| +.+|+||||||+|||++.++.+||+|||+++....+.........+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 234678889999999999999999 88999999999999999999999999999976544322222233458899999
Q ss_pred cccccCCC----------------------CccccEEEcchhHHHHhhCCC-CCC
Q 005691 498 EYALYGQL----------------------TEKSDVYSFGVVILEIMCGRK-ALD 529 (683)
Q Consensus 498 E~~~~~~~----------------------s~ksDVwSfGvlLlELltGr~-p~~ 529 (683)
|.+..... ..+.||||+||+++||++|.. |+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 98764321 235799999999999999985 554
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=294.73 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=197.2
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeecc--CccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIES--DFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
..|++.++||+||...|||+...+.+.+|+|++... +.+....|++|+.+|.+|+ |.+||+|+.|-+ .++.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv------~d~~ 434 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV------TDGY 434 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec------cCce
Confidence 457778899999999999999998899999987543 3444567999999999995 999999999977 4578
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
+|+||||= +.+|..+|.... .....| .++.+..|++.++.++| +.+|||.||||.|.|+-. |.+||+
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~-------~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLI 501 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK-------SIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLI 501 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc-------CCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEee
Confidence 99999986 458888884321 223445 77889999999999999 899999999999999864 689999
Q ss_pred ccCcccccccCCccc-cccccCCCcccCccccccC-----------CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCC
Q 005691 470 DFGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYG-----------QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537 (683)
Q Consensus 470 DFGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~-----------~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~ 537 (683)
|||+|.....+.+.. ....+||+.||+||.+... +.+.++||||+||+||+|+.|+.||...
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------ 575 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------ 575 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------
Confidence 999999887665543 4457899999999988632 2567999999999999999999999632
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...|+ ++..+.||.-.-+.+. ..+.. .+++++..|++.||.+|||+.++++
T Consensus 576 ---~n~~a-------Kl~aI~~P~~~Iefp~--~~~~~---~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 576 ---INQIA-------KLHAITDPNHEIEFPD--IPEND---ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---HHHHH-------HHHhhcCCCccccccC--CCCch---HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 22332 3445566643222111 11112 2789999999999999999999874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-33 Score=323.52 Aligned_cols=253 Identities=29% Similarity=0.396 Sum_probs=197.7
Q ss_pred HhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeecc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.+-++...++||.|.||.||.++. ++|...|+|.++-. .....+...+|..++..|+|||+|+.+|+=. ..
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv------HR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV------HR 1306 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee------cH
Confidence 345778889999999999999995 56888999987543 3334566889999999999999999999876 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
++.++.||||++|+|.+.+. ..+..++....-+..|++.|++||| +.+||||||||.||+||.+|-+|
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~---------~gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLE---------HGRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHH---------hcchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEE
Confidence 78899999999999999983 2334666666778899999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCcc---ccccccCCCcccCccccccC---CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 468 VADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALYG---QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 468 LaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
++|||.|......... .....+||+-|||||++.+. ....+.||||+|||++||+||++|+...+.
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------- 1446 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------- 1446 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------
Confidence 9999999877543211 12356899999999999753 355689999999999999999999875432
Q ss_pred hhhhhhh-hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 542 TDWVWSL-VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 542 ~~~v~~~-~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
+|+.-. +..|+.-. -|+.....=.+.+..|++.||++|-++.|+++.=
T Consensus 1447 -e~aIMy~V~~gh~Pq---------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1447 -EWAIMYHVAAGHKPQ---------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred -hhHHHhHHhccCCCC---------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 454332 23343311 1112333334567789999999998888776543
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=296.81 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=200.4
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.-+.+|.....||+|.|+.|..|+.. .+..||+|.+.+..... ...+.+|+++|..|+|||||+|+.+.. .
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~------t 126 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE------T 126 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee------e
Confidence 34578888999999999999999965 58999999987754433 345889999999999999999999986 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
...+|+||||..+|.++++|... ..+.......++.|+.+|++||| +..|+|||||++|||||.++++
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~---------gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKH---------GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNI 194 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhc---------ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccce
Confidence 67899999999999999999433 34455777889999999999999 9999999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
||+|||++..+..+ ......+|++.|.|||+..+.+| .+++|+||+||+||-|+.|..||+...-..
T Consensus 195 kIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------- 262 (596)
T KOG0586|consen 195 KIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------- 262 (596)
T ss_pred eeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----------
Confidence 99999999887643 34455789999999999998776 579999999999999999999998432211
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+=++.+.+... -+.-+...+-+++...+-.+|.+|++++++.+.
T Consensus 263 -----------Lr~rvl~gk~r----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 263 -----------LRPRVLRGKYR----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -----------ccchheeeeec----ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111111100 001123356677777888999999999999764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=313.42 Aligned_cols=145 Identities=30% Similarity=0.426 Sum_probs=127.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...++||+|+||.||+|+.. +++.||||++....... ...+..|+.++..++|+||+++++++. ...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~------~~~ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ------SAN 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE------ECC
Confidence 57888999999999999999976 68899999987643322 356889999999999999999998876 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++.. ...+++...+.|+.||+.||.||| ..+|+||||||+||||+.++.+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~---------~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL 145 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI---------YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKL 145 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEE
Confidence 89999999999999999832 235788899999999999999999 789999999999999999999999
Q ss_pred cccCccc
Q 005691 469 ADFGLAK 475 (683)
Q Consensus 469 aDFGla~ 475 (683)
+|||+++
T Consensus 146 ~DFGls~ 152 (669)
T cd05610 146 TDFGLSK 152 (669)
T ss_pred EeCCCCc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=307.60 Aligned_cols=274 Identities=20% Similarity=0.208 Sum_probs=173.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEcC-----CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~-----g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
..++|...++||+|+||.||+|++.+ +..||||++..... .+.+.+| .+....+.+++.++..+.......
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999754 68999998754321 1112222 122223333333332221111112
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCC-----------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDG-----------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-----------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.+.+.++||||+++++|.+++....... .........+.....|+.|++.||+||| +.+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5678999999999999999885321000 0000011122334579999999999999 8899999999
Q ss_pred CCceeecc-CCcEEEcccCcccccccCCccccccccCCCcccCccccccC----------------------CCCccccE
Q 005691 455 ATNILLDA-DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG----------------------QLTEKSDV 511 (683)
Q Consensus 455 psNILLd~-~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------------------~~s~ksDV 511 (683)
|+|||+++ ++.+||+|||+|+....+.........||++|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 58999999999987665555555567899999999965321 24457799
Q ss_pred EEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCc----cccccCcc----ccccccccCCChHHHHHHHHHH
Q 005691 512 YSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK----VWQALDPS----LLKEDDFLSLNPKAIMERFVLV 583 (683)
Q Consensus 512 wSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~----l~e~vD~~----l~~~~~~~~~~~~e~~~~l~~l 583 (683)
|||||++|||+++..+.+.. +..+...+...+. +...+++. +....+.. ........++
T Consensus 363 wSlGviL~el~~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----d~~~~~~~dL 429 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN---------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVL----DLDGGAGWEL 429 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH---------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhc----cccchHHHHH
Confidence 99999999999987664321 1111111100000 00111111 00000000 0001234578
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 005691 584 GILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 584 al~C~~~dP~~RPtm~eVl~~ 604 (683)
+..|++.||++|||+.++++.
T Consensus 430 i~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHccCCcccCCCHHHHhCC
Confidence 899999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=265.54 Aligned_cols=238 Identities=29% Similarity=0.366 Sum_probs=191.5
Q ss_pred CceEEEEEEEcC-CcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCc
Q 005691 325 GFGLVYKGILQD-GTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNV 402 (683)
Q Consensus 325 gfG~Vykg~l~~-g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL 402 (683)
+||.||+|+..+ |+.+|+|++....... .+.+.+|++.+++++|+|++++++++. .....++++||+++++|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE------DEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee------eCCEEEEEEeCCCCCCH
Confidence 689999999874 8999999997765554 678999999999999999999999997 45689999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCc
Q 005691 403 DDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482 (683)
Q Consensus 403 ~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~ 482 (683)
.+++... ..+++..++.++.++++++.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 75 ~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~- 141 (244)
T smart00220 75 FDLLKKR---------GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG- 141 (244)
T ss_pred HHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence 9998321 23889999999999999999999 7899999999999999999999999999998765432
Q ss_pred cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccc
Q 005691 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSL 562 (683)
Q Consensus 483 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l 562 (683)
......++..|++||.+....++.++|||+||++++||++|+.|+...... ..+ .+....+....
T Consensus 142 -~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~----~~~~~~~~~~~------ 206 (244)
T smart00220 142 -LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LEL----FKKIGKPKPPF------ 206 (244)
T ss_pred -ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHH----HHHHhccCCCC------
Confidence 233456889999999999889999999999999999999999998642111 111 11111111100
Q ss_pred cccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 563 LKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 563 ~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
. .........+.+++.+|+..+|++||++.++++
T Consensus 207 --~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 --P-----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred --c-----cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 000003457788999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=280.31 Aligned_cols=252 Identities=22% Similarity=0.249 Sum_probs=198.6
Q ss_pred cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+.|+..+.||+|.-|+||.+.+++ +..+|+|++.+..... ..+...|-+||+.++||.|+.|++.+. ..+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe------t~~ 150 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE------TDK 150 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee------ccc
Confidence 345667789999999999999875 4889999997754433 345778999999999999999999986 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..+||||||+||+|+..++.. ..+.++....+-++..|.-||+||| -.|||.|||||+||||.++|++.|
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQ-------p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQ-------PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eeEEEEecCCCccHHHHHhhC-------CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEe
Confidence 889999999999999988543 3567999999999999999999999 999999999999999999999999
Q ss_pred cccCccccccc---------------------------------CCc----------------------cccccccCCCc
Q 005691 469 ADFGLAKQSRE---------------------------------GQS----------------------HLTTRVAGTHG 493 (683)
Q Consensus 469 aDFGla~~~~~---------------------------------~~~----------------------~~~~~~~GT~~ 493 (683)
+||.|+..... ... ..+...+||..
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998642210 000 01123579999
Q ss_pred ccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCCh
Q 005691 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNP 573 (683)
Q Consensus 494 Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~ 573 (683)
|+|||++.+...+.++|.|+|||++|||+.|+-||...+... .+...+.+ +..+.+.
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----Tl~NIv~~-----------~l~Fp~~-------- 357 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----TLRNIVGQ-----------PLKFPEE-------- 357 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh----hHHHHhcC-----------CCcCCCC--------
Confidence 999999999999999999999999999999999998654322 12111111 1111111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 005691 574 KAIMERFVLVGILCAHVMVALRPT----ISDALK 603 (683)
Q Consensus 574 ~e~~~~l~~lal~C~~~dP~~RPt----m~eVl~ 603 (683)
.+.+..+.+++..-+-.||.+|-. +.||-+
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 134556778888889999999998 777754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=272.31 Aligned_cols=221 Identities=21% Similarity=0.202 Sum_probs=174.3
Q ss_pred cCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCc
Q 005691 324 GGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNV 402 (683)
Q Consensus 324 GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL 402 (683)
|.||.||+++.. +++.+|+|++.... ++..|...+....|||++++++++. .....++||||+++|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~------~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV------SEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee------cCCeEEEEEecCCCCCH
Confidence 889999999975 68899999986643 3445666666678999999999986 56789999999999999
Q ss_pred cccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCc
Q 005691 403 DDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482 (683)
Q Consensus 403 ~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~ 482 (683)
.+++.. ...+++.....++.+++.||.||| +.+|+||||||+||+++.++.+|++|||++......
T Consensus 73 ~~~l~~---------~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-- 138 (237)
T cd05576 73 WSHISK---------FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-- 138 (237)
T ss_pred HHHHHH---------hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--
Confidence 998832 235899999999999999999999 899999999999999999999999999987654332
Q ss_pred cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccc
Q 005691 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSL 562 (683)
Q Consensus 483 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l 562 (683)
.....++..|+|||+...+.++.++||||+|++++|+++|+.|+........ .. ....+
T Consensus 139 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~~-----~~~~~ 197 (237)
T cd05576 139 --CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------TH-----TTLNI 197 (237)
T ss_pred --cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------cc-----cccCC
Confidence 1234567789999999888899999999999999999999988653211000 00 00001
Q ss_pred cccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005691 563 LKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600 (683)
Q Consensus 563 ~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~e 600 (683)
+......+..++..|++.||++||++.+
T Consensus 198 ----------~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 198 ----------PEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred ----------cccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 0112345678889999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=269.96 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=187.8
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCeeEEEE
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
...||.|..|+|+|.+++ .|..+|||.+.+... +..+..+..++++.+-+ .|.||+.+||++. +...++.|
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~------n~dV~IcM 170 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT------NTDVFICM 170 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee------CchHHHHH
Confidence 345999999999999976 588999999977543 33456777787776664 8999999999994 45678889
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
|.|.- -++..|. ...+++++...-++...+.+||.||.+ +.+|||||+||+|||+|+.|++|++|||++
T Consensus 171 elMs~-C~ekLlk--------rik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 171 ELMST-CAEKLLK--------RIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHH-HHHHHHH--------HhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccc
Confidence 98843 3444442 123467777777999999999999985 679999999999999999999999999998
Q ss_pred cccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 475 KQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 475 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
-..-+... .++.+|-+.|||||.+. ...|+.++||||||+.|+||.||+.||..-..+- ..+ -....
T Consensus 240 GrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---e~l----tkvln- 309 (391)
T KOG0983|consen 240 GRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---EVL----TKVLN- 309 (391)
T ss_pred ceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---HHH----HHHHh-
Confidence 77655443 46678999999999886 4578999999999999999999999997532211 011 11111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..-|.|.+.. .....+.++...|++.|+.+||...++++
T Consensus 310 -----~ePP~L~~~~--------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 310 -----EEPPLLPGHM--------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -----cCCCCCCccc--------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1124443331 13557788999999999999999988764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=269.81 Aligned_cols=259 Identities=21% Similarity=0.332 Sum_probs=199.7
Q ss_pred ehHHHHHHhcCcccceeeeecCceEEEEEE-EcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeec
Q 005691 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVD 381 (683)
Q Consensus 304 ~~~el~~at~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~ 381 (683)
+++|+-+.|+ ++||+|+|+.|-..+ +.+|.++|||++.+..........+||+++...+ |+||+.|+.|+.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE-- 146 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE-- 146 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--
Confidence 4677777776 479999999999887 6789999999998876666778899999999985 999999999996
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
+....|||||-|.+|+|..+++ +++.+++.+..++..+||.||.||| .++|.|||+||+|||-.
T Consensus 147 ----dd~~FYLVfEKm~GGplLshI~---------~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 147 ----DDTRFYLVFEKMRGGPLLSHIQ---------KRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCE 210 (463)
T ss_pred ----ccceEEEEEecccCchHHHHHH---------HhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeec
Confidence 5678999999999999999994 3467899999999999999999999 99999999999999996
Q ss_pred cCC---cEEEcccCcccccccC------CccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCC
Q 005691 462 ADM---RARVADFGLAKQSREG------QSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKA 527 (683)
Q Consensus 462 ~~~---~~KLaDFGla~~~~~~------~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p 527 (683)
... -+||+||.|....... .+......+|+..|||||++. ...|+.+.|.||+||+||-|++|.+|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 544 4899999987643221 112223467889999999774 24578899999999999999999999
Q ss_pred CCCCCCCCCCccchhhhh------------hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCC
Q 005691 528 LDLSTSGSPRACLITDWV------------WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR 595 (683)
Q Consensus 528 ~~~~~~~~~~~~~l~~~v------------~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~R 595 (683)
|...-..+- .|- .+-+++|.. +.-| .+...+..+...++..-+-.+|.+|
T Consensus 291 FvG~Cg~dC------GWdrGe~Cr~CQ~~LFesIQEGkY-eFPd-----------kdWahIS~eakdlisnLlvrda~~r 352 (463)
T KOG0607|consen 291 FVGHCGADC------GWDRGEVCRVCQNKLFESIQEGKY-EFPD-----------KDWAHISSEAKDLISNLLVRDAKQR 352 (463)
T ss_pred ccCccCCcC------CccCCCccHHHHHHHHHHHhccCC-cCCh-----------hhhHHhhHHHHHHHHHHHhccHHhh
Confidence 976544221 121 111222222 1111 1222344444556666666999999
Q ss_pred CCHHHHHH
Q 005691 596 PTISDALK 603 (683)
Q Consensus 596 Ptm~eVl~ 603 (683)
-++.+|+.
T Consensus 353 lsa~~vln 360 (463)
T KOG0607|consen 353 LSAAQVLN 360 (463)
T ss_pred hhhhhccC
Confidence 99998876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=272.83 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=189.9
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
...||.|.||+|+|-.++ .|+.+|||+++.... ...++++.|++...+- +.||||+++|.+. ..+..++.|
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F------~EGdcWiCM 142 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF------SEGDCWICM 142 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh------cCCceeeeH
Confidence 456999999999999865 699999999987654 4466799999876555 7999999999987 456789999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
|.|+ .||+.+..... ......+++...-.|..-+.+||.||.+ ...|||||+||+|||||..|.+||+|||++
T Consensus 143 ELMd-~SlDklYk~vy----~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVY----SVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred HHHh-hhHHHHHHHHH----HHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccch
Confidence 9995 47665431110 1234467787888888999999999986 578999999999999999999999999998
Q ss_pred cccccCCccccccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 475 KQSREGQSHLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 475 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
-.+.++ ...+.-+|-..|||||.+.. ..|+.+|||||+|++|+|+.||+.|+..... +.+.+... ..|
T Consensus 216 GqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~V-v~g 285 (361)
T KOG1006|consen 216 GQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQV-VIG 285 (361)
T ss_pred HhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHH-HcC
Confidence 765432 23456789999999998863 3489999999999999999999999864321 11222221 122
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.. |.|... ....+....+...+-.|+-.|-.+||...++.++
T Consensus 286 dp-----p~l~~~-----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DP-----PILLFD-----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CC-----CeecCc-----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22 111111 0111234467778888999999999999987653
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-31 Score=267.05 Aligned_cols=205 Identities=27% Similarity=0.427 Sum_probs=168.0
Q ss_pred cCcccceeeeecCceEEEEEEEcC-----CcEEEEEEeeccCc-cC-hHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKVIESDF-QG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-----g~~VAVK~l~~~~~-~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
..|+....||+|.||.|||++-.+ ...+|+|+++.... .+ .....+|+.+++.++|+|++.|..++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~----- 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS----- 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc-----
Confidence 457778899999999999997432 23799999865422 22 3468899999999999999999998873
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC--
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-- 463 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-- 463 (683)
.....+|++||.+. +|...++..... +.+.++-.....|..||..|+.||| +.=|+||||||.|||+..+
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~----~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgp 170 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRAS----KAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGP 170 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccc----hhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCC
Confidence 35789999999976 666666444322 2357888899999999999999999 7889999999999999877
Q ss_pred --CcEEEcccCcccccccCCccc--cccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 464 --MRARVADFGLAKQSREGQSHL--TTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 464 --~~~KLaDFGla~~~~~~~~~~--~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
|.+||+|||++|.+...-... ...++-|+.|+|||.+.+ ..||.+.|||+.||++.||+|-.+-|..
T Consensus 171 erG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 171 ERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 899999999999886543332 456778999999999886 5689999999999999999998877753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=285.89 Aligned_cols=266 Identities=25% Similarity=0.374 Sum_probs=214.1
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
..++.+...++.|.+.+.||+|.+|.|||++. ++++.+|||++.. ....+++...|.++++.. .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34555666788899999999999999999994 5688899987644 445567888999999988 79999999999986
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
... ..+++++||||||.+||..|.+.+.. ...+.|..+..|+..+.+||.+|| +..+||||||-.||||
T Consensus 88 ~~~-~~~DqLWLVMEfC~gGSVTDLVKn~~-------g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLL 156 (953)
T KOG0587|consen 88 KDP-GNGDQLWLVMEFCGGGSVTDLVKNTK-------GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLL 156 (953)
T ss_pred ecC-CCCCeEEEEeeccCCccHHHHHhhhc-------ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEE
Confidence 655 47889999999999999999985432 567999999999999999999999 8999999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
+.++.+||.|||++........ ......||+-|||||++.. ..|+..+|+||+|++..||--|.+|+-.+.+.-
T Consensus 157 T~e~~VKLvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 157 TENAEVKLVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred eccCcEEEeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 9999999999999877654322 2344679999999999874 347789999999999999999999986554321
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+... ...--|.|. .++.-.+++.+.+..|+..|-++||++.++++
T Consensus 236 -----------aLF~I---pRNPPPkLk--------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 -----------ALFLI---PRNPPPKLK--------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----------hhccC---CCCCCcccc--------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11110 011122222 23455678999999999999999999988764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=273.58 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=194.8
Q ss_pred cCcccceeeeecCceEEEEEE-EcCCcEEEEEEeecc-CccCh------HHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIES-DFQGD------AEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~-~~~~~------~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
++|-..++||+|||+.|||+. +.+.+.||||+-... ++.++ +...+|.+|-+.|.||.||+++.|+..+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD--- 539 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD--- 539 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec---
Confidence 466677899999999999998 456788999975332 22221 3467899999999999999999999764
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc--
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-- 462 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-- 462 (683)
.+..+-|.||+++.+|+-||.. .+.+++...+.|+.||..||.||.+ .+++|||-||||.||||-+
T Consensus 540 --tdsFCTVLEYceGNDLDFYLKQ---------hklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 540 --TDSFCTVLEYCEGNDLDFYLKQ---------HKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred --cccceeeeeecCCCchhHHHHh---------hhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCc
Confidence 4568899999999999999932 4578899999999999999999984 4899999999999999954
Q ss_pred -CCcEEEcccCcccccccCCc------cccccccCCCcccCccccccC----CCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 463 -DMRARVADFGLAKQSREGQS------HLTTRVAGTHGYLAPEYALYG----QLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 463 -~~~~KLaDFGla~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
-|.+||.||||++..+++.. .++...+||+.|++||.+.-+ +.+.|+||||.||++|..+.|++||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 57899999999998765432 245678999999999988754 5788999999999999999999999864
Q ss_pred CCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005691 532 TSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601 (683)
Q Consensus 532 ~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eV 601 (683)
.... ..+.++.+...-+-.+... ..+..+...++..|++.--++|-...++
T Consensus 688 qsQQ-----------dILqeNTIlkAtEVqFP~K--------PvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 688 QSQQ-----------DILQENTILKATEVQFPPK--------PVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hhHH-----------HHHhhhchhcceeccCCCC--------CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 4321 1122333332222222111 1122344567788999999988766554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=260.14 Aligned_cols=201 Identities=27% Similarity=0.397 Sum_probs=171.7
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChH---HHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDA---EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~---~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...++||+|.||.|-..+-+ .|+.+|+|++++.-.-..+ .-+.|-++|...+||.+..|.--+. ..
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ------t~ 240 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ------TQ 240 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc------cC
Confidence 468999999999999999998854 6899999998765333332 3567889999999999998865554 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
+.+++||||..+|.|.-||. +.+.+++...+-.-..|..||.||| +.+||.||||.+|.|||.+|++|
T Consensus 241 drlCFVMeyanGGeLf~HLs---------rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLS---------RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred ceEEEEEEEccCceEeeehh---------hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceE
Confidence 78999999999999999993 2456888777888899999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
|+||||++..-... ..+...+||+.|+|||++....|...+|.|.+||++|||++||.||...
T Consensus 309 itDFGLCKE~I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 309 ITDFGLCKEEIKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred eeecccchhccccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 99999998543222 2345689999999999999999999999999999999999999999754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=282.37 Aligned_cols=240 Identities=23% Similarity=0.296 Sum_probs=190.6
Q ss_pred HhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++.|.....+|.|.|+.|-++.. .+++..+||++.+...+ -.+|+.++... +|+|++++.+.+. .+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~------~~~ 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYE------DGK 389 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceec------CCc
Confidence 366777778899999999999985 46889999998765222 34578777666 7999999999986 778
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee-ccCCcEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL-DADMRAR 467 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL-d~~~~~K 467 (683)
+.++|||.+.+|-|.+.+... +... ..+..|+.+++.|+.||| ..+||||||||+|||+ ++.++++
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~---------~~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lr 456 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSK---------PEFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLR 456 (612)
T ss_pred eeeeeehhccccHHHHHHHhc---------chhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEE
Confidence 999999999999887777321 2233 667789999999999999 8999999999999999 5889999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||.++....+ ....+-|..|.|||++....|++++|+||||++||||++|+.||.....+. -+..
T Consensus 457 ltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--------ei~~ 524 (612)
T KOG0603|consen 457 LTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--------EIHT 524 (612)
T ss_pred EEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------HHHH
Confidence 9999999887654 222345889999999999999999999999999999999999997654321 1112
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..++.. ..+.+...+++.+|+|.||.+||+|.++..
T Consensus 525 ~i~~~~~s------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 525 RIQMPKFS------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hhcCCccc------------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22222221 233455667888999999999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=271.83 Aligned_cols=242 Identities=25% Similarity=0.364 Sum_probs=186.9
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
.+.||.|.||+||-|+.+ +|+.||||.+.+.. .+++.++++||.||.+++||.||.|.-.|. ..+..++||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E------T~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE------TPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec------CCceEEEEe
Confidence 468999999999999965 79999999997643 344577999999999999999999987775 567899999
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC---CcEEEccc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD---MRARVADF 471 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~---~~~KLaDF 471 (683)
|-+.+ +..+.+..+ ++..|+...-.-++.||..||.||| .++|+|+||||+||||... -.+||+||
T Consensus 643 EKl~G-DMLEMILSs-------EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSS-------EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred hhhcc-hHHHHHHHh-------hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccc
Confidence 99954 554544332 2456877777788999999999999 8999999999999999543 47999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+||...+.. ....++||+.|+|||++....|...-|+||.||++|--++|..||....+ +.+.+..
T Consensus 712 GfARiIgEks--FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQN---- 778 (888)
T KOG4236|consen 712 GFARIIGEKS--FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQN---- 778 (888)
T ss_pred cceeecchhh--hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhc----
Confidence 9999987643 23458999999999999999999999999999999999999999974332 2111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eV 601 (683)
- .. .+-..+..|+....++++-.-+|..-.+|=+..+-
T Consensus 779 A--------aF----MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 779 A--------AF----MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred c--------cc----ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 0 00 00011334555556666666677777777776654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=265.54 Aligned_cols=200 Identities=27% Similarity=0.427 Sum_probs=168.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cCh--HHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGD--AEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~--~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.+|+...+||+|+||.|..+..+ ..+.+|||++++.-. |.+ +--+.|-++|+.- +-|.||+|+.++. .-
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ------Tm 422 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ------TM 422 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh------hh
Confidence 46888899999999999999866 356799999876422 222 2245677788776 6778999999886 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
+.+|+||||+.+|+|-.++.. -..+.++...-.+..||-||-+|| +.+||.||||..||+||.+|++|
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ---------~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiK 490 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQ---------VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIK 490 (683)
T ss_pred hheeeEEEEecCchhhhHHHH---------hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceE
Confidence 789999999999999998843 235777888889999999999999 99999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
|+|||+++..-.+. ..+...+||+.|+|||++.+.+|+..+|.|||||+||||+.|++||+..
T Consensus 491 i~DFGmcKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 491 IADFGMCKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred eeecccccccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999998543322 2345689999999999999999999999999999999999999999854
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=246.51 Aligned_cols=212 Identities=25% Similarity=0.376 Sum_probs=170.8
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeecc-CccChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIES-DFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~-~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
.+.++...+.......||+|++|.|-|-++ .+|+..|||++... ..+..++.++|+.+..+- ..|.+|.++|...
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-- 115 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-- 115 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--
Confidence 333455555666667899999999988875 47999999999764 344466788999987664 7999999999765
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.....++.||.|. .||+.|-.... .....+++...-+|+..|.+||.|||+ +..|||||+||+|||++
T Consensus 116 ----regdvwIcME~M~-tSldkfy~~v~-----~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn 183 (282)
T KOG0984|consen 116 ----REGDVWICMELMD-TSLDKFYRKVL-----KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILIN 183 (282)
T ss_pred ----ccccEEEeHHHhh-hhHHHHHHHHH-----hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEc
Confidence 5677999999995 48877653322 235578888888999999999999995 78999999999999999
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCccccc----cCCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
.+|++|++|||.+-.+.++- ..+..+|...|||||.+. ...|+.|+||||+|+.+.||.++|.|++...
T Consensus 184 ~~GqVKiCDFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 184 YDGQVKICDFGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cCCcEEEcccccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 99999999999987765432 233357889999999875 3479999999999999999999999997543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=259.77 Aligned_cols=277 Identities=26% Similarity=0.358 Sum_probs=198.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeec-cCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCC--CCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIE-SDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN--ERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~-~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~--~~~ 387 (683)
..|....+||+|.||.|||++.+ .|+.||+|++.- ....+ -....+|+++|..|+|+|++.++..|...... ...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999965 578899987643 33333 23467899999999999999999999754322 234
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...||||++++. +|...|.+ ....++..++.++..++..||.|+| +..|+|||+||.|+||+.++..|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--------~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--------RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILK 164 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--------ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEE
Confidence 568999999976 67776622 2356888999999999999999999 99999999999999999999999
Q ss_pred EcccCcccccccCCcc---ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCC------
Q 005691 468 VADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR------ 537 (683)
Q Consensus 468 LaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~------ 537 (683)
|+|||+|+.+...... ..+..+-|..|++||.+.+ .+|+++.|||.-||++.||++|.+-+...++..+-
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 9999999877543322 2344456999999998875 67999999999999999999999887654432210
Q ss_pred ccchhhhhhhhhhcCccccccCcc-ccccccccCCChHHHHH------HHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPS-LLKEDDFLSLNPKAIME------RFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~-l~~~~~~~~~~~~e~~~------~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
...+.--+|+.+.+-.+.+.+... +.+. ..+ ..++.+. ..+++....+..||.+||+.++++..
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~-~~r--kv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKG-QKR--KVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcc-hhh--hhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 011222244444333333333111 1111 000 0011111 44567777889999999999998753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=255.25 Aligned_cols=258 Identities=20% Similarity=0.273 Sum_probs=198.6
Q ss_pred HhcCcccc-eeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 311 ATDKFSQK-NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~-~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.|++|++. ++||-|-.|.|.....+ .|+.+|+|.+.+ ....++||++--.. .|+|||.++.++....+ ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~--~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQ--GR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc--Cc
Confidence 45666654 57999999999998865 688999998865 33466889876555 69999999998854322 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc---CC
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DM 464 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---~~ 464 (683)
.-+++|||.|+||.|...+.+. ....+++.+.-.|..+|+.|+.||| +.+|.||||||+|+|... |-
T Consensus 132 kcLLiVmE~meGGeLfsriq~~-------g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDR-------GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred eeeEeeeecccchHHHHHHHHc-------ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCc
Confidence 6688999999999999988543 2456899999999999999999999 999999999999999964 45
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
.+||+|||+|+....... ....+-|+-|.|||++...+|+...|+||+||++|-|++|.+||...... -+.-=
T Consensus 202 ~lKLtDfGFAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----aispg 274 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPG 274 (400)
T ss_pred ceEecccccccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----cCChh
Confidence 789999999997654322 33356799999999999999999999999999999999999999653321 01111
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.++.++.|.. .+-.....++.+...+++...++.+|++|-|+.+++..
T Consensus 275 Mk~rI~~gqy------------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 275 MKRRIRTGQY------------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHhHhhccCc------------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1222222222 11112345666777788888999999999999999753
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=290.90 Aligned_cols=209 Identities=27% Similarity=0.362 Sum_probs=180.3
Q ss_pred ehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceee
Q 005691 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCV 379 (683)
Q Consensus 304 ~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~ 379 (683)
.+.+++-..++|.+.++||+|+||.|...+.+ .++.+|.|++.+..+ ....-|..|-.+|..-+.+=||.|+-.+.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35566667789999999999999999999975 578899999977432 23455899999999888888999986665
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
+...+|+|||||+||+|-..+.. ...++....+-++..|.-||.-|| +.|+|||||||.|||
T Consensus 146 ------D~~~LYlVMdY~pGGDlltLlSk---------~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvL 207 (1317)
T KOG0612|consen 146 ------DERYLYLVMDYMPGGDLLTLLSK---------FDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVL 207 (1317)
T ss_pred ------CccceEEEEecccCchHHHHHhh---------cCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeE
Confidence 67889999999999999999832 126888888888999999999999 999999999999999
Q ss_pred eccCCcEEEcccCcccccccCCccccccccCCCcccCccccc----c-CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 460 LDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL----Y-GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~----~-~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
||..|++||+|||.+-....+....+...+|||-|++||++. + +.|+...|.||+||++|||+.|..||..
T Consensus 208 ld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 208 LDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred ecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 999999999999988777766666667788999999999986 3 6799999999999999999999999963
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=235.95 Aligned_cols=211 Identities=35% Similarity=0.544 Sum_probs=180.1
Q ss_pred eeecCceEEEEEEEcC-CcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecC
Q 005691 321 IGRGGFGLVYKGILQD-GTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMP 398 (683)
Q Consensus 321 LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~ 398 (683)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++. .....++++||++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE------DENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee------cCCeEEEEEecCC
Confidence 6899999999999865 899999998765433 3467999999999999999999999986 4468999999999
Q ss_pred CCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-CCcEEEcccCccccc
Q 005691 399 NGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQS 477 (683)
Q Consensus 399 ~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-~~~~KLaDFGla~~~ 477 (683)
+++|.+++... ...+++..++.++.+++++|.||| +.+++|+||+|.||+++. ++.++|+|||.+...
T Consensus 75 ~~~l~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 75 GGSLKDLLKEN--------EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred CCcHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 99999998321 136889999999999999999999 889999999999999999 899999999998866
Q ss_pred ccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcccc
Q 005691 478 REGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQ 556 (683)
Q Consensus 478 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e 556 (683)
..... ......+...|++||..... ..+.++|+|++|++++||
T Consensus 144 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------- 187 (215)
T cd00180 144 TSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------- 187 (215)
T ss_pred cCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------
Confidence 54321 22335578899999999887 888999999999999999
Q ss_pred ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 557 ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 557 ~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ---------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2456788889999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-29 Score=279.68 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=184.9
Q ss_pred CcccceeeeecCceE-EEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeE
Q 005691 314 KFSQKNFIGRGGFGL-VYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~-Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
-|...+++|.|.-|+ ||+|.+. |+.||||++.... .+-..+||..|..- +|||||+++|.-. ....+|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~------d~qF~Y 579 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQ------DRQFLY 579 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeecc------CCceEE
Confidence 466778899999985 6999996 8999999985533 23456899999888 6999999876532 567889
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-----CCcE
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-----DMRA 466 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-----~~~~ 466 (683)
+..|.| ..+|++++.....+ .....-...+.+..|++.||++|| +.+||||||||.||||+. ..++
T Consensus 580 IalELC-~~sL~dlie~~~~d-----~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra 650 (903)
T KOG1027|consen 580 IALELC-ACSLQDLIESSGLD-----VEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRA 650 (903)
T ss_pred EEehHh-hhhHHHHHhccccc-----hhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeE
Confidence 999999 46999999543111 011111445678899999999999 899999999999999975 3589
Q ss_pred EEcccCcccccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhC-CCCCCCCCCCCCCccchhh
Q 005691 467 RVADFGLAKQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG-RKALDLSTSGSPRACLITD 543 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltG-r~p~~~~~~~~~~~~~l~~ 543 (683)
+|+|||+++....+++.. .....||.||+|||.+....-+..+|+||+||++|..++| .+||...-..+ .++..
T Consensus 651 ~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---~NIl~ 727 (903)
T KOG1027|consen 651 KISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---ANILT 727 (903)
T ss_pred EecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---hhhhc
Confidence 999999999987776544 3457899999999999998888899999999999999997 89997543221 11110
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
- ...+ .. |... .+. ...+++..+++++|..||++.+|+
T Consensus 728 ~------~~~L-~~----L~~~--------~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 728 G------NYTL-VH----LEPL--------PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred C------ccce-ee----eccC--------chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 0 0000 00 1011 111 456888999999999999999996
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=239.89 Aligned_cols=198 Identities=33% Similarity=0.488 Sum_probs=170.7
Q ss_pred cccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++. .....++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~------~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE------DPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee------cCCceEE
Confidence 4567889999999999999875 889999998765544 5678999999999999999999999986 4567899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCC-CCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRP-LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~-L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++||+++++|.+++... .. +++.....++.+++++|.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 75 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 75 VMEYCEGGDLFDYLRKK---------GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred EEeccCCCCHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeC
Confidence 99999999999998422 22 889999999999999999999 789999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCcccc-ccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYA-LYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
|.+...............++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 143 g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99987754431122345678899999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=247.93 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=194.2
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChH---HHHHHHHHHHhc-cCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDA---EFCNEVEIISNL-KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~---~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|....+||+|.|..|..+++. ..+.+|+|.+++.-...++ =...|-.+...- +||.+|.|..++. .
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq------t 322 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ------T 322 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc------c
Confidence 467888999999999999999875 5678899988764333322 245666666655 7999999999987 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
...+++|.||+++|+|--++. ..+.|+++..+-....|.-||.||| +.+||.||||..|||||.+|.+
T Consensus 323 esrlffvieyv~ggdlmfhmq---------rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQ---------RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred cceEEEEEEEecCcceeeehh---------hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCce
Confidence 678999999999999988873 3457899998889999999999999 8999999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||.|+|+++..-.. ...+...+||+.|.|||.+.+..|...+|.|++||+++||+.||.||+.-....++ .+-.++..
T Consensus 391 kltdygmcke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-~ntedylf 468 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-MNTEDYLF 468 (593)
T ss_pred eecccchhhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-cchhHHHH
Confidence 99999999854222 22356689999999999999999999999999999999999999999865432222 34445555
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP 596 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP 596 (683)
+.+-+..+. -+.....+...|...-++.||.+|-
T Consensus 469 qvilekqir----------------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 QVILEKQIR----------------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHhhhccc----------------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 554443331 1112233455666677788888774
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=251.45 Aligned_cols=277 Identities=19% Similarity=0.277 Sum_probs=200.1
Q ss_pred cceehHHHHHHhcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhcc-CC-----Cccc
Q 005691 301 IWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HR-----NLVP 373 (683)
Q Consensus 301 ~~f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~-----NLV~ 373 (683)
..|...| ..+++|.+..++|+|.||.|-+..... +..||||+++..... .+..+-|+++|.++. +. ..|.
T Consensus 79 ~v~~~gD--~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 79 YVYQVGD--ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEEecc--ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 3444444 348899999999999999999998654 688999988764433 344677999999993 22 3667
Q ss_pred ccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 374 L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
+.+|+- ..++..+|+|.| +-|+.+||... ...+++....+.|+.|+.++++||| +.+++|-||
T Consensus 156 m~~wFd------yrghiCivfell-G~S~~dFlk~N-------~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDL 218 (415)
T KOG0671|consen 156 MRDWFD------YRGHICIVFELL-GLSTFDFLKEN-------NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDL 218 (415)
T ss_pred eehhhh------ccCceEEEEecc-ChhHHHHhccC-------CccccchHHHHHHHHHHHHHHHHHH---hcceeecCC
Confidence 777764 567889999998 56999999432 3457888999999999999999999 999999999
Q ss_pred CCCceeecc--------------------CCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEE
Q 005691 454 KATNILLDA--------------------DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYS 513 (683)
Q Consensus 454 KpsNILLd~--------------------~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwS 513 (683)
||+|||+-+ +..+||.|||.|....+.. ..++.|..|.|||++.+-.++.++||||
T Consensus 219 KPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWS 294 (415)
T KOG0671|consen 219 KPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWS 294 (415)
T ss_pred ChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCcee
Confidence 999999932 3468999999998765543 4467899999999999999999999999
Q ss_pred cchhHHHHhhCCCCCCCCCCCCCC----------ccchhhh--hhhhhhcCccc-----------cccCccccccccccC
Q 005691 514 FGVVILEIMCGRKALDLSTSGSPR----------ACLITDW--VWSLVKAGKVW-----------QALDPSLLKEDDFLS 570 (683)
Q Consensus 514 fGvlLlELltGr~p~~~~~~~~~~----------~~~l~~~--v~~~~~~g~l~-----------e~vD~~l~~~~~~~~ 570 (683)
+||+|.|+.+|..-|......+.- ......- ..+....|++. .+.++-... ...+
T Consensus 295 iGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl-~~~~- 372 (415)
T KOG0671|consen 295 IGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPL-KKYM- 372 (415)
T ss_pred eeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccH-HHHh-
Confidence 999999999999988765422100 0000000 11111222111 111110000 0001
Q ss_pred CChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 571 LNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 571 ~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
....++..++++++..++..||.+|+|..|++.
T Consensus 373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred ccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 112234568999999999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=226.70 Aligned_cols=196 Identities=24% Similarity=0.396 Sum_probs=160.1
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|...++||+|.||+||||+.. .++.||+|+++-... ++ -....+|+.+++.++|+|||+++.... ..+..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh------sdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH------SDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc------cCcee
Confidence 4556678999999999999965 478899999865322 22 346889999999999999999998876 56778
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
.||+||+.. .|..+.. + -...++....+.+..|+.+||.++| +..+.|||+||.|.||+.+|+.|++|
T Consensus 77 tlvfe~cdq-dlkkyfd-s-------lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelklad 144 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFD-S-------LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLAD 144 (292)
T ss_pred EEeHHHhhH-HHHHHHH-h-------cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecc
Confidence 999999954 5666552 1 1346888889999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCC
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
||+++-+.-.-.. ....+-|..|.+|.++.+. -|+...|+||-||++.|+....+|.
T Consensus 145 fglarafgipvrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 145 FGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred cchhhhcCCceEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 9999977543222 2234568999999998865 5788999999999999998755554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-28 Score=257.33 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=195.4
Q ss_pred CcccceeeeecCceEEEEEEEcCCc-EEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGT-TVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~-~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++.....||-||||.|=....+... .+|+|.+++... ...+....|-+||...+.+.||+|+-.+. +...
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr------d~ky 494 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR------DSKY 494 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc------cchh
Confidence 4444566999999999988876433 378888766433 33445788999999999999999998886 6678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.|++||-|-+|.|...|. .+..++.....-++..+.+|++||| +.+||.|||||+|.+||.+|-+||.
T Consensus 495 vYmLmEaClGGElWTiLr---------dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILR---------DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred hhhhHHhhcCchhhhhhh---------hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEe
Confidence 899999999999999994 3457888888889999999999999 9999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+|+....+.. +-..+||+.|.|||++.+...+..+|.|++|++++||++|++||...++.. ...++
T Consensus 563 DFGFAKki~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---------tYn~I 631 (732)
T KOG0614|consen 563 DFGFAKKIGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---------TYNLI 631 (732)
T ss_pred ehhhHHHhccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---------HHHHH
Confidence 9999999876654 445799999999999999999999999999999999999999997654321 11122
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALKM 604 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~~ 604 (683)
-.| +|.- ..|..+.....+++..-+..+|.+|-. +.+|-+.
T Consensus 632 LkG-----id~i---------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 632 LKG-----IDKI---------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred Hhh-----hhhh---------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 122 1110 012233444556666667889999986 6666543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=258.21 Aligned_cols=221 Identities=29% Similarity=0.422 Sum_probs=176.2
Q ss_pred hHHHHHHh---cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccce
Q 005691 305 IQDLERAT---DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGC 377 (683)
Q Consensus 305 ~~el~~at---~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~ 377 (683)
|--|++|. .-|...+.||-|+||.|-.+...| ...+|.|.+.+.+.- .....+.|-.||+.-+.+=+|+|+--
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44455553 357788899999999999987544 567899988765432 23457889999999999999999866
Q ss_pred eeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCc
Q 005691 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATN 457 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsN 457 (683)
+. +.+.+|+||||++||++-.+|.. ...+.+...+-.+..++.|+++.| +.++|||||||.|
T Consensus 698 FQ------DkdnLYFVMdYIPGGDmMSLLIr---------mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDN 759 (1034)
T KOG0608|consen 698 FQ------DKDNLYFVMDYIPGGDMMSLLIR---------MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDN 759 (1034)
T ss_pred ec------cCCceEEEEeccCCccHHHHHHH---------hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccc
Confidence 64 67789999999999999998842 235667777778889999999999 9999999999999
Q ss_pred eeeccCCcEEEcccCcccccc---------cCCc--------------------------------cccccccCCCcccC
Q 005691 458 ILLDADMRARVADFGLAKQSR---------EGQS--------------------------------HLTTRVAGTHGYLA 496 (683)
Q Consensus 458 ILLd~~~~~KLaDFGla~~~~---------~~~~--------------------------------~~~~~~~GT~~Y~A 496 (683)
||||.+|.+||.||||+.-+. .++. ......+||..|+|
T Consensus 760 ILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 760 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred eEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 999999999999999974321 1100 00112479999999
Q ss_pred ccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 497 PEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 497 PE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||++....++.-.|.||.||+|+||+.|+.||...++.+.. ..+..|
T Consensus 840 pevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq-~kv~nw 886 (1034)
T KOG0608|consen 840 PEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQ-YKVINW 886 (1034)
T ss_pred hHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcce-eeeeeh
Confidence 99999999999999999999999999999999877765543 344455
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-28 Score=241.37 Aligned_cols=272 Identities=23% Similarity=0.312 Sum_probs=193.8
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEeecc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEE
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
.+.||-|.||.||....+ ||+.||.|++... +...-+.+.+|+.+|..++|.|+..++....-. +...-.+.|++.
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp-h~dfFqEiYV~T 136 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA-NPSFFQELYVLT 136 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC-CchHHHHHHHHH
Confidence 457999999999999864 7999999998653 223346788999999999999999888765311 111224678899
Q ss_pred eecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 395 DYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 395 Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
|.|. .+|+..+- ....|+-....-+..||.+||+||| +.+|.||||||.|.|++.|...||+|||+|
T Consensus 137 ELmQ-SDLHKIIV---------SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV---------SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHH-hhhhheec---------cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccc
Confidence 9984 47877772 3457888888889999999999999 999999999999999999999999999999
Q ss_pred cccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh-------h
Q 005691 475 KQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV-------W 546 (683)
Q Consensus 475 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v-------~ 546 (683)
|....++....+..+-|.-|.|||.+++ ..|+...||||.||++.||+..|.-|....+.++- ..+++.. -
T Consensus 204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAM 282 (449)
T ss_pred cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHH
Confidence 9887666655666667889999999996 56899999999999999999988887654332210 1222111 0
Q ss_pred hhhhcCccccccCccccc-----cccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 547 SLVKAGKVWQALDPSLLK-----EDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~-----~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
+..-+|.-..++...... -.... .+...-.+-+++..+.++.+|..|-+..+.+..+.
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtls--S~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIA--SPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeec--CCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000112111111111110 00000 01111123456667788999999999888876654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=241.13 Aligned_cols=195 Identities=24% Similarity=0.396 Sum_probs=163.6
Q ss_pred CcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCc-----cChH---HHHHHHHHHHhcc---CCCcccccceeeec
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDF-----QGDA---EFCNEVEIISNLK---HRNLVPLRGCCVVD 381 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~-----~~~~---~f~~Ev~iL~~L~---H~NLV~L~G~c~~~ 381 (683)
+|...+.+|+|+||.|+.++++. ..+|+||.+.+... ..++ ..-.|++||+.|+ |+||++++.++.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE-- 639 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE-- 639 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee--
Confidence 57888999999999999999864 56788887754321 1111 2456999999997 999999999996
Q ss_pred CCCCCCCeeEEEEeec-CCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 382 GDNERGSERYLVYDYM-PNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~-~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
+.+..||++|-. ++-+|.+++ ..++.+++....-|+.||+.|+++|| +.+|||||||-+||.+
T Consensus 640 ----ddd~yyl~te~hg~gIDLFd~I---------E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenviv 703 (772)
T KOG1152|consen 640 ----DDDYYYLETEVHGEGIDLFDFI---------EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIV 703 (772)
T ss_pred ----cCCeeEEEecCCCCCcchhhhh---------hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEE
Confidence 567889999976 556788888 24567999999999999999999999 9999999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCC-ccccEEEcchhHHHHhhCCCCCC
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT-EKSDVYSFGVVILEIMCGRKALD 529 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSfGvlLlELltGr~p~~ 529 (683)
|.+|-+||.|||.|.+...+. ....+||.+|.|||++.+.+|- ..-|||++|++||.++....|+.
T Consensus 704 d~~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ecCCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999987765443 2346899999999999988775 55899999999999999888874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-26 Score=221.63 Aligned_cols=263 Identities=19% Similarity=0.337 Sum_probs=192.4
Q ss_pred hcCcccceeeeecCceEEEEEE-EcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|+..+++|+|-|+.||.|. ..+.+.++||.++... .+...+|+.||..|+ ||||++|+...... ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp----~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP----ESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc----cccC
Confidence 4678888999999999999998 4568899999987643 456789999999997 99999999987532 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC-CcEEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARV 468 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-~~~KL 468 (683)
..||+||+.|.+..... +.|+...+...+.++..||.|+| +.||+|||+||.|+++|.. -..+|
T Consensus 110 paLiFE~v~n~Dfk~ly------------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY------------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred chhHhhhhccccHHHHh------------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeee
Confidence 88999999987765543 46777888889999999999999 9999999999999999965 57999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccc-cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh--
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV-- 545 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v-- 545 (683)
.|+|+|....+++.... .+.+.-|--||.+. ...|+..-|+|||||++.+|+..+.||-...+..+ .++..+
T Consensus 175 IDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D---QLVkIakV 249 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVKIAKV 249 (338)
T ss_pred eecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH---HHHHHHHH
Confidence 99999998766654321 23355678999876 56788899999999999999999999854333221 122111
Q ss_pred ------hhhhhcCccccccCccccc---c------ccccCCChHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 ------WSLVKAGKVWQALDPSLLK---E------DDFLSLNPKAI-MERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ------~~~~~~g~l~e~vD~~l~~---~------~~~~~~~~~e~-~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+..-.+ .+||...+ . ..+........ ..+.+.+.-.-+..|-.+|||+.|.+.
T Consensus 250 LGt~el~~Yl~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hChHHHHHHHHHHcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111111 24444322 0 00111111111 135566777778899999999999763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=244.26 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=194.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|.....+|.|.||.|||++.. .++..|||.++-.......-...|+-+++..+|+|||.++|-+. ..+..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl------r~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL------RRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh------hhcCc
Confidence 457778889999999999999954 68899999987765555666778999999999999999999987 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++.|||+.+|+|.+.-|.. .+|++.+....++...+||+||| +.+-+|||||-.|||+.+.+.+|++|
T Consensus 88 wicMEycgggslQdiy~~T---------gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaD 155 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT---------GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLAD 155 (829)
T ss_pred EEEEEecCCCcccceeeec---------ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecc
Confidence 9999999999999987643 47888888899999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
||.+-.+...- .......||+.|||||+.. .+.|..++|||+.|+...|+---.+|.-...+ .-+..
T Consensus 156 fgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------mr~l~ 225 (829)
T KOG0576|consen 156 FGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------MRALF 225 (829)
T ss_pred cCchhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------HHHHH
Confidence 99875443211 1123467999999999874 57789999999999999999777666422111 11111
Q ss_pred hhhcCccccccCc-cccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 548 LVKAGKVWQALDP-SLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 548 ~~~~g~l~e~vD~-~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
++.. ...+| .+.+. ..-.+-+-+++..|+-.+|.+|||....+
T Consensus 226 LmTk----S~~qpp~lkDk--------~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 226 LMTK----SGFQPPTLKDK--------TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred Hhhc----cCCCCCcccCC--------ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1111 11222 22211 12244667788889999999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=267.94 Aligned_cols=202 Identities=14% Similarity=0.198 Sum_probs=141.0
Q ss_pred HhccC-CCcccccceeeecCCC-CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHh
Q 005691 364 SNLKH-RNLVPLRGCCVVDGDN-ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLH 441 (683)
Q Consensus 364 ~~L~H-~NLV~L~G~c~~~~~~-~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH 441 (683)
+.++| .||+++++++...... ......++++||+ +++|.++|.. ....+++.+++.|+.||++||.|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--------~~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--------PDRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--------ccccccHHHHHHHHHHHHHHHHHHH
Confidence 34556 5888888887332211 1224577888987 5699999942 1346999999999999999999999
Q ss_pred cccCCCccccCCCCCceeecc-------------------CCcEEEcccCcccccccCC--------c-------ccccc
Q 005691 442 YGVKPAIYHRDIKATNILLDA-------------------DMRARVADFGLAKQSREGQ--------S-------HLTTR 487 (683)
Q Consensus 442 ~~~~~~IiHrDIKpsNILLd~-------------------~~~~KLaDFGla~~~~~~~--------~-------~~~~~ 487 (683)
+.+|+||||||+||||+. ++.+||+|||+++...... . .....
T Consensus 98 ---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 ---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred ---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 899999999999999954 4567777777776432100 0 00112
Q ss_pred ccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCcccccccc
Q 005691 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDD 567 (683)
Q Consensus 488 ~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~ 567 (683)
..||+.|||||++.+..++.++|||||||+||||++|..|+.... ..+.. +... .+.+....
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~-----~~~~----~~~~~~~~--- 236 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSS-----LRHR----VLPPQILL--- 236 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHH-----HHHh----hcChhhhh---
Confidence 468999999999999999999999999999999999988754210 00101 1110 11111100
Q ss_pred ccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 568 FLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 568 ~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+...++.+|++++|.+||+|.||++
T Consensus 237 --------~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 --------NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred --------cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1223456778999999999999999975
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=229.64 Aligned_cols=198 Identities=26% Similarity=0.400 Sum_probs=162.2
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc--CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES--DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~--~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+|.....+|.|.- .|-.+... .++.||+|++... ..+..+...+|..++..+.|+|+++++.++.-.....+-.+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555566788776 44444322 5889999998654 233356678899999999999999999998755444455678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
|+|||||. ++|...++ -.++-.+...|..|+..|+.||| +.+|+||||||+||++..+..+||.|
T Consensus 97 y~v~e~m~-~nl~~vi~-----------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL-----------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHHHHhhh-hHHHHHHH-----------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeecc
Confidence 99999995 58877774 24666778899999999999999 99999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCC
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~ 529 (683)
||+|+....+ ...+.++.|.-|.|||++.+..+.+.+||||.||++.||++|+--|.
T Consensus 162 fg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 162 FGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred chhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 9999865443 45667788999999999998889999999999999999999997765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=228.28 Aligned_cols=202 Identities=29% Similarity=0.446 Sum_probs=165.7
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecC
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDG 382 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~ 382 (683)
+....+.|...++||+|.|++||++.+. .+..||+|.+...+.. ....+|+++|..+. |.|++++.++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~r--- 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFR--- 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhc---
Confidence 3444567888999999999999999864 3678999998765433 35889999999994 999999999987
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.+++..+|+||++.-...+++ ..++.......+..+..||+++| ..+||||||||+|+|.+.
T Consensus 106 ---nnd~v~ivlp~~~H~~f~~l~------------~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 106 ---NNDQVAIVLPYFEHDRFRDLY------------RSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNR 167 (418)
T ss_pred ---cCCeeEEEecccCccCHHHHH------------hcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCcccccccc
Confidence 678899999999998888877 25778888999999999999999 999999999999999986
Q ss_pred C-CcEEEcccCcccccccC-------------Cc------------------------------cccccccCCCcccCcc
Q 005691 463 D-MRARVADFGLAKQSREG-------------QS------------------------------HLTTRVAGTHGYLAPE 498 (683)
Q Consensus 463 ~-~~~KLaDFGla~~~~~~-------------~~------------------------------~~~~~~~GT~~Y~APE 498 (683)
. +.-.|.|||+|...... .. ......+||+||.|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 5 56789999998621000 00 0011247999999999
Q ss_pred ccc-cCCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 499 YAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 499 ~~~-~~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
++. .+.-+.++||||-||+++-+++++.||-...
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccCc
Confidence 886 5677999999999999999999999985443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-25 Score=212.18 Aligned_cols=166 Identities=23% Similarity=0.224 Sum_probs=123.5
Q ss_pred CCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccccc
Q 005691 400 GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479 (683)
Q Consensus 400 GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~ 479 (683)
|+|.+++.. .+..++|.+++.|+.|+++||.||| +.+ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~--------~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEV--------RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHH--------hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecc
Confidence 678888832 1346999999999999999999999 444 999999999999999 999887544
Q ss_pred CCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccC
Q 005691 480 GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALD 559 (683)
Q Consensus 480 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD 559 (683)
.. ..||+.|||||++.+..++.|+|||||||++|||++|+.|+....... ..+..+.... .. .+
T Consensus 62 ~~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~-~~------~~ 125 (176)
T smart00750 62 EQ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGM-PA------DD 125 (176)
T ss_pred cc------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHh-cc------CC
Confidence 22 258999999999999999999999999999999999999986432211 1111111110 00 00
Q ss_pred ccccccccccCCChHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 560 PSLLKEDDFLSLNPKAIME--RFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 560 ~~l~~~~~~~~~~~~e~~~--~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+... ........ .+.+++..|++.+|++||++.|+++.+..
T Consensus 126 ~~~~-------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 126 PRDR-------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cccc-------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 0000 01122232 58899999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=227.34 Aligned_cols=167 Identities=20% Similarity=0.215 Sum_probs=130.1
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc--CCcEEEEEEeeccCc-----cChHHHHHHHHHHHhccCCCcccccceeeec
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ--DGTTVAVKKVIESDF-----QGDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~--~g~~VAVK~l~~~~~-----~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~ 381 (683)
....++|...+.||+|+||+||+|+.. +++.||||++..... ...+.|.+|+++|++++|+|+++.+..
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 344578999999999999999999875 577889998753311 124468999999999999999963321
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC-CCCceee
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI-KATNILL 460 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI-KpsNILL 460 (683)
....+|||||+++++|.... . .. ...++.++++||.||| +.+|+|||| ||+|||+
T Consensus 90 -----~~~~~LVmE~~~G~~L~~~~--~--------~~------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv 145 (365)
T PRK09188 90 -----TGKDGLVRGWTEGVPLHLAR--P--------HG------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLM 145 (365)
T ss_pred -----cCCcEEEEEccCCCCHHHhC--c--------cc------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEE
Confidence 13479999999999996321 0 00 1467889999999999 899999999 9999999
Q ss_pred ccCCcEEEcccCcccccccCCcc-------ccccccCCCcccCccccccC
Q 005691 461 DADMRARVADFGLAKQSREGQSH-------LTTRVAGTHGYLAPEYALYG 503 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~-------~~~~~~GT~~Y~APE~~~~~ 503 (683)
+.++++||+|||+|+........ ..+.+.+++.|+|||++...
T Consensus 146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999999999976543211 12457889999999998743
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-23 Score=207.53 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=185.2
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.+.|.+.+.||+|-||.+-.+.++ ..+.+++|-+... ....++|.+|..-=-.| .|.||+.-+..-.. ..+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq-----t~d~ 96 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ-----TSDA 96 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhh-----cCce
Confidence 457888899999999999999976 4667888877553 33467899998765455 69999987655432 4457
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee-ccC-CcEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL-DAD-MRAR 467 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL-d~~-~~~K 467 (683)
.++++||+|.|+|..-+- ...+.+..-.+++.|++.||.|+| +..+||||||.+|||+ +.| .++|
T Consensus 97 YvF~qE~aP~gdL~snv~----------~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVE----------AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred EEEeeccCccchhhhhcC----------cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEE
Confidence 889999999999998772 235777788899999999999999 9999999999999999 333 4899
Q ss_pred EcccCcccccccCCccccccccCCCcccCcccccc---C--CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY---G--QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~--~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
|+|||+.+..+. ...+..-+..|.|||.... + +..+.+|||.||++++.++||+.|++-....++ .
T Consensus 164 lcDFG~t~k~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-----~ 234 (378)
T KOG1345|consen 164 LCDFGLTRKVGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-----P 234 (378)
T ss_pred eeecccccccCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-----h
Confidence 999999865432 1223345678999997653 2 356789999999999999999999984433222 2
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
-|-|..|..+.... +..... -..++..++-..-+.++|++|=-+.++-+|-
T Consensus 235 Y~~~~~w~~rk~~~-----~P~~F~-------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 235 YWEWEQWLKRKNPA-----LPKKFN-------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHHHHhcccCcc-----Cchhhc-------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 36666676665432 222111 1123445556667889999995555555544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=217.12 Aligned_cols=135 Identities=24% Similarity=0.359 Sum_probs=111.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-----C---CCcccccceeeecCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-----H---RNLVPLRGCCVVDGD 383 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-----H---~NLV~L~G~c~~~~~ 383 (683)
.+|...++||-|.|++||.+... +.+.||+|+.+... .-.+..+.||++|++++ | .+||+|+.++...+.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999964 56789999875532 22445788999999984 3 369999999976654
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.+.+.++|+|++ |-+|..+|.... .+.++.....+|+.||+.||.|||.+| +|||-||||+||||
T Consensus 157 --NG~HVCMVfEvL-GdnLLklI~~s~-------YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 --NGQHVCMVFEVL-GDNLLKLIKYSN-------YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred --CCcEEEEEehhh-hhHHHHHHHHhC-------CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 678999999999 567777774332 357899999999999999999999754 89999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-23 Score=219.08 Aligned_cols=210 Identities=22% Similarity=0.271 Sum_probs=167.9
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc------CCCccccc
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK------HRNLVPLR 375 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~------H~NLV~L~ 375 (683)
|.+.=-+..-.+|......|+|-|++|.+|... -|+.||||++...... .+.=+.|++||.+|. ..|.++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333334455678888889999999999999864 4889999999775432 334467999999995 34788887
Q ss_pred ceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCC
Q 005691 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455 (683)
Q Consensus 376 G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKp 455 (683)
-.+. ..++++||+|-+ ..+|.+.|.... ..-.|.......++.|+.-||..|. +-+|+|.||||
T Consensus 501 r~F~------hknHLClVFE~L-slNLRevLKKyG------~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKP 564 (752)
T KOG0670|consen 501 RHFK------HKNHLCLVFEPL-SLNLREVLKKYG------RNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKP 564 (752)
T ss_pred HHhh------hcceeEEEehhh-hchHHHHHHHhC------cccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCc
Confidence 7765 578899999987 458888884432 2346888888999999999999999 88999999999
Q ss_pred CceeeccC-CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 456 TNILLDAD-MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 456 sNILLd~~-~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
.|||+++. ...||+|||.|-...+.+. +.+.-+.-|.|||++.+-.|+...|+||.||.||||.||+..|...+
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cceEeccCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99999876 4679999999977655432 22233557999999999999999999999999999999998886443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=196.40 Aligned_cols=261 Identities=28% Similarity=0.371 Sum_probs=193.7
Q ss_pred cccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCC-CcccccceeeecCCCCCCCee
Q 005691 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHR-NLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~-NLV~L~G~c~~~~~~~~~~~~ 390 (683)
|.....||.|+||.||++... ..+++|.+....... ...|.+|+.+++.+.|+ |++++..++. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~------~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ------DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe------cCCEE
Confidence 556778999999999999987 889999987654433 56799999999999988 7999998884 33447
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~KLa 469 (683)
++++||+.++++.+++..... . ..+.......+..+++.++.|+| ..+++|||+||+||+++... .+|+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~ 144 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGR-----K-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLI 144 (384)
T ss_pred EEEEecCCCCcHHHHHHhccc-----c-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEe
Confidence 999999999999966622110 0 36888889999999999999999 88899999999999999988 79999
Q ss_pred ccCcccccccCCcc-----ccccccCCCcccCcccccc---CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 470 DFGLAKQSREGQSH-----LTTRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 470 DFGla~~~~~~~~~-----~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
|||+++........ ......||..|+|||.+.. ...+...|+|++|++++++++|+.|+...... ..
T Consensus 145 dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~ 219 (384)
T COG0515 145 DFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SA 219 (384)
T ss_pred ccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----cc
Confidence 99999866544332 2456789999999999987 68889999999999999999999996543321 00
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
....+..+...... ......... ........+..+...|+..+|..|.++.+....
T Consensus 220 ~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 220 TSQTLKIILELPTP-SLASPLSPS------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHHhcCCc-ccccccCcc------ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11122222111110 000000000 001112356677788888999999999987764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=195.03 Aligned_cols=260 Identities=17% Similarity=0.168 Sum_probs=185.8
Q ss_pred CcccceeeeecCceEEEEEEEcCC--cEEEEEEeeccCccChHHHHHHHHHHHhccC----CCcccccceeeecCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDG--TTVAVKKVIESDFQGDAEFCNEVEIISNLKH----RNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g--~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H----~NLV~L~G~c~~~~~~~~~ 387 (683)
+|...++||+|+||.||++...+. ..+|+|.-..........+..|+.++..+.+ +++..++.... ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-----~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-----STE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-----CCC
Confidence 789999999999999999997654 4788887665444433378899999999974 35666655542 145
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC----
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD---- 463 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~---- 463 (683)
...++||+.+ +.+|.++.... ..+.++-.+.++|+.|+..+|++|| +.+++||||||.|+++...
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~-------~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRN-------PPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhC-------CCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcc
Confidence 5689999877 77898866221 1357899999999999999999999 9999999999999999754
Q ss_pred -CcEEEcccCccc--ccccCCc----cc---cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 464 -MRARVADFGLAK--QSREGQS----HL---TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 464 -~~~KLaDFGla~--~~~~~~~----~~---~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
..++|.|||+++ ....... .. .....||..|.++....+...+.+.|+||++.++.|++.|..|+.....
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 469999999998 3321111 11 1235599999999999999999999999999999999999988754332
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
... ...+..........+ +.. .. ...+..+...+-..+...+|....+...|+...
T Consensus 243 ~~~---------~~~~~~~~~~~~~~~-~~~-------~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 243 TDL---------KSKFEKDPRKLLTDR-FGD-------LK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred cch---------HHHHHHHhhhhcccc-ccC-------CC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 111 001111111111111 111 11 223444545555689999999999999887543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-21 Score=194.96 Aligned_cols=245 Identities=20% Similarity=0.306 Sum_probs=180.5
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeec
Q 005691 320 FIGRGGFGLVYKGILQDGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYM 397 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~ 397 (683)
+|.+...|..|+|+++ |..+++|.+.... ....++|..|.-.|+-+.||||.+++|.|. ......++..||
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn------sppnlv~isq~m 269 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN------SPPNLVIISQYM 269 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc------CCCCceEeeeec
Confidence 5788889999999998 6667777775433 333567999999999999999999999997 556789999999
Q ss_pred CCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 398 PNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 398 ~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
|.|||...|+... .-..+-.+..+++.+||+|++|||.- ++-|.---|.+..|++|++.+++|+- +-++..
T Consensus 270 p~gslynvlhe~t-------~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfs 340 (448)
T KOG0195|consen 270 PFGSLYNVLHEQT-------SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS 340 (448)
T ss_pred cchHHHHHHhcCc-------cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceee
Confidence 9999999997542 34577788999999999999999943 34444456899999999999998752 111211
Q ss_pred ccCCccccccccCCCcccCccccccCCCC---ccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCcc
Q 005691 478 REGQSHLTTRVAGTHGYLAPEYALYGQLT---EKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKV 554 (683)
Q Consensus 478 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s---~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l 554 (683)
... ....-.+.||+||.++..+-+ ..+|+|||.+++|||.|..-||....+.+-. -.-.
T Consensus 341 fqe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------------mkia 402 (448)
T KOG0195|consen 341 FQE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------------MKIA 402 (448)
T ss_pred eec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------------hhhh
Confidence 110 111235789999999876554 4799999999999999999999755442210 0011
Q ss_pred ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 555 WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 555 ~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.|-+...+ +......+.+++.-|.++||.+||....|+-.||..
T Consensus 403 leglrv~i----------ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 403 LEGLRVHI----------PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred hccccccC----------CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 12222222 122344556777779999999999999999999853
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=184.70 Aligned_cols=138 Identities=17% Similarity=0.238 Sum_probs=108.0
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCcc--C-------hHHH-----------------HHHHHHHHhccCCCcc
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ--G-------DAEF-----------------CNEVEIISNLKHRNLV 372 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~--~-------~~~f-----------------~~Ev~iL~~L~H~NLV 372 (683)
..||+|+||.||+|...+|+.||||+++..... . ...| ..|++++.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999888999999999754221 1 1122 3499999999888774
Q ss_pred cccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHH-hcccCCCcccc
Q 005691 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL-HYGVKPAIYHR 451 (683)
Q Consensus 373 ~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yL-H~~~~~~IiHr 451 (683)
....+.. ...++||||++++++...+. ....+++....+++.+++.+|.|| | +.+|+||
T Consensus 83 ~p~~~~~--------~~~~iVmE~i~g~~l~~~~~---------~~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHr 142 (190)
T cd05147 83 CPEPILL--------KSHVLVMEFIGDDGWAAPRL---------KDAPLSESKARELYLQVIQIMRILYQ---DCRLVHA 142 (190)
T ss_pred CCcEEEe--------cCCEEEEEEeCCCCCcchhh---------hcCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 4332211 22489999999987765431 124688889999999999999999 6 7799999
Q ss_pred CCCCCceeeccCCcEEEcccCccccc
Q 005691 452 DIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 452 DIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
||||+|||++ ++.++|+|||+|...
T Consensus 143 DlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 143 DLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCHHHEEEE-CCcEEEEEccccccC
Confidence 9999999998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-20 Score=187.77 Aligned_cols=177 Identities=10% Similarity=0.103 Sum_probs=136.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHH---------HHHHHHHHHhccCCCcccccceeeec
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE---------FCNEVEIISNLKHRNLVPLRGCCVVD 381 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~---------f~~Ev~iL~~L~H~NLV~L~G~c~~~ 381 (683)
..++|...++||.|+||.||.... ++..+|||.+.+........ |.+|++.+.+++|++|..+..+....
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999655 57789999997654333222 68999999999999999998886532
Q ss_pred CC--CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 382 GD--NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 382 ~~--~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
.. .......+|||||++|.+|.++. .++ .....+++.+|..+| +.+++|||+||+||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------------~~~----~~~~~~i~~~l~~lH---~~gi~H~Dikp~Nil 167 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------------EIS----EDVKAKIKASIESLH---QHGMVSGDPHKGNFI 167 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------------hcc----HHHHHHHHHHHHHHH---HcCCccCCCChHHEE
Confidence 11 01235689999999999997764 111 134669999999999 899999999999999
Q ss_pred eccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHh
Q 005691 460 LDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELl 522 (683)
++.++ ++|.|||..+...+..... .++....+..++|+|+||+.+.-..
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 99988 9999999887654322111 1445555678999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=178.35 Aligned_cols=141 Identities=19% Similarity=0.196 Sum_probs=110.8
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC--------------------------hHHHHHHHHHHHhccCCCc
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--------------------------DAEFCNEVEIISNLKHRNL 371 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--------------------------~~~f~~Ev~iL~~L~H~NL 371 (683)
...||+|+||.||+|+..+|+.||||.+....... ...+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35799999999999998889999999987642110 1124578999999999987
Q ss_pred ccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccc
Q 005691 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYH 450 (683)
Q Consensus 372 V~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiH 450 (683)
.....+.. ...+|||||++++++..... ....++.....+++.+++.+|.||| . .+|+|
T Consensus 82 ~~p~~~~~--------~~~~lVmE~~~g~~~~~~~l---------~~~~~~~~~~~~i~~~l~~~l~~lH---~~~givH 141 (190)
T cd05145 82 PVPEPILL--------KKNVLVMEFIGDDGSPAPRL---------KDVPLEEEEAEELYEQVVEQMRRLY---QEAGLVH 141 (190)
T ss_pred CCceEEEe--------cCCEEEEEEecCCCchhhhh---------hhccCCHHHHHHHHHHHHHHHHHHH---HhCCEec
Confidence 55544432 12489999999886544321 1235667788999999999999999 6 89999
Q ss_pred cCCCCCceeeccCCcEEEcccCccccccc
Q 005691 451 RDIKATNILLDADMRARVADFGLAKQSRE 479 (683)
Q Consensus 451 rDIKpsNILLd~~~~~KLaDFGla~~~~~ 479 (683)
|||||+|||++ +++++|+|||+++....
T Consensus 142 rDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 142 GDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 99999999999 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=201.30 Aligned_cols=215 Identities=28% Similarity=0.396 Sum_probs=162.6
Q ss_pred HHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhc
Q 005691 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHY 442 (683)
Q Consensus 363 L~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~ 442 (683)
|+.+.|.|+.+++|.+. .+.+.+.|.+|+..|+|.|.+.. ....++|..+..++.+++.||+|||
T Consensus 1 l~~l~h~n~~~f~g~~~------~~~~~~~i~~~c~rGsl~D~i~~--------~~~~~d~~F~~s~~rdi~~Gl~ylh- 65 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASV------DGPEMIVIWEYCSRGSLLDILSN--------EDIKLDYFFILSFIRDISKGLAYLH- 65 (484)
T ss_pred CcccchhhhhhheeeEe------cCCceEEEEeeecCccHHhHHhc--------cccCccHHHHHHHHHHHHHHHHHHh-
Confidence 35789999999999998 56889999999999999999954 2457999999999999999999999
Q ss_pred ccCCCc-cccCCCCCceeeccCCcEEEcccCcccccccC-CccccccccCCCcccCccccccC-------CCCccccEEE
Q 005691 443 GVKPAI-YHRDIKATNILLDADMRARVADFGLAKQSREG-QSHLTTRVAGTHGYLAPEYALYG-------QLTEKSDVYS 513 (683)
Q Consensus 443 ~~~~~I-iHrDIKpsNILLd~~~~~KLaDFGla~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~-------~~s~ksDVwS 513 (683)
..+| .|+.++++|.++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||
T Consensus 66 --~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 66 --NSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS 143 (484)
T ss_pred --cCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence 4444 99999999999999999999999998776421 11111122235679999988753 2577899999
Q ss_pred cchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCC
Q 005691 514 FGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVA 593 (683)
Q Consensus 514 fGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~ 593 (683)
||++++||++.+.||+........ ..+..+ ++. .-...+.|.+... .+....++.++..||..+|+
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~----~~~-~~~~~~rP~i~~~--------~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDP-DEIILR----VKK-GGSNPFRPSIELL--------NELPPELLLLVARCWEEIPE 209 (484)
T ss_pred HHHHHHHHHhccCccccccccCCh-HHHHHH----HHh-cCCCCcCcchhhh--------hhcchHHHHHHHHhcccChh
Confidence 999999999999999875433221 112222 222 1122333443222 13344688999999999999
Q ss_pred CCCCHHHHHHHHhcC
Q 005691 594 LRPTISDALKMLEGD 608 (683)
Q Consensus 594 ~RPtm~eVl~~L~~~ 608 (683)
+||++.+|-..++..
T Consensus 210 ~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 210 KRPSIEQIRSKLLTI 224 (484)
T ss_pred hCccHHHHHhhhhhh
Confidence 999999999888754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=213.73 Aligned_cols=251 Identities=20% Similarity=0.234 Sum_probs=181.3
Q ss_pred cceeeeecCceEEEEEEEc-CCcEEEEEEeecc--CccCh----HHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 317 QKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES--DFQGD----AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~--~~~~~----~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
..+++|.|.+|.|+..... +....+.|..... ..... ..+..|+.+-..++|+|++..+..+. +...
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~------~~~~ 395 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ------EIDG 395 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh------hccc
Confidence 4678999999988777643 3444455443210 11111 12556777778899999988776654 3344
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.+-+|||+++ +|..++-. ...+.-..+-.++.|+..|+.||| ..+|.|||+|++|++++.++.+||.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~---------~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMS---------NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred chhhhhcccH-HHHHHHhc---------ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEe
Confidence 4455999999 99988821 236777888899999999999999 9999999999999999999999999
Q ss_pred ccCcccccccCC---ccccccccCCCcccCccccccCCCCc-cccEEEcchhHHHHhhCCCCCCCCCCCCCCc--cchhh
Q 005691 470 DFGLAKQSREGQ---SHLTTRVAGTHGYLAPEYALYGQLTE-KSDVYSFGVVILEIMCGRKALDLSTSGSPRA--CLITD 543 (683)
Q Consensus 470 DFGla~~~~~~~---~~~~~~~~GT~~Y~APE~~~~~~~s~-ksDVwSfGvlLlELltGr~p~~~~~~~~~~~--~~l~~ 543 (683)
|||.+..+.... .+....+.|+-+|+|||.+....|.+ ..||||.|+++..|++|+.|+......++.. ..-.+
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~ 542 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD 542 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc
Confidence 999998775332 25667789999999999999999986 5899999999999999999987654332210 00000
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
| . .+.. +.. .-......+...++..+++++|.+|-||.+|++.
T Consensus 543 ~---------~--~~~~---~~~----~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 543 Q---------R--NIFE---GPN----RLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred c---------c--cccc---ChH----HHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0 0 0000 000 0112344566778889999999999999999853
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-18 Score=170.36 Aligned_cols=188 Identities=14% Similarity=0.079 Sum_probs=140.1
Q ss_pred ccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccCh----HHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCee
Q 005691 316 SQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD----AEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~----~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.....|++|+||+||.+.- ++..++.+.+........ ..|.+|+++|++|. |+++.+++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD----------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----------CE
Confidence 3456899999999997665 577888777765443211 24789999999995 57888888752 36
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC-CCCceeeccCCcEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI-KATNILLDADMRARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI-KpsNILLd~~~~~KLa 469 (683)
+++|||+++.+|...+. . ....++.++.++|.|+| +.+|+|||| ||+|||++.++.++|+
T Consensus 74 ~lvmeyI~G~~L~~~~~----------~------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LI 134 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPP----------R------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVI 134 (218)
T ss_pred EEEEeeecCccHHhhhh----------h------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEE
Confidence 99999999988865430 0 11357789999999999 899999999 7999999999999999
Q ss_pred ccCcccccccCCcc------------ccccccCCCcccCcccccc-CCCC-ccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 470 DFGLAKQSREGQSH------------LTTRVAGTHGYLAPEYALY-GQLT-EKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 470 DFGla~~~~~~~~~------------~~~~~~GT~~Y~APE~~~~-~~~s-~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
|||+|......... .......++.|+.|+-..- ...+ ...+.++-|.-+|.++||+.+.-...+
T Consensus 135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 99999865432210 0112346788888885432 2333 567899999999999999988654443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.7e-18 Score=170.33 Aligned_cols=140 Identities=19% Similarity=0.211 Sum_probs=106.1
Q ss_pred ccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhc-----cCCCcccccceeeecCCCCCCCee
Q 005691 316 SQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-----KHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-----~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.....||+|+||.||. .++....+||++........+++.+|+.+++.+ .||||++++|++..+.. .+...
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g--~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG--TGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC--CeEEE
Confidence 4457899999999996 443333479988765555567899999999999 57999999999874321 12223
Q ss_pred EEEEee--cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHH-HHHhcccCCCccccCCCCCceeecc----C
Q 005691 391 YLVYDY--MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL-AYLHYGVKPAIYHRDIKATNILLDA----D 463 (683)
Q Consensus 391 ~LV~Ey--~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL-~yLH~~~~~~IiHrDIKpsNILLd~----~ 463 (683)
.+|+|| +++|+|.+++.. ..+++. ..++.++..++ +||| +.+|+||||||+|||++. +
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~----------~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ----------CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred EEEecCCCCcchhHHHHHHc----------ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCC
Confidence 478999 668999999921 124444 35678888888 9999 899999999999999974 3
Q ss_pred CcEEEcccCcc
Q 005691 464 MRARVADFGLA 474 (683)
Q Consensus 464 ~~~KLaDFGla 474 (683)
.+++|+||+.+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 48999995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=164.90 Aligned_cols=134 Identities=20% Similarity=0.305 Sum_probs=111.7
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccC--------hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--------DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+.||+|++|.||+|.. +|..|+||+........ ...+.+|++++..++|+|+.....++. .....
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~------~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV------DPENF 74 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE------eCCCC
Confidence 4799999999999988 57889999865433221 135788999999999999888777765 34567
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++.. ..+ .+..++.+++.+|.+|| +.+++|||++|.|||++ ++.++|+|
T Consensus 75 ~lv~e~~~G~~L~~~~~~------------~~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liD 137 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS------------NGM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLID 137 (211)
T ss_pred EEEEEEeCCcCHHHHHHh------------ccH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEE
Confidence 899999999999998821 112 78899999999999999 89999999999999999 78999999
Q ss_pred cCcccc
Q 005691 471 FGLAKQ 476 (683)
Q Consensus 471 FGla~~ 476 (683)
||+++.
T Consensus 138 f~~a~~ 143 (211)
T PRK14879 138 FGLAEF 143 (211)
T ss_pred CCcccC
Confidence 999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-17 Score=168.92 Aligned_cols=145 Identities=16% Similarity=0.131 Sum_probs=109.7
Q ss_pred cCcccceeeeecCceEEEEEE--EcCCcEEEEEEeeccCccC------------------------hHHHHHHHHHHHhc
Q 005691 313 DKFSQKNFIGRGGFGLVYKGI--LQDGTTVAVKKVIESDFQG------------------------DAEFCNEVEIISNL 366 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~--l~~g~~VAVK~l~~~~~~~------------------------~~~f~~Ev~iL~~L 366 (683)
.-|...+.||+|+||.||+|+ ..+|+.||||++....... ...+..|++++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357788899999999999998 5689999999987542110 02256899999999
Q ss_pred cCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC
Q 005691 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP 446 (683)
Q Consensus 367 ~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~ 446 (683)
.|..+ .....+. ....++||||+++++|...+.. ...+.......++.+++.+|+||| ..
T Consensus 108 ~~~~i-~~p~~~~-------~~~~~lV~E~~~g~~L~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH---~~ 167 (237)
T smart00090 108 YEAGV-PVPKPIA-------WRRNVLVMEFIGGDGLPAPRLK---------DVEPEEEEEFELYDDILEEMRKLY---KE 167 (237)
T ss_pred HhcCC-CCCeeeE-------ecCceEEEEEecCCcccccccc---------cCCcchHHHHHHHHHHHHHHHHHH---hc
Confidence 76432 2222221 1235899999999888776521 123445556789999999999999 88
Q ss_pred C-ccccCCCCCceeeccCCcEEEcccCcccccc
Q 005691 447 A-IYHRDIKATNILLDADMRARVADFGLAKQSR 478 (683)
Q Consensus 447 ~-IiHrDIKpsNILLd~~~~~KLaDFGla~~~~ 478 (683)
+ |+||||||+||+++ +++++|+|||++....
T Consensus 168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 8 99999999999999 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.3e-17 Score=161.93 Aligned_cols=146 Identities=18% Similarity=0.173 Sum_probs=112.8
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc----------------------ChHHHHHHHHHH
Q 005691 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ----------------------GDAEFCNEVEII 363 (683)
Q Consensus 306 ~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ev~iL 363 (683)
.++.+....|...+.||+|+||.||++...+|+.||||++...... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444544457778899999999999999888999999987543210 011367789999
Q ss_pred HhccCCCc--ccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHh
Q 005691 364 SNLKHRNL--VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLH 441 (683)
Q Consensus 364 ~~L~H~NL--V~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH 441 (683)
..+.|+++ ...++ ....++||||+++++|.+... -.....++.+++.++.++|
T Consensus 88 ~~l~~~~i~v~~~~~----------~~~~~lv~e~~~g~~L~~~~~---------------~~~~~~~~~~i~~~l~~lh 142 (198)
T cd05144 88 KALYEEGFPVPKPID----------WNRHAVVMEYIDGVELYRVRV---------------LEDPEEVLDEILEEIVKAY 142 (198)
T ss_pred HHHHHcCCCCCceee----------cCCceEEEEEeCCcchhhccc---------------cccHHHHHHHHHHHHHHHH
Confidence 99988753 33322 234589999999999876541 0234678999999999999
Q ss_pred cccCCCccccCCCCCceeeccCCcEEEcccCccccccc
Q 005691 442 YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479 (683)
Q Consensus 442 ~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~ 479 (683)
+.+|+||||||+||++++++.++|+|||++.....
T Consensus 143 ---~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 143 ---KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ---HCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 79999999999999999999999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.6e-17 Score=171.52 Aligned_cols=200 Identities=21% Similarity=0.326 Sum_probs=162.6
Q ss_pred cCcccceeeeecCceEEEEEE-EcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
-+|...++||+|.||..+.|+ +-+++.||||. +.......++..|.+..+.|. -++|-..+-|-. ++..-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf--EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGq------eG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF--EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ------EGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEe--ccccCCcchHHHHHHHHHHHcCCCCCCceeeecc------ccchh
Confidence 478889999999999999998 45799999995 333334556888888888884 566666554432 56777
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC-----Cc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-----MR 465 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-----~~ 465 (683)
.||+|.+ +-||+|... ...+.++..+...||.|+..-++|+| ...+|.|||||+|.||... ..
T Consensus 100 iLVidLL-GPSLEDLFD--------~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFD--------LCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhhh-CcCHHHHHH--------HhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCce
Confidence 8999988 778888762 23567899999999999999999999 8999999999999999643 35
Q ss_pred EEEcccCcccccccCCccc------cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 466 ARVADFGLAKQSREGQSHL------TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~------~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
+.|.|||||+...+..+.. .....||-.||+--...+..-+.+-|.-|+|-+++..+-|..|+....
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 8999999999887654432 234579999999999999999999999999999999999999997543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=4e-17 Score=187.02 Aligned_cols=146 Identities=22% Similarity=0.316 Sum_probs=114.9
Q ss_pred ehHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc--------ChHHHHHHHHHHHhccCCCccccc
Q 005691 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ--------GDAEFCNEVEIISNLKHRNLVPLR 375 (683)
Q Consensus 304 ~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~--------~~~~f~~Ev~iL~~L~H~NLV~L~ 375 (683)
++...+.....|...++||+|+||+||+|.+.+. .+++|+....... ..+.+.+|++++.+++|+|++...
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3344444455667788999999999999998644 4455543221111 124588999999999999998887
Q ss_pred ceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCC
Q 005691 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455 (683)
Q Consensus 376 G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKp 455 (683)
.++. .....++||||+++++|.+++. .+..++.+++++|.||| +.+|+||||||
T Consensus 403 ~~~~------~~~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp 456 (535)
T PRK09605 403 IYDV------DPEEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLH---KAGIVHGDLTT 456 (535)
T ss_pred EEEE------eCCCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHH---hCCCccCCCCh
Confidence 7765 3345789999999999998871 35679999999999999 89999999999
Q ss_pred CceeeccCCcEEEcccCccccc
Q 005691 456 TNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 456 sNILLd~~~~~KLaDFGla~~~ 477 (683)
+|||+ +++.++|+|||+++..
T Consensus 457 ~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 457 SNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred HHEEE-ECCcEEEEeCcccccC
Confidence 99999 6789999999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.4e-17 Score=161.27 Aligned_cols=202 Identities=24% Similarity=0.332 Sum_probs=161.6
Q ss_pred hcCcccceeeeecCceEEEEEE-EcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCC-CcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHR-NLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~-NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...++||.|+||.+|.|. ..+|.+||||.=.. .....++.-|..+.+.|+|- .|..+..|.. +...
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~------e~~y 85 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGT------EKDY 85 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhcc------cccc
Confidence 4678899999999999999998 56899999996433 33445678899999999764 4444554443 5667
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC---CcE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD---MRA 466 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~---~~~ 466 (683)
-.||||.+ +-||++.+.- -.+.++..+.+-++-|+..-++|+| ..++|||||||+|.|..-+ ..+
T Consensus 86 nvlVMdLL-GPsLEdLfnf--------C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNF--------CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred ceeeeecc-CccHHHHHHH--------HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceE
Confidence 78999998 7788887722 2356888899999999999999999 8999999999999999644 468
Q ss_pred EEcccCcccccccCCc--cc----cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 467 RVADFGLAKQSREGQS--HL----TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 467 KLaDFGla~~~~~~~~--~~----~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
.+.|||+|+.+.+..+ |. .....||..|.+--...+..-+.+.|+-|+|.+|...--|+.|++....
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 9999999998765432 22 2346799999888777777778899999999999999999999976543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.3e-18 Score=175.87 Aligned_cols=243 Identities=22% Similarity=0.350 Sum_probs=149.7
Q ss_pred cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCc---cChHHHHHHHHHHHhccC-----------CCcccccce
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDF---QGDAEFCNEVEIISNLKH-----------RNLVPLRGC 377 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H-----------~NLV~L~G~ 377 (683)
..+.....||.|+++.||.++..+ |+++|||.+..... ...+++++|.-.+..+.+ +-++++ ..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~ 90 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DL 90 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EE
Confidence 345567899999999999999874 89999999865432 224567777665555433 122222 11
Q ss_pred eeecCCC-----CCCC------eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC
Q 005691 378 CVVDGDN-----ERGS------ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP 446 (683)
Q Consensus 378 c~~~~~~-----~~~~------~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~ 446 (683)
....... ..+. ..+++|+-+ -++|.+++..-.... .....+....|+.+..|+.+.+++|| ..
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~--~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~ 164 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA--QTHSPLAFAARLSLTVQMIRLVANLH---SY 164 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc--cccchhHHHHHHHHHHHHHHHHHHHh---hc
Confidence 1111000 0011 235677766 567777642100000 01234666778888899999999999 89
Q ss_pred CccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc--------CCCCccccEEEcchhH
Q 005691 447 AIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY--------GQLTEKSDVYSFGVVI 518 (683)
Q Consensus 447 ~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~s~ksDVwSfGvlL 518 (683)
+++|+||||+|++++.+|.++|+||+.......... . ...+..|.+||.... -.++.+.|.|++|+++
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE--G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCceee--c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999999999987654332111 1 234578999997754 2478899999999999
Q ss_pred HHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCC
Q 005691 519 LEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR 595 (683)
Q Consensus 519 lELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~R 595 (683)
|.|++|+.||+...+... .+| .+.. .. +..+.+..++...++.||++|
T Consensus 241 y~lWC~~lPf~~~~~~~~-----~~~----------------~f~~------C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEAD-----PEW----------------DFSR------CR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGST-----SGG----------------GGTT------SS-----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCcccc-----ccc----------------cchh------cC--CcCHHHHHHHHHHccCCcccC
Confidence 999999999986543221 122 1111 11 445667788889999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.2e-17 Score=159.61 Aligned_cols=131 Identities=21% Similarity=0.389 Sum_probs=105.8
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEeeccCccC--------hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 320 FIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--------DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.||+|+||.||+|.+ +|..|++|+........ .+++.+|++++..++|+++.....++. .....+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~------~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV------DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE------ECCCCE
Confidence 489999999999996 47889999865433211 245778999999999988766555554 234568
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++++|.+++... .. .++.+++.+|.+|| +.+++|||+||.||+++ ++.+++.||
T Consensus 74 lv~e~~~g~~l~~~~~~~---------~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDf 133 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG---------ND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDF 133 (199)
T ss_pred EEEEEECCccHHHHHhhc---------HH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEEC
Confidence 999999999999887211 00 78999999999999 89999999999999999 899999999
Q ss_pred Cccccc
Q 005691 472 GLAKQS 477 (683)
Q Consensus 472 Gla~~~ 477 (683)
|+++..
T Consensus 134 g~a~~~ 139 (199)
T TIGR03724 134 GLGKYS 139 (199)
T ss_pred CCCcCC
Confidence 998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.9e-18 Score=187.20 Aligned_cols=185 Identities=25% Similarity=0.346 Sum_probs=151.8
Q ss_pred eeecCceEEEEEE----EcCCcEEEEEEeeccCccC--hHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCeeEEE
Q 005691 321 IGRGGFGLVYKGI----LQDGTTVAVKKVIESDFQG--DAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 321 LG~GgfG~Vykg~----l~~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
+|+|.||.|+... .+.|..+|.|.+.+..... ......|..++..++ |+.+|++.-.+. .....+++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq------t~~kl~l~ 75 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ------TDGKLYLI 75 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec------cccchhHh
Confidence 7899999998654 3346778888776543221 124667888999997 999999986665 56789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
.+|..+|.|...+.. ....+..........++-++.++| +.+|+|||+|++||++|.+|.+|+.|||+
T Consensus 76 ld~~rgg~lft~l~~---------~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfgl 143 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSK---------EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGL 143 (612)
T ss_pred hhhcccchhhhcccc---------CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchh
Confidence 999999999988843 345666666777888999999999 99999999999999999999999999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
.+..-+.... +||..|||||++. .....+|.||||++++|++||-.||..
T Consensus 144 ske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 144 SKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9876544332 8999999999998 567899999999999999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=185.09 Aligned_cols=198 Identities=22% Similarity=0.273 Sum_probs=156.3
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc---CCCcccccceeeecCC
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK---HRNLVPLRGCCVVDGD 383 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~~~~~ 383 (683)
+.+...+.|.+.+.||+|+||.||+|...+|+.||+|.=+..... +|.-=.+++.+|+ -+-+..+...++
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~---- 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHV---- 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHc----
Confidence 445556789999999999999999999988999999986655433 2333334445554 112333333332
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec--
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD-- 461 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd-- 461 (683)
..+.-+||+||.+.|+|.+++. ..+.++|...+-|+.++++-++.|| ..+|||+||||+|.||.
T Consensus 765 --~~~~S~lv~ey~~~Gtlld~~N---------~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 765 --FQNASVLVSEYSPYGTLLDLIN---------TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRRE 830 (974)
T ss_pred --cCCcceeeeeccccccHHHhhc---------cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecc
Confidence 3456799999999999999993 3468999999999999999999999 89999999999999993
Q ss_pred -----cCCcEEEcccCccccc---ccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCC
Q 005691 462 -----ADMRARVADFGLAKQS---REGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527 (683)
Q Consensus 462 -----~~~~~KLaDFGla~~~---~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p 527 (683)
++..++|+|||-+--. .++ ..-..+.+|-++--+|...+..++..+|-|.+..+++-|+.|+..
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 2346899999987533 332 234457889999999999999999999999999999999999864
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.6e-17 Score=188.38 Aligned_cols=249 Identities=27% Similarity=0.313 Sum_probs=176.8
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccC-ccChHHHHHHHHHH--HhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESD-FQGDAEFCNEVEII--SNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL--~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++...+.||.+.|=.|.+++.++|. |+||.+.+.. ....+.|.++++-+ ..++|||.+++.-+-. ...-.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~------t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV------TDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH------hhHHH
Confidence 5666778999999999999999887 9999987655 33355566555444 4558999999876543 34456
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
|||-+|..+ +|.|.|. .++-|...+.+-|+.|+..||.-+| +.+|.|+|||.+||||+.-.=+.|+|
T Consensus 97 ylvRqyvkh-nLyDRlS---------TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtD 163 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLS---------TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTD 163 (1431)
T ss_pred HHHHHHHhh-hhhhhhc---------cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhc
Confidence 788888855 7777772 2456778888899999999999999 99999999999999999877789999
Q ss_pred cCccccc--ccCCccccc----cccCCCcccCcccccc-----------CCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 471 FGLAKQS--REGQSHLTT----RVAGTHGYLAPEYALY-----------GQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 471 FGla~~~--~~~~~~~~~----~~~GT~~Y~APE~~~~-----------~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|..-|.. +++.....+ .-..-..|+|||-+.. ...+++.||||.||++.||++ |+++|....
T Consensus 164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ 243 (1431)
T KOG1240|consen 164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ 243 (1431)
T ss_pred ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence 9876542 232221111 1122346999997653 126789999999999999988 577775321
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCcc--ccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPS--LLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~--l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
++ .++.|. ..|+. |.+- + ...+.++++.++|.||++|-++.+.++.-+|.
T Consensus 244 -------L~------aYr~~~---~~~~e~~Le~I------e----d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 244 -------LL------AYRSGN---ADDPEQLLEKI------E----DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -------HH------hHhccC---ccCHHHHHHhC------c----CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11 122221 11111 1111 0 11456788999999999999999999986553
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=147.81 Aligned_cols=137 Identities=19% Similarity=0.213 Sum_probs=97.7
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC--hHHH----------------------HHHHHHHHhccCCC--c
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--DAEF----------------------CNEVEIISNLKHRN--L 371 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~f----------------------~~Ev~iL~~L~H~N--L 371 (683)
.+.||+|+||+||+|...+|+.||||++....... ...+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999998889999999886532211 1111 24555555554433 2
Q ss_pred ccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccc
Q 005691 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYH 450 (683)
Q Consensus 372 V~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiH 450 (683)
.+.+++ ...++||||++++.+........ ... ....+++.+++.++.++| . .+|+|
T Consensus 82 ~~~~~~----------~~~~lv~e~~~g~~~~~~~l~~~---------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH 138 (187)
T cd05119 82 PKPIDL----------NRHVLVMEFIGGDGIPAPRLKDV---------RLL-EDPEELYDQILELMRKLY---REAGLVH 138 (187)
T ss_pred CceEec----------CCCEEEEEEeCCCCccChhhhhh---------hhc-ccHHHHHHHHHHHHHHHh---hccCcCc
Confidence 222221 24689999999976543221110 011 567889999999999999 6 89999
Q ss_pred cCCCCCceeeccCCcEEEcccCcccccc
Q 005691 451 RDIKATNILLDADMRARVADFGLAKQSR 478 (683)
Q Consensus 451 rDIKpsNILLd~~~~~KLaDFGla~~~~ 478 (683)
|||||+||+++ ++.++|+|||.+....
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-15 Score=138.02 Aligned_cols=135 Identities=20% Similarity=0.197 Sum_probs=111.1
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccC--CCcccccceeeecCCCCCCCeeEEEEe
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH--RNLVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H--~NLV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++.. ..+..++++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~------~~~~~~~v~e 73 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE------SDGWSYLLME 73 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC------CCCccEEEEE
Confidence 4679999999999999864 7899998755433 4679999999999987 48888877664 3467899999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
|++++.+..+ ++..+..++.+++++|++||.....+++|+|+||+||+++.++.+++.|||.++
T Consensus 74 ~~~g~~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 74 WIEGETLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecCCeecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 9988776542 455677899999999999995444689999999999999999999999999987
Q ss_pred cc
Q 005691 476 QS 477 (683)
Q Consensus 476 ~~ 477 (683)
..
T Consensus 138 ~~ 139 (155)
T cd05120 138 YG 139 (155)
T ss_pred CC
Confidence 54
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-16 Score=174.67 Aligned_cols=123 Identities=24% Similarity=0.439 Sum_probs=106.8
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++.|+++...+|.+||.... .....+|...+.++.+++.|+.| ++.+|||+||.||+...+..+||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~------~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR------TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC------cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhh
Confidence 5789999999999999995332 23467888899999999999999 68999999999999999999999
Q ss_pred cccCcccccccCC-----ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh
Q 005691 469 ADFGLAKQSREGQ-----SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC 523 (683)
Q Consensus 469 aDFGla~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt 523 (683)
+|||+........ ....+.-.||..||+||.+.+.+|+.|+|||++|++|+|+++
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9999987665443 223456789999999999999999999999999999999987
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.1e-14 Score=147.88 Aligned_cols=140 Identities=19% Similarity=0.234 Sum_probs=106.3
Q ss_pred ceeee-ecCceEEEEEEEcCCcEEEEEEeeccCc-------------cChHHHHHHHHHHHhccCCCc--ccccceeeec
Q 005691 318 KNFIG-RGGFGLVYKGILQDGTTVAVKKVIESDF-------------QGDAEFCNEVEIISNLKHRNL--VPLRGCCVVD 381 (683)
Q Consensus 318 ~~~LG-~GgfG~Vykg~l~~g~~VAVK~l~~~~~-------------~~~~~f~~Ev~iL~~L~H~NL--V~L~G~c~~~ 381 (683)
..+|| .||.|+||+.... +..++||++..... .....+.+|++++.+|+|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999886 77899998854221 123457889999999999885 6667765432
Q ss_pred CCCCCCCeeEEEEeecCC-CCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 382 GDNERGSERYLVYDYMPN-GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.. .....++|+||+++ .+|.+++.. ..++. ..+.+++.+|.+|| +.+|+||||||.|||+
T Consensus 115 ~~--~~~~~~lV~e~l~G~~~L~~~l~~----------~~l~~----~~~~~i~~~l~~lH---~~GI~HrDlkp~NILv 175 (239)
T PRK01723 115 HG--LFYRADILIERIEGARDLVALLQE----------APLSE----EQWQAIGQLIARFH---DAGVYHADLNAHNILL 175 (239)
T ss_pred cC--cceeeeEEEEecCCCCCHHHHHhc----------CCCCH----HHHHHHHHHHHHHH---HCCCCCCCCCchhEEE
Confidence 11 11234699999997 688887721 12332 34678999999999 8999999999999999
Q ss_pred ccCCcEEEcccCccccc
Q 005691 461 DADMRARVADFGLAKQS 477 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~ 477 (683)
+.++.++|+|||.++..
T Consensus 176 ~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 176 DPDGKFWLIDFDRGELR 192 (239)
T ss_pred cCCCCEEEEECCCcccC
Confidence 99999999999988753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.6e-14 Score=148.90 Aligned_cols=202 Identities=23% Similarity=0.293 Sum_probs=134.1
Q ss_pred cCCCcccccceeeecC---------------------CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccc
Q 005691 367 KHRNLVPLRGCCVVDG---------------------DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425 (683)
Q Consensus 367 ~H~NLV~L~G~c~~~~---------------------~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~ 425 (683)
+|||||++.++++..- ..+++...||||.-.+. +|.++|-. +..+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----------~~~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----------RHRSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----------CCCchHH
Confidence 5999999998876321 12456678888876644 78888832 2455566
Q ss_pred hhhhHHHHHHHHHHHhcccCCCccccCCCCCceee--ccCC--cEEEcccCcccccccCCcc---c--cccccCCCcccC
Q 005691 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL--DADM--RARVADFGLAKQSREGQSH---L--TTRVAGTHGYLA 496 (683)
Q Consensus 426 r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL--d~~~--~~KLaDFGla~~~~~~~~~---~--~~~~~GT~~Y~A 496 (683)
+.-|+.|+.+|+.||| +.+|.|||+|+.|||| |+|. ...|+|||.+--.+...-. . .-...|.-.-||
T Consensus 343 ~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 6778999999999999 9999999999999999 4444 4689999976432211100 0 111346677899
Q ss_pred cccccc--CCC----CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccC
Q 005691 497 PEYALY--GQL----TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLS 570 (683)
Q Consensus 497 PE~~~~--~~~----s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~ 570 (683)
||+... |+. -.|+|.|+.|.+.|||+..+.||..... ..+.. +.+++..+ |.+.+
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-----m~L~~---r~Yqe~qL-----Palp~------ 480 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-----MLLDT---RTYQESQL-----PALPS------ 480 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-----heech---hhhhhhhC-----CCCcc------
Confidence 998763 222 3599999999999999999999864111 11110 01222222 22222
Q ss_pred CChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 571 LNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 571 ~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.+...+.+++..-++.||.+||+..-....|
T Consensus 481 ----~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 481 ----RVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ----cCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 2223445677778899999999865544443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.8e-14 Score=165.64 Aligned_cols=166 Identities=27% Similarity=0.490 Sum_probs=118.1
Q ss_pred cCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+|+..++|..|+||.||..++++ .+.+|.| +.+.. . |+ +||..+- +..+
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----l------il-----Rnilt~a------------~npf 133 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----L------IL-----RNILTFA------------GNPF 133 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----h------hh-----hcccccc------------CCcc
Confidence 578889999999999999998764 5667773 32211 0 11 1122211 1122
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
.| |+-...+.. -++++ .+++.+++||| +.+|+|||+||+|.||..-|.+|+.||
T Consensus 134 vv------gDc~tllk~---------~g~lP--------vdmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDf 187 (1205)
T KOG0606|consen 134 VV------GDCATLLKN---------IGPLP--------VDMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDF 187 (1205)
T ss_pred ee------chhhhhccc---------CCCCc--------chhhHHhHhhc---cCCeecCCCCCCcceeeecccccccch
Confidence 22 222222211 11222 12378999999 999999999999999999999999999
Q ss_pred CcccccccC------------Cc--cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 472 GLAKQSREG------------QS--HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 472 Gla~~~~~~------------~~--~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
|+.+..-.. .+ .....++||+.|.|||++....|...+|.|++|+++||.+-|.-||...++
T Consensus 188 gLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred hhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 998753211 11 123457999999999999999999999999999999999999999986654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-13 Score=151.77 Aligned_cols=146 Identities=23% Similarity=0.241 Sum_probs=103.6
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccCh----------------------------------------
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD---------------------------------------- 353 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~---------------------------------------- 353 (683)
.|+ .+.||.|++|.||+|++.+|+.||||+.+.......
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 444 367999999999999999999999999855321100
Q ss_pred HHHHHHHHHHHhcc----CCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhh
Q 005691 354 AEFCNEVEIISNLK----HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429 (683)
Q Consensus 354 ~~f~~Ev~iL~~L~----H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~I 429 (683)
-+|.+|.+.+.+++ |.+-|.+-.++.. .....+|||||++|++|.++..... ... .+.++
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~-----~~~~~vLvmE~i~G~~L~~~~~~~~--------~~~---~~~~i 261 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWD-----RTSERVLTMEWIDGIPLSDIAALDE--------AGL---DRKAL 261 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehh-----hcCCceEEEEeECCcccccHHHHHh--------cCC---CHHHH
Confidence 02445555555542 3333444333321 2345799999999999998762110 111 35667
Q ss_pred HHHHHH-HHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccccc
Q 005691 430 ILDVAK-GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479 (683)
Q Consensus 430 a~~iA~-gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~ 479 (683)
+..+++ .+..+| ..+++|+|+||.||++++++++++.|||++....+
T Consensus 262 a~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 262 AENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 777776 467888 78999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-14 Score=161.52 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=178.9
Q ss_pred cccceeeeecCceEEEEEEEcC--CcEEEEEEeeccC--ccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCe
Q 005691 315 FSQKNFIGRGGFGLVYKGILQD--GTTVAVKKVIESD--FQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~--g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
|....-||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++... ....
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~------~~~~ 95 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS------SPRS 95 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC------CCcc
Confidence 4444559999999998877643 3456666665443 111223445777777776 999999998875 5677
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cEEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARV 468 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~KL 468 (683)
.+++.||..+|++.+.+... .....+-...-..+.++..++.|+|. ..++.||||||+|.+++..+ ..|+
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~-------~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~ 166 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHP-------DSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKI 166 (601)
T ss_pred cccccCcccccccccccccC-------CccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccC
Confidence 89999999999999888311 11134555666788999999999994 56899999999999999999 9999
Q ss_pred cccCccccccc--CCccccccccC-CCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 469 ADFGLAKQSRE--GQSHLTTRVAG-THGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 469 aDFGla~~~~~--~~~~~~~~~~G-T~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
+|||+|..+.. +.........| ++.|+|||..... ...+..|+||.|+++.-+++|..|.+....... ....|
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~ 243 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSW 243 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceee
Confidence 99999988765 33333445678 9999999998874 557789999999999999999999876544321 12222
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
.... +.... ............+...++..+|..|.+.+++.
T Consensus 244 ~~~~---~~~~~--------------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 244 KSNK---GRFTQ--------------LPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccc---ccccc--------------CccccCChhhhhcccccccCCchhcccccccc
Confidence 2110 11000 01112233445555667778999999887764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.7e-11 Score=118.18 Aligned_cols=128 Identities=18% Similarity=0.088 Sum_probs=95.6
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecC
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMP 398 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~ 398 (683)
+.|+.|.++.||++... +..+++|....... ....+.+|+.++..+.+.++++-+-.+. ....++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEecC
Confidence 46889999999999876 78899998654321 2334688999999997766654332221 223589999999
Q ss_pred CCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC-----ccccCCCCCceeeccCCcEEEcccCc
Q 005691 399 NGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA-----IYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 399 ~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~-----IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
+.++.+.. .....+..+++++|+.|| ..+ ++|+|++|.||+++ ++.+++.|||.
T Consensus 75 G~~l~~~~-----------------~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 75 GSELLTED-----------------FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred CCcccccc-----------------ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 98775421 112346789999999999 555 59999999999999 66899999998
Q ss_pred ccc
Q 005691 474 AKQ 476 (683)
Q Consensus 474 a~~ 476 (683)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-12 Score=132.61 Aligned_cols=161 Identities=20% Similarity=0.313 Sum_probs=121.8
Q ss_pred HHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHH
Q 005691 360 VEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439 (683)
Q Consensus 360 v~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~y 439 (683)
..-|-.+.|-|||+++.|+.. ...++..+..++.|||.-|+|..+|.... ...+.+....-.+++-||..||.|
T Consensus 118 FdnllqlvHsnlvkfH~yw~d-~K~~e~~rviFiteymssgs~~~fLkrt~-----~~~~a~~~~~wkkw~tqIlsal~y 191 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTD-KKYEEKPRVIFITEYMSSGSLKQFLKRTK-----KNQKALFQKAWKKWCTQILSALSY 191 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcc-cccccccceEEEEecccchhHHHHHHHHH-----HhhhhhhHHHHHHHHHHHHhhhhh
Confidence 344666789999999998753 33335667889999999999999995543 223456667777899999999999
Q ss_pred HhcccCCCccccCCCCCceeeccCCcEEEcccCcc--ccc-ccCCccccccccCCCcccCccccccCCCCccccEEEcch
Q 005691 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLA--KQS-REGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGV 516 (683)
Q Consensus 440 LH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla--~~~-~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGv 516 (683)
|| .+.++|+|+++..+-|++..++-+||+----. ... ............|-++|.+||+-...+.+..+|||+||+
T Consensus 192 Lh-s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 192 LH-SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM 270 (458)
T ss_pred hh-ccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence 99 45899999999999999999998887632111 000 000111122345678999999998888999999999999
Q ss_pred hHHHHhhCCCC
Q 005691 517 VILEIMCGRKA 527 (683)
Q Consensus 517 lLlELltGr~p 527 (683)
..+|+..|..-
T Consensus 271 cAlemailEiq 281 (458)
T KOG1266|consen 271 CALEMAILEIQ 281 (458)
T ss_pred HHHHHHHheec
Confidence 99999888754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.3e-11 Score=134.64 Aligned_cols=148 Identities=19% Similarity=0.209 Sum_probs=96.1
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccC----------------------------------hH--
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQG----------------------------------DA-- 354 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~----------------------------------~~-- 354 (683)
-..|+. +.||.|++|.||+|++++ |+.||||.++....+. .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446776 689999999999999987 9999999987542110 01
Q ss_pred ----HHHHHHHHHHhcc----CCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccch
Q 005691 355 ----EFCNEVEIISNLK----HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426 (683)
Q Consensus 355 ----~f~~Ev~iL~~L~----H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r 426 (683)
+|.+|...+.+++ +.+.+.+-.++. +...+.+|||||++|+.+.++-.-. .... .+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~-----d~st~~VLvmE~i~G~~l~d~~~l~--------~~g~---d~ 261 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYW-----DYCSETVMVMERMYGIPVSDVAALR--------AAGT---DM 261 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeec-----ccCCCceEEEeeecCccHHhHHHHH--------hcCC---CH
Confidence 1344444444442 333343333332 1245689999999999997742100 0111 12
Q ss_pred hhhHHHHHHH-HHHHhcccCCCccccCCCCCceeeccCC----cEEEcccCccccccc
Q 005691 427 KNIILDVAKG-LAYLHYGVKPAIYHRDIKATNILLDADM----RARVADFGLAKQSRE 479 (683)
Q Consensus 427 ~~Ia~~iA~g-L~yLH~~~~~~IiHrDIKpsNILLd~~~----~~KLaDFGla~~~~~ 479 (683)
..++...++. +.-++ ..+++|+|+||.||+++.++ ++++.|||++....+
T Consensus 262 ~~la~~~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 262 KLLAERGVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344333332 22334 67999999999999999988 999999999876644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-10 Score=130.46 Aligned_cols=246 Identities=22% Similarity=0.209 Sum_probs=170.4
Q ss_pred Ccccceeeee--cCceEEEEEEE---cCCcEEEEEEeeccCc--cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCC
Q 005691 314 KFSQKNFIGR--GGFGLVYKGIL---QDGTTVAVKKVIESDF--QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 314 ~f~~~~~LG~--GgfG~Vykg~l---~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~ 385 (683)
.|.....+|. |.+|.||++.. .++..+|+|+-+.... +....=.+|+....++ .|+|.|+..-.+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e------ 188 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE------ 188 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc------
Confidence 4556678999 99999999987 3688899998433322 2223334577777777 4999999655553
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHH----HHHHHhcccCCCccccCCCCCceeec
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK----GLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~----gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.++..++-.|++. .+|..+.+... ..++....+.+..+... ||.++| ...++|-|+||.||++.
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~--------~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPC--------NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTT 256 (524)
T ss_pred cCCcceeeecccc-chhHHhhhccc--------ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecc
Confidence 5566777777764 67777764322 23555556666666666 999999 99999999999999999
Q ss_pred cC-CcEEEcccCcccccccCCcc----ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 462 AD-MRARVADFGLAKQSREGQSH----LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 462 ~~-~~~KLaDFGla~~~~~~~~~----~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
.+ ...++.|||+...+.++.-. ...+..|...|++||.. .+-++.+.|+|++|.+.+|..+|.......
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g----- 330 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG----- 330 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC-----
Confidence 99 88999999999887665422 22344677889999965 467789999999999999999998765421
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
....| ...+.+-+. +....+. ..++..+..++++++|-.|++...+.
T Consensus 331 ---~~~~W--~~~r~~~ip---~e~~~~~-----------s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 331 ---KNSSW--SQLRQGYIP---LEFCEGG-----------SSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred ---CCCCc--cccccccCc---hhhhcCc-----------chhhhhHHHHhcCcchhhhhHHHHHh
Confidence 11123 222222211 1111111 11233377889999999999877664
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=6e-10 Score=111.63 Aligned_cols=145 Identities=18% Similarity=0.267 Sum_probs=108.6
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCC--cccccceeeecCCCCCCCeeEEEEe
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRN--LVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~N--LV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++.+ +.+++++..... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~---~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS---VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC---ccCCceEEEE
Confidence 46899999999999988778999998754332 23456899999999997644 456666653110 1135689999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcc--------------------------------
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYG-------------------------------- 443 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~-------------------------------- 443 (683)
|+++.++.+.+. ...++..++..++.+++++|.+||+-
T Consensus 81 ~i~G~~l~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 81 RVDGRVLRDRLL----------RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred EeCCEecCCCCC----------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 999998887652 12466677778888888888888842
Q ss_pred ---------------------cCCCccccCCCCCceeecc--CCcEEEcccCcccc
Q 005691 444 ---------------------VKPAIYHRDIKATNILLDA--DMRARVADFGLAKQ 476 (683)
Q Consensus 444 ---------------------~~~~IiHrDIKpsNILLd~--~~~~KLaDFGla~~ 476 (683)
....++|+|+++.||++++ ++.+.|.||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.3e-10 Score=127.67 Aligned_cols=250 Identities=17% Similarity=0.169 Sum_probs=174.2
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc--CCcEEEEEEeeccCccChHH--HHHHHHHHHhc-cCCCcccccceeeecC
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ--DGTTVAVKKVIESDFQGDAE--FCNEVEIISNL-KHRNLVPLRGCCVVDG 382 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~--~g~~VAVK~l~~~~~~~~~~--f~~Ev~iL~~L-~H~NLV~L~G~c~~~~ 382 (683)
....+.+|.....||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.+.++..--+.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--- 336 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--- 336 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc---
Confidence 4456778999999999999999998754 57789999887755443322 34566666666 5777777544433
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
...+.++=-||++++++...+. -...++...++++..+++.++.++| ++.++|+|+||+||++..
T Consensus 337 ---~~r~~~ip~e~~~~~s~~l~~~---------~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 337 ---QLRQGYIPLEFCEGGSSSLRSV---------TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISN 401 (524)
T ss_pred ---ccccccCchhhhcCcchhhhhH---------HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeecc
Confidence 3456778899999999877661 2346788889999999999999999 999999999999999988
Q ss_pred C-CcEEEcccCcccccccCCccccccccCCCccc--CccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 463 D-MRARVADFGLAKQSREGQSHLTTRVAGTHGYL--APEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 463 ~-~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~--APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
+ +.-+++|||.+..+.-.. ....++-+++ +|+......+-.+.|+||||.-+.|.++|..-...
T Consensus 402 ~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------- 468 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------- 468 (524)
T ss_pred chhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc---------
Confidence 6 788999999986422111 1111223344 55555567788999999999999999999864321
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.++|. .++.|.+ +.+.+ . .+.+..++.-...+++..||...+...+.+-
T Consensus 469 -~~~~~--~i~~~~~-----p~~~~----------~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 469 -GVQSL--TIRSGDT-----PNLPG----------L-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -cccce--eeecccc-----cCCCc----------h-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11221 1223322 11111 1 1334455566778999999998887766553
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.8e-09 Score=105.42 Aligned_cols=136 Identities=16% Similarity=0.166 Sum_probs=94.4
Q ss_pred eeeeecCceEEEEEEEcC-------CcEEEEEEeeccC--ccC--------------------hHHH----HHHHHHHHh
Q 005691 319 NFIGRGGFGLVYKGILQD-------GTTVAVKKVIESD--FQG--------------------DAEF----CNEVEIISN 365 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~-------g~~VAVK~l~~~~--~~~--------------------~~~f----~~Ev~iL~~ 365 (683)
..||.|--+.||.|.-.+ +..+|||..+... .++ .+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4799999874321 110 1122 278888988
Q ss_pred ccCC--CcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHH-hc
Q 005691 366 LKHR--NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL-HY 442 (683)
Q Consensus 366 L~H~--NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yL-H~ 442 (683)
+... ++-..+++ ...+|||||+.++.+..... +...++..+...+..++..+|.+| |
T Consensus 83 l~~~Gv~vP~pi~~----------~~~~lvME~Ig~~~~~~~~L---------kd~~~~~~~~~~i~~~i~~~l~~l~H- 142 (197)
T cd05146 83 MQKAGIPCPEVVVL----------KKHVLVMSFIGDDQVPAPKL---------KDAKLNDEEMKNAYYQVLSMMKQLYK- 142 (197)
T ss_pred HHHcCCCCCeEEEe----------cCCEEEEEEcCCCCccchhh---------hccccCHHHHHHHHHHHHHHHHHHHH-
Confidence 8543 44444432 24689999997754432110 111233345567789999999999 7
Q ss_pred ccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 443 GVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 443 ~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
+.+|||+||++.|||++ ++.++|+|||.+-..
T Consensus 143 --~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 143 --ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred --hCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 78999999999999997 467999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-08 Score=99.42 Aligned_cols=132 Identities=23% Similarity=0.348 Sum_probs=97.5
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEeeccCccC--------hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 320 FIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--------DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+++|+-..+|.+.+. |..+.+|.=..+.... .+.-.+|..+|.+++--.+---.-|.. +.....
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv------D~~~~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV------DPDNGL 75 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE------cCCCCE
Confidence 5789999999999775 4456666433322221 124678999999886443332222322 456678
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
++|||+++-.|.+.+. ..+..++..+-+-+.-|| ..+|+|+||.++||++..+. +.+.||
T Consensus 76 I~me~I~G~~lkd~l~----------------~~~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 76 IVMEYIEGELLKDALE----------------EARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred EEEEEeCChhHHHHHH----------------hcchHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEEC
Confidence 9999999999988882 114678889999999999 99999999999999998765 999999
Q ss_pred Ccccccc
Q 005691 472 GLAKQSR 478 (683)
Q Consensus 472 Gla~~~~ 478 (683)
||++...
T Consensus 136 GLg~~s~ 142 (204)
T COG3642 136 GLGEFSD 142 (204)
T ss_pred Ccccccc
Confidence 9987543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.5e-09 Score=116.87 Aligned_cols=166 Identities=15% Similarity=0.171 Sum_probs=118.4
Q ss_pred EcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCC
Q 005691 334 LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG 413 (683)
Q Consensus 334 l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~ 413 (683)
..++.+|.|...........+...+-++.|+.+|||||++++.... ..+..|||+|-+. -|..++.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e------~~~~~ylvTErV~--Pl~~~lk------ 99 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE------EEGTLYLVTERVR--PLETVLK------ 99 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc------ccCceEEEeeccc--cHHHHHH------
Confidence 4578889998877655433445677889999999999999998875 4568999999774 2333441
Q ss_pred CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCc
Q 005691 414 SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493 (683)
Q Consensus 414 ~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~ 493 (683)
.+.-...--.+.||+.||.|||+ +.+++|++|.-..|++++.|..||++|-++........ ......--..
T Consensus 100 ------~l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s 170 (690)
T KOG1243|consen 100 ------ELGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIES 170 (690)
T ss_pred ------HhHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhc
Confidence 12233344577899999999996 56899999999999999999999999988754432211 0001111224
Q ss_pred ccCccccccCCCCccccEEEcchhHHHHhhC
Q 005691 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524 (683)
Q Consensus 494 Y~APE~~~~~~~s~ksDVwSfGvlLlELltG 524 (683)
|..|+.+.... -..|.|-||++++|++.|
T Consensus 171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 56666443222 346999999999999999
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.6e-08 Score=108.37 Aligned_cols=178 Identities=21% Similarity=0.263 Sum_probs=133.4
Q ss_pred eEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCC-CCccc
Q 005691 327 GLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPN-GNVDD 404 (683)
Q Consensus 327 G~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~-GsL~~ 404 (683)
.+.||+.. .||..++.||++....+....-..-++.++++.|.|+|+++.++..... ....++|||+|.|+ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF--~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF--GDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc--CcceEEEEEecCCCCchHHH
Confidence 57899985 4899999999954333333233456889999999999999998874433 45678999999987 57777
Q ss_pred cccCCCCCC------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccc
Q 005691 405 HLFPSFNDG------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 478 (683)
Q Consensus 405 ~L~~~~~~~------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~ 478 (683)
.-|...... .......+++...|.++.|++.||.++| +.|+.-+-|.+++||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 665543221 1123445778899999999999999999 8899999999999999999999999998876665
Q ss_pred cCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCC
Q 005691 479 EGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527 (683)
Q Consensus 479 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p 527 (683)
.+.. |-+.. -.+-|.=-||.+++.|.||...
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4431 11111 1245666799999999999765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.6e-08 Score=95.23 Aligned_cols=125 Identities=24% Similarity=0.276 Sum_probs=82.6
Q ss_pred EEEEEEEcCCcEEEEEEeeccCcc---------------------C-----hHHHHHHHHHHHhccCCC--cccccceee
Q 005691 328 LVYKGILQDGTTVAVKKVIESDFQ---------------------G-----DAEFCNEVEIISNLKHRN--LVPLRGCCV 379 (683)
Q Consensus 328 ~Vykg~l~~g~~VAVK~l~~~~~~---------------------~-----~~~f~~Ev~iL~~L~H~N--LV~L~G~c~ 379 (683)
.||.|...+|..+|||..+..... . .....+|.+.|.++...+ +-+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999999999999987432110 0 023678999999997664 4444433
Q ss_pred ecCCCCCCCeeEEEEeecC--CCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHH-HhcccCCCccccCCCCC
Q 005691 380 VDGDNERGSERYLVYDYMP--NGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY-LHYGVKPAIYHRDIKAT 456 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~--~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~y-LH~~~~~~IiHrDIKps 456 (683)
..-.|||||++ +..+..... ..++......++.++...+.. +| ..+|+|+|+.+.
T Consensus 79 --------~~~~ivME~I~~~G~~~~~l~~-----------~~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~ 136 (188)
T PF01163_consen 79 --------NRNVIVMEYIGEDGVPLPRLKD-----------VDLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEY 136 (188)
T ss_dssp --------ETTEEEEE--EETTEEGGCHHH-----------CGGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STT
T ss_pred --------eCCEEEEEecCCCccchhhHHh-----------ccccchhHHHHHHHHHHHHHHHHH---hcCceecCCChh
Confidence 23589999998 544444321 122245566788888886665 57 889999999999
Q ss_pred ceeeccCCcEEEcccCccccc
Q 005691 457 NILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 457 NILLd~~~~~KLaDFGla~~~ 477 (683)
|||++++ .+.|.|||.+...
T Consensus 137 NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 137 NILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp SEEEETT-CEEE--GTTEEET
T ss_pred hEEeecc-eEEEEecCcceec
Confidence 9999988 9999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.2e-07 Score=92.37 Aligned_cols=143 Identities=17% Similarity=0.293 Sum_probs=100.2
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc--------ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ--------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~--------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
...+|-||+-+.|+++.+. |+...||.-...... .....++|.++|.+++--.|.--.-+++ +..
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~------D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI------DTY 83 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE------ecC
Confidence 4568999999999999987 777777653222211 1245788999999987544433333333 233
Q ss_pred eeEEEEeecCC-CCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC---
Q 005691 389 ERYLVYDYMPN-GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM--- 464 (683)
Q Consensus 389 ~~~LV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~--- 464 (683)
.-.|+|||+++ -++.+++...... .-.-......+..|-+.+.-|| ...|||+||..+||+|..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~-------~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMED-------ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccC-------cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcC
Confidence 45789999977 4777877543311 1111222678889999999999 89999999999999996554
Q ss_pred cEEEcccCcccc
Q 005691 465 RARVADFGLAKQ 476 (683)
Q Consensus 465 ~~KLaDFGla~~ 476 (683)
.+.+.|||++..
T Consensus 154 ~~~lIdfgls~~ 165 (229)
T KOG3087|consen 154 TPILIDFGLSSV 165 (229)
T ss_pred ceEEEeecchhc
Confidence 568999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.5e-07 Score=98.64 Aligned_cols=146 Identities=16% Similarity=0.102 Sum_probs=101.6
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCcc-----------ChHHHHHHHHHHHhccCCCc--ccccceeeecCCCC
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ-----------GDAEFCNEVEIISNLKHRNL--VPLRGCCVVDGDNE 385 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~-----------~~~~f~~Ev~iL~~L~H~NL--V~L~G~c~~~~~~~ 385 (683)
+.+-+.....|++..+ +|+.+.||+....... ....+.+|.+.+.++...+| ..++++..... ..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~-~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS-NP 105 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC-CC
Confidence 3444444456778776 4789999987443311 11247899999998854444 34455653211 11
Q ss_pred CCCeeEEEEeecCCC-CccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc--
Q 005691 386 RGSERYLVYDYMPNG-NVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-- 462 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~G-sL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-- 462 (683)
...+-+||+|++++- +|.+++.... ....+...+..++.+++..+.-|| ..+|+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~-------~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~ 175 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA-------TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPF 175 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc-------ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccc
Confidence 134578999999986 8888873111 123344567789999999999999 999999999999999985
Q ss_pred -----CCcEEEcccCcccc
Q 005691 463 -----DMRARVADFGLAKQ 476 (683)
Q Consensus 463 -----~~~~KLaDFGla~~ 476 (683)
++.+.++||+.++.
T Consensus 176 ~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 176 PGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred cCCCCCceEEEEECCcccc
Confidence 47899999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.5e-08 Score=118.84 Aligned_cols=205 Identities=22% Similarity=0.250 Sum_probs=137.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
..+.|...+-+-+|.++.++-..-. .|...++|...... ....+....+-.++-..+||-++...-- ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s------~~~ 875 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS------FPC 875 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC------CCC
Confidence 3456666667888999998876533 23233333322111 1111112222222222334444432221 114
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....+|+++|..+++|...|+... .++..-....+..+..+++||| ...+.|||++|.|+|...++..
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~---------~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~ 943 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG---------CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHR 943 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC---------CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCc
Confidence 567899999999999998886432 3444445556677888999999 7779999999999999999999
Q ss_pred EEcccCccccccc---------------------C---------CccccccccCCCcccCccccccCCCCccccEEEcch
Q 005691 467 RVADFGLAKQSRE---------------------G---------QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGV 516 (683)
Q Consensus 467 KLaDFGla~~~~~---------------------~---------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGv 516 (683)
+++|||..+.... + .......+.||+.|.+||...+......+|.|++|+
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence 9999984322100 0 001122367999999999999999999999999999
Q ss_pred hHHHHhhCCCCCCCCCC
Q 005691 517 VILEIMCGRKALDLSTS 533 (683)
Q Consensus 517 lLlELltGr~p~~~~~~ 533 (683)
.++|.++|..||....+
T Consensus 1024 ~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred hhhhhhcCCCCCCCcch
Confidence 99999999999986554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.8e-08 Score=110.85 Aligned_cols=153 Identities=26% Similarity=0.344 Sum_probs=100.8
Q ss_pred HHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCc--------cccccccCCCcccCcccccc
Q 005691 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS--------HLTTRVAGTHGYLAPEYALY 502 (683)
Q Consensus 431 ~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~--------~~~~~~~GT~~Y~APE~~~~ 502 (683)
.+++.||.|+|. +.++||++|.|++|.++.++..||+.|+.+-....... ....-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345599999995 68999999999999999999999999998654332111 11111234567999999999
Q ss_pred CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHH
Q 005691 503 GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVL 582 (683)
Q Consensus 503 ~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~ 582 (683)
...+.++|+||+|++++-|..|.++.-...... ......... .+....+ ...++..++.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~~~~~~---------~~~~~~~-------~s~~~p~el~~ 243 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYSFSRNL---------LNAGAFG-------YSNNLPSELRE 243 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc----chhhhhhcc---------ccccccc-------ccccCcHHHHH
Confidence 888999999999999999996665542221110 000001100 0111111 11233445555
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 005691 583 VGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 583 lal~C~~~dP~~RPtm~eVl~~L 605 (683)
=....+..++.-||+|.++....
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred HHHHHhcCCcccCcchhhhhccc
Confidence 56667899999999888876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.4e-06 Score=88.51 Aligned_cols=202 Identities=15% Similarity=0.140 Sum_probs=127.6
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCC-CCCCCeeEEEEe
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD-NERGSERYLVYD 395 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~-~~~~~~~~LV~E 395 (683)
...||+||-+.+|----- ..-+.|+..........+ .+..|... .||-+-.=+.+-...-. ..++...-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 346999999999964311 122346665544332222 23334444 45533321221110000 012333667777
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
.+++..=-..++... .....-...+|...++.+..+|.+.+-|| ..+.+-+|+.++|+|+.++..+.|.|=..-.
T Consensus 91 ~v~g~~pI~~~y~p~--tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 91 KVSGKEPIHMIYSPA--TRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cCCCccchhhhcCch--hhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence 776652222222221 11234456899999999999999999999 8899999999999999999999998754322
Q ss_pred ccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhC-CCCCCCC
Q 005691 476 QSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCG-RKALDLS 531 (683)
Q Consensus 476 ~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltG-r~p~~~~ 531 (683)
....+ ......+|...|.+||.-. +-..+...|-|.+||++++++.| ++||...
T Consensus 166 i~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22221 2233457888999999654 33457789999999999999887 9998654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=1e-06 Score=88.83 Aligned_cols=111 Identities=23% Similarity=0.317 Sum_probs=84.7
Q ss_pred hHHHHHHHHHHHhccCC--CcccccceeeecCCCCCCCeeEEEEeecCCC-CccccccCCCCCCCCCCCCCCCccchhhh
Q 005691 353 DAEFCNEVEIISNLKHR--NLVPLRGCCVVDGDNERGSERYLVYDYMPNG-NVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429 (683)
Q Consensus 353 ~~~f~~Ev~iL~~L~H~--NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~G-sL~~~L~~~~~~~~~~~~~~L~w~~r~~I 429 (683)
...+.+|...+.+|+.. ...+.+++...... .....+||+|++++. +|.+++... ..++-..+..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~--~~~~s~lite~l~~~~~L~~~~~~~---------~~~~~~~~~~l 123 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG--GGYRSYLITEALPGAQDLRDLLQQW---------EQLDPSQRREL 123 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC--CceeEEEEEEeCCCcccHHHHHHhh---------cccchhhHHHH
Confidence 44688899988888644 34556666543221 124568999999984 788888321 12555677899
Q ss_pred HHHHHHHHHHHhcccCCCccccCCCCCceeeccCC---cEEEcccCccccc
Q 005691 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM---RARVADFGLAKQS 477 (683)
Q Consensus 430 a~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~---~~KLaDFGla~~~ 477 (683)
+.++++.++-|| ..+|+|+|+++.|||++.+. .+.+.||+-++..
T Consensus 124 l~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 124 LRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999 99999999999999999887 8999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.8e-06 Score=85.48 Aligned_cols=142 Identities=18% Similarity=0.165 Sum_probs=103.4
Q ss_pred eeecCceEEEEEEEcCCcEEEEEEeecc---C---ccChHHHHHHHHHHHhccCCC--cccccceeeecCCCCCCCeeEE
Q 005691 321 IGRGGFGLVYKGILQDGTTVAVKKVIES---D---FQGDAEFCNEVEIISNLKHRN--LVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 321 LG~GgfG~Vykg~l~~g~~VAVK~l~~~---~---~~~~~~f~~Ev~iL~~L~H~N--LV~L~G~c~~~~~~~~~~~~~L 392 (683)
-|+||-+-|++-.+. |..+-+|+-... + .-+...|.+|+..|.+|...+ +.+.. ++..... ...-+-+|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~-~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKI-EGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeecc-CCceEEEE
Confidence 467899999997776 557999987421 1 336678999999999996433 33333 3322111 12445789
Q ss_pred EEeecCC-CCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc--EEEc
Q 005691 393 VYDYMPN-GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR--ARVA 469 (683)
Q Consensus 393 V~Ey~~~-GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~--~KLa 469 (683)
|+|-+++ -+|.+++... ...+.+...+..++.++++.++-|| +.++.|+|+-+.|||++.++. +++.
T Consensus 103 VTe~L~g~~~L~~~l~~~-------~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH-------AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred EEEeCCCCccHHHHHhcC-------CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEE
Confidence 9998864 5788887321 1124566777899999999999999 999999999999999986666 9999
Q ss_pred ccCccc
Q 005691 470 DFGLAK 475 (683)
Q Consensus 470 DFGla~ 475 (683)
||--++
T Consensus 173 DlEk~r 178 (216)
T PRK09902 173 DLEKSR 178 (216)
T ss_pred Ehhccc
Confidence 997554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.7e-06 Score=86.88 Aligned_cols=134 Identities=21% Similarity=0.160 Sum_probs=93.1
Q ss_pred cccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc----------------------ChHHHHHHHHHHHhccCC--C
Q 005691 315 FSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ----------------------GDAEFCNEVEIISNLKHR--N 370 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~----------------------~~~~f~~Ev~iL~~L~H~--N 370 (683)
....++||.|--+.||.|..++|.++|||.=+..... ......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3445789999999999999999999999854221110 012356788888888644 4
Q ss_pred cccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccc
Q 005691 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450 (683)
Q Consensus 371 LV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiH 450 (683)
+.+.+++ +...+||||+++--|...- ++-...-.|+..|.+-+.-+- ..+|||
T Consensus 173 VP~P~~~----------nRHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~~~~~~---~~GiVH 225 (304)
T COG0478 173 VPKPIAW----------NRHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEEVRKAY---RRGIVH 225 (304)
T ss_pred CCCcccc----------ccceeeeehcccceeeccc--------------CcccCHHHHHHHHHHHHHHHH---HcCccc
Confidence 4444433 4578999999886554322 122333345555555554444 578999
Q ss_pred cCCCCCceeeccCCcEEEcccCccc
Q 005691 451 RDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 451 rDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
+|+.+-||++++||.+.+.||--+-
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccc
Confidence 9999999999999999999996543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2e-06 Score=97.70 Aligned_cols=148 Identities=20% Similarity=0.249 Sum_probs=97.6
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccCh------------------------------H--------
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD------------------------------A-------- 354 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~------------------------------~-------- 354 (683)
..|+. +-|+.++-|.||+|++++|+.||||..+..-.... +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 45553 57999999999999999999999999865432110 0
Q ss_pred --HHHHHHHHHHhc----cCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhh
Q 005691 355 --EFCNEVEIISNL----KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428 (683)
Q Consensus 355 --~f~~Ev~iL~~L----~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~ 428 (683)
++..|...+.++ ++..-+++-.++. +......|+|||++|-.+.+..... ...++ +..
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~w-----e~t~~~VLtmE~i~Gi~i~d~~~l~--------~~g~d---~k~ 268 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYW-----EYTTRRVLTMEWIDGIKISDIAALK--------SAGID---RKE 268 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeeh-----hccCCcEEEEEeeCCEecccHHHHH--------hcCCC---HHH
Confidence 123333333333 2222233333332 1346789999999999998875211 12233 455
Q ss_pred hHHHHHHHH-HHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccC
Q 005691 429 IILDVAKGL-AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480 (683)
Q Consensus 429 Ia~~iA~gL-~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~ 480 (683)
|+..++++. .-+- .-+++|.|.+|.||+++.+++.-+.|||+....++.
T Consensus 269 ia~~~~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 269 LAELLVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 666655543 2222 468999999999999999999999999998765443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1e-05 Score=91.82 Aligned_cols=148 Identities=20% Similarity=0.213 Sum_probs=96.7
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccCh---------------------------H----------H
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD---------------------------A----------E 355 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~---------------------------~----------~ 355 (683)
..|+. +-||.-..|.||+|++++|+.||||.-+..-.... + +
T Consensus 162 ~~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 162 SEFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred HhcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 34543 47999999999999999999999998755432210 0 2
Q ss_pred HHHHHHHHHhc----cCCC---cccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhh
Q 005691 356 FCNEVEIISNL----KHRN---LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428 (683)
Q Consensus 356 f~~Ev~iL~~L----~H~N---LV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~ 428 (683)
|.+|.+-..+. +|-+ -|.+-.++.. -...+.|+||||+|..+.|.-.-. +..++-. .
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~-----~st~RVLtME~~~G~~i~Dl~~i~--------~~gi~~~---~ 304 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWD-----LSTKRVLTMEYVDGIKINDLDAID--------KRGISPH---D 304 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhh-----cCcceEEEEEecCCccCCCHHHHH--------HcCCCHH---H
Confidence 45555444333 4555 2223333331 345799999999999888764221 1223322 4
Q ss_pred hHHHHHHHHHHHhcccCCCccccCCCCCceeecc----CCcEEEcccCccccccc
Q 005691 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA----DMRARVADFGLAKQSRE 479 (683)
Q Consensus 429 Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~----~~~~KLaDFGla~~~~~ 479 (683)
|+..+.++...+ -...|++|+|-.|-||+++. ++.+.+-|||+......
T Consensus 305 i~~~l~~~~~~q--If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 305 ILNKLVEAYLEQ--IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHHHH--HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 555555443322 12467999999999999983 67899999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.1e-06 Score=81.63 Aligned_cols=105 Identities=23% Similarity=0.299 Sum_probs=83.3
Q ss_pred HHHHHHHHhccC-CCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHH
Q 005691 357 CNEVEIISNLKH-RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435 (683)
Q Consensus 357 ~~Ev~iL~~L~H-~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~ 435 (683)
.+|.-++..+++ +++.+++|+|- .++|.||.+.+++...-. .. ..--.-+|..|.+|+.++.+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----------~~~v~E~~~~~~~~~~~~-~l-----~~~~~~~w~~R~~iA~~lL~ 70 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----------RFYVVEYVGAGSLYGIYR-PL-----SQFLQSPWEQRAKIALQLLE 70 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----------CEEEEEeecCcccccccc-cc-----ccccccCHHHHHHHHHHHHH
Confidence 358888999976 59999999993 588999999876643200 00 01125789999999999999
Q ss_pred HHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 436 gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
.+.+|++.....+.-.|++++|+-+++++++|+.|...+-..
T Consensus 71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999766566888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1e-06 Score=99.22 Aligned_cols=185 Identities=18% Similarity=0.127 Sum_probs=131.5
Q ss_pred ccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC-cccccceeeecCCCCCCCeeEEEE
Q 005691 316 SQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN-LVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N-LV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
..-+-+++|.++.+||.+-.-.+...++.+... .+..-++++|.+++||| .++.++-+ +.+...++++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~------~~E~~~~i~~ 313 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDY------DGEDYLWIPM 313 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccC------Ccccccchhh
Confidence 333457899999999987543444445544332 45667899999999999 44444333 2456678899
Q ss_pred eecCCC-CccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 395 DYMPNG-NVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 395 Ey~~~G-sL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
++...| +...-.. .....+...+...+...-+++|+||| +..=+||| ||+..+ ...|.+||+.
T Consensus 314 ~i~s~~rs~~~~~~--------~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 314 RICSTGRSSALEMT--------VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred hhhcCCccccccCC--------hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccC
Confidence 998877 3222210 11223444455567777789999999 55568999 887766 6789999999
Q ss_pred ccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCC
Q 005691 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529 (683)
Q Consensus 474 a~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~ 529 (683)
...+.... ......+|..|+|||....+.+..+.|+|+.|+--.++--|-+|-.
T Consensus 378 ~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 378 PPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 87765543 2344678999999999999999999999999998777777776643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.7e-05 Score=77.95 Aligned_cols=143 Identities=14% Similarity=0.115 Sum_probs=81.5
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCc--ccccceeeecCCCCCCCeeEEEEee
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL--VPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NL--V~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.++++. ......+|||+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~------~~~~~glv~e~ 75 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE------DGGRLGLIYEL 75 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe------cCCeeeeeeee
Confidence 46899999999984 25567788765422 34457889999999875544 34455543 33456789999
Q ss_pred cCCCC-ccccccCC-----------------CCCCCCCCCCCCCccchhh-h----------HHHHHH-HHHHHhc-ccC
Q 005691 397 MPNGN-VDDHLFPS-----------------FNDGSGVAKRPLTWPQRKN-I----------ILDVAK-GLAYLHY-GVK 445 (683)
Q Consensus 397 ~~~Gs-L~~~L~~~-----------------~~~~~~~~~~~L~w~~r~~-I----------a~~iA~-gL~yLH~-~~~ 445 (683)
++|.. +...+... .+.. .........+.. + ...+.+ ...+|.. ...
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~---~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHST---KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCC---CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99863 22211100 0000 000001010000 0 000111 1222221 123
Q ss_pred CCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 446 PAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 446 ~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
..++|+|+.|.||++++++ +.|.||+.+..
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 4578999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.91 E-value=6e-05 Score=77.25 Aligned_cols=152 Identities=20% Similarity=0.217 Sum_probs=97.5
Q ss_pred eehHHHHHHhcCcccceeee---ecCceEEEEEEEcCCcEEEEEEeeccCccC---------hHH---------------
Q 005691 303 FKIQDLERATDKFSQKNFIG---RGGFGLVYKGILQDGTTVAVKKVIESDFQG---------DAE--------------- 355 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG---~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~---------~~~--------------- 355 (683)
.+.+.+....++.......| .|--..||+|.-.++..+|||+++...... +..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34566777777766666655 455568999998889999999986532221 111
Q ss_pred HHHHHHHHHhcc--CCCcccccceeeecCCCCCCCeeEEEEeecCCCCcc-ccccCCCCCCCCCCCCCCCccchhhhHHH
Q 005691 356 FCNEVEIISNLK--HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVD-DHLFPSFNDGSGVAKRPLTWPQRKNIILD 432 (683)
Q Consensus 356 f~~Ev~iL~~L~--H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~-~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~ 432 (683)
..+|+.-|.++. +-.+-+-+++ ..-.|||||+....+. -.| +.-++.......+..+
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----------~~nVLvMEfIg~~g~pAP~L----------kDv~~e~~e~~~~~~~ 174 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----------RNNVLVMEFIGDDGLPAPRL----------KDVPLELEEAEGLYED 174 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----------cCCeEEEEeccCCCCCCCCc----------ccCCcCchhHHHHHHH
Confidence 234555566553 3333333333 2358999999654211 111 1112222245566777
Q ss_pred HHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 433 iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
+.+.+.-|-. ..++||+||..-|||++ ++.+.|+|||-|-..
T Consensus 175 ~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 175 VVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 7777777761 47999999999999999 889999999977543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.86 E-value=6.4e-05 Score=75.38 Aligned_cols=151 Identities=21% Similarity=0.262 Sum_probs=86.1
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC--cccccceeeecCCCCCCCeeEEEEee
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN--LVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N--LV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+.... +.++++++.... .....+++|+|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~---~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE---FNGFPYLLMEY 76 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE---ETSEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc---ccccceEEEEE
Confidence 578999999999999887 68999986543 33567889999998886443 345565443221 23347999999
Q ss_pred cCCCCccccccC---------------CCCCCCCCCCCCCCccc---------hhhh------------HHHHHH-HHHH
Q 005691 397 MPNGNVDDHLFP---------------SFNDGSGVAKRPLTWPQ---------RKNI------------ILDVAK-GLAY 439 (683)
Q Consensus 397 ~~~GsL~~~L~~---------------~~~~~~~~~~~~L~w~~---------r~~I------------a~~iA~-gL~y 439 (683)
+++..+...+.. ...... .....+.+.. .... ...+.+ .+..
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVP-PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSH-TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhccccc-ccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999888771100 000000 0001111110 0000 112222 2333
Q ss_pred Hhc----ccCCCccccCCCCCceeec-cCCcEEEcccCcccc
Q 005691 440 LHY----GVKPAIYHRDIKATNILLD-ADMRARVADFGLAKQ 476 (683)
Q Consensus 440 LH~----~~~~~IiHrDIKpsNILLd-~~~~~KLaDFGla~~ 476 (683)
++. .....++|+|+.+.|||++ +++.+.|.||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 2357799999999999999 666668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00015 Score=73.48 Aligned_cols=142 Identities=13% Similarity=0.164 Sum_probs=90.4
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHH---------HHHHHHHHHhccCCCc---ccccceee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE---------FCNEVEIISNLKHRNL---VPLRGCCV 379 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~---------f~~Ev~iL~~L~H~NL---V~L~G~c~ 379 (683)
.++|...+++-......|.+-..+ |+.+.+|..+.......+. ..+++..+.+++...+ +.++....
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 457777777777766666666554 7888888765533222222 2334444445433222 22222211
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
..........+|+|||++|..|.++. .++. .++..+.+++.-|| +.|+.|+|..|.|++
T Consensus 109 -kk~~~~~~~~~ll~EYIeG~~l~d~~-------------~i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 109 -KKIFRYTSSYVLLMEYIEGVELNDIE-------------DIDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFL 167 (229)
T ss_pred -eeeccceeEEEEEEEEecCeecccch-------------hcCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEE
Confidence 11111234567999999998887764 1211 35567888899999 899999999999999
Q ss_pred eccCCcEEEcccCcccc
Q 005691 460 LDADMRARVADFGLAKQ 476 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~ 476 (683)
+++++ +++.||+..+.
T Consensus 168 v~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EECCc-EEEEECccccc
Confidence 98655 99999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00015 Score=74.51 Aligned_cols=145 Identities=15% Similarity=0.088 Sum_probs=82.5
Q ss_pred eeecCc-eEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCeeEEEEeecC
Q 005691 321 IGRGGF-GLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSERYLVYDYMP 398 (683)
Q Consensus 321 LG~Ggf-G~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~ 398 (683)
|-.|.. ..||+.... +..+.||+..... ..+...|++++..+. +--+.+++++.. .++..++||||++
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~------~~~~~~lv~e~i~ 75 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGS------DDGRAWLLTSAVP 75 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEe------cCCccEEEEEeeC
Confidence 444555 788999765 4678888764432 345778999998884 333335555543 2245789999999
Q ss_pred CCCccccccCC---------------CCCCCCCCCCCCC--ccchh-----------------------hhHHHHHHHHH
Q 005691 399 NGNVDDHLFPS---------------FNDGSGVAKRPLT--WPQRK-----------------------NIILDVAKGLA 438 (683)
Q Consensus 399 ~GsL~~~L~~~---------------~~~~~~~~~~~L~--w~~r~-----------------------~Ia~~iA~gL~ 438 (683)
|.+|....... .+... .....+. +..++ .....+..-|.
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 154 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALP-VADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE 154 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCC-cccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence 98876442100 00000 0000100 00000 00111111111
Q ss_pred HHh-cccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 439 YLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 439 yLH-~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
-.. ....+.++|+|+.|.|||++++....|.||+.+..
T Consensus 155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 111 11246699999999999999987789999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00035 Score=84.68 Aligned_cols=83 Identities=12% Similarity=0.195 Sum_probs=57.1
Q ss_pred ceeeeecCceEEEEEEEcCC---cEEEEEEeeccCc-cChHHHHHHHHHHHhcc-CCCc--ccccceeeecCCCCCCCee
Q 005691 318 KNFIGRGGFGLVYKGILQDG---TTVAVKKVIESDF-QGDAEFCNEVEIISNLK-HRNL--VPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g---~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~-H~NL--V~L~G~c~~~~~~~~~~~~ 390 (683)
...|+.|.++.+|+....++ ..+++|+...... .....+.+|+++++.+. |.++ .+++++|... ......
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~---~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA---SVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC---CcCCCc
Confidence 45688999999999887654 3677776543222 23456889999999995 6665 5666666421 122457
Q ss_pred EEEEeecCCCCcc
Q 005691 391 YLVYDYMPNGNVD 403 (683)
Q Consensus 391 ~LV~Ey~~~GsL~ 403 (683)
++||||+++..+.
T Consensus 120 flVME~v~G~~~~ 132 (822)
T PLN02876 120 FYIMEYLEGRIFV 132 (822)
T ss_pred eEEEEecCCcccC
Confidence 8999999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00083 Score=68.81 Aligned_cols=78 Identities=13% Similarity=0.129 Sum_probs=45.8
Q ss_pred eeeeecCce-EEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCC---CcccccceeeecCCCCCCCeeEEEE
Q 005691 319 NFIGRGGFG-LVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHR---NLVPLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 319 ~~LG~GgfG-~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~---NLV~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
+.|+.||.. .||+. +..+.+|.... ......+..|.+++..+... .+-+.++... ..+.....+++|
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~---~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGE---PGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCC---CccCCCcceEEE
Confidence 457777776 48875 23566775433 22345788999999888632 1222222221 111112458899
Q ss_pred eecCCCCcccc
Q 005691 395 DYMPNGNVDDH 405 (683)
Q Consensus 395 Ey~~~GsL~~~ 405 (683)
|+++|.++.+.
T Consensus 74 ~~i~G~~l~~~ 84 (235)
T cd05155 74 RWLEGETATAA 84 (235)
T ss_pred EeecCCCCCcc
Confidence 99999887643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.002 Score=68.78 Aligned_cols=81 Identities=11% Similarity=0.094 Sum_probs=56.8
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccC---CCcccccceeeecCCCCCCCeeEEE
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH---RNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H---~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
..+.||.|..+.||+-...+++ +.+|..+. ......|..|.+.|+.|.- ..+.+++++|... ...+..+||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~---~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE---QSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC---CcCCCeEEE
Confidence 3457999999999999876664 66665322 1123578999999999853 3566777776421 123568999
Q ss_pred EeecCCCCcc
Q 005691 394 YDYMPNGNVD 403 (683)
Q Consensus 394 ~Ey~~~GsL~ 403 (683)
||+++++++.
T Consensus 92 mE~i~G~~~~ 101 (297)
T PRK10593 92 LERLRGVSVE 101 (297)
T ss_pred EeccCCEecC
Confidence 9999998763
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00049 Score=67.26 Aligned_cols=129 Identities=19% Similarity=0.232 Sum_probs=86.9
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
..+.||+|++|.||+|.+. |..+|+|.-...+ ....+..|+++|..+.--++.+=+-++ ++-++.|||
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---------g~~~i~me~ 93 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---------GEDFIRMEY 93 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---------chhhhhhhh
Confidence 3467999999999999987 6688998754433 345688999999998866665433222 234556999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC-CCceeeccCCcEEEcccCccc
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK-ATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK-psNILLd~~~~~KLaDFGla~ 475 (683)
+.|-.|.+.-.. . + .+-...+++.---|- ..+|-|..|. |..++|-.+..+.|.||.-|+
T Consensus 94 i~G~~L~~~~~~------------~---~-rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIG------------G---D-RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhc------------c---c-HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 988777665410 0 1 233445555533344 6789999887 444555555599999999887
Q ss_pred c
Q 005691 476 Q 476 (683)
Q Consensus 476 ~ 476 (683)
.
T Consensus 155 ~ 155 (201)
T COG2112 155 F 155 (201)
T ss_pred h
Confidence 3
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0011 Score=70.04 Aligned_cols=155 Identities=16% Similarity=0.111 Sum_probs=88.6
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC--cccccceeeecCCCCCCCeeEEEEe
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN--LVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N--LV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
.+.|..|-...+|+....+ ..+++|+... ...++...|++++..+++.+ +.+.+.......-...++..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4557777778999987654 4688887654 23456778898888886543 3333322100000012345789999
Q ss_pred ecCCCCcccc--------------ccCCCCC--CCCCCCCCCCccchh----------hhHHHHHHHHHHHhc----ccC
Q 005691 396 YMPNGNVDDH--------------LFPSFND--GSGVAKRPLTWPQRK----------NIILDVAKGLAYLHY----GVK 445 (683)
Q Consensus 396 y~~~GsL~~~--------------L~~~~~~--~~~~~~~~L~w~~r~----------~Ia~~iA~gL~yLH~----~~~ 445 (683)
|++|..+... +|..... ..........|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876541 0110000 000011122333221 111223344555542 224
Q ss_pred CCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 446 PAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 446 ~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
..++|+|+.|.|||++++....|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999987788999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00096 Score=66.99 Aligned_cols=129 Identities=19% Similarity=0.234 Sum_probs=86.7
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccC----------------ccChHHHHHHHHHHHhcc------CCCcccc
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESD----------------FQGDAEFCNEVEIISNLK------HRNLVPL 374 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~----------------~~~~~~f~~Ev~iL~~L~------H~NLV~L 374 (683)
....||+|+.-.||. +++.....||...... ....+++.+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356799999999987 4666778888876654 223566778887766665 7889999
Q ss_pred cceeeecCCCCCCCeeEEEEeecCC--C----CccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCc
Q 005691 375 RGCCVVDGDNERGSERYLVYDYMPN--G----NVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448 (683)
Q Consensus 375 ~G~c~~~~~~~~~~~~~LV~Ey~~~--G----sL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~I 448 (683)
+|+.. ......+|+|.+.+ | +|.+++. ...++. . +...+-+-..||- +..|
T Consensus 83 ~G~ve------T~~G~Glv~e~I~d~dG~~s~TL~~~l~----------~~~~~~-~---~~~~L~~f~~~l~---~~~I 139 (199)
T PF10707_consen 83 YGFVE------TNLGLGLVVELIRDADGNISPTLEDYLK----------EGGLTE-E---LRQALDEFKRYLL---DHHI 139 (199)
T ss_pred eEEEe------cCCceEEEEEEEECCCCCcCccHHHHHH----------cCCccH-H---HHHHHHHHHHHHH---HcCC
Confidence 99986 44557889988754 3 3555551 123433 2 2222333345565 6779
Q ss_pred cccCCCCCceeeccCC----cEEEcc
Q 005691 449 YHRDIKATNILLDADM----RARVAD 470 (683)
Q Consensus 449 iHrDIKpsNILLd~~~----~~KLaD 470 (683)
+.+|++|.||++..+. .+.|.|
T Consensus 140 v~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 140 VIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred eecCCCcccEEEEecCCCceEEEEEe
Confidence 9999999999995432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0015 Score=65.58 Aligned_cols=131 Identities=27% Similarity=0.378 Sum_probs=93.8
Q ss_pred cCcccceeeeecCc-eEEEEEEEcCCcEEEEEEeecc---Cc-------c-----------ChHHHHHHHHHHHhcc---
Q 005691 313 DKFSQKNFIGRGGF-GLVYKGILQDGTTVAVKKVIES---DF-------Q-----------GDAEFCNEVEIISNLK--- 367 (683)
Q Consensus 313 ~~f~~~~~LG~Ggf-G~Vykg~l~~g~~VAVK~l~~~---~~-------~-----------~~~~f~~Ev~iL~~L~--- 367 (683)
.+++..+.||.|.- |.|||.++. |+.+|+|.+..- .. . -.+.|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 999999997 789999994221 00 0 0124889999988885
Q ss_pred CCCc--ccccceeeecCC------------CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHH
Q 005691 368 HRNL--VPLRGCCVVDGD------------NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433 (683)
Q Consensus 368 H~NL--V~L~G~c~~~~~------------~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~i 433 (683)
+.++ |+.+||...+.+ ......+.+|.||++... ....+-+.+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------------~~~~~~~~~~ 173 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------------PLQIRDIPQM 173 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------------ccchhHHHHH
Confidence 4466 899999865421 012233567888775422 1123445677
Q ss_pred HHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcc
Q 005691 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 434 A~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla 474 (683)
.+-|..+| ..+|+-+|+|+.|.. .-||.|||.+
T Consensus 174 ~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 174 LRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 78888899 999999999999985 3489999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0015 Score=67.78 Aligned_cols=143 Identities=14% Similarity=0.130 Sum_probs=78.6
Q ss_pred eeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCccc-ccceeeecCCCCCCCeeEEEEeecCC
Q 005691 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVP-LRGCCVVDGDNERGSERYLVYDYMPN 399 (683)
Q Consensus 321 LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~-L~G~c~~~~~~~~~~~~~LV~Ey~~~ 399 (683)
+..|-.+.+|+... ++..+++|........-.-...+|.++++.+....+++ ++++. ..++||||++|
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----------~~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----------EHWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----------CCEEEEEeccC
Confidence 44566788998874 46778888654332221123578999999987554543 23221 13689999998
Q ss_pred CCcccccc-C------------CCCCCCCCCCCCCCccchh-h---------hHHHHHHHHHHHhc-----ccCCCcccc
Q 005691 400 GNVDDHLF-P------------SFNDGSGVAKRPLTWPQRK-N---------IILDVAKGLAYLHY-----GVKPAIYHR 451 (683)
Q Consensus 400 GsL~~~L~-~------------~~~~~~~~~~~~L~w~~r~-~---------Ia~~iA~gL~yLH~-----~~~~~IiHr 451 (683)
..+..... . ..+.. .....+++...+. . +...+.+-+..+-. .....++|+
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQ-PRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 77654210 0 00000 0011111111110 0 00111111222211 113468999
Q ss_pred CCCCCceeeccCCcEEEcccCcccc
Q 005691 452 DIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 452 DIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
|+.|.||++++++ ++|.||..|..
T Consensus 152 Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999877 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0028 Score=64.50 Aligned_cols=74 Identities=16% Similarity=0.174 Sum_probs=48.0
Q ss_pred eeeeecCceEEEEEEEcC--CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccc-cceeeecCCCCCCCeeEEEEe
Q 005691 319 NFIGRGGFGLVYKGILQD--GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPL-RGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~--g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L-~G~c~~~~~~~~~~~~~LV~E 395 (683)
+.|..|-...+|+....+ +..+++|...... ........|+.++..+...++++- ++.. . ..++||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-------~---~~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATF-------Q---NGLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEe-------C---CcEEEE
Confidence 457777788999988764 6788888654322 111233478999998865555443 3221 1 247999
Q ss_pred ecCCCCcc
Q 005691 396 YMPNGNVD 403 (683)
Q Consensus 396 y~~~GsL~ 403 (683)
|+++.++.
T Consensus 73 ~i~G~~l~ 80 (235)
T cd05157 73 FIPGRTLE 80 (235)
T ss_pred eeCCCcCC
Confidence 99997764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0034 Score=69.61 Aligned_cols=75 Identities=16% Similarity=0.127 Sum_probs=52.7
Q ss_pred eeeeecCceEEEEEEEcCC-cEEEEEEeecc-----C--ccChHHHHHHHHHHHhcc---CCCcccccceeeecCCCCCC
Q 005691 319 NFIGRGGFGLVYKGILQDG-TTVAVKKVIES-----D--FQGDAEFCNEVEIISNLK---HRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g-~~VAVK~l~~~-----~--~~~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~~~~~~~~~ 387 (683)
+.||.|.+..||+....+| +.|.||+-... . ....+.+..|.+.|..+. -.++.+++.+ ..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--------D~ 103 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--------DE 103 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--------CC
Confidence 4689999999999999887 48999985321 1 123456778888888763 2345556655 23
Q ss_pred CeeEEEEeecCCCC
Q 005691 388 SERYLVYDYMPNGN 401 (683)
Q Consensus 388 ~~~~LV~Ey~~~Gs 401 (683)
...++||||+++..
T Consensus 104 ~~~~lVME~L~~~~ 117 (401)
T PRK09550 104 ELAVTVMEDLSDHK 117 (401)
T ss_pred CCCEEEEecCCCcc
Confidence 45789999998743
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0062 Score=65.18 Aligned_cols=166 Identities=15% Similarity=0.152 Sum_probs=86.1
Q ss_pred hHHHHHHhcCccc-----ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCc--ccccce
Q 005691 305 IQDLERATDKFSQ-----KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL--VPLRGC 377 (683)
Q Consensus 305 ~~el~~at~~f~~-----~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NL--V~L~G~ 377 (683)
.+++...-..|.. .+.|+.|....+|+....+| .+++|+... ...++...|+.++..|...++ .+.+..
T Consensus 9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 3444444444533 23466677778999887655 688887652 223445556777777643332 222211
Q ss_pred eeecCC--CCCCCeeEEEEeecCCCCcccc--------------ccCCCCCC--CCCCCCCCCcc-chhh----------
Q 005691 378 CVVDGD--NERGSERYLVYDYMPNGNVDDH--------------LFPSFNDG--SGVAKRPLTWP-QRKN---------- 428 (683)
Q Consensus 378 c~~~~~--~~~~~~~~LV~Ey~~~GsL~~~--------------L~~~~~~~--~~~~~~~L~w~-~r~~---------- 428 (683)
.++. ....+..++++||++|..+... +|....+- .......+.|. ....
T Consensus 85 --~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 85 --RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred --CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 0000 0123467899999999765321 11111000 00011122231 1111
Q ss_pred --hH-HHHHHHHHHHhc----ccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 429 --II-LDVAKGLAYLHY----GVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 429 --Ia-~~iA~gL~yLH~----~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
.. ..+...+..+.. ....++||+|+.+.|||++.+...-|.||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 11 111112233321 1356899999999999999766568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0078 Score=64.26 Aligned_cols=154 Identities=16% Similarity=0.108 Sum_probs=84.2
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC--cccccceeeecCCCCCCCeeEEEEee
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN--LVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N--LV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
..++.|--..+|+....+| .+++|+..... ..++...|++++..|.... +.+.+............+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3466666678999876555 57778654421 2345667788888875433 23333221000000123567899999
Q ss_pred cCCCCcccc--------------ccCCCCC--CCCCC-CCCCCccchh------------hhHHHHHHHHHHHhc----c
Q 005691 397 MPNGNVDDH--------------LFPSFND--GSGVA-KRPLTWPQRK------------NIILDVAKGLAYLHY----G 443 (683)
Q Consensus 397 ~~~GsL~~~--------------L~~~~~~--~~~~~-~~~L~w~~r~------------~Ia~~iA~gL~yLH~----~ 443 (683)
++|..+... +|..... ..... ...-.|.... .....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 998765421 1111000 00000 0011222110 111223345555542 2
Q ss_pred cCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 444 VKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 444 ~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
...+++|+|+++.||+++.+....|.||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 35789999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.02 Score=60.69 Aligned_cols=146 Identities=24% Similarity=0.237 Sum_probs=83.4
Q ss_pred eeeecCceEEEEEEEcC-------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCCeeE
Q 005691 320 FIGRGGFGLVYKGILQD-------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~-------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~~~~ 391 (683)
.|..|--..||+....+ ++.+++|...... ....+..+|.+++..+....++ ++++++. -.
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----------~~ 73 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----------NG 73 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----------CC
Confidence 45556667899988765 4788888865432 2233467888888888654444 3344331 13
Q ss_pred EEEeecCCCCccccc-----------------cCCCCCC-C-CCCCCCCCccchhh------------------------
Q 005691 392 LVYDYMPNGNVDDHL-----------------FPSFNDG-S-GVAKRPLTWPQRKN------------------------ 428 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L-----------------~~~~~~~-~-~~~~~~L~w~~r~~------------------------ 428 (683)
+|+||++|..+.... |...... . .......-|....+
T Consensus 74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (302)
T cd05156 74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL 153 (302)
T ss_pred chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence 589999998775421 1110000 0 00000111111110
Q ss_pred --hHHHHHHHHHHHhc------ccCCCccccCCCCCceeeccC----CcEEEcccCcccc
Q 005691 429 --IILDVAKGLAYLHY------GVKPAIYHRDIKATNILLDAD----MRARVADFGLAKQ 476 (683)
Q Consensus 429 --Ia~~iA~gL~yLH~------~~~~~IiHrDIKpsNILLd~~----~~~KLaDFGla~~ 476 (683)
+...+.+-+.+|-. .....++|+|+.+.|||++++ +.+++.||..|..
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11122223334431 246679999999999999985 8899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.002 Score=57.88 Aligned_cols=48 Identities=25% Similarity=0.393 Sum_probs=39.4
Q ss_pred ccccccCCCCChhhhHHHHHhhhhhccc-cccccCCccccccceeEeeec
Q 005691 156 LDSSCKSDLTDLSACDSCVAAGFKVQSQ-LIAVDGNTSHATDCFYFTILY 204 (683)
Q Consensus 156 ~~~~C~~dL~~~~~C~~Cl~~~~~~~~~-l~~~~g~~~~~~~c~~~~~~~ 204 (683)
.-+||++|| ++.+|..||+.++..+.. ++...|.+.....|++|++.|
T Consensus 56 gl~qC~~Dl-s~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C~lRY~~~ 104 (106)
T PF01657_consen 56 GLAQCRGDL-SPSDCRACLADAVANISSCCPGSRGGRVWYDSCFLRYENY 104 (106)
T ss_dssp EEEEE-TTS--HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSEEEEEESS
T ss_pred EEEEcCCCC-ChhhhHHHHHHHHHHHHHhCCCCceEEEECCCEEEEEECC
Confidence 358999999 899999999999987666 677788888889999997655
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.0024 Score=77.15 Aligned_cols=200 Identities=17% Similarity=0.135 Sum_probs=131.6
Q ss_pred HHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHH
Q 005691 356 FCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435 (683)
Q Consensus 356 f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~ 435 (683)
..-|.+.+.++.|+|++.+++|-..... .+-...+..|++..-++...+.. ...++....+.+..+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~--~g~~~~v~~~~~s~~~~~~~~q~---------v~~i~~~~~r~~~~~~~~ 297 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLF--RGIVLDVLQEICSKVELRSLLQS---------VGSIPLETLRILHQKLLE 297 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhc--chHHHHHHHhhcCccchHHHHhh---------ccccCHHHHHHHHHHHhh
Confidence 4456677888999999999998764322 12233455677777777777632 346777888888999999
Q ss_pred HHHHHhcccCCCccccCCCCC---ceeeccCCcEEEc--ccCcccccccCCccccccccCCCcccCccccccCCCCc--c
Q 005691 436 GLAYLHYGVKPAIYHRDIKAT---NILLDADMRARVA--DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE--K 508 (683)
Q Consensus 436 gL~yLH~~~~~~IiHrDIKps---NILLd~~~~~KLa--DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~--k 508 (683)
||+|+| .....|.-+..+ +...+.++...++ ||+..+.......... ..-+..|.+||......++. +
T Consensus 298 GL~~~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~ 372 (1351)
T KOG1035|consen 298 GLAYLH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRL 372 (1351)
T ss_pred hHHHHH---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhh
Confidence 999999 555555555554 4445666777777 8888776544322211 22345678888877666554 4
Q ss_pred ccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhc
Q 005691 509 SDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCA 588 (683)
Q Consensus 509 sDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~ 588 (683)
.|+|.+|.+...+..|..+........ ..++.. . ..........|.
T Consensus 373 ~dL~~lgll~~~~~~~~~i~~~~~~~~--------------------~~l~~~----------~----~~~~~d~~~~~~ 418 (1351)
T KOG1035|consen 373 TDLWCLGLLLLQLSQGEDISEKSAVPV--------------------SLLDVL----------S----TSELLDALPKCL 418 (1351)
T ss_pred hHHHHHHHHHhhhhhcCcccccccchh--------------------hhhccc----------c----chhhhhhhhhhc
Confidence 799999999999999887643211100 000000 0 002344556799
Q ss_pred ccCCCCCCCHHHHHHHH
Q 005691 589 HVMVALRPTISDALKML 605 (683)
Q Consensus 589 ~~dP~~RPtm~eVl~~L 605 (683)
..++++|+...+++.+.
T Consensus 419 ~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 419 DEDSEERLSALELLTHP 435 (1351)
T ss_pred chhhhhccchhhhhhch
Confidence 99999999999998765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.048 Score=57.57 Aligned_cols=33 Identities=30% Similarity=0.503 Sum_probs=26.8
Q ss_pred CCCccccCCCCCceeeccCCc-EEEcccCccccc
Q 005691 445 KPAIYHRDIKATNILLDADMR-ARVADFGLAKQS 477 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~-~KLaDFGla~~~ 477 (683)
...++|+|+++.|||++++++ .-|.||+.+...
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 345899999999999997555 469999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.038 Score=58.74 Aligned_cols=146 Identities=23% Similarity=0.283 Sum_probs=71.6
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc---CCCcccccceeeecCCCCCCCeeEEE
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK---HRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
..+.++-|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+.+++.. ..+..+||
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~------~~~~~fLl 90 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGE------YDDDAFLL 90 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-------SSCCEEE
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe------ecCCceEE
Confidence 34568888889999977 6788999997652 23456889999888884 334556777765 23445999
Q ss_pred EeecCCCCcc--c---------cccC-CCCCCC--------CCCCC----CCCcc-----chhhhHHHHH----------
Q 005691 394 YDYMPNGNVD--D---------HLFP-SFNDGS--------GVAKR----PLTWP-----QRKNIILDVA---------- 434 (683)
Q Consensus 394 ~Ey~~~GsL~--~---------~L~~-~~~~~~--------~~~~~----~L~w~-----~r~~Ia~~iA---------- 434 (683)
+||++.+... + .||. .....- +.... .-+|. +|+.-..+.+
T Consensus 91 le~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~ 170 (288)
T PF03881_consen 91 LEFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAEL 170 (288)
T ss_dssp EE--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHH
T ss_pred EEeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHH
Confidence 9999887111 1 1122 100000 00001 11221 2222222221
Q ss_pred ----HHH-HHHh-cccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 435 ----KGL-AYLH-YGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 435 ----~gL-~yLH-~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
+.+ ..|+ ....+.++|+||.+.|++.+.++.+.|.|=.
T Consensus 171 ~~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 171 ERLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 111 1233 1236789999999999999999989998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.053 Score=57.54 Aligned_cols=70 Identities=13% Similarity=0.182 Sum_probs=41.4
Q ss_pred EEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCC---CCCCCeeEEEEeecCCCCcc
Q 005691 328 LVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD---NERGSERYLVYDYMPNGNVD 403 (683)
Q Consensus 328 ~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~---~~~~~~~~LV~Ey~~~GsL~ 403 (683)
.||+...++| .+++|++.. ..+....|+..+..|....+ ++.......+. ...++..+.++||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~----~~~~~~~~~~~~~~L~~~g~-~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINY----PPERLLFILGAQEHLRKNGF-NIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCC----CHHHHHHHHHHHHHHHHcCC-CCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4888876555 688888742 23446667888877754443 32222221110 01235689999999987664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.07 Score=58.16 Aligned_cols=142 Identities=15% Similarity=0.128 Sum_probs=78.8
Q ss_pred eeecCceEEEEEEEcC-----CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCCeeEEEE
Q 005691 321 IGRGGFGLVYKGILQD-----GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 321 LG~GgfG~Vykg~l~~-----g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
|-.|-...+|+....+ ++.|.+|.......... .-.+|..++..+...++. +++++.. + ..|+
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~-------~---g~v~ 112 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFP-------N---GRVE 112 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEEC-------C---ceEE
Confidence 4345566788876542 35788887654332221 236799999888665555 3445431 1 2589
Q ss_pred eecCCCCcccc-----------------ccCCCCCCCCCCCCCCCccchhhhHH-----------------HHHHHHHHH
Q 005691 395 DYMPNGNVDDH-----------------LFPSFNDGSGVAKRPLTWPQRKNIIL-----------------DVAKGLAYL 440 (683)
Q Consensus 395 Ey~~~GsL~~~-----------------L~~~~~~~~~~~~~~L~w~~r~~Ia~-----------------~iA~gL~yL 440 (683)
||+++.+|... +|..... .......|.+..++.. .+..-+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~---~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMP---GPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCC---CCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 99988776532 1111100 0011112222222211 111112222
Q ss_pred ----hc-ccCCCccccCCCCCceeecc-CCcEEEcccCcccc
Q 005691 441 ----HY-GVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQ 476 (683)
Q Consensus 441 ----H~-~~~~~IiHrDIKpsNILLd~-~~~~KLaDFGla~~ 476 (683)
.. .....++|+|+++.|||+++ +..+++.||..+..
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 21 22457899999999999986 46899999988754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.017 Score=61.60 Aligned_cols=132 Identities=18% Similarity=0.170 Sum_probs=87.2
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeec--cCcc--------------C------hHHHHHHHHHHHhccC-C-
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIE--SDFQ--------------G------DAEFCNEVEIISNLKH-R- 369 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~--~~~~--------------~------~~~f~~Ev~iL~~L~H-~- 369 (683)
-++..+.||-|--+.||.+...+|++.++|.-+- .+.. + .-...+|+..|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567889999999999999999999998874211 1110 0 0124567777777742 2
Q ss_pred CcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcc
Q 005691 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIY 449 (683)
Q Consensus 370 NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~Ii 449 (683)
-+.+.+ +....++|||++.+-.|...-+ ..+-++ +...+..-+.-|- ..++|
T Consensus 173 pVPkpi----------D~~RH~Vvmelv~g~Pl~~v~~------------v~d~~~---ly~~lm~~Iv~la---~~GlI 224 (465)
T KOG2268|consen 173 PVPKPI----------DHNRHCVVMELVDGYPLRQVRH------------VEDPPT---LYDDLMGLIVRLA---NHGLI 224 (465)
T ss_pred CCCCcc----------cccceeeHHHhhcccceeeeee------------cCChHH---HHHHHHHHHHHHH---HcCce
Confidence 222333 2345789999998877665431 112222 2223333334444 78999
Q ss_pred ccCCCCCceeeccCCcEEEcccCc
Q 005691 450 HRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 450 HrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|+|..-=||+++++..++++||--
T Consensus 225 HgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred ecccchheeEEecCCCEEEeechH
Confidence 999999999999999999999964
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.17 Score=54.18 Aligned_cols=32 Identities=16% Similarity=0.269 Sum_probs=28.6
Q ss_pred CCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
..+++|+|+.+.|||++.++.+.|.||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 55799999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.29 Score=52.72 Aligned_cols=35 Identities=26% Similarity=0.460 Sum_probs=30.3
Q ss_pred CCCccccCCCCCceeeccCCcEEEcccCccccccc
Q 005691 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~ 479 (683)
...++|+|+.+.||+++.+.-.=|.||+++..-++
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 45799999999999999988899999999876543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.0017 Score=79.92 Aligned_cols=162 Identities=11% Similarity=0.008 Sum_probs=109.9
Q ss_pred HHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHH
Q 005691 357 CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436 (683)
Q Consensus 357 ~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~g 436 (683)
..|+..++...|++++....-.. ..+..+.+.+++|+..|.+.+.|-.... +...++..-....-.+....
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~----ps~s~ee~~r~~~~~~g~~f~iIikg~e-----e~~~ld~~~v~~~~kvsvl~ 1347 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIP----PSESTEEYIRSLYVEFGKLFSIIIKGLE-----ESPDLDRSPVHLRHKVSVLN 1347 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCC----CCCChHHHHHHHHHHHhHHHHHHHhccc-----cCCcchhchHHHHHHHHHhc
Confidence 34455556678888776442221 2256678899999999999998854432 22333333322222222333
Q ss_pred HHHHhc--ccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEc
Q 005691 437 LAYLHY--GVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSF 514 (683)
Q Consensus 437 L~yLH~--~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSf 514 (683)
..-.|. +...-.+|+++|+-|.+|+.+.++|++++|+.+..... ........+++-|+.|+....-.++.++|+|..
T Consensus 1348 ~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1348 RNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred cchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence 333332 22345789999999999999999999999999833222 222333567788999999988889999999999
Q ss_pred chhHHHHhhCCCCC
Q 005691 515 GVVILEIMCGRKAL 528 (683)
Q Consensus 515 GvlLlELltGr~p~ 528 (683)
|..+++.--|..++
T Consensus 1427 s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhcccHHH
Confidence 99999988877665
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.37 Score=60.05 Aligned_cols=153 Identities=22% Similarity=0.311 Sum_probs=82.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccC--CC-----cccc-cceeeecCCCCCC-Ce
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH--RN-----LVPL-RGCCVVDGDNERG-SE 389 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H--~N-----LV~L-~G~c~~~~~~~~~-~~ 389 (683)
..|+ |..-.+|+....+|..+++|+..... ...+...|...|..|.. +. +++- -|-.........+ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 45678899888888889999876532 23344556666665532 22 2221 1211100000012 24
Q ss_pred eEEEEeecCCCCcccccc-----------------C---CCCCCCCCCCCCCCccchh-----------------hhHHH
Q 005691 390 RYLVYDYMPNGNVDDHLF-----------------P---SFNDGSGVAKRPLTWPQRK-----------------NIILD 432 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~-----------------~---~~~~~~~~~~~~L~w~~r~-----------------~Ia~~ 432 (683)
.+-+++|++|..|.+... . .... ....+.+.|..+. .++..
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~--p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~ 185 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMH--PGALRDLDWDLRHAGRARDRLHFIDDPEDRALVER 185 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCC--CCcccccccccccchhhhhhhhhcCCHHHHHHHHH
Confidence 567899999987765210 0 0100 0112345554321 22223
Q ss_pred HHHHHH----HHhcccCCCccccCCCCCceeeccCC--cEE-EcccCcccc
Q 005691 433 VAKGLA----YLHYGVKPAIYHRDIKATNILLDADM--RAR-VADFGLAKQ 476 (683)
Q Consensus 433 iA~gL~----yLH~~~~~~IiHrDIKpsNILLd~~~--~~K-LaDFGla~~ 476 (683)
+.+.+. .........+||.|+.+.|||++.+. ++. |.|||-+..
T Consensus 186 ~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 186 FLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 322221 11122356799999999999999875 555 999997653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.29 Score=53.16 Aligned_cols=146 Identities=20% Similarity=0.271 Sum_probs=82.9
Q ss_pred CceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc------cccceeeecCCCCCCCeeEEEEeecC
Q 005691 325 GFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV------PLRGCCVVDGDNERGSERYLVYDYMP 398 (683)
Q Consensus 325 gfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV------~L~G~c~~~~~~~~~~~~~LV~Ey~~ 398 (683)
.-..||+....+|+. ++|..... ....+...|...+..|.-..+. .+-|-....-. .+...+-+++|++
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~--~~~r~a~lf~~l~ 111 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALS--GGPRPAALFEYLP 111 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhcc--CCceeEEEEEecC
Confidence 446789988887776 66665443 4566677788888877432221 22221111100 1147889999999
Q ss_pred CCCccc-cc--------------cCCCCCC---CCCCCCCCCcc-------------chhhhHHHHHHHHHHHhccc---
Q 005691 399 NGNVDD-HL--------------FPSFNDG---SGVAKRPLTWP-------------QRKNIILDVAKGLAYLHYGV--- 444 (683)
Q Consensus 399 ~GsL~~-~L--------------~~~~~~~---~~~~~~~L~w~-------------~r~~Ia~~iA~gL~yLH~~~--- 444 (683)
|..+.. -- |....+- .........|. ........+...+..+.+..
T Consensus 112 G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~ 191 (331)
T COG2334 112 GRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAH 191 (331)
T ss_pred CcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhh
Confidence 988883 11 1000000 00111233443 11123334444444444322
Q ss_pred -CCC---ccccCCCCCceeeccCCc-EEEcccCccc
Q 005691 445 -KPA---IYHRDIKATNILLDADMR-ARVADFGLAK 475 (683)
Q Consensus 445 -~~~---IiHrDIKpsNILLd~~~~-~KLaDFGla~ 475 (683)
... +||+|+.|.||++|.+.. ..+.||+-+.
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 222 999999999999999875 8899999764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.43 Score=51.52 Aligned_cols=74 Identities=19% Similarity=0.115 Sum_probs=46.3
Q ss_pred cCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCC--Ccccc---cceeeecCCCCCCCeeEEEEeecC
Q 005691 324 GGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHR--NLVPL---RGCCVVDGDNERGSERYLVYDYMP 398 (683)
Q Consensus 324 GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~--NLV~L---~G~c~~~~~~~~~~~~~LV~Ey~~ 398 (683)
+.-..||+....+|..+++|.... ......+...|++.+..|... .++.. -|-... ..++..+.++++++
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~----~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLH----EHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEE----EECCEEEEEEeeeC
Confidence 344679999888888898887643 333456677888888877432 22222 121100 12346788999998
Q ss_pred CCCc
Q 005691 399 NGNV 402 (683)
Q Consensus 399 ~GsL 402 (683)
|...
T Consensus 111 G~~~ 114 (325)
T PRK11768 111 GRAP 114 (325)
T ss_pred CCCC
Confidence 8654
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.022 Score=41.68 Aligned_cols=28 Identities=25% Similarity=0.583 Sum_probs=14.0
Q ss_pred eEEEeehhHHHHHHHHHHHHHHHHHhhhc
Q 005691 241 ALVFGLTGAGVAIFVMFALLGLYFWWDKK 269 (683)
Q Consensus 241 ~~ii~ii~~~~~~vv~l~~~~~~~~~~rk 269 (683)
++..| ++++++++++++++++++||||+
T Consensus 12 aIa~~-VvVPV~vI~~vl~~~l~~~~rR~ 39 (40)
T PF08693_consen 12 AIAVG-VVVPVGVIIIVLGAFLFFWYRRK 39 (40)
T ss_pred EEEEE-EEechHHHHHHHHHHhheEEecc
Confidence 33344 44555555555545555555554
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.19 Score=55.08 Aligned_cols=73 Identities=18% Similarity=0.143 Sum_probs=47.5
Q ss_pred eeeecCceEEEEEEEcCC-cEEEEEEeeccC-------ccChHHHHHHHHHHHhcc--CCCccc-ccceeeecCCCCCCC
Q 005691 320 FIGRGGFGLVYKGILQDG-TTVAVKKVIESD-------FQGDAEFCNEVEIISNLK--HRNLVP-LRGCCVVDGDNERGS 388 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g-~~VAVK~l~~~~-------~~~~~~f~~Ev~iL~~L~--H~NLV~-L~G~c~~~~~~~~~~ 388 (683)
.||.|....||++..++| +.|+||+-...- .-..+...-|.+.|.... -|..|+ ++.| +..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--------D~e 73 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--------DTE 73 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--------ccc
Confidence 479999999999998765 589999863211 112344556777776652 343343 4433 445
Q ss_pred eeEEEEeecCCC
Q 005691 389 ERYLVYDYMPNG 400 (683)
Q Consensus 389 ~~~LV~Ey~~~G 400 (683)
...+|||+++..
T Consensus 74 ~~~~vMEdL~~~ 85 (370)
T TIGR01767 74 MAVTVMEDLSHH 85 (370)
T ss_pred cceehHhhCccc
Confidence 678999999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.23 Score=49.90 Aligned_cols=31 Identities=29% Similarity=0.478 Sum_probs=21.9
Q ss_pred CCccccCCCCCceee-ccCCcEEEcccCcccc
Q 005691 446 PAIYHRDIKATNILL-DADMRARVADFGLAKQ 476 (683)
Q Consensus 446 ~~IiHrDIKpsNILL-d~~~~~KLaDFGla~~ 476 (683)
..+.|.|+.+.|||+ +.++.+++.||-.|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468899999999999 8889999999987754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.65 E-value=0.28 Score=50.10 Aligned_cols=151 Identities=17% Similarity=0.157 Sum_probs=94.0
Q ss_pred eEEEEEEEcCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCcccc
Q 005691 327 GLVYKGILQDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH 405 (683)
Q Consensus 327 G~Vykg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~ 405 (683)
.+.-+|.-+- ....+|++...... ...-|.++.+++++++ .|++|. . ..+...-++.|++-.-.
T Consensus 76 sTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~----N----Dn~~~yGvIlE~Cy~~~---- 140 (308)
T PF07387_consen 76 STLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK----N----DNNYKYGVILERCYKIK---- 140 (308)
T ss_pred eEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee----c----CCCceeEEEEeeccCcc----
Confidence 4444443332 34567877665555 5667899999999886 466665 1 14456778888873210
Q ss_pred ccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCcccc
Q 005691 406 LFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485 (683)
Q Consensus 406 L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~ 485 (683)
.+. ..++.-=.++|.-.|.+ ..+.+|+|-.|+||+-|..|.+||.|=+.-- +
T Consensus 141 --------------i~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll---~------ 192 (308)
T PF07387_consen 141 --------------INF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL---E------ 192 (308)
T ss_pred --------------cch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh---h------
Confidence 010 11222224567778854 7889999999999999999999999976321 0
Q ss_pred ccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCC
Q 005691 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527 (683)
Q Consensus 486 ~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p 527 (683)
.+..|.-- .+...|.++.+=+|=.-+++++.-.+.
T Consensus 193 ----~~V~~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~~~~ 227 (308)
T PF07387_consen 193 ----NQVNMVNI---EYESLTQEAEVKVFVKSCLKLVEKQRS 227 (308)
T ss_pred ----heeeEEee---eccccChHHHHHHHHHHHHHHHHHHhc
Confidence 01122221 233456777777777777887766554
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.044 Score=61.68 Aligned_cols=47 Identities=15% Similarity=0.216 Sum_probs=35.1
Q ss_pred HHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccc
Q 005691 354 AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL 406 (683)
Q Consensus 354 ~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L 406 (683)
.+..-..++++.+.|+|+...+.+... ......+|+|+. +.||.+.+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~-----~~~r~IVV~e~~-~~Sled~~ 73 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRG-----KHERVIVVMEHY-TMSLEDIL 73 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecC-----ccceEEEEehhh-ccchHHHH
Confidence 456677888999999999888766531 223467889988 67888887
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.74 Score=51.32 Aligned_cols=80 Identities=10% Similarity=0.075 Sum_probs=51.0
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCc-------cChHHHHHHHHHHHhcc---CCCcccccceeeecCCCCCC
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF-------QGDAEFCNEVEIISNLK---HRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~-------~~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~~~~~~~~~ 387 (683)
.+.||.|....||+.... +..++||+-..... -....-..|.+.|..+. ..++.++++++.
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-------- 107 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-------- 107 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--------
Confidence 346899999999998764 56799998642111 12223344566666553 246677887763
Q ss_pred CeeEEEEeecCC--CCccccc
Q 005691 388 SERYLVYDYMPN--GNVDDHL 406 (683)
Q Consensus 388 ~~~~LV~Ey~~~--GsL~~~L 406 (683)
+..+++|||+++ ..+.+.|
T Consensus 108 d~~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 108 TMALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CCCEEEEeecCCcceehhhhh
Confidence 456889999977 3444433
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.80 E-value=0.22 Score=54.32 Aligned_cols=136 Identities=17% Similarity=0.215 Sum_probs=86.6
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCc---------cChHH-----------------HHHHHHHHHhccCCCcc
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDF---------QGDAE-----------------FCNEVEIISNLKHRNLV 372 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~---------~~~~~-----------------f~~Ev~iL~~L~H~NLV 372 (683)
..|..|--..||.+.-.+|..+|||+++.... .++-. ..+|++-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46788888999999999999999998743211 11111 23455556666543322
Q ss_pred cccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccC
Q 005691 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRD 452 (683)
Q Consensus 373 ~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrD 452 (683)
----. .-....|||+|+-... |-... .+...++.......-.++++-+.-|.+ .-++||.|
T Consensus 230 ~PePI--------lLk~hVLVM~FlGrdg---w~aPk------LKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHAD 290 (520)
T KOG2270|consen 230 CPEPI--------LLKNHVLVMEFLGRDG---WAAPK------LKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHAD 290 (520)
T ss_pred CCCce--------eeecceEeeeeccCCC---CcCcc------cccccCChHHHHHHHHHHHHHHHHHHH--Hhceeccc
Confidence 11111 1124579999985321 22111 122345655667777788888877764 44799999
Q ss_pred CCCCceeeccCCcEEEcccCcc
Q 005691 453 IKATNILLDADMRARVADFGLA 474 (683)
Q Consensus 453 IKpsNILLd~~~~~KLaDFGla 474 (683)
|.--|+|+.+ |.+.|+|.+-+
T Consensus 291 LSEfN~Lyhd-G~lyiIDVSQS 311 (520)
T KOG2270|consen 291 LSEFNLLYHD-GKLYIIDVSQS 311 (520)
T ss_pred hhhhhheEEC-CEEEEEEcccc
Confidence 9999999864 67899998754
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.84 Score=49.42 Aligned_cols=73 Identities=15% Similarity=0.117 Sum_probs=44.3
Q ss_pred eeeecCceEEEEEEEcC----CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCCeeEEEE
Q 005691 320 FIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGSERYLVY 394 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~~~~LV~ 394 (683)
.|..|=-..+|+....+ +..|.+|........ .-.-.+|..+++.+...++. +++++.. . .+|.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~------~----G~i~ 89 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG------N----GMIQ 89 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC------C----cEee
Confidence 34445556788887543 237888876543222 22245789999988766664 3454431 1 1589
Q ss_pred eecCCCCcc
Q 005691 395 DYMPNGNVD 403 (683)
Q Consensus 395 Ey~~~GsL~ 403 (683)
+|+++..|.
T Consensus 90 ~fi~g~~l~ 98 (330)
T PLN02421 90 SFINARTLT 98 (330)
T ss_pred hhhcCCCCC
Confidence 999776663
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=92.11 E-value=0.32 Score=50.78 Aligned_cols=74 Identities=19% Similarity=0.139 Sum_probs=52.6
Q ss_pred eeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHH---HHHHhccCCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 320 FIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEV---EIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev---~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
.+-.|..+.|++++..||+++++|...... ++..|. ..|+..+=...|+++.. +.....|++|.
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~-----~~~~E~~g~~~L~~w~G~GaVrll~~--------d~~~~AlLLEr 75 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHA-----EAEHEARGEAALRWWNGRGAVRLLAA--------DPERGALLLER 75 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCcc-----cchhhhhHHhHhheeCCCCceeeecc--------ccccchhhhhh
Confidence 456788899999999999999999865432 222343 44766666778888865 23457888999
Q ss_pred c-CCCCccccc
Q 005691 397 M-PNGNVDDHL 406 (683)
Q Consensus 397 ~-~~GsL~~~L 406 (683)
+ ++.+|.+..
T Consensus 76 l~~g~~L~~~~ 86 (253)
T PF04655_consen 76 LDPGRSLASLP 86 (253)
T ss_pred ccCCCchhhcc
Confidence 9 556776654
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.66 E-value=0.25 Score=54.49 Aligned_cols=62 Identities=16% Similarity=0.078 Sum_probs=43.8
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
...|+=+|+++-++..++. .+..+...+.+++.-.++||--+-. --+.+|.|+.|.||++--
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~----------~~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVK----------WKSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhh----------cccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 3567777888888888872 2234445667777777777654431 457999999999999954
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.38 E-value=1.4 Score=48.82 Aligned_cols=74 Identities=19% Similarity=0.185 Sum_probs=44.1
Q ss_pred eeeecCceEEEEEEEcCCc--E-----EEEEEeeccCccChHHHHHHHHHHHhccCCCccccc-ceeeecCCCCCCCeeE
Q 005691 320 FIGRGGFGLVYKGILQDGT--T-----VAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLR-GCCVVDGDNERGSERY 391 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~~g~--~-----VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~-G~c~~~~~~~~~~~~~ 391 (683)
.|..|--..+|+....++. . |.++.... ...-.-+-..|+++++.+...++.+-+ |.+ .-.
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f----------~~g 125 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF----------GDF 125 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEec----------CCE
Confidence 4444667889998765432 2 33332211 111111235789999999777766544 333 236
Q ss_pred EEEeecCCCCccc
Q 005691 392 LVYDYMPNGNVDD 404 (683)
Q Consensus 392 LV~Ey~~~GsL~~ 404 (683)
+|+||+++.+|..
T Consensus 126 ~l~efIeGr~l~~ 138 (383)
T PTZ00384 126 TIQEWVEGNTMGI 138 (383)
T ss_pred EEEEEeccccCCh
Confidence 9999999987753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 683 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-60 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-58 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-33 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 422 bits (1088), Expect = e-144
Identities = 132/308 (42%), Positives = 187/308 (60%), Gaps = 18/308 (5%)
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG-DAEFCNEV 360
F +++L+ A+D FS KN +GRGGFG VYKG L DGT VAVK++ E QG + +F EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 361 EIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP 420
E+IS HRNL+ LRG C+ +ER LVY YM NG+V L ++ P
Sbjct: 79 EMISMAVHRNLLRLRGFCM------TPTERLLVYPYMANGSVASCLR-----ERPESQPP 127
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
L WP+R+ I L A+GLAYLH P I HRD+KA NILLD + A V DFGLAK
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540
+H+TT V GT G++APEY G+ +EK+DV+ +GV++LE++ G++A DL+ + +
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600
+ DWV L+K K+ +D L + ++ +E+ + V +LC RP +S+
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDL--QGNY----KDEEVEQLIQVALLCTQSSPMERPKMSE 301
Query: 601 ALKMLEGD 608
++MLEGD
Sbjct: 302 VVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-135
Identities = 125/338 (36%), Positives = 184/338 (54%), Gaps = 25/338 (7%)
Query: 276 GSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ 335
GS +++ + S + DLE AT+ F K IG G FG VYKG+L+
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 336 DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395
DG VA+K+ QG EF E+E +S +H +LV L G C +E +E L+Y
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DE-RNEMILIYK 115
Query: 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455
YM NGN+ HL+ GS + ++W QR I + A+GL YLH AI HRD+K+
Sbjct: 116 YMENGNLKRHLY-----GSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKS 167
Query: 456 TNILLDADMRARVADFGLAKQ-SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSF 514
NILLD + ++ DFG++K+ + Q+HL+T V GT GY+ PEY + G+LTEKSDVYSF
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 515 GVVILEIMCGRKALDLSTSGSPRACL-ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNP 573
GVV+ E++C R A+ S PR + + +W G++ Q +DP+L D P
Sbjct: 228 GVVLFEVLCARSAIVQS---LPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKI---RP 279
Query: 574 KAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEV 611
++ + +F + C + RP++ D L LE + +
Sbjct: 280 ES-LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-121
Identities = 111/337 (32%), Positives = 164/337 (48%), Gaps = 48/337 (14%)
Query: 284 SLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQK------NFIGRGGFGLVYKGILQDG 337
SLE +R F +L+ T+ F ++ N +G GGFG+VYKG + +
Sbjct: 4 SLEVSDTRFH--------SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NN 54
Query: 338 TTVAVKK----VIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393
TTVAVKK V + + +F E+++++ +H NLV L G DGD + LV
Sbjct: 55 TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGD-----DLCLV 108
Query: 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453
Y YMPNG++ D L PL+W R I A G+ +LH + HRDI
Sbjct: 109 YVYMPNGSLLDRLSCLDG------TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDI 159
Query: 454 KATNILLDADMRARVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVY 512
K+ NILLD A+++DFGLA+ S + + +T+R+ GT Y+APE L G++T KSD+Y
Sbjct: 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIY 218
Query: 513 SFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK-AGKVWQALDPSLLKEDDFLSL 571
SFGVV+LEI+ G A+D L+ D + + +D + +D
Sbjct: 219 SFGVVLLEIITGLPAVDEH---REPQLLL-DIKEEIEDEEKTIEDYIDKKM---NDA--- 268
Query: 572 NPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608
+E V C H RP I ++L+
Sbjct: 269 -DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 2e-79
Identities = 75/333 (22%), Positives = 120/333 (36%), Gaps = 39/333 (11%)
Query: 292 PKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ 351
++ + ++L + RG FG V+K L VAVK D Q
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ 61
Query: 352 GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
+ EV + +KH N++ G + +L+ + G++ D L
Sbjct: 62 S-WQNEYEVYSLPGMKHENILQFIGAEK--RGTSVDVDLWLITAFHEKGSLSDFLK---- 114
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYLH-------YGVKPAIYHRDIKATNILLDADM 464
++W + +I +A+GLAYLH G KPAI HRDIK+ N+LL ++
Sbjct: 115 ------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168
Query: 465 RARVADFGLAKQSREGQSHL-TTRVAGTHGYLAPEYA-----LYGQLTEKSDVYSFGVVI 518
A +ADFGLA + G+S T GT Y+APE + D+Y+ G+V+
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
Query: 519 LEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQA-----LDPSLLKEDDFLSLNP 573
E+ A D + + + + P L
Sbjct: 229 WELASRCTAAD--GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD-----YWQK 281
Query: 574 KAIMERFVLVGILCAHVMVALRPTISDALKMLE 606
A M C R + + +
Sbjct: 282 HAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-63
Identities = 79/351 (22%), Positives = 120/351 (34%), Gaps = 52/351 (14%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
+ D IGRG +G VYKG L D VAVK ++ Q F NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 363 --ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP 420
+ ++H N+ + R E LV +Y PNG++ +L
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGR-MEYLLVMEYYPNGSLXKYLS----------LHT 107
Query: 421 LTWPQRKNIILDVAKGLAYLH------YGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
W + V +GLAYLH KPAI HRD+ + N+L+ D ++DFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 475 K-------QSREGQSHLTTRVAGTHGYLAPEYA-------LYGQLTEKSDVYSFGVVILE 520
+ + GT Y+APE ++ D+Y+ G++ E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 521 IMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALD--------PSLLKEDDFLSLN 572
I L S V + + + P KE+ +
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 573 PKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVPPLPDRPMPLGH 623
K +E C R T A + + + + P H
Sbjct: 288 LKETIED-------CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 9e-59
Identities = 72/240 (30%), Positives = 110/240 (45%), Gaps = 17/240 (7%)
Query: 288 QSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIE 347
P D++ + K IG G FG V++ G+ VAVK ++E
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILME 70
Query: 348 SDFQGDA--EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH 405
DF + EF EV I+ L+H N+V G + +V +Y+ G++
Sbjct: 71 QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT------QPPNLSIVTEYLSRGSLYRL 124
Query: 406 LFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465
L A+ L +R ++ DVAKG+ YLH P I HR++K+ N+L+D
Sbjct: 125 LH------KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYT 177
Query: 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+V DFGL++ + AGT ++APE EKSDVYSFGV++ E+ +
Sbjct: 178 VKVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 6e-56
Identities = 46/211 (21%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLVPLRGCC 378
+ G ++KG Q G + VK + D+ +F E + H N++P+ G C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+ L+ +MP G++ + L + Q LD+A+G+A
Sbjct: 77 Q----SPPAPHPTLITHWMPYGSLYNVLHEG-------TNFVVDQSQAVKFALDMARGMA 125
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE 498
+LH ++P I + + ++++D DM AR++ + S + ++APE
Sbjct: 126 FLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE 178
Query: 499 YAL----YGQLTEKSDVYSFGVVILEIMCGR 525
AL +D++SF V++ E++
Sbjct: 179 -ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 38/222 (17%)
Query: 321 IGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDA-------EFCNEVEIISNLKHRNLV 372
IG+GGFGLV+KG L D + VA+K +I D +G+ EF EV I+SNL H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L G + +V +++P G++ L P+ W + ++LD
Sbjct: 87 KLYGLMH--------NPPRMVMEFVPCGDLYHRLL--------DKAHPIKWSVKLRLMLD 130
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLD-----ADMRARVADFGLAKQSREGQSHLTTR 487
+A G+ Y+ P I HRD+++ NI L A + A+VADFGL++Q H +
Sbjct: 131 IALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSG 185
Query: 488 VAGTHGYLAPEYALYGQL---TEKSDVYSFGVVILEIMCGRK 526
+ G ++APE + + TEK+D YSF +++ I+ G
Sbjct: 186 LLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+ + +GRG FG+V K + VA+K++ + F E+ +S + H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L G C+ + LV +Y G++ + L + T + L
Sbjct: 65 KLYGACL--------NPVCLVMEYAEGGSLYNVLHGAEP------LPYYTAAHAMSWCLQ 110
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMR-ARVADFGLAKQSREGQSHLTTRVAGT 491
++G+AYLH A+ HRD+K N+LL A ++ DFG + + Q+H+T G+
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT---ACDIQTHMTNNK-GS 166
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK 526
++APE +EK DV+S+G+++ E++ RK
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-54
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA----EFCNEVEIISNLKHRNLVPLRG 376
IG GGFG VY+ G VAVK + + E ++ + LKH N++ LRG
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
C+ + LV ++ G ++ L + + + N + +A+G
Sbjct: 74 VCL------KEPNLCLVMEFARGGPLNRVL----------SGKRIPPDILVNWAVQIARG 117
Query: 437 LAYLHYGVKPAIYHRDIKATNILLDADMRAR--------VADFGLAKQSREGQSHLTTRV 488
+ YLH I HRD+K++NIL+ + + DFGL +RE
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL---AREWHRTTKMSA 174
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
AG + ++APE ++ SDV+S+GV++ E++ G
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-53
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 32/246 (13%)
Query: 286 EGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKV 345
+G + W E + + IG G FG VYKG VAVK +
Sbjct: 3 KGHHHHHHGSRDAADDW------EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKML 54
Query: 346 IESDFQGD--AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVD 403
+ F NEV ++ +H N++ G + +V + ++
Sbjct: 55 NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-------TAPQLAIVTQWCEGSSLY 107
Query: 404 DHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463
HL ++ + +I A+G+ YLH +I HRD+K+ NI L D
Sbjct: 108 HHLH--------ASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHED 156
Query: 464 MRARVADFGLAK-QSREGQSHLTTRVAGTHGYLAPE---YALYGQLTEKSDVYSFGVVIL 519
++ DFGLA +SR SH +++G+ ++APE + +SDVY+FG+V+
Sbjct: 157 NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 520 EIMCGR 525
E+M G+
Sbjct: 217 ELMTGQ 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 4e-53
Identities = 78/349 (22%), Positives = 128/349 (36%), Gaps = 57/349 (16%)
Query: 279 LDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGT 338
++ S S S P L T I +IQ +++ IG+G +G V+ G + G
Sbjct: 15 IEQSQSSGSGSGLPLLVQRT--IAKQIQMVKQ----------IGKGRYGEVWMGKWR-GE 61
Query: 339 TVAVKKVIESDFQGDAEFCNEVEI--ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396
VAVK ++ + E EI ++H N++ + ++ YL+ DY
Sbjct: 62 KVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAADI--KGTGSWTQLYLITDY 116
Query: 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLH-----YGVKPAIYHR 451
NG++ D+L L + GL +LH KPAI HR
Sbjct: 117 HENGSLYDYL----------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166
Query: 452 DIKATNILLDADMRARVADFGLAKQSREGQSHL---TTRVAGTHGYLAPEYALYGQL--- 505
D+K+ NIL+ + +AD GLA + + + GT Y+ PE L L
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRN 225
Query: 506 ----TEKSDVYSFGVVILEIMCGRKALDLSTSGSP--RACLITDWVWSLVKAGKVWQALD 559
+D+YSFG+++ E+ + + + +D + ++ + L
Sbjct: 226 HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285
Query: 560 PSLLKEDDFLSLNP--KAIMERFVLVGILCAHVMVALRPTISDALKMLE 606
PS +M C A R T K L
Sbjct: 286 PSFPNRWSSDECLRQMGKLMTE-------CWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-53
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI--ISNLKHRNLVPLRGCC 378
+G+G +G V++G Q G VAVK D + + E E+ L+H N++
Sbjct: 16 VGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASD 71
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+ ++ +L+ Y G++ D+L L I+L +A GLA
Sbjct: 72 M--TSRHSSTQLWLITHYHEMGSLYDYL----------QLTTLDTVSCLRIVLSIASGLA 119
Query: 439 YLH-----YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL---TTRVAG 490
+LH KPAI HRD+K+ NIL+ + + +AD GLA + + L G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 491 THGYLAPE------YALYGQLTEKSDVYSFGVVILEIMCG 524
T Y+APE ++ D+++FG+V+ E+
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 71/263 (26%), Positives = 110/263 (41%), Gaps = 46/263 (17%)
Query: 279 LDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGT 338
+ ++ S P L T I I E IG+G FG V++G + G
Sbjct: 20 IYDMTTSGSGSGLPLLVQRT--IARTIVLQES----------IGKGRFGEVWRGKWR-GE 66
Query: 339 TVAVKKVIESDFQGDAEFCNEVEI--ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396
VAVK + + + E EI L+H N++ DN ++ +LV DY
Sbjct: 67 EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN--KDNGTWTQLWLVSDY 121
Query: 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLH-----YGVKPAIYHR 451
+G++ D+L + +T + L A GLA+LH KPAI HR
Sbjct: 122 HEHGSLFDYL----------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 452 DIKATNILLDADMRARVADFGLAKQSREGQSHLT---TRVAGTHGYLAPEYALYGQL--- 505
D+K+ NIL+ + +AD GLA + + GT Y+APE L +
Sbjct: 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMK 230
Query: 506 ----TEKSDVYSFGVVILEIMCG 524
+++D+Y+ G+V EI
Sbjct: 231 HFESFKRADIYAMGLVFWEIARR 253
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-51
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 321 IGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
+G+G FG K + G + +K++I D + F EV+++ L+H N++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
+ + +Y+ G + + W QR + D+A G+AY
Sbjct: 78 ------KDKRLNFITEYIKGGTLRGIIKSM--------DSQYPWSQRVSFAKDIASGMAY 123
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-------------KQSREGQSHLTT 486
LH I HRD+ + N L+ + VADFGLA + ++
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527
V G ++APE EK DV+SFG+V+ EI+ A
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-49
Identities = 57/263 (21%), Positives = 98/263 (37%), Gaps = 38/263 (14%)
Query: 278 GLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDG 337
G + + SL S P+ + + SI +Q+ + ++ IG+G FG VY G
Sbjct: 1 GPEMNLSLLSARSFPR-KASQTSI--FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG- 56
Query: 338 TTVAVKKVIESDFQGD--AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395
VA++ + D F EV +H N+V G C+ ++
Sbjct: 57 -EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM------SPPHLAIITS 109
Query: 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455
+ + AK L + + I ++ KG+ YLH I H+D+K+
Sbjct: 110 LCKGRTLYSVVR--------DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKS 158
Query: 456 TNILLDADMRARVADFGLAKQSRE----GQSHLTTRVAGTHGYLAPE---------YALY 502
N+ D + + + DFGL S + G +LAPE
Sbjct: 159 KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 503 GQLTEKSDVYSFGVVILEIMCGR 525
++ SDV++ G + E+
Sbjct: 218 LPFSKHSDVFALGTIWYELHARE 240
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 26/223 (11%)
Query: 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQDGTT-VAVKKVIE-SDFQGDAEFCNEVEII 363
+ IGRG FG V+ G L+ T VAVK E A+F E I+
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL 166
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTW 423
H N+V L G C + Y+V + + G+ L L
Sbjct: 167 KQYSHPNIVRLIGVCT------QKQPIYIVMELVQGGDFLTFL--------RTEGARLRV 212
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
++ D A G+ YL K I HRD+ A N L+ +++DFG++++ +G
Sbjct: 213 KTLLQMVGDAAAGMEYLES--KCCI-HRDLAARNCLVTEKNVLKISDFGMSREEADGV-- 267
Query: 484 LTTRVAGTHGY----LAPEYALYGQLTEKSDVYSFGVVILEIM 522
G APE YG+ + +SDV+SFG+++ E
Sbjct: 268 -YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDG----TTVAVK--KVIESDFQGDAEFC 357
K++D+ + +G G FG V +G L+ VAVK K+ S + EF
Sbjct: 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 358 NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA 417
+E + + H N++ L G C+ + ++ + ++ +M G++ +L S +
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCI-EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP-- 141
Query: 418 KRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
+ + ++D+A G+ YL ++ + HRD+ A N +L DM VADFGL+
Sbjct: 142 -KHIPLQTLLKFMVDIALGMEYLSNRNF-----L-HRDLAARNCMLRDDMTVCVADFGLS 194
Query: 475 KQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
K+ G + G + A E T KSDV++FGV + EI
Sbjct: 195 KKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 27/233 (11%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQDG----TTVAVK--KVIESDFQGDAEFC 357
K++D+ +F+ +G+G FG V + L+ VAVK K EF
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 358 NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA 417
E + H ++ L G + R ++ +M +G++ L S +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP-- 131
Query: 418 KRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
L ++D+A G+ YL ++ HRD+ A N +L DM VADFGL+
Sbjct: 132 -FNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 475 KQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
++ G + G L A E T SDV++FGV + EIM
Sbjct: 185 RKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 22/224 (9%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+ +G GGF V L DG A+K+++ + Q E E ++ H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L C+ + E +L+ + G + + + + LT Q ++L
Sbjct: 90 RLVAYCLRERGA--KHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLG 142
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA--- 489
+ +GL +H HRD+K TNILL + + + D G Q+ +
Sbjct: 143 ICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 490 -----GTHGYLAPE---YALYGQLTEKSDVYSFGVVILEIMCGR 525
T Y APE + + E++DV+S G V+ +M G
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 321 IGRGGFGLVYKGILQDG------TTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG V+ + VAVK + E+ +F E E+++ L+H+++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHL------FPSFNDGSGVAKRPLTWPQRKN 428
G C G +V++YM +G+++ L G VA PL Q
Sbjct: 109 FGVCT------EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 429 IILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ VA G+ YL H+ V HRD+ N L+ + ++ DFG+ SR+ S
Sbjct: 163 VASQVAAGMVYLAGLHF-V-----HRDLATRNCLVGQGLVVKIGDFGM---SRDIYSTDY 213
Query: 486 TRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
RV G L PE LY + T +SDV+SFGVV+ EI
Sbjct: 214 YRV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 318 KNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
K +G G FG V+ +D VAVK + + +F E E+++NL+H ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-------FPSFNDGSGVAKRPLTWP 424
V G C G +V++YM +G+++ L + AK L
Sbjct: 80 VKFYGVCG------DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 425 QRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
Q +I +A G+ YL H+ HRD+ N L+ A++ ++ DFG++ R+
Sbjct: 134 QMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMS---RDVY 184
Query: 482 SHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
S RV G H L PE +Y + T +SDV+SFGV++ EI
Sbjct: 185 STDYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLVPLRGC 377
IGRG F VYKG+ + VA ++ + F E E++ L+H N+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR--PLTWPQRKNIILDVAK 435
++ LV + M +G + +L KR + ++ + K
Sbjct: 94 WESTVKGKK--CIVLVTELMTSGTLKTYL-----------KRFKVMKIKVLRSWCRQILK 140
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
GL +LH P I HRD+K NI + ++ D GLA ++ V GT +
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEF 196
Query: 495 LAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+APE + E DVY+FG+ +LE+
Sbjct: 197 MAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 321 IGRGGFGLVYKGIL-----QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G+G FG V G VAVKK+ S + +F E+EI+ +L+H N+V +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C G L+ +Y+P G++ D+L K + + + K
Sbjct: 78 GVCYSAG----RRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICK 125
Query: 436 GLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
G+ YL Y I HRD+ NIL++ + R ++ DFGL K + + +
Sbjct: 126 GMEYLGTKRY-----I-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK---EP 176
Query: 493 GYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G APE + + SDV+SFGVV+ E+
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 321 IGRGGFGLVYKGILQDG-----TTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVP 373
+G G FG VYKG+ VA+K + S E +E +++++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVDNPHVCR 81
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G C+ S L+ MP G + D++ K + N + +
Sbjct: 82 LLGICL-------TSTVQLITQLMPFGCLLDYVREH--------KDNIGSQYLLNWCVQI 126
Query: 434 AKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
AKG+ YL + HRD+ A N+L+ ++ DFGLAK +
Sbjct: 127 AKGMNYLEDRRL-----V-HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA---- 176
Query: 491 THGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G + A E L+ T +SDV+S+GV + E+M
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 34/215 (15%)
Query: 321 IGRGGFGLVYKGIL-----QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G+G FG V G VAVK++ S +F E++I+ L +V R
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G G LV +Y+P+G + D L + L + + K
Sbjct: 91 GVSYGPG----RQSLRLVMEYLPSGCLRDFLQRH--------RARLDASRLLLYSSQICK 138
Query: 436 GLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
G+ YL + HRD+ A NIL++++ ++ADFGLAK + + R
Sbjct: 139 GMEYLGSRRC-----V-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR---EP 189
Query: 493 GYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G APE + +SDV+SFGVV+ E+
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 73/312 (23%), Positives = 117/312 (37%), Gaps = 37/312 (11%)
Query: 226 LSLMSPMKSSNKRHSALVFGLTGAGVAIFVMFALLGLYFWWDKKLRKRFYGSGLDSSSSL 285
+S + PM + H AG+ + L ++ + +G ++
Sbjct: 1 MSPIDPMGHHHHHHGRRR-ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59
Query: 286 EGQSSRPKLRPNTGSIWFKIQDLERATDKFSQK--NFIGRGGFGLVYKGILQDG----TT 339
+ L + +Q + IGRG FG VY G L D
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 340 VAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMP 398
AVK + G+ ++F E I+ + H N++ L G C+ +V YM
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL-----RSEGSPLVVLPYMK 174
Query: 399 NGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKA 455
+G++ + + T L VAKG+ +L + HRD+ A
Sbjct: 175 HGDLRNFIRNE--------THNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAA 220
Query: 456 TNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSD 510
N +LD +VADFGLA+ + + T L A E + T KSD
Sbjct: 221 RNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 511 VYSFGVVILEIM 522
V+SFGV++ E+M
Sbjct: 279 VWSFGVLLWELM 290
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 321 IGRGGFGLVYKGILQD-----GTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG V G VAVK + ++ Q + + E++I+ L H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
+GCC G + LV +Y+P G++ D+L + + Q +
Sbjct: 99 KGCCEDAG----AASLQLVMEYVPLGSLRDYL----------PRHSIGLAQLLLFAQQIC 144
Query: 435 KGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
+G+AYL HY I HRD+ A N+LLD D ++ DFGLAK EG + R
Sbjct: 145 EGMAYLHAQHY-----I-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR---E 195
Query: 492 HGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G APE + SDV+SFGV + E++
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 321 IGRGGFGLVYKGIL-----QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G+G FG V G VAVKK+ S + +F E+EI+ +L+H N+V +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C G L+ +Y+P G++ D+L K + + + K
Sbjct: 109 GVCYSAG----RRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICK 156
Query: 436 GLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
G+ YL Y I HRD+ NIL++ + R ++ DFGL K + + + +
Sbjct: 157 GMEYLGTKRY-----I-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK---EP 207
Query: 493 GYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G APE + + SDV+SFGVV+ E+
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 64/229 (27%), Positives = 94/229 (41%), Gaps = 36/229 (15%)
Query: 308 LERATDKFSQKNFIGRGGFGLVYKGILQDG----TTVAVKKVIE-SDFQGDAEFCNEVEI 362
+ ++ IGRG FG VY G L D AVK + +D ++F E I
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+ + H N++ L G C+ +V YM +G++ + + T
Sbjct: 80 MKDFSHPNVLSLLGICL-----RSEGSPLVVLPYMKHGDLRNFIRNE--------THNPT 126
Query: 423 WPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479
L VAKG+ YL + HRD+ A N +LD +VADFGL +R+
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGL---ARD 177
Query: 480 GQSHLTTRVAGTHGYL------APEYALYGQLTEKSDVYSFGVVILEIM 522
V G A E + T KSDV+SFGV++ E+M
Sbjct: 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 40/216 (18%)
Query: 321 IGRGGFGLVYKGILQDG---TTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G G FG V KG Q TVAVK K +D E E ++ L + +V +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C LV + G ++ +L R + ++ V+
Sbjct: 85 GICE-------AESWMLVMEMAELGPLNKYL---------QQNRHVKDKNIIELVHQVSM 128
Query: 436 GLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG-- 490
G+ YL ++ HRD+ A N+LL A+++DFGL+K R +++ + G
Sbjct: 129 GMKYLEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 491 ----THGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
APE Y + + KSDV+SFGV++ E
Sbjct: 183 PVKWY----APECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH 368
E + +G G FG+V G + VA+K +I+ + EF E +++ NL H
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSH 78
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
LV L G C + +++ +YM NG + ++L + Q
Sbjct: 79 EKLVQLYGVCT------KQRPIFIITEYMANGCLLNYL--------REMRHRFQTQQLLE 124
Query: 429 IILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ DV + + YL + + HRD+ A N L++ +V+DFGL+ R
Sbjct: 125 MCKDVCEAMEYLESKQF-----L-HRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEY 175
Query: 486 TRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
T G PE +Y + + KSD+++FGV++ EI
Sbjct: 176 TSSVG--SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 304 KIQDLE--RATDKFSQKNFIGRGGFGLVYKGILQDG----TTVAVKKVIESDFQGD-AEF 356
+++D+ IG+G FG+VY G D A+K + F
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF 69
Query: 357 CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGV 416
E ++ L H N++ L G + +++ YM +G++ +
Sbjct: 70 LREGLLMRGLNHPNVLALIGIML-----PPEGLPHVLLPYMCHGDLLQFIRSP------- 117
Query: 417 AKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGL 473
+R T + L VA+G+ YL + HRD+ A N +LD +VADFGL
Sbjct: 118 -QRNPTVKDLISFGLQVARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGL 170
Query: 474 AKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
A+ + + + H L A E + T KSDV+SFGV++ E++
Sbjct: 171 ARDILDREY--YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 318 KNFIGRGGFGLVYKGILQDG------TTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRN 370
+G FG VYKG L VA+K + + ++ EF +E + + L+H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-------FPSFNDGSGVAKRPLTW 423
+V L G + +++ Y +G++ + L D K L
Sbjct: 74 VVCLLGVVT------KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 424 PQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
P +++ +A G+ YL H V H+D+ N+L+ + +++D GL RE
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHV-V-----HKDLATRNVLVYDKLNVKISDLGLF---REV 178
Query: 481 QSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
+ + + L APE +YG+ + SD++S+GVV+ E+
Sbjct: 179 YAADYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 321 IGRGGFGLVYKGIL-----QDGTTVAVKKVIESDFQGD-AEFCNEVEIISNLKHRNLVPL 374
+G G FG V G VAVK + A+ E+EI+ NL H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
+G C DG G+ L+ +++P+G++ ++L + K + Q+ + +
Sbjct: 89 KGICTEDG----GNGIKLIMEFLPSGSLKEYLPKN--------KNKINLKQQLKYAVQIC 136
Query: 435 KGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
KG+ YL Y + HRD+ A N+L++++ + ++ DFGL K + + T +
Sbjct: 137 KGMDYLGSRQY-----V-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK---D 187
Query: 492 HGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
APE + + SDV+SFGV + E++
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGC 377
IG G FGLV+ G + VA+K I + +F E E++ L H LV L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
C+ + LV ++M +G + D+L G + LDV +G+
Sbjct: 72 CL------EQAPICLVTEFMEHGCLSDYL--RTQRGL------FAAETLLGMCLDVCEGM 117
Query: 438 AYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH-- 492
AYL HRD+ A N L+ + +V+DFG+ R T GT
Sbjct: 118 AYLEEACV------IHRDLAARNCLVGENQVIKVSDFGMT---RFVLDDQYTSSTGTKFP 168
Query: 493 -GYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ +PE + + + KSDV+SFGV++ E+
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH 368
E ++ + +G G FG+V G + VAVK +I+ + EF E + + L H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSH 62
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
LV G C + Y+V +Y+ NG + ++L + L Q
Sbjct: 63 PKLVKFYGVCS------KEYPIYIVTEYISNGCLLNYL--------RSHGKGLEPSQLLE 108
Query: 429 IILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ DV +G+A+L + HRD+ A N L+D D+ +V+DFG+ R
Sbjct: 109 MCYDVCEGMAFLESHQF------IHRDLAARNCLVDRDLCVKVSDFGMT---RYVLDDQY 159
Query: 486 TRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G APE Y + + KSDV++FG+++ E+
Sbjct: 160 VSSVG--TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 25/238 (10%)
Query: 288 QSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIE 347
+ S P + W K E + + +G G FG V+ T VAVK +
Sbjct: 164 KLSVPCMSSKPQKPWEK-DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP 222
Query: 348 SDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF 407
+ F E ++ L+H LV L Y++ ++M G++ D L
Sbjct: 223 GSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT-------KEPIYIITEFMAKGSLLDFLK 274
Query: 408 PSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467
P+ + +A+G+A++ + I HRD++A NIL+ A + +
Sbjct: 275 SD-------EGSKQPLPKLIDFSAQIAEGMAFI--EQRNYI-HRDLRAANILVSASLVCK 324
Query: 468 VADFGLAKQSREGQSHLTTRVAGTHG---YLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+ADFGLA R + + T G + APE +G T KSDV+SFG++++EI+
Sbjct: 325 IADFGLA---RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH 368
E + +G G FG V+ G T VAVK + + D F E ++ L+H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQH 67
Query: 369 RNLVPLRGCCVVDGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+ LV L ++ Y++ +YM NG++ D L G LT +
Sbjct: 68 QRLVRLYAVV---------TQEPIYIITEYMENGSLVDFL--KTPSG-----IKLTINKL 111
Query: 427 KNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
++ +A+G+A++ +Y HRD++A NIL+ + ++ADFGLA R + +
Sbjct: 112 LDMAAQIAEGMAFIEERNY------IHRDLRAANILVSDTLSCKIADFGLA---RLIEDN 162
Query: 484 LTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
T G APE YG T KSDV+SFG+++ EI+
Sbjct: 163 EYTAREG--AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDG------TTVAVKKVIESDFQGD-AEFCNEVEIISN 365
+ +G G FG VY+G + VAVK + E + D +F E IIS
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
H+N+V G + + R+++ + M G++ L + S L
Sbjct: 90 FNHQNIVRCIGVSL------QSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLD 141
Query: 426 RKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDA---DMRARVADFGLAKQSRE 479
++ D+A G YL H+ I HRDI A N LL A++ DFG+A R+
Sbjct: 142 LLHVARDIACGCQYLEENHF-----I-HRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 192
Query: 480 GQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
R G L PE + G T K+D +SFGV++ EI
Sbjct: 193 IYRASYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 318 KNFIGRGGFGLVYKGILQDG---TTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVP 373
+G G FG V +G+ + VA+K + ++ E E +I+ L + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G C + LV + G + L + + ++ V
Sbjct: 75 LIGVC-------QAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQV 119
Query: 434 AKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ G+ YL ++ HRD+ A N+LL A+++DFGL+K S+ T R AG
Sbjct: 120 SMGMKYLEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
Query: 491 ------THGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
APE + + + +SDV+S+GV + E +
Sbjct: 174 KWPLKWY----APECINFRKFSSRSDVWSYGVTMWEAL 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-36
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
+G+G FG V+ G T VA+K + + F E +++ L+H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS- 249
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
Y+V +YM G++ D L G + L PQ ++ +A G+AY+
Sbjct: 250 ------EEPIYIVTEYMSKGSLLDFLKG--ETG-----KYLRLPQLVDMAAQIASGMAYV 296
Query: 441 ---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
+Y + HRD++A NIL+ ++ +VADFGLA+ + + + AP
Sbjct: 297 ERMNY-----V-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350
Query: 498 EYALYGQLTEKSDVYSFGVVILEIM 522
E ALYG+ T KSDV+SFG+++ E+
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELT 375
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 38/233 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQGD-AEFCNEVEIISN 365
D+ +GRG FG V + TVAVK + E + +E++I+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 366 L-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-------FPSFNDGSGVA 417
+ H N+V L G C + G ++ ++ GN+ +L P +
Sbjct: 87 IGHHLNVVNLLGACT-----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 418 KRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
K LT VAKG+ +L I HRD+ A NILL ++ DFGLA
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKC-----I-HRDLAARNILLSEKNVVKICDFGLA 195
Query: 475 KQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
+ + + V L APE T +SDV+SFGV++ EI
Sbjct: 196 RDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 32/226 (14%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDG------TTVAVKKVIESDFQGD-AEFCNEVEIISN 365
+K + +G+G FG+VY+G+ + T VA+K V E+ + EF NE ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPS-FNDGSGVAKRPLTWP 424
++V L G +G ++ + M G++ +L + P +
Sbjct: 85 FNCHHVVRLLGVVS------QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 425 QRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
+ + ++A G+AYL + HRD+ A N ++ D ++ DFG+ R+
Sbjct: 139 KMIQMAGEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMT---RDIY 189
Query: 482 SHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
R G G L +PE G T SDV+SFGVV+ EI
Sbjct: 190 ETDYYRK-GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 69/239 (28%), Positives = 112/239 (46%), Gaps = 36/239 (15%)
Query: 292 PKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ 351
P +P T + ++ R + + K +G+G FG V+ G T VA+K +
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS 305
Query: 352 GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
+ F E +++ L+H LV L Y+V +YM G++ D L
Sbjct: 306 PE-AFLQEAQVMKKLRHEKLVQLYAVVS-------EEPIYIVTEYMSKGSLLDFLKG--E 355
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARV 468
G + L PQ ++ +A G+AY+ +Y + HRD++A NIL+ ++ +V
Sbjct: 356 TG-----KYLRLPQLVDMAAQIASGMAYVERMNY-----V-HRDLRAANILVGENLVCKV 404
Query: 469 ADFGLAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
ADFGLA+ + + A APE ALYG+ T KSDV+SFG+++ E+
Sbjct: 405 ADFGLARLIEDNE-----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 32/236 (13%)
Query: 292 PKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ 351
F + IG+G FG V G + G VAVK +
Sbjct: 172 VMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA 230
Query: 352 GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
F E +++ L+H NLV L G V + Y+V +YM G++ D+L
Sbjct: 231 QA--FLAEASVMTQLRHSNLVQLLGVIVEEKGG-----LYIVTEYMAKGSLVDYLRSR-- 281
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARV 468
+ L LDV + + YL ++ + HRD+ A N+L+ D A+V
Sbjct: 282 -----GRSVLGGDCLLKFSLDVCEAMEYLEGNNF-----V-HRDLAARNVLVSEDNVAKV 330
Query: 469 ADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
+DFGL K++ Q L + + APE + + KSDV+SFG+++ EI
Sbjct: 331 SDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIY 380
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 36/228 (15%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDG------TTVAVKKVIESDFQGD-AEFCNEVEIISN 365
+ +G G FG VY+G + VAVK + E + D +F E IIS
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
H+N+V G + + R+++ + M G++ L + S L
Sbjct: 131 FNHQNIVRCIGVSL------QSLPRFILLELMAGGDLKSFLRETRPRPS--QPSSLAMLD 182
Query: 426 RKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDA---DMRARVADFGLAKQSRE 479
++ D+A G YL H+ I HRDI A N LL A++ DFG+A R+
Sbjct: 183 LLHVARDIACGCQYLEENHF-----I-HRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 233
Query: 480 GQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
R G L PE + G T K+D +SFGV++ EI
Sbjct: 234 IYRAGYYRK-GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 72/255 (28%), Positives = 110/255 (43%), Gaps = 45/255 (17%)
Query: 288 QSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDG---TTVAVKK 344
K P+ L+ + ++ IG G FG V K ++ A+K+
Sbjct: 6 HHHHGKNNPDPTIYPV----LDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR 59
Query: 345 VIESDFQGD-AEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNV 402
+ E + D +F E+E++ L H N++ L G C G YL +Y P+GN+
Sbjct: 60 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG------YLYLAIEYAPHGNL 113
Query: 403 DDHL-------FPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRD 452
D L + L+ Q + DVA+G+ YL + I HRD
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF-----I-HRD 167
Query: 453 IKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTE 507
+ A NIL+ + A++ADFGL SR + + V T G L A E Y T
Sbjct: 168 LAARNILVGENYVAKIADFGL---SRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTT 220
Query: 508 KSDVYSFGVVILEIM 522
SDV+S+GV++ EI+
Sbjct: 221 NSDVWSYGVLLWEIV 235
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 18/232 (7%)
Query: 292 PKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDF 350
+ +P + E + K+ +G G +G VY+G+ + TVAVK + E
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 258
Query: 351 QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSF 410
+ + EF E ++ +KH NLV L G C R Y++ ++M GN+ D+L
Sbjct: 259 EVE-EFLKEAAVMKEIKHPNLVQLLGVCT------REPPFYIITEFMTYGNLLDYL---- 307
Query: 411 NDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470
++ ++ + ++ + YL K HR++ A N L+ + +VAD
Sbjct: 308 ---RECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVAD 361
Query: 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
FGL++ + APE Y + + KSDV++FGV++ EI
Sbjct: 362 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD--------GTTVAVKKVIE-SDFQGDAEFCNEVEII 363
DK + +G G FG V TVAVK + + + + ++ +E+E++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 364 SNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-------FPSFNDGSG 415
+ KH+N++ L G C DG Y++ +Y GN+ ++L D +
Sbjct: 141 KMIGKHKNIINLLGACTQDG------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFG 472
V + +T+ + +A+G+ YL I HRD+ A N+L+ + ++ADFG
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFG 248
Query: 473 LAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
LA+ + T+G L APE T +SDV+SFGV++ EI
Sbjct: 249 LARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD--------GTTVAVKKVIESDFQGD-AEFCNEVEII 363
DK + +G G FG V TVAVK + + + D ++ +E+E++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 364 SNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-------FPSFNDGSG 415
+ KH+N++ L G C DG Y++ +Y GN+ ++L D +
Sbjct: 95 KMIGKHKNIINLLGACTQDG------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFG 472
V + +T+ + +A+G+ YL I HRD+ A N+L+ + ++ADFG
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFG 202
Query: 473 LAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
LA+ + T+G L APE T +SDV+SFGV++ EI
Sbjct: 203 LARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 41/217 (18%)
Query: 321 IGRGGFGLVYKGILQDG-----TTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVP 373
+G G FG VYKG+ VA+K + S E +E +++++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVDNPHVCR 81
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G C+ S L+ MP G + D++ K + N + +
Sbjct: 82 LLGICL-------TSTVQLITQLMPFGCLLDYVREH--------KDNIGSQYLLNWCVQI 126
Query: 434 AKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
AKG+ YL HRD+ A N+L+ ++ DFGLAK +
Sbjct: 127 AKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA---- 176
Query: 491 THGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G + A E L+ T +SDV+S+GV + E+M
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTT-VAVKKVIESDFQGDAEFCNEVEIISNLK 367
E + K+ +G G +G VY+G+ + + VAVK + E + + EF E ++ +K
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H NLV L G C R Y++ ++M GN+ D+L ++ ++
Sbjct: 68 HPNLVQLLGVCT------REPPFYIITEFMTYGNLLDYL-------RECNRQEVSAVVLL 114
Query: 428 NIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
+ ++ + YL ++ I HRD+ A N L+ + +VADFGL++
Sbjct: 115 YMATQISSAMEYLEKKNF-----I-HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--- 165
Query: 485 TTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
A APE Y + + KSDV++FGV++ EI
Sbjct: 166 --YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 321 IGRGGFGLVYKGILQDG----TTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVPLR 375
IG G G V G L+ VA+K + + +F +E I+ H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G RG +V +YM NG++D L T Q ++ V
Sbjct: 117 GVVT------RGRLAMIVTEYMENGSLDTFLRTH--------DGQFTIMQLVGMLRGVGA 162
Query: 436 GLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
G+ YL Y + HRD+ A N+L+D+++ +V+DFGL SR + T
Sbjct: 163 GMRYLSDLGY-----V-HRDLAARNVLVDSNLVCKVSDFGL---SRVLEDDPDAAYTTTG 213
Query: 493 GYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G + APE + + SDV+SFGVV+ E++
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 66/275 (24%), Positives = 101/275 (36%), Gaps = 39/275 (14%)
Query: 257 FALLGLYFWWDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFS 316
LYF +L+ R ++S +L+ P RP + F
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPS-RPES-----------FFQQSFQ 60
Query: 317 QKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNL-KHRNL 371
+ + +G G +G V+K +DG AVK+ S F+G + EV + +H
Sbjct: 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
V L G YL + ++ H L Q +
Sbjct: 120 VRLEQAWEEGGI------LYLQTELC-GPSLQQHC--------EAWGASLPEAQVWGYLR 164
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
D LA+LH + H D+K NI L R ++ DFGL + + G
Sbjct: 165 DTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGD 219
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK 526
Y+APE L G +DV+S G+ ILE+ C +
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 46/276 (16%)
Query: 277 SGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQD 336
+ L S L+ P + + K+ LE + IG G FG V++
Sbjct: 11 TTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 337 G------TTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389
T VAVK + E + A+F E +++ + N+V L G C G
Sbjct: 71 LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA------VGKP 124
Query: 390 RYLVYDYMPNGNVDDHL---------------FPSFNDGSGVAKRPLTWPQRKNIILDVA 434
L+++YM G++++ L + S PL+ ++ I VA
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184
Query: 435 KGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
G+AYL + V HRD+ N L+ +M ++ADFGL SR S +
Sbjct: 185 AGMAYLSERKF-V-----HRDLATRNCLVGENMVVKIADFGL---SRNIYSADYYKA-DG 234
Query: 492 HGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
+ + PE Y + T +SDV+++GVV+ EI
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDG------TTVAVKKVIESDFQGD-AEFCNEVEIISN 365
+G G FG V K TTVAVK + E+ + + +E ++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL---------------FPSF 410
+ H +++ L G C DG L+ +Y G++ L +
Sbjct: 83 VNHPHVIKLYGACSQDG------PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 411 NDGSGVAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRAR 467
+ +R LT + +++G+ YL + HRD+ A NIL+ + +
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL-----V-HRDLAARNILVAEGRKMK 190
Query: 468 VADFGLAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
++DFGL++ E S+ V + G + A E T +SDV+SFGV++ EI+
Sbjct: 191 ISDFGLSRDVYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH 368
+ IG+G FG V G + G VAVK + F E +++ L+H
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRH 73
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
NLV L G V + Y+V +YM G++ D+L + L
Sbjct: 74 SNLVQLLGVIVEEKGG-----LYIVTEYMAKGSLVDYL-------RSRGRSVLGGDCLLK 121
Query: 429 IILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
LDV + + YL ++ + HRD+ A N+L+ D A+V+DFGL K++ Q
Sbjct: 122 FSLDVCEAMEYLEGNNF-----V-HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-- 173
Query: 486 TRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G L APE + + KSDV+SFG+++ EI
Sbjct: 174 -------GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 39/229 (17%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGT-----TVAVKKVIESDFQGDA-EFCNEVEI 362
E +++ IG G FG VYKG+L+ + VA+K + + +F E I
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+ H N++ L G + ++ +YM NG +D L DG +
Sbjct: 100 MGQFSHHNIIRLEGVIS------KYKPMMIITEYMENGALDKFL--REKDGE------FS 145
Query: 423 WPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479
Q ++ +A G+ YL +Y + HRD+ A NIL+++++ +V+DFGL++ +
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNY-----V-HRDLAARNILVNSNLVCKVSDFGLSRVLED 199
Query: 480 GQSHLTTRVAG------THGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
T G T APE Y + T SDV+SFG+V+ E+M
Sbjct: 200 DPEATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 36/251 (14%)
Query: 281 SSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTT 339
+ EG KL+P ++ + + +GRG FG V++ Q G
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYREEVHW-------MTHQPRVGRGSFGEVHRMKDKQTGFQ 85
Query: 340 VAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPN 399
AVKKV F+ + E+ + L +VPL G G + + +
Sbjct: 86 CAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVRE------GPWVNIFMELLEG 134
Query: 400 GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459
G++ + L + + +GL YLH I H D+KA N+L
Sbjct: 135 GSLGQLI---------KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVL 182
Query: 460 LDAD-MRARVADFGLAKQSREGQSHLTTR----VAGTHGYLAPEYALYGQLTEKSDVYSF 514
L +D RA + DFG A + + + GT ++APE + K D++S
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 515 GVVILEIMCGR 525
++L ++ G
Sbjct: 243 CCMMLHMLNGC 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQGD-AEFCNEVEIISN 365
+ +G G FG V + VAVK + + + +E++I+S+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 366 L-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-----FPSFNDGSGVAKR 419
L +H N+V L G C G ++ +Y G++ + L + +A
Sbjct: 106 LGQHENIVNLLGACTHGG------PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 420 PLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476
+ + VA+G+A+L + I HRD+ A N+LL A++ DFGLA+
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNC-----I-HRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 477 SREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
++ + + L APE T +SDV+S+G+++ EI
Sbjct: 214 IMNDSNY----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 41/217 (18%)
Query: 321 IGRGGFGLVYKGILQDG-----TTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVP 373
+G G FG V+KG+ V +K + Q + + I +L H ++V
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVR 79
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G C GS LV Y+P G++ DH+ + L N + +
Sbjct: 80 LLGLCP-------GSSLQLVTQYLPLGSLLDHVRQH--------RGALGPQLLLNWGVQI 124
Query: 434 AKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
AKG+ YL HR++ A N+LL + + +VADFG+A L
Sbjct: 125 AKGMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY---- 174
Query: 491 THGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
+ A E +G+ T +SDV+S+GV + E+M
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC----NEVEIISNLKHRNLVPLR 375
+G GG VY VA+K I + E EV S L H+N+V
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVS-- 75
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
++D D E YLV +Y+ + +++ + PL+ N +
Sbjct: 76 ---MIDVDEEDDC-YYLVMEYIEGPTLSEYI---------ESHGPLSVDTAINFTNQILD 122
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
G+ + H I HRDIK NIL+D++ ++ DFG+AK E T V GT Y
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+PE A E +D+YS G+V+ E++ G
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 51/229 (22%), Positives = 94/229 (41%), Gaps = 27/229 (11%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK 367
+R F + IG GGFG V+K DG T +K+V + + EV+ ++ L
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAE-REVKALAKLD 62
Query: 368 HRNLVPLRGCCVVDGDNERGSER----------YLVYDYMPNGNVDDHLFPSFNDGSGVA 417
H N+V GC + S + ++ ++ G ++ +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-------EKRR 115
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
L + + KG+ Y+H + +RD+K +NI L + ++ DFGL
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 478 REGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK 526
+ TR GT Y++PE ++ D+Y+ G+++ E++
Sbjct: 173 KNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 15/220 (6%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFC-NEVEIISNLKHR 369
+ + IG G +G K DG + K++ S + + + +EV ++ LKH
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N+V + + + Y+V +Y G++ + ++ L +
Sbjct: 66 NIVRYYDRII----DRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRV 116
Query: 430 ILDVAKGLAYLHYGVKPA--IYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+ + L H + HRD+K N+ LD ++ DFGLA+ S T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF 176
Query: 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527
V GT Y++PE EKSD++S G ++ E+
Sbjct: 177 V-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 313 DKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQGD-AEFCNEVEIISN 365
++ S +G G FG V + TVAVK + S + +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 366 L-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL---------FPSFNDGSG 415
L H N+V L G C + G ++ +Y G++ + L +
Sbjct: 83 LGNHMNIVNLLGACTIGG------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFG 472
+ L + VAKG+A+L + I HRD+ A NILL ++ DFG
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNC-----I-HRDLAARNILLTHGRITKICDFG 190
Query: 473 LAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
LA+ + ++ V + L APE T +SDV+S+G+ + E+
Sbjct: 191 LARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 41/235 (17%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD--------GTTVAVKKVIESDFQGD-AEFCNEVEII 363
D+ +G G FG V T VAVK + + D ++ +E+E++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 364 SNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL-------FPSFNDGSG 415
+ KH+N++ L G C DG Y++ +Y GN+ ++L + S
Sbjct: 129 KMIGKHKNIINLLGACTQDG------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFG 472
+ L+ + VA+G+ YL I HRD+ A N+L+ D ++ADFG
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKC-----I-HRDLAARNVLVTEDNVMKIADFG 236
Query: 473 LAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
LA+ + T+G L APE T +SDV+SFGV++ EI
Sbjct: 237 LARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 53/241 (21%), Positives = 93/241 (38%), Gaps = 42/241 (17%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH 368
R F + +G+G FG V K D A+K I + + +EV ++++L H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNH 61
Query: 369 RNLVPLRGCCVVDGDNERGSER-------YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
+ +V + + + ++ +Y NG + D +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--------ENLNQ 113
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ----- 476
+ + + + L+Y+H I HRD+K NI +D ++ DFGLAK
Sbjct: 114 QRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 477 ---------SREGQSHLTTRVAGTHGYLAPE----YALYGQLTEKSDVYSFGVVILEIMC 523
+LT+ + GT Y+A E Y EK D+YS G++ E++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYN---EKIDMYSLGIIFFEMIY 226
Query: 524 G 524
Sbjct: 227 P 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 41/218 (18%)
Query: 321 IGRGGFGLVYKGILQ----DGTTVAVKKVIE---SDFQGDAEFCNEVEIISNLKHRNLVP 373
+G G FG+V +G +VAVK + S + +F EV + +L HRNL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G + +V + P G++ D L + G + V
Sbjct: 86 LYGVVL-------TPPMKMVTELAPLGSLLDRL--RKHQGH------FLLGTLSRYAVQV 130
Query: 434 AKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
A+G+ YL + HRD+ A N+LL ++ DFGL + + H +
Sbjct: 131 AEGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 491 ------THGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
APE + SD + FGV + E+
Sbjct: 185 KVPFAWC----APESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 321 IGRGGFGLVYKG---ILQDGTTVAVKKVIESDFQGDAEFC----NEVEIISNLKHRNLVP 373
+G GG V+ VAVK V+ +D D F E + + L H +V
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 374 LRGCCVVD---GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
V D + G Y+V +Y+ + D + + P+T + +I
Sbjct: 77 -----VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---------HTEGPMTPKRAIEVI 122
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT--RV 488
D + L + H + I HRD+K NI++ A +V DFG+A+ + + +T V
Sbjct: 123 ADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT YL+PE A + +SDVYS G V+ E++ G
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 321 IGRGGFGLVYKGILQ----DGTTVAVKKVIE-SDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G G FG V G L+ +VA+K + + +F E I+ H N++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G + +V +YM NG++D L +D T Q ++ +A
Sbjct: 113 GVVT------KSKPVMIVTEYMENGSLDSFL--RKHDAQ------FTVIQLVGMLRGIAS 158
Query: 436 GLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
G+ YL Y HRD+ A NIL+++++ +V+DFGL R +
Sbjct: 159 GMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGL---GRVLEDDPEAAYTTRG 209
Query: 493 GYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
G + +PE Y + T SDV+S+G+V+ E+M
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 299 GSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDG----TTVAVK--KVIESDFQG 352
G++ +D E ++ IG G FG V++GI VA+K K SD
Sbjct: 1 GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 60
Query: 353 DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFND 412
+ +F E + H ++V L G + +++ + G + L
Sbjct: 61 E-KFLQEALTMRQFDHPHIVKLIGVIT-------ENPVWIIMELCTLGELRSFLQVR--- 109
Query: 413 GSGVAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVA 469
K L ++ LAYL + HRDI A N+L+ ++ ++
Sbjct: 110 -----KYSLDLASLILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLG 158
Query: 470 DFGLAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
DFGL++ + +T + G L APE + + T SDV+ FGV + EI+
Sbjct: 159 DFGLSRYMED-----STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-34
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 38/215 (17%)
Query: 321 IGRGGFGLVYKGILQDG---TTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRNLVPLRG 376
+G G FG V +G+ + VA+K + ++ E E +I+ L + +V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKG 436
C + LV + G + L + + ++ V+ G
Sbjct: 404 VC-------QAEALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMG 448
Query: 437 LAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG--- 490
+ YL ++ HR++ A N+LL A+++DFGL+K S+ T R AG
Sbjct: 449 MKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 491 ---THGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522
APE + + + +SDV+S+GV + E +
Sbjct: 503 LKWY----APECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 31/225 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNLKH 368
F + IGRG F VY+ L DG VA+KKV D E++++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
N++ + D E +V + G++ + KR +
Sbjct: 92 PNVIKYYASFIEDN------ELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWK 140
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+ + L ++H + HRDIK N+ + A ++ D GL + + + V
Sbjct: 141 YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197
Query: 489 AGTHGYLAPE------YALYGQLTEKSDVYSFGVVILEIMCGRKA 527
GT Y++PE Y KSD++S G ++ E+ +
Sbjct: 198 -GTPYYMSPERIHENGY------NFKSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFC-NEVEIISNLKHR 369
+K+ + IG G FG +DG +K++ I + E EV +++N+KH
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N+V R +G Y+V DY G++ + + Q +
Sbjct: 84 NIVQYRESFEENG------SLYIVMDYCEGGDLFKRI-------NAQKGVLFQEDQILDW 130
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
+ + L ++H I HRDIK+ NI L D ++ DFG+A+ +
Sbjct: 131 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI- 186
Query: 490 GTHGYLAPE------YALYGQLTEKSDVYSFGVVILEIMCGRKA 527
GT YL+PE Y KSD+++ G V+ E+ + A
Sbjct: 187 GTPYYLSPEICENKPY------NNKSDIWALGCVLYELCTLKHA 224
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 20/226 (8%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEI 362
+ + + D+ + +G+G +G+VY G L + +A+K++ E D + E+ +
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+LKH+N+V G + + + +P G++ L +
Sbjct: 73 HKHLKHKNIVQYLGSFSEN------GFIKIFMEQVPGGSLSALLRSKWG------PLKDN 120
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARVADFGLAKQSREGQ 481
+ +GL YLH I HRDIK N+L++ +++DFG +K+
Sbjct: 121 EQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 482 SHLTTRVAGTHGYLAPEYALYGQL--TEKSDVYSFGVVILEIMCGR 525
T GT Y+APE G + +D++S G I+E+ G+
Sbjct: 178 PCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 52/234 (22%), Positives = 96/234 (41%), Gaps = 30/234 (12%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLK 367
R F +GRGGFG+V++ D A+K++ + + + EV+ ++ L+
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 368 HRNLVPLRGCCVVDGDNERGSER------YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
H +V + E+ Y+ N+ D + N + +R
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM----NGRCTIEERE- 116
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ----- 476
+I L +A+ + +LH + HRD+K +NI D +V DFGL
Sbjct: 117 -RSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 477 ------SREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMC 523
+ T GT Y++PE ++G + K D++S G+++ E++
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 41/216 (18%)
Query: 321 IGRGGFGLVYKGILQDG----TTVAVK--KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG VY+G+ + VAVK K + + +F +E I+ NL H ++V L
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-KFMSEAVIMKNLDHPHIVKL 78
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
G +++ + P G + +L N S L L +
Sbjct: 79 IGIIE-------EEPTWIIMELYPYGELGHYL--ERNKNS------LKVLTLVLYSLQIC 123
Query: 435 KGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
K +AYL + HRDI NIL+ + ++ DFGL SR + + +
Sbjct: 124 KAMAYLESINC------VHRDIAVRNILVASPECVKLGDFGL---SRYIEDEDYYKASV- 173
Query: 492 HGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
L +PE + + T SDV+ F V + EI+
Sbjct: 174 -TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 46/240 (19%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDG------TTVAVKKVIESDFQGD-AEFCNEVEIISN 365
+ +G G FG V VAVK + E + +E+++++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 366 L-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL--------------FPSF 410
L H N+V L G C + G YL+++Y G++ ++L
Sbjct: 105 LGSHENIVNLLGACTLSG------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 411 NDGSGVAKRPLTWPQRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRAR 467
LT+ VAKG+ +L + HRD+ A N+L+ +
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC-----V-HRDLAARNVLVTHGKVVK 212
Query: 468 VADFGLAKQSREGQSHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
+ DFGLA+ ++ V + L APE G T KSDV+S+G+++ EI
Sbjct: 213 ICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-33
Identities = 54/359 (15%), Positives = 105/359 (29%), Gaps = 68/359 (18%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD---AEFCNEVEIISNL---KHRNLVP 373
+G+ + + G + V ++ + EV + L K++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 374 LRGCCVVDGDNERGSERYLVYD---------------YMPNGNVDDHLFPSFNDGSGVAK 418
+ + D + ++ + P + F
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 419 RPLTWPQRKNIILDVAKGLAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
+ L R + L V + LA LH YG + H ++ +I+LD + F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 478 REGQSHLTTRVAGTHGYLAPEYALYGQ-----LTEKSDVYSFGVVILEIMCGR------- 525
R A +GQ +T D ++ G+ I I C
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 526 --KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLV 583
+ I V +L++ FL + +R + +
Sbjct: 322 ALGGSEWIFRSCKN---IPQPVRALLEG----------------FLRYPKE---DRLLPL 359
Query: 584 GILCAHVMVALRPTISDALKMLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGL 642
+ LR +S AL + + D E P P G D++ G + A++ +
Sbjct: 360 QAMETPEYEQLRTELSAALPLYQTDGE-PTREGGAPPSGTSQ--PDEA--GAAEAVTAI 413
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 48/237 (20%), Positives = 93/237 (39%), Gaps = 24/237 (10%)
Query: 306 QDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIIS 364
Q +E + + + GGF VY+ + G A+K+++ ++ + + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 365 NLK-HRNLVPLRGCCVVDG-DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
L H N+V + +++ G +L+ + G + + L ++ PL+
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM------ESRGPLS 134
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
I + + ++H KP I HRD+K N+LL ++ DFG A
Sbjct: 135 CDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 483 HLTTRVA-----------GTHGYLAPE-YALYGQL--TEKSDVYSFGVVILEIMCGR 525
+ + T Y PE LY EK D+++ G ++ + +
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 45/237 (18%), Positives = 86/237 (36%), Gaps = 59/237 (24%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD--------GTTVAVKKVIESDFQGDAEFCNEVEIIS 364
+ +G+G F ++KG+ ++ T V +K + ++ F ++S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
L H++LV G CV G E LV +++ G++D +L + K +
Sbjct: 68 KLSHKHLVLNYGVCV------CGDENILVQEFVKFGSLDTYLKKN--------KNCINIL 113
Query: 425 QRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRAR--------VADFGL 473
+ + +A + +L I H ++ A NILL + + ++D G+
Sbjct: 114 WKLEVAKQLAAAMHFLEENTL-----I-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 474 AKQSREGQSHLTTRVAGTHGYL-------APEYALYGQL-TEKSDVYSFGVVILEIM 522
+ L PE + +D +SFG + EI
Sbjct: 168 S------------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 36/247 (14%)
Query: 290 SRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESD 349
S P L + G + + + F K+ +G G G + + D VAV K I +
Sbjct: 3 SSPSLEQDDGDEETSVVIVGK--ISFCPKDVLGHGAEGTIVYRGMFDNRDVAV-KRILPE 59
Query: 350 FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFP 408
A+ EV+++ +H N++ + +Y+ + + +++
Sbjct: 60 CFSFAD--REVQLLRESDEHPNVIRYFCTE------KDRQFQYIAIELCA-ATLQEYV-- 108
Query: 409 SFNDGSGVAKR-PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL-----DA 462
K + ++ GLA+LH I HRD+K NIL+
Sbjct: 109 -------EQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHG 158
Query: 463 DMRARVADFGLAKQSREGQSHLTTR--VAGTHGYLAPEY---ALYGQLTEKSDVYSFGVV 517
++A ++DFGL K+ G+ + R V GT G++APE T D++S G V
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
Query: 518 ILEIMCG 524
++
Sbjct: 219 FYYVISE 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 46/221 (20%)
Query: 321 IGRGGFGLVYKGILQD---GTTVAVKKVIESDFQGDAEFC----NEVEIISNLKHRNLVP 373
+GRGG G VY+ +D VA+K ++ D F E L+ ++VP
Sbjct: 42 VGRGGMGDVYEA--EDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPS--FNDGSGVAKR-----PLTWPQR 426
++D+ G +D L+ +G +A PL P+
Sbjct: 99 -------------------IHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA 136
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
I+ + L H HRD+K NIL+ AD A + DFG+A + LT
Sbjct: 137 VAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQ 191
Query: 487 --RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT Y+APE T ++D+Y+ V+ E + G
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-32
Identities = 61/286 (21%), Positives = 104/286 (36%), Gaps = 54/286 (18%)
Query: 264 FWWDKKLRKRFYGSGLDSSSSLEGQSSRPK-LRPNTGSIWFKIQD------------LER 310
F + + ++ E Q R + + + +I D E
Sbjct: 328 FIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEI 387
Query: 311 ATDKFSQKNFIGRGGFGLVYKGILQDG----TTVAVK--KVIESDFQGDAEFCNEVEIIS 364
++ IG G FG V++GI VA+K K SD + +F E +
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMR 446
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
H ++V L G + +++ + G + L K L
Sbjct: 447 QFDHPHIVKLIGVIT-------ENPVWIIMELCTLGELRSFLQVR--------KFSLDLA 491
Query: 425 QRKNIILDVAKGLAYL---HYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
++ LAYL + HRDI A N+L+ ++ ++ DFGL++ +
Sbjct: 492 SLILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-- 543
Query: 482 SHLTTRVAGTHGYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
+T + G L APE + + T SDV+ FGV + EI+
Sbjct: 544 ---STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 33/238 (13%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHR 369
+ F +G G +G VYK I + G VA+K+V +ESD Q E E+ I+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSP 84
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
++V G + ++ ++V +Y G+V D + + + LT + I
Sbjct: 85 HVVKYYGSYF------KNTDLWIVMEYCGAGSVSDII--------RLRNKTLTEDEIATI 130
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
+ KGL YLH HRDIKA NILL+ + A++ADFG+A Q + + T +
Sbjct: 131 LQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI- 186
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-STSGSPR 537
GT ++APE +D++S G+ +E+ G+ +A+ + T+ P
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT 244
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHR 369
+ F++ IG+G FG V+KGI + VA+K + +E + E+ ++S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
+ G + + ++ +++ +Y+ G+ D L P PL Q I
Sbjct: 81 YVTKYYGSYL------KDTKLWIIMEYLGGGSALDLLEP----------GPLDETQIATI 124
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
+ ++ KGL YLH HRDIKA N+LL ++ADFG+A Q + Q T V
Sbjct: 125 LREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV- 180
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
GT ++APE K+D++S G+ +E+
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 5e-31
Identities = 32/268 (11%), Positives = 63/268 (23%), Gaps = 33/268 (12%)
Query: 282 SSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTV 340
+ ++ + P L + K + G +V+ ++
Sbjct: 32 EPAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDF 90
Query: 341 AVKKVIESDFQGDAE---FCNEVEIISNLKHRNLVPLRGCC-----------------VV 380
A+K +E + L + R
Sbjct: 91 ALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
+ MP +VD L S D V + + + + A L
Sbjct: 151 LSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANL 210
Query: 441 H-YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEY 499
G + H N+ + D R + D + + Y E+
Sbjct: 211 QSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREF 262
Query: 500 AL--YGQLTEKSDVYSFGVVILEIMCGR 525
T + + G+ I + C
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 37/274 (13%)
Query: 281 SSSSLEGQSSRPKLRPNTGS---IWFKIQDLERATD---KFSQKNFIGRGGFGLVYKGI- 333
SS ++ + + + ++ + D IG G G+V
Sbjct: 7 HSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLARE 66
Query: 334 LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393
G VAVK + Q NEV I+ + +H N+V + +V G E +++
Sbjct: 67 KHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV------GEELWVL 120
Query: 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453
+++ G + D V++ L Q + V + LAYLH + HRDI
Sbjct: 121 MEFLQGGALTDI----------VSQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 454 KATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYS 513
K+ +ILL D R +++DFG Q + + V GT ++APE + D++S
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWS 226
Query: 514 FGVVILEIMCGR---------KALDL-STSGSPR 537
G++++E++ G +A+ S P+
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK 260
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 31/237 (13%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN 370
K+++ IG+G G VY + + G VA++++ NE+ ++ K+ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V + G E ++V +Y+ G++ D V + + Q +
Sbjct: 79 IVNYLDSYL------VGDELWVVMEYLAGGSLTDV----------VTETCMDEGQIAAVC 122
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ + L +LH + HRDIK+ NILL D ++ DFG Q QS +T V G
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 178
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-STSGSPR 537
T ++APE K D++S G++ +E++ G +AL L +T+G+P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 305 IQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEII 363
+ L F +G G +G VYKG ++ G A+K V++ + E E+ ++
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINML 74
Query: 364 SNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
HRN+ G + + +LV ++ G+V D + + L
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLK 127
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
I ++ +GL++LH + + HRDIK N+LL + ++ DFG++ Q
Sbjct: 128 EEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTE-----KSDVYSFGVVILEI 521
T GT ++APE + + KSD++S G+ +E+
Sbjct: 185 RRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 29/227 (12%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRN 370
+ + +G+G V++G + G A+K F + E E++ L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L + + R + L+ ++ P G++ L N L + ++
Sbjct: 69 IVKLFA--IEEETTTR--HKVLIMEFCPCGSLYTVLEEPSNAYG------LPESEFLIVL 118
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVADFGLAKQSREGQSHLTT 486
DV G+ +L + I HR+IK NI+ D ++ DFG A++ + + +
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS 174
Query: 487 RVAGTHGYLAPE--------YALYGQLTEKSDVYSFGVVILEIMCGR 525
GT YL P+ + D++S GV G
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 48/227 (21%), Positives = 88/227 (38%), Gaps = 29/227 (12%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHRN 370
+ + +G+G V++G + G A+K F + E E++ L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L + + R + L+ ++ P G++ L N L + ++
Sbjct: 69 IVKLF--AIEEETTTR--HKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVL 118
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVADFGLAKQSREGQSHLTT 486
DV G+ +L + I HR+IK NI+ D ++ DFG A++ + + +
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS 174
Query: 487 RVAGTHGYLAPE--------YALYGQLTEKSDVYSFGVVILEIMCGR 525
GT YL P+ + D++S GV G
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 48/225 (21%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFC-----------------NEVEII 363
+ +G F + +D A+KK +S + +F NE++II
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTW 423
+++K+ + G ++ +E Y++Y+YM N ++ F +
Sbjct: 98 TDIKNEYCLTCEG--IITNYDEV----YIIYEYMENDSILKFD-EYFFVLDKNYTCFIPI 150
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH 483
K II V +Y+H + I HRD+K +NIL+D + R +++DFG ++ +
Sbjct: 151 QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--K 206
Query: 484 LTTRVAGTHGYLAPEYALYGQLT---EKSDVYSFGVVILEIMCGR 525
+ GT+ ++ PE + + K D++S G+ + +
Sbjct: 207 IKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 16/222 (7%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNL 366
+ + K +G GGFG V + I G VA+K+ + + E +C E++I+ L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
H N+V R L +Y G++ +L N L
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG------LKEGPI 123
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DMRARVADFGLAKQSREGQSH 483
+ ++ D++ L YLH + I HRD+K NI+L + ++ D G AK+ +G
Sbjct: 124 RTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-EL 179
Query: 484 LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
T V GT YLAPE + T D +SFG + E + G
Sbjct: 180 CTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 42/284 (14%), Positives = 86/284 (30%), Gaps = 47/284 (16%)
Query: 266 WDKKLRKRFYGSGLDSSSS-----LEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNF 320
WD KL + SGL S E Q P ++P T + + + +
Sbjct: 22 WDDKLIFKLL-SGLSKPVSSYPNTFEWQCKLPAIKPKT--------EFQLGSKLVYVHHL 72
Query: 321 IGRGGFGLVYKGI------LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G F VY+ ++ +K ++ +E + +
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
+ + LV + G + + + N ++ + + + +
Sbjct: 133 YSAHLFQ------NGSVLVGELYSYGTLLNAI----NLYKNTPEKVMPQGLVISFAMRML 182
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILL-----------DADMRARVADFGLAKQSR-EGQS 482
+ +H I H DIK N +L D + D G + + +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 483 HLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGR 525
+ T T G+ E L + + D + + ++ G
Sbjct: 240 TIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 51/245 (20%), Positives = 102/245 (41%), Gaps = 30/245 (12%)
Query: 288 QSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK--- 343
P P I + D R+ ++ + F+G+GGF ++ A K
Sbjct: 17 APGAPAAAPPAKEIPEVLVD-PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVP 75
Query: 344 --KVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGN 401
+++ + + E+ I +L H+++V G E ++V + +
Sbjct: 76 KSLLLKPHQRE--KMSMEISIHRSLAHQHVVGFHGFF------EDNDFVFVVLELCRRRS 127
Query: 402 VDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461
+ + ++ LT P+ + + + G YLH + + HRD+K N+ L+
Sbjct: 128 LLELH---------KRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLN 175
Query: 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILE 520
D+ ++ DFGLA + + GT Y+APE L + + + DV+S G ++
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYT 233
Query: 521 IMCGR 525
++ G+
Sbjct: 234 LLVGK 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 29/227 (12%)
Query: 304 KIQDLERATD---KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCN 358
+ + + R D + +G G FG VYK + G A K VIE+ + + E +
Sbjct: 7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAK-VIETKSEEELEDYIV 65
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
E+EI++ H +V L G + +++ ++ P G VD +
Sbjct: 66 EIEILATCDHPYIVKLLGAYY------HDGKLWIMIEFCPGGAVDAIMLEL--------D 111
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 478
R LT PQ + + + + L +LH I HRD+KA N+L+ + R+ADFG++ ++
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168
Query: 479 EGQSHLTTRVAGTHGYLAPEYALYGQLTE-----KSDVYSFGVVILE 520
+ + + GT ++APE + + + K+D++S G+ ++E
Sbjct: 169 KTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 46/247 (18%), Positives = 87/247 (35%), Gaps = 57/247 (23%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE---FCNEVEIISN 365
R T +F + IG G FG V+K + DG A+K+ + G + EV +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAV 66
Query: 366 L-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
L +H ++V D + +Y G++ D + +
Sbjct: 67 LGQHSHVVRYFSAWAEDD------HMLIQNEYCNGGSLADAI-----SENYRIMSYFKEA 115
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-------------------MR 465
+ K+++L V +GL Y+H ++ H DIK +NI + +
Sbjct: 116 ELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE-------YALYGQLTEKSDVYSFGVVI 518
++ D G + Q G +LA E + K+D+++ + +
Sbjct: 173 FKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTH------LPKADIFALALTV 221
Query: 519 LEIMCGR 525
+
Sbjct: 222 VCAAGAE 228
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 46/220 (20%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNL 366
++ + F+G+GGF ++ A K +++ + + E+ I +L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRSL 72
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
H+++V G E ++V + ++ + ++ LT P+
Sbjct: 73 AHQHVVGFHGFF------EDNDFVFVVLELCRRRSLLELH---------KRRKALTEPEA 117
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ + + G YLH + + HRD+K N+ L+ D+ ++ DFGLA +
Sbjct: 118 RYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 487 RVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGR 525
+ GT Y+APE L + + + DV+S G ++ ++ G+
Sbjct: 175 -LCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 29/219 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNL 366
+ F +G+G FG VY Q +A+K ++ ++ + + EVEI S+L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH--QLRREVEIQSHL 66
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N++ L G D R YL+ +Y P G V L +
Sbjct: 67 RHPNILRLYG---YFHDATR---VYLILEYAPLGTVYREL---------QKLSKFDEQRT 111
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
I ++A L+Y H + HRDIK N+LL + ++ADFG + +
Sbjct: 112 ATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDL 167
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT YL PE EK D++S GV+ E + G+
Sbjct: 168 --CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 73/257 (28%), Positives = 117/257 (45%), Gaps = 25/257 (9%)
Query: 276 GSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQD---LERATDKFSQKNFIGRGGFGLVYKG 332
GS S++ L G P L I D E+ ++ IG G FG+V++
Sbjct: 1 GSFTMSNAPLNGVKLNP-LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQA 59
Query: 333 ILQDGTTVAVKKVIESDFQGDAEFCN-EVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391
L + VA+KKV++ D F N E++I+ +KH N+V L+ +GD +
Sbjct: 60 KLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451
LV +Y+P + + K+ + K + + + LAY+H I HR
Sbjct: 115 LVLEYVPE---TVY---RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHR 165
Query: 452 DIKATNILLDADMRA-RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEK 508
DIK N+LLD ++ DFG AK G+ + + + Y APE ++G T
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSYIC-SRYYRAPE-LIFGATNYTTN 222
Query: 509 SDVYSFGVVILEIMCGR 525
D++S G V+ E+M G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 71/221 (32%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCN-EVEIISNLKHR 369
++ IG G FG+VY+ L D G VA+KKV++ D F N E++I+ L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N+V LR G+ + LV DY+P + AK+ L K
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE---TVY---RVARHYSRAKQTLPVIYVKLY 161
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA-RVADFGLAKQSREGQSHLTTRV 488
+ + + LAY+H I HRDIK N+LLD D ++ DFG AKQ G+ + +
Sbjct: 162 MYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYI 217
Query: 489 AGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILEIMCGR 525
+ Y APE Y T DV+S G V+ E++ G+
Sbjct: 218 C-SRYYRAPELIFGATDY---TSSIDVWSAGCVLAELLLGQ 254
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 65/245 (26%), Positives = 99/245 (40%), Gaps = 33/245 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRN 370
D + + IG G +V VA+K++ +E E E++ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V VV E +LV + G+V D + G + L I+
Sbjct: 75 IVSYYTSFVV------KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATIL 127
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR--- 487
+V +GL YLH K HRD+KA NILL D ++ADFG++ G +
Sbjct: 128 REVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 488 -VAGTHGYLAPE----YALYGQLTEKSDVYSFGVVILEIMCGR---------KALDL-ST 532
GT ++APE Y K+D++SFG+ +E+ G K L L
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYD---FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241
Query: 533 SGSPR 537
+ P
Sbjct: 242 NDPPS 246
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 47/229 (20%), Positives = 95/229 (41%), Gaps = 38/229 (16%)
Query: 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNL 371
+S IG GG V++ + + A+K V + + NE+ ++ L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 372 --VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
+ L + D Y+V + N +++ L K+ + +RK+
Sbjct: 70 KIIRLYDYEITD------QYIYMVMEC-GNIDLNSWL---------KKKKSIDPWERKSY 113
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS--HLTTR 487
++ + + +H + I H D+K N L+ D ++ DFG+A Q + + ++
Sbjct: 114 WKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 488 VAGTHGYLAPE-----------YALYGQLTEKSDVYSFGVVILEIMCGR 525
V GT Y+ PE +++ KSDV+S G ++ + G+
Sbjct: 170 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 47/229 (20%), Positives = 93/229 (40%), Gaps = 38/229 (16%)
Query: 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNL 371
+S IG GG V++ + + A+K V + + NE+ ++ L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 372 --VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
+ L + D Y+V + N +++ L K+ + +RK+
Sbjct: 89 KIIRLYDYEITD------QYIYMVMECG-NIDLNSWL---------KKKKSIDPWERKSY 132
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK--QSREGQSHLTTR 487
++ + + +H + I H D+K N L+ D ++ DFG+A Q ++
Sbjct: 133 WKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 488 VAGTHGYLAPE-----------YALYGQLTEKSDVYSFGVVILEIMCGR 525
V GT Y+ PE +++ KSDV+S G ++ + G+
Sbjct: 189 V-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 33/212 (15%)
Query: 321 IGRGGFGLVYKG---ILQDGTTVAVKKVIESDFQGDAE----FCNEVEIISNLKHRNLVP 373
I GG G +Y + +G V +K ++ S GDAE E + ++ + H ++V
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
+ V D Y+V +Y+ ++ + L + +L++
Sbjct: 144 IFNF-VEHTDRHGDPVGYIVMEYVGGQSLKRSK-----------GQKLPVAEAIAYLLEI 191
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
L+YLH + + D+K NI+L + + ++ D G R + GT G
Sbjct: 192 LPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS---FGYLYGTPG 242
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+ APE T +D+Y+ G + +
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 68/280 (24%), Positives = 105/280 (37%), Gaps = 47/280 (16%)
Query: 280 DSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATD---KFSQKNFIGRGGFGLVYKGI-LQ 335
++ P + +L D FS IG G FG VY ++
Sbjct: 18 ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77
Query: 336 DGTTVAVKKV---IESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392
+ VA+KK+ + + + EV + L+H N + RGC + R +L
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL------REHTAWL 131
Query: 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRD 452
V +Y D V K+PL + + +GLAYLH + HRD
Sbjct: 132 VMEYCLGSASDLLE---------VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRD 179
Query: 453 IKATNILLDADMRARVADFGLAKQSREGQSHLTTR--VAGTHGYLAPEYALYGQLTE--- 507
+KA NILL ++ DFG A + GT ++APE L +
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASI-------MAPANSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 508 KSDVYSFGVVILEIMCGR---------KALDL-STSGSPR 537
K DV+S G+ +E+ + AL + + SP
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 32/222 (14%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNL 366
+ F N +G+G F VY+ + G VA+K + ++ NEV+I L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ--RVQNEVKIHCQL 68
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
KH +++ L E + YLV + NG ++ +L +P + +
Sbjct: 69 KHPSILELYNYF------EDSNYVYLVLEMCHNGEMNRYL--------KNRVKPFSENEA 114
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
++ + + G+ YLH I HRD+ +N+LL +M ++ADFGLA Q + T
Sbjct: 115 RHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
Query: 487 RVAGTHGYLAPEYA---LYGQLTEKSDVYSFGVVILEIMCGR 525
+ GT Y++PE A +G +SDV+S G + ++ GR
Sbjct: 172 -LCGTPNYISPEIATRSAHG---LESDVWSLGCMFYTLLIGR 209
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 47/226 (20%), Positives = 79/226 (34%), Gaps = 35/226 (15%)
Query: 312 TDKFSQKNFIGRG--GFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEF-CNEVEIISNL 366
+ IG+G V G V V+++ +E+ F E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
H N+VP R + +E ++V +M G+ D + F DG +
Sbjct: 84 NHPNIVPYRATFIA------DNELWVVTSFMAYGSAKDLICTHFMDG-------MNELAI 130
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
I+ V K L Y+H HR +KA++IL+ D + ++
Sbjct: 131 AYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 487 R------VAGTHGYLAPE-----YALYGQLTEKSDVYSFGVVILEI 521
+L+PE Y KSD+YS G+ E+
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYD---AKSDIYSVGITACEL 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 50/262 (19%), Positives = 99/262 (37%), Gaps = 45/262 (17%)
Query: 281 SSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTV 340
S L I K + +S IG GG V++ + +
Sbjct: 31 DSPDLGTDDDDKASSSANECISVKGRI-------YSILKQIGSGGSSKVFQVLNEKKQIY 83
Query: 341 AVKKVIESDFQGDA--EFCNEVEIISNLKHRNL--VPLRGCCVVDGDNERGSERYLVYDY 396
A+K V + + NE+ ++ L+ + + L + D Y+V +
Sbjct: 84 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD------QYIYMVMEC 137
Query: 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKAT 456
N +++ L K+ + +RK+ ++ + + +H + I H D+K
Sbjct: 138 -GNIDLNSWL---------KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPA 184
Query: 457 NILLDADMRARVADFGLAKQSREGQS--HLTTRVAGTHGYLAPE-----------YALYG 503
N L+ D ++ DFG+A Q + + ++V G Y+ PE
Sbjct: 185 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 504 QLTEKSDVYSFGVVILEIMCGR 525
+++ KSDV+S G ++ + G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNL 366
D F +G+G FG VY Q+ +A+K ++ + + + E+EI S+L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH--QLRREIEIQSHL 71
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N++ + D +R YL+ ++ P G + L +
Sbjct: 72 RHPNILRMYN---YFHDRKR---IYLMLEFAPRGELYKEL---------QKHGRFDEQRS 116
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ ++A L Y H + + HRDIK N+L+ ++ADFG + + S
Sbjct: 117 ATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRR 170
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+ GT YL PE EK D++ GV+ E + G
Sbjct: 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 56/236 (23%), Positives = 91/236 (38%), Gaps = 39/236 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEI-ISNLKHRNL 371
+ + +G G G V G VAV K + DF A E+++ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAV-KRMLIDFCDIAL--MEIKLLTESDDHPNV 71
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
+ Y+ + N N+ D + + S + +++
Sbjct: 72 IRYYCSE------TTDRFLYIALELC-NLNLQDLV--ESKNVSDENLKLQKEYNPISLLR 122
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLD-------------ADMRARVADFGLAKQSR 478
+A G+A+LH I HRD+K NIL+ ++R ++DFGL K+
Sbjct: 123 QIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 479 EGQSHLTTR---VAGTHGYLAPE-------YALYGQLTEKSDVYSFGVVILEIMCG 524
GQS T +GT G+ APE +LT D++S G V I+
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 61/250 (24%), Positives = 91/250 (36%), Gaps = 38/250 (15%)
Query: 291 RPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----K 344
P + G I D D + IG+G F +V + I + G AVK K
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 345 VIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDD 404
S + E I LKH ++V L Y+V+++M +
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETY------SSDGMLYMVFEFMDGAD--- 112
Query: 405 HLFPSFND---GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL- 460
L A + + + + + L Y H I HRD+K +LL
Sbjct: 113 -LC----FEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLA 164
Query: 461 --DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE---YALYGQLTEKSDVYSFG 515
+ ++ FG+A Q E RV GT ++APE YG + DV+ G
Sbjct: 165 SKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYG---KPVDVWGCG 220
Query: 516 VVILEIM-CG 524
VIL I+ G
Sbjct: 221 -VILFILLSG 229
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 33/233 (14%)
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAE 355
F ++ + + +G G +G V A+K V S +++
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS---NSK 82
Query: 356 FCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSG 415
EV ++ L H N++ L E YLV + G + D +
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFF------EDKRNYYLVMECYKGGELFDEI--------- 127
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFG 472
+ + II V G+ YLH K I HRD+K N+LL + D ++ DFG
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFG 184
Query: 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
L+ + GT Y+APE L + EK DV+S GV++ ++ G
Sbjct: 185 LSAVFENQKKM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 57/244 (23%), Positives = 110/244 (45%), Gaps = 26/244 (10%)
Query: 286 EGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKK 344
E + + + + K + E D F + + +G G G+V+K G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 345 V-IESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVD 403
+ +E + E++++ +V G DG+ + ++M G++D
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE------ISICMEHMDGGSLD 119
Query: 404 DHLFPSFNDGSGVAKRPLTWPQR--KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461
L K+ P++ + + V KGL YL K I HRD+K +NIL++
Sbjct: 120 QVL-----------KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN 166
Query: 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
+ ++ DFG++ Q + ++ + V GT Y++PE + +SD++S G+ ++E+
Sbjct: 167 SRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 522 MCGR 525
GR
Sbjct: 224 AVGR 227
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 37/249 (14%), Positives = 76/249 (30%), Gaps = 61/249 (24%)
Query: 320 FIGRGGFGLVYKGI-LQDGTTVAVK----------------------------KVIESDF 350
+G+ + + G + V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 351 QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYM--PNGNVDDHLFP 408
+ F +++ + + + ++ +R D + R+ +Y M + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRL----DERDMWVLSRFFLYPRMQSNLQTFGEVLL- 194
Query: 409 SFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLH-YGVKPAIYHRDIKATNILLDADMRAR 467
+ L R + L V + LA LH YG + H ++ +I+LD
Sbjct: 195 ----SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVF 246
Query: 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-----------GQLTEKSDVYSFGV 516
+ F R+G +++ + G+ PE +T D ++ G+
Sbjct: 247 LTGFEHLV--RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301
Query: 517 VILEIMCGR 525
VI I C
Sbjct: 302 VIYWIWCAD 310
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 47/273 (17%), Positives = 92/273 (33%), Gaps = 64/273 (23%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLK 367
R F +GRGGFG+V++ D A+K++ + + + EV+ ++ L+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDD----------------------- 404
H +V + + E ++ + +
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 405 --HLFPSFNDGSGV----------------AKRPLTWPQRKNIILD----VAKGLAYLHY 442
+ + +R + + L +A+ + +LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH- 181
Query: 443 GVKPAIYHRDIKATNILLDADMRARVADFGLAK------------QSREGQSHLTTRVAG 490
+ HRD+K +NI D +V DFGL + T +V G
Sbjct: 182 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-G 238
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMC 523
T Y++PE + K D++S G+++ E +
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFE-LL 270
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 62/245 (25%), Positives = 99/245 (40%), Gaps = 32/245 (13%)
Query: 289 SSRPKLRPNTGS-IWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVI 346
S L G + D++ + +G+G FG V G AVK +
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFS---DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60
Query: 347 ESDFQGDAE---FCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVD 403
+ + + EV+++ L H N++ L E YLV + G +
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF------EDKGYFYLVGEVYTGGELF 114
Query: 404 DHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL--- 460
D + ++++ + II V G+ Y+H K I HRD+K N+LL
Sbjct: 115 DEI---------ISRKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESK 162
Query: 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520
D R+ DFGL+ + GT Y+APE L+G EK DV+S GV++
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYI 219
Query: 521 IMCGR 525
++ G
Sbjct: 220 LLSGC 224
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 68/236 (28%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEF----CNEVEII 363
K+ + IG+G FG V+K + G VA+KKV +E++ +G F E++I+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKIL 70
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSER--YLVYDYMPNGNVDDHLFPSFNDGSGVAKRP- 420
LKH N+V L C + YLV+D+ +H D +G+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EH------DLAGLLSNVL 118
Query: 421 --LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-- 476
T + K ++ + GL Y+H + I HRD+KA N+L+ D ++ADFGLA+
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 477 --SREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKAL 528
+ T RV T Y PE L G D++ G ++ E M R +
Sbjct: 176 LAKNSQPNRYTNRVV-TLWYRPPEL-LLGERDYGPPIDLWGAGCIMAE-MWTRSPI 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISN 365
++++ +G+G FG V K AVK D EVE++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS---TILREVELLKK 77
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
L H N++ L E S Y+V + G + D + + ++ +
Sbjct: 78 LDHPNIMKLFEIL------EDSSSFYIVGELYTGGELFDEI---------IKRKRFSEHD 122
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQS 482
II V G+ Y+H K I HRD+K NILL + D ++ DFGL+ ++
Sbjct: 123 AARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+ R+ GT Y+APE L G EK DV+S GV++ ++ G
Sbjct: 180 -MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 50/236 (21%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCN---------------- 358
IG+G +G+V D T A+K K+I
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 359 -----EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG 413
E+ I+ L H N+V L V+D NE Y+V++ + G V +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV--EVLDDPNE--DHLYMVFELVNQGPVMEV-------- 128
Query: 414 SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473
+PL+ Q + D+ KG+ YLHY I HRDIK +N+L+ D ++ADFG+
Sbjct: 129 --PTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 474 AKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE----KSDVYSFGVVILEIMCGR 525
+ + + + L+ GT ++APE +L DV++ GV + + G+
Sbjct: 184 SNEFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK--------KVIESDFQGDAE-FCNEVE 361
+ + K +GRG +V + I AVK + Q E EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 362 IISNLK-HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP 420
I+ + H N++ L+ E + +LV+D M G + D+L K
Sbjct: 76 ILRKVSGHPNIIQLKDTY------ETNTFFFLVFDLMKKGELFDYL---------TEKVT 120
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
L+ + + I+ + + + LH K I HRD+K NILLD DM ++ DFG + Q G
Sbjct: 121 LSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 481 QSHLTTRVAGTHGYLAPE------YALYGQLTEKSDVYSFGVVILEIM-CG 524
+ L GT YLAPE + ++ D++S G VI+ + G
Sbjct: 178 EK-LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAG 225
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 55/229 (24%), Positives = 86/229 (37%), Gaps = 38/229 (16%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAE---FCNEVEI 362
D++ +G G G V + VA++ K + E+EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+ L H ++ ++ D ++ Y+V + M G + D + V + L
Sbjct: 194 LKKLNHPCIIKIKN--FFDAED-----YYIVLELMEGGELFDKV---------VGNKRLK 237
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSRE 479
K + + YLH + I HRD+K N+LL + D ++ DFG +K E
Sbjct: 238 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
Query: 480 GQSHLTTRVAGTHGYLAPE---YALYGQLTEKSDVYSFGVVILEIM-CG 524
+ T GT YLAPE D +S G VIL I G
Sbjct: 295 TS-LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSG 340
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEI 362
+ +D + K +G+G F +V + + G A K K+ DFQ + E I
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARI 58
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
L+H N+V L + S YLV+D + G + + + VA+ +
Sbjct: 59 CRKLQHPNIVRLHDSI------QEESFHYLVFDLVTGGELFEDI---------VAREFYS 103
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSRE 479
+ I + + +AY H I HR++K N+LL ++ADFGLA + +
Sbjct: 104 EADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 480 GQSHLTTRVAGTHGYLAPE---YALYGQLTEKSDVYSFGVVILEIM-CG 524
++ GT GYL+PE Y + D+++ G VIL I+ G
Sbjct: 161 SEA-WHGFA-GTPGYLSPEVLKKDPYS---KPVDIWACG-VILYILLVG 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 35/223 (15%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISN 365
++++ +G+G FG V K AVK D EVE++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS---TILREVELLKK 77
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
L H N++ L E S Y+V + G + D + + ++ +
Sbjct: 78 LDHPNIMKLFEIL------EDSSSFYIVGELYTGGELFDEI---------IKRKRFSEHD 122
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQS 482
II V G+ Y+H K I HRD+K NILL + D ++ DFGL+ ++
Sbjct: 123 AARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
+ R+ GT Y+APE L G EK DV+S G VIL I+ G
Sbjct: 180 -MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAG-VILYILLSG 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 30/229 (13%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCN-EVEII--- 363
+ D+F + G+G FG V G + G +VA+KKV Q D F N E++I+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQ-DPRFRNRELQIMQDL 73
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYL--VYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
+ L H N+V L+ G+ +R + YL V +Y+P+ H +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDR-RDIYLNVVMEYVPD---TLH---RCCRNYYRRQVAP 126
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD-ADMRARVADFGLAKQSREG 480
K + + + + LH + HRDIK N+L++ AD ++ DFG AK+
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 481 QSHLTTRVAGTHGYLAPEYAL----YGQLTEKSDVYSFGVVILEIMCGR 525
+ + + + Y APE Y T D++S G + E+M G
Sbjct: 186 EPN-VAYIC-SRYYRAPELIFGNQHY---TTAVDIWSVGCIFAEMMLGE 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 54/219 (24%), Positives = 87/219 (39%), Gaps = 24/219 (10%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHR 369
D F K +G G FG V+ G +K + + Q E E+E++ +L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N++ + E Y+V + G L K L+ +
Sbjct: 81 NIIKIFEVF------EDYHNMYIVMETCEGGE----LLERIVSAQARGKA-LSEGYVAEL 129
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQSHLTT 486
+ + LAY H + H+D+K NIL ++ DFGLA+ + + H T
Sbjct: 130 MKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTN 185
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
GT Y+APE +T K D++S G V++ + G
Sbjct: 186 AA-GTALYMAPE-VFKRDVTFKCDIWSAG-VVMYFLLTG 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 57/241 (23%), Positives = 102/241 (42%), Gaps = 38/241 (15%)
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAE 355
+ + + + + + +G G +G V + A+K + + + D +
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 356 FC--------NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF 407
NE+ ++ +L H N++ L E YLV ++ G + + +
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVF------EDKKYFYLVTEFYEGGELFEQI- 137
Query: 408 PSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADM 464
+ + NI+ + G+ YLH K I HRDIK NILL ++ +
Sbjct: 138 --------INRHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL 186
Query: 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
++ DFGL+ + L R+ GT Y+APE L + EK DV+S GV++ ++CG
Sbjct: 187 NIKIVDFGLSSFFSKDYK-LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
Query: 525 R 525
Sbjct: 244 Y 244
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 32/232 (13%)
Query: 306 QDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEII 363
Q + + IGRG +G V K + G +AVK++ D + + +++++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 364 -SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+ +V G +GD ++ + M + + D V +
Sbjct: 75 MRSSDCPYIVQFYGALFREGD------CWICMELM-STSFDKFY----KYVYSVLDDVIP 123
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
I L K L +L +K I HRDIK +NILLD ++ DFG++ Q
Sbjct: 124 EEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ------ 175
Query: 483 HLT-----TRVAGTHGYLAPE----YALYGQLTEKSDVYSFGVVILEIMCGR 525
L TR AG Y+APE A +SDV+S G+ + E+ GR
Sbjct: 176 -LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK 367
F +G G F V+ G A+K + +S D+ NE+ ++ +K
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H N+V L E + YLV + G + D + + + T
Sbjct: 65 HENIVTLEDIY------ESTTHYYLVMQLVSGGELFDRI---------LERGVYTEKDAS 109
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQSHL 484
+I V + YLH + I HRD+K N+L + + + + DFGL+K + G +
Sbjct: 110 LVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--M 164
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
+T GT GY+APE ++ D +S G VI I+ CG
Sbjct: 165 ST-ACGTPGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 44/233 (18%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-------KVIESDFQGDAE-FCNEVEI 362
K+ K+ IGRG +V + + G AVK ++ + E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 363 ISNLK-HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
+ + H +++ L E S +LV+D M G + D+L K L
Sbjct: 153 LRQVAGHPHIITLIDSY------ESSSFMFLVFDLMRKGELFDYL---------TEKVAL 197
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
+ + ++I+ + + +++LH I HRD+K NILLD +M+ R++DFG + G+
Sbjct: 198 SEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254
Query: 482 SHLTTRVAGTHGYLAPE---------YALYGQLTEKSDVYSFGVVILEIM-CG 524
L GT GYLAPE + YG ++ D+++ G VIL + G
Sbjct: 255 K-LRELC-GTPGYLAPEILKCSMDETHPGYG---KEVDLWACG-VILFTLLAG 301
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 36/238 (15%)
Query: 299 GSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQG 352
G FK Q +E D + +G G F +V K G A K + S
Sbjct: 1 GMETFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 353 DAE-FCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
E EV I+ + H N++ L E ++ L+ + + G + D L
Sbjct: 58 CREEIEREVSILRQVLHPNIITLHDVY------ENRTDVVLILELVSGGELFDFL----- 106
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRAR 467
K L+ + + I + G+ YLH I H D+K NI+L +
Sbjct: 107 ----AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
+ DFGLA + +G GT ++APE Y L ++D++S G VI I+ G
Sbjct: 160 LIDFGLAHEIEDGVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAE-FCNEVEIIS 364
D + +G G F +V K G A K ++ S E EV I+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
++H N++ L E ++ L+ + + G + D L K LT
Sbjct: 64 EIRHPNIITLHDIF------ENKTDVVLILELVSGGELFDFL---------AEKESLTED 108
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVADFGLAKQSREG 480
+ + + G+ YLH I H D+K NI+L + R ++ DFG+A + G
Sbjct: 109 EATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
GT ++APE Y L ++D++S G VI I+ G
Sbjct: 166 NE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSG 207
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN 370
++ +N IGRG +G V + A KK+ + + F E+EI+ +L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
++ L E ++ YLV + G + + + V KR I+
Sbjct: 68 IIRLYETF------EDNTDIYLVMELCTGGELFERV---------VHKRVFRESDAARIM 112
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQSHLTTR 487
DV +AY H K + HRD+K N L D ++ DFGLA + + G+ + T+
Sbjct: 113 KDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTK 168
Query: 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
V GT Y++P+ L G + D +S G V++ ++ CG
Sbjct: 169 V-GTPYYVSPQ-VLEGLYGPECDEWSAG-VMMYVLLCG 203
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEII-SNLKHRNLVPLRGC 377
+GRG +G+V K + G +AVK++ + Q +++I + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGL 437
+GD ++ + M + ++D + G + + I + + K L
Sbjct: 75 LFREGD------VWICMELM-DTSLDKFYKQVIDKG-----QTIPEDILGKIAVSIVKAL 122
Query: 438 AYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
+LH + + HRD+K +N+L++A + ++ DFG++ AG Y+AP
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAP 178
Query: 498 E----YALYGQLTEKSDVYSFGVVILEIMCGR 525
E + KSD++S G+ ++E+ R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 62/249 (24%), Positives = 104/249 (41%), Gaps = 40/249 (16%)
Query: 289 SSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK---- 343
+S + F + + +D + K +G+G F +V + + G A K
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 344 -KVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNV 402
K+ DFQ + E I L+H N+V L + S YLV+D + G +
Sbjct: 65 KKLSARDFQ---KLEREARICRKLQHPNIVRLHDSI------QEESFHYLVFDLVTGGEL 115
Query: 403 DDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL-- 460
+ + VA+ + + I + + +AY H I HR++K N+LL
Sbjct: 116 FEDI---------VAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLAS 163
Query: 461 -DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE---YALYGQLTEKSDVYSFGV 516
++ADFGLA + + ++ GT GYL+PE Y + D+++ G
Sbjct: 164 KAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYS---KPVDIWACG- 217
Query: 517 VILEIM-CG 524
VIL I+ G
Sbjct: 218 VILYILLVG 226
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 46/213 (21%), Positives = 84/213 (39%), Gaps = 35/213 (16%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCC 378
+G G F + K + + AVK +I + + + E+ + + H N+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVK-IISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+LV + + G + + + K+ + + I+ + ++
Sbjct: 76 ------HDQLHTFLVMELLNGGELFERI---------KKKKHFSETEASYIMRKLVSAVS 120
Query: 439 YLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
++H + HRD+K N+L + ++ ++ DFG A+ L T T Y
Sbjct: 121 HMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYA 176
Query: 496 APE---YALYGQLTEKSDVYSFGVVILEIM-CG 524
APE Y E D++S G VIL M G
Sbjct: 177 APELLNQNGYD---ESCDLWSLG-VILYTMLSG 205
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 57/254 (22%), Positives = 102/254 (40%), Gaps = 52/254 (20%)
Query: 308 LERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCN-EVEIISN 365
LE ++ K+S +G G FG+V + + G A+KKV++ D + N E++I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56
Query: 366 LKHRNLVPLRGCCVVDGDNERGSER--------------------------------YLV 393
L H N++ L GD E + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453
+Y+P+ H + R + I + + + ++H I HRDI
Sbjct: 117 MEYVPD---TLH---KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDI 167
Query: 454 KATNILLDA-DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDV 511
K N+L+++ D ++ DFG AK+ + + + Y APE L + T D+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYIC-SRFYRAPELMLGATEYTPSIDL 225
Query: 512 YSFGVVILEIMCGR 525
+S G V E++ G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/234 (25%), Positives = 93/234 (39%), Gaps = 36/234 (15%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAE- 355
FK Q +E D + +G G F +V K G A K + S E
Sbjct: 5 FKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 356 FCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSG 415
EV I+ + H N++ L E ++ L+ + + G + D L
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY------ENRTDVVLILELVSGGELFDFL--------- 106
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVADF 471
K L+ + + I + G+ YLH I H D+K NI+L ++ DF
Sbjct: 107 AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
GLA + +G GT ++APE Y L ++D++S G VI I+ G
Sbjct: 164 GLAHEIEDGVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSG 214
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
+ +G G +G V I + G VA+KK + FQ F E+ ++ ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK-LSRPFQ-SEIFAKRAYRELLLLKHM 80
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N++ L + YLV +M D + + +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQ---------KIMGLKFSEEKI 128
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ ++ + KGL Y+H + HRD+K N+ ++ D ++ DFGLA R + +T
Sbjct: 129 QYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTG 182
Query: 487 RVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
V T Y APE L + + D++S G ++ E++ G+
Sbjct: 183 YVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/229 (24%), Positives = 87/229 (37%), Gaps = 38/229 (16%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-------KVIESDFQGDAE-FCNEVEI 362
D++ +G G G V + VA+K + + A E+EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 363 ISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
+ L H ++ ++ D ++ Y+V + M G + D + V + L
Sbjct: 69 LKKLNHPCIIKIKN--FFDAED-----YYIVLELMEGGELFDKV---------VGNKRLK 112
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSRE 479
K + + YLH + I HRD+K N+LL + D ++ DFG +K E
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 480 GQSHLTTRVAGTHGYLAPE---YALYGQLTEKSDVYSFGVVILEIM-CG 524
+ T GT YLAPE D +S G VIL I G
Sbjct: 170 TSL-MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSG 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 61/278 (21%), Positives = 96/278 (34%), Gaps = 61/278 (21%)
Query: 296 PNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESD 349
+++F+ L K+ K IG+G +G+V I Q A+K K+ + +
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 350 FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNG--------- 400
+ EV ++ L H N+ L E LV + G
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVY------EDEQYICLVMELCHGGHLLDKLNVF 122
Query: 401 ----------------------NVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
++ + S + NI+ + L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 439 YLHYGVKPAIYHRDIKATNILLDADMRARV--ADFGLAK---QSREGQSHLTTRVAGTHG 493
YLH I HRDIK N L + + DFGL+K + G+ + T AGT
Sbjct: 183 YLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 494 YLAPE-----YALYGQLTEKSDVYSFGVVILEIM-CGR 525
++APE YG K D +S G V+L ++ G
Sbjct: 240 FVAPEVLNTTNESYG---PKCDAWSAG-VLLHLLLMGA 273
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 33/225 (14%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAE-FCNEVEIIS 364
D + +G G F +V K G A K + S E EV I+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
++H N++ L E ++ L+ + + G + D L K LT
Sbjct: 70 EIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFL---------AEKESLTEE 114
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVADFGLAKQSREG 480
+ + + G+ YLH I H D+K NI+L R ++ DFGLA + G
Sbjct: 115 EATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
GT ++APE Y L ++D++S G VI I+ G
Sbjct: 172 NE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSG 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
++ IG G G+V VA+KK + FQ + E+ ++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK-LSRPFQ-NQTHAKRAYRELVLMKCV 81
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
H+N++ L E + Y+V + M + V + L +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA------------NLCQVIQMELDHERM 129
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
++ + G+ +LH I HRD+K +NI++ +D ++ DFGLA+ + +T
Sbjct: 130 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTP 185
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
V T Y APE L E D++S G ++ E++ G
Sbjct: 186 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/253 (24%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 281 SSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTT 339
S S S+ P W + + +D F ++ +GRG +VY+
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 340 VAV----KKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYD 395
A+ K V + + E+ ++ L H N++ L+ E +E LV +
Sbjct: 81 YALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIKLKEIF------ETPTEISLVLE 128
Query: 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKA 455
+ G + D + V K + + + + + +AYLH + I HRD+K
Sbjct: 129 LVTGGELFDRI---------VEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKP 176
Query: 456 TNILL---DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVY 512
N+L D ++ADFGL+K + T V GT GY APE + D++
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT-VCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 513 SFGVVILEIM-CG 524
S G +I I+ CG
Sbjct: 235 SVG-IITYILLCG 246
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 306 QDLERATDKFSQKNF-IGRGGFGLVYKGILQDGTT---VAVKKVIESDFQGDAEFCNEVE 361
+ ER D F + +GRG +G VYK +DG A+K++ + A C E+
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIA 70
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH-----LFPSFNDGSGV 416
++ LKH N++ L+ + D + +L++DY +H + +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKV----WLLFDYA------EHDLWHIIKFHRASKANK 120
Query: 417 AKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR----VADFG 472
L K+++ + G+ YLH + HRD+K NIL+ + R +AD G
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 473 LAKQ---SREGQSHLTTRVAGTHGYLAPE 498
A+ + + L V T Y APE
Sbjct: 178 FARLFNSPLKPLADLDPVVV-TFWYRAPE 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISN 365
T+++ +G+G F +V + + + G A K+ D Q + E I
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRL 66
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
LKH N+V L YL++D + G + + + VA+ +
Sbjct: 67 LKHPNIVRLHDSI------SEEGHHYLIFDLVTGGELFEDI---------VAREYYSEAD 111
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQS 482
+ I + + + + H + + HR++K N+LL ++ADFGLA + Q
Sbjct: 112 ASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 483 HLTTRVAGTHGYLAPE---YALYGQLTEKSDVYSFGVVILEIM-CG 524
GT GYL+PE YG + D+++ G VIL I+ G
Sbjct: 169 AWFGFA-GTPGYLSPEVLRKDPYG---KPVDLWACG-VILYILLVG 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/244 (25%), Positives = 97/244 (39%), Gaps = 53/244 (21%)
Query: 311 ATDKFS---------QKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEV 360
+TD FS Q++ +G G V I L AVK + + + EV
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 361 EIISNLK-HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR 419
E++ + HRN++ L E YLV++ M G++ H+ +R
Sbjct: 62 EMLYQCQGHRNVLELIEFF------EEEDRFYLVFEKMRGGSILSHI---------HKRR 106
Query: 420 PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQ 476
+ ++ DVA L +LH I HRD+K NIL + ++ DF L
Sbjct: 107 HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 477 SREGQSH-------LTTRVAGTHGYLAPE--------YALYGQLTEKSDVYSFGVVILEI 521
+ L T G+ Y+APE ++Y ++ D++S G VIL I
Sbjct: 164 IKLNGDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYD---KRCDLWSLG-VILYI 218
Query: 522 M-CG 524
+ G
Sbjct: 219 LLSG 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 24/228 (10%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCN----EVEII 363
AT ++ IG G +G VYK G VA+K V + + G EV ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 364 SNLK---HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP 420
L+ H N+V L C + LV++++ D ++ D +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIK-VTLVFEHV------DQDLRTYLDKAP--PPG 116
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
L K+++ +GL +LH I HRD+K NIL+ + ++ADFGLA+
Sbjct: 117 LPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY- 172
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528
Q LT V T Y APE L D++S G + E M RK L
Sbjct: 173 QMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKPL 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
S+ +G G FG V+K G +A K + + E NE+ +++ L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L E ++ LV +Y+ G LF D LT +
Sbjct: 150 QLYDAF------ESKNDIVLVMEYVDGGE----LFDRIID----ESYNLTELDTILFMKQ 195
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILL--DADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ +G+ ++H + I H D+K NIL + ++ DFGLA++ + + L G
Sbjct: 196 ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-G 250
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
T +LAPE Y ++ +D++S G VI ++ G
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVG-VIAYMLLSG 284
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 37/223 (16%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEII-SNLKHR 369
TD + K IG G + + + I AVK + +S E+EI+ +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEIEILLRYGQHP 76
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N++ L+ + G Y+V + M G + D + + ++ + + +
Sbjct: 77 NIITLKDVY------DDGKYVYVVTELMKGGELLDKI---------LRQKFFSEREASAV 121
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRARVADFGLAKQSREGQSHLT 485
+ + K + YLH + HRD+K +NIL R+ DFG AKQ R L
Sbjct: 122 LFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 486 TRVAGTHGYLAPE---YALYGQLTEKSDVYSFGVVILEIM-CG 524
T T ++APE Y D++S G V+L M G
Sbjct: 179 TPC-YTANFVAPEVLERQGYD---AACDIWSLG-VLLYTMLTG 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 59/233 (25%), Positives = 109/233 (46%), Gaps = 30/233 (12%)
Query: 300 SIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKV-IESDFQG-DAEFC 357
+++F+ +K+ + +G G +G+VYK G VA+K++ ++++ +G +
Sbjct: 13 NLYFQ-----GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 358 NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA 417
E+ ++ L H N+V L V+ + LV+++M + D +
Sbjct: 68 REISLLKELHHPNIVSLI--DVIHSERCL----TLVFEFM------EKDLKKVLDENKT- 114
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
L Q K + + +G+A+ H + I HRD+K N+L+++D ++ADFGLA+
Sbjct: 115 --GLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF 169
Query: 478 REGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKAL 528
T V T Y AP+ L G + + D++S G + E M K L
Sbjct: 170 GIPVRSYTHEVV-TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAE-MITGKPL 219
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
++ IG G G+V VA+KK + FQ + E+ ++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK-LSRPFQ-NQTHAKRAYRELVLMKCV 118
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
H+N++ L E + YLV + M + V + L +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA------------NLCQVIQMELDHERM 166
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
++ + G+ +LH I HRD+K +NI++ +D ++ DFGLA+ + +T
Sbjct: 167 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTP 222
Query: 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
V T Y APE L E D++S G ++ E++ +
Sbjct: 223 YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 35/233 (15%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCN----EV 360
D++ ++ + +F+G G F VYK VA+KK+ + + E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 361 EIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR- 419
+++ L H N++ L + LV+D+M + D + K
Sbjct: 64 KLLQELSHPNIIGLLD--AFGHKSNI----SLVFDFM------ET------DLEVIIKDN 105
Query: 420 --PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
LT K +L +GL YLH + I HRD+K N+LLD + ++ADFGLAK
Sbjct: 106 SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
Query: 478 REGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKAL 528
T +V T Y APE L+G D+++ G ++ E + R
Sbjct: 163 GSPNRAYTHQVV-TRWYRAPE-LLFGARMYGVGVDMWAVGCILAE-LLLRVPF 212
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 45/221 (20%), Positives = 87/221 (39%), Gaps = 26/221 (11%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK 367
D + +G G FG+V++ + G K + NE+ I++ L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR-PLTWPQR 426
H L+ L E E L+ +++ G + D + A+ ++ +
Sbjct: 107 HPKLINLHDAF------EDKYEMVLILEFLSGGELFDRI---------AAEDYKMSEAEV 151
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL--DADMRARVADFGLAKQSREGQSHL 484
N + +GL ++H + +I H DIK NI+ ++ DFGLA + + +
Sbjct: 152 INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-V 207
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
T + APE + +D+++ G V+ ++ G
Sbjct: 208 KVTT-ATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSG 246
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 55/265 (20%), Positives = 103/265 (38%), Gaps = 31/265 (11%)
Query: 266 WDKKLRKRFYGSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGG 325
+D + + SS+ + + + K + D + +G G
Sbjct: 113 YDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL---DHYDIHEELGTGA 169
Query: 326 FGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC-NEVEIISNLKHRNLVPLRGCCVVDGD 383
FG+V++ G A K + + + D E E++ +S L+H LV L
Sbjct: 170 FGVVHRVTERATGNNFAAK-FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF----- 223
Query: 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR-PLTWPQRKNIILDVAKGLAYLHY 442
E +E ++Y++M G + + + + ++ + + V KGL ++H
Sbjct: 224 -EDDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEYMRQVCKGLCHMH- 272
Query: 443 GVKPAIYHRDIKATNILL--DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA 500
+ H D+K NI+ ++ DFGL QS + GT + APE A
Sbjct: 273 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTT-GTAEFAAPEVA 328
Query: 501 LYGQLTEKSDVYSFGVVILEIM-CG 524
+ +D++S G V+ I+ G
Sbjct: 329 EGKPVGYYTDMWSVG-VLSYILLSG 352
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
IG+G F V + G VA+K ++ + Q + EV I+ L H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKL 79
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
V+ E YL+ +Y G V D+L VA + + ++ +
Sbjct: 80 FE--VI----ETEKTLYLIMEYASGGEVFDYL---------VAHGRMKEKEARSKFRQIV 124
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
+ Y H + I HRD+KA N+LLDADM ++ADFG + + G L G Y
Sbjct: 125 SAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPY 179
Query: 495 LAPEYALYGQLTE--KSDVYSFGVVILEIMCGR 525
APE G+ + + DV+S GV++ ++ G
Sbjct: 180 AAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 5e-23
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 25/221 (11%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLKHR 369
K+ + IG G +G V+K + VA+K+V ++ D +G + E+ ++ LKH+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N+V L V+ D + LV+++ D + D L K+
Sbjct: 62 NIVRLH--DVLHSDKKL----TLVFEFC------DQDLKKYFDSCNG---DLDPEIVKSF 106
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
+ + KGL + H + HRD+K N+L++ + ++A+FGLA+ + V
Sbjct: 107 LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 490 GTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKAL 528
T Y P+ L+G + D++S G + E+ + L
Sbjct: 164 -TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 41/221 (18%), Positives = 90/221 (40%), Gaps = 27/221 (12%)
Query: 309 ERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK 367
+ +K+ +GRG FG+V++ + T K ++ E+ I++ +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIAR 59
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP-LTWPQR 426
HRN++ L E E ++++++ ++ + + L +
Sbjct: 60 HRNILHLHESF------ESMEELVMIFEFISGLDIFERI---------NTSAFELNEREI 104
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL--DADMRARVADFGLAKQSREGQSHL 484
+ + V + L +LH I H DI+ NI+ ++ +FG A+Q + G +
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-F 160
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
Y APE + ++ +D++S G ++ ++ G
Sbjct: 161 RLLF-TAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSG 199
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
+ +G G +G V + + G VA+KK + FQ F E+ ++ ++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK-LYRPFQ-SELFAKRAYRELRLLKHM 81
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N++ L D + ++ YLV +M D + L +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM---GTDLGKL--------MKHEKLGEDRI 130
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ ++ + KGL Y+H I HRD+K N+ ++ D ++ DFGLA R+ S +T
Sbjct: 131 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTG 184
Query: 487 RVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
V T Y APE L + + T+ D++S G ++ E++ G+
Sbjct: 185 YVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 46/237 (19%), Positives = 94/237 (39%), Gaps = 27/237 (11%)
Query: 297 NTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDA 354
TG + Q + + +G G G V+K + G +AVK++ + + +
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 355 EFCNEVEII-SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG 413
+++++ + +V G + + D ++ + M +
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTD------VFIAMELM-GTCAEKLK------- 114
Query: 414 SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473
+ P+ + + + K L YL + HRD+K +NILLD + ++ DFG+
Sbjct: 115 -KRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 474 AKQSREGQSHLTTRVAGTHGYLAPE-----YALYGQLTEKSDVYSFGVVILEIMCGR 525
+ + R AG Y+APE ++DV+S G+ ++E+ G+
Sbjct: 172 SGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 57/245 (23%), Positives = 99/245 (40%), Gaps = 32/245 (13%)
Query: 292 PKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDF 350
++G ++ +K+ +G G +G+V K G VA+KK +ESD
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD 63
Query: 351 QGDAEFCN--EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPN---GNVDDH 405
+ E++++ L+H NLV L C YLV++++ + +++
Sbjct: 64 DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR------WYLVFEFVDHTILDDLELF 117
Query: 406 LFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465
L + + + + G+ + H I HRDIK NIL+
Sbjct: 118 ------------PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGV 162
Query: 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMC 523
++ DFG A+ VA T Y APE L G + + DV++ G ++ E M
Sbjct: 163 VKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE-LLVGDVKYGKAVDVWAIGCLVTE-MF 219
Query: 524 GRKAL 528
+ L
Sbjct: 220 MGEPL 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 27/226 (11%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAE--FCN---------EV 360
++ + FI G +G V G+ +G VA+K+V + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 361 EIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP 420
++++ H N++ LR V + + YLV + M D +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHF-EEPAMHKLYLVTELMR---TDLAQVIHDQ------RIV 130
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
++ + + + GL LH + HRD+ NILL + + DF LA++
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA- 186
Query: 481 QSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
++ T V Y APE + + T+ D++S G V+ E+ +
Sbjct: 187 DANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 37/217 (17%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKHR-NLVP 373
+GRG F +V + I G A K + + E +E+ ++ K ++
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA---EILHEIAVLELAKSCPRVIN 93
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK--NIIL 431
L E SE L+ +Y G + + + + +I
Sbjct: 94 LHEVY------ENTSEIILILEYAAGGEIFSLC---------LPELAEMVSENDVIRLIK 138
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQSHLTTRV 488
+ +G+ YLH + I H D+K NILL ++ DFG++++ L +
Sbjct: 139 QILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM 194
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
GT YLAPE Y +T +D+++ G +I ++
Sbjct: 195 -GTPEYLAPEILNYDPITTATDMWNIG-IIAYMLLTH 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 23/213 (10%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK----KVIESDFQGDAEFCNEVEIISNLKHRNLVPLR 375
+G G +G V + + + AVK K + G+A E++++ L+H+N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
V+ + + + Y+V +Y G + + S V ++ Q +
Sbjct: 73 D--VLYNEEK--QKMYMVMEYCVCGMQE--MLDS------VPEKRFPVCQAHGYFCQLID 120
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL-AKQSREGQSHLTTRVAGTHGY 494
GL YLH I H+DIK N+LL +++ G+ G+ +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 495 LAPEYALYGQLTE--KSDVYSFGVVILEIMCGR 525
PE A K D++S GV + I G
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG V G G VAVK K+ D G + E++ + +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKL 76
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
V+ ++ ++V +Y+ G + D++ + + + + +
Sbjct: 77 YQ--VI----STPTDFFMVMEYVSGGELFDYI---------CKHGRVEEMEARRLFQQIL 121
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
+ Y H + + HRD+K N+LLDA M A++ADFGL+ +G+ L T G+ Y
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNY 176
Query: 495 LAPEYALYGQLTE--KSDVYSFGVVILEIMCGR 525
APE + G+L + D++S GV++ ++CG
Sbjct: 177 AAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
+++ + +G G +G V + G VAVKK + FQ E+ ++ ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK-LSRPFQ-SIIHAKRTYRELRLLKHM 85
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
KH N++ L E ++ YLV M D + + V + LT
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMG---ADLN--------NIVKCQKLTDDHV 134
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
+ +I + +GL Y+H I HRD+K +N+ ++ D ++ DFGLA R +T
Sbjct: 135 QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTG 188
Query: 487 RVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
VA T Y APE L + + D++S G ++ E++ GR
Sbjct: 189 YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 9e-22
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVK----KVIESDFQGDAEFCNE---VEIIS 364
+ FS IGRGGFG VY D G A+K K I+ QG+ NE + ++S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVS 247
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
+V + + + D M G++ HL +
Sbjct: 248 TGDCPFIVCMSYA------FHTPDKLSFILDLMNGGDLHYHLS---------QHGVFSEA 292
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
+ ++ GL ++H + +RD+K NILLD R++D GLA + + H
Sbjct: 293 DMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH- 348
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGR 525
V GTHGY+APE G + S D +S G ++ +++ G
Sbjct: 349 -ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-21
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 29/231 (12%)
Query: 303 FKIQDLERAT-DKFSQKNFIGRGGFGLVYKGILQD-GTTVAVK----KVIESDFQGDAEF 356
+K + + T + F Q +G+GGFG V ++ G A K K I+ E
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---KGEA 229
Query: 357 C--NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGS 414
NE +I+ + R +V L E LV M G++ H+
Sbjct: 230 MALNEKQILEKVNSRFVVSLAYAY------ETKDALCLVLTLMNGGDLKFHI-------Y 276
Query: 415 GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
+ + + ++ GL LH + I +RD+K NILLD R++D GLA
Sbjct: 277 HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 475 KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
EGQ+ GT GY+APE + T D ++ G ++ E++ G+
Sbjct: 334 VHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKV-IESDFQG-DAEFCNEVEIISNLKHRN 370
+K+ IG G +G+VYK G T A+KK+ +E + +G + E+ I+ LKH N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L V+ LV++++ D D L K+ +
Sbjct: 62 IVKLY--DVIHTKKRL----VLVFEHL------DQDLKKLLDVCEG---GLESVTAKSFL 106
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
L + G+AY H + HRD+K N+L++ + ++ADFGLA+ T +
Sbjct: 107 LQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV- 162
Query: 491 THGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKAL 528
T Y AP+ L G + + D++S G + E M L
Sbjct: 163 TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAE-MVNGTPL 200
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 63/275 (22%), Positives = 92/275 (33%), Gaps = 72/275 (26%)
Query: 313 DKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQGD-AEFCNEVEIISN 365
D+ +GRG FG V + TVAVK + E + +E++I+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 366 L-KHRNLVPLRGCC---------------------------------VVDGDNERGSERY 391
+ H N+V L G C G R + Y
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 392 LVYDYMPNGNVDDHLFPSFNDGSGVA-------------------KRPLTWPQRKNIILD 432
+ + D + S + S K LT
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
VAKG+ +L HRD+ A NILL ++ DFGLA+ + + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGD 254
Query: 493 GYL-----APEYALYGQLTEKSDVYSFGVVILEIM 522
L APE T +SDV+SFGV++ EI
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 34/225 (15%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN--EVEIISNLKHR 369
+K+ + IG G +G+V+K G VA+KK +ES+ + E+ ++ LKH
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPN---GNVDDHLFPSFNDGSGVAKRPLTWPQR 426
NLV L V +LV++Y + +D + +R +
Sbjct: 63 NLVNLL--EVFRRKRRL----HLVFEYCDHTVLHELDRY------------QRGVPEHLV 104
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
K+I + + + H K HRD+K NIL+ ++ DFG A+ +
Sbjct: 105 KSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161
Query: 487 RVAGTHGYLAPEYALYGQLTEKS---DVYSFGVVILEIMCGRKAL 528
VA T Y +PE L G T+ DV++ G V E + L
Sbjct: 162 EVA-TRWYRSPE-LLVGD-TQYGPPVDVWAIGCVFAE-LLSGVPL 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 56/259 (21%), Positives = 107/259 (41%), Gaps = 38/259 (14%)
Query: 280 DSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGT 338
+LE Q+ P + + + D++ + +G G +G VYK I
Sbjct: 7 HHMGTLEAQTQGPG-SMSVSAAPSA-----TSIDRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 339 TVAVKKV-IESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDY 396
TVA+K++ +E + +G EV ++ L+HRN++ L+ V+ ++ +L+++Y
Sbjct: 61 TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK--SVIHHNHRL----HLIFEY 114
Query: 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKAT 456
++ + D + ++ K+ + + G+ + H HRD+K
Sbjct: 115 A------ENDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQ 161
Query: 457 NILLDADMRAR-----VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKS 509
N+LL + + DFGLA+ T + T Y PE L G +
Sbjct: 162 NLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE-ILLGSRHYSTSV 219
Query: 510 DVYSFGVVILEIMCGRKAL 528
D++S + E M + L
Sbjct: 220 DIWSIACIWAE-MLMKTPL 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 60/255 (23%), Positives = 103/255 (40%), Gaps = 32/255 (12%)
Query: 283 SSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNF-----IGRGGFGLVYKGILQD- 336
+ L + L + + + LE + F +GRGGFG V+ ++
Sbjct: 152 AHLGQAPFQEFLDSLYFLRFLQWKWLEA--QPMGEDWFLDFRVLGRGGFGEVFACQMKAT 209
Query: 337 GTTVAVK----KVIESDFQGDAEFC--NEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390
G A K K ++ E +I++ + R +V L E ++
Sbjct: 210 GKLYACKKLNKKRLKKR---KGYQGAMVEKKILAKVHSRFIVSLAYAF------ETKTDL 260
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450
LV M G++ H++ P+ + GL +LH + I +
Sbjct: 261 CLVMTIMNGGDIRYHIYNV-----DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIY 312
Query: 451 RDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSD 510
RD+K N+LLD D R++D GLA + + GQ+ GT G++APE L + D
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVD 371
Query: 511 VYSFGVVILEIMCGR 525
++ GV + E++ R
Sbjct: 372 YFALGVTLYEMIAAR 386
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC--NEVEIISNLKHRNLVPLRGC 377
+G G +G V + VAVK +++ D E+ I L H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ-RK---NIILDV 433
G+ +YL +Y G + D + + P ++ ++
Sbjct: 73 -HR----REGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDAQRFFHQLMA-- 116
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS--HLTTRVAGT 491
G+ YLH I HRDIK N+LLD +++DFGLA R L GT
Sbjct: 117 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GT 170
Query: 492 HGYLAPEYALYGQL--TEKSDVYSFGVVILEIMCGR 525
Y+APE L + E DV+S G+V+ ++ G
Sbjct: 171 LPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 36/230 (15%)
Query: 311 ATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCN-----EVEII 363
++ +F Q +G G + VYKG+ G VA+K+V ++S+ E E+ ++
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-----EGTPSTAIREISLM 57
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPN---GNVDDHLFPSFNDGSGVAKRP 420
LKH N+V L + LV+++M N +D G R
Sbjct: 58 KELKHENIVRLYDVIHTENK------LTLVFEFMDNDLKKYMDSR-------TVGNTPRG 104
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
L K + +GLA+ H + I HRD+K N+L++ + ++ DFGLA+
Sbjct: 105 LELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161
Query: 481 QSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKAL 528
+ ++ V T Y AP+ L G + D++S G ++ E M K L
Sbjct: 162 VNTFSSEVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAE-MITGKPL 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 52/260 (20%), Positives = 96/260 (36%), Gaps = 37/260 (14%)
Query: 280 DSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGT 338
SS + S + ++ E ++ +G GGFG VY GI + D
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 339 TVAVK-----KVIESDFQGDAEFCN-EVEIISNLKHR--NLVPLRGCCVVDGDNERGSER 390
VA+K ++ + + EV ++ + ++ L ER
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD--WF----ERPDSF 123
Query: 391 YLVYDYMPNGNVD--DHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448
L+ + P D D + + L ++ V + + + H +
Sbjct: 124 VLILER-PEPVQDLFDFI---------TERGALQEELARSFFWQVLEAVRHCH---NCGV 170
Query: 449 YHRDIKATNILLDAD-MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE 507
HRDIK NIL+D + ++ DFG ++ T GT Y PE+ +
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD-GTRVYSPPEW-IRYHRYH 226
Query: 508 --KSDVYSFGVVILEIMCGR 525
+ V+S G+++ +++CG
Sbjct: 227 GRSAAVWSLGILLYDMVCGD 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 48/217 (22%), Positives = 82/217 (37%), Gaps = 33/217 (15%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK----KVIESDFQGDAEFCN----EVEIISNLKHRNL 371
+G G FG V+ + + V VK + + D + E+ I+S ++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGN-VDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+ + + + LV + +G + + L P I
Sbjct: 92 IKVLD--IFENQ----GFFQLVMEKHGSGLDLFAFI---------DRHPRLDEPLASYIF 136
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ + YL I HRDIK NI++ D ++ DFG A G+ T G
Sbjct: 137 RQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCG 191
Query: 491 THGYLAPEYALYGQLTE--KSDVYSFGVVILEIMCGR 525
T Y APE L G + +++S GV + ++
Sbjct: 192 TIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 36/233 (15%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKG--ILQDGTTVAVKKV-IESDFQGDAEFCNEVEI---- 362
RA ++ IG G +G V+K + G VA+K+V +++ +G + +
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-------MPLSTIR 60
Query: 363 -ISNLK------HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSG 415
++ L+ H N+V L C V + LV++++ D ++ D
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK-LTLVFEHV------DQDLTTYLDKVP 113
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475
+ + K+++ + +GL +LH + HRD+K NIL+ + + ++ADFGLA+
Sbjct: 114 --EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 476 QSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528
Q LT+ V T Y APE L D++S G + E M RK L
Sbjct: 169 IYSF-QMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAE-MFRRKPL 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
+++ ++IG G +G+V + VA+KK+ S F+ +C E++I+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFE-HQTYCQRTLREIKILLRF 82
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N++ + + E+ + Y+V D M D + + + L+
Sbjct: 83 RHENIIGINDI-IRAPTIEQMKDVYIVQDLME---TDLYKL--------LKTQHLSNDHI 130
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH--- 483
+ + +GL Y+H + HRD+K +N+LL+ ++ DFGLA+ + H
Sbjct: 131 CYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 484 LTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKAL 528
LT VA T Y APE L T+ D++S G ++ E++ + +
Sbjct: 188 LTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPI 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRN 370
+ + + + +G G + VYKG VA+K++ +E + EV ++ +LKH N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L ++ + LV++Y+ D + D G + K +
Sbjct: 62 IVTLH--DIIHTEKSL----TLVFEYL------DKDLKQYLDDCGN---IINMHNVKLFL 106
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ +GLAY H + + HRD+K N+L++ ++ADFGLA+ V
Sbjct: 107 FQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV- 162
Query: 491 THGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKAL 528
T Y P+ L G + + D++ G + E M + L
Sbjct: 163 TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYE-MATGRPL 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 58/216 (26%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFC--NEVEIISNLKHRNLVPLRGC 377
+G G +G V + VAVK +++ D E+ I L H N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72
Query: 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ-RK---NIILDV 433
G+ +YL +Y G + D + + P ++ ++
Sbjct: 73 -HR----REGNIQYLFLEYCSGGELFDRI---------EPDIGMPEPDAQRFFHQLMA-- 116
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS--HLTTRVAGT 491
G+ YLH I HRDIK N+LLD +++DFGLA R L GT
Sbjct: 117 --GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GT 170
Query: 492 HGYLAPEYALYGQL--TEKSDVYSFGVVILEIMCGR 525
Y+APE L + E DV+S G+V+ ++ G
Sbjct: 171 LPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 37/232 (15%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
++ +G GG GLV+ + VA+KK++ D + E++II L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LT-DPQSVKHALREIKIIRRL 65
Query: 367 KHRNLV--------PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
H N+V G + Y+V +YM D + +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME---TDLANV--------LEQ 114
Query: 419 RPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQS 477
PL + + + +GL Y+H + HRD+K N+ ++ D+ ++ DFGLA+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 478 REGQSH---LTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
SH L+ + T Y +P L T+ D+++ G + E++ G+
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 52/263 (19%), Positives = 98/263 (37%), Gaps = 47/263 (17%)
Query: 281 SSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQ-----KNFIGRGGFGLVYKGI-L 334
+ + + P P + L+ + +G G G V +
Sbjct: 25 TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84
Query: 335 QDGTTVAVKKVIESDFQGDAEFC-NEVEIISNL-KHRNLVPLRGCCVVDGDNERGSER-- 390
+ A+K +++ D EVE+ + ++V + +N +
Sbjct: 85 RTQEKFALK-MLQ-----DCPKARREVELHWRASQCPHIVRIVDVY----ENLYAGRKCL 134
Query: 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK--NIILDVAKGLAYLHYGVKPAI 448
+V + + G + + + + +R+ I+ + + + YLH I
Sbjct: 135 LIVMECLDGGELFSRI---------QDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 182
Query: 449 YHRDIKATNILL---DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPE---YALY 502
HRD+K N+L + ++ DFG AK++ S LTT T Y+APE Y
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKY 240
Query: 503 GQLTEKSDVYSFGVVILEIM-CG 524
+ D++S G VI+ I+ CG
Sbjct: 241 D---KSCDMWSLG-VIMYILLCG 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 318 KNFIGRGGFGLVYKGI-LQDGTTVAVKKVIE--SDFQGDAEFCNEVEIISNL-KHRNLVP 373
K +G G G V + + G A+K ++ + EV+ ++V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKAR------QEVDHHWQASGGPHIVC 86
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK--NIIL 431
+ V + + ++ + M G + + + + +R+ I+
Sbjct: 87 ILD--VYENMHHGKRCLLIIMECMEGGELFSRI---------QERGDQAFTEREAAEIMR 135
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQSREGQSHLTTRV 488
D+ + +LH I HRD+K N+L + D ++ DFG AK++ + L T
Sbjct: 136 DIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC 190
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM-CG 524
T Y+APE + + D++S G VI+ I+ CG
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCG 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG V G G VAVK K+ D G E++ + +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKL 81
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
V+ S+ ++V +Y+ G + D++ L + + + +
Sbjct: 82 YQ--VI----STPSDIFMVMEYVSGGELFDYI---------CKNGRLDEKESRRLFQQIL 126
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
G+ Y H + + HRD+K N+LLDA M A++ADFGL+ +G+ L T G+ Y
Sbjct: 127 SGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNY 181
Query: 495 LAPEYALYGQLTE--KSDVYSFGVVILEIMCGR 525
APE + G+L + D++S GV++ ++CG
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
+G G FG V + VA+K + +SD E E+ + L+H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKL 74
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434
V+ ++ +V +Y G + D++ V K+ +T + + +
Sbjct: 75 YD--VI----TTPTDIVMVIEYA-GGELFDYI---------VEKKRMTEDEGRRFFQQII 118
Query: 435 KGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGY 494
+ Y H + I HRD+K N+LLD ++ ++ADFGL+ +G L T G+ Y
Sbjct: 119 CAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNY 173
Query: 495 LAPEYALYGQLTE--KSDVYSFGVVILEIMCGR 525
APE + G+L + DV+S G+V+ ++ GR
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 57/244 (23%), Positives = 93/244 (38%), Gaps = 35/244 (14%)
Query: 276 GSGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-L 334
GS + + SS+P ++I D++ ++ IG G +G V +
Sbjct: 22 GSQQEGQQRKQHHSSKPTASMPRPHSDWQI------PDRYEIRHLIGTGSYGHVCEAYDK 75
Query: 335 QDGTTVAVKKVIESDFQGDAEFCN----EVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390
+ VA+KK I F+ D C E+ I++ L H ++V + + D E+ E
Sbjct: 76 LEKRVVAIKK-ILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPK-DVEKFDEL 132
Query: 391 YLVYDYMPNGNVDDH-LFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIY 449
Y+V + D LF + LT K ++ ++ G+ Y+H I
Sbjct: 133 YVVLEIAD---SDFKKLFRT--------PVYLTELHIKTLLYNLLVGVKYVHSA---GIL 178
Query: 450 HRDIKATNILLDADMRARVADFGLA------KQSREGQSHLTTRVAGTHGYLAPEYALYG 503
HRD+K N L++ D +V DFGLA + L
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
Query: 504 QLTE 507
QLT
Sbjct: 239 QLTG 242
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 37/258 (14%)
Query: 283 SSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVA 341
S L P P T + +D E ++ +G+GGFG V+ G L D VA
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60
Query: 342 VK-----KVIESDFQGDAEFCN-EVEIISNL----KHRNLVPLRGCCVVDGDNERGSERY 391
+K +V+ D+ C EV ++ + H ++ L E
Sbjct: 61 IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD--WF----ETQEGFM 114
Query: 392 LVYDY-MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450
LV + +P ++ D++ K PL + V + + H + H
Sbjct: 115 LVLERPLPAQDLFDYI---------TEKGPLGEGPSRCFFGQVVAAIQHCH---SRGVVH 162
Query: 451 RDIKATNILLDADM-RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE-- 507
RDIK NIL+D A++ DFG + T GT Y PE+ +
Sbjct: 163 RDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD-GTRVYSPPEW-ISRHQYHAL 218
Query: 508 KSDVYSFGVVILEIMCGR 525
+ V+S G+++ +++CG
Sbjct: 219 PATVWSLGILLYDMVCGD 236
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 27/210 (12%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
IG G FG+ VAVK IE D E+ +L+H N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI- 85
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
+ ++ +Y G + + + + + + + G++Y
Sbjct: 86 -----LTPTHLAIIMEYASGGELYERI---------CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 440 LHYGVKPAIYHRDIKATNILLDAD--MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAP 497
H I HRD+K N LLD R ++ DFG +K S S + V GT Y+AP
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAP 186
Query: 498 EYALYGQLTE--KSDVYSFGVVILEIMCGR 525
E L Q + +DV+S GV + ++ G
Sbjct: 187 E-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 56/263 (21%), Positives = 92/263 (34%), Gaps = 56/263 (21%)
Query: 281 SSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQD-GTT 339
++ G S +P + +D F +G G F V
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSRE 57
Query: 340 VAVK-----KVIESDFQGDAEF-CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393
A+K +I+ + + E +++S L H V L D+E+ Y
Sbjct: 58 YAIKILEKRHIIKEN---KVPYVTRERDVMSRLDHPFFVKLYFTFQ---DDEK---LYFG 108
Query: 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL-DVAK--------GLAYLHYGV 444
Y NG + ++ ++ + L YLH
Sbjct: 109 LSYAKNGELLKYI------------------RKIGSFDETCTRFYTAEIVSALEYLH--- 147
Query: 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR-VAGTHGYLAPEYALYG 503
I HRD+K NILL+ DM ++ DFG AK GT Y++PE L
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTE 206
Query: 504 QLTEKS-DVYSFGVVILEIMCGR 525
+ KS D+++ G +I +++ G
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGL 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
+ F K+ +G G +G+V G VA+KK+ F F E++I+ +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFD-KPLFALRTLREIKILKHF 66
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
KH N++ + D E +E Y++ + M D H ++ + L+
Sbjct: 67 KHENIITIFNIQRPD-SFENFNEVYIIQELMQ---TDLHRV--------ISTQMLSDDHI 114
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA----------KQ 476
+ I + + LH + HRD+K +N+L++++ +V DFGLA +
Sbjct: 115 QYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 477 SREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGR 525
QS + VA T Y APE L + + DV+S G ++ E+ R
Sbjct: 172 PTGQQSGMVEFVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 24/203 (11%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
D + K+ IGRG +G VY VA+KK + F+ D C E+ I++ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK-VNRMFE-DLIDCKRILREITILNRL 82
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH-LFPSFNDGSGVAKRPLTWPQ 425
K ++ L + D D + E Y+V + D LF + LT
Sbjct: 83 KSDYIIRLYDLIIPD-DLLKFDELYIVLEIAD---SDLKKLFKT--------PIFLTEEH 130
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA-KQSREGQSHL 484
K I+ ++ G ++H I HRD+K N LL+ D +V DFGLA + E +++
Sbjct: 131 IKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 485 TTRVAGTHGYLAPEYALYGQLTE 507
+ L QLT
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTS 210
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 60/227 (26%), Positives = 84/227 (37%), Gaps = 57/227 (25%)
Query: 321 IGRGGFGLVYKGILQD-GTTVAVK-----KVIESDFQGDAEFCNEVEIISNLKHRNLVPL 374
IG+G FG V D A+K K +E + E++I+ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQGLEHPFLVNL 80
Query: 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL-DV 433
D E ++V D + G++ HL Q+ +
Sbjct: 81 WYSF---QDEED---MFMVVDLLLGGDLRYHL------------------QQNVHFKEET 116
Query: 434 AK--------GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
K L YL I HRD+K NILLD + DF +A T
Sbjct: 117 VKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173
Query: 486 TRVAGTHGYLAPE------YALYGQLTEKS-DVYSFGVVILEIMCGR 525
+AGT Y+APE A Y + D +S GV E++ GR
Sbjct: 174 --MAGTKPYMAPEMFSSRKGAGYS----FAVDWWSLGVTAYELLRGR 214
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 50/222 (22%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HR 369
D + +GRG + V++ I + + V VK + + + E++I+ NL+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH-LFPSFNDGSGVAKRPLTWPQRKN 428
N++ L +V R + + N D L+ + D +
Sbjct: 92 NIITLA--DIVKDPVSR-TPALVFEHVN---NTDFKQLYQTLTD-----------YDIRF 134
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA-RVADFGLAKQSREGQSHLTTR 487
+ ++ K L Y H I HRD+K N+++D + R R+ D+GLA+ GQ R
Sbjct: 135 YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVR 190
Query: 488 VAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGRKAL 528
VA + + PE + Q+ + S D++S G ++ ++ ++
Sbjct: 191 VA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 64/280 (22%), Positives = 93/280 (33%), Gaps = 68/280 (24%)
Query: 279 LDSSSSLEGQSSRPKLRPNTGSIWF---------KIQDLERATDKFSQKNFIGRGGFGLV 329
LD +L P LR N F KI+DL + + IGRG FG V
Sbjct: 26 LDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEV 85
Query: 330 Y----KGILQDGTTVAVK----KVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381
K A+K + A F E +I++ +V L D
Sbjct: 86 QLVRHKS---TRKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSPWVVQLF-YAFQD 140
Query: 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK------ 435
Y+V +YMP G L ++ A+
Sbjct: 141 DRY-----LYMVMEYMPGG----DLV--------------NLMSNYDVPEKWARFYTAEV 177
Query: 436 --GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
L +H HRD+K N+LLD ++ADFG + + GT
Sbjct: 178 VLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 494 YLAPE-------YALYGQLTEKS-DVYSFGVVILEIMCGR 525
Y++PE YG + D +S GV + E++ G
Sbjct: 235 YISPEVLKSQGGDGYYG----RECDWWSVGVFLYEMLVGD 270
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 22/223 (9%), Positives = 56/223 (25%), Gaps = 58/223 (26%)
Query: 321 IGRGGFGLVYKGILQD---GTTVAVKKVIESDFQGD----AEFCNEVEIISNLKHRNLVP 373
G ++ D VA+ ++ E + +S + +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
V+D + R +V +++ G++ + VA + + +
Sbjct: 96 -----VLDVVHTRAGG-LVVAEWIRGGSLQE-----------VADTSPSPVGAIRAMQSL 138
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHG 493
A H + + + + + D +A
Sbjct: 139 AAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------A 174
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536
+ + D+ G + ++ R L + S
Sbjct: 175 TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 59/280 (21%), Positives = 94/280 (33%), Gaps = 63/280 (22%)
Query: 279 LDSSSSLEGQSSRPKLRPNTGSI----WFKIQDLERATDKFSQKNF-----IGRGGFGLV 329
LD + + +L + W + + + + +F IGRG F V
Sbjct: 18 LDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEV 77
Query: 330 Y----KGILQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNLKHRNLVPLRGCCVVDG 382
K G A+K + + D E F E +++ N R + L D
Sbjct: 78 AVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDE 133
Query: 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL--DVAK----- 435
+ YLV +Y G L T + + ++A+
Sbjct: 134 NY-----LYLVMEYYVGG----DLL--------------TLLSKFGERIPAEMARFYLAE 170
Query: 436 ---GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ +H + HRDIK NILLD R+ADFG + R + + GT
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 493 GYLAPEYALYGQLTEKSDVY-------SFGVVILEIMCGR 525
YL+PE + Y + GV E+ G+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-17
Identities = 62/279 (22%), Positives = 101/279 (36%), Gaps = 63/279 (22%)
Query: 279 LDSSSSLEGQSSRPKLRPNTGSI----WFKIQDLERATDKFSQKNF-----IGRGGFGLV 329
LD L + + LR + W K + + +++F IGRG FG V
Sbjct: 31 LDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEV 90
Query: 330 Y----KGILQDGTTVAV----KKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381
K A+ K + + A F E +++ N + + L D
Sbjct: 91 AVVKLKN---ADKVFAMKILNKWEMLKRAET-ACFREERDVLVNGDSKWITTLH-YAFQD 145
Query: 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL--DVAK---- 435
+N YLV DY G L T + L ++A+
Sbjct: 146 DNN-----LYLVMDYYVGG----DLL--------------TLLSKFEDRLPEEMARFYLA 182
Query: 436 ----GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGT 491
+ +H + HRDIK NIL+D + R+ADFG + E + ++ GT
Sbjct: 183 EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 492 HGYLAPEYALYGQLTEKS-----DVYSFGVVILEIMCGR 525
Y++PE + + D +S GV + E++ G
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.5 bits (200), Expect = 7e-17
Identities = 38/211 (18%), Positives = 63/211 (29%), Gaps = 38/211 (18%)
Query: 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKV-------IESDFQGDA-EFCNEVEI 362
T+K + IG G FG V++ I D T VA+K + + Q E E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 363 ISNL---------KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG 413
L + + L V G +D+ + + P F
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGS--YPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 414 SGV----------------AKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATN 457
+ + + K+I+ + LA HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 458 ILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+LL ++ K S L +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 8e-17
Identities = 72/245 (29%), Positives = 111/245 (45%), Gaps = 50/245 (20%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCN----EVEIISNL 366
K+ +G+G +G+V+K I + G VAVKK I FQ ++ E+ I++ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK-IFDAFQ-NSTDAQRTFREIMILTEL 65
Query: 367 K-HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
H N+V L D D + YLV+DYM D H + L
Sbjct: 66 SGHENIVNLLNVLRADNDRDV----YLVFDYME---TDLHAV--------IRANILEPVH 110
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA----------- 474
++ ++ + K + YLH G + HRD+K +NILL+A+ +VADFGL+
Sbjct: 111 KQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 475 ----------KQSREGQSHLTTRVAGTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMC 523
+ + Q LT VA T Y APE L + T+ D++S G ++ EI+
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL- 225
Query: 524 GRKAL 528
K +
Sbjct: 226 CGKPI 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 49/239 (20%)
Query: 307 DLERATDKFSQKNF-----IGRGGFGLVY----KGILQDGTTVAVK----KVIESDFQGD 353
L + + + F +G+G FG V K G A+K +VI +
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAK---- 189
Query: 354 AEFCNEVE-------IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL 406
+EV ++ N +H L L+ D V +Y G + HL
Sbjct: 190 ----DEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDR-----LCFVMEYANGGELFFHL 239
Query: 407 FPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466
+R + + + ++ L YLH + + +RD+K N++LD D
Sbjct: 240 ---------SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHI 288
Query: 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
++ DFGL K+ + + + T GT YLAPE D + GVV+ E+MCGR
Sbjct: 289 KITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 60/228 (26%), Positives = 90/228 (39%), Gaps = 48/228 (21%)
Query: 313 DKFSQKNFIGRGGFGLVY----KGILQDGTTVAVK-----KVIESDFQGDAEFCNEVEII 363
D+F + +G G FG V K G A+K KV++ NE I+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQI--EHTLNEKRIL 95
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHL--FPSFNDGSGVAKRPL 421
+ LV L DN Y+V +Y+ G + HL F++
Sbjct: 96 QAVNFPFLVKLEFSF---KDNSN---LYMVMEYVAGGEMFSHLRRIGRFSE--------- 140
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
P + + YLH + +RD+K N+L+D +V DFG AK+ +
Sbjct: 141 --PHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194
Query: 482 SHLTTRVAGTHGYLAPEYAL---YGQLTEKS-DVYSFGVVILEIMCGR 525
T + GT LAPE L Y K+ D ++ GV+I E+ G
Sbjct: 195 ---TWTLCGTPEALAPEIILSKGYN----KAVDWWALGVLIYEMAAGY 235
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 63/280 (22%), Positives = 108/280 (38%), Gaps = 66/280 (23%)
Query: 277 SGLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNF-----IGRGGFG---L 328
SG + +S +G +L + + +L +K +NF +G G +G L
Sbjct: 15 SGGAAGTSADGGDGGEQLLTVKHEL--RTANLTGHAEKVGIENFELLKVLGTGAYGKVFL 72
Query: 329 VYKGILQD-GTTVAVK-----KVIESDFQGDAEFCNEVE--IISNLKHRN-LVPLRGCCV 379
V K D G A+K +++ + E ++ +++ LV L
Sbjct: 73 VRKISGHDTGKLYAMKVLKKATIVQKAKTTE---HTRTERQVLEHIRQSPFLVTLH-YAF 128
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII-LDVAK--- 435
+L+ DY+ G LF T ++ +
Sbjct: 129 QTETK-----LHLILDYINGG----ELF--------------THLSQRERFTEHEVQIYV 165
Query: 436 -----GLAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
L +LH G+ IY RDIK NILLD++ + DFGL+K+ ++
Sbjct: 166 GEIVLALEHLHKLGI---IY-RDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 490 GTHGYLAPE---YALYGQLTEKS-DVYSFGVVILEIMCGR 525
GT Y+AP+ G +K+ D +S GV++ E++ G
Sbjct: 222 GTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 43/247 (17%), Positives = 87/247 (35%), Gaps = 62/247 (25%)
Query: 287 GQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV 345
G + L+ +I + + +G G G V + + A+K +
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQV---------LGLGINGKVLQIFNKRTQEKFALK-M 50
Query: 346 IESDFQGDAEFC-NEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVD 403
++ D EVE+ + ++V + V + +V + + G +
Sbjct: 51 LQ-----DCPKARREVELHWRASQCPHIVRIVD--VYENLYAGRKCLLIVMECLDGGELF 103
Query: 404 DHLFPSFNDGSGVAKRPLTWPQRK--NIILDVAKGLAYLHYGVKPAIYHRDIKATNILL- 460
+ + + +R+ I+ + + + YLH I HRD+K N+L
Sbjct: 104 SRI---------QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYT 151
Query: 461 --DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVI 518
+ ++ DFG AK++ + Y + D++S G VI
Sbjct: 152 SKRPNAILKLTDFGFAKETTGEK--------------------YD---KSCDMWSLG-VI 187
Query: 519 LEIM-CG 524
+ I+ CG
Sbjct: 188 MYILLCG 194
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 58/245 (23%)
Query: 306 QDLERATDKFSQKNF-----IGRGGFG---LVYKGILQD-GTTVAVK-----KVIESDFQ 351
++ +K F +G+G FG LV K D A+K + D
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-- 69
Query: 352 GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
E +I+ + H +V L YL+ D++ G LF
Sbjct: 70 -RVRTKMERDILVEVNHPFIVKLH-YAFQTEGK-----LYLILDFLRGG----DLF---- 114
Query: 412 DGSGVAKRPLTWPQRKNIIL-DVAK--------GLAYLH-YGVKPAIYHRDIKATNILLD 461
T ++ + + K L +LH G+ IY RD+K NILLD
Sbjct: 115 ----------TRLSKEVMFTEEDVKFYLAELALALDHLHSLGI---IY-RDLKPENILLD 160
Query: 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILE 520
+ ++ DFGL+K+S + GT Y+APE + + +S D +SFGV++ E
Sbjct: 161 EEGHIKLTDFGLSKESIDH-EKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFE 218
Query: 521 IMCGR 525
++ G
Sbjct: 219 MLTGT 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 69/240 (28%)
Query: 314 KFSQKNF-----IGRGGFGLVY----KGILQDGTTVAVK-----KVIESDFQGDAE-FCN 358
K+S ++F +G G FG V+ + +G A+K V+ E +
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLK---QVEHTND 55
Query: 359 EVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAK 418
E ++S + H ++ + G D ++ +++ DY+ G LF
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQ---DAQQ---IFMIMDYIEGG----ELF----------- 94
Query: 419 RPLTWPQRKNIIL-DVAK--------GLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469
+ ++ VAK L YLH I +RD+K NILLD + ++
Sbjct: 95 ---SLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 148
Query: 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKS-DVYSFGVVILEIMCGR 525
DFG AK + T + GT Y+APE Y KS D +SFG++I E++ G
Sbjct: 149 DFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLAGY 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 59/237 (24%), Positives = 89/237 (37%), Gaps = 60/237 (25%)
Query: 314 KFSQKNF-----IGRGGFGLV----YKGILQDGTTVAVK----KVIESDFQGDAEFCNEV 360
K + +F +G+G FG V K G A+K +VI + +EV
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAK--------DEV 49
Query: 361 E-------IISNLKHRNLVPLRGC-----CVVDGDNERGSERYLVYDYMPNGNVDDHLFP 408
++ N +H L L+ + V +Y G + HL
Sbjct: 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRL-----------CFVMEYANGGELFFHL-- 96
Query: 409 SFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468
+R T + + ++ L YLH + +RDIK N++LD D ++
Sbjct: 97 -------SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146
Query: 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
DFGL K+ GT YLAPE D + GVV+ E+MCGR
Sbjct: 147 TDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 58/250 (23%), Positives = 95/250 (38%), Gaps = 66/250 (26%)
Query: 306 QDLERATDKFSQKNF-----IGRGGFG---LVYKGILQD-GTTVAVK----KVIESDFQG 352
+ R +K + F +G+GG+G V K + G A+K +I +
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA-- 62
Query: 353 DAEFCNEVE-------IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH 405
+ I+ +KH +V L G YL+ +Y+ G
Sbjct: 63 -----KDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGK-----LYLILEYLSGG----E 107
Query: 406 LFPSFNDGSGVAKRPLTWPQRKNIIL-DVAK--------GLAYLH-YGVKPAIYHRDIKA 455
LF +R+ I + D A L +LH G+ IY RD+K
Sbjct: 108 LF--------------MQLEREGIFMEDTACFYLAEISMALGHLHQKGI---IY-RDLKP 149
Query: 456 TNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFG 515
NI+L+ ++ DFGL K+S +T GT Y+APE + D +S G
Sbjct: 150 ENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLG 208
Query: 516 VVILEIMCGR 525
++ +++ G
Sbjct: 209 ALMYDMLTGA 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 56/235 (23%), Positives = 94/235 (40%), Gaps = 53/235 (22%)
Query: 313 DKFSQKNF-----IGRGGFGLV----YKGILQDGTTVAVK----KVIESDFQGDAEFCNE 359
K ++F +G+G FG V +K A+K V+ D ++
Sbjct: 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMD--------DD 60
Query: 360 VEII--------SNLKHRNLVPLRGCCVVDGDNERGSER-YLVYDYMPNGNVDDHLFPSF 410
VE +H L + + E + V +Y+ G++ H+
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMFCTF-------QTKENLFFVMEYLNGGDLMYHIQSC- 112
Query: 411 NDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470
+ ++ GL +LH I +RD+K NILLD D ++AD
Sbjct: 113 --------HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIAD 161
Query: 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
FG+ K++ G + T GT Y+APE L + D +SFGV++ E++ G+
Sbjct: 162 FGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 5e-13
Identities = 59/259 (22%), Positives = 98/259 (37%), Gaps = 53/259 (20%)
Query: 289 SSRPKLRPNTGSIWFKIQDLERATDKFSQKNF-----IGRGGFGLV----YKGILQDGTT 339
K + D D+ +F +G+G FG V KG
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDEL 368
Query: 340 VAV----KKVIESDFQGDAEFCNEVE--------IISNLKHRNLVPLRGCCVVDGDNERG 387
AV K V+ D ++VE + K L L C +
Sbjct: 369 YAVKILKKDVVIQD--------DDVECTMVEKRVLALPGKPPFLTQLHSCF-------QT 413
Query: 388 SER-YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP 446
+R Y V +Y+ G++ H+ P ++A GL +L
Sbjct: 414 MDRLYFVMEYVNGGDLMYHI---------QQVGRFKEPHAVFYAAEIAIGLFFLQ---SK 461
Query: 447 AIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT 506
I +RD+K N++LD++ ++ADFG+ K++ T GT Y+APE Y
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQPYG 520
Query: 507 EKSDVYSFGVVILEIMCGR 525
+ D ++FGV++ E++ G+
Sbjct: 521 KSVDWWAFGVLLYEMLAGQ 539
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-13
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 53/237 (22%)
Query: 311 ATDKFSQKNF-----IGRGGFGLVY----KGILQDGTTVAVK----KVIESDFQGDAEFC 357
A D ++F IGRG + V K A+K +++ D
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDD-------- 50
Query: 358 NEVE--------IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPS 409
+++ H LV L C + S + V +Y+ G++ H+
Sbjct: 51 EDIDWVQTEKHVFEQASNHPFLVGLHSCF------QTESRLFFVIEYVNGGDLMFHMQ-- 102
Query: 410 FNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469
+R L + +++ L YLH + I +RD+K N+LLD++ ++
Sbjct: 103 -------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLT 152
Query: 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGR 525
D+G+ K+ T+ GT Y+APE L G+ S D ++ GV++ E+M GR
Sbjct: 153 DYGMCKEGLRPGD-TTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 55/237 (23%), Positives = 93/237 (39%), Gaps = 53/237 (22%)
Query: 311 ATDKFSQKNF-----IGRGGFGLVY----KGILQDGTTVAVK----KVIESDFQGDAEFC 357
++++ NF +G+G FG V K G AVK VI D
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQD-------- 64
Query: 358 NEVE--------IISNLKHRNLVPLRGCCVVDGDNERGSER-YLVYDYMPNGNVDDHLFP 408
++VE + H L L C + +R + V +++ G++ H+
Sbjct: 65 DDVECTMTEKRILSLARNHPFLTQLFCCF-------QTPDRLFFVMEFVNGGDLMFHI-- 115
Query: 409 SFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468
R + + ++ L +LH I +RD+K N+LLD + ++
Sbjct: 116 -------QKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKL 165
Query: 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
ADFG+ K+ T GT Y+APE D ++ GV++ E++CG
Sbjct: 166 ADFGMCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 72/279 (25%), Positives = 103/279 (36%), Gaps = 74/279 (26%)
Query: 278 GLDSSSSLEGQSSRPKLRPNTGSIWFKIQDLERATDKFSQKNF-----IGRGGFGLVY-- 330
G+ E ++ P P +I + +F IG+G FG V
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQ---QINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLA 57
Query: 331 --KGILQDGTTVAVK----KVIESDFQGDAEFCNEVE--------IISNLKHRNLVPLRG 376
K + AVK K I E + ++ N+KH LV L
Sbjct: 58 RHKA---EEVFYAVKVLQKKAILKK--------KEEKHIMSERNVLLKNVKHPFLVGLH- 105
Query: 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL-DVAK 435
D Y V DY+ G + HL QR+ L A+
Sbjct: 106 FSFQTADK-----LYFVLDYINGGELFYHL------------------QRERCFLEPRAR 142
Query: 436 --------GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
L YLH I +RD+K NILLD+ + DFGL K++ E S T+
Sbjct: 143 FYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-TTST 198
Query: 488 VAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGR 525
GT YLAPE L+ Q +++ D + G V+ E++ G
Sbjct: 199 FCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 54/238 (22%), Positives = 98/238 (41%), Gaps = 53/238 (22%)
Query: 310 RATDKFSQKNF-----IGRGGFGLVY----KGILQDGTTVAVK----KVIESDFQGDAEF 356
+A+ ++F IGRG + V K A++ +++ D
Sbjct: 44 KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDD------- 93
Query: 357 CNEVE--------IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFP 408
+++ H LV L C + S + V +Y+ G++ H+
Sbjct: 94 -EDIDWVQTEKHVFEQASNHPFLVGLHSCF------QTESRLFFVIEYVNGGDLMFHMQ- 145
Query: 409 SFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468
+R L + +++ L YLH + I +RD+K N+LLD++ ++
Sbjct: 146 --------RQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKL 194
Query: 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKS-DVYSFGVVILEIMCGR 525
D+G+ K+ T+ GT Y+APE L G+ S D ++ GV++ E+M GR
Sbjct: 195 TDYGMCKEGLRPGD-TTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 51/240 (21%)
Query: 307 DLERATDKFSQKNF-----IGRGGFGLV----YKGILQDGTTVAVK----KVIESDFQGD 353
D D+ +F +G+G FG V KG AVK V+ D
Sbjct: 9 DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQD---- 61
Query: 354 AEFCNEVE--------IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDH 405
++VE + K L L C + Y V +Y+ G++ H
Sbjct: 62 ----DDVECTMVEKRVLALPGKPPFLTQLHSCF------QTMDRLYFVMEYVNGGDLMYH 111
Query: 406 LFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465
+ P ++A GL +L I +RD+K N++LD++
Sbjct: 112 I---------QQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 159
Query: 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
++ADFG+ K++ T GT Y+APE Y + D ++FGV++ E++ G+
Sbjct: 160 IKIADFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 46/229 (20%), Positives = 79/229 (34%), Gaps = 47/229 (20%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
+G G F V+ + + T VA+K ++ D +E++++ +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVND----------- 74
Query: 380 VDGDNERGSERYLV---YDY-MPNGNVDDHLFPSF-------------NDGSGVAKRPLT 422
D E + D+ G H+ F + R +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH-----RGIP 129
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA------RVADFGLAKQ 476
K I + GL Y+H I H DIK N+L++ ++AD G A
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
E H T + Y +PE L +D++S +I E++ G
Sbjct: 188 YDE---HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 54/264 (20%), Positives = 93/264 (35%), Gaps = 77/264 (29%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCC 378
+G G F V+ +Q VA+K V++S +E+ ++ ++++ + P R
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 379 V-------VDGDNERGSERYLVYDYMPNG-NVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
V + G N G+ +V++ + G ++ + S + L P K II
Sbjct: 104 VQLLDDFKISGVN--GTHICMVFEVL--GHHLLKWIIKSNY-------QGLPLPCVKKII 152
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD--------------------------- 463
V +GL YLH K I H DIK NILL +
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 464 ----------------------MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL 501
++ ++AD G A H T + T Y + E +
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDI-QTRQYRSLEVLI 266
Query: 502 YGQLTEKSDVYSFGVVILEIMCGR 525
+D++S + E+ G
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 61/238 (25%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVI--ESDFQGDAEFCNEVEIISNLKH 368
++ IG+G FG V K + VA+K ++ E F A E+ I+ +L+
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAA--EEIRILEHLRK 152
Query: 369 R------NLVPLRGC-------CVVD---GDNERGSERYLVYDYMPNGNVDDHLFPSFND 412
+ N++ + C+ N +Y+ +
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMN--------LYELIKKNKF---------- 194
Query: 413 GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA--RVAD 470
+ + P + + + L LH K I H D+K NILL R+ +V D
Sbjct: 195 ------QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID 245
Query: 471 FGLAKQSREGQSHLT---TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
FG + E Q T +R Y APE L + D++S G ++ E++ G
Sbjct: 246 FGSS--CYEHQRVYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 9e-08
Identities = 57/353 (16%), Positives = 102/353 (28%), Gaps = 101/353 (28%)
Query: 330 YKGILQDGTTVAVKKVIESDFQGDAEFCN-------------EVEIISNLKHRNLVPLRG 376
YK IL V E F + + C E++ I K LR
Sbjct: 18 YKDILS---------VFEDAFVDNFD-CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL 67
Query: 377 CCVVDGDNERGSERYLV------YDYM----------PNGNVDDHLF---PSFNDGSGVA 417
+ E ++++ Y ++ P+ ++ +ND A
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIY---HRDI---K---ATNILLDADMRARV 468
K ++ R L + + L ++PA + K A ++ L ++ +
Sbjct: 128 KYNVS---RLQPYLKLRQAL----LELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK- 179
Query: 469 ADFG-----LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGV--VILEI 521
DF L + L L Q+ S + L I
Sbjct: 180 MDFKIFWLNLKNCNS------------PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 522 MCGRKALD--LSTSGSPRACLITDWVWSLVKAGKVWQALDPS---LLKEDDFLSLNPKAI 576
+ L L + L+ V + K W A + S LL K +
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQN----AKAWNAFNLSCKILLTTRF------KQV 277
Query: 577 MERFVLVGILCAHVMVALRP---TISDALKMLEGDIEVPP--LPDRPMPLGHP 624
+ L H+ + T + +L ++ P LP R + +P
Sbjct: 278 TD--FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-REVLTTNP 327
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 51/244 (20%), Positives = 95/244 (38%), Gaps = 53/244 (21%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVI--ESDFQGDAEFCNE 359
+ +++ E+ D++ + IG+G FG V K + VA+K +I + F A+ E
Sbjct: 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQ--IE 100
Query: 360 VEIISNLKHR------NLVPLRGC-------CVVD---GDNERGSERYLVYDYMPNGNVD 403
V ++ + +V L+ C+V N +YD + N N
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN--------LYDLLRNTN-- 150
Query: 404 DHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463
R ++ + + L +L + +I H D+K NILL
Sbjct: 151 --------------FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP 195
Query: 464 MRA--RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521
R+ ++ DFG + Q + + + Y +PE L D++S G +++E+
Sbjct: 196 KRSAIKIVDFGSSCQLGQ---RIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEM 251
Query: 522 MCGR 525
G
Sbjct: 252 HTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 23/175 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
+KF IG G FG +Y G +Q VA+K +E+ + E +I L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTG 64
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
+P V+GD Y+ + V D L PS D R L+ +
Sbjct: 65 IPNVRWFGVEGD----------YNVL----VMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR---VADFGLAKQSREGQSH 483
+ + ++H HRDIK N L+ RA + DFGLAK+ R+ +H
Sbjct: 111 QMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 37/176 (21%), Positives = 60/176 (34%), Gaps = 25/176 (14%)
Query: 314 KFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
F IG G FG + G L VA+K +E + E L + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGI 67
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
P G Y+ M V + L PS D + R + I +
Sbjct: 68 PQVYYFGPCGK----------YNAM----VLELLGPSLEDLFDLCDRTFSLKTVLMIAIQ 113
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR-----VADFGLAKQSREGQSH 483
+ + Y+H + +RD+K N L+ + DF LAK+ + ++
Sbjct: 114 LISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 43/225 (19%), Positives = 73/225 (32%), Gaps = 49/225 (21%)
Query: 288 QSSRPKLRPNTGSIWFKIQDLERATDKFSQK----NFIGRGGFGLVYKGILQDGTTVAVK 343
+ + + + E TD + IG+GGFG +Y + +V
Sbjct: 6 AAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSD 65
Query: 344 KVI--------------ESDFQGDAEFCNEVEIISNLKHRNL--VP-LRGCCVVDGDNER 386
E F A +++ + VP G + D + +
Sbjct: 66 APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS 125
Query: 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI------ILDVAKGLAYL 440
Y +M + D + + RK + ILD+ L Y+
Sbjct: 126 -------YRFM----IMDRFGSDLQKIYEANAKRFS---RKTVLQLSLRILDI---LEYI 168
Query: 441 HYGVKPAIYHRDIKATNILLDADMRARV--ADFGLAKQSREGQSH 483
H + H DIKA+N+LL+ +V D+GLA + H
Sbjct: 169 H---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 42/167 (25%), Positives = 67/167 (40%), Gaps = 23/167 (13%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
IG G FG +Y G + G VA+K +E + E +I ++ +P C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
+GD Y+ M V + L PS D R + + + + Y
Sbjct: 75 AEGD----------YNVM----VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRA---RVADFGLAKQSREGQSH 483
+H HRD+K N L+ + + DFGLAK+ R+ ++H
Sbjct: 121 IHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 33/190 (17%), Positives = 60/190 (31%), Gaps = 49/190 (25%)
Query: 321 IGRGGFGLVYKGI---------LQDGTTVAVK-------KVIESDFQGDAEFCNEVEIIS 364
R G++Y+ ++K E +F A +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 365 NLKHRNLV---PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
L L+ G G ++ R+LV + G K L
Sbjct: 110 KLYSTPLLAIPTCMGF----GVHQ-DKYRFLVLPSL--GRSLQSALDVSP------KHVL 156
Query: 422 TWPQRKNI------ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV--ADFGL 473
+ +++ +LD L +LH H ++ A NI +D + +++V A +G
Sbjct: 157 S---ERSVLQVACRLLDA---LEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 474 AKQSREGQSH 483
A + H
Sbjct: 208 AFRYCPSGKH 217
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 35/169 (20%), Positives = 60/169 (35%), Gaps = 25/169 (14%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
IG G FG++++G L + VA+K E + +E L +P
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAY 439
+G ++ + V D L PS D + R + + +
Sbjct: 76 QEGL----------HNVL----VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 440 LHYGVKPAIYHRDIKATNILLDADMRAR-----VADFGLAKQSREGQSH 483
+H ++ +RDIK N L+ V DFG+ K R+ +
Sbjct: 122 IHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 41/190 (21%), Positives = 63/190 (33%), Gaps = 52/190 (27%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKV-----------IESDF----QGDAEFCNEVEIIS 364
IG GGFGL+Y A V E F +E
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER-K 103
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSG--------- 415
L + + G + + S R++V + + G + +G
Sbjct: 104 QLDYLGIPLFYGSGLTEFKG--RSYRFMVMERL--GIDLQKIS----GQNGTFKKSTVLQ 155
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV--ADFGL 473
+ R +LDV L Y+H + H DIKA N+LL +V AD+GL
Sbjct: 156 LGIR----------MLDV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 474 AKQSREGQSH 483
+ + +H
Sbjct: 200 SYRYCPNGNH 209
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 57/295 (19%), Positives = 95/295 (32%), Gaps = 95/295 (32%)
Query: 285 LEGQSSRPKLRPNTGSIW------FKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDG 337
+ R N F + + F +G G FG V + +
Sbjct: 1 MHHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK 60
Query: 338 TTVAVKKVIES--DFQGDAEFCNEVEIISNLKHR-----NLVPLRGC-------CVVD-- 381
AVK V+ + + A+ E +I+ +++ N+V G C++
Sbjct: 61 KYYAVK-VVRNIKKYTRSAK--IEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP 117
Query: 382 -GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
G + +Y+ + N K +++ K L YL
Sbjct: 118 LGPS--------LYEIITRNN----------------YNGFHIEDIKLYCIEILKALNYL 153
Query: 441 HYGVKPAIYHRDIKATNILLDADMRA-------------------------RVADFGLAK 475
K ++ H D+K NILLD ++ DFG A
Sbjct: 154 R---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA- 209
Query: 476 QSREGQSHLT---TRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCG 524
+ + H + TR Y APE L + SD++SFG V+ E+ G
Sbjct: 210 -TFKSDYHGSIINTR----Q-YRAPEVILNLGWDV---SSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 49/255 (19%), Positives = 89/255 (34%), Gaps = 79/255 (30%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI--LQDGTTVAVKKVIES--DFQGDAEFCNEVEIISNLK 367
+++ +G G FG V + + + + VA+K +I + ++ A E+ ++ +K
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALK-IIRNVGKYREAARL--EINVLKKIK 74
Query: 368 HR------NLVPLRGC-------CVVD---GDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
+ V + C+ G N ++++ N
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKN--------TFEFLKENN---------- 116
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA----- 466
+P P +++ + L +LH + + H D+K NIL
Sbjct: 117 ------FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE 167
Query: 467 --------------RVADFGLAKQSREGQSHLT---TRVAGTHGYLAPEYALYGQLTEKS 509
RVADFG A + + + H T TR Y PE L +
Sbjct: 168 HKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRH-----YRPPEVILELGWAQPC 220
Query: 510 DVYSFGVVILEIMCG 524
DV+S G ++ E G
Sbjct: 221 DVWSIGCILFEYYRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.16 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.44 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.1 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.49 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 96.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.45 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.43 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 96.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.26 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.29 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.46 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.49 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.49 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 86.12 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 84.7 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.08 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 81.77 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=466.79 Aligned_cols=266 Identities=26% Similarity=0.417 Sum_probs=207.3
Q ss_pred cCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...++||+|+||+||+|++. +++.||||++........++|.+|+++|++++|||||+++|+|. +
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~------~ 114 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT------E 114 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE------E
Confidence 56777889999999999999874 47889999998766666678999999999999999999999997 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCC------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDG------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
....+||||||++|+|.++|+...... ......+++|.++++|+.|||+||+||| +.+||||||||+||||
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLV 191 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEE
Confidence 678999999999999999996543211 1123457999999999999999999999 7899999999999999
Q ss_pred ccCCcEEEcccCcccccccCC-ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCc
Q 005691 461 DADMRARVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRA 538 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~ 538 (683)
|+++++||+|||+|+...... ....+...||+.|||||++.+..++.|+|||||||++|||+| |+.||.....
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~----- 266 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN----- 266 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----
Confidence 999999999999999765443 234456789999999999999999999999999999999999 9999964321
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEV 611 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~~ 611 (683)
..+...+..+...+ .+..+...+.+++..||+.||++||||.||+++|+.....
T Consensus 267 ----~~~~~~i~~g~~~~---------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 ----TEAIDCITQGRELE---------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ----HHHHHHHHHTCCCC---------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHHcCCCCC---------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11222333332111 1122345678899999999999999999999999875443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=458.16 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=210.2
Q ss_pred CcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++...++||+|+||+||+|++. +++.||||++..... ...++|.+|+.++++++|||||+++|+|. .
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~ 100 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT------K 100 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE------E
Confidence 3455678999999999999973 467899999976433 33578999999999999999999999997 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
....+||||||++|+|.++|+...... .......++|.++++|+.|||+||+||| +.+||||||||+|||
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVL 177 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceE
Confidence 567899999999999999996432111 0112356999999999999999999999 889999999999999
Q ss_pred eccCCcEEEcccCcccccccCC-ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCC
Q 005691 460 LDADMRARVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPR 537 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~ 537 (683)
||+++++||+|||+|+.....+ ....+...||+.|||||++.++.++.|+|||||||++|||+| |+.||.....
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---- 253 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---- 253 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999999999765443 334556789999999999999999999999999999999999 8999864321
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
. .+...+..+.... .+.++...+.+++..||+.||++||||+||+++|+.
T Consensus 254 -~----~~~~~i~~~~~~~---------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 -Q----DVVEMIRNRQVLP---------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -H----HHHHHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -H----HHHHHHHcCCCCC---------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1 1222333333211 112334567889999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=459.56 Aligned_cols=263 Identities=25% Similarity=0.438 Sum_probs=212.5
Q ss_pred cCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||+||+|++. ++..||||+++....+..++|.+|+++|++++|||||+++|+|. +
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~------~ 86 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV------E 86 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe------e
Confidence 57788899999999999999864 47889999998766666778999999999999999999999997 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCC----CCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFN----DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~----~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
++..+||||||++|+|.++|+.... .........++|.++++|+.|||+||+||| +.+||||||||+|||||+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECC
Confidence 6789999999999999999954320 001123457999999999999999999999 789999999999999999
Q ss_pred CCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccc
Q 005691 463 DMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACL 540 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~ 540 (683)
++++||+|||+|+........ ......||+.|||||++.++.++.|+|||||||++|||+| |+.||.....
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------- 236 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------- 236 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 999999999999876544332 3445679999999999999999999999999999999999 8999964321
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..+...+..|...+ .+..+...+.+++..||+.||++||||.||+++|++.
T Consensus 237 --~~~~~~i~~~~~~~---------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 237 --NEVIECITQGRVLQ---------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp --HHHHHHHHHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCC---------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11222333333211 1122345678899999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=450.38 Aligned_cols=257 Identities=28% Similarity=0.401 Sum_probs=201.7
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...++||+|+||+||+|+++ ..||||+++.... +..++|.+|++++++++|||||+++|+|. .+.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-------~~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-------KDN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-------SSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-------CCe
Confidence 467788899999999999999875 3699999865332 33467999999999999999999999984 346
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.+||||||++|+|.++|+.. ...++|.++++|+.|||+||+||| +.+||||||||+|||||+++++||+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~--------~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~ 174 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQ--------ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIG 174 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTS--------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEEC
T ss_pred EEEEEEcCCCCCHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEe
Confidence 89999999999999999532 346999999999999999999999 7899999999999999999999999
Q ss_pred ccCcccccccCC-ccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 470 DFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 470 DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|||+|+...... ....+...||+.|||||++. .+.|+.|+|||||||++|||+||+.||..... ...+
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~ 246 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQI 246 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHH
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHH
Confidence 999998765432 33455678999999999986 35689999999999999999999999964322 1122
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
...+..+.. .|.+.. .+.++...+.+++..||+.||++||||.||+++|+.
T Consensus 247 ~~~~~~~~~----~p~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 247 IFMVGRGYA----SPDLSK-------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp HHHHHTTCC----CCCSTT-------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred HHHHhcCCC----CCCccc-------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 223333321 222211 112234567789999999999999999999998874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=447.67 Aligned_cols=274 Identities=26% Similarity=0.316 Sum_probs=202.8
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHH--HHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEF--CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f--~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+++...++||+|+||+||+|+++ |+.||||++.... .+++ ..|+..+.+++|||||+++|+|..+.. ...+.
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~--~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG--TWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS--SSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC--CceEE
Confidence 35677889999999999999985 8999999986532 3333 445666678999999999999975421 23468
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc-----CCCccccCCCCCceeeccCCc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV-----KPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~-----~~~IiHrDIKpsNILLd~~~~ 465 (683)
+||||||++|+|.++|+ ...++|..+++|+.|+|+||+|||+.. +++||||||||+|||||.+++
T Consensus 77 ~lV~Ey~~~gsL~~~l~----------~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLN----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEEECCTTCBHHHHHH----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred EEEecCCCCCcHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 99999999999999993 246999999999999999999999542 359999999999999999999
Q ss_pred EEEcccCcccccccCCcc---ccccccCCCcccCccccccC------CCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 466 ARVADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALYG------QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
+||+|||+|+........ ......||+.|||||++.+. .++.|+|||||||++|||+||++|+........
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~ 226 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence 999999999877554332 23346899999999998754 478899999999999999999988764432211
Q ss_pred Ccc--chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 537 RAC--LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 537 ~~~--~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
... ...++....+......+.++|.+... ....+....+.+++..||+.||++||||.||+++|+.
T Consensus 227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cchhcccccchHHHHHHHHhcccCCCCCCcc-----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 000 00001111111111112233443322 1223556788899999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=450.17 Aligned_cols=275 Identities=26% Similarity=0.352 Sum_probs=219.4
Q ss_pred ceehHHHHHHhcCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCccC-hHHHHHHHHHHHhccC-CCccc
Q 005691 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQG-DAEFCNEVEIISNLKH-RNLVP 373 (683)
Q Consensus 302 ~f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H-~NLV~ 373 (683)
.++..+++...++|...+.||+|+||+||+|++.. ++.||||++....... .++|.+|+++|.+++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 35556677778899999999999999999998642 3689999997654433 4579999999999965 89999
Q ss_pred ccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCC-------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC
Q 005691 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFND-------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP 446 (683)
Q Consensus 374 L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~-------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~ 446 (683)
++|+|.. .+...++|||||++|+|.++|+..... .....+..++|.+++.|+.|||+||+||| +.
T Consensus 133 l~g~~~~-----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~ 204 (353)
T 4ase_A 133 LLGACTK-----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SR 204 (353)
T ss_dssp EEEEECC-----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred EEEEEEe-----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hC
Confidence 9999963 345689999999999999999643211 01122456999999999999999999999 88
Q ss_pred CccccCCCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-C
Q 005691 447 AIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-G 524 (683)
Q Consensus 447 ~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-G 524 (683)
+||||||||+||||++++.+||+|||+|+....+... .++...||+.|||||++.++.|+.|+|||||||++|||+| |
T Consensus 205 ~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 9999999999999999999999999999977544433 3456789999999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 525 RKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 525 r~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.||..... .+.+.+.+.+|...+ . +.....++.+++..||+.||++||||.||++.
T Consensus 285 ~~Pf~~~~~--------~~~~~~~i~~g~~~~-----~----------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 285 ASPYPGVKI--------DEEFCRRLKEGTRMR-----A----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCSSTTCCC--------SHHHHHHHHHTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCH--------HHHHHHHHHcCCCCC-----C----------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999964322 123334444442211 1 11223467789999999999999999999999
Q ss_pred Hhc
Q 005691 605 LEG 607 (683)
Q Consensus 605 L~~ 607 (683)
|+.
T Consensus 342 L~~ 344 (353)
T 4ase_A 342 LGN 344 (353)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=429.90 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=207.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. ..+..|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~------~~~~~~ 147 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL------VGDELW 147 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE------ETTEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE------ECCEEE
Confidence 46888899999999999999975 69999999998766666677999999999999999999999997 567899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
|||||+++|+|.+++. +..+++.+...|+.||+.||+||| +.+||||||||+||||+.++.+||+||
T Consensus 148 ivmEy~~gg~L~~~l~----------~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DF 214 (346)
T 4fih_A 148 VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 214 (346)
T ss_dssp EEECCCTTEEHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEeCCCCCcHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecC
Confidence 9999999999999883 246999999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+|+....... ..+..+||+.|||||++....|+.++|||||||++|||++|+.||..... . + +...+..
T Consensus 215 Gla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~---~-~~~~i~~ 284 (346)
T 4fih_A 215 GFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----L---K-AMKMIRD 284 (346)
T ss_dssp TTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H---H-HHHHHHH
T ss_pred cCceecCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----H---H-HHHHHHc
Confidence 99987754433 24457899999999999999999999999999999999999999964221 1 1 1122222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+ ..+.+. ....+...+.+++..|++.||++|||+.|+++
T Consensus 285 ~-----~~~~~~--------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 285 N-----LPPRLK--------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp S-----SCCCCS--------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-----CCCCCC--------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 111111 11233456778999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=417.13 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=195.1
Q ss_pred ccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 316 SQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
...++||+|+||+||+|+.. ++..||||++..... ...+.|.+|++++++++|||||++++++..... .....+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~--~~~~~~l 106 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK--GKKCIVL 106 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET--TEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC--CCcEEEE
Confidence 45668999999999999975 588999999976432 224569999999999999999999999863211 2356899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeecc-CCcEEEc
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLDA-DMRARVA 469 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd~-~~~~KLa 469 (683)
|||||++|+|.++|.. ...+++...+.|+.||+.||+||| +.+ ||||||||+||||+. ++.+||+
T Consensus 107 vmEy~~gg~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR---------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred EEeCCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEE
Confidence 9999999999999942 357999999999999999999999 555 999999999999984 7999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+|+..... .....+||+.|||||++. ++|+.++|||||||++|||+||+.||..... . ..+...+
T Consensus 175 DFGla~~~~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~-~~~~~~i 242 (290)
T 3fpq_A 175 DLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------A-AQIYRRV 242 (290)
T ss_dssp CTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------H-HHHHHHH
T ss_pred eCcCCEeCCCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------H-HHHHHHH
Confidence 99999864332 344578999999999876 5799999999999999999999999963221 1 1122222
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+.... .+.. .....+.+++..|++.||++|||+.|+++
T Consensus 243 ~~~~~~~----~~~~----------~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 243 TSGVKPA----SFDK----------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTCCCG----GGGG----------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCCCC----CCCc----------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2221111 1111 11235678899999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=424.71 Aligned_cols=251 Identities=22% Similarity=0.258 Sum_probs=201.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.+.|...++||+|+||.||+|+.. +|+.||||++..... +.+|+.++++++|||||++++++. .+...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~------~~~~~ 125 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR------EGPWV 125 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE------ETTEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE------ECCEE
Confidence 456888899999999999999975 689999999975432 246999999999999999999987 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~KLa 469 (683)
+|||||+++|+|.++|.. ...+++...+.|+.||+.||+||| +.+||||||||+||||+.++ .+||+
T Consensus 126 ~ivmEy~~gg~L~~~l~~---------~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQ---------MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEEECCCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEEeccCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEe
Confidence 999999999999999942 347999999999999999999999 89999999999999999988 69999
Q ss_pred ccCcccccccCCcc----ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 470 DFGLAKQSREGQSH----LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 470 DFGla~~~~~~~~~----~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|||+|+....+... ....++||+.|||||++.+..|+.++|||||||++|||++|+.||....... + .
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~---~ 265 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----L---C 265 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----C---H
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----H---H
Confidence 99999987543221 1234689999999999999999999999999999999999999997543211 1 1
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
......... +.. .+..+...+.+++..|++.||++|||+.|+++.|..
T Consensus 266 ~~i~~~~~~-------~~~-------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 266 LKIASEPPP-------IRE-------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp HHHHHSCCG-------GGG-------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCC-------chh-------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111111110 000 111234466788999999999999999999988865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=429.57 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=199.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.|.+|++++++|+|||||++++++. ..+.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~------~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE------ENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------ETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE------ECCE
Confidence 68999999999999999999975 6999999999764332 2457999999999999999999999997 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.||||||+++|+|.++|... ....+++.+.+.|+.||+.||+||| +.+||||||||+||||+.++.+||+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~-------~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQ-------KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHT-------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHHc-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEc
Confidence 99999999999999999432 2345788899999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+|+....... ..+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...+ ..+...+..
T Consensus 168 DFGla~~~~~~~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~ 238 (350)
T 4b9d_A 168 DFGIARVLNSTVE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKII 238 (350)
T ss_dssp STTEESCCCHHHH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHH
T ss_pred ccccceeecCCcc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHH
Confidence 9999987654322 2345689999999999999999999999999999999999999996422 112222222
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+... .+ +......+.+++..|++.||++|||+.|+++
T Consensus 239 -~~~~~-----~~----------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 239 -SGSFP-----PV----------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -HTCCC-----CC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cCCCC-----CC----------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22211 11 1122345678999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=430.74 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=207.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+.|...++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. .++..|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~------~~~~~~ 224 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL------VGDELW 224 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE------ETTEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE------ECCEEE
Confidence 56999999999999999999975 69999999998766666777999999999999999999999997 467899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
||||||++|+|.+++. ...+++.+...|+.||+.||+||| +.+||||||||+||||+.++.+||+||
T Consensus 225 iVmEy~~gG~L~~~i~----------~~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 225 VVMEFLEGGALTDIVT----------HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEEECCTTEEHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEEeCCCCCcHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecC
Confidence 9999999999999883 236999999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+|+....... ..+..+||+.|||||++....|+.++|||||||++|||++|+.||..... . + +...+..
T Consensus 292 Gla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~---~-~~~~i~~ 361 (423)
T 4fie_A 292 GFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----L---K-AMKMIRD 361 (423)
T ss_dssp TTCEECCSSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H---H-HHHHHHH
T ss_pred ccceECCCCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----H---H-HHHHHHc
Confidence 99987654433 34457899999999999999999999999999999999999999964221 1 1 1122222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+ ..+.+.. ...+...+.+++..|++.||++|||+.|+++
T Consensus 362 ~-----~~~~~~~--------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 362 N-----LPPRLKN--------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp S-----CCCCCSC--------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-----CCCCCcc--------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1111111 1122346778999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=417.00 Aligned_cols=247 Identities=20% Similarity=0.276 Sum_probs=204.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||+||+++.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++. +.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~------~~~ 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ------DDE 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE------CSS
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE------eCC
Confidence 57999999999999999999975 6899999999753 2334567999999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..|+||||+++|+|.+++. ....+++...+.++.||+.||+||| +.+||||||||+||||+.++.+||
T Consensus 106 ~~yivmEy~~gG~L~~~i~---------~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl 173 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIR---------KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173 (311)
T ss_dssp EEEEEECCCTTEEHHHHHH---------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCCHHHHHH---------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEE
Confidence 8999999999999999993 2347999999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCC-ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+|+...... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+ +..
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~-~~~ 244 (311)
T 4aw0_A 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GL-IFA 244 (311)
T ss_dssp CCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHH
T ss_pred EEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HH-HHH
Confidence 9999999875433 2345567899999999999999999999999999999999999999964221 11 112
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
.+..+.. .+ +......+.+++..|++.||++|||+.|++
T Consensus 245 ~i~~~~~------~~----------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 245 KIIKLEY------DF----------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHTCC------CC----------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHcCCC------CC----------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2222221 11 111234567889999999999999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=411.08 Aligned_cols=294 Identities=45% Similarity=0.737 Sum_probs=250.6
Q ss_pred ccceehHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCccccccee
Q 005691 300 SIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCC 378 (683)
Q Consensus 300 ~~~f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c 378 (683)
...|+++++..++++|...++||+|+||.||+|...+|+.||||++...... ....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4578999999999999999999999999999999888999999998764332 334799999999999999999999999
Q ss_pred eecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 379 ~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
. .....++||||+++|+|.+++.... .....++|..++.|+.+++.||+|||+.+.++|+||||||+||
T Consensus 97 ~------~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 97 M------TPTERLLVYPYMANGSVASCLRERP-----ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp C------CSSCCEEEEECCTTCBHHHHHHCCS-----TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred e------cCCceEEEEEeccCCCHHHHHHhcc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 6 4567899999999999999995432 2345699999999999999999999954444999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 459 LLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
|++.++.+||+|||+++..............||+.|+|||.+..+.++.++||||||+++|||++|+.||+.........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred EECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 99999999999999998876555555666779999999999999999999999999999999999999997432222222
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
..+.+|+........+...++..+... ...+....+.+++..|++.||++|||+.+|+++|++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 246 VMLLDWVKGLLKEKKLEALVDVDLQGN------YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp SBHHHHHTTTTSSCCSTTSSCTTCTTS------CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhHHHHHHHHhhchhhhhhcChhhccc------cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 567788888888888888888877665 445667899999999999999999999999999997643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=403.46 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=187.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||+||+|+.. +|+.||||++.+... ...+.+.+|++++++++|||||++++++. ..+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~------~~~ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK------SKD 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE------CSS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE------ECC
Confidence 68999999999999999999964 699999999975432 23457999999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+ +|+|.+++. ....+++.+.+.++.|++.||+||| +.+|+||||||+||||++++++||
T Consensus 87 ~~~ivmEy~-~g~L~~~l~---------~~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl 153 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIV---------QRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKI 153 (275)
T ss_dssp EEEEEEECC-CEEHHHHHH---------HSCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEE
T ss_pred EEEEEEeCC-CCCHHHHHH---------HcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEE
Confidence 899999999 689999883 2357999999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+|+...... ......||+.|||||.+.+..+ +.++||||+||++|||++|+.||.... ... ..+
T Consensus 154 ~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~-~~~ 222 (275)
T 3hyh_A 154 ADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPV-LFK 222 (275)
T ss_dssp CCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHH-HHH
T ss_pred eecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHH-HHH
Confidence 9999998765432 2344689999999999988776 579999999999999999999996421 111 122
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+.. .+ +......+.+++..|++.||++|||+.|+++
T Consensus 223 ~i~~~~~------~~----------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 223 NISNGVY------TL----------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHTCC------CC----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHcCCC------CC----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222221 11 1112345678899999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=411.20 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=193.3
Q ss_pred cCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|+..+.||+|+||+||+|+.. .++.||||++..... .....+.+|++++++++|||||++++++. .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~------~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ------T 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE------E
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE------E
Confidence 57899999999999999999862 478999999865422 22346889999999999999999999987 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
.+..++||||+++|+|.++|. +...+++.+...++.|++.||+||| +.+||||||||+|||++.++.+
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~---------~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLS---------KEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHH---------HHCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCE
T ss_pred CCEEEEEEEcCCCCCHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCE
Confidence 578999999999999999993 2347999999999999999999999 8999999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+|+....... .....+||+.|||||.+.+..|+.++|||||||++|||++|+.||...+. .+..
T Consensus 166 Kl~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~- 235 (304)
T 3ubd_A 166 KLTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETM- 235 (304)
T ss_dssp EEESSEEEEC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-
T ss_pred EecccccceeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHH-
Confidence 9999999987644332 23457899999999999999999999999999999999999999964221 1111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
..+..+.. .+ +......+.+++..|++.||++||| ++|+++
T Consensus 236 ~~i~~~~~------~~----------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 236 TMILKAKL------GM----------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHCCC------CC----------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHcCCC------CC----------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 11222211 01 1122345678899999999999998 467663
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=401.54 Aligned_cols=285 Identities=41% Similarity=0.685 Sum_probs=242.8
Q ss_pred ceehHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeec
Q 005691 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381 (683)
Q Consensus 302 ~f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~ 381 (683)
.+.+.+++.++++|...+.||+|+||.||+|+..+|+.||||++........+.+.+|++++++++||||+++++++.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 105 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-- 105 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--
Confidence 455667778899999999999999999999998889999999987766666778999999999999999999999986
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.....++||||+++|+|.+++.... .....++|..++.|+.|++.||+||| +.+|+||||||+|||++
T Consensus 106 ----~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 106 ----ERNEMILIYKYMENGNLKRHLYGSD-----LPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLD 173 (321)
T ss_dssp ----CTTCCEEEEECCTTCBTGGGSSSSC-----CCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEEC
T ss_pred ----CCCeEEEEEEcCCCCcHHHHHhccC-----CCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEEC
Confidence 5567899999999999999995432 12346999999999999999999999 78999999999999999
Q ss_pred cCCcEEEcccCcccccccC-CccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 462 ADMRARVADFGLAKQSREG-QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
.++.+||+|||+++..... .........||+.|+|||.+..+.++.++||||||+++|||++|+.||....+... ..
T Consensus 174 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~--~~ 251 (321)
T 2qkw_B 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VN 251 (321)
T ss_dssp TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC--CC
T ss_pred CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH--HH
Confidence 9999999999999865432 22334456799999999999999999999999999999999999999976544322 35
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+..|.......+.+.+.+++.+... ...+....+.+++..|++.||++|||+.||++.|+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 252 LAEWAVESHNNGQLEQIVDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHHHTHHHHTTTCCCSSSSSSCTTC------SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhhccccccHHHhcChhhccc------cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6677777777778888888877554 3456678899999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=401.41 Aligned_cols=256 Identities=20% Similarity=0.322 Sum_probs=186.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCC------
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN------ 384 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~------ 384 (683)
++|+..+.||+|+||+||+|+.. +|+.||||++.....+ ..+.+.+|+++|++++|||||++++++......
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999975 6899999999765433 245689999999999999999999998754321
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
......++||||+++|+|.+++.... .....++...+.|+.||+.||+||| +.+||||||||+||||+.++
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC------TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC------SGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC------CCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCC
Confidence 12234789999999999999994321 1223556678899999999999999 88999999999999999999
Q ss_pred cEEEcccCcccccccCCcc-----------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 465 RARVADFGLAKQSREGQSH-----------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~-----------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
.+||+|||+|+........ ..+..+||+.|||||.+.+..|+.++|||||||++|||++ ||....
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~- 231 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM- 231 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-
Confidence 9999999999876543221 1234679999999999999999999999999999999996 553210
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.... .......... |. ...+.......++..|++.||++|||+.|+++
T Consensus 232 ------~~~~-~~~~~~~~~~-----p~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ------ERVR-TLTDVRNLKF-----PP----------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ------HHHH-HHHHHHTTCC-----CH----------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHH-HHHHHhcCCC-----CC----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000 1111112111 00 01122334567889999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=395.77 Aligned_cols=269 Identities=22% Similarity=0.329 Sum_probs=201.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++...........
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 6999999999654322 23568899999999999999999999865444445578
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.|||||||+ |+|.+++. ..+.+++.....|+.||+.||.||| +.+||||||||+|||++.++.+||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---------~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---------SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---------SSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCC-CCHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEe
Confidence 999999995 78999883 2357999999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCC---ccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 470 DFGLAKQSREGQ---SHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 470 DFGla~~~~~~~---~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|||+|+...... ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||...+..+ ...-+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-----~l~~I 275 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-----QLQLI 275 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-----HHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-----HHHHH
Confidence 999998764322 2234567899999999998865 56999999999999999999999996432110 00000
Q ss_pred hhh-----------hhcCccccccCccccccccccCCChH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSL-----------VKAGKVWQALDPSLLKEDDFLSLNPK----AIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~-----------~~~g~l~e~vD~~l~~~~~~~~~~~~----e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... .........+. .+... ...... .....+.+++..|++.||++|||+.|+++
T Consensus 276 ~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 276 MMVLGTPSPAVIQAVGAERVRAYIQ-SLPPR---QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHCCCCGGGTC-----CHHHHHH-SSCCC---CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhh-cCCCc---CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000000 00000 000000 11345678999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=388.87 Aligned_cols=202 Identities=24% Similarity=0.427 Sum_probs=171.1
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 306 ~el~~at~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
+++....++|...++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|..+ +|||||++++++.
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~- 90 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR- 90 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE-
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE-
Confidence 334445688999999999999999999853 46789999986542 345688999999998 6999999999987
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
..+..++||||+++|+|.+++ +.+++.+.+.++.|++.||+||| +.+||||||||+|||+
T Consensus 91 -----~~~~~~lvmE~~~g~~L~~~~------------~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl 150 (361)
T 4f9c_A 91 -----KNDHVVIAMPYLEHESFLDIL------------NSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLY 150 (361)
T ss_dssp -----ETTEEEEEEECCCCCCHHHHH------------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred -----ECCEEEEEEeCCCcccHHHHH------------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEE
Confidence 567899999999999999988 25889999999999999999999 8999999999999999
Q ss_pred ccC-CcEEEcccCcccccccCCc---------------------------cccccccCCCcccCccccccC-CCCccccE
Q 005691 461 DAD-MRARVADFGLAKQSREGQS---------------------------HLTTRVAGTHGYLAPEYALYG-QLTEKSDV 511 (683)
Q Consensus 461 d~~-~~~KLaDFGla~~~~~~~~---------------------------~~~~~~~GT~~Y~APE~~~~~-~~s~ksDV 511 (683)
+.+ +.+||+|||+|+...+... ...+..+||+.|||||++.+. .++.++||
T Consensus 151 ~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di 230 (361)
T 4f9c_A 151 NRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230 (361)
T ss_dssp ETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred eCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccch
Confidence 877 7999999999986543221 112345799999999999875 58999999
Q ss_pred EEcchhHHHHhhCCCCCCC
Q 005691 512 YSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 512 wSfGvlLlELltGr~p~~~ 530 (683)
||+||+++||++|+.||..
T Consensus 231 WSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 231 WSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHHHHTCSSSSC
T ss_pred hhhHHHHHHHHHCCCCCCC
Confidence 9999999999999999954
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=368.16 Aligned_cols=282 Identities=36% Similarity=0.569 Sum_probs=228.2
Q ss_pred CccceehHHHHHHhcCcccc------eeeeecCceEEEEEEEcCCcEEEEEEeeccC----ccChHHHHHHHHHHHhccC
Q 005691 299 GSIWFKIQDLERATDKFSQK------NFIGRGGFGLVYKGILQDGTTVAVKKVIESD----FQGDAEFCNEVEIISNLKH 368 (683)
Q Consensus 299 ~~~~f~~~el~~at~~f~~~------~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~----~~~~~~f~~Ev~iL~~L~H 368 (683)
....|++.+++.++++|... ++||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34578999999999999988 8999999999999987 58899999986532 1224579999999999999
Q ss_pred CCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCc
Q 005691 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448 (683)
Q Consensus 369 ~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~I 448 (683)
|||+++++++. .....++||||+++|+|.+++.... ....++|..++.|+.+++.||+||| +.+|
T Consensus 90 ~~i~~~~~~~~------~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i 154 (307)
T 2nru_A 90 ENLVELLGFSS------DGDDLCLVYVYMPNGSLLDRLSCLD------GTPPLSWHMRCKIAQGAANGINFLH---ENHH 154 (307)
T ss_dssp TTBCCEEEEEC------SSSSCEEEEECCTTCBHHHHHHTGG------GCCCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred CCeEEEEEEEe------cCCceEEEEEecCCCcHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHh---cCCe
Confidence 99999999986 5567899999999999999984321 2346999999999999999999999 8899
Q ss_pred cccCCCCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCC
Q 005691 449 YHRDIKATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527 (683)
Q Consensus 449 iHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p 527 (683)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+. +.++.++||||||+++|||++|+.|
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCS
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999987654322 2344567999999999875 4689999999999999999999999
Q ss_pred CCCCCCCCCCccchhhhhhhhhh-cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 528 LDLSTSGSPRACLITDWVWSLVK-AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 528 ~~~~~~~~~~~~~l~~~v~~~~~-~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
|+..... ..+..+...... ...+.+.+++.+.. .+....+.+.+++..|++.||.+|||+.+|+++|+
T Consensus 234 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 234 VDEHREP----QLLLDIKEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp BCTTBSS----SBTTHHHHHHHTTSCCHHHHSCSSCSC-------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cccCcch----HHHHHHHHHhhhhhhhhhhhccccccc-------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 9754332 223233322222 22334455555432 23455678899999999999999999999999998
Q ss_pred cC
Q 005691 607 GD 608 (683)
Q Consensus 607 ~~ 608 (683)
..
T Consensus 303 ~l 304 (307)
T 2nru_A 303 EM 304 (307)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.17 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=214.8
Q ss_pred ceehHHHHHHhcC----------cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC
Q 005691 302 WFKIQDLERATDK----------FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN 370 (683)
Q Consensus 302 ~f~~~el~~at~~----------f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N 370 (683)
.|++++++.+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 5788999998875 677789999999999999986 79999999998777667788999999999999999
Q ss_pred cccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccc
Q 005691 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYH 450 (683)
Q Consensus 371 LV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiH 450 (683)
|+++++++. .....++||||+++|+|.+++. ...++|..++.++.|++.||+||| +.+|+|
T Consensus 104 iv~~~~~~~------~~~~~~lv~e~~~~~~L~~~l~----------~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH 164 (321)
T 2c30_A 104 VVEMYKSYL------VGEELWVLMEFLQGGALTDIVS----------QVRLNEEQIATVCEAVLQALAYLH---AQGVIH 164 (321)
T ss_dssp BCCEEEEEE------ETTEEEEEECCCCSCBHHHHHT----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred cceEEEEEE------ECCEEEEEEecCCCCCHHHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 999999997 4568999999999999999983 236999999999999999999999 789999
Q ss_pred cCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 451 RDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 451 rDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
|||||+|||++.++.+||+|||+++....... ......||+.|+|||++..+.++.++||||||+++|||++|+.||..
T Consensus 165 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999987654322 23456799999999999999999999999999999999999999864
Q ss_pred CCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 531 STSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 531 ~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
... .+. ...+..+ ..+.+.. .......+.+++..|++.||++|||+.++++.
T Consensus 244 ~~~--------~~~-~~~~~~~-----~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 244 DSP--------VQA-MKRLRDS-----PPPKLKN--------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp SCH--------HHH-HHHHHHS-----SCCCCTT--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCH--------HHH-HHHHhcC-----CCCCcCc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 221 111 1111111 1111111 11223456788899999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=377.76 Aligned_cols=269 Identities=27% Similarity=0.323 Sum_probs=207.4
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|...++||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++|||||++++++..... .....+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS--VDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS--SSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC--CCceEE
Confidence 468999999999999999999986 8999999986543 223456678999999999999999999975321 234579
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC----------CccccCCCCCceeec
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP----------AIYHRDIKATNILLD 461 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~----------~IiHrDIKpsNILLd 461 (683)
+||||+++|+|.+++. ...++|..++.|+.|++.||+||| +. +|+||||||+|||++
T Consensus 99 lv~e~~~~g~L~~~l~----------~~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~ 165 (322)
T 3soc_A 99 LITAFHEKGSLSDFLK----------ANVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLK 165 (322)
T ss_dssp EEEECCTTCBHHHHHH----------HCCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred EEEecCCCCCHHHHHH----------hcCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEEC
Confidence 9999999999999993 235999999999999999999999 66 999999999999999
Q ss_pred cCCcEEEcccCcccccccCCcc-ccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 462 ADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
.++.+||+|||+++........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 9999999999999876544332 2344679999999999886 356678999999999999999999997644322
Q ss_pred CCcc--------chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 536 PRAC--------LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 536 ~~~~--------~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.... ...++ ......+. ..+.+... .........+.+++..|++.||++|||+.||++.|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDM-QEVVVHKK----KRPVLRDY-----WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CCTTHHHHCSSCCHHHH-HHHHTTSC----CCCCCCGG-----GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccchhhhhccCCchhhh-hhhhhccc----CCCCcccc-----ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1000 00001 01111111 11222111 1122445678999999999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=363.48 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=205.6
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHh--ccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISN--LKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~--L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||+||+|+. +|+.||||++... ....+..|.+++.. ++||||+++++++..... ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~--~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH--SSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET--TEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC--CCce
Confidence 46899999999999999999998 5899999998653 35567778888777 799999999999864321 3456
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc-----CCCccccCCCCCceeeccCC
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV-----KPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~-----~~~IiHrDIKpsNILLd~~~ 464 (683)
.++||||+++|+|.+++. ...+++..+++|+.|++.||+|||... +.+|+||||||+|||++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ----------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHT----------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHh----------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 899999999999999992 246999999999999999999999432 67899999999999999999
Q ss_pred cEEEcccCcccccccCCccc---cccccCCCcccCccccccC------CCCccccEEEcchhHHHHhhC----------C
Q 005691 465 RARVADFGLAKQSREGQSHL---TTRVAGTHGYLAPEYALYG------QLTEKSDVYSFGVVILEIMCG----------R 525 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~---~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSfGvlLlELltG----------r 525 (683)
.+||+|||+++......... .....||+.|+|||.+... .++.++||||||+++|||++| +
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999998765443322 2345799999999999876 556799999999999999999 6
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 526 KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 526 ~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.||........ .. ........... ..+.+... .........+.+++..|++.||++|||+.+|+++|
T Consensus 231 ~pf~~~~~~~~---~~-~~~~~~~~~~~----~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 231 PPFYDVVPNDP---SF-EDMRKVVCVDQ----QRPNIPNR-----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CTTTTTSCSSC---CH-HHHHHHHTTSC----CCCCCCGG-----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccCCCCc---ch-hhhhHHHhccC----CCCCCChh-----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 66654332221 11 11111111111 11111111 11234567889999999999999999999999999
Q ss_pred hc
Q 005691 606 EG 607 (683)
Q Consensus 606 ~~ 607 (683)
+.
T Consensus 298 ~~ 299 (301)
T 3q4u_A 298 TK 299 (301)
T ss_dssp HH
T ss_pred hc
Confidence 85
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=405.18 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=205.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+++.. +|+.||||++........+.+.+|+++|+.++|||||++++++. .....
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~------~~~~~ 229 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE------DDNEM 229 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE------CSSEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE------ECCEE
Confidence 368999999999999999999975 68999999997765555667899999999999999999999987 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC--CcEEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD--MRARV 468 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~--~~~KL 468 (683)
+||||||++|+|.++|.. ....+++.+...++.||+.||.||| +.+|+||||||+|||++.+ +.+||
T Consensus 230 ~iv~E~~~gg~L~~~i~~--------~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVAD--------EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp EEEEECCCCCBHHHHHTC--------TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEeecCCCcHHHHHHH--------hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEE
Confidence 999999999999999832 2346899999999999999999999 8999999999999999854 89999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+|+....... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+ ....
T Consensus 299 ~DFG~a~~~~~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~-~~~~ 367 (573)
T 3uto_A 299 IDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DE-TLRN 367 (573)
T ss_dssp CCCSSCEECCTTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HH-HHHH
T ss_pred eeccceeEccCCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HH-HHHH
Confidence 99999998765432 3346799999999999999999999999999999999999999964321 11 1111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..+... +++. ....+...+.+++..|++.||++|||+.|+++
T Consensus 368 i~~~~~~--~~~~----------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 368 VKSCDWN--MDDS----------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHTTCCC--CCSG----------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhCCCC--CCcc----------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222110 0010 11122345678899999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=368.26 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=207.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...++||+|+||+||+|+.. +++.||+|++........+.|.+|++++++++||||+++++++. .+...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~ 82 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY------KDKRL 82 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE------ETTEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe------cCCee
Confidence 357888999999999999999975 58999999987666556678999999999999999999999997 45779
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++... ...++|.+++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSM--------DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEEECCTTCBHHHHHHHC--------CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEee
Confidence 9999999999999999432 346999999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccc-------------cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCC
Q 005691 471 FGLAKQSREGQSHL-------------TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537 (683)
Q Consensus 471 FGla~~~~~~~~~~-------------~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~ 537 (683)
||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998764332211 12467999999999999999999999999999999999999998654332211
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
........ .+... +......+.+++..|++.||++|||+.++++.|+..
T Consensus 232 ---~~~~~~~~---------~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 232 ---FGLNVRGF---------LDRYC----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ---SSBCHHHH---------HHHTC----------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---Hhhhhhcc---------ccccC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000000 01111 111223567889999999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=389.00 Aligned_cols=262 Identities=25% Similarity=0.411 Sum_probs=213.3
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 306 ~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++++...++|...+.||+|+||.||+|.++++..||||++.... ...++|.+|++++++++|||||++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------ 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------ 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------
Confidence 34455678899999999999999999999989999999987643 44678999999999999999999999984
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
....++||||+++|+|.+++... ....+++..++.++.||+.||+||| +.+|+||||||+|||++.++.
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~ 322 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSD-------EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLV 322 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSH-------HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCC
T ss_pred -CCccEEEEeecCCCcHHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCc
Confidence 35689999999999999999432 1236889999999999999999999 789999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
+||+|||+++..............+|..|+|||.+..+.++.++|||||||++|||++ |+.||..... .+
T Consensus 323 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~- 393 (454)
T 1qcf_A 323 CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PE- 393 (454)
T ss_dssp EEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH-
T ss_pred EEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HH-
Confidence 9999999998765433333344557889999999999999999999999999999999 9999864321 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+...+..+.... .+......+.+++..|++.||++||||.+|+++|+...
T Consensus 394 ~~~~i~~~~~~~---------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 394 VIRALERGYRMP---------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HHHHHHHTCCCC---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHcCCCCC---------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 112222221100 11123456788999999999999999999999999754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.06 Aligned_cols=264 Identities=30% Similarity=0.435 Sum_probs=200.3
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
++....++|...+.||+|+||+||+|+. +|+.||||++....... .++|.+|++++++++||||+++++++.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 104 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT----- 104 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----
Confidence 3334467899999999999999999987 48899999987654332 357899999999999999999999986
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeecc
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLDA 462 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd~ 462 (683)
.....++||||+++|+|.+++.... ....+++..++.|+.|++.||+||| +.+ |+||||||+|||++.
T Consensus 105 -~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 105 -QPPNLSIVTEYLSRGSLYRLLHKSG------AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp -STTCCEEEEECCTTCBHHHHHHSTT------HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECT
T ss_pred -ECCceEEEEecCCCCcHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeC
Confidence 4567899999999999999994321 1224999999999999999999999 777 999999999999999
Q ss_pred CCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 463 DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .
T Consensus 175 ~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~ 245 (309)
T 3p86_A 175 KYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------A 245 (309)
T ss_dssp TCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------H
T ss_pred CCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 9999999999998654322 123346799999999999999999999999999999999999999964321 1
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
+........... ..+ +......+.+++..|++.||++|||+.+|+++|+....
T Consensus 246 ~~~~~~~~~~~~-----~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 246 QVVAAVGFKCKR-----LEI----------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHHSCCC-----CCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHhcCCC-----CCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111111110 001 11223457789999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=360.91 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=206.7
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++. .+...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL------VGDEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE------ETTEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE------ECCEE
Confidence 46799999999999999999995 568999999998766666778999999999999999999999987 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 93 ~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~D 159 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTD 159 (297)
T ss_dssp EEEEECCTTCBHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCCHHHHHh----------hcCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEee
Confidence 99999999999999983 235899999999999999999999 78999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .........
T Consensus 160 fg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~ 230 (297)
T 3fxz_A 160 FGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIAT 230 (297)
T ss_dssp CTTCEECCSTTCC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred CCCceecCCcccc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh
Confidence 9999876544332 3446799999999999999999999999999999999999999964321 111111111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.. .+ ..+......+.+++..|++.||++|||+.|+++
T Consensus 231 ~~~~------~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 231 NGTP------EL--------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HCSC------CC--------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC------CC--------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111 11 012233456778999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.17 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=208.2
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||+|+..+++.||||++.... ...+++.+|++++++++||||+++++++. .....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~l 82 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL------EQAPICL 82 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC------SSSSEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCceEE
Confidence 5788899999999999999999889999999987543 34567999999999999999999999986 5567899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 83 v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 151 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQ--------RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG 151 (269)
T ss_dssp EEECCTTCBHHHHHHTT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTT
T ss_pred EEEeCCCCcHHHHHHhc--------CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccc
Confidence 99999999999998432 346899999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............+|..|+|||.+....++.++||||||++++||++ |+.||..... .+. ...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~-~~~~~~ 222 (269)
T 4hcu_A 152 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEV-VEDIST 222 (269)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH-HHHHHT
T ss_pred ccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHH-HHHHhc
Confidence 998765544334445667889999999999999999999999999999999 9999864221 111 111222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. ... +......+.+++..|++.||++|||+.+++++|+.
T Consensus 223 ~~~--~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 223 GFR--LYK-------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp TCC--CCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Ccc--CCC-------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 110 001 11123457789999999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=396.38 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=196.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHH---HHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNE---VEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~E---v~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++|...++||+|+||.||+++.. +|+.||||++.+.. ......+.+| +.+++.++|||||++++++.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~------ 262 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH------ 262 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE------
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE------
Confidence 57999999999999999999975 68999999996532 2223334444 56667779999999999987
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....||||||++||+|.++|.. ...+++...+.++.||+.||+||| +.+||||||||+|||||.+|.
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~---------~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ---------HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH---------HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSC
T ss_pred ECCEEEEEEecCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCC
Confidence 56789999999999999999942 347999999999999999999999 899999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
+||+|||+|+...... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+ .. .
T Consensus 331 vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~-~ 401 (689)
T 3v5w_A 331 VRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KH-E 401 (689)
T ss_dssp EEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HH-H
T ss_pred EEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HH-H
Confidence 9999999998765433 334689999999999975 479999999999999999999999997533221 11 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
+......... . .+......+..++..|++.||++|++ +.||.+
T Consensus 402 i~~~i~~~~~------~----------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 402 IDRMTLTMAV------E----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHHHCCC------C----------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HHHhhcCCCC------C----------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111111111 1 11122345678999999999999998 677754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=353.98 Aligned_cols=256 Identities=28% Similarity=0.442 Sum_probs=210.0
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|...+.||+|+||.||+|...++..||||++.... ...+++.+|++++.+++||||+++++++. .....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS------KEYPIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSSEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc------cCCceE
Confidence 46788999999999999999999988899999987643 34567999999999999999999999986 556789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++... ...+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 80 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH--------GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDF 148 (268)
T ss_dssp EEEECCTTCBHHHHHHHH--------GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCT
T ss_pred EEEEccCCCcHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccC
Confidence 999999999999998432 246999999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++..............+|..|+|||.+.+..++.++||||||++++||++ |+.||+.... .+... ...
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~-~~~ 219 (268)
T 3sxs_A 149 GMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVL-KVS 219 (268)
T ss_dssp TCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHH-HHH
T ss_pred ccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHH-HHH
Confidence 9998766554444445567888999999999899999999999999999999 9999864321 11111 111
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.+.. ...+ ......+.+++..|++.||++|||+.++++.|+.-.
T Consensus 220 ~~~~--~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 220 QGHR--LYRP-------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTCC--CCCC-------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred cCCC--CCCC-------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2111 0011 111335778999999999999999999999998643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=363.07 Aligned_cols=266 Identities=25% Similarity=0.384 Sum_probs=203.7
Q ss_pred hcCcccceeeeecCceEEEEEEE-----cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-----QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||+||++++ .+++.||||++........+.|.+|++++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA----G 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH----H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----C
Confidence 36788899999999999999985 36889999999766555567799999999999999999999998532 2
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~ 153 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRV 153 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHC--------GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred CCceEEEEEeCCCCCHHHHHHhc--------ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeE
Confidence 34589999999999999999432 235899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCC-------CCC
Q 005691 467 RVADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSG-------SPR 537 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~-------~~~ 537 (683)
||+|||+++........ ......||..|+|||.+....++.++||||||+++|||++|+.|+...... ...
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~ 233 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc
Confidence 99999999876543322 233455788899999999999999999999999999999999987532110 000
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..............+... ..+......+.+++..|++.||++|||+.|++++|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNGRL---------------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp THHHHHHHHHHHHTTCCC---------------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHHHHHHHHhccCcC---------------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 001111111111111110 0112234567889999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=382.79 Aligned_cols=260 Identities=29% Similarity=0.428 Sum_probs=205.4
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+...++|...++||+|+||.||+|.+.++..||||++.... ...++|.+|++++++++||||++++|++. ..
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~ 251 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-------EE 251 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-------SS
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc-------CC
Confidence 34567889999999999999999999988899999987643 34678999999999999999999999984 25
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++... ....+++..++.|+.|++.||+||| +.+|+||||||+|||+++++.+||
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGE-------TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHH-------HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred ceEEEehhhcCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEE
Confidence 689999999999999999432 1246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++..............+|..|+|||.+..+.++.++||||||+++|||++ |+.||..... ..+..
T Consensus 322 ~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---------~~~~~ 392 (452)
T 1fmk_A 322 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLD 392 (452)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHH
T ss_pred CCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---------HHHHH
Confidence 9999998765443333344567889999999999999999999999999999999 9999864221 11122
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
.+..+... . .+..+.+.+.+++..|++.||++|||+.+|+++|+....
T Consensus 393 ~i~~~~~~-----~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 393 QVERGYRM-----P----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHTTCCC-----C----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHcCCCC-----C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 22222110 0 111234567789999999999999999999999997544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=366.86 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=203.8
Q ss_pred cCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...++||+|+||.||+|+.. .+..||||++..... ...+.|.+|++++++++||||+++++++. .+
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~ 122 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT------RG 122 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------GG
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE------eC
Confidence 56788899999999999999974 355699999976432 33457999999999999999999999986 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ...+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~k 191 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH--------DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCK 191 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT--------TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEE
Confidence 6789999999999999998422 246999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 468 VADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 468 LaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
|+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... . +
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~---~- 262 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----R---D- 262 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----H---H-
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----H---H-
Confidence 9999999876543322 2334456889999999999999999999999999999999 9999864321 1 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+...+..+... . .+......+.+++..|++.||++|||+.+|+++|+...
T Consensus 263 ~~~~~~~~~~~-----~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 263 VISSVEEGYRL-----P----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HHHHHHTTCCC-----C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC-----C----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11222222110 0 11122446778999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=372.62 Aligned_cols=275 Identities=26% Similarity=0.352 Sum_probs=214.6
Q ss_pred ceehHHHHHHhcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCccc
Q 005691 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVP 373 (683)
Q Consensus 302 ~f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~ 373 (683)
.++..+++...++|...+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|++++.++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 355667777889999999999999999999984 24678999999764332 245699999999999 8999999
Q ss_pred ccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCC----------------------------------------
Q 005691 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG---------------------------------------- 413 (683)
Q Consensus 374 L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~---------------------------------------- 413 (683)
+++++.. .+...++||||+++|+|.+++.......
T Consensus 91 ~~~~~~~-----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (359)
T 3vhe_A 91 LLGACTK-----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165 (359)
T ss_dssp EEEEECS-----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred eeeeeec-----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence 9999863 3445899999999999999996543110
Q ss_pred -----------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 414 -----------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 414 -----------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
.......+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 242 (359)
T ss_dssp ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceee
Confidence 0001223889999999999999999999 88999999999999999999999999999986
Q ss_pred cccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhcCcc
Q 005691 477 SREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKAGKV 554 (683)
Q Consensus 477 ~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l 554 (683)
...... .......||+.|+|||++....++.++||||||+++|||++ |+.||...... ..+...+..+..
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~ 314 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTR 314 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--------HHHHHHHHHTCC
T ss_pred ecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--------HHHHHHHHcCCC
Confidence 644322 23445678999999999999999999999999999999998 99998643221 122222222221
Q ss_pred ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 555 WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 555 ~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. . +......+.+++..|++.||++||||.||+++|+.
T Consensus 315 ~~-----~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 315 MR-----A----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC-----C----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11 1 11123457788999999999999999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=372.47 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=208.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc--------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ--------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
.++|...+.||+|+||.||+|+.. ++..||||++...... ..+++.+|+++++++ +|||||++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence 468889999999999999999862 3567999998764332 245799999999999 8999999999986
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.....++||||+++|+|.+++....... .......++|..++.++.||+.||+||| +.+|+|||||
T Consensus 158 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlk 230 (370)
T 2psq_A 158 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 230 (370)
T ss_dssp ----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred ----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence 5567999999999999999995432110 0112346899999999999999999999 8899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999987654332 22344567899999999999999999999999999999999 999986432
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
. . -+...+..+...+ .+......+.+++..|++.||++|||+.|+++.|+..
T Consensus 311 ~-----~----~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 311 V-----E----ELFKLLKEGHRMD---------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp G-----G----GHHHHHHTTCCCC---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-----H----HHHHHHhcCCCCC---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1 1122222222110 1112234677899999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=379.19 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=194.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+|++. ++..||||++..... ...++|.+|++++++++||||++++|++. .
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT------K 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------e
Confidence 357889999999999999999875 577899999875432 23457999999999999999999999986 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++... ...++|.+++.|+.|+++||+||| +.+|+||||||+|||++.++.+
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTT--------TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred CCceEEEEeCCCCCcHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCE
Confidence 56789999999999999999422 346999999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 467 RVADFGLAKQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
||+|||+++......... .....+|..|+|||++....++.++||||||+++|||++ |+.||..... . +
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~---~ 258 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----Q---D 258 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----H---H
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----H---H
Confidence 999999998765443222 223346788999999999999999999999999999998 9999864321 1 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+...+..+.. .. .+......+.+++..|++.||++||+|.+|+++|+..
T Consensus 259 -~~~~i~~~~~---------~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 259 -VIKAVDEGYR---------LP------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -HHHHHHTTEE---------CC------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHcCCC---------CC------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 1112222210 00 1112345678899999999999999999999999764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=364.79 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=198.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcE----EEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTT----VAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~----VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...++||+|+||+||+|+.. +++. ||+|++.... ....++|.+|+.++++++||||++++++|.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------- 87 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL------- 87 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEE-------
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-------
Confidence 57889999999999999999964 3443 5888875433 344678999999999999999999999996
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++|+||+++|+|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++++
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~ 156 (327)
T 3poz_A 88 TSTVQLITQLMPFGCLLDYVREH--------KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHS--------TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred cCCeEEEEEecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCE
Confidence 23478999999999999998432 346999999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++........ ......||..|+|||++.++.++.++||||||+++|||++ |+.||+.... . .
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~----~ 227 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----S----E 227 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G----G
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----H----H
Confidence 99999999876544332 2334567889999999999999999999999999999999 9999964322 1 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+...+..+.... .+......+..++..|++.||++||||.+|+++|+..
T Consensus 228 ~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 228 ISSILEKGERLP---------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHTTCCCC---------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC---------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 122222221100 1112234677899999999999999999999999763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=353.87 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=206.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..++|...+.||+|+||.||+|...++..||||++.... ...+++.+|++++.+++|+||+++++++. .....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 94 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT------KQRPI 94 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC------SSSSE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe------cCCCe
Confidence 356889999999999999999999988899999987543 33577999999999999999999999986 56678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 95 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM--------RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG--------GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECS
T ss_pred EEEEeccCCCcHHHHHHHh--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcc
Confidence 9999999999999999432 346999999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+++..............+|+.|+|||.+....++.++||||||+++|||++ |+.||..... .+. ...+
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~-~~~~ 234 (283)
T 3gen_A 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SET-AEHI 234 (283)
T ss_dssp TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH-HHHH
T ss_pred ccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHH-HHHH
Confidence 99998765443333444567889999999999999999999999999999998 9999864321 111 1112
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+.. .. .+......+.+++..|++.+|++|||+.++++.|+.
T Consensus 235 ~~~~~-----~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 235 AQGLR-----LY----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp HTTCC-----CC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred hcccC-----CC----------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 22110 00 011113467789999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.23 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=203.6
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+++.. +++.||+|++....... .+.|.+|+.++++++||||+++++++. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~------~~ 83 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE------ED 83 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE------CS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee------eC
Confidence 357899999999999999999965 68899999986544333 356899999999999999999999986 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES---------HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeCCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence 789999999999999999832 346999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~ 223 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIK 223 (294)
T ss_dssp ECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHH
T ss_pred EEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHH
Confidence 999999987765444444556799999999999999999999999999999999999999964321 111222
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-TISDALKMLEGDI 609 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-tm~eVl~~L~~~~ 609 (683)
....... .+... ...+....+.+++..|++.||++|| ++.++.+.|+...
T Consensus 224 ~~~~~~~------~~~~~------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 224 HIQDSVP------NVTTD------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSSCCC------CHHHH------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HhhccCC------Ccchh------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 2211110 00000 0112234677899999999999999 9999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=375.80 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=205.6
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
..++|...+.||+|+||.||+|+.. +++.||||.+...... ..++|.+|++++++++|||||+++|++. ...
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT------QKQ 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe------cCC
Confidence 3468888999999999999999986 7899999998754322 2346889999999999999999999996 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE--------GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--------GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEE
Confidence 789999999999999999422 246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCcccc-ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 469 ADFGLAKQSREGQSHLT-TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~-~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
+|||+++.......... ....+|..|+|||.+..+.++.++||||||+++|||++ |+.|+..... ..+.
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~ 325 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTR 325 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHH
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH
Confidence 99999986543322111 12345778999999999999999999999999999998 9999864321 1222
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+..+.... .+......+.+++..|++.||++|||+.+|++.|+.
T Consensus 326 ~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 326 EFVEKGGRLP---------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp HHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCCC---------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 2233322110 111123456789999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.65 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++. ...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~------~~~ 87 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE------TEK 87 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------CSS
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------ECC
Confidence 46899999999999999999997 5799999999976432 23456889999999999999999999986 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++...+.++.|++.||+||| +.+|+||||||+|||++.++++||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~---------~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl 155 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVA---------HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKI 155 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHH---------HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred EEEEEEECCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEE
Confidence 89999999999999999842 346899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCC-ccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT-EKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++....+. ......||+.|+|||.+.+..++ .++|||||||++|||++|+.||+... ..+. ..
T Consensus 156 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~-~~ 224 (328)
T 3fe3_A 156 ADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKEL-RE 224 (328)
T ss_dssp CSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH-HH
T ss_pred eeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHH-HH
Confidence 9999998765433 23456799999999999988775 79999999999999999999996422 1111 12
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+..+... + +......+.+++..|++.||.+|||+.|+++.
T Consensus 225 ~i~~~~~~------~----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 225 RVLRGKYR------I----------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHCCCC------C----------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHhCCCC------C----------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22222110 0 11123456788999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=386.52 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=212.4
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+...++|...++||+|+||.||+|++.+ +..||||++.... ...++|.+|++++++++|||||+++|+|. ..
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~------~~ 288 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT------RE 288 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe------cC
Confidence 3345778899999999999999999875 8899999987543 34678999999999999999999999996 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ....+++..++.|+.||+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~k 358 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLREC-------NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVK 358 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHS-------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEE
T ss_pred CcEEEEEEccCCCCHHHHHHhc-------CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEE
Confidence 6789999999999999999532 1346899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+++..............+|..|+|||.+..+.++.++|||||||++|||++ |+.||..... ..+.
T Consensus 359 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---------~~~~ 429 (495)
T 1opk_A 359 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------SQVY 429 (495)
T ss_dssp ECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------GGHH
T ss_pred EeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---------HHHH
Confidence 99999998765443333344567889999999999999999999999999999999 9999864321 1122
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
..+..+... . .+..+...+.+++..|++.||++||||.+|+++|+...
T Consensus 430 ~~~~~~~~~---------~------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 430 ELLEKDYRM---------E------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHTTCCC---------C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHcCCCC---------C------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 222222110 0 11123456778999999999999999999999999653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=355.63 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=209.1
Q ss_pred HHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
...++|...+.||+|+||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++. ...
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------~~~ 81 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-------QEP 81 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-------SSS
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-------CCC
Confidence 3456889999999999999999999888899999986543 34678999999999999999999999974 345
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++++|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||+++++.+||+
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTP-------SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSH-------HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred cEEEEecCCCCCHHHHHhcC-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEEC
Confidence 89999999999999999421 1236899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||+++..............+|..|+|||.+..+.++.++||||||++++||++ |+.||..... .+. ...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~-~~~ 222 (279)
T 1qpc_A 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEV-IQN 222 (279)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHH-HHH
T ss_pred CCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHH-HHH
Confidence 999998776544333445567889999999999999999999999999999999 8999864221 111 112
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+..+.. .. .+......+.+++..|++.||++|||+.+++++|+..
T Consensus 223 ~~~~~~-----~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 223 LERGYR-----MV----------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp HHTTCC-----CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccC-----CC----------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 222210 00 0112234677899999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=364.48 Aligned_cols=271 Identities=27% Similarity=0.417 Sum_probs=211.7
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCccccccee
Q 005691 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCC 378 (683)
Q Consensus 306 ~el~~at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c 378 (683)
.+++...++|...+.||+|+||.||+|+.. +++.||||++...... ..+.|.+|++++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344455789999999999999999999975 3478999998764332 245799999999999999999999998
Q ss_pred eecCCCCCCCeeEEEEeecCCCCccccccCCCCCC---------------CCCCCCCCCccchhhhHHHHHHHHHHHhcc
Q 005691 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG---------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYG 443 (683)
Q Consensus 379 ~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~---------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~ 443 (683)
. .+...++||||+++|+|.+++....... .......+++.+++.|+.|+++||.|||
T Consensus 120 ~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-- 191 (343)
T 1luf_A 120 A------VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-- 191 (343)
T ss_dssp C------SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred c------cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 6 5667899999999999999985432100 0011257999999999999999999999
Q ss_pred cCCCccccCCCCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHh
Q 005691 444 VKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIM 522 (683)
Q Consensus 444 ~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELl 522 (683)
+.+|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+....++.++||||||+++|||+
T Consensus 192 -~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 192 -ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp -HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 88999999999999999999999999999987643322 2234457899999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005691 523 C-GRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601 (683)
Q Consensus 523 t-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eV 601 (683)
+ |+.||..... ......+..+.... + +......+.+++..|++.||++|||+.+|
T Consensus 271 t~g~~p~~~~~~---------~~~~~~~~~~~~~~-----~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 271 SYGLQPYYGMAH---------EEVIYYVRDGNILA-----C----------PENCPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp TTTCCTTTTSCH---------HHHHHHHHTTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCcCCCCCh---------HHHHHHHhCCCcCC-----C----------CCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9 9999864221 11222233332211 0 11223467789999999999999999999
Q ss_pred HHHHhcCC
Q 005691 602 LKMLEGDI 609 (683)
Q Consensus 602 l~~L~~~~ 609 (683)
+++|+...
T Consensus 327 ~~~L~~~~ 334 (343)
T 1luf_A 327 HRILQRMC 334 (343)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHH
Confidence 99999754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=354.78 Aligned_cols=268 Identities=25% Similarity=0.339 Sum_probs=201.9
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhc--cCCCcccccceeeecCCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL--KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L--~H~NLV~L~G~c~~~~~~~~ 386 (683)
....++|...+.||+|+||.||+|+.. |+.||||++... ....+..|.+++..+ +|+||+++++++..... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~--~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG--S 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG--G
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC--C
Confidence 344578999999999999999999986 899999998643 244566677776655 99999999999874321 2
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC--------CccccCCCCCce
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP--------AIYHRDIKATNI 458 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~--------~IiHrDIKpsNI 458 (683)
....++||||+++|+|.+++. ...+++..++.|+.+++.||+||| +. +|+||||||+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLK----------STTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHH----------HCCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGE
T ss_pred CCceEEEEeccCCCcHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHE
Confidence 267899999999999999993 236899999999999999999999 56 999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCccc---cccccCCCcccCccccccCCCCcc------ccEEEcchhHHHHhhCCCCC-
Q 005691 459 LLDADMRARVADFGLAKQSREGQSHL---TTRVAGTHGYLAPEYALYGQLTEK------SDVYSFGVVILEIMCGRKAL- 528 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~~---~~~~~GT~~Y~APE~~~~~~~s~k------sDVwSfGvlLlELltGr~p~- 528 (683)
|++.++.+||+|||+++......... .....||+.|+|||.+.....+.+ +|||||||++|||++|..|+
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~ 253 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence 99999999999999997664433221 234579999999999987766665 99999999999999995444
Q ss_pred ---------CCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005691 529 ---------DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS 599 (683)
Q Consensus 529 ---------~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~ 599 (683)
........ .. ........... ..+.+... ....++...+.+++..|++.||++|||+.
T Consensus 254 ~~~~~~~p~~~~~~~~~---~~-~~~~~~~~~~~----~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 254 IVEEYQLPYHDLVPSDP---SY-EDMREIVCIKK----LRPSFPNR-----WSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp BCCCCCCTTTTTSCSSC---CH-HHHHHHHTTSC----CCCCCCGG-----GGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ccccccccHhhhcCCCC---ch-hhhHHHHhhhc----cCcccccc-----chhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 32222111 00 11111111111 11222111 12235677899999999999999999999
Q ss_pred HHHHHHhcC
Q 005691 600 DALKMLEGD 608 (683)
Q Consensus 600 eVl~~L~~~ 608 (683)
+|++.|+..
T Consensus 321 ell~~L~~l 329 (337)
T 3mdy_A 321 RVKKTLAKM 329 (337)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.52 Aligned_cols=253 Identities=28% Similarity=0.388 Sum_probs=202.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.+++.++|||||++++++. .+..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~------~~~~ 79 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR------EGNI 79 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE------CSSE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe------cCCe
Confidence 468999999999999999999976 7899999998654332 2456899999999999999999999987 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++. ....+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 80 ~~lv~e~~~~~~L~~~l~---------~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIE---------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp EEEEEECCTTEEGGGGSB---------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHh---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEE
Confidence 899999999999999983 2346999999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCC-ccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 470 DFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 470 DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|||+++...... ........||+.|+|||++....+ +.++||||||+++|||++|+.||....... .....|
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~--- 221 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDW--- 221 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHH---
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHH---
Confidence 999998765332 223445789999999999987775 789999999999999999999997543321 111111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
...... .. ........+.+++..|++.||++|||+.|+++.
T Consensus 222 --~~~~~~--~~------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 222 --KEKKTY--LN------------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --HTTCTT--ST------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --hccccc--CC------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111110 00 111223456789999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=349.25 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=196.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--------------------------ChHHHHHHHHHHH
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--------------------------GDAEFCNEVEIIS 364 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--------------------------~~~~f~~Ev~iL~ 364 (683)
.++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999975 6889999998654321 1256899999999
Q ss_pred hccCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc
Q 005691 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV 444 (683)
Q Consensus 365 ~L~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~ 444 (683)
+++||||+++++++... .....++||||+++|+|.+++ ....+++..++.++.|++.||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~----~~~~~~lv~e~~~~~~l~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH--- 154 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP----NEDHLYMVFELVNQGPVMEVP----------TLKPLSEDQARFYFQDLIKGIEYLH--- 154 (298)
T ss_dssp TCCCTTBCCEEEEEECS----SSSEEEEEEECCTTCBSCCSS----------CSSCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred hCCCCCCCeEEEEEEcC----CCCEEEEEEecCCCCcHHHHh----------hcCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 99999999999998632 356789999999999999876 2347999999999999999999999
Q ss_pred CCCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCC---CCccccEEEcchhHHHH
Q 005691 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ---LTEKSDVYSFGVVILEI 521 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSfGvlLlEL 521 (683)
+.+|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.... ++.++||||||+++|||
T Consensus 155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 78999999999999999999999999999987654332 234467999999999998655 47899999999999999
Q ss_pred hhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005691 522 MCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601 (683)
Q Consensus 522 ltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eV 601 (683)
++|+.||.... ...+. ..+..+... . +. .......+.+++..|++.||++|||+.|+
T Consensus 234 ~~g~~pf~~~~--------~~~~~-~~~~~~~~~-~--~~-----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~ 290 (298)
T 2zv2_A 234 VFGQCPFMDER--------IMCLH-SKIKSQALE-F--PD-----------QPDIAEDLKDLITRMLDKNPESRIVVPEI 290 (298)
T ss_dssp HHSSCSSCCSS--------HHHHH-HHHHHCCCC-C--CS-----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred HHCCCCCCCcc--------HHHHH-HHHhcccCC-C--CC-----------ccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 99999986321 11111 112221110 0 00 01123457789999999999999999998
Q ss_pred HH
Q 005691 602 LK 603 (683)
Q Consensus 602 l~ 603 (683)
++
T Consensus 291 l~ 292 (298)
T 2zv2_A 291 KL 292 (298)
T ss_dssp TT
T ss_pred hc
Confidence 74
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=346.33 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=207.2
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++. .....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~~l 80 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL------EQAPICL 80 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC------SSSSCEE
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc------cCCCeEE
Confidence 57888999999999999999998899999999876443 3567999999999999999999999986 4567899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ...+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 81 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg 149 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQ--------RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG 149 (267)
T ss_dssp EECCCTTCBHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTT
T ss_pred EEeCCCCCcHHHHHhhC--------cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccc
Confidence 99999999999998432 246899999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............||..|+|||.+....++.++||||||+++|||++ |+.||..... .+.. ..+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~-~~i~~ 220 (267)
T 3t9t_A 150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVV-EDIST 220 (267)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH-HHHHT
T ss_pred cccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHH-HHHhc
Confidence 998765433333344567889999999999999999999999999999999 8999864221 1111 11222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. .. .+......+.+++..|++.||++|||+.+++++|+.
T Consensus 221 ~~~-----~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 221 GFR-----LY----------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp TCC-----CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCc-----CC----------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 211 00 011123456789999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.00 Aligned_cols=267 Identities=25% Similarity=0.312 Sum_probs=209.5
Q ss_pred cCcccceeeeecCceEEEEEEE-----cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-----QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++|+||+++++++... ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP----GR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS----SS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC----CC
Confidence 5788899999999999999984 36889999999776555566799999999999999999999998632 44
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ...+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRH--------RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHH--------GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred ceEEEEEeecCCCCHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEE
Confidence 6789999999999999998421 246999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCC------CCcc
Q 005691 468 VADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS------PRAC 539 (683)
Q Consensus 468 LaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~------~~~~ 539 (683)
|+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 9999999876543322 2344568899999999999999999999999999999999999985321100 0000
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
............+. ... .+......+.+++..|++.||++|||+.+++++|+...
T Consensus 248 ~~~~~~~~~~~~~~---------~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 248 PALSRLLELLEEGQ---------RLP------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp CHHHHHHHHHHTTC---------CCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred ccHHHHHHHhhccc---------CCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000111111111 000 11223456788999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=355.11 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=196.0
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||+|+.. ++.||||++... ...+.|.+|++++++++||||++++|++. +..++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--------~~~~l 76 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--------NPVCL 76 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--------TTTEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--------CCcEE
Confidence 57888999999999999999986 789999998542 23567999999999999999999999874 34799
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc-EEEccc
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR-ARVADF 471 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~-~KLaDF 471 (683)
||||+++|+|.+++.... ....+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+||
T Consensus 77 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAE------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp EEECCTTCBHHHHHHCSS------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEcCCCCCHHHHHhccC------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 999999999999995321 1235788899999999999999999432289999999999999998886 799999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+++..... .....||..|+|||.+.+..++.++||||||+++|||++|+.||+..... .....+... .
T Consensus 151 g~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~-~ 219 (307)
T 2eva_A 151 GTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVH-N 219 (307)
T ss_dssp CC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHH-T
T ss_pred ccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHh-c
Confidence 999765432 22346899999999999999999999999999999999999999643221 111112211 1
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
+.. +.+. ......+.+++..|++.||++|||+.+++++|+....
T Consensus 220 ~~~-----~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 220 GTR-----PPLI----------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TCC-----CCCB----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCC-----CCcc----------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111 1111 1123456789999999999999999999999986443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=369.51 Aligned_cols=270 Identities=16% Similarity=0.157 Sum_probs=205.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCccC-----------hHHHHHHHHHHHhccCCCccc
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQG-----------DAEFCNEVEIISNLKHRNLVP 373 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~~~-----------~~~f~~Ev~iL~~L~H~NLV~ 373 (683)
..++|...++||+|+||.||+|.+.+ ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999865 4789999986543211 112344556677778999999
Q ss_pred ccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 374 L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
+++++..... .....++||||+ +|+|.+++.. ....++|..++.|+.|++.||+||| +.+|+||||
T Consensus 113 ~~~~~~~~~~--~~~~~~lv~e~~-g~~L~~~~~~--------~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDl 178 (364)
T 3op5_A 113 YWGSGLHDKN--GKSYRFMIMDRF-GSDLQKIYEA--------NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDI 178 (364)
T ss_dssp EEEEEEEEET--TEEEEEEEEECE-EEEHHHHHHH--------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred EEeeeeeccC--CcceEEEEEeCC-CCCHHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecC
Confidence 9999975321 235589999999 9999999842 2357999999999999999999999 789999999
Q ss_pred CCCceeec--cCCcEEEcccCcccccccCCccc------cccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCC
Q 005691 454 KATNILLD--ADMRARVADFGLAKQSREGQSHL------TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525 (683)
Q Consensus 454 KpsNILLd--~~~~~KLaDFGla~~~~~~~~~~------~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr 525 (683)
||+|||++ .++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~ 258 (364)
T 3op5_A 179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258 (364)
T ss_dssp CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999 88999999999998765433221 13356999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 526 KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 526 ~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.||...... .....+....+ ...+.+++++.+... .....+..++..|++.+|++||++.+|+++|
T Consensus 259 ~Pf~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 259 LPWEDNLKD----PKYVRDSKIRY-RENIASLMDKCFPAA---------NAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp CTTGGGTTC----HHHHHHHHHHH-HHCHHHHHHHHSCTT---------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred CCccccccC----HHHHHHHHHHh-hhhHHHHHHHhcccc---------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 999743221 11111221111 122334444443221 1234677889999999999999999999999
Q ss_pred hcC
Q 005691 606 EGD 608 (683)
Q Consensus 606 ~~~ 608 (683)
+..
T Consensus 325 ~~~ 327 (364)
T 3op5_A 325 LQG 327 (364)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=385.23 Aligned_cols=261 Identities=29% Similarity=0.425 Sum_probs=211.8
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++...++|...++||+|+||.||+|.+.++..||||++.... ...++|.+|++++++++|+|||+++|++. .
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-------~ 333 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-------E 333 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-------S
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe-------e
Confidence 344567889999999999999999999988899999987644 34678999999999999999999999984 2
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.++|... ....+++.+++.|+.||+.||+||| +.+|+||||||+|||+++++.+|
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~k 403 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGE-------TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCK 403 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHH-------HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred ccceEeeehhcCCcHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEE
Confidence 5689999999999999999432 1246899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+++..............+|..|+|||.+..+.++.++|||||||++|||++ |+.||..... ..+.
T Consensus 404 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---------~~~~ 474 (535)
T 2h8h_A 404 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVL 474 (535)
T ss_dssp ECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---------HHHH
T ss_pred EcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH
Confidence 99999998765433222334567889999999999999999999999999999999 9999864221 1122
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
..+..+.... .+..+.+.+.+++..||+.||++|||+.+|+++|+....
T Consensus 475 ~~i~~~~~~~---------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 475 DQVERGYRMP---------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHcCCCCC---------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 2222221100 111224467789999999999999999999999997543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=371.80 Aligned_cols=262 Identities=26% Similarity=0.362 Sum_probs=206.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||.||+|++. +++.||||++.... .....++.+|+.++++++|||||++++++.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----- 144 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 144 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence 367888999999999999999953 46789999986542 333457899999999999999999999986
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....++||||+++|+|.+++...... ......++|..++.|+.|++.||+||| +.+|+||||||+|||++.++
T Consensus 145 -~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 145 -QSLPRFILLELMAGGDLKSFLRETRPR--PSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHHSCC--SSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred -cCCCCEEEEEeCCCCCHHHHHHhhccc--cCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCC
Confidence 556789999999999999999543211 122346999999999999999999999 88999999999999999555
Q ss_pred ---cEEEcccCcccccccCC-ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCcc
Q 005691 465 ---RARVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRAC 539 (683)
Q Consensus 465 ---~~KLaDFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~ 539 (683)
.+||+|||+++...... ........||+.|+|||.+..+.++.++|||||||++|||++ |+.||..... .
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~ 293 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----Q 293 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----H
Confidence 59999999998654322 223344678999999999999999999999999999999998 9999864321 1
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+ +...+..+.... .+......+.+++..|++.||++|||+.+|++.|+..
T Consensus 294 ---~-~~~~i~~~~~~~---------------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 294 ---E-VLEFVTSGGRMD---------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ---H-HHHHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---H-HHHHHHcCCCCC---------------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 112222221100 1112234577899999999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=345.28 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=191.9
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc----cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF----QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~----~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+|+.. |+.||||++..... ...+.+.+|+++++.++||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL------KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC------CC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe------cC
Confidence 357888999999999999999986 89999999865432 22467999999999999999999999986 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-----
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA----- 462 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~----- 462 (683)
...++||||+++++|.+++. .+.+++..++.++.|++.||+|||+....+|+||||||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~ 148 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS----------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENG 148 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT----------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSS
T ss_pred CceEEEEEcCCCCCHHHHhh----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccc
Confidence 67899999999999999982 346899999999999999999999322223999999999999986
Q ss_pred ---CCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 463 ---DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 463 ---~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
++.+||+|||+++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 219 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------ 219 (271)
T ss_dssp CCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------
T ss_pred cccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 6789999999998654332 2245789999999999999999999999999999999999999964321
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.......... ... ..+ +......+.+++..|++.||++|||+.|++++|+.
T Consensus 220 --~~~~~~~~~~-~~~----~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 220 --LAVAYGVAMN-KLA----LPI----------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --HHHHHHHHTS-CCC----CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --HHHHHhhhcC-CCC----CCC----------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0111111111 110 001 11223467789999999999999999999999974
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=365.52 Aligned_cols=266 Identities=27% Similarity=0.410 Sum_probs=210.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEc--------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ--------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
..++|...++||+|+||.||+|+.. ++..||||++...... ..+++.+|+++++++ +|||||++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence 3468899999999999999999862 3467999998764332 246799999999999 9999999999996
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
.....++||||+++|+|.+++....... .......+++..++.|+.|++.||+||| +.+|+||||
T Consensus 146 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dl 217 (382)
T 3tt0_A 146 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDL 217 (382)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred -----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCC
Confidence 5567899999999999999985432110 0112346999999999999999999999 789999999
Q ss_pred CCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCC
Q 005691 454 KATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLS 531 (683)
Q Consensus 454 KpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~ 531 (683)
||+|||++.++.+||+|||+++....... .......||..|+|||++.+..++.++||||||++++||++ |+.|+...
T Consensus 218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654332 23444567899999999999999999999999999999999 99998632
Q ss_pred CCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 532 TSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 532 ~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.. ..+...+..+...+ . +......+.+++..|++.||++|||+.||++.|+...
T Consensus 298 ~~---------~~~~~~~~~~~~~~-----~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 298 PV---------EELFKLLKEGHRMD-----K----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp CH---------HHHHHHHHTTCCCC-----C----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CH---------HHHHHHHHcCCCCC-----C----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21 11222233322111 0 1112346778999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.37 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=192.3
Q ss_pred hcCcccceeeeecCceEEEEEEEcC----CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+|+... +..||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------- 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------- 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-------
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-------
Confidence 4688899999999999999999753 45799998865432 22456999999999999999999999973
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR--------KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT--------TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred cCccEEEEecCCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCE
Confidence 35689999999999999998421 246899999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v 545 (683)
||+|||+++..............+|+.|+|||.+....++.++||||||+++|||++ |+.||..... . +..
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~---~~~ 227 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----N---DVI 227 (281)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G---GHH
T ss_pred EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----H---HHH
Confidence 999999998776544333445567889999999999999999999999999999996 9999864322 1 111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+..+.... + +......+.+++..|++.||++|||+.+++++|+.
T Consensus 228 -~~i~~~~~~~-----~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 228 -GRIENGERLP-----M----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp -HHHHTTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHcCCCCC-----C----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1122221100 1 11223467789999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.88 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=201.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcE----EEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTT----VAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~----VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...++||+|+||.||+|+.. +++. ||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------- 85 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------- 85 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-------
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------
Confidence 47888999999999999999965 4443 7888775433 233456889999999999999999999983
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
+...++||||+++|+|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~ 154 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH--------RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQV 154 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS--------GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCE
T ss_pred CCccEEEEEeCCCCCHHHHHHHc--------cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeE
Confidence 45689999999999999998432 347899999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++........ ......||..|+|||.+..+.++.++||||||+++|||++ |+.||...... .
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------~ 225 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---------E 225 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---------H
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---------H
Confidence 99999999987544332 3445678899999999999999999999999999999999 99999753321 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+...+..+.... .+ ......+..++..|++.||++|||+.++++.|+...
T Consensus 226 ~~~~~~~~~~~~--~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 226 VPDLLEKGERLA--QP-------------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHHHHHTTCBCC--CC-------------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCC--CC-------------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 122222221110 01 111224567888999999999999999999998644
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=373.55 Aligned_cols=251 Identities=30% Similarity=0.399 Sum_probs=203.8
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..++|...+.||+|+||.||+|... |+.||||+++... ..+.|.+|++++++++|||||+++|++.. .....
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE-----EKGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC-----TTSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc-----CCCce
Confidence 4568888999999999999999986 7899999987643 45679999999999999999999999863 23468
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++.... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRG-------RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHC-------TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEee
Confidence 99999999999999995321 234789999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+++..... .....+|..|+|||.+.++.++.++||||||+++|||++ |+.||......+ +...+
T Consensus 333 fG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------~~~~i 399 (450)
T 1k9a_A 333 FGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRV 399 (450)
T ss_dssp CTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---------HHHHH
T ss_pred CCCccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHH
Confidence 9999854322 122367889999999999999999999999999999998 999987543211 11222
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+...+ .+..+...+.+++..|++.||++|||+.++++.|+.
T Consensus 400 ~~~~~~~---------------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 400 EKGYKMD---------------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp HTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCC---------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2321110 111223467789999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.90 Aligned_cols=258 Identities=20% Similarity=0.307 Sum_probs=199.0
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCC----
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN---- 384 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~---- 384 (683)
..++|+..+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++......
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3568999999999999999999986 7999999999754433 356799999999999999999999998653210
Q ss_pred -----------------------------------------------CCCCeeEEEEeecCCCCccccccCCCCCCCCCC
Q 005691 385 -----------------------------------------------ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA 417 (683)
Q Consensus 385 -----------------------------------------------~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~ 417 (683)
......++||||+++|+|.+++.... .
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~ 157 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC------S 157 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC------S
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc------C
Confidence 11224799999999999999995432 2
Q ss_pred CCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCc-----------cccc
Q 005691 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS-----------HLTT 486 (683)
Q Consensus 418 ~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~-----------~~~~ 486 (683)
....++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 234567778999999999999999 88999999999999999999999999999987654321 1223
Q ss_pred cccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccc
Q 005691 487 RVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKED 566 (683)
Q Consensus 487 ~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~ 566 (683)
...||+.|+|||.+.+..++.++||||||+++|||++|..|+.. . .........+.. +.
T Consensus 235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~-~~~~~~~~~~~~-----~~----- 293 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------R-VRIITDVRNLKF-----PL----- 293 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------H-HHHHHHHHTTCC-----CH-----
T ss_pred ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------H-HHHHHHhhccCC-----Cc-----
Confidence 45799999999999999999999999999999999998766421 0 011111111111 00
Q ss_pred cccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 567 DFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 567 ~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
........+..++..|++.||++|||+.|+++
T Consensus 294 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 294 -----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -----HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -----ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 11223345678999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=349.79 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=194.7
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...++||+|+||.||+|+.. ..||||++...... ..+.|.+|++++++++|+||+++++++ ....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-------~~~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-------TAPQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-------CSSS
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-------cCCc
Confidence 468899999999999999999864 46999998654322 245699999999999999999999976 3456
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++++|.+++.. ....+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~ 162 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHA--------SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIG 162 (289)
T ss_dssp CEEEEECCCEEEHHHHHTT--------C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cEEEEEecCCCcHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEc
Confidence 8999999999999999843 2346999999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccC-CccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 470 DFGLAKQSREG-QSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 470 DFGla~~~~~~-~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|||+++..... .........||+.|+|||.+. ...++.++||||||+++|||++|+.||...... +..
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~ 234 (289)
T 3og7_A 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--------DQI 234 (289)
T ss_dssp CCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--------HHH
T ss_pred cceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--------HHH
Confidence 99999865432 222334567999999999986 667899999999999999999999999643221 122
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
......+.....+.. ........+.+++..|++.||++|||+.+++++|+..
T Consensus 235 ~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 235 IEMVGRGSLSPDLSK-----------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp HHHHHHTSCCCCTTS-----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHhcccccCcchhh-----------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 233333322111111 0112245678899999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.73 Aligned_cols=272 Identities=24% Similarity=0.336 Sum_probs=194.4
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEcCCc----EEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQDGT----TVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDG 382 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~~g~----~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~ 382 (683)
....++|...+.||+|+||.||+|+..... .||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 344578999999999999999999965432 79999986642 233567999999999999999999999997433
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
........++||||+++|+|.+++...... .....+++..++.|+.|++.||+||| +.+|+||||||+|||++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIG---ENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAE 172 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhcc---ccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcC
Confidence 222222349999999999999998543211 12236899999999999999999999 889999999999999999
Q ss_pred CCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccc
Q 005691 463 DMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACL 540 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~ 540 (683)
++.+||+|||+++........ ......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... .
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~- 246 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----A- 246 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G-
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----H-
Confidence 999999999999876543322 2334567889999999999999999999999999999999 8999864322 1
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
+ ....+..+.... .+.+....+.+++..|++.||++|||+.++++.|++...
T Consensus 247 --~-~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 247 --E-IYNYLIGGNRLK---------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp --G-HHHHHHTTCCCC---------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H-HHHHHhcCCCCC---------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 111122221100 111223467889999999999999999999999987433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=354.42 Aligned_cols=271 Identities=26% Similarity=0.330 Sum_probs=198.6
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHH--HhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEII--SNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL--~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.+++ ..++|+||+++++++..... .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA-DGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT-TSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccccc-CCCce
Confidence 36888999999999999999987 58999999986532 34455555554 45899999999987653322 13446
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC---------CccccCCCCCceee
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP---------AIYHRDIKATNILL 460 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~---------~IiHrDIKpsNILL 460 (683)
.++||||+++|+|.+++. ...++|..++.|+.|++.||+||| +. +|+||||||+|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLS----------LHTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEECCCTTCBHHHHHH----------HCCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred EEEEEecCCCCcHHHHHh----------hcccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEE
Confidence 789999999999999993 234589999999999999999999 66 99999999999999
Q ss_pred ccCCcEEEcccCcccccccCCc-------cccccccCCCcccCcccccc-------CCCCccccEEEcchhHHHHhhCCC
Q 005691 461 DADMRARVADFGLAKQSREGQS-------HLTTRVAGTHGYLAPEYALY-------GQLTEKSDVYSFGVVILEIMCGRK 526 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~-------~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSfGvlLlELltGr~ 526 (683)
+.++.+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 9999999999999987643221 12234579999999999876 456789999999999999999988
Q ss_pred CCCCCCCCCCCccchh---------hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC
Q 005691 527 ALDLSTSGSPRACLIT---------DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT 597 (683)
Q Consensus 527 p~~~~~~~~~~~~~l~---------~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt 597 (683)
|+............+. ............ .+.+.... .........+.+++..|++.||++|||
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAW----KENSLAVRSLKETIEDCWDQDAEARLT 305 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTC----CCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred cCCCccchhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCccc----ccccchHHHHHHHHHHHhcCChhhCcc
Confidence 7644322211100000 000011111111 11111110 112235667899999999999999999
Q ss_pred HHHHHHHHhcC
Q 005691 598 ISDALKMLEGD 608 (683)
Q Consensus 598 m~eVl~~L~~~ 608 (683)
+.||++.|+..
T Consensus 306 ~~e~l~~L~~l 316 (336)
T 3g2f_A 306 AQXAEERMAEL 316 (336)
T ss_dssp HHHHHHHHHHH
T ss_pred hHHHHHHHHHH
Confidence 99999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=354.78 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|+++++.++||||+++++++. ..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~------~~ 77 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ------TH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE------CS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE------eC
Confidence 367899999999999999999975 6899999999764 2334567899999999999999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ...+++..++.++.+|+.||+||| +.+|+||||||+|||++.++.+|
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSR---------ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEE
Confidence 789999999999999998832 346899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ..
T Consensus 146 L~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~-~~ 215 (337)
T 1o6l_A 146 ITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERL-FE 215 (337)
T ss_dssp ECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH-HH
T ss_pred EeeccchhhcccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHH-HH
Confidence 999999986433222 23456799999999999999999999999999999999999999964221 111 11
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
.+..+.. .+ +......+..++..|++.||++|| ++.||++
T Consensus 216 ~i~~~~~------~~----------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 216 LILMEEI------RF----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHCCC------CC----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHcCCC------CC----------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1111111 01 111234567889999999999999 8999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=356.89 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=192.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|+..++||+|+||+||+|+.. +|+.||||++...... ...++..|+..+.++ +|+|||++++++. .+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~------~~ 129 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE------EG 129 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------ET
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE------eC
Confidence 368999999999999999999986 7999999998654322 233466667666665 8999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+ +++|.+++... ...++|..++.|+.|++.||+||| +.+|+||||||+|||++.++++|
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAW--------GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHH--------CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEE
T ss_pred CEEEEEEecc-CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEE
Confidence 7899999999 77998888432 346999999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++...... ......||++|+|||++.+ .++.++|||||||++|||++|+.++... -.+.
T Consensus 198 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------------~~~~ 262 (311)
T 3p1a_A 198 LGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------------EGWQ 262 (311)
T ss_dssp ECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------------HHHH
T ss_pred EccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------------cHHH
Confidence 99999988764332 2344579999999998775 7999999999999999999998765421 0122
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+... +.+. ......+.+++..|++.||++|||+.|+++
T Consensus 263 ~~~~~~~~----~~~~----------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 QLRQGYLP----PEFT----------AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTTTCCC----HHHH----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhccCCC----cccc----------cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 22222211 1111 112356788999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=349.18 Aligned_cols=278 Identities=17% Similarity=0.212 Sum_probs=212.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++... .....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~ 84 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET----TTRHK 84 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT----TTCCE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC----CCceE
Confidence 57889999999999999999976 48999999997643 33456788999999999999999999998632 23468
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee----ccCCcE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMRA 466 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL----d~~~~~ 466 (683)
++||||+++|+|.+++.... ....+++..++.|+.|++.||+||| +.+|+||||||+|||+ +.++.+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPS------NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGG------GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred EEEEeCCCCCCHHHHHHHhc------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceE
Confidence 99999999999999995432 1234999999999999999999999 8899999999999999 888899
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccc--------cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL--------YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
||+|||+++....... .....||..|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 156 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-- 231 (319)
T 4euu_A 156 KLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-- 231 (319)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--
T ss_pred EEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--
Confidence 9999999987654432 23457999999999886 57889999999999999999999999975433211
Q ss_pred cchhhhhhhhhhcC---ccccc---cCccc--cccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 539 CLITDWVWSLVKAG---KVWQA---LDPSL--LKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 539 ~~l~~~v~~~~~~g---~l~e~---vD~~l--~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
..+......... .+... ....+ .................+..++..|++.||++|||+.|+++....+.
T Consensus 232 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 232 --NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp --CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred --hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111222222111 00000 00000 00000000123455677888999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.39 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=207.9
Q ss_pred HhcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
..++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 96 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS---- 96 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe----
Confidence 357889999999999999999986 2457899999875432 23457899999999999999999999986
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCC---------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCc
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDG---------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~---------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~I 448 (683)
.....++||||+++|+|.+++....... .......+++..++.++.|++.||+||| +.+|
T Consensus 97 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i 171 (314)
T 2ivs_A 97 --QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKL 171 (314)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred --cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCC
Confidence 5567899999999999999995432100 0011235889999999999999999999 7899
Q ss_pred cccCCCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCC
Q 005691 449 YHRDIKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRK 526 (683)
Q Consensus 449 iHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~ 526 (683)
+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543332 2334567889999999999999999999999999999999 999
Q ss_pred CCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 527 ALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 527 p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
||..... ......+..+.... .+......+.+++..|++.||++|||+.++++.|+
T Consensus 252 p~~~~~~---------~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 252 PYPGIPP---------ERLFNLLKTGHRME---------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp SSTTCCG---------GGHHHHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCH---------HHHHHHhhcCCcCC---------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9864322 11222222222111 11122346788999999999999999999999998
Q ss_pred c
Q 005691 607 G 607 (683)
Q Consensus 607 ~ 607 (683)
.
T Consensus 308 ~ 308 (314)
T 2ivs_A 308 K 308 (314)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=365.30 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=199.2
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...++||+|+||.||+++.. +++.||||++.+... ...+.+..|..++.++ +|||||++++++. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~------~ 124 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ------T 124 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE------C
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE------E
Confidence 467999999999999999999976 578899999976432 2234588999999887 8999999999987 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++.. ...+++..++.++.+|+.||+||| +.+|+||||||+||||+.++.+
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~i 192 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQR---------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHI 192 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEEcCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCE
Confidence 6789999999999999999842 346999999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............++..
T Consensus 193 kL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~ 271 (396)
T 4dc2_A 193 KLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271 (396)
T ss_dssp EECCCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH
T ss_pred EEeecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH
Confidence 999999998633222 2244578999999999999999999999999999999999999999754322111111222233
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
+....+.+ . .+......+..++..|++.||++||++
T Consensus 272 ~~i~~~~~------~----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 272 QVILEKQI------R----------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHCCC------C----------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHhcccc------C----------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 33222221 0 111223456789999999999999995
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.78 Aligned_cols=260 Identities=17% Similarity=0.206 Sum_probs=206.0
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++++.++ +|+|++++++++. .+..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~------~~~~ 80 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ------EGLH 80 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE------ETTE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC------CCce
Confidence 35799999999999999999996 578999999986543 234588999999999 8999999999986 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc----
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR---- 465 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~---- 465 (683)
.++||||+ +++|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLC--------GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTT
T ss_pred eEEEEEec-CCCHHHHHHHh--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCC
Confidence 89999999 99999999422 246999999999999999999999 899999999999999987776
Q ss_pred -EEEcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 466 -ARVADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 466 -~KLaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 226 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-- 226 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--
Confidence 999999999876543321 23456799999999999999999999999999999999999999976433221
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.........+..... .+.+. ......+.+++..|++.||++|||+.+|++.|+..
T Consensus 227 ----~~~~~~~~~~~~~~~-~~~~~----------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 227 ----KQKYERIGEKKQSTP-LRELC----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp ----HHHHHHHHHHHHHSC-HHHHT----------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHhhccCcc-HHHHH----------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 111111111100000 00000 11234678899999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.54 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=208.8
Q ss_pred HHHhcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
+...++|...+.||+|+||.||+|+. .++..||||++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 119 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT- 119 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence 44567899999999999999999996 245689999997543 23456799999999999 8999999999986
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCC--------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCC
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG--------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP 446 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~--------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~ 446 (683)
.....++||||+++|+|.+++....... .......++|..++.|+.|++.||+||| +.
T Consensus 120 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~ 191 (344)
T 1rjb_A 120 -----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FK 191 (344)
T ss_dssp -----SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred -----eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 4567999999999999999995432110 0011235899999999999999999999 88
Q ss_pred CccccCCCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-C
Q 005691 447 AIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-G 524 (683)
Q Consensus 447 ~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-G 524 (683)
+|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+..+.++.++||||||+++|||++ |
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999999876544332 2344567899999999999999999999999999999998 9
Q ss_pred CCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 525 RKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 525 r~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.||...... .........+.. +.. +......+..++..|++.||.+|||+.+|++.
T Consensus 272 ~~p~~~~~~~--------~~~~~~~~~~~~-----~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 272 VNPYPGIPVD--------ANFYKLIQNGFK-----MDQ----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCSSTTCCCS--------HHHHHHHHTTCC-----CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCCcH--------HHHHHHHhcCCC-----CCC----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9998653221 112222222211 000 11123467789999999999999999999999
Q ss_pred HhcCCC
Q 005691 605 LEGDIE 610 (683)
Q Consensus 605 L~~~~~ 610 (683)
|+....
T Consensus 329 l~~~~~ 334 (344)
T 1rjb_A 329 LGCQLA 334 (344)
T ss_dssp HHHHC-
T ss_pred HHHHHH
Confidence 987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=351.24 Aligned_cols=272 Identities=27% Similarity=0.361 Sum_probs=208.9
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHh--ccCCCcccccceeeecCCCC
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISN--LKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~--L~H~NLV~L~G~c~~~~~~~ 385 (683)
-....++|...+.||+|+||.||+|+.. |+.||||++... ....+.+|++++.. ++||||+++++++.....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-- 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG-- 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS--
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC--
Confidence 3455679999999999999999999985 899999998643 35678899999988 799999999999874221
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc-----CCCccccCCCCCceee
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV-----KPAIYHRDIKATNILL 460 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~-----~~~IiHrDIKpsNILL 460 (683)
.....++||||+++|+|.+++. ...++|..++.++.+++.||+|||... +.+|+||||||+|||+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLN----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHH----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred ccceeEEEEeecCCCcHHHHHh----------ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 1237899999999999999993 236899999999999999999999422 4689999999999999
Q ss_pred ccCCcEEEcccCcccccccCCcc---ccccccCCCcccCccccccC------CCCccccEEEcchhHHHHhhC-------
Q 005691 461 DADMRARVADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALYG------QLTEKSDVYSFGVVILEIMCG------- 524 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSfGvlLlELltG------- 524 (683)
+.++++||+|||+++........ ......||+.|+|||.+... .++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 99999999999999876544322 23456799999999998765 344789999999999999999
Q ss_pred ---CCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005691 525 ---RKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601 (683)
Q Consensus 525 ---r~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eV 601 (683)
+.||........ ....+ ...+..+. ..+.+... ....+....+.+++..|++.||++|||+.+|
T Consensus 261 ~~~~~p~~~~~~~~~---~~~~~-~~~~~~~~----~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP---SVEEM-RKVVCEQK----LRPNIPNR-----WQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp CCCCCTTTTTSCSSC---CHHHH-HHHHTTSC----CCCCCCGG-----GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cccccCccccCcCcc---cHHHH-HHHHHHHH----hCCCCccc-----ccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 556544322211 11111 11121221 12222211 1123556788999999999999999999999
Q ss_pred HHHHhcC
Q 005691 602 LKMLEGD 608 (683)
Q Consensus 602 l~~L~~~ 608 (683)
+++|+..
T Consensus 328 ~~~L~~i 334 (342)
T 1b6c_B 328 KKTLSQL 334 (342)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.37 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=210.7
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+...++|...+.||+|+||.||+|...+ +..||||++... ....+.+.+|++++++++||||+++++++. ..
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 81 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT------RE 81 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc------cC
Confidence 3456789999999999999999999864 788999998653 233567999999999999999999999986 55
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ....+++..++.|+.+++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~ 151 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLREC-------NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 151 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC-------CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEE
T ss_pred CCEEEEEEcCCCCcHHHHHHhc-------ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEE
Confidence 6789999999999999999432 2346899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+++..............+|+.|+|||.+....++.++||||||+++|||++ |+.|+..... . ...
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~----~~~ 222 (288)
T 3kfa_A 152 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----S----QVY 222 (288)
T ss_dssp ECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----G----GHH
T ss_pred EccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----H----HHH
Confidence 99999998776554444455667889999999999999999999999999999999 9999864321 1 111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+..+.. .. .+......+.+++..|++.||++|||+.+++++|+.
T Consensus 223 ~~~~~~~~-----~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 223 ELLEKDYR-----ME----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp HHHHTTCC-----CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccCC-----CC----------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 11221110 00 111223467889999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.99 Aligned_cols=268 Identities=25% Similarity=0.363 Sum_probs=205.0
Q ss_pred cccceeeeecCceEEEEEEEc-----CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-----DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-----~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
|...+.||+|+||.||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++... ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 108 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA----GAA 108 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET----TTT
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC----CCc
Confidence 488899999999999998753 688999999976432 2345699999999999999999999999742 246
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++. ...+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~----------~~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl 175 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLP----------RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKI 175 (318)
T ss_dssp EEEEEECCCTTCBHHHHGG----------GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred eEEEEEecccCCcHHHHHh----------hCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEE
Confidence 7899999999999999993 235899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 469 ADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 469 aDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+..
T Consensus 176 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~ 252 (318)
T 3lxp_A 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LELIGIAQ 252 (318)
T ss_dssp CCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHHCSCC
T ss_pred CCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhhhcccc
Confidence 999999877554322 2344568889999999999999999999999999999999999986421100 00000111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.......+.+.++...... .+......+.+++..|++.||++|||+.+++++|+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLP------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhcccCCC------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111111111111111 1122345678899999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=354.53 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=209.0
Q ss_pred HhcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeeecC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDG 382 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~ 382 (683)
..++|...+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 97 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--- 97 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence 356899999999999999999985 3467899999875433 2346799999999999 9999999999986
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCC---------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDG---------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~---------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
.+...++||||+++|+|.+++....... .......+++..++.++.|++.||+||| +.+|+||||
T Consensus 98 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl 171 (313)
T 1t46_A 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDL 171 (313)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ---cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCC
Confidence 5567899999999999999985432100 0011235899999999999999999999 889999999
Q ss_pred CCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCC
Q 005691 454 KATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLS 531 (683)
Q Consensus 454 KpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~ 531 (683)
||+|||++.++.+||+|||+++........ ......||+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 251 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999999876544332 2334567889999999999999999999999999999999 99998643
Q ss_pred CCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 532 TSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 532 ~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
... .........+.. +. .+......+.+++..|++.||.+|||+.+++++|+..
T Consensus 252 ~~~--------~~~~~~~~~~~~-----~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 252 PVD--------SKFYKMIKEGFR-----ML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp CSS--------HHHHHHHHHTCC-----CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cch--------hHHHHHhccCCC-----CC----------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 221 112222222211 00 1112234677899999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=347.29 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=200.4
Q ss_pred hcCcccceeeeecCceEEEEEEEcC----CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+|+..+ +..||||.+..... ...+.|.+|++++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------- 83 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------- 83 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-------
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-------
Confidence 5688999999999999999998653 23599999876432 33567999999999999999999999974
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++++|.+++... ...+++..++.++.+++.||.||| +.+|+||||||+|||++.++.+
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLERN--------KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH--------TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEE
T ss_pred CCCCEEEEecCCCCCHHHHHHhc--------cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcE
Confidence 34579999999999999998432 346899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v 545 (683)
||+|||+++..............+|+.|+|||.+....++.++||||||+++|||++ |+.||...... .+
T Consensus 153 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~---- 223 (281)
T 3cc6_A 153 KLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DV---- 223 (281)
T ss_dssp EECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GH----
T ss_pred EeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HH----
Confidence 999999998765544333445667899999999999999999999999999999998 99998643221 11
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
......+.... .+......+.+++..|++.||++|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 224 IGVLEKGDRLP---------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp HHHHHHTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCCCCC---------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 11122221100 011123457789999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=360.73 Aligned_cols=269 Identities=18% Similarity=0.217 Sum_probs=200.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCcc-----------ChHHHHHHHHHHHhccCCCcccccc
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDFQ-----------GDAEFCNEVEIISNLKHRNLVPLRG 376 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~~-----------~~~~f~~Ev~iL~~L~H~NLV~L~G 376 (683)
.++|...+.||+|+||.||+|+.. ++..||||++...... ....+.+|+.++..++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 368999999999999999999985 5788999998764321 1234678888999999999999999
Q ss_pred eeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCC
Q 005691 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKAT 456 (683)
Q Consensus 377 ~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKps 456 (683)
++.... ......++||||+ +++|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+
T Consensus 116 ~~~~~~--~~~~~~~lv~e~~-~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~ 180 (345)
T 2v62_A 116 SGLTEF--KGRSYRFMVMERL-GIDLQKISGQ---------NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAA 180 (345)
T ss_dssp EEEEES--SSCEEEEEEEECE-EEEHHHHCBG---------GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred cccccc--CCCcEEEEEEecc-CCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHH
Confidence 987432 1356799999999 9999999832 237999999999999999999999 789999999999
Q ss_pred ceeeccCC--cEEEcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCC
Q 005691 457 NILLDADM--RARVADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 457 NILLd~~~--~~KLaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
|||++.++ .+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf 260 (345)
T 2v62_A 181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW 260 (345)
T ss_dssp GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999887 9999999999876543221 124467999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 529 DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 529 ~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
....... ..+ ....... ...+.+.+... .........+.+++..|++.||++|||+.+|+++|+..
T Consensus 261 ~~~~~~~---~~~-~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 261 EQNLKDP---VAV-QTAKTNL-----LDELPQSVLKW-----APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp GGGTTCH---HHH-HHHHHHH-----HHTTTHHHHHH-----SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccccc---HHH-HHHHHhh-----cccccHHHHhh-----ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 6322111 111 1111111 11111111110 00012244678899999999999999999999999974
Q ss_pred C
Q 005691 609 I 609 (683)
Q Consensus 609 ~ 609 (683)
.
T Consensus 327 ~ 327 (345)
T 2v62_A 327 G 327 (345)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=361.53 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=203.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc------ChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||.||+++.. +|+.||||.+...... ..+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence 467899999999999999999976 6899999999765432 2467999999999999999999999986
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....++||||+++|+|.+++. ....+++..++.++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 86 -~~~~~~lv~e~~~gg~L~~~l~---------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 86 -NRTDVVLILELVSGGELFDFLA---------QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHT---------TCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred -eCCEEEEEEEcCCCCcHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCC
Confidence 5678999999999999999993 2346999999999999999999999 88999999999999998877
Q ss_pred ----cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 465 ----RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 465 ----~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 153 ~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----~- 224 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q- 224 (361)
T ss_dssp SSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H-
T ss_pred CCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----H-
Confidence 79999999998765432 23446799999999999999999999999999999999999999964321 1
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+. ...+..+... .++.. .......+.+++..|++.||++|||+.|+++
T Consensus 225 --~~-~~~i~~~~~~--~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 225 --ET-LANITAVSYD--FDEEF----------FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --HH-HHHHHTTCCC--CCHHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HH-HHHHHhcCCC--CCchh----------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 1112222110 01111 0112345678999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=356.62 Aligned_cols=258 Identities=16% Similarity=0.177 Sum_probs=204.4
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||.||+|+. .+|+.||||.+..... .+.+.+|+++++++ +|+||+++++++. .+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~------~~~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP------CGKY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE------ETTE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe------cCCc
Confidence 36789999999999999999996 5789999999865432 34588999999999 9999999999987 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc----
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR---- 465 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~---- 465 (683)
.++||||+ +|+|.+++... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC--------DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTT
T ss_pred cEEEEEeC-CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCc
Confidence 89999999 99999998422 347999999999999999999999 789999999999999999887
Q ss_pred -EEEcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 466 -ARVADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 466 -~KLaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--- 224 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--- 224 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---
Confidence 999999999876543321 1245789999999999999999999999999999999999999997543221
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.+... .+....... ....+.. ... .+.+++..|++.+|.+||++.+|+++|+.
T Consensus 225 --~~~~~~-~i~~~~~~~-~~~~~~~----------~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 225 --LKERYQ-KIGDTKRAT-PIEVLCE----------NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp --HHHHHH-HHHHHHHHS-CHHHHTT----------TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred --HHHHHH-HHHhhhccC-CHHHHhc----------cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 111111 111110000 0000000 112 67889999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=355.16 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=202.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc------ChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||.||+++.. +|+.||||.+...... ..+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----- 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 457889999999999999999975 5899999999764332 3567999999999999999999999987
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 85 -~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 85 -NKTDVILILELVAGGELFDFLAE---------KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHTT---------SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSS
T ss_pred -eCCEEEEEEEcCCCCCHHHHHHh---------cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCC
Confidence 56789999999999999999832 346999999999999999999999 88999999999999999887
Q ss_pred ----cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 465 ----RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 465 ----~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
.+||+|||+++....... .....||+.|+|||.+....++.++|||||||++|||++|+.||.....
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------- 222 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------- 222 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------
T ss_pred CCCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------
Confidence 899999999987654322 3346799999999999999999999999999999999999999864221
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.... +..... . ..... .......+.+++..|++.||++|||+.|+++
T Consensus 223 -~~~~~~-~~~~~~-~-~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 223 -QETLAN-VSAVNY-E-FEDEY----------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -HHHHHH-HHHTCC-C-CCHHH----------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -HHHHHH-HHhcCC-C-cCccc----------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 111110 0 00000 0112345678899999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.91 Aligned_cols=252 Identities=33% Similarity=0.557 Sum_probs=200.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccCh-------HHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGD-------AEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~-------~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+|+.. +++.||||++........ +.+.+|++++++++||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---- 93 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH---- 93 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET----
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec----
Confidence 367888999999999999999974 789999999865443322 57899999999999999999999984
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeec
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLD 461 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd 461 (683)
. ..++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+ |+||||||+|||++
T Consensus 94 --~--~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 94 --N--PPRMVMEFVPCGDLYHRLLDK--------AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp --T--TTEEEEECCTTCBHHHHHHCT--------TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEES
T ss_pred --C--CCeEEEEecCCCCHHHHHhcc--------cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEe
Confidence 1 237999999999999888432 347999999999999999999999 777 99999999999998
Q ss_pred cCCc-----EEEcccCcccccccCCccccccccCCCcccCcccc--ccCCCCccccEEEcchhHHHHhhCCCCCCCCCCC
Q 005691 462 ADMR-----ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA--LYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSG 534 (683)
Q Consensus 462 ~~~~-----~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~--~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~ 534 (683)
.++. +||+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred ccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 8776 99999999975433 23346799999999998 4566789999999999999999999999754321
Q ss_pred CCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 535 SPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 535 ~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
. ..+.......+ . .+.+. ......+.+++..|++.||++|||+.+|++.|++
T Consensus 235 ~------~~~~~~~~~~~-~----~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 235 K------IKFINMIREEG-L----RPTIP----------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H------HHHHHHHHHSC-C----CCCCC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H------HHHHHHHhccC-C----CCCCC----------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 11111111111 1 11111 1223467889999999999999999999999984
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=351.22 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=198.0
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...++||+|+||+||+|+..+|+.||||++....... .+.+.+|++++++++||||+++++++. ....
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH------SERC 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC------CSSC
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc------cCCE
Confidence 47899999999999999999999889999999986543222 356889999999999999999999986 5567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++ +|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 94 ~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDE--------NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp EEEEEECCSE-EHHHHHHT--------CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEcCCCC-CHHHHHHh--------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEc
Confidence 8999999985 77777732 2346899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||+++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+. + ..+...
T Consensus 162 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~-~~i~~~ 235 (311)
T 3niz_A 162 DFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ----L-PKIFSI 235 (311)
T ss_dssp CCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH----H-HHHHHH
T ss_pred cCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH----H-HHHHHH
Confidence 9999987643322 2334578999999999876 5689999999999999999999999975443221 1 111111
Q ss_pred hhcCc----------------cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGK----------------VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~----------------l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..... .....+...... ........+.+++..|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSS------IIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHH------HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HCCCChHHhhhhhccchhhhcccccccCCcHHH------hCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 10000 000000000000 00112346678999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=373.44 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=208.9
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCccccccee
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCC 378 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c 378 (683)
+.+.+++..+++|...++||+|+||+||+|+..+ ++.||||++.+.. ....+.+.+|+.++..++|||||++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456677778999999999999999999999864 7889999997532 12233489999999999999999999999
Q ss_pred eecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 379 ~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
. .....++||||+++|+|.+++... ...+++..++.++.+++.||.||| +.+||||||||+||
T Consensus 144 ~------~~~~~~lV~Ey~~gg~L~~~l~~~--------~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NI 206 (437)
T 4aw2_A 144 Q------DDNNLYLVMDYYVGGDLLTLLSKF--------EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNI 206 (437)
T ss_dssp E------CSSEEEEEECCCTTCBHHHHHHTT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred e------eCCEEEEEEecCCCCcHHHHHHHc--------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHe
Confidence 7 567899999999999999999431 346999999999999999999999 88999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 459 LLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
|||.++.+||+|||+++..........+...||+.|+|||++. .+.++.++|||||||++|||++|+.||.....
T Consensus 207 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp EECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999877655555555678999999999987 56799999999999999999999999964321
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL--RPTISDALKM 604 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~--RPtm~eVl~~ 604 (683)
.+.......... ...-|... ......+..++..|+..+|++ ||++.|+++.
T Consensus 287 --------~~~~~~i~~~~~--~~~~p~~~----------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 287 --------VETYGKIMNHKE--RFQFPTQV----------TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------HHHHHHHHTHHH--HCCCCSSC----------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------hHHHHhhhhccc--cccCCccc----------ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111111111000 00001100 112335567778888777777 9999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=359.39 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=204.1
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
...++|...+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|++++++++|||||++++++. .
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~------~ 99 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ------E 99 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------C
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE------e
Confidence 34578999999999999999999975 6899999999764332 2356889999999999999999999987 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC--
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-- 464 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-- 464 (683)
....++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~ 167 (362)
T 2bdw_A 100 ESFHYLVFDLVTGGELFEDIVA---------REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKG 167 (362)
T ss_dssp SSEEEEEECCCCSCBHHHHHTT---------CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTT
T ss_pred CCEEEEEEecCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCC
Confidence 6789999999999999998832 346899999999999999999999 88999999999999998654
Q ss_pred -cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 465 -RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 465 -~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
.+||+|||+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||..... .
T Consensus 168 ~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---------~ 236 (362)
T 2bdw_A 168 AAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------H 236 (362)
T ss_dssp CCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------H
T ss_pred CCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------H
Confidence 59999999998765432 23446799999999999999999999999999999999999999864221 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+..+..+... ...+ ........+.+++..|++.||++|||+.++++.
T Consensus 237 ~~~~~i~~~~~~-~~~~-----------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 237 RLYAQIKAGAYD-YPSP-----------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHHHHTCCC-CCTT-----------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhCCCC-CCcc-----------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112222222211 0000 011223467789999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=353.87 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=194.5
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+++. .+++.||||++....... ...+.+|++++++++||||+++++++..... .+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP--AG 88 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET--TE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC--CC
Confidence 46899999999999999999996 578999999997654333 3468899999999999999999999874321 22
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT---------EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEE
T ss_pred cccEEEEecCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEE
Confidence 345999999999999999842 346899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 468 VADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 468 LaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+..
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~ 228 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVA 228 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHH
Confidence 9999999876543322 23346799999999999999999999999999999999999999964321 1222
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+......... +... .......+..++..|++.||++||+..++++
T Consensus 229 ~~~~~~~~~~----~~~~---------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 229 YQHVREDPIP----PSAR---------HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHHCCCCC----HHHH---------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHhcCCCCC----cccc---------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 2222222110 0000 0112346778999999999999997666553
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=384.20 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=199.7
Q ss_pred cCcccce-eeeecCceEEEEEEEc---CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKN-FIGRGGFGLVYKGILQ---DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~-~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+++...+ .||+|+||.||+|.+. ++..||||+++.... ...++|.+|++++++++|||||+++|+|. .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-------~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-------A 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-------S
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-------c
Confidence 3444444 7999999999999874 466799999976533 34678999999999999999999999985 2
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ...+++..++.|+.||+.||+||| +.+|+||||||+||||++++.+|
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGK--------REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTC--------TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred CCeEEEEEeCCCCcHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEE
Confidence 4589999999999999999432 346999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCcccc--ccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 468 VADFGLAKQSREGQSHLT--TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~--~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
|+|||+++.......... ....+|+.|+|||++..+.++.++|||||||++|||++ |+.||..... . -
T Consensus 477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~----~ 547 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P----E 547 (613)
T ss_dssp ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----H----H
T ss_pred EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----H----H
Confidence 999999987654433222 23346789999999999999999999999999999998 9999975332 1 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+...+..+...+ .+..+...+.+++..||+.+|++||++.+|+++|+.
T Consensus 548 ~~~~i~~~~~~~---------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 548 VMAFIEQGKRME---------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp HHHHHHTTCCCC---------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHcCCCCC---------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 222233332111 111234567889999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=340.19 Aligned_cols=252 Identities=20% Similarity=0.325 Sum_probs=200.5
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...+.||+|+||.||+|+.+ ++.||||++..... ...++|.+|+.++++++||||+++++++... .....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~ 84 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP----PAPHP 84 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT----TSSSC
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC----CCCCe
Confidence 57888999999999999999986 89999999876432 2345799999999999999999999998632 23678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeeccCCcEEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd~~~~~KL 468 (683)
++||||+++|+|.+++... ....+++..++.|+.|++.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l 154 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEG-------TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARI 154 (271)
T ss_dssp EEEEECCTTCBHHHHHHSC-------SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEE
T ss_pred EeeecccCCCcHHHHHhhc-------ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeE
Confidence 9999999999999999532 1236899999999999999999999 677 999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCc---cccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTE---KSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~---ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
.|||++..... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... .+..
T Consensus 155 ~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~ 220 (271)
T 3kmu_A 155 SMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIG 220 (271)
T ss_dssp EGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHH
T ss_pred Eeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHH
Confidence 99988654322 2346899999999998765554 89999999999999999999864321 1122
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
......+.. +.+. ......+.+++..|++.||++|||+.++++.|+..
T Consensus 221 ~~~~~~~~~-----~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 221 MKVALEGLR-----PTIP----------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHHHHSCCC-----CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCC-----CCCC----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 222222211 1111 11234577899999999999999999999999853
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=354.49 Aligned_cols=264 Identities=23% Similarity=0.373 Sum_probs=204.0
Q ss_pred cCcccceeeeecCceEEEEEEE-----cCCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-----QDGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-----~~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||.||++++ .+++.||||++.... ....+.+.+|++++++++|+||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~ 96 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED----G 96 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC----C
Confidence 4588889999999999999984 368899999997543 33457799999999999999999999998732 2
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++... ...+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKN--------KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHH--------TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred CceEEEEEEeCCCCcHHHHHHhc--------cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCE
Confidence 35689999999999999998432 346899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc--cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC-------CCCC
Q 005691 467 RVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS-------GSPR 537 (683)
Q Consensus 467 KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~-------~~~~ 537 (683)
||+|||+++....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ....
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence 9999999987755433 223446788999999999999999999999999999999999998642210 0000
Q ss_pred ccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..........+..+... ..+......+.+++..|++.||++|||+.+++++|+.
T Consensus 246 -~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 246 -QMTVTRLVNTLKEGKRL---------------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp -GGHHHHHHHHHHTTCCC---------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -ccCHHHHHHHHhccCCC---------------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 00001111111111110 0112234567889999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=357.23 Aligned_cols=268 Identities=24% Similarity=0.357 Sum_probs=208.1
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEcC------CcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceee
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCV 379 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~~------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~ 379 (683)
++...++|...+.||+|+||.||+|.... +..||||.+..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999742 24799999876433 2345699999999999 8999999999986
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCC-----CCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFN-----DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~-----~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.....++||||+++|+|.+++..... .........+++..++.++.|++.||+||| +.+|+|||||
T Consensus 121 ------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 191 (333)
T 2i1m_A 121 ------HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVA 191 (333)
T ss_dssp ------SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred ------cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcc
Confidence 55679999999999999999853210 000011346899999999999999999999 7899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999999999876543322 2334567889999999999999999999999999999999 999986432
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. .........+.. .. .+......+..++..|++.||.+|||+.+|+++|+.
T Consensus 272 ~~--------~~~~~~~~~~~~-----~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 272 VN--------SKFYKLVKDGYQ-----MA----------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp SS--------HHHHHHHHHTCC-----CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hh--------HHHHHHHhcCCC-----CC----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 21 122222222211 00 011113467789999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.41 Aligned_cols=266 Identities=23% Similarity=0.264 Sum_probs=205.7
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+++. .+|+.||||++........+.+.+|++++++++||||+++++++..... .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG--AKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET--TEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC--CCcee
Confidence 46899999999999999999997 5789999999977655556779999999999999999999999864221 34578
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++.... .....+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLK-----DKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHH-----TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 99999999999999985321 12357999999999999999999999 78999999999999999999999999
Q ss_pred cCcccccccCCcc--------ccccccCCCcccCccccccCC---CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 471 FGLAKQSREGQSH--------LTTRVAGTHGYLAPEYALYGQ---LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 471 FGla~~~~~~~~~--------~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
||+++........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.||+.......
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--- 254 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--- 254 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---
Confidence 9998765321110 112346799999999987543 78999999999999999999999853211111
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.+ ....... . .+. ........+.+++..|++.||.+|||+.+|++.|+...
T Consensus 255 ~~----~~~~~~~-~------~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 255 SV----ALAVQNQ-L------SIP--------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp CH----HHHHHCC---------CC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hh----hHHhhcc-C------CCC--------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 01 1111110 0 000 01112346788999999999999999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=354.54 Aligned_cols=275 Identities=24% Similarity=0.408 Sum_probs=213.6
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCccccc
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLR 375 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~ 375 (683)
+..++++...++|...+.||+|+||.||+|+.. +++.||||++..... ....+|.+|++++++++|+||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455667789999999999999999999864 367899999875432 2345689999999999999999999
Q ss_pred ceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCC-CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 376 G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
+++. .+...++||||+++|+|.+++....... .......+++..+++|+.|++.||.||| +.+|+|||||
T Consensus 95 ~~~~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dik 165 (322)
T 1p4o_A 95 GVVS------QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLA 165 (322)
T ss_dssp EEEC------SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCS
T ss_pred EEEc------cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCc
Confidence 9986 5567899999999999999984321000 0001245789999999999999999999 7899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+|||++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||++ |+.|+....
T Consensus 166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 99999999999999999999866443322 2334567889999999999999999999999999999999 888886422
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
. ......+..+.... .+......+.+++..|++.||++|||+.++++.|+....
T Consensus 246 ~---------~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 246 N---------EQVLRFVMEGGLLD---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp H---------HHHHHHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H---------HHHHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1 11122222222211 011223457789999999999999999999999997543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.22 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=188.7
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
....++|...+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++. ..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~------~~ 120 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE------TP 120 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE------CS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe------cC
Confidence 345678999999999999999999986 57899999987543 3456889999999999999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc---CC
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DM 464 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---~~ 464 (683)
...++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++. ++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~ 188 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVE---------KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDA 188 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTT---------CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTC
T ss_pred CeEEEEEEeCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCC
Confidence 789999999999999999832 346899999999999999999999 789999999999999975 88
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 189 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~ 258 (349)
T 2w4o_A 189 PLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--------QF 258 (349)
T ss_dssp CEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--------HH
T ss_pred CEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--------HH
Confidence 99999999998764322 234467999999999999999999999999999999999999998643211 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
....+..+.. ....+. ..+....+.+++..|++.||++|||+.|+++
T Consensus 259 ~~~~i~~~~~-~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 259 MFRRILNCEY-YFISPW-----------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHTTCC-CCCTTT-----------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCC-ccCCch-----------hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2222222211 001110 1122346778999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.68 Aligned_cols=267 Identities=23% Similarity=0.261 Sum_probs=200.9
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc-----CccChHHHHHHHHHHHhccCCCcccccceeee
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES-----DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~-----~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~ 380 (683)
++....++|...+.||+|+||.||+|+.. ++..||+|++... .....+.+.+|++++++++|||||++++++.
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 98 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE- 98 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence 34567789999999999999999999974 6889999998654 2233567999999999999999999999997
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCC-------------------------------CCCCCCCCCccchhhh
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------------------------------SGVAKRPLTWPQRKNI 429 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------------------------------~~~~~~~L~w~~r~~I 429 (683)
.....++||||+++|+|.+++....... .......+++..++.|
T Consensus 99 -----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 99 -----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp -----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred -----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 5678999999999999999884211000 0000122456677889
Q ss_pred HHHHHHHHHHHhcccCCCccccCCCCCceeeccCC--cEEEcccCcccccccCCc---cccccccCCCcccCcccccc--
Q 005691 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM--RARVADFGLAKQSREGQS---HLTTRVAGTHGYLAPEYALY-- 502 (683)
Q Consensus 430 a~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~--~~KLaDFGla~~~~~~~~---~~~~~~~GT~~Y~APE~~~~-- 502 (683)
+.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+..
T Consensus 174 ~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 174 MRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 999999999999 78999999999999998776 899999999986643221 22345679999999999875
Q ss_pred CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHH
Q 005691 503 GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVL 582 (683)
Q Consensus 503 ~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~ 582 (683)
..++.++||||||+++|||++|+.||..... .+............ ..+ ........+.+
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~--~~~-----------~~~~~~~~~~~ 309 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCF--ENP-----------NYNVLSPLARD 309 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCT--TSG-----------GGGGSCHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhccccc--CCc-----------ccccCCHHHHH
Confidence 6789999999999999999999999964321 11222222221110 001 11122346778
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 005691 583 VGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 583 lal~C~~~dP~~RPtm~eVl~ 603 (683)
++..|++.||.+|||+.++++
T Consensus 310 li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 310 LLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=351.66 Aligned_cols=274 Identities=26% Similarity=0.359 Sum_probs=213.1
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccc
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPL 374 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L 374 (683)
+...+++...++|...+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45556666778999999999999999999984 34688999998764332 245689999999999 79999999
Q ss_pred cceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC
Q 005691 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA 447 (683)
Q Consensus 375 ~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~ 447 (683)
++++.. .+...++||||+++|+|.+++....... .......+++..++.++.|++.||.||| +.+
T Consensus 97 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ 168 (316)
T 2xir_A 97 LGACTK-----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRK 168 (316)
T ss_dssp EEEECC-----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred EEEEec-----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 999863 3456899999999999999995432110 0001233889999999999999999999 889
Q ss_pred ccccCCCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CC
Q 005691 448 IYHRDIKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GR 525 (683)
Q Consensus 448 IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr 525 (683)
|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+....++.++||||||+++|||++ |+
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999876543322 2344568899999999999999999999999999999998 99
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 526 KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 526 ~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.||...... ......+..+.... . +......+.+++..|++.||++|||+.+|++.|
T Consensus 249 ~p~~~~~~~--------~~~~~~~~~~~~~~-----~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 249 SPYPGVKID--------EEFCRRLKEGTRMR-----A----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp CSSTTCCCS--------HHHHHHHHHTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcccchh--------HHHHHHhccCccCC-----C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 998643221 11222222222111 1 111234577889999999999999999999999
Q ss_pred hc
Q 005691 606 EG 607 (683)
Q Consensus 606 ~~ 607 (683)
+.
T Consensus 306 ~~ 307 (316)
T 2xir_A 306 GN 307 (316)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=354.94 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=198.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||+++.. +++.||+|++....... .+.+.+|+.++.++ +|||||++++++. ..
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~------~~ 82 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ------TE 82 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE------CS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE------eC
Confidence 57889999999999999999976 58899999997654332 34588999999988 8999999999987 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~k 150 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR---------QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIK 150 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEE
Confidence 789999999999999999832 246899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................+
T Consensus 151 L~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (345)
T 3a8x_A 151 LTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229 (345)
T ss_dssp ECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH
T ss_pred EEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH
Confidence 99999998643222 22345689999999999999999999999999999999999999997532211100111122222
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
....+.. .+ +......+..++..|++.||++||++
T Consensus 230 ~i~~~~~------~~----------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 230 VILEKQI------RI----------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHCCC------CC----------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHcCCC------CC----------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 2222221 01 11123456788999999999999995
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=368.15 Aligned_cols=261 Identities=21% Similarity=0.258 Sum_probs=207.4
Q ss_pred ehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceee
Q 005691 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379 (683)
Q Consensus 304 ~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~ 379 (683)
.+.+++...++|...++||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.+++.++|||||++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34556667789999999999999999999976 58899999986522 223345889999999999999999999997
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
.....++||||+++|+|.+++. ...+++..++.++.+++.||+||| +.+|+||||||+|||
T Consensus 140 ------~~~~~~lV~E~~~gg~L~~~l~----------~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NIL 200 (410)
T 3v8s_A 140 ------DDRYLYMVMEYMPGGDLVNLMS----------NYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNML 200 (410)
T ss_dssp ------CSSEEEEEECCCTTEEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred ------ECCEEEEEEeCCCCCcHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHee
Confidence 5678999999999999999883 235889999999999999999999 889999999999999
Q ss_pred eccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCC----CCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 460 LDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ----LTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
|+.++.+||+|||+++..............||+.|+|||++.... ++.++|||||||++|||++|+.||.....
T Consensus 201 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-- 278 (410)
T 3v8s_A 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-- 278 (410)
T ss_dssp ECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--
T ss_pred ECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--
Confidence 999999999999999876654443445678999999999998655 88999999999999999999999964221
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL--RPTISDALKM 604 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~--RPtm~eVl~~ 604 (683)
.+....... +.. ...-+. .......+..++..|++.+|.+ ||++.||++.
T Consensus 279 ------~~~~~~i~~-~~~-~~~~p~-----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 279 ------VGTYSKIMN-HKN-SLTFPD-----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ------HHHHHHHHT-HHH-HCCCCT-----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ------hhHHHHHHh-ccc-cccCCC-----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 111111111 100 000000 0112345678889999999988 9999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=342.24 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=206.4
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .+++.+|+++++.++|+|++..++++.. .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-----EGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE-----ETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC-----CCCce
Confidence 56899999999999999999996 5789999999865432 3468999999999999998888877754 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---ccCCcEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRAR 467 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL---d~~~~~K 467 (683)
++||||+ +++|.+++.. ....+++..++.|+.|++.||+||| +.+|+||||||+|||+ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNF--------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHH--------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEec-CCCHHHHHHh--------hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEE
Confidence 9999999 9999999842 1346999999999999999999999 8899999999999999 5889999
Q ss_pred EcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 468 VADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 468 LaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
|+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~ 227 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKY 227 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-hhh
Confidence 9999999876544331 134567999999999999999999999999999999999999999764432221 111
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.... .+..... .+.+. ......+.+++..|++.||++|||+.+|++.|+..
T Consensus 228 ~~~~-----~~~~~~~-~~~~~----------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 228 ERIS-----EKKMSTP-IEVLC----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHH-----HHHHHSC-HHHHT----------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhc-----ccccCCc-hHHHH----------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 1111 1110000 00000 11234678899999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=357.83 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=193.9
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccC--CCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKH--RNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H--~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||++...+++.||||++...... ..+.+.+|++++.+++| +||+++++++. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~------~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI------TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE------CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe------eC
Confidence 4678999999999999999999988999999998754332 23678999999999987 99999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||| +.+|+|.+++.. ...+++..++.|+.|++.||.||| +.+|+||||||+|||++ ++.+|
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~k 147 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKK---------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLK 147 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH---------SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEE
T ss_pred CEEEEEEe-CCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEE
Confidence 78999999 568899999842 347899999999999999999999 78999999999999997 57899
Q ss_pred EcccCcccccccCCcc-ccccccCCCcccCcccccc-----------CCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 468 VADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALY-----------GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 468 LaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
|+|||+++........ ......||+.|+|||++.. +.++.++|||||||++|||++|+.||.....
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 225 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-- 225 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--
Confidence 9999999876544332 3345679999999999865 7789999999999999999999999963211
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
...... ..+++..... .+......+.+++..|++.||.+|||+.|+++.-
T Consensus 226 -----~~~~~~---------~~~~~~~~~~------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 226 -----QISKLH---------AIIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -----HHHHHH---------HHHCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----HHHHHH---------HHhcCCcccC------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 001111 1111111111 0111123567899999999999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=342.61 Aligned_cols=263 Identities=20% Similarity=0.276 Sum_probs=202.7
Q ss_pred HHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
...++|...+.||+|+||.||+|+. .+++.||||++..... .+++.+|++++..++|+|++..++++.. .+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----~~~ 78 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-----EGD 78 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE-----ETT
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC-----CCC
Confidence 3457899999999999999999996 5788999998755432 2358899999999999999988888754 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---ccCCc
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMR 465 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL---d~~~~ 465 (683)
..++||||+ +|+|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~ 146 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNF--------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHH--------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTC
T ss_pred ceEEEEEcc-CCCHHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCe
Confidence 789999999 9999999842 1346999999999999999999999 8899999999999999 78999
Q ss_pred EEEcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 466 ARVADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
+||+|||+++........ ......||..|+|||.+.+..++.++|||||||++|||++|+.||......... .
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~ 225 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-Q 225 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-S
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-h
Confidence 999999999876544321 233567999999999999999999999999999999999999999764432221 1
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+......... ... +.+. ......+.+++..|++.||++|||+.+|+++|+..
T Consensus 226 ~~~~~~~~~~~-~~~-----~~~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 226 KYERISEKKMS-TPI-----EVLC----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHHHHHH-SCH-----HHHT----------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhhhccccc-chh-----hhhh----------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 11111000000 000 0000 11234678899999999999999999999999863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.72 Aligned_cols=267 Identities=23% Similarity=0.292 Sum_probs=197.0
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH------TKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE------CSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc------cCCeE
Confidence 57888999999999999999998899999999865432 23467899999999999999999999987 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++ +|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 76 ~lv~e~~~~-~l~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 143 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVC--------EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIAD 143 (288)
T ss_dssp EEEEECCSE-EHHHHHHTS--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecCC-CHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeE
Confidence 999999985 888887322 246899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+ ..+.+..
T Consensus 144 fg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~-~~~~~~~ 217 (288)
T 1ob3_A 144 FGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQL-MRIFRIL 217 (288)
T ss_dssp TTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHH-HHHHHHH
T ss_pred CccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHH-HHHHHHH
Confidence 999987543222 2234578999999999875 45899999999999999999999999643211 001 1111110
Q ss_pred hcC--------ccccccCcccccccc-ccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAG--------KVWQALDPSLLKEDD-FLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g--------~l~e~vD~~l~~~~~-~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... ......++.+..... ..........+.+.+++..|++.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000111111110000 000001123456778999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=347.52 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=199.9
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-C-------cEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-G-------TTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-g-------~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+|+... + ..||+|++........+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV---- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence 3578889999999999999998653 3 479999997766666778999999999999999999999996
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.+...++||||+++|+|.+++... ...+++..++.|+.|++.||.||| +.+|+||||||+|||++.+
T Consensus 83 --~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 83 --CGDENILVQEFVKFGSLDTYLKKN--------KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIRE 149 (289)
T ss_dssp --CTTCCEEEEECCTTCBHHHHHHHT--------GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEEC
T ss_pred --eCCCCEEEEECCCCCCHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecC
Confidence 456789999999999999999432 234899999999999999999999 8899999999999999988
Q ss_pred Cc--------EEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCC
Q 005691 464 MR--------ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSG 534 (683)
Q Consensus 464 ~~--------~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~ 534 (683)
+. +||+|||+++..... ....||..|+|||.+.. ..++.++||||||+++|||++|..|+.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~- 223 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD- 223 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-
T ss_pred CcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-
Confidence 87 999999998754332 23457899999999987 7799999999999999999996655432111
Q ss_pred CCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 535 SPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 535 ~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
... ......... .+... ....+.+++..|++.||++|||+.++++.|+...
T Consensus 224 ------~~~-~~~~~~~~~-------~~~~~----------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 224 ------SQR-KLQFYEDRH-------QLPAP----------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp ------HHH-HHHHHHTTC-------CCCCC----------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ------hHH-HHHHhhccC-------CCCCC----------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 000 111111110 01000 1224567889999999999999999999999654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=359.28 Aligned_cols=255 Identities=23% Similarity=0.284 Sum_probs=202.2
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-----ccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-----FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-----~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
.++|...+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+++++.++|||||++++++.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~------ 96 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS------ 96 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE------
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE------
Confidence 457999999999999999999975 68999999986421 223567999999999999999999999987
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++||||+++|+|.+++.... .....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRA-----DAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHH-----HTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSST
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhc-----ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCC
Confidence 4568999999999999988874321 12335899999999999999999999 889999999999999987655
Q ss_pred ---EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 466 ---ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 466 ---~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
+||+|||+++....... ......||+.|+|||.+....++.++|||||||++|||++|+.||.... .
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~--- 238 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------E--- 238 (351)
T ss_dssp TCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------H---
T ss_pred CCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------H---
Confidence 99999999987654332 2344679999999999999999999999999999999999999996421 0
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
-....+..+... .++.. .......+.+++..|++.||++|||+.|+++
T Consensus 239 -~~~~~i~~~~~~--~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 239 -RLFEGIIKGKYK--MNPRQ----------WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -HHHHHHHHTCCC--CCHHH----------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHcCCCC--CCccc----------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111112222110 01100 0112346778999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.79 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=197.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+++.. +|+.||||++... .....+.+.+|.+++..+ +||||+++++++. .
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~------~ 95 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ------T 95 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE------C
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE------e
Confidence 478999999999999999999975 5899999999753 223355688999999998 7999999999987 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+||||+.++.+
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~i 163 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQK---------SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHC 163 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCE
Confidence 6789999999999999999842 346999999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+++...... .......||+.|+|||++....++.++|||||||++|||++|+.||..... .+. .
T Consensus 164 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~-~ 233 (353)
T 3txo_A 164 KLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDL-F 233 (353)
T ss_dssp EECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH-H
T ss_pred EEccccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHH-H
Confidence 999999998643322 223456899999999999988999999999999999999999999964321 111 1
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI------SDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm------~eVl~ 603 (683)
..+..+.. . .+......+..++..|++.||++||++ .++++
T Consensus 234 ~~i~~~~~------~----------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 234 EAILNDEV------V----------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHCCC------C----------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHcCCC------C----------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22222211 0 111123456788999999999999998 66654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=344.98 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=196.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+++.. +++.||||++....... .+.+.+|+.++++++||||+++++++. ..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~------~~ 106 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE------ID 106 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE------ET
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe------eC
Confidence 478999999999999999999975 68899999987543332 366899999999999999999999987 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~k 174 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR---------QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAY 174 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred CeEEEEEEecCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEE
Confidence 689999999999999999842 246899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++..............||..|+|||.+....++.++||||||+++|||++|+.||..... .....
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~ 245 (309)
T 2h34_A 175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGA 245 (309)
T ss_dssp ECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHH
T ss_pred EecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHH
Confidence 999999987655443334456799999999999999999999999999999999999999863211 11122
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCCCC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-TISDALKMLEGDIEV 611 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-tm~eVl~~L~~~~~~ 611 (683)
....... .+.. .+......+.+++..|++.||++|| ++.++++.|+.....
T Consensus 246 ~~~~~~~----~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 246 HINQAIP----RPST---------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHHSCCC----CGGG---------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HhccCCC----Cccc---------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 2211110 0000 0111233567889999999999999 999999999976543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.95 Aligned_cols=256 Identities=29% Similarity=0.398 Sum_probs=198.4
Q ss_pred cCcccceeeeecCceEEEEEEEcCC----cEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDG----TTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g----~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.+|...++||+|+||.||+|+..++ ..||||.+..... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-----SE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-----SS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-----CC
Confidence 4678889999999999999996432 3589998865333 234679999999999999999999999753 34
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ....+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN--------ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC--------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEE
T ss_pred CceEEEEeCCCCCCHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEE
Confidence 578999999999999999943 2346889999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCc---cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCC-CCCCCCCCCCCCccchhh
Q 005691 468 VADFGLAKQSREGQS---HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR-KALDLSTSGSPRACLITD 543 (683)
Q Consensus 468 LaDFGla~~~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr-~p~~~~~~~~~~~~~l~~ 543 (683)
|+|||+++....... .......||+.|+|||.+.+..++.++||||||++++||++|. +|+...... .+
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~~-- 241 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DI-- 241 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----TH--
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----HH--
Confidence 999999987644322 1234456788999999999999999999999999999999954 555432211 11
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
... ...+... . .+......+.+++..|++.||++|||+.+++++|+..
T Consensus 242 -~~~-~~~~~~~--~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 242 -TVY-LLQGRRL--L-------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -HHH-HHTTCCC--C-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHH-HhcCCCC--C-------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111110 0 0111234577899999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.13 Aligned_cols=273 Identities=25% Similarity=0.351 Sum_probs=200.0
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCccccccee
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCC 378 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c 378 (683)
++++....++|...+.||+|+||.||+|... .+..||||++...... ..+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3444555678999999999999999999864 2458999998654322 245699999999999999999999998
Q ss_pred eecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 379 ~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
...... .....++||||+++|+|.+++...... .....+++..++.|+.++++||.||| +.+|+||||||+||
T Consensus 106 ~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NI 178 (313)
T 3brb_A 106 IEMSSQ-GIPKPMVILPFMKYGDLHTYLLYSRLE---TGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNC 178 (313)
T ss_dssp EC--------CEEEEEECCTTCBHHHHHHHTTBT---TSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGE
T ss_pred eecccc-CCcccEEEEecccCCCHHHHHHHhhhh---cCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceE
Confidence 743211 123469999999999999998433211 12457999999999999999999999 88999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCC
Q 005691 459 LLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSP 536 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~ 536 (683)
|++.++.+||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 255 (313)
T 3brb_A 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--- 255 (313)
T ss_dssp EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---
Confidence 9999999999999999876543322 2334567889999999999999999999999999999999 8888864322
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
. .. ......+... . .+......+.+++..|++.||++|||+.+++++|+..
T Consensus 256 --~---~~-~~~~~~~~~~-----~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 256 --H---EM-YDYLLHGHRL-----K----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp --G---GH-HHHHHTTCCC-----C----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --H---HH-HHHHHcCCCC-----C----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 11 1112222110 0 1112234678899999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=336.58 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=203.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
..++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++. .+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~ 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR------EGN 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE------ETT
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE------cCC
Confidence 3468999999999999999999976 689999999875433 33467999999999999999999999987 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++.. ...+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBT---------TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEEecCCCcHHHHHhh---------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEE
Confidence 78999999999999999832 346899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCc-cccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 469 ADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 469 aDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
+|||+++....... .......||..|+|||.+....+ +.++||||||++++||++|+.||....... .....|
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~-- 221 (276)
T 2yex_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDW-- 221 (276)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHH--
T ss_pred eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHh--
Confidence 99999987643322 22345679999999999987665 789999999999999999999997543221 111111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+... .. ........+.+++..|++.||++|||+.|+++
T Consensus 222 ---~~~~~~--~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 222 ---KEKKTY--LN------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---HTTCTT--ST------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---hhcccc--cC------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 111110 00 11122345678999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.31 Aligned_cols=244 Identities=23% Similarity=0.320 Sum_probs=201.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~------~~~ 79 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ------DAQ 79 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE------CSS
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE------eCC
Confidence 67889999999999999999975 68999999997542 234567889999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 147 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK---------SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI 147 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH---------TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEE
Confidence 89999999999999999942 346899999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .......
T Consensus 148 ~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i 215 (318)
T 1fot_A 148 TDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKI 215 (318)
T ss_dssp CCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred eecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 999999865432 3346799999999999999999999999999999999999999964221 1111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
. .+.. .+ +......+..++..|++.||++|| ++.++++
T Consensus 216 ~-~~~~------~~----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 216 L-NAEL------RF----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp H-HCCC------CC----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred H-hCCC------CC----------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 1111 01 111234567888999999999999 8898874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.58 Aligned_cols=264 Identities=27% Similarity=0.436 Sum_probs=206.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc--------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ--------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
.++|...+.||+|+||.||+|... ++..||||++..... ...+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence 478999999999999999999863 467899999875432 2345689999999999 8999999999986
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.....++||||+++|+|.+++....... .......++|..++.++.|++.||+||| +.+|+|||||
T Consensus 112 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlk 184 (334)
T 2pvf_A 112 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 184 (334)
T ss_dssp ----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred ----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCc
Confidence 5567899999999999999995432110 0011245899999999999999999999 8899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999999999876543322 2344567889999999999999999999999999999999 999986422
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
. .+ ....+..+... .. +......+.+++..|++.+|++|||+.++++.|+..
T Consensus 265 ~--------~~-~~~~~~~~~~~-----~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 265 V--------EE-LFKLLKEGHRM-----DK----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp H--------HH-HHHHHHHTCCC-----CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--------HH-HHHHHhcCCCC-----CC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11 11222222111 01 111234677899999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.79 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=204.4
Q ss_pred cCcccce-eeeecCceEEEEEEEc---CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKN-FIGRGGFGLVYKGILQ---DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~-~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+ .||+|+||.||+|+.. ++..||||++..... ...+++.+|++++++++||||+++++++. .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------~ 81 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-------A 81 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-------S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-------C
Confidence 4555655 8999999999999864 578899999976432 33567999999999999999999999983 3
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ....+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVG--------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTT--------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred CCcEEEEEeCCCCCHHHHHHh--------CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEE
Confidence 458999999999999999842 2346999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 468 VADFGLAKQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
|+|||+++......... .....||+.|+|||.+....++.++||||||+++|||++ |+.||..... . +
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~---~- 221 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P---E- 221 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----H---H-
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----H---H-
Confidence 99999998765433322 233457899999999998899999999999999999999 9999864322 1 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.......+... .+ +......+.+++..|++.||++||++.++++.|+...
T Consensus 222 ~~~~i~~~~~~-----~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 222 VMAFIEQGKRM-----EC----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HHHHHHTTCCC-----CC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCcC-----CC----------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11222222111 11 1122346778999999999999999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=366.69 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=203.0
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
...++|...+.||+|+||.||+++.. +|+.+|+|++...... ..+.+.+|++++++++|||||++++++. .
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~ 81 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS------E 81 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE------C
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE------E
Confidence 34678999999999999999999864 6899999998764432 2456899999999999999999999987 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec---cC
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD---AD 463 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd---~~ 463 (683)
....++||||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++ .+
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~---------~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVA---------REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHH---------CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTT
T ss_pred CCEEEEEEEeCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCC
Confidence 6789999999999999998842 346999999999999999999999 88999999999999998 45
Q ss_pred CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 464 MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
+.+||+|||+++....... ......||+.|+|||.+....++.++|||||||++|||++|+.||..... .
T Consensus 150 ~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---------~ 219 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---------H 219 (444)
T ss_dssp CCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------H
T ss_pred CcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---------H
Confidence 7899999999987654332 23446799999999999999999999999999999999999999964221 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
-....+..+... ...+. .......+.+++..|++.||++|||+.|+++
T Consensus 220 ~~~~~i~~~~~~-~~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 220 RLYQQIKAGAYD-FPSPE-----------WDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHTCCC-CCTTT-----------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhCCCC-CCccc-----------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 112222232221 00111 1122346778999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=337.62 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++. .+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~ 81 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE------DNTDI 81 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE------CSSEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCeE
Confidence 467999999999999999999976 47789999998776667788999999999999999999999997 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---ccCCcEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRAR 467 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL---d~~~~~K 467 (683)
++||||+++++|.+++.. ...+++..++.|+.+++.||+||| +.+|+||||||+|||+ +.++.+|
T Consensus 82 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~ 149 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVH---------KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLK 149 (277)
T ss_dssp EEEEECCCSCBHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEeccCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEE
Confidence 999999999999998842 346899999999999999999999 8899999999999999 8889999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... .....||+.|+|||.+.+ .++.++||||||++++||++|+.||..... .....
T Consensus 150 l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~~ 217 (277)
T 3f3z_A 150 LIDFGLAARFKPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---------SEVML 217 (277)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH
T ss_pred EEecccceeccCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---------HHHHH
Confidence 999999987654332 234579999999998764 599999999999999999999999964321 11112
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+.... +. . ........+..++..|++.||++|||+.++++
T Consensus 218 ~~~~~~~~~---~~---~------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 218 KIREGTFTF---PE---K------DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHCCCCC---CH---H------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHhCCCCC---Cc---h------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222221100 00 0 00012346778999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.93 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=195.6
Q ss_pred cccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 315 FSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 315 f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
|...+.||+|+||.||+|+.. +|+.||||++........+++.+|++++++++|||||++++++. .....++|
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~------~~~~~~lv 164 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE------SKNDIVLV 164 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE------CSSEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE------ECCEEEEE
Confidence 344678999999999999974 68999999998766555678999999999999999999999997 56789999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee--ccCCcEEEccc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL--DADMRARVADF 471 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL--d~~~~~KLaDF 471 (683)
|||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 165 ~E~~~~~~L~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DF 233 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE--------SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDF 233 (373)
T ss_dssp EECCTTCEEHHHHHHT--------GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCC
T ss_pred EeCCCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeC
Confidence 9999999999988422 246899999999999999999999 8899999999999999 56789999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+++....... .....||+.|+|||++..+.++.++|||||||++|||++|+.||..... .+........
T Consensus 234 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~ 303 (373)
T 2x4f_A 234 GLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILAC 303 (373)
T ss_dssp SSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHT
T ss_pred CCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc
Confidence 99987654332 2335699999999999999999999999999999999999999964321 1111111111
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.. ...++. .......+.+++..|++.||++|||+.|+++
T Consensus 304 -~~-~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 304 -RW-DLEDEE-----------FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -CC-CSCSGG-----------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cC-CCChhh-----------hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 000000 1122346778999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=365.44 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=192.2
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...++||+|+||.||+++.. +|+.||||++... .......+.+|+++++.++||||+++++++. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~------~~ 220 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ------TH 220 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE------ET
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe------eC
Confidence 468999999999999999999965 6899999999753 2333456889999999999999999999997 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCCceeeccCCcE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKpsNILLd~~~~~ 466 (683)
...++||||+++|+|.+++.. ...+++..++.++.|++.||+||| + .+|+||||||+||||+.++.+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSR---------ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHH---------HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCE
T ss_pred CEEEEEEeeCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCE
Confidence 679999999999999999832 347899999999999999999999 6 899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 289 kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~- 358 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLF- 358 (446)
T ss_dssp EECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH-
T ss_pred EEccCCCceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHH-
Confidence 9999999986443322 23447899999999999999999999999999999999999999964221 1111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
.....+.. .+ +......+..++..|++.||++|| ++.|+++
T Consensus 359 ~~i~~~~~------~~----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 359 ELILMEEI------RF----------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHCCC------CC----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHhCCC------CC----------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11111111 01 111234567899999999999999 9999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=384.10 Aligned_cols=246 Identities=27% Similarity=0.372 Sum_probs=196.4
Q ss_pred eeeeecCceEEEEEEEc---CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQ---DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||.||+|.+. .++.||||+++.... ...++|.+|++++++++|||||+++|+|. ....++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-------~~~~~lv 447 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-------AESWMLV 447 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-------SSSEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-------cCCEEEE
Confidence 47999999999999763 467899999976433 23568999999999999999999999984 3458999
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++. ....++|..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 448 ~E~~~~g~L~~~l~---------~~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 448 MEMAELGPLNKYLQ---------QNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp EECCTTEEHHHHHH---------HCTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred EEccCCCCHHHHHh---------hCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 99999999999993 2346999999999999999999999 78999999999999999999999999999
Q ss_pred ccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 474 AKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 474 a~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
++........ ..+...||+.|+|||++....++.++|||||||++|||++ |+.||..... ..+...+.
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---------~~~~~~i~ 586 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLE 586 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHH
T ss_pred ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHH
Confidence 9877544322 2334567889999999999999999999999999999998 9999964321 11223333
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+.... .+..+...+.+++..|++.||++|||+.+|+++|+.
T Consensus 587 ~~~~~~---------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 587 KGERMG---------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TTCCCC---------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCCCCC---------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 332111 111223567889999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=358.80 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=193.4
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--------cChHHHHHHHHHHHhccCCCcccccceee
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--------QGDAEFCNEVEIISNLKHRNLVPLRGCCV 379 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--------~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~ 379 (683)
....++|...+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++|||||++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345689999999999999999999975 578999999875421 11234889999999999999999999974
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
....++||||+++|+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+|||
T Consensus 211 -------~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIl 271 (419)
T 3i6u_A 211 -------AEDYYIVLELMEGGELFDKVVG---------NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVL 271 (419)
T ss_dssp -------SSEEEEEEECCTTCBGGGGTSS---------SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred -------cCceEEEEEcCCCCcHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEE
Confidence 3468999999999999998842 347999999999999999999999 789999999999999
Q ss_pred eccC---CcEEEcccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 460 LDAD---MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 460 Ld~~---~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
++.+ +.+||+|||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 272 l~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 272 LSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp ESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred EecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 9654 45999999999876532 2334567999999999986 36788999999999999999999999974332
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.. .+ ...+..+.... .+.. ..+....+.+++..|++.||++|||+.|+++
T Consensus 350 ~~----~~----~~~i~~~~~~~--~~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 350 QV----SL----KDQITSGKYNF--IPEV----------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SC----CH----HHHHHTTCCCC--CHHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hH----HH----HHHHhcCCCCC--Cchh----------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11 11 12222222110 0000 0122456788999999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=360.26 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=204.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+|+.. +|+.||+|.+..........+.+|++++++++|||||++++++. .....
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~------~~~~~ 123 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE------DKYEM 123 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE------CSSEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE------eCCEE
Confidence 468999999999999999999975 68899999987655444567999999999999999999999987 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc--CCcEEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA--DMRARV 468 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~--~~~~KL 468 (683)
++||||+++|+|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+|||++. ++.+||
T Consensus 124 ~lv~E~~~gg~L~~~l~~--------~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL 192 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAA--------EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKI 192 (387)
T ss_dssp EEEEECCCCCBHHHHTTC--------TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEE
T ss_pred EEEEEcCCCCcHHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEE
Confidence 999999999999999842 1246899999999999999999999 889999999999999974 478999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||..... .+....
T Consensus 193 ~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~- 261 (387)
T 1kob_A 193 IDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQN- 261 (387)
T ss_dssp CCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHH-
T ss_pred EecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHH-
Confidence 99999987654332 2345799999999999999999999999999999999999999964321 111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+..+.. ..++.. .......+.+++..|++.||++|||+.|+++.
T Consensus 262 i~~~~~--~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 262 VKRCDW--EFDEDA----------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHCCC--CCCSST----------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhCCC--CCCccc----------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111 011111 11223467789999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=360.26 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=191.3
Q ss_pred CcccceeeeecCceEEEEEEEc--CC--cEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ--DG--TTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~--~g--~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.|...++||+|+||.||+|++. ++ ..||||.+..... ...++|.+|+.++++++|||||+++++|.. ...
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-----SEG 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC-----CSS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCC
Confidence 4667789999999999999864 22 3689998865332 334679999999999999999999999853 345
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ....+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL 233 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRN--------ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKV 233 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHC--------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred CeEEEEECCCCCCHHHHHhh--------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEE
Confidence 68999999999999999943 2346889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCc---cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 469 ADFGLAKQSREGQS---HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 469 aDFGla~~~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
+|||+++....... .......+|..|+|||.+....++.++||||||+++|||++ |.+||...... .+..
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~~~- 307 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITV- 307 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CHHH-
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HHHH-
Confidence 99999986643321 12334567889999999999999999999999999999999 66676543221 1111
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
....+... . .+......+.+++..|++.||++|||+.++++.|+..
T Consensus 308 ---~~~~~~~~--~-------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 308 ---YLLQGRRL--L-------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---HHHTTCCC--C-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHcCCCC--C-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11222110 0 1111234677899999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=353.70 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=199.7
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++. ..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~------~~ 81 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT------TP 81 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE------CS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE------eC
Confidence 36889999999999999999997 578999999986532 223457899999999999999999999987 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+ +|+|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~---------~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVE---------KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEE
T ss_pred CEEEEEEECC-CCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEE
Confidence 7899999999 7899888832 346999999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+++....+.. .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+....... .
T Consensus 149 l~DFG~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------~ 217 (336)
T 3h4j_B 149 IADFGLSNIMTDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------F 217 (336)
T ss_dssp ECCSSCTBTTTTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------B
T ss_pred EEEeccceeccCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------H
Confidence 999999987654332 334579999999999987776 7899999999999999999999975322110 0
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.....+.. . .+......+.+++..|++.||.+|||+.|+++.
T Consensus 218 ~~i~~~~~------~----------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 218 KKVNSCVY------V----------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCSSCC------C----------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HHHHcCCC------C----------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111100 0 111123456789999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=350.22 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=197.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcE----EEEEEeecc-CccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTT----VAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~----VAVK~l~~~-~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
.++|...++||+|+||.||+|+.. +++. ||+|.+... .....+++.+|+.++++++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------ 87 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL------ 87 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE------
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe------
Confidence 357899999999999999999964 4443 577777543 3344678999999999999999999999996
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
....++|+||+++|+|.+++... ...+++..++.|+.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 88 -~~~~~~v~~~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 88 -TSTVQLITQLMPFGCLLDYVREH--------KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp -SSSEEEEECCCSSCBHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTE
T ss_pred -cCCceEEEEecCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCC
Confidence 23488999999999999998432 346899999999999999999999 889999999999999999999
Q ss_pred EEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 466 ARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~-- 228 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEI-- 228 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH--
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHH--
Confidence 999999999876543322 2334567889999999999999999999999999999999 9999964322 111
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
...+..+.... .+......+.+++..|++.||++|||+.|+++.|+...
T Consensus 229 --~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 229 --SSILEKGERLP---------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --HHHHHTTCCCC---------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHcCCCCC---------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 12222221100 11112345778999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.47 Aligned_cols=262 Identities=17% Similarity=0.177 Sum_probs=203.2
Q ss_pred hcCcccceeeeecCceEEEEEEEcC---------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCccc---------
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD---------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVP--------- 373 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~---------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~--------- 373 (683)
.++|...+.||+|+||.||+|+... ++.||||.+... +.+.+|++++++++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999764 789999998653 46889999999999999998
Q ss_pred ------ccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC
Q 005691 374 ------LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA 447 (683)
Q Consensus 374 ------L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~ 447 (683)
+++++.. .+...++||||+ +|+|.+++... ....+++..++.|+.|++.||+||| +.+
T Consensus 116 ~~~i~~~~~~~~~-----~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ 179 (352)
T 2jii_A 116 LLAIPTCMGFGVH-----QDKYRFLVLPSL-GRSLQSALDVS-------PKHVLSERSVLQVACRLLDALEFLH---ENE 179 (352)
T ss_dssp TCSCCCCCEEEEE-----TTTEEEEEEECC-CEEHHHHHHHS-------GGGCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred ccCccchhhcccc-----CCcEEEEEecCC-CcCHHHHHHhC-------CcCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 4556542 356889999999 99999999432 1357999999999999999999999 789
Q ss_pred ccccCCCCCceeeccCC--cEEEcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHH
Q 005691 448 IYHRDIKATNILLDADM--RARVADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVIL 519 (683)
Q Consensus 448 IiHrDIKpsNILLd~~~--~~KLaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLl 519 (683)
|+||||||+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|
T Consensus 180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 99999999999999998 9999999999876543321 123457999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005691 520 EIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS 599 (683)
Q Consensus 520 ELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~ 599 (683)
||++|+.||....... ..+........ ....+..+..... ......+.+++..|++.||++|||+.
T Consensus 260 el~~g~~pf~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~ 325 (352)
T 2jii_A 260 KWLYGFLPWTNCLPNT---EDIMKQKQKFV--DKPGPFVGPCGHW---------IRPSETLQKYLKVVMALTYEEKPPYA 325 (352)
T ss_dssp HHHHSCCTTGGGTTCH---HHHHHHHHHHH--HSCCCEECTTSCE---------ECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHHhCCCCcccCCcCH---HHHHHHHHhcc--CChhhhhhhcccc---------CCCcHHHHHHHHHHHhCChhhCCCHH
Confidence 9999999997543211 11111111111 1111122211111 11234677899999999999999999
Q ss_pred HHHHHHhcC
Q 005691 600 DALKMLEGD 608 (683)
Q Consensus 600 eVl~~L~~~ 608 (683)
+|+++|+..
T Consensus 326 ~l~~~L~~~ 334 (352)
T 2jii_A 326 MLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=352.00 Aligned_cols=249 Identities=26% Similarity=0.330 Sum_probs=200.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++++.++|||||++++++. ...
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~------~~~ 88 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ------DEE 88 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE------CSS
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE------eCC
Confidence 67899999999999999999976 58899999986532 334567899999999999999999999997 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++..++.++.+++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQ---------NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHT---------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEE
Confidence 89999999999999999842 346999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc---CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .....
T Consensus 157 ~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~ 229 (384)
T 4fr4_A 157 TDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIV 229 (384)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHH
T ss_pred eccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHH
Confidence 9999998765432 2345689999999999874 458999999999999999999999997543221 11111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-ISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-m~eVl~ 603 (683)
........ . .+......+..++..|++.||++||+ +.+|.+
T Consensus 230 -~~~~~~~~------~----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 230 -HTFETTVV------T----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -HHHHHCCC------C----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -HHHhhccc------C----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11111110 0 11122346788999999999999998 777764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.08 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCceEEEEEEE----cCCcEEEEEEeeccC----ccChHHHHHHHHHHHhc-cCCCcccccceeeecC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKVIESD----FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDG 382 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l----~~g~~VAVK~l~~~~----~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~ 382 (683)
.++|...++||+|+||.||+++. .+|+.||||++.... ....+.+.+|++++.++ +|+||+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--- 129 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--- 129 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe---
Confidence 36899999999999999999997 368999999986532 23345678899999999 6999999999987
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.....++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+|+||||||+|||++.
T Consensus 130 ---~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 130 ---TETKLHLILDYINGGELFTHLSQ---------RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDS 194 (355)
T ss_dssp ---ETTEEEEEECCCCSCBHHHHHHH---------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred ---eCceEEEEeecCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECC
Confidence 45679999999999999999842 246899999999999999999999 789999999999999999
Q ss_pred CCcEEEcccCcccccccCCccccccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 463 DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
++.+||+|||+++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~ 270 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----S 270 (355)
T ss_dssp TSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----C
T ss_pred CCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----h
Confidence 9999999999998765544444555789999999999985 347899999999999999999999997543221 1
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALKML 605 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~~L 605 (683)
............ +. .+.+....+.+++..|++.||++|| ++.|+++..
T Consensus 271 ~~~~~~~~~~~~-------~~----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 271 QAEISRRILKSE-------PP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHHHHCC-------CC----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHHHhccC-------CC----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112221111110 11 1112234567899999999999999 999998755
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=349.43 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=191.2
Q ss_pred hcCcccceeeeecCceEEEEEEE----cCCcEEEEEEeeccCc----cChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDF----QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l----~~g~~VAVK~l~~~~~----~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+++. .+|+.||+|++..... .....+.+|++++++++||||+++++++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 91 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ---- 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence 36789999999999999999997 4789999999876432 23456889999999999999999999987
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.....++||||+++|+|.+++.. ...+++...+.++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 92 --~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 92 --TGGKLYLILEYLSGGELFMQLER---------EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp --CSSCEEEEEECCTTEEHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTT
T ss_pred --cCCEEEEEEeCCCCCcHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCC
Confidence 56789999999999999999832 346889999999999999999999 7899999999999999999
Q ss_pred CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 464 MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
+.+||+|||+++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||..... ..
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~ 228 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KK 228 (327)
T ss_dssp SCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HH
T ss_pred CcEEEEeCCcccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HH
Confidence 9999999999986543222 23446799999999999999999999999999999999999999964221 11
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
...... .+.. .+ +......+.+++..|++.||++|| ++.++++
T Consensus 229 ~~~~i~-~~~~------~~----------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 229 TIDKIL-KCKL------NL----------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHH-HTCC------CC----------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHH-hCCC------CC----------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111111 1111 01 111234567889999999999999 7778765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.63 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+++.. +++.||+|.+.... .....+.+|+++++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~------~~~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE------SMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE------ETTEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe------cCCEE
Confidence 468999999999999999999976 57889999886432 33456889999999999999999999997 45689
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc--CCcEEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA--DMRARV 468 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~--~~~~KL 468 (683)
++||||+++|+|.+++.. ....+++..++.++.|++.||.||| +.+|+||||||+|||++. ++.+||
T Consensus 77 ~lv~e~~~g~~L~~~l~~--------~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 77 VMIFEFISGLDIFERINT--------SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEEECCCCCCBHHHHHTS--------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEEeCCCCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEE
Confidence 999999999999999832 2246899999999999999999999 889999999999999987 789999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....+.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+....
T Consensus 146 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~- 214 (321)
T 1tki_A 146 IEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIEN- 214 (321)
T ss_dssp CCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH-
T ss_pred EECCCCeECCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHH-
Confidence 99999987654332 3346789999999999988899999999999999999999999964321 111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+..+... .++. ...+....+.+++..|++.||++|||+.|+++.
T Consensus 215 i~~~~~~--~~~~----------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 215 IMNAEYT--FDEE----------AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTCCC--CCHH----------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHcCCCC--CChh----------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111110 0000 011224467789999999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.89 Aligned_cols=268 Identities=19% Similarity=0.245 Sum_probs=197.0
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...++||+|+||+||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++. .+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH------SDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE------ETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE------eCCE
Confidence 57889999999999999999975 58999999997644332 367889999999999999999999987 4568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++ +|.+++.. ....+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~-~l~~~~~~--------~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~ 143 (292)
T 3o0g_A 76 LTLVFEFCDQ-DLKKYFDS--------CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEEECCSE-EHHHHHHH--------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCC-CHHHHHHh--------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEe
Confidence 9999999986 44444421 2346999999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCC-CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||+++....... ......||+.|+|||.+.+.. ++.++|||||||+++||++|+.|+...... ......+.+.
T Consensus 144 Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~----~~~~~~i~~~ 218 (292)
T 3o0g_A 144 NFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRL 218 (292)
T ss_dssp CCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH----HHHHHHHHHH
T ss_pred ecccceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH----HHHHHHHHHH
Confidence 9999987643322 234467899999999998766 799999999999999999999886422111 0011111111
Q ss_pred hhc---Cc---cccccCcc---ccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKA---GK---VWQALDPS---LLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~---g~---l~e~vD~~---l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... .. ..+..+.. ..................+.+++..|++.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 100 00 00000000 000000000011123446778999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=338.81 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=205.4
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCC-----
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD----- 383 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~----- 383 (683)
...++|...+.||+|+||.||+|+.. +|+.||||++.... +.+.+|++++++++||||+++++++.....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34568999999999999999999986 79999999986543 457789999999999999999998753110
Q ss_pred -----CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 384 -----NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 384 -----~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
.......++||||+++|+|.+++... ....+++..++.|+.|++.||.||| +.+|+||||||+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Ni 153 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-------RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNI 153 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG-------GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc-------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHE
Confidence 01245589999999999999999432 1346899999999999999999999 78999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 459 LLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
|++.++.+||+|||+++....... .....||+.|+|||.+....++.++||||||+++|||++|..|+...
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 224 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------- 224 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------
T ss_pred EEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------
Confidence 999999999999999987654332 23457999999999999999999999999999999999999886311
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCCC
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEVP 612 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~~~ 612 (683)
.. .+.....+.+. .. ....+..++..|++.||++|||+.|+++.|+.....+
T Consensus 225 ---~~-~~~~~~~~~~~--------~~----------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 225 ---SK-FFTDLRDGIIS--------DI----------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ---HH-HHHHHHTTCCC--------TT----------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ---HH-HHHHhhccccc--------cc----------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 01 11222222111 11 1234668889999999999999999999998754433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=350.85 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=196.4
Q ss_pred cCcccceeeeecCceEEEEEEEcC-----CcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-----g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|...+.||+|+||.||+|+... +..||||++..... .....+.+|++++++++||||+++++++. .
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~ 117 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS------K 117 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe------c
Confidence 456678899999999999998753 23599999875432 22456899999999999999999999986 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++... ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~ 186 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREK--------DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 186 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT--------TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred CCCcEEEEeCCCCCcHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcE
Confidence 56799999999999999998421 346899999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhh
Q 005691 467 RVADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~ 543 (683)
||+|||+++........ ......+|..|+|||.+....++.++||||||+++|||++ |+.||..... .
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---------~ 257 (333)
T 1mqb_A 187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---------H 257 (333)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------H
T ss_pred EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---------H
Confidence 99999999876543222 2233456889999999999999999999999999999999 9999863221 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
-+...+..+.... .+......+.+++..|++.||++||++.+|+++|+..
T Consensus 258 ~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 258 EVMKAINDGFRLP---------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHHHHHHTTCCCC---------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHCCCcCC---------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122222221100 0112234677899999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=339.29 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=198.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 81 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH------DA 81 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE------CS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe------cC
Confidence 568999999999999999999876 57789999986532 223567899999999999999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~ 149 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQK---------LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELK 149 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEE
Confidence 789999999999999999832 246899999999999999999999 89999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||..... .....
T Consensus 150 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~ 217 (279)
T 3fdn_A 150 IADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------QETYK 217 (279)
T ss_dssp ECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHH
T ss_pred EEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---------HHHHH
Confidence 99999986544322 2345789999999999999999999999999999999999999863221 11111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
....... .+ +......+.+++..|++.||++|||+.|+++.
T Consensus 218 ~~~~~~~------~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 218 RISRVEF------TF----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHTCC------CC----------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHhCCC------CC----------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111 11 11123456788999999999999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.55 Aligned_cols=250 Identities=19% Similarity=0.253 Sum_probs=178.7
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCeeEEEEe
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
.++||+|+||.||+++.. +|+.||||++... ....+.+|+.++..++ ||||+++++++. .....++|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~------~~~~~~lv~e 86 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH------DQLHTFLVME 86 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE------CSSEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE------cCCEEEEEEE
Confidence 478999999999999975 6899999998653 3567889999999997 999999999997 5678999999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC---cEEEcccC
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM---RARVADFG 472 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~---~~KLaDFG 472 (683)
|+++|+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++ .+||+|||
T Consensus 87 ~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 87 LLNGGELFERIKK---------KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp CCCSCBHHHHHHH---------CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred ccCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 9999999999942 347999999999999999999999 88999999999999997665 89999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
+++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||......... ... ......+..+
T Consensus 155 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~-~~~~~~i~~~ 231 (325)
T 3kn6_A 155 FARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSA-VEIMKKIKKG 231 (325)
T ss_dssp TCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCH-HHHHHHHTTT
T ss_pred cceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccH-HHHHHHHHcC
Confidence 9986654332 233457899999999999999999999999999999999999999754332110 111 1122222232
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... .... ........+.+++..|++.||++|||+.|+++
T Consensus 232 ~~~------~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 232 DFS------FEGE------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCC------CCSH------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCC------CCcc------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 210 0000 11123456788999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=353.07 Aligned_cols=255 Identities=13% Similarity=0.151 Sum_probs=202.6
Q ss_pred HHHhcCcccceeeeecCceEEEEEE------EcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc---CCCcccccceee
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGI------LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK---HRNLVPLRGCCV 379 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~------l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~ 379 (683)
+...++|...++||+|+||+||+|+ ..+++.||||++... ...++..|++++.+++ |+|++++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456789999999999999999994 456889999998653 3567889999999887 999999999997
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
..+..++||||+++|+|.+++..... .....++|..++.|+.|++.||+||| +.+|+||||||+|||
T Consensus 138 ------~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIl 204 (365)
T 3e7e_A 138 ------FQNGSVLVGELYSYGTLLNAINLYKN----TPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFI 204 (365)
T ss_dssp ------CSSCEEEEECCCCSCBHHHHHHHHHT----STTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEE
T ss_pred ------cCCCcEEEEeccCCCcHHHHHHHhhc----ccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEE
Confidence 56778999999999999999953221 12357999999999999999999999 889999999999999
Q ss_pred ecc-----------CCcEEEcccCcccccccC-CccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCC
Q 005691 460 LDA-----------DMRARVADFGLAKQSREG-QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKA 527 (683)
Q Consensus 460 Ld~-----------~~~~KLaDFGla~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p 527 (683)
|+. ++.+||+|||+|+..... .....+...||++|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 998 899999999999765422 22334557899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHh
Q 005691 528 LDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR-PTISDALKMLE 606 (683)
Q Consensus 528 ~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~R-Ptm~eVl~~L~ 606 (683)
|....... | .++..+... .. .+.+.++...|++.+|.+| |++.++.+.|+
T Consensus 285 f~~~~~~~--------~------------~~~~~~~~~------~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 285 KVKNEGGE--------C------------KPEGLFRRL------PH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp CEEEETTE--------E------------EECSCCTTC------SS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred cccCCCCc--------e------------eechhcccc------Cc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 85322110 0 011111111 11 2345567788999999998 67888888887
Q ss_pred cC
Q 005691 607 GD 608 (683)
Q Consensus 607 ~~ 608 (683)
..
T Consensus 336 ~~ 337 (365)
T 3e7e_A 336 KV 337 (365)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=360.25 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=194.0
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--cChHHHHHHHHHHHhcc--CCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLK--HRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~--H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||++...+++.||||++..... +..+.+.+|++++.+++ |+|||++++++. ...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~------~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI------TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE------CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe------cCC
Confidence 46999999999999999999988899999999875432 23467999999999996 599999999987 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||| +.+++|.+++.. ...+++..++.|+.||+.||.||| +.+|+||||||+|||++ ++.+||
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl 195 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK---------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKL 195 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH---------CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEE
T ss_pred EEEEEEe-cCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEE
Confidence 7999999 578899999842 346889999999999999999999 88999999999999996 588999
Q ss_pred cccCcccccccCCcc-ccccccCCCcccCcccccc-----------CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 469 ADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALY-----------GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 469 aDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
+|||+++........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--- 272 (390)
T 2zmd_A 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--- 272 (390)
T ss_dssp CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC---
T ss_pred EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH---
Confidence 999999877544322 2345679999999999865 4689999999999999999999999964221
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
....... ++++..... .+......+.+++..|++.||++|||+.||++.
T Consensus 273 ----~~~~~~~---------~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 273 ----QISKLHA---------IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----HHHHHHH---------HHCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHH---------HhCccccCC------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0111111 112111111 001112356788999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=355.40 Aligned_cols=204 Identities=21% Similarity=0.307 Sum_probs=174.7
Q ss_pred hcCcccceeeeec--CceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRG--GFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~G--gfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...++||+| +||.||+++.. +|+.||||++...... ..+.+.+|++++++++|||||++++++. .
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------~ 97 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI------A 97 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------E
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE------E
Confidence 4678999999999 99999999986 6899999999764322 2356888999999999999999999997 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++.... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~ 167 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHF-------MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKV 167 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTC-------TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhc-------ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCE
Confidence 568999999999999999984321 246899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc------cccccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 467 RVADFGLAKQSREGQS------HLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 467 KLaDFGla~~~~~~~~------~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
||+|||++........ .......||..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999875432211 11233478999999999987 67999999999999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.56 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=205.7
Q ss_pred cCcccceeeeecCceEEEEEEE-----cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-----QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-----~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||++++ .+|+.||||++........+.+.+|++++++++|+||+++++++... ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 116 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA----GR 116 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec----CC
Confidence 5688899999999999999984 36889999999776555567899999999999999999999998632 23
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHS--------TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEE
T ss_pred CceEEEEECCCCCCHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEE
Confidence 4689999999999999999432 246899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC-------CCCCc
Q 005691 468 VADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS-------GSPRA 538 (683)
Q Consensus 468 LaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~-------~~~~~ 538 (683)
|+|||+++........ ......+|..|+|||.+....++.++||||||+++|||++|+.|+..... .....
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch
Confidence 9999999876544322 12345678889999999998999999999999999999999998753210 00000
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..........+..+... . .+......+.+++..|++.||++|||+.+|++.|+.
T Consensus 266 ~~~~~~~~~~~~~~~~~---------~------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRL---------P------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHHHHHHHTTCCC---------C------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCC---------C------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00001111111111100 0 112234567889999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.60 Aligned_cols=274 Identities=23% Similarity=0.257 Sum_probs=199.0
Q ss_pred HhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc-----ChHHHHHHHHHHHhcc---CCCcccccceeeec
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ-----GDAEFCNEVEIISNLK---HRNLVPLRGCCVVD 381 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~-----~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~~~ 381 (683)
.+++|...++||+|+||+||+|+. .+|+.||||++...... ....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999996 46899999998753321 2346788888888775 99999999999743
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.. ......++||||++ |+|.+++.... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++
T Consensus 87 ~~-~~~~~~~lv~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 87 RT-DREIKVTLVFEHVD-QDLRTYLDKAP-------PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVT 154 (308)
T ss_dssp CS-SSEEEEEEEEECCC-CBHHHHHHTCC-------TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEEC
T ss_pred CC-CCceeEEEEehhhh-cCHHHHHhhcc-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEc
Confidence 21 12235799999997 69999984321 234999999999999999999999 88999999999999999
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
.++.+||+|||+++...... ......||+.|+|||.+....++.++|||||||++|||++|+.||...... ..
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~ 227 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQ 227 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-----HH
T ss_pred CCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence 99999999999998764332 234567999999999999999999999999999999999999999643221 11
Q ss_pred hhhhhhhhhc---Ccccc---ccCcccccccc-ccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 542 TDWVWSLVKA---GKVWQ---ALDPSLLKEDD-FLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 542 ~~~v~~~~~~---g~l~e---~vD~~l~~~~~-~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+...... ..... ..+..+..... .......+..+.+.+++..|++.||++|||+.|+++
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111111100 00000 00000000000 000000122356788999999999999999999885
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=338.52 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=180.5
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|++++++++||||+++++++. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 83 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE------DS 83 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE------CS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc------cC
Confidence 46789999999999999999997 478999999986532 223467999999999999999999999987 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNR--------VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTC--------SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEE
T ss_pred CeEEEEEecCCCCcHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEE
Confidence 7899999999999999998422 246899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||........ + ..
T Consensus 153 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~----~~ 223 (278)
T 3cok_A 153 IADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----L----NK 223 (278)
T ss_dssp ECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------
T ss_pred EEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----H----HH
Confidence 999999987643222 12345789999999999998999999999999999999999999875332110 0 00
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.. .. +..+ +......+.+++..|++.||++|||+.++++
T Consensus 224 ~~-~~------~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 224 VV-LA------DYEM----------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC-SS------CCCC----------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Hh-hc------ccCC----------ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 00 0011 1112345678999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.47 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=196.6
Q ss_pred cCccc-ceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQ-KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~-~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
+.|.. .++||+|+||.||+++.. +++.||||++........+.+.+|++++.++ +||||+++++++. ....
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~------~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE------EEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE------ETTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe------eCCE
Confidence 46666 368999999999999954 6899999999876666677899999999995 7999999999987 4568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc---E
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR---A 466 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~---~ 466 (683)
.++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++. +
T Consensus 86 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~ 153 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHK---------RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPV 153 (316)
T ss_dssp EEEEEECCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred EEEEEEcCCCCcHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCce
Confidence 9999999999999999842 346899999999999999999999 789999999999999998776 9
Q ss_pred EEcccCcccccccCCc------cccccccCCCcccCcccccc-----CCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 467 RVADFGLAKQSREGQS------HLTTRVAGTHGYLAPEYALY-----GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 467 KLaDFGla~~~~~~~~------~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
||+|||+++....... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......+
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 233 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence 9999999976542211 11223569999999999875 568999999999999999999999997544322
Q ss_pred CCcc---ch---hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 536 PRAC---LI---TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 536 ~~~~---~l---~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.... .. .......+..+.. .+... ........+.+++..|++.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 234 CGWDRGEACPACQNMLFESIQEGKY------EFPDK------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp SCC----CCHHHHHHHHHHHHHCCC------CCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccccchhHHHHHHHHHhccCc------ccCch------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1000 00 0001111111111 00000 001123467889999999999999999999873
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=355.22 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=201.3
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~ 383 (683)
....++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+..|.+++..+ +||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~---- 88 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ---- 88 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE----
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE----
Confidence 344678999999999999999999986 58899999997642 23456688999999987 9999999999987
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.....++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.+
T Consensus 89 --~~~~~~lv~E~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~ 154 (345)
T 1xjd_A 89 --TKENLFFVMEYLNGGDLMYHIQS---------CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKD 154 (345)
T ss_dssp --CSSEEEEEEECCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTT
T ss_pred --eCCEEEEEEeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCC
Confidence 56789999999999999999832 246899999999999999999999 8899999999999999999
Q ss_pred CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 464 MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
+.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+
T Consensus 155 g~vkL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~ 225 (345)
T 1xjd_A 155 GHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EE 225 (345)
T ss_dssp SCEEECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH
T ss_pred CCEEEeEChhhhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HH
Confidence 9999999999986533222 24457899999999999999999999999999999999999999964221 11
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS-DAL 602 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~-eVl 602 (683)
....+..+.. .+ +......+..++..|++.||++||++. +|+
T Consensus 226 -~~~~i~~~~~------~~----------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 226 -LFHSIRMDNP------FY----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -HHHHHHHCCC------CC----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -HHHHHHhCCC------CC----------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111222211 11 111234567889999999999999997 664
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=342.12 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=199.5
Q ss_pred CcccceeeeecCceEEEEEEEcC-C---cEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQD-G---TTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~-g---~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.|...++||+|+||.||+|+..+ + ..||+|++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP-----PEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-----SSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec-----CCC
Confidence 45566899999999999998643 2 2799999865433 234678999999999999999999999862 233
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+.+|+|.+++.. ....+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl 165 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRS--------PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKV 165 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHC--------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred CcEEEEecccCCCHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEe
Confidence 45899999999999999943 2356899999999999999999999 789999999999999999999999
Q ss_pred cccCcccccccCCc---cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 469 ADFGLAKQSREGQS---HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 469 aDFGla~~~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+...... ..+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~---- 237 (298)
T 3pls_A 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDL---- 237 (298)
T ss_dssp CCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGH----
T ss_pred CcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHH----
Confidence 99999986543321 2234467899999999999999999999999999999999976664322111 111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
......+.... .+......+.+++..|++.||.+|||+.+++++|+..
T Consensus 238 ~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 238 THFLAQGRRLP---------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp HHHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCCCCC---------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122221100 1111234677899999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=338.62 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=201.7
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|++++++++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ------EES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------CSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE------cCC
Confidence 578999999999999999999975 5889999998764322 2356889999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc---
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR--- 465 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~--- 465 (683)
..++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+||+++.++.
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~ 146 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVA---------REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAA 146 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCC
T ss_pred EEEEEEecCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCc
Confidence 78999999999999888832 346899999999999999999999 889999999999999987665
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||++........ .....||+.|+|||.+....++.++||||||+++|||++|+.||..... . . .
T Consensus 147 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~---~-~ 215 (284)
T 3kk8_A 147 VKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----H---R-L 215 (284)
T ss_dssp EEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---H-H
T ss_pred EEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----h---H-H
Confidence 99999999976654322 2346799999999999999999999999999999999999999864221 1 1 1
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
......+... ...+. .......+.+++..|++.||++|||+.|+++
T Consensus 216 ~~~~~~~~~~-~~~~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 216 YAQIKAGAYD-YPSPE-----------WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHTCCC-CCTTT-----------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhcccc-CCchh-----------hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122222110 00111 0122345678999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=352.75 Aligned_cols=247 Identities=31% Similarity=0.435 Sum_probs=198.2
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.+.|...+.||+|+||.||+|+. .+|+.||||++....... .+++.+|++++++++|||||++++++. ..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~ 126 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL------RE 126 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------ET
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------EC
Confidence 35688899999999999999996 578999999997643332 346889999999999999999999997 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||++ |+|.+++.. ....+++..++.|+.++++||+||| +.+|+||||||+|||++.++.+|
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~--------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 194 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEV--------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK 194 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHH--------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEE
T ss_pred CeEEEEEecCC-CCHHHHHHH--------hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 68999999997 678777732 2357999999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
|+|||+++..... ....||+.|+|||++. .+.++.++|||||||++|||++|+.||..... ...
T Consensus 195 L~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~ 261 (348)
T 1u5q_A 195 LGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSA 261 (348)
T ss_dssp ECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHH
T ss_pred EeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHH
Confidence 9999999865432 2357999999999984 57899999999999999999999999864221 122
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
......... +.+.. ....+.+..++..|++.||++|||+.++++.
T Consensus 262 ~~~~~~~~~------~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 262 LYHIAQNES------PALQS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHSCC------CCCCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHhcCC------CCCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 222222211 11111 1123456788899999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=347.80 Aligned_cols=261 Identities=19% Similarity=0.281 Sum_probs=189.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCC--CCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGD--NER 386 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~--~~~ 386 (683)
...+|...++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++..... ...
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3468999999999999999999974 68999999997766555677999999999996 9999999999864322 124
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeeccCC
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLDADM 464 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd~~~ 464 (683)
....++||||++ |+|.+++.... ....+++..++.|+.+++.||+||| +.+ |+||||||+|||++.++
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME------SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH------TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTS
T ss_pred CceEEEEEEecC-CCHHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCC
Confidence 556899999995 79988884321 2346999999999999999999999 777 99999999999999999
Q ss_pred cEEEcccCcccccccCCcc-----------ccccccCCCcccCcccc---ccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 465 RARVADFGLAKQSREGQSH-----------LTTRVAGTHGYLAPEYA---LYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~-----------~~~~~~GT~~Y~APE~~---~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
.+||+|||+++........ ......||+.|+|||.+ ....++.++||||||+++|||++|+.||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999876543221 11134689999999998 567789999999999999999999999864
Q ss_pred CCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 531 STSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 531 ~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..... .. .+... ... .......+..++..|++.||++|||+.|+++.|+..
T Consensus 256 ~~~~~--------~~-----~~~~~----~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 256 GAKLR--------IV-----NGKYS----IPP----------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp -----------------------CC----CCT----------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHH--------hh-----cCccc----CCc----------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22110 00 00000 000 001112356788999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=346.91 Aligned_cols=273 Identities=21% Similarity=0.320 Sum_probs=187.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH------TENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC------CTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE------ECCe
Confidence 457888999999999999999965 689999999975433 33467899999999999999999999986 5568
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++ |+|.+++..... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 78 ~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 78 LTLVFEFMD-NDLKKYMDSRTV---GNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp EEEEEECCC-CBHHHHHHHHHS---SSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEEecC-CCHHHHHHhccc---cccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEEC
Confidence 999999998 699988843211 112346899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||+++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 151 Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~ 224 (317)
T 2pmi_A 151 DFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-----EQLKLIFDI 224 (317)
T ss_dssp CCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHH
T ss_pred cCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHH
Confidence 9999987643322 2234578999999999876 46899999999999999999999999643221 011111110
Q ss_pred hhc--Ccc------ccccCcccccccc--c----cCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKA--GKV------WQALDPSLLKEDD--F----LSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~--g~l------~e~vD~~l~~~~~--~----~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... ... ....++.+..... . ...........+.+++..|++.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000 000 0000010000000 0 00000112346788999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=352.20 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=201.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++. ...
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~ 114 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK------DNS 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE------CSS
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE------cCC
Confidence 57889999999999999999975 68999999986532 234567899999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 182 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH---------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEE
Confidence 89999999999999999842 246899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+. ...
T Consensus 183 ~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~-~~~ 249 (350)
T 1rdq_E 183 TDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQI-YEK 249 (350)
T ss_dssp CCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH-HHH
T ss_pred cccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHH-HHH
Confidence 999999876432 2346799999999999999999999999999999999999999964221 111 122
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
+..+.. .+ +......+..++..|++.||++||+ +.+|++
T Consensus 250 i~~~~~------~~----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 250 IVSGKV------RF----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHCCC------CC----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCC------CC----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 222221 01 1112345678999999999999998 888865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=364.16 Aligned_cols=263 Identities=22% Similarity=0.260 Sum_probs=206.9
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCccccccee
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCC 378 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c 378 (683)
+.+++++...++|...++||+|+||.||+++.. +|+.||||++.+... ...+.+.+|++++..++|+|||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445666677899999999999999999999985 689999999975321 2234588999999999999999999998
Q ss_pred eecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 379 ~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
. .....++||||+++|+|.+++... ...+++..++.++.+|+.||+||| +.+|+||||||+||
T Consensus 131 ~------~~~~~~lVmE~~~gg~L~~~l~~~--------~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NI 193 (412)
T 2vd5_A 131 Q------DENYLYLVMEYYVGGDLLTLLSKF--------GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNI 193 (412)
T ss_dssp E------CSSEEEEEECCCCSCBHHHHHHHH--------SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred e------eCCEEEEEEcCCCCCcHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHe
Confidence 7 567899999999999999999421 246899999999999999999999 88999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCccccccccCCCcccCccccc-------cCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 459 LLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-------YGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-------~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
|||.++++||+|||+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||...
T Consensus 194 Lld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 273 (412)
T 2vd5_A 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD 273 (412)
T ss_dssp EECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence 9999999999999999877655444445578999999999987 467899999999999999999999999643
Q ss_pred CCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 005691 532 TSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR---PTISDALK 603 (683)
Q Consensus 532 ~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~R---Ptm~eVl~ 603 (683)
.. .+.......... ...-+.+. ......+..++..|++ +|++| |++.|+++
T Consensus 274 ~~--------~~~~~~i~~~~~--~~~~p~~~----------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 274 ST--------AETYGKIVHYKE--HLSLPLVD----------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp SH--------HHHHHHHHTHHH--HCCCC--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CH--------HHHHHHHHhccc--CcCCCccc----------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 21 111111111000 00001110 1123456788899998 99998 68999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=341.44 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=200.1
Q ss_pred hcCcccce-eeeecCceEEEEEEEc---CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 312 TDKFSQKN-FIGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 312 t~~f~~~~-~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
.++|...+ .||+|+||.||+|.+. +++.||||++....... .+++.+|++++++++||||+++++++.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------ 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence 35677777 9999999999999653 46789999987643322 467999999999999999999999983
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
....++||||+++++|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 89 -~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~ 155 (291)
T 1xbb_A 89 -AESWMLVMEMAELGPLNKYLQQ---------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHY 155 (291)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHH---------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred -CCCcEEEEEeCCCCCHHHHHHh---------CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCc
Confidence 3568999999999999999942 346899999999999999999999 889999999999999999999
Q ss_pred EEEcccCcccccccCCccc--cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchh
Q 005691 466 ARVADFGLAKQSREGQSHL--TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~ 542 (683)
+||+|||+++......... .....+|..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------- 226 (291)
T 1xbb_A 156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------- 226 (291)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------
T ss_pred EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---------
Confidence 9999999998765443322 233456789999999998899999999999999999999 9999864321
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.-+...+..+... .. +......+.+++..|++.||++||++.+|+++|++
T Consensus 227 ~~~~~~~~~~~~~-----~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 227 SEVTAMLEKGERM-----GC----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp HHHHHHHHTTCCC-----CC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHcCCCC-----CC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1122222222211 11 11223467789999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.31 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=203.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+++.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 80 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR----TNT 80 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG----GGT
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC----CCc
Confidence 468899999999999999999975 6899999999764322 245689999999999999999999988632 356
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC-----ccccCCCCCceeeccC
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA-----IYHRDIKATNILLDAD 463 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~-----IiHrDIKpsNILLd~~ 463 (683)
..++||||+++|+|.+++.... .....+++..++.|+.|++.||+||| +.+ |+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGT-----KERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHH-----HTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSS
T ss_pred eEEEEEeCCCCCCHHHHHHhhc-----ccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCC
Confidence 7899999999999999985322 12345999999999999999999999 556 9999999999999999
Q ss_pred CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 464 MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
+.+||+|||+++....... ......||..|+|||.+....++.++||||||+++|||++|+.||..... . +
T Consensus 153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~---~ 223 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----K---E 223 (279)
T ss_dssp SCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---H
T ss_pred CCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----H---H
Confidence 9999999999987654322 12335689999999999999999999999999999999999999864321 1 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
....+..+.... +. ......+.+++..|++.||++|||+.||++.+..
T Consensus 224 -~~~~i~~~~~~~-----~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 224 -LAGKIREGKFRR-----IP----------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -HHHHHHHTCCCC-----CC----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -HHHHHhhccccc-----CC----------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 112222332211 11 1123467789999999999999999999987764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=345.29 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=195.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...++||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++. ....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 76 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR------RKRR 76 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------ETTE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee------cCCe
Confidence 67899999999999999999986 58999999986643322 356889999999999999999999997 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++++|.+++. ....+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 77 ~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~ 144 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDR---------YQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLC 144 (311)
T ss_dssp EEEEEECCSEEHHHHHHH---------TSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEeCCCchHHHHHh---------hhcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEe
Confidence 999999999999998873 2346899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh-
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS- 547 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~- 547 (683)
|||+++....... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ....+..
T Consensus 145 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~ 218 (311)
T 4agu_A 145 DFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD-----QLYLIRKT 218 (311)
T ss_dssp CCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHH
T ss_pred eCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHH
Confidence 9999987653322 2334578999999999876 678999999999999999999999996432211 0000110
Q ss_pred ----------hhhcCcccc---ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 ----------LVKAGKVWQ---ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ----------~~~~g~l~e---~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+....... ..++.-..... .........+.+++..|++.||++|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 219 LGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE---LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHH---HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccccccccCcCCCccccchhh---hhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 111111100 00110000000 0001223457889999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=362.07 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=204.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++. ...
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~------~~~ 89 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS------TPS 89 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE------CSS
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE------ECC
Confidence 57888999999999999999976 79999999996542 223467899999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++++||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~---------~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK---------NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS---------SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEE
Confidence 89999999999999999932 346999999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++....+. ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||+.... ... ..
T Consensus 158 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~-~~ 226 (476)
T 2y94_A 158 ADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTL-FK 226 (476)
T ss_dssp CCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHH-HH
T ss_pred Eeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHH-HH
Confidence 9999998765432 2334579999999999988765 6899999999999999999999974321 111 12
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK--MLEGD 608 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~--~L~~~ 608 (683)
.+..+... .+......+..++..|++.||++|||+.|+++ .+...
T Consensus 227 ~i~~~~~~----------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 227 KICDGIFY----------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHTTCCC----------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHhcCCcC----------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 22222110 01112235678899999999999999999987 45543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.01 Aligned_cols=210 Identities=23% Similarity=0.291 Sum_probs=180.0
Q ss_pred ccceehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-----CCCccc
Q 005691 300 SIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-----HRNLVP 373 (683)
Q Consensus 300 ~~~f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-----H~NLV~ 373 (683)
...|++++.....++|...++||+|+||.||+|+.. +++.||||++... ....+.+..|+++++.++ |+|||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 345666666677899999999999999999999974 6889999998642 233456888999999997 999999
Q ss_pred ccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 374 L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
+++++. .....++||||+ +++|.+++.... ...+++..++.|+.|++.||+||| +.+|+||||
T Consensus 101 ~~~~~~------~~~~~~lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDl 163 (360)
T 3llt_A 101 YHGKFM------YYDHMCLIFEPL-GPSLYEIITRNN-------YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDL 163 (360)
T ss_dssp EEEEEE------ETTEEEEEECCC-CCBHHHHHHHTT-------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred ccceee------ECCeeEEEEcCC-CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCC
Confidence 999997 456899999999 999999984321 235899999999999999999999 889999999
Q ss_pred CCCceeecc-------------------------CCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCcc
Q 005691 454 KATNILLDA-------------------------DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEK 508 (683)
Q Consensus 454 KpsNILLd~-------------------------~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k 508 (683)
||+|||++. ++.+||+|||+++..... .....||+.|+|||++.+..++.+
T Consensus 164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~ 239 (360)
T 3llt_A 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVS 239 (360)
T ss_dssp SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTT
T ss_pred CcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCc
Confidence 999999975 789999999999864432 234678999999999999999999
Q ss_pred ccEEEcchhHHHHhhCCCCCCCC
Q 005691 509 SDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 509 sDVwSfGvlLlELltGr~p~~~~ 531 (683)
+|||||||++|||++|+.||...
T Consensus 240 ~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 240 SDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cchHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.33 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=192.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++|||||++++++. .....
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~~~ 91 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL------TPTHL 91 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE------CSSEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe------eCCEE
Confidence 467999999999999999999976 68999999987643 33467899999999999999999999997 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc--EEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR--ARV 468 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~--~KL 468 (683)
++||||+++|+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++. +||
T Consensus 92 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 92 AIIMEYASGGELYERICN---------AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp EEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred EEEEEeCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEE
Confidence 999999999999999832 346999999999999999999999 889999999999999988775 999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCcc-ccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEK-SDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k-sDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++...... ......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||........ .......
T Consensus 160 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~~ 233 (361)
T 3uc3_A 160 CDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQR 233 (361)
T ss_dssp CCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHHH
T ss_pred eecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHHH
Confidence 9999997543222 2234579999999999988888766 8999999999999999999975433221 1111111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
... ... .+.. .......+.+++..|++.||++|||+.|+++.
T Consensus 234 ~~~-~~~------~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 234 ILS-VKY------SIPD--------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHT-TCC------CCCT--------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred Hhc-CCC------CCCC--------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111 110 0000 00123456789999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.60 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=203.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc------ChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||.||+++.. +|+.||||.+...... ..+++.+|++++++++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 467899999999999999999976 6899999999764332 2567999999999999999999999987
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....++||||+++++|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 86 -~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 86 -NRTDVVLILELVSGGELFDFLAQ---------KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp -CSSEEEEEECCCCSCBHHHHHHT---------CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred -cCCEEEEEEEcCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCC
Confidence 56789999999999999999932 346899999999999999999999 88999999999999999888
Q ss_pred ----cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 465 ----RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 465 ----~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------- 223 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------- 223 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------
T ss_pred CCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------
Confidence 799999999987654322 2345799999999999999999999999999999999999999964221
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+... .+..+.. ..++.+. ......+.+++..|++.||++|||+.|+++
T Consensus 224 -~~~~~-~i~~~~~--~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 224 -QETLA-NITSVSY--DFDEEFF----------SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -HHHHH-HHHTTCC--CCCHHHH----------TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -HHHHH-HHHhccc--ccChhhh----------cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111 1111111 0111111 112345678999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.65 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=196.0
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+|.. .+|+.||||++...... ..+++.+|++++++++|+||+++++++. ..
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~ 104 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI------ED 104 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------ET
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------cC
Confidence 45799999999999999999996 47899999998753322 2456899999999999999999999997 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.... .....+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFK-----KQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHH-----HTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CcEEEEEecCCCCCHHHHHHHhc-----ccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEE
Confidence 68999999999999999884321 12346899999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... ......||..|+|||.+....++.++||||||+++|||++|+.||..... ....+. .
T Consensus 177 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~ 248 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLC-K 248 (310)
T ss_dssp ECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHH-H
T ss_pred EEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHH-H
Confidence 999999986644322 22345789999999999999999999999999999999999999864221 111121 1
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.+..+.... + ........+.+++..|++.||++|||+.+|+++|+...
T Consensus 249 ~~~~~~~~~-----~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 249 KIEQCDYPP-----L---------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HHHTTCSCC-----C---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcccCCC-----C---------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 122222111 1 01112346778999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.83 Aligned_cols=252 Identities=22% Similarity=0.298 Sum_probs=195.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++. .....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~ 95 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE------DYHNM 95 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE------CSSEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee------cCCeE
Confidence 57899999999999999999975 68899999987654 334578999999999999999999999996 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---ccCCcEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRAR 467 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL---d~~~~~K 467 (683)
++||||+++|+|.+++.... .....+++..++.|+.+++.||+||| +.+|+||||||+|||+ +.++.+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQ-----ARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHH-----HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHhhh-----hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEE
Confidence 99999999999999884321 12357999999999999999999999 8899999999999999 4568899
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++...... ......||..|+|||.+. +.++.++||||||++++||++|+.||..... .+....
T Consensus 168 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~ 236 (285)
T 3is5_A 168 IIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQK 236 (285)
T ss_dssp ECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhh
Confidence 99999998765432 234467999999999875 5789999999999999999999999864221 111111
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+.. ..... .......+.+++..|++.||++|||+.||++
T Consensus 237 -~~~~~~------~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 237 -ATYKEP------NYAVE-------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -HHHCCC------CCCC---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -hccCCc------ccccc-------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111110 00000 0011345678999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=361.99 Aligned_cols=202 Identities=23% Similarity=0.342 Sum_probs=167.6
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++|||||++++++......+...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999865 58899999997642 223456889999999999999999999987544333456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||++++ |.+.+ ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 141 ~~~lv~E~~~~~-l~~~~-----------~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVI-----------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp EEEEEEECCSEE-HHHHH-----------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeCCCCC-HHHHH-----------hhcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEE
Confidence 789999999865 55555 124889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
+|||+++..... ...+...||+.|+|||++.+..++.++|||||||+++||++|+.||..
T Consensus 206 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 206 LDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp CCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999876543 234456899999999999999999999999999999999999999964
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=354.58 Aligned_cols=277 Identities=18% Similarity=0.229 Sum_probs=210.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...++||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----~~~~ 83 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET----TTRH 83 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT----TTCC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC----CCCe
Confidence 357889999999999999999976 489999999976433 3456788999999999999999999998632 2346
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee----ccCCc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADMR 465 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL----d~~~~ 465 (683)
.++||||+++|+|.+++.... ....+++..++.|+.|++.||+||| +.+|+||||||+|||+ +.++.
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPS------NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGG------GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEE
T ss_pred eEEEEecCCCCCHHHHHHhhh------cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCcee
Confidence 899999999999999995332 1234999999999999999999999 8899999999999999 88889
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCcccccc--------CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCC
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY--------GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~ 537 (683)
+||+|||+++....... .....||..|+|||++.. ..++.++|||||||++|||++|+.||.........
T Consensus 155 ~kL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 155 YKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EEECCGGGCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEEecCCCceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 99999999987654332 234679999999998865 56788999999999999999999999754332211
Q ss_pred ccchhhhhhhhhhcCcccccc-------Cccc--cccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 538 ACLITDWVWSLVKAGKVWQAL-------DPSL--LKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 538 ~~~l~~~v~~~~~~g~l~e~v-------D~~l--~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+........ .....+ +..+ .................+..++..|++.||++||++.|+++.|+..
T Consensus 233 ----~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 233 ----KEVMYKIITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp ----HHHHHHHHHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHhcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 1122222211 110000 0000 0000000012245566788999999999999999999999988763
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=347.16 Aligned_cols=282 Identities=21% Similarity=0.272 Sum_probs=202.8
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC-----------hHHHHHHHHHHHhccCCCc
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG-----------DAEFCNEVEIISNLKHRNL 371 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~-----------~~~f~~Ev~iL~~L~H~NL 371 (683)
..++++....++|...+.||+|+||.||+|+..+|+.||||++....... .+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45678899999999999999999999999998889999999996543322 2679999999999999999
Q ss_pred ccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcccc
Q 005691 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHR 451 (683)
Q Consensus 372 V~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHr 451 (683)
+++++++..... ......++||||++ |+|.+++.. ....+++..++.|+.|++.||.||| +.+|+||
T Consensus 92 v~~~~~~~~~~~-~~~~~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 158 (362)
T 3pg1_A 92 LGLRDIFVHFEE-PAMHKLYLVTELMR-TDLAQVIHD--------QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHR 158 (362)
T ss_dssp CCCSEEEEECCT-TTCCEEEEEEECCS-EEHHHHHHC--------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred cceeeeEEeccC-CCcceEEEEEccCC-CCHHHHHHh--------cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEec
Confidence 999999865432 24457899999998 688887742 2346999999999999999999999 7899999
Q ss_pred CCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 452 DIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 452 DIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
||||+|||++.++.+||+|||+++...... ......||..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999997544322 2344678999999999876 7789999999999999999999999964
Q ss_pred CCCCCCCccchhhhhhhhhhcC-----------ccccccCccccccccc-cCCChHHHHHHHHHHHHHhcccCCCCCCCH
Q 005691 531 STSGSPRACLITDWVWSLVKAG-----------KVWQALDPSLLKEDDF-LSLNPKAIMERFVLVGILCAHVMVALRPTI 598 (683)
Q Consensus 531 ~~~~~~~~~~l~~~v~~~~~~g-----------~l~e~vD~~l~~~~~~-~~~~~~e~~~~l~~lal~C~~~dP~~RPtm 598 (683)
..... ....+....... ...+.+...+...... ...........+.+++..|++.||++|||+
T Consensus 237 ~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 311 (362)
T 3pg1_A 237 STFYN-----QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311 (362)
T ss_dssp SSHHH-----HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCHHH-----HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 32110 000000000000 0001111111000000 000001123457789999999999999999
Q ss_pred HHHHHH
Q 005691 599 SDALKM 604 (683)
Q Consensus 599 ~eVl~~ 604 (683)
.|+++.
T Consensus 312 ~ell~h 317 (362)
T 3pg1_A 312 EQALRH 317 (362)
T ss_dssp HHHHTS
T ss_pred HHHHcC
Confidence 999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=338.17 Aligned_cols=247 Identities=20% Similarity=0.326 Sum_probs=197.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~ 386 (683)
.+++|...+.||+|+||.||+|+.. +++.||||++..... ....++.+|+..+.++ +||||+++++++. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~------~ 82 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA------E 82 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE------E
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee------c
Confidence 4578999999999999999999986 799999999876433 2345788999999999 9999999999997 4
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc----
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---- 462 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---- 462 (683)
....++||||+++|+|.+++.... .....+++..++.|+.|++.||+||| +.+|+||||||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~ 154 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENY-----RIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIP 154 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHH-----HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----
T ss_pred CCeEEEEEEecCCCcHHHHHHhhc-----ccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCC
Confidence 568999999999999999994321 11246899999999999999999999 889999999999999984
Q ss_pred ---------------CCcEEEcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCC
Q 005691 463 ---------------DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRK 526 (683)
Q Consensus 463 ---------------~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~ 526 (683)
...+||+|||+++...... ...||..|+|||.+... .++.++||||||++++||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp ---------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred cccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 4479999999998765432 23589999999999865 66789999999999999999998
Q ss_pred CCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 527 ALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 527 p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
++... . .+..+..+... .+.. .....+.+++..|++.||++|||+.++++
T Consensus 230 ~~~~~-------~-----~~~~~~~~~~~-----~~~~----------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 230 LPRNG-------D-----QWHEIRQGRLP-----RIPQ----------VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCSSS-------H-----HHHHHHTTCCC-----CCSS----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcch-------h-----HHHHHHcCCCC-----CCCc----------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 75321 0 11222233221 1111 12345678999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=333.26 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=196.5
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.|...+.||+|+||.||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++++..... .....
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~ 104 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK--GKKCI 104 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS--SCEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC--CCceE
Confidence 4677788999999999999975 578899999875432 234568999999999999999999999864321 34668
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeec-cCCcEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLD-ADMRAR 467 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd-~~~~~K 467 (683)
++||||+++|+|.+++.. ...+++..++.|+.+++.||.||| +.+ |+||||||+|||++ +++.+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred EEEEEecCCCCHHHHHHH---------ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEE
Confidence 999999999999999932 246899999999999999999999 677 99999999999998 789999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||..... .... ..
T Consensus 173 l~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~-~~ 240 (290)
T 1t4h_A 173 IGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQI-YR 240 (290)
T ss_dssp ECCTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHH-HH
T ss_pred EeeCCCccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHH-HH
Confidence 9999999754432 233457999999999776 5699999999999999999999999964321 1111 12
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
....+.... .+.. .....+.+++..|++.||++|||+.++++
T Consensus 241 ~~~~~~~~~----~~~~----------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 241 RVTSGVKPA----SFDK----------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHTTTCCCG----GGGG----------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhccCCcc----ccCC----------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 222221111 1111 11235778999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.57 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=200.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+++.. +|+.||||++........+.+.+|++++++++||||+++++++. .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 81 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE------STTHY 81 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE------CSSEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc------cCCEE
Confidence 468899999999999999999975 68999999998765555667999999999999999999999986 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---ccCCcEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRAR 467 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL---d~~~~~K 467 (683)
++||||+++|+|.+++.. ...+++..++.++.+++.||.||| +.+|+||||||+|||+ +.++.+|
T Consensus 82 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~k 149 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILE---------RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIM 149 (304)
T ss_dssp EEEECCCCSCBHHHHHHH---------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEE
T ss_pred EEEEEcCCCccHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEE
Confidence 999999999999998832 346899999999999999999999 7899999999999999 7889999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++..... ......||+.|+|||.+....++.++||||||+++|||++|+.||..... . . ...
T Consensus 150 l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~---~-~~~ 217 (304)
T 2jam_A 150 ITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----S---K-LFE 217 (304)
T ss_dssp BCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----H---H-HHH
T ss_pred EccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----H---H-HHH
Confidence 9999998764432 22345689999999999999999999999999999999999999864321 1 1 112
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+... . ... ........+.+++..|++.||++|||+.|+++
T Consensus 218 ~i~~~~~~-~-~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 218 KIKEGYYE-F-ESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHCCCC-C-CTT----------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHcCCCC-C-Ccc----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222210 0 000 11122346778999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.27 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=200.5
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccC---ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESD---FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+++..+ |+.||||++.... ....+.+..|..++..+ +||||+++++++. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~------~ 92 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ------T 92 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE------C
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE------c
Confidence 4689999999999999999999864 7889999997642 23456788999999988 8999999999987 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++.. ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~v 160 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ---------VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI 160 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcE
Confidence 6789999999999999999832 246899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+...
T Consensus 161 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~ 231 (353)
T 2i0e_A 161 KIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQ 231 (353)
T ss_dssp EECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHH
T ss_pred EEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHH
Confidence 999999998643222 223456899999999999999999999999999999999999999964221 11111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
. +..+.. .+ +......+..++..|++.||++||+ +.+|++
T Consensus 232 ~-i~~~~~------~~----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 232 S-IMEHNV------AY----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp H-HHHCCC------CC----------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred H-HHhCCC------CC----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 112211 01 1122346678999999999999995 566654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.13 Aligned_cols=256 Identities=19% Similarity=0.243 Sum_probs=192.1
Q ss_pred cCcccc-eeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHh-ccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQK-NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISN-LKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~-~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~-L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|... ++||+|+||+||+++.. +|+.||||++.. ...+.+|++++.+ .+|+||+++++++..... ....
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~--~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA--GRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET--TEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeeccc--CCcE
Confidence 456555 68999999999999975 688999999863 3567889998754 589999999998853111 2456
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc---CCcE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DMRA 466 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---~~~~ 466 (683)
.++||||+++|+|.+++... ....+++..++.|+.||+.||.||| +.+|+||||||+|||++. ++.+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR-------GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEEeCCCCcHHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccE
Confidence 89999999999999999532 1246999999999999999999999 789999999999999998 7899
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||........ .....
T Consensus 204 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~ 276 (400)
T 1nxk_A 204 KLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMK 276 (400)
T ss_dssp EECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-----CCSHH
T ss_pred EEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-----cHHHH
Confidence 999999998654322 23456789999999999999999999999999999999999999975432211 01111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+..+... ...+ ........+.+++..|++.||++|||+.|+++.
T Consensus 277 ~~i~~~~~~-~~~~-----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 277 TRIRMGQYE-FPNP-----------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHHHTCCC-CCTT-----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHcCccc-CCCc-----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222222210 0000 011234467889999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.16 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=199.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc------ChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++|...+.||+|+||.||+++.. +|+.||||.+...... ..+.+.+|++++++++||||+++++++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------ 78 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE------ 78 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE------
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec------
Confidence 57889999999999999999986 6899999998764322 3567999999999999999999999987
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM- 464 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~- 464 (683)
.....++||||+++++|.+++.. ...+++..++.++.+++.||.||| +.+|+||||||+||+++.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAE---------KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSS
T ss_pred CCCeEEEEEeecCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCC
Confidence 56789999999999999999832 346899999999999999999999 88999999999999998877
Q ss_pred ---cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 465 ---RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 465 ---~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
.+||+|||+++....... .....||+.|+|||.+....++.++||||||+++|||++|+.||.....
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------- 216 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------- 216 (283)
T ss_dssp SSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------
T ss_pred CCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------
Confidence 899999999987644322 2345689999999999999999999999999999999999999864321
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+. ...+..... ..++.. .......+.+++..|++.||++|||+.++++
T Consensus 217 ~~~-~~~~~~~~~--~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 217 QET-LTNISAVNY--DFDEEY----------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHH-HHHHHTTCC--CCCHHH----------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHH-HHHhHhccc--CCcchh----------cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 011 111111111 001111 0112346778999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=339.03 Aligned_cols=250 Identities=30% Similarity=0.402 Sum_probs=194.8
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|...+.||+|+||.||+|... |+.||||++.... ..+.+.+|++++++++||||+++++++.. .....+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE-----EKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC-----C--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCCceE
Confidence 468899999999999999999885 8899999986532 45679999999999999999999998752 334689
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++.... ...+++..++.++.+++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 92 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Df 161 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRG-------RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF 161 (278)
T ss_dssp EEECCCTTEEHHHHHHHHH-------HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCCHHHHHHhcc-------cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeec
Confidence 9999999999999984221 124889999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
|+++...... ....+|..|+|||.+....++.++||||||+++|||++ |+.|+..... . +. .....
T Consensus 162 g~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~---~~-~~~~~ 228 (278)
T 1byg_A 162 GLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K---DV-VPRVE 228 (278)
T ss_dssp CC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----G---GH-HHHHT
T ss_pred cccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----H---HH-HHHHh
Confidence 9987654322 22457889999999999999999999999999999998 9999864321 1 11 11122
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+.. +.. +......+.+++..|++.||++|||+.++++.|+.
T Consensus 229 ~~~~-----~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 229 KGYK-----MDA----------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp TTCC-----CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCC-----CCC----------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 2211 111 11223467789999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=349.67 Aligned_cols=243 Identities=20% Similarity=0.294 Sum_probs=199.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--------ChHHHHHHHHHHHhccCCCcccccceeeec
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--------GDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~ 381 (683)
..++|...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 4568999999999999999999964 6889999999765322 2335788999999999999999999997
Q ss_pred CCCCCCCeeEEEEeecCCC-CccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 382 GDNERGSERYLVYDYMPNG-NVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~G-sL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.....++||||+.+| +|.+++.. ...+++..++.|+.|++.||.||| +.+|+||||||+|||+
T Consensus 100 ----~~~~~~lv~e~~~~g~~l~~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll 163 (335)
T 3dls_A 100 ----NQGFFQLVMEKHGSGLDLFAFIDR---------HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVI 163 (335)
T ss_dssp ----CSSEEEEEEECCTTSCBHHHHHHT---------CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred ----eCCEEEEEEEeCCCCccHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEE
Confidence 567899999999877 99998832 346999999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
+.++.+||+|||+++....... .....||+.|+|||.+....+ +.++||||||+++|||++|+.||.....
T Consensus 164 ~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------ 235 (335)
T 3dls_A 164 AEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------ 235 (335)
T ss_dssp CTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------
T ss_pred cCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------
Confidence 9999999999999987654332 334679999999999988777 8899999999999999999999863211
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
. +...+. .+......+..++..|++.||++|||+.++++.
T Consensus 236 ----~-------------~~~~~~--------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----T-------------VEAAIH--------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----G-------------TTTCCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----H-------------HhhccC--------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 001123456789999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.94 Aligned_cols=249 Identities=23% Similarity=0.362 Sum_probs=202.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||++... +++.||+|.+...... ..+.+.+|+.++++++|+||+++++++. ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~ 87 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE------DN 87 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------CS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec------cC
Confidence 467888999999999999999986 4788999998764322 2456889999999999999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++. ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHK---------RRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHH---------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred CEEEEEEecCCCCCHHHHHH---------hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEE
Confidence 78999999999999999873 2346899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... ......||..|+|||.+....++.++||||||++++||++|+.||..... .+.. .
T Consensus 156 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~-~ 225 (294)
T 2rku_A 156 IGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETY-L 225 (294)
T ss_dssp ECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHH-H
T ss_pred EEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-H
Confidence 999999987643322 23346799999999999998999999999999999999999999864321 1111 1
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+..+.. .+ +......+.+++..|++.||++|||+.|+++.
T Consensus 226 ~~~~~~~------~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 226 RIKKNEY------SI----------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHTTCC------CC----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHhhccC------CC----------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111111 01 11122356788999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=359.65 Aligned_cols=253 Identities=15% Similarity=0.191 Sum_probs=188.3
Q ss_pred HhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccC---ccChHHHHHHH---HHHHhccCCCcccccceee----
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESD---FQGDAEFCNEV---EIISNLKHRNLVPLRGCCV---- 379 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~---~~~~~~f~~Ev---~iL~~L~H~NLV~L~G~c~---- 379 (683)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.|.+|+ +++++++|||||++++.+.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356788899999999999999996 569999999997532 23346789999 5556668999999985432
Q ss_pred ---ecCC------CCCCC-----eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC
Q 005691 380 ---VDGD------NERGS-----ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK 445 (683)
Q Consensus 380 ---~~~~------~~~~~-----~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~ 445 (683)
.... ...+. ..++||||+ +|+|.+++..... .......++|..++.|+.|++.||+||| +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 224 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRLLASLH---H 224 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc--cccccccccHHHHHHHHHHHHHHHHHHH---h
Confidence 1100 00001 378999999 6899999953210 0011234567889999999999999999 7
Q ss_pred CCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccC-----------CCCccccEEEc
Q 005691 446 PAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-----------QLTEKSDVYSF 514 (683)
Q Consensus 446 ~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----------~~s~ksDVwSf 514 (683)
.+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++|||||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 8999999999999999999999999999985332 2334567 999999999887 89999999999
Q ss_pred chhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCC
Q 005691 515 GVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL 594 (683)
Q Consensus 515 GvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~ 594 (683)
||++|||++|+.||........ ..++. .. . . .....+.+++..|++.||++
T Consensus 300 G~il~elltg~~Pf~~~~~~~~-----~~~~~----~~---------~-~----------~~~~~~~~li~~~L~~dp~~ 350 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGG-----SEWIF----RS---------C-K----------NIPQPVRALLEGFLRYPKED 350 (377)
T ss_dssp HHHHHHHHHSSCCC------CC-----SGGGG----SS---------C-C----------CCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHCCCCCcccccccc-----hhhhh----hh---------c-c----------CCCHHHHHHHHHHcCCCchh
Confidence 9999999999999864332111 01110 00 0 0 11245678899999999999
Q ss_pred CCCHHHHHH
Q 005691 595 RPTISDALK 603 (683)
Q Consensus 595 RPtm~eVl~ 603 (683)
|||+.|+++
T Consensus 351 Rpt~~e~l~ 359 (377)
T 3byv_A 351 RLLPLQAME 359 (377)
T ss_dssp CCCHHHHHT
T ss_pred CCCHHHHhh
Confidence 999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.57 Aligned_cols=262 Identities=26% Similarity=0.367 Sum_probs=201.6
Q ss_pred hcCcccceeeeecCceEEEEEEE------cCCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l------~~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||.||+|+. .++..||||++.... .....++.+|+.++++++||||+++++++.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 103 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----- 103 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence 46899999999999999999984 257789999986543 233457999999999999999999999986
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc--
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-- 462 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-- 462 (683)
.....++||||+++|+|.+++...... ......+++..++.++.+++.||.||| +.+|+||||||+|||++.
T Consensus 104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 104 -QSLPRFILMELMAGGDLKSFLRETRPR--PSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp -SSSSCEEEEECCTTEEHHHHHHHTSCC--SSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred -CCCCcEEEEecCCCCcHHHHHHhhccc--ccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCC
Confidence 456789999999999999999543211 122346899999999999999999999 889999999999999984
Q ss_pred -CCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCcc
Q 005691 463 -DMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRAC 539 (683)
Q Consensus 463 -~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~ 539 (683)
+..+||+|||+++....... .......||+.|+|||.+..+.++.++||||||+++|||++ |+.||..... .
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~ 252 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----Q 252 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----H
Confidence 45699999999986543322 22334568999999999999999999999999999999998 9999864221 1
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
+ +...+..+.... .+......+.+++..|++.||++|||+.+|++.|+..
T Consensus 253 ---~-~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 253 ---E-VLEFVTSGGRMD---------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---H-HHHHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---H-HHHHHhcCCCCC---------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 112222221110 0111234677899999999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=337.02 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=203.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.+.|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++|+||+++++++. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~ 94 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL------KDTK 94 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE------ETTE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe------cCCe
Confidence 356888999999999999999864 688999999876543 34577999999999999999999999997 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++++|.+++. ...+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 95 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 161 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLE----------PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLA 161 (303)
T ss_dssp EEEEEECCTTEEHHHHHT----------TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEeCCCCcHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEe
Confidence 999999999999999982 246899999999999999999999 7899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+++....... ......||..|+|||.+....++.++||||||+++|||++|+.|+..... . ... ...
T Consensus 162 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~---~~~-~~~ 231 (303)
T 3a7i_A 162 DFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----M---KVL-FLI 231 (303)
T ss_dssp CCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H---HHH-HHH
T ss_pred ecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----H---HHH-HHh
Confidence 9999987654322 23346789999999999999999999999999999999999999864221 1 111 111
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+. .+.+... ....+..++..|++.||++|||+.++++.
T Consensus 232 ~~~~-----~~~~~~~----------~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 232 PKNN-----PPTLEGN----------YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHSC-----CCCCCSS----------CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred hcCC-----CCCCccc----------cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 1111111 23457789999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.57 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=193.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 83 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS------TP 83 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE------CS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe------cC
Confidence 367889999999999999999986 78999999986532 234567899999999999999999999987 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++.. ...+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK---------HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeccCCCcHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEE
Confidence 789999999999999999842 246899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|||+++....... .....||+.|+|||.+.+..+ +.++||||||++++||++|+.||+.... ....
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~ 220 (276)
T 2h6d_A 152 IADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---------PTLF 220 (276)
T ss_dssp ECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHH
T ss_pred EeecccccccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---------HHHH
Confidence 999999987654322 234568999999999987765 6899999999999999999999864211 1112
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+....+.. .+ +......+..++..|++.||++|||+.++++.
T Consensus 221 ~~~~~~~~------~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 221 KKIRGGVF------YI----------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHCCC------CC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhhcCcc------cC----------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22222211 00 11123456788999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=333.88 Aligned_cols=245 Identities=22% Similarity=0.332 Sum_probs=200.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++. ...
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~ 87 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH------DRK 87 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE------CSS
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE------cCC
Confidence 67889999999999999999976 57789999986532 233567999999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 155 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQK---------HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKI 155 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEEEEeCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEE
Confidence 89999999999999999842 246899999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||..... .+. ...
T Consensus 156 ~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~-~~~ 223 (284)
T 2vgo_A 156 ADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TET-HRR 223 (284)
T ss_dssp CCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHH-HHH
T ss_pred ecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHH-HHH
Confidence 9999987654322 2345789999999999999999999999999999999999999864321 111 111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...... .+. ......+.+++..|++.||.+|||+.++++
T Consensus 224 ~~~~~~------~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 224 IVNVDL------KFP----------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHTTCC------CCC----------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Hhcccc------CCC----------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111111 111 112345678999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.03 Aligned_cols=266 Identities=23% Similarity=0.370 Sum_probs=200.7
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeee
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVV 380 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~ 380 (683)
+++.++....++|...+.||+|+||.||+|+.. +|+.||||++.... ...+++.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 455566667889999999999999999999974 68999999986543 3456799999999999 89999999999975
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
..........++||||+++|+|.+++... ....+++..++.|+.|++.||.||| +.+|+||||||+|||+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~ 162 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-------KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLL 162 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHS-------GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEE
Confidence 43322356899999999999999998432 1246889999999999999999999 7899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
+.++.+||+|||++........ ......||..|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-- 239 (326)
T 2x7f_A 163 TENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-- 239 (326)
T ss_dssp CTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--
T ss_pred cCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--
Confidence 9999999999999886543221 223457899999999987 56789999999999999999999999864221
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..-..... .+.. +.+.. ......+..++..|++.||++|||+.++++
T Consensus 240 ------~~~~~~~~-~~~~-----~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 ------MRALFLIP-RNPA-----PRLKS---------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ------HHHHHHHH-HSCC-----CCCSC---------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHhh-cCcc-----ccCCc---------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01111111 1111 11111 112345678899999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.09 Aligned_cols=203 Identities=31% Similarity=0.516 Sum_probs=162.4
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~ 385 (683)
...++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++.++. |+|||++++++...
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---- 81 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---- 81 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT----
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC----
Confidence 34678999999999999999999964 68999999986532 223456889999999997 99999999998732
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++||||++ |+|.+++. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~----------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIR----------ANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHH----------HTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCC
T ss_pred CCCEEEEEecccC-cCHHHHHH----------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCC
Confidence 3456899999997 68888883 246889999999999999999999 889999999999999999999
Q ss_pred EEEcccCcccccccC--------------------CccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhC
Q 005691 466 ARVADFGLAKQSREG--------------------QSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCG 524 (683)
Q Consensus 466 ~KLaDFGla~~~~~~--------------------~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltG 524 (683)
+||+|||+++..... .....+...||+.|+|||.+.+ ..++.++|||||||+++||++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 999999999865321 1122344689999999999876 6789999999999999999999
Q ss_pred CCCCCC
Q 005691 525 RKALDL 530 (683)
Q Consensus 525 r~p~~~ 530 (683)
+.||..
T Consensus 228 ~~pf~~ 233 (388)
T 3oz6_A 228 KPIFPG 233 (388)
T ss_dssp SCSCCC
T ss_pred CCCCCC
Confidence 999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.70 Aligned_cols=261 Identities=28% Similarity=0.411 Sum_probs=200.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcE--EEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTT--VAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~--VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||.||+|+.. ++.. ||||++.... ....+.+.+|++++.++ +||||+++++++. ..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~------~~ 98 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE------HR 98 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE------ET
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee------eC
Confidence 67888999999999999999965 4554 4999887532 33456799999999999 9999999999997 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
...++||||+++|+|.+++....... .......+++..++.|+.|++.||+||| +.+|+||||||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEE
Confidence 68999999999999999995321000 0012347999999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCcc
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRAC 539 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~ 539 (683)
+.++.+||+|||+++...... ......+|..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------ 247 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------ 247 (327)
T ss_dssp CGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------
T ss_pred cCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------
Confidence 999999999999987533221 1233457889999999999899999999999999999998 9999864321
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+ ....+..+.. .. .+......+.+++..|++.||++|||+.++++.|+..
T Consensus 248 --~~-~~~~~~~~~~-----~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 248 --AE-LYEKLPQGYR-----LE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp --HH-HHHHGGGTCC-----CC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HH-HHHHhhcCCC-----CC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1112222210 00 1112234677899999999999999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.31 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=203.4
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccCh-----------------HHHHHHHHHHHhccCCCcccc
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGD-----------------AEFCNEVEIISNLKHRNLVPL 374 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~-----------------~~f~~Ev~iL~~L~H~NLV~L 374 (683)
.++|...+.||+|+||.||+|.. +|+.||||++........ +.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 899999999975432211 789999999999999999999
Q ss_pred cceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCC
Q 005691 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDI 453 (683)
Q Consensus 375 ~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDI 453 (683)
++++. .....++||||+++|+|.+++..... ........+++..++.++.|++.||.||| + .+|+||||
T Consensus 109 ~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl 178 (348)
T 2pml_X 109 EGIIT------NYDEVYIIYEYMENDSILKFDEYFFV-LDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDV 178 (348)
T ss_dssp SEEEE------SSSEEEEEEECCTTCBSSEESSSEES-SCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCC
T ss_pred EEEEe------eCCeEEEEEeccCCCcHHHHHHHhhh-hhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCC
Confidence 99997 56789999999999999999421100 00112457999999999999999999999 6 89999999
Q ss_pred CCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccC-CCCc-cccEEEcchhHHHHhhCCCCCCCC
Q 005691 454 KATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTE-KSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 454 KpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~-ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
||+|||++.++.+||+|||+++..... ......||..|+|||.+... .++. ++||||||+++|||++|+.||...
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876443 23446799999999999877 6666 999999999999999999999754
Q ss_pred CCCCCCccchhhhhhhhhhcCccccc------cCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 532 TSGSPRACLITDWVWSLVKAGKVWQA------LDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 532 ~~~~~~~~~l~~~v~~~~~~g~l~e~------vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.... + ....+..+...-- ..+...... ..........+.+++..|++.||++|||+.|+++
T Consensus 256 ~~~~-------~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 256 ISLV-------E-LFNNIRTKNIEYPLDRNHFLYPLTNKKS---TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCSH-------H-HHHHHTSCCCCCCCSSSSSTTTTCC-----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcHH-------H-HHHHHhccCcCCccchhhhhcccccccc---ccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3211 1 1111222211100 000000000 0001223456788999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.77 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=197.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++. .....
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~ 91 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY------HDGKL 91 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE------CC-CE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee------eCCeE
Confidence 468899999999999999999986 58899999997766666788999999999999999999999997 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++++|.+++... ...+++..++.++.+++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 92 ~lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~D 160 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLEL--------DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLAD 160 (302)
T ss_dssp EEEEECCTTEEHHHHHHHH--------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEE
Confidence 9999999999999988421 346899999999999999999999 78999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
||++....... .......||..|+|||++. ...++.++||||||+++|||++|+.|+..... ....
T Consensus 161 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~ 231 (302)
T 2j7t_A 161 FGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVL 231 (302)
T ss_dssp CHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH
T ss_pred CCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHH
Confidence 99976432211 1123357899999999984 67789999999999999999999999864321 1111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
........ . .+ ..+......+..++..|++.||++|||+.++++
T Consensus 232 ~~~~~~~~-~-----~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 232 LKIAKSDP-P-----TL--------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHSCC-C-----CC--------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHhccCC-c-----cc--------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 22111111 0 00 011222346778999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.58 Aligned_cols=271 Identities=24% Similarity=0.296 Sum_probs=194.8
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC-----hHHHHHHHHHHHhccCCCcccccceeeecC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-----DAEFCNEVEIISNLKHRNLVPLRGCCVVDG 382 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~-----~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~ 382 (683)
....++|...+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--- 82 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--- 82 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe---
Confidence 344578999999999999999999975 58999999986532221 246889999999999999999999986
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.....++||||+++ +|.+++.. ....+++..++.++.+++.||+||| +.+|+||||||+|||++.
T Consensus 83 ---~~~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 83 ---HKSNISLVFDFMET-DLEVIIKD--------NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDE 147 (346)
T ss_dssp ---CTTCCEEEEECCSE-EHHHHHTT--------CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred ---eCCceEEEEEcCCC-CHHHHHHh--------cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcC
Confidence 45678999999986 88888732 2346899999999999999999999 889999999999999999
Q ss_pred CCcEEEcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 463 DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
++.+||+|||+++....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~----~~~ 222 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQL 222 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHH
T ss_pred CCCEEEEecccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHH
Confidence 99999999999987654322 23446789999999998754 5899999999999999999999998643211 001
Q ss_pred hhhhhhhhhcC---ccc---cccCccccccccccCCCh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005691 542 TDWVWSLVKAG---KVW---QALDPSLLKEDDFLSLNP----KAIMERFVLVGILCAHVMVALRPTISDALKML 605 (683)
Q Consensus 542 ~~~v~~~~~~g---~l~---e~vD~~l~~~~~~~~~~~----~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L 605 (683)
.-+....... ... ...+...... ...... ......+.+++..|++.||++|||+.|+++.-
T Consensus 223 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 223 -TRIFETLGTPTEEQWPDMCSLPDYVTFKS--FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp -HHHHHHHCCCCTTTSSSTTSSTTCCCCCC--CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred -HHHHHHcCCCChhhhhhhccCcccccccc--cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 1111110000 000 0000000000 000000 12235678899999999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.85 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=195.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|....+||+|+||.||+|+.. +++.||||++........+.+.+|+.+++.++||||+++++++. .....+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~ 95 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS------ENGFIK 95 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE------ETTEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE------eCCcEE
Confidence 34555679999999999999964 68899999998766666678999999999999999999999997 456799
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-CCcEEEcc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVAD 470 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-~~~~KLaD 470 (683)
+||||+++++|.+++.... ....+++..++.++.+++.||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 96 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKW------GPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp EEEECCSEEEHHHHHHHTT------CCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhc------cCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEee
Confidence 9999999999999985321 1235678888999999999999999 789999999999999987 89999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCC--CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
||+++....... ......||+.|+|||.+..+. ++.++||||||+++|||++|+.||....... . . ....
T Consensus 167 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~-~-~~~~ 238 (295)
T 2clq_A 167 FGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----A-A-MFKV 238 (295)
T ss_dssp TTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----H-H-HHHH
T ss_pred cccccccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----H-H-HHhh
Confidence 999987643221 233457899999999987654 7899999999999999999999986422110 0 0 0110
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... ...+.+. ......+.+++..|++.||++|||+.++++
T Consensus 239 ~~~-----~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 239 GMF-----KVHPEIP----------ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHH-----CCCCCCC----------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc-----ccccccc----------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0111111 122346678899999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=343.03 Aligned_cols=261 Identities=21% Similarity=0.291 Sum_probs=202.6
Q ss_pred hHHHHHHhcCcccc-eeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhc-cCCCcccccceee
Q 005691 305 IQDLERATDKFSQK-NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNL-KHRNLVPLRGCCV 379 (683)
Q Consensus 305 ~~el~~at~~f~~~-~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~ 379 (683)
++..+...++|... +.||+|+||.||+|+.. +|+.||||++.... .....++.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34455666777776 88999999999999976 58999999987543 23356799999999999 4699999999986
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
.....++||||+++|+|.+++... ....+++..++.|+.|++.||+||| +.+|+||||||+|||
T Consensus 100 ------~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl 163 (327)
T 3lm5_A 100 ------NTSEIILILEYAAGGEIFSLCLPE-------LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNIL 163 (327)
T ss_dssp ------CSSEEEEEEECCTTEEGGGGGSSC-------C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred ------eCCeEEEEEEecCCCcHHHHHHHh-------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEE
Confidence 567899999999999999998432 2357999999999999999999999 889999999999999
Q ss_pred ecc---CCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 460 LDA---DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 460 Ld~---~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
++. ++.+||+|||+++...... ......||+.|+|||++....++.++||||||+++|||++|+.||......
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-- 239 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-- 239 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred EecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--
Confidence 998 7899999999998765332 223467999999999999999999999999999999999999999643210
Q ss_pred CccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 537 ~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+.... ...... ..... ........+.+++..|++.||++|||+.++++.
T Consensus 240 ------~~~~~-i~~~~~------~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 ------ETYLN-ISQVNV------DYSEE------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------HHHHH-HHHTCC------CCCTT------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------HHHHH-HHhccc------ccCch------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11111 111110 00000 111223467789999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.81 Aligned_cols=197 Identities=24% Similarity=0.401 Sum_probs=171.7
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++||||+++++++. .+...
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~ 106 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY------SDGEI 106 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE------ETTEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE------ECCEE
Confidence 57899999999999999999976 688999999876432 22457899999999999999999999987 45679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCceeeccCCcEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNILLd~~~~~KLa 469 (683)
++||||+++|+|.+++.. ...+++..+..|+.+++.||+||| +. +|+||||||+|||++.++.+||+
T Consensus 107 ~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK---------AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEECCCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCCCCCHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEE
Confidence 999999999999999842 246899999999999999999999 54 89999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCC
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDL 530 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~ 530 (683)
|||+++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 175 Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 175 DFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999765432 22345799999999999999999999999999999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=367.25 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=204.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+++.. +|+.||||++.... ......+.+|++++++++|||||++++++. ..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~------~~ 256 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE------TK 256 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE------CS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe------eC
Confidence 467889999999999999999975 68999999996532 334567899999999999999999999987 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.... ...+++..++.++.||+.||+||| +.+|+||||||+||||+.++.+|
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~-------~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMG-------QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSS-------SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeE
Confidence 78999999999999999985321 235899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....+.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.+
T Consensus 327 L~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-----~~~i~~ 399 (576)
T 2acx_A 327 ISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVER 399 (576)
T ss_dssp ECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-----HHHHHH
T ss_pred EEecccceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-----HHHHHH
Confidence 999999987654432 2345899999999999999999999999999999999999999975432111 111112
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
....... .+ +......+..++..|++.||++|| ++.||++
T Consensus 400 ~i~~~~~------~~----------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 400 LVKEVPE------EY----------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHCCC------CC----------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred Hhhcccc------cC----------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111110 11 112234667889999999999999 7888874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.54 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=204.7
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--------hHHHHHHHHHHHhc-cCCCcccc
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--------DAEFCNEVEIISNL-KHRNLVPL 374 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--------~~~f~~Ev~iL~~L-~H~NLV~L 374 (683)
........++|...+.||+|+||.||+|++. +|+.||||++....... .+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445566788999999999999999999986 79999999987643221 24578999999999 79999999
Q ss_pred cceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 375 RGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 375 ~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
++++. .....++||||+++|+|.+++.. ...+++..++.++.|++.||.||| +.+|+|||||
T Consensus 166 ~~~~~------~~~~~~lv~e~~~g~~L~~~l~~---------~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlk 227 (365)
T 2y7j_A 166 IDSYE------SSSFMFLVFDLMRKGELFDYLTE---------KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLK 227 (365)
T ss_dssp EEEEE------BSSEEEEEECCCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred EEEEe------eCCEEEEEEEeCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 99986 56789999999999999999842 346999999999999999999999 7899999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc------CCCCccccEEEcchhHHHHhhCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY------GQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
|+|||++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 228 p~NIl~~~~~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 228 PENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred HHHEEECCCCCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999987654332 344679999999998863 36889999999999999999999998
Q ss_pred CCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 529 DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 529 ~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..... . .....+..+... ...+.. ......+..++..|++.||++|||+.++++
T Consensus 306 ~~~~~-----~----~~~~~i~~~~~~-~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 306 WHRRQ-----I----LMLRMIMEGQYQ-FSSPEW-----------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCSSH-----H----HHHHHHHHTCCC-CCHHHH-----------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCH-----H----HHHHHHHhCCCC-CCCccc-----------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 64211 1 111112222110 000000 112345778999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.51 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=194.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc--CCc--EEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ--DGT--TVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~--~g~--~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||.||+|++. +++ .||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----- 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL----- 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-----
Confidence 357899999999999999999864 233 68999886542 223467899999999999999999999985
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
....++|+||+++|+|.+++... ...+++..++.++.+++.||.||| +.+|+||||||+|||++.++
T Consensus 92 --~~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 92 --TPPMKMVTELAPLGSLLDRLRKH--------QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD 158 (291)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHH--------GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETT
T ss_pred --cCCceeeEecccCCCHHHHHHhc--------cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCC
Confidence 23489999999999999998432 246899999999999999999999 78999999999999999999
Q ss_pred cEEEcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccch
Q 005691 465 RARVADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLI 541 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l 541 (683)
.+||+|||+++........ ......+|..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------- 230 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------- 230 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------
Confidence 9999999999876543322 2334568889999999998899999999999999999999 9999864321
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.+........+... . .+......+.+++..|++.||++|||+.++++.|+...
T Consensus 231 ~~~~~~~~~~~~~~-----~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 231 SQILHKIDKEGERL-----P----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHHHHHHTSCCCC-----C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHccCCCC-----C----------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11222221111110 0 11122356788999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.51 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=201.8
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||.||+++.. +++.||+|.+...... ..+.+.+|+.++++++|+||+++++++. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~ 113 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE------DN 113 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------CS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------cC
Confidence 467889999999999999999976 4788999998764322 2456899999999999999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++++|.+++.. ...+++.+++.|+.|++.||+||| +.+|+||||||+|||++.++.+|
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR---------RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEE
T ss_pred CeEEEEEecCCCCCHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEE
Confidence 789999999999999998832 346899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... ......||..|+|||.+....++.++||||||+++|||++|+.||..... .+.. .
T Consensus 182 l~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~-~ 251 (335)
T 2owb_A 182 IGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETY-L 251 (335)
T ss_dssp ECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHH-H
T ss_pred EeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHH-H
Confidence 999999987653322 23346799999999999999999999999999999999999999864221 1111 1
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+.. .+. ......+..++..|++.||++|||+.|+++
T Consensus 252 ~~~~~~~------~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 252 RIKKNEY------SIP----------KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHTCC------CCC----------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHhcCCC------CCC----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 111 112235678899999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.43 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=200.5
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecC
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDG 382 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~ 382 (683)
.++++...++|...+.||+|+||.||+|...+ .||+|++.... ....+.|.+|+.++++++|+||+++++++.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--- 99 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM--- 99 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE---
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe---
Confidence 44555556889999999999999999999763 49999986532 223456889999999999999999999997
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.....++||||+++++|.+++.. ....+++..++.|+.+++.||+||| +.+|+||||||+|||++
T Consensus 100 ---~~~~~~iv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~- 164 (319)
T 2y4i_B 100 ---SPPHLAIITSLCKGRTLYSVVRD--------AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD- 164 (319)
T ss_dssp ---CSSCEEEECBCCCSEEHHHHTTS--------SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC-
T ss_pred ---cCCceEEEeecccCCcHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-
Confidence 45679999999999999999942 2346899999999999999999999 78999999999999998
Q ss_pred CCcEEEcccCcccccccCC----ccccccccCCCcccCcccccc---------CCCCccccEEEcchhHHHHhhCCCCCC
Q 005691 463 DMRARVADFGLAKQSREGQ----SHLTTRVAGTHGYLAPEYALY---------GQLTEKSDVYSFGVVILEIMCGRKALD 529 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~----~~~~~~~~GT~~Y~APE~~~~---------~~~s~ksDVwSfGvlLlELltGr~p~~ 529 (683)
++.+||+|||+++...... ........||..|+|||.+.. ..++.++||||||+++|||++|+.||.
T Consensus 165 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 244 (319)
T 2y4i_B 165 NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244 (319)
T ss_dssp --CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 6799999999987653221 122334568999999999874 457899999999999999999999986
Q ss_pred CCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 530 LSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 530 ~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
.... ....+. ...+.. +.+... .....+.+++..|++.||++|||+.+++++|+...
T Consensus 245 ~~~~--------~~~~~~-~~~~~~-----~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 245 TQPA--------EAIIWQ-MGTGMK-----PNLSQI---------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp SCCH--------HHHHHH-HHTTCC-----CCCCCS---------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCCH--------HHHHHH-hccCCC-----CCCCcC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 4321 111222 222211 111110 11234678899999999999999999999999754
Q ss_pred C
Q 005691 610 E 610 (683)
Q Consensus 610 ~ 610 (683)
.
T Consensus 302 ~ 302 (319)
T 2y4i_B 302 K 302 (319)
T ss_dssp -
T ss_pred H
Confidence 3
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.12 Aligned_cols=260 Identities=12% Similarity=0.047 Sum_probs=183.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHHHHhc--cCCCccccc-------cee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEIISNL--KHRNLVPLR-------GCC 378 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~iL~~L--~H~NLV~L~-------G~c 378 (683)
..+|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456888999999999999999975 7899999999875432 234577886655555 599988754 333
Q ss_pred eecCCC-----------CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccch------hhhHHHHHHHHHHHh
Q 005691 379 VVDGDN-----------ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR------KNIILDVAKGLAYLH 441 (683)
Q Consensus 379 ~~~~~~-----------~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r------~~Ia~~iA~gL~yLH 441 (683)
...... ......++||||++ |+|.+++... ...+.+..+ +.|+.|++.||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--------DFVYVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--------HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--------ccccchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 221110 01145899999999 8999999432 235677777 888999999999999
Q ss_pred cccCCCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCcccccc--CCCCccccEEEcchhHH
Q 005691 442 YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVIL 519 (683)
Q Consensus 442 ~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLl 519 (683)
+.+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 212 ---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ 284 (371)
T 3q60_A 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284 (371)
T ss_dssp ---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHH
T ss_pred ---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHH
Confidence 889999999999999999999999999999865432 113457799999999987 67999999999999999
Q ss_pred HHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005691 520 EIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS 599 (683)
Q Consensus 520 ELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~ 599 (683)
||++|+.||......... .|. ...........+... ........+..++..|++.||++|||+.
T Consensus 285 elltg~~Pf~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 285 RVWCLFLPFGLVTPGIKG-----SWK-----RPSLRVPGTDSLAFG------SCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp HHHHSSCSTTBCCTTCTT-----CCC-----BCCTTSCCCCSCCCT------TSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred HHHhCCCCCCCcCccccc-----chh-----hhhhhhccccccchh------hccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999999999765432211 110 000000000011000 0112244677899999999999999999
Q ss_pred HHHH
Q 005691 600 DALK 603 (683)
Q Consensus 600 eVl~ 603 (683)
++++
T Consensus 349 e~l~ 352 (371)
T 3q60_A 349 EAME 352 (371)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=341.52 Aligned_cols=266 Identities=25% Similarity=0.347 Sum_probs=184.2
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++. ..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~ 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV------VK 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE------SS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe------ec
Confidence 34578999999999999999999854 68999999886543 233567889999999999999999999997 45
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++...... .......+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAK-GEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHT-TTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhc-cccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEE
Confidence 6799999999999999998432110 0112356899999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCc----cccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 468 VADFGLAKQSREGQS----HLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 468 LaDFGla~~~~~~~~----~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
|+|||+++....... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------- 234 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------- 234 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------
Confidence 999999986643321 12234579999999999875 568999999999999999999999997532211
Q ss_pred hhhhhhhhcCc--c-ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGK--V-WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~--l-~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.......... . ....++.+.. .....+.+++..|++.||++|||+.++++
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 235 -VLMLTLQNDPPSLETGVQDKEMLK----------KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -HHHHHHTSSCCCTTC-----CCCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHhccCCCccccccccchhhh----------hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111111110 0 0001111111 12345678999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.94 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=155.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|+|||++++++.... .....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD-VEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC-TTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC-cccCc
Confidence 368999999999999999999865 689999999865322 22456899999999999999999999986432 12346
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+ +|+|.+++. ....+++..++.|+.||+.||+||| +.+|+||||||+||||+.++.+||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~---------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFR---------TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CEEEEECCC-SEEHHHHHH---------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-ccchhhhcc---------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEee
Confidence 789999998 578888883 2346999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCc--------------------------cccccccCCCcccCcccc-ccCCCCccccEEEcchhHHHH
Q 005691 469 ADFGLAKQSREGQS--------------------------HLTTRVAGTHGYLAPEYA-LYGQLTEKSDVYSFGVVILEI 521 (683)
Q Consensus 469 aDFGla~~~~~~~~--------------------------~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSfGvlLlEL 521 (683)
+|||+++....... ...+...||+.|+|||++ ....++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 99999987643211 123446789999999976 466799999999999999999
Q ss_pred hhCC
Q 005691 522 MCGR 525 (683)
Q Consensus 522 ltGr 525 (683)
++|.
T Consensus 278 ltg~ 281 (458)
T 3rp9_A 278 LNMI 281 (458)
T ss_dssp HTTS
T ss_pred HHhc
Confidence 9943
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.97 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=197.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC----ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD----FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~----~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE----E 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC----C
Confidence 478999999999999999999974 68899999986542 23356799999999999999999999998522 3
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||++++ |.+++... ....+++..++.|+.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~ 148 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSV-------PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTL 148 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHS-------TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred CCeEEEEehhccCC-HHHHHHhC-------cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcE
Confidence 45789999999887 66666322 2346899999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCC-ccccccccCCCcccCccccccCC--CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 467 RVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 467 KLaDFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
||+|||+++...... ........||..|+|||.+.... ++.++||||||+++|||++|+.||.... ...
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~ 220 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYK 220 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHH
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHH
Confidence 999999998764322 22234467999999999987643 4789999999999999999999986421 111
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
....+..+.. .+.. .....+.+++..|++.||++|||+.|+++.
T Consensus 221 -~~~~i~~~~~------~~~~----------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 221 -LFENIGKGSY------AIPG----------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHHHHHCCC------CCCS----------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHHHHhcCCC------CCCC----------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122222211 1111 123456789999999999999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.30 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=199.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
..++|...+.||+|+||.||+++.. +|+.||||++...... +.+|++++.++ +||||+++++++. .+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~------~~~ 89 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD------DGK 89 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE------CSS
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE------cCC
Confidence 3568999999999999999999976 5889999998764332 45688999888 7999999999986 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC----C
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD----M 464 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~----~ 464 (683)
..++||||+++|+|.+++.. ...+++..+..++.+++.||+||| +.+|+||||||+|||+.++ +
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~---------~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~ 157 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILR---------QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPE 157 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHT---------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGG
T ss_pred EEEEEEeCCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcC
Confidence 89999999999999999842 346899999999999999999999 8899999999999998433 3
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
.+||+|||+++....... ......||+.|+|||.+....++.++|||||||++|||++|+.||....... . ..
T Consensus 158 ~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~-~~ 230 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----P-EE 230 (342)
T ss_dssp GEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----H-HH
T ss_pred eEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----H-HH
Confidence 599999999987654332 2334678999999999988889999999999999999999999997432211 1 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+...+..+... +... ........+.+++..|++.||++|||+.++++
T Consensus 231 ~~~~i~~~~~~------~~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 231 ILARIGSGKFS------LSGG------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHCCCC------CCST------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHccCCcc------cCcc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22222233221 0000 11123346778999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.15 Aligned_cols=265 Identities=19% Similarity=0.280 Sum_probs=189.7
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
...++|...++||+|+||+||+|+.. +++.||||++....... .+.+.+|++++++++||||+++++++. .
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~ 104 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH------H 104 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE------E
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe------c
Confidence 44578999999999999999999865 68899999986543322 346789999999999999999999997 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee-----c
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL-----D 461 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL-----d 461 (683)
+...++||||++ |+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+|||+ +
T Consensus 105 ~~~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~ 171 (329)
T 3gbz_A 105 NHRLHLIFEYAE-NDLKKYMDK---------NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDAS 171 (329)
T ss_dssp TTEEEEEEECCS-EEHHHHHHH---------CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC----
T ss_pred CCEEEEEEecCC-CCHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCC
Confidence 678999999998 599998832 346899999999999999999999 7899999999999999 4
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
+++.+||+|||+++....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------ 244 (329)
T 3gbz_A 172 ETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------ 244 (329)
T ss_dssp -CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred ccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------
Confidence 556699999999987643322 23345789999999999874 4899999999999999999999999643211
Q ss_pred hhhhhhhhhhc-Ccccc-------------ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLVKA-GKVWQ-------------ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~~~-g~l~e-------------~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+......+. +...+ ...+...... ............+.+++..|++.||++|||+.|+++
T Consensus 245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 245 --DQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKT-LKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp --HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC-HHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhcccc-HhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 001111000 00000 0000000000 000000112346778999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.21 Aligned_cols=247 Identities=26% Similarity=0.341 Sum_probs=190.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc---ChHHHHHHHHH-HHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ---GDAEFCNEVEI-ISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~---~~~~f~~Ev~i-L~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+++.. +++.||||++...... ....+..|..+ ++.++|||||++++++. .
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~------~ 110 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ------T 110 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE------C
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE------e
Confidence 367999999999999999999976 5789999999765332 23456777776 57789999999999987 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++.. ...+++...+.++.+|+.||+||| +.+|+||||||+|||++.++.+
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQR---------ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCE
Confidence 6789999999999999999832 346889999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+. .
T Consensus 179 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~-~ 248 (373)
T 2r5t_A 179 VLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEM-Y 248 (373)
T ss_dssp EECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHH-H
T ss_pred EEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHH-H
Confidence 999999998643322 234456899999999999999999999999999999999999999964221 111 1
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
..+..+.. .+. ......+..++..|++.||++||++.+.+
T Consensus 249 ~~i~~~~~------~~~----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 249 DNILNKPL------QLK----------PNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HHHHHSCC------CCC----------SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred HHHHhccc------CCC----------CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 11111111 010 11233567889999999999999985433
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.56 Aligned_cols=268 Identities=23% Similarity=0.384 Sum_probs=197.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...++||+|+||.||+|+.. +|+.||||++....... .+.+.+|++++++++||||+++++++. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~ 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK------KKK 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------ETT
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee------cCC
Confidence 357899999999999999999976 48999999986654332 345889999999999999999999997 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++. ....+++..++.|+.+++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 98 ~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLEL---------FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EEEEEEECCSEEHHHHHHH---------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEecCCcchHHHHHh---------hccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEE
Confidence 8999999999999998763 2346999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh---
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW--- 544 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~--- 544 (683)
+|||+++....... ......||..|+|||.+.+. .++.++||||||+++|||++|+.||......+ .+...
T Consensus 166 ~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~ 240 (331)
T 4aaa_A 166 CDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID----QLYHIMMC 240 (331)
T ss_dssp CCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred EeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHH
Confidence 99999986544322 23345789999999998875 78999999999999999999999986433211 01000
Q ss_pred -------hhhhhhcCc-cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 -------VWSLVKAGK-VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 -------v~~~~~~g~-l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+.... ......+.+....... .......+.+.+++..|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLE-RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hCCCChhhhhHhhhccccccccCccccccchhh-hcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011111111 0111111111110000 000123456789999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=333.96 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=197.7
Q ss_pred HHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
...++|...+.||+|+||.||+|+.. +|+.||||++.... ..+++.+|++++.+++||||+++++++. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~ 97 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF------KNT 97 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE------ETT
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE------eCC
Confidence 34568999999999999999999976 58999999987532 3567999999999999999999999997 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ....+++..++.++.+++.||.||| +.+|+||||||+||+++.++.+||
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 166 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRL--------RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKL 166 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHH--------HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEEeecCCCCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEE
Confidence 78999999999999999832 2346899999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... ......||..|+|||.+....++.++||||||+++|||++|+.||..... .......
T Consensus 167 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~ 237 (314)
T 3com_A 167 ADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFMI 237 (314)
T ss_dssp CCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHH
T ss_pred eecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHH
Confidence 99999987654322 23345789999999999999999999999999999999999999864221 0111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+. .+.+. .+......+..++..|++.||++|||+.++++
T Consensus 238 -~~~~-----~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 238 -PTNP-----PPTFR--------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -HHSC-----CCCCS--------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -hcCC-----CcccC--------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111 11110 11122346778999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.73 Aligned_cols=265 Identities=25% Similarity=0.345 Sum_probs=194.6
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++.++||||+++++++..........
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999974 6899999998653222 2356889999999999999999999987443322335
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+ +++|.+++. ...+++..+..++.|+++||+||| +.+|+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~----------~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl 169 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK----------HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKI 169 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecC-CCCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEE
Confidence 679999999 889999883 236889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++..... .+...||+.|+|||.+.+ ..++.++||||+||+++||++|+.||...... +....
T Consensus 170 ~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~l~~ 237 (367)
T 1cm8_A 170 LDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--------DQLKE 237 (367)
T ss_dssp CCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred Eeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 999999875432 334678999999999887 78999999999999999999999999643211 01111
Q ss_pred hhh-cCccc-------------cccC--ccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVK-AGKVW-------------QALD--PSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~-~g~l~-------------e~vD--~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+ .|... ..+. +..... ++.. ........+.+++..|++.||++|||+.|+++.
T Consensus 238 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 238 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK-DFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC-CGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCC-CHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 00000 0000 000000 0000 001123467789999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.60 Aligned_cols=262 Identities=20% Similarity=0.295 Sum_probs=198.6
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||.||+|+. .+++.||||++.. ...+.+.+|++++++++ |+||+++++++... .....
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~----~~~~~ 108 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP----VSRTP 108 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT----TTCCE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccC----CCCce
Confidence 6789999999999999999986 4689999999864 33567999999999997 99999999998632 25678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~KLa 469 (683)
++||||+++++|.+++ +.+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+
T Consensus 109 ~lv~e~~~~~~l~~~~------------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~ 173 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLI 173 (330)
T ss_dssp EEEEECCCCCCHHHHG------------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEeccCchhHHHHH------------HhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence 9999999999999987 24888999999999999999999 88999999999999999776 89999
Q ss_pred ccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh----
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW---- 544 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~---- 544 (683)
|||+++....... .....||..|+|||.+.. ..++.++|||||||+++||++|+.||....... ..+...
T Consensus 174 Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~l~~~~~~~ 248 (330)
T 3nsz_A 174 DWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAKVL 248 (330)
T ss_dssp CCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH---HHHHHHHHHH
T ss_pred eCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH---HHHHHHHHhc
Confidence 9999987654332 234578999999999876 678999999999999999999999985432210 001000
Q ss_pred ----hhhhhhcCccccccCcccc--------cc-cc-ccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 ----VWSLVKAGKVWQALDPSLL--------KE-DD-FLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 ----v~~~~~~g~l~e~vD~~l~--------~~-~~-~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+..... .+++.+. .. .. ............+.+++..|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 249 GTEDLYDYIDKYNI--ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CHHHHHHHHHHTTC--CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhHHHHhcc--ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000110000 0000000 00 00 000011223457788999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=361.71 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=203.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...++||+|+||.||+++.. +|+.||+|++.... ....+.+.+|++++++++|||||++++++. ...
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~------~~~ 258 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE------TKT 258 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE------CSS
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe------eCC
Confidence 57888899999999999999985 68999999996542 234567899999999999999999999986 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.||| +.+|+||||||+||||+.++.+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~-----~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVD-----EDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSS-----TTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEEeccCCCHHHHHHHhh-----cccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEE
Confidence 8999999999999999985432 12346999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......
T Consensus 331 ~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~- 404 (543)
T 3c4z_A 331 SDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQR- 404 (543)
T ss_dssp CCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHH-
T ss_pred eecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHH-
Confidence 99999987654432 23446899999999999999999999999999999999999999975432111 1111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH-----HHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI-----SDAL 602 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm-----~eVl 602 (683)
...+.. . .+......+..++..|++.||++||++ .+|+
T Consensus 405 i~~~~~------~----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 405 VLEQAV------T----------YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp HHHCCC------C----------CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred Hhhccc------C----------CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 111111 0 111223456788999999999999975 5665
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=333.35 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=183.8
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc-ChHH-HHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ-GDAE-FCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~-~~~~-f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+++. .+|+.||||++...... ...+ +..+...++.++||||+++++++. .+.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~------~~~ 79 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF------REG 79 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE------CSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee------ccC
Confidence 46899999999999999999997 47899999998654322 2223 444555578889999999999997 556
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCceeeccCCcEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNILLd~~~~~K 467 (683)
..++||||++ |+|.+++.... .....+++..++.|+.|++.||+||| +. +|+||||||+|||++.++.+|
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVI-----DKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHH-----HTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEE
T ss_pred CEEEEEehhc-cchHHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEE
Confidence 7999999997 58877774321 12357999999999999999999999 66 999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCcccc----ccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA----LYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
|+|||+++....... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||+..... . .
T Consensus 151 l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~ 221 (290)
T 3fme_A 151 MCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------F-Q 221 (290)
T ss_dssp BCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------H-H
T ss_pred EeecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------H-H
Confidence 999999987654322 2334699999999996 5667899999999999999999999999642211 0 1
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.......... +.. ........+.+++..|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 222 QLKQVVEEPS------PQL---------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHHSCC------CCC---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhccCC------CCc---------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1112222211 111 11122346778999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.43 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=195.7
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--------cChHHHHHHHHHHHhccCCCcccccceeeec
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--------QGDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--------~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~ 381 (683)
..++|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++.
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 85 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-- 85 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc--
Confidence 4568999999999999999999975 578999999865321 11235889999999999999999999985
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
....++||||+++|+|.+++.. ...+++...+.++.|++.||.||| +.+|+||||||+|||++
T Consensus 86 -----~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~ 148 (322)
T 2ycf_A 86 -----AEDYYIVLELMEGGELFDKVVG---------NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS 148 (322)
T ss_dssp -----SSSEEEEEECCTTEETHHHHST---------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEES
T ss_pred -----CCceEEEEecCCCCcHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEe
Confidence 2348999999999999998832 346899999999999999999999 88999999999999998
Q ss_pred cCCc---EEEcccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 462 ADMR---ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 462 ~~~~---~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
.++. +||+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 149 ~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (322)
T 2ycf_A 149 SQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 226 (322)
T ss_dssp SSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS
T ss_pred cCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH
Confidence 7664 9999999998764322 223457999999999874 5678999999999999999999999997543211
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+ ...+..+... ..+.. ..+....+.+++..|++.||++|||+.++++
T Consensus 227 ----~~----~~~~~~~~~~--~~~~~----------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 227 ----SL----KDQITSGKYN--FIPEV----------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----CH----HHHHHHTCCC--CCHHH----------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HH----HHHHHhCccc--cCchh----------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11 1112222210 00111 0122356788999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.02 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=191.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...+.||+|+||.||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++. .....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH------TEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE------CSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe------eCCEE
Confidence 57889999999999999999976 68999999986543222 224567999999999999999999987 55679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++ |+|.+++... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 76 ~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 76 TLVFEYLD-KDLKQYLDDC--------GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp EEEEECCS-EEHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECS
T ss_pred EEEecccc-cCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEcc
Confidence 99999997 5888887422 346899999999999999999999 88999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+++....... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+.+..
T Consensus 144 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~ 217 (324)
T 3mtl_A 144 FGLARAKSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----EQLHFIFRIL 217 (324)
T ss_dssp SSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHH
T ss_pred CcccccccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHh
Confidence 999986543322 2334578999999999876 56899999999999999999999999653221 1111111111
Q ss_pred hcC---cccccc---------CccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAG---KVWQAL---------DPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g---~l~e~v---------D~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... ...... .+..... ... .........+.+++..|++.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 218 GTPTEETWPGILSNEEFKTYNYPKYRAE-ALL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCTTTSTTGGGCHHHHHTCCCCCCCC-CHH-HHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChHhchhhhcchhhcccccccccch-hhh-hhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 000000 0000000 000 000112346678999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.40 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=201.3
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc---------cChHHHHHHHHHHHhcc-CCCcccccceee
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF---------QGDAEFCNEVEIISNLK-HRNLVPLRGCCV 379 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~---------~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~ 379 (683)
..++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999975 688999999875431 11345889999999996 999999999986
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
.....++||||+++|+|.+++.. ...+++..++.++.+++.||.||| +.+|+||||||+||+
T Consensus 95 ------~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil 156 (298)
T 1phk_A 95 ------TNTFFFLVFDLMKKGELFDYLTE---------KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENIL 156 (298)
T ss_dssp ------CSSEEEEEEECCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred ------cCCeEEEEEeccCCCcHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEE
Confidence 56789999999999999999832 346899999999999999999999 889999999999999
Q ss_pred eccCCcEEEcccCcccccccCCccccccccCCCcccCccccc------cCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 460 LDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL------YGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 460 Ld~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
++.++.+||+|||+++....... .....||..|+|||.+. ...++.++||||||++++||++|+.||.....
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EcCCCcEEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 99999999999999987654322 33457899999999885 45688999999999999999999999864221
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.. .......+... ...+ ........+.+++..|++.||++|||+.|+++
T Consensus 235 --------~~-~~~~~~~~~~~-~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 --------ML-MLRMIMSGNYQ-FGSP-----------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --------HH-HHHHHHHTCCC-CCTT-----------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --------HH-HHHHHhcCCcc-cCcc-----------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 11122222110 0000 11223456788999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=358.43 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=202.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...++||+|+||.||+++.. +|+.||||++.... ....+.+.+|++++++++|||||++++++. ..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~ 98 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE------DK 98 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE------CS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE------eC
Confidence 468999999999999999999976 78999999986543 234567999999999999999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---ccCC
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADM 464 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL---d~~~ 464 (683)
...++||||+++|+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+|||+ +.++
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIIS---------RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHT---------CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTC
T ss_pred CEEEEEEecCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCC
Confidence 789999999999999998842 346899999999999999999999 8899999999999999 5678
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
.+||+|||+++....... .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||..... . .
T Consensus 167 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~----~ 234 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----Y----D 234 (484)
T ss_dssp CEEECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H----H
T ss_pred cEEEEeeeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----H----H
Confidence 999999999987654332 334579999999998865 799999999999999999999999964321 1 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
....+..+...- ... ........+.+++..|++.||++|||+.|+++
T Consensus 235 ~~~~i~~~~~~~----~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 235 ILKKVEKGKYTF----ELP--------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHCCCCC----CSG--------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCC----CCc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 122222222210 000 11123456778999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.48 Aligned_cols=275 Identities=23% Similarity=0.328 Sum_probs=195.9
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCC--
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN-- 384 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~-- 384 (683)
++...++|...+.||+|+||.||+|+. .+|+.||||++...... ..+|+++++.++|+|||++++++......
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999996 47899999998654322 33699999999999999999998654321
Q ss_pred ------------------------------CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHH
Q 005691 385 ------------------------------ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVA 434 (683)
Q Consensus 385 ------------------------------~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA 434 (683)
......++||||++ |+|.+.+.... .....+++..++.++.|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-----RSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHH-----HTTCCCCHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-----hcCCCCCHHHHHHHHHHHH
Confidence 23445889999998 58777764321 1235799999999999999
Q ss_pred HHHHHHhcccCCCccccCCCCCceeec-cCCcEEEcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEE
Q 005691 435 KGLAYLHYGVKPAIYHRDIKATNILLD-ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVY 512 (683)
Q Consensus 435 ~gL~yLH~~~~~~IiHrDIKpsNILLd-~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVw 512 (683)
+||+||| +.+|+||||||+|||++ .++.+||+|||+++....... .....||..|+|||.+.+. .++.++|||
T Consensus 152 ~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999999 89999999999999998 689999999999987654332 2345789999999998764 589999999
Q ss_pred EcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh----------cCccccccCccccccccccCCChHHHHHHHHH
Q 005691 513 SFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK----------AGKVWQALDPSLLKEDDFLSLNPKAIMERFVL 582 (683)
Q Consensus 513 SfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~----------~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~ 582 (683)
||||++|||++|+.||......+ .+...+. ... .....+..-+.+... .+....+......+.+
T Consensus 227 slG~il~ell~g~~pf~~~~~~~----~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSID----QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAK-DWRKILPEGTPSLAID 300 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCC-CHHHHSCTTCCHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCChHH----HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcc-cHHhhCCCCCCHHHHH
Confidence 99999999999999997432211 1111110 000 000000000111000 0000011122345788
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 005691 583 VGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 583 lal~C~~~dP~~RPtm~eVl~ 603 (683)
++..|++.||++|||+.|+++
T Consensus 301 li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.21 Aligned_cols=271 Identities=25% Similarity=0.307 Sum_probs=198.7
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCC--CCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD--NER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~--~~~ 386 (683)
.++|...+.||+|+||.||+|+. .+|+.||||++...... ....+.+|++++++++||||+++++++..... ...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36899999999999999999997 47899999998654322 24578899999999999999999999875321 112
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++ +|.+.+... ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--------LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--------TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccCC-CHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCE
Confidence 4578999999985 676666322 246999999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCC---ccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 467 RVADFGLAKQSREGQ---SHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 467 KLaDFGla~~~~~~~---~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
||+|||+++...... ........||+.|+|||.+.+ ..++.++|||||||+++||++|+.||...... ...
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~ 238 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQL 238 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHH
Confidence 999999998765322 222345678999999998875 56899999999999999999999998743221 011
Q ss_pred hhhhhh-----------hhcCccccccCccccccccccCCChHHH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 543 DWVWSL-----------VKAGKVWQALDPSLLKEDDFLSLNPKAI------MERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 543 ~~v~~~-----------~~~g~l~e~vD~~l~~~~~~~~~~~~e~------~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+... +......+.+....... ....+. ...+.+++..|++.||++|||+.|+++.
T Consensus 239 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQK-----RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCC-----CCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCChhhccccccchhhcccccccccc-----cCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111111 00000000000000000 011111 2346789999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=355.11 Aligned_cols=204 Identities=27% Similarity=0.381 Sum_probs=167.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++|+||+++++++..... ....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL-LKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT-TTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC-CcCC
Confidence 468999999999999999999975 578899999975422 224578999999999999999999999864321 1235
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||++ |+|.+++. ....+++..++.++.||++||+||| +.+|+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~---------~~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK---------TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH---------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCC-cCHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEE
Confidence 7899999986 59999883 2346999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCc---------------------cccccccCCCcccCcccc-ccCCCCccccEEEcchhHHHHhhCCC
Q 005691 469 ADFGLAKQSREGQS---------------------HLTTRVAGTHGYLAPEYA-LYGQLTEKSDVYSFGVVILEIMCGRK 526 (683)
Q Consensus 469 aDFGla~~~~~~~~---------------------~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSfGvlLlELltGr~ 526 (683)
+|||+++....... ...+...||+.|+|||.+ ....++.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 99999987643321 123557899999999986 56679999999999999999999766
Q ss_pred CCC
Q 005691 527 ALD 529 (683)
Q Consensus 527 p~~ 529 (683)
|+.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.68 Aligned_cols=273 Identities=21% Similarity=0.242 Sum_probs=192.5
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++..........
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999965 688999999875432 22356889999999999999999999987543333445
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++ +|.+++. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl 168 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 168 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEEcCCC-CHHHHHh-----------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEE
Confidence 78999999974 7777772 35889999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc-------c--
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA-------C-- 539 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~-------~-- 539 (683)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .
T Consensus 169 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 169 LDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246 (371)
T ss_dssp CCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCC
T ss_pred EEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998654322 2334679999999999999999999999999999999999999996432100000 0
Q ss_pred -----chhhhhhhhhhcCc------cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 540 -----LITDWVWSLVKAGK------VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 540 -----~l~~~v~~~~~~g~------l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+............ +.+.+...+... ...........+.+++..|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA---DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCC---SSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcc---cccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000000 000000000000 000112235578899999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=358.22 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=196.6
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||+||+|+.. ++..||||++.... ......+.+|+.+++.++|||||++++++. ...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~ 109 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE------DKR 109 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE------CSS
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE------eCC
Confidence 457999999999999999999976 68899999987643 333567999999999999999999999997 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC---Cc
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD---MR 465 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~---~~ 465 (683)
..++||||+++|+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.+ +.
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 177 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIH---------RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDAL 177 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCC
T ss_pred EEEEEEecCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCc
Confidence 89999999999999988832 346899999999999999999999 8899999999999999764 45
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|||++|+.||..... .+ +
T Consensus 178 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~ 245 (494)
T 3lij_A 178 IKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QE-I 245 (494)
T ss_dssp EEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-H
T ss_pred EEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HH-H
Confidence 9999999998765432 234467999999999876 5799999999999999999999999964321 11 1
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...+..+... ...+.. ......+..++..|++.||.+|||+.|+++
T Consensus 246 ~~~i~~~~~~-~~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 246 LRKVEKGKYT-FDSPEW-----------KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHTCCC-CCSGGG-----------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCC-CCchhc-----------ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 2222222211 001111 122345678999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=371.34 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=202.2
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEcC----CcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeec
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVD 381 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~ 381 (683)
+.+...++|...+.||+|+||.||+|++.. +..||||++...... ..+.|.+|+.++++++|||||+++|++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-- 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--
Confidence 334445788899999999999999999742 457999988654322 2367999999999999999999999983
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.+..++||||+++|+|.+++... ...++|..++.++.|++.||+||| +.+|+||||||+|||++
T Consensus 462 -----~~~~~lv~E~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~ 525 (656)
T 2j0j_A 462 -----ENPVWIIMELCTLGELRSFLQVR--------KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVS 525 (656)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHT--------TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred -----cCceEEEEEcCCCCcHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEe
Confidence 34589999999999999999421 246899999999999999999999 78999999999999999
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccc
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACL 540 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~ 540 (683)
.++.+||+|||+++..............+|+.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 526 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------- 598 (656)
T 2j0j_A 526 SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------- 598 (656)
T ss_dssp ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------
T ss_pred CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------
Confidence 99999999999998775544444445667889999999999999999999999999999997 9999864321
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+.. ..+..+.... + +......+..++..|++.||++|||+.+|+++|+.
T Consensus 599 -~~~~-~~i~~~~~~~-----~----------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 599 -NDVI-GRIENGERLP-----M----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp -HHHH-HHHHHTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHH-HHHHcCCCCC-----C----------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111 1122221100 1 11223467789999999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.99 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=201.7
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...++||+|+||.||+|+. .+++.||||++..... ..++..|++++..++|.+.+..+.++.. .....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~-----~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV-----EGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE-----ETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe-----eCCEE
Confidence 46899999999999999999996 5689999998765433 3358899999999988665555544432 45678
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---ccCCcEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRAR 467 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL---d~~~~~K 467 (683)
++||||+ +++|.+++... ...++|..++.|+.||+.||+||| +.+|+||||||+|||| +.++.+|
T Consensus 79 ~lvme~~-g~sL~~ll~~~--------~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEEECC-CCBHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEEECC-CCCHHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEE
Confidence 9999999 99999998421 346999999999999999999999 8899999999999999 6889999
Q ss_pred EcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 468 VADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 468 LaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
|+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~----- 221 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----- 221 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-----
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-----
Confidence 9999999877554322 12356799999999999999999999999999999999999999976443221
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.... ..+........++. +. ......+.+++..|++.+|++||++.+|+++|+.
T Consensus 222 ~~~~-~~i~~~~~~~~~~~-l~----------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 222 KQKY-EKISEKKVATSIEA-LC----------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHHH-HHHHHHHHHSCHHH-HH----------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHH-HHHhhccccccHHH-Hh----------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 1111 11111111111000 00 1123467889999999999999999999998865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=356.15 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=200.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...++||+|+||+||+++.. +++.||||++.... ......+.+|++++++++|||||++++++. ...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~ 94 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE------DSS 94 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE------CSS
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE------cCC
Confidence 468999999999999999999975 68999999986532 334667999999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec---cCCc
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD---ADMR 465 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd---~~~~ 465 (683)
..++||||+++|+|.+++.. ...+++..++.|+.|++.||.||| +.+|+||||||+|||++ .++.
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 162 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIK---------RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCD 162 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCC
T ss_pred EEEEEEEcCCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCC
Confidence 89999999999999998832 346899999999999999999999 88999999999999995 4567
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .+ .
T Consensus 163 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~-~ 230 (486)
T 3mwu_A 163 IKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YD-I 230 (486)
T ss_dssp EEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-H
T ss_pred EEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH-H
Confidence 9999999998765432 2334579999999998865 699999999999999999999999964221 11 1
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
...+..+.... ... ........+.+++..|++.||++|||+.++++.
T Consensus 231 ~~~i~~~~~~~----~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 231 LKRVETGKYAF----DLP--------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHTCCCS----CSG--------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHhCCCCC----CCc--------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 12222222110 000 111223467789999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=336.33 Aligned_cols=270 Identities=22% Similarity=0.322 Sum_probs=194.0
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecC--------
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDG-------- 382 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~-------- 382 (683)
.++|...+.||+|+||.||+|+..+ |+.||||++........+++.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3678999999999999999999864 8999999997665555677999999999999999999999874321
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec-
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD- 461 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd- 461 (683)
........++||||++ |+|.+++. ...+++..++.++.|++.||+||| +.+|+||||||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 155 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----------QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINT 155 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEET
T ss_pred cccccCceeEEeeccC-CCHHHHhh----------cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcC
Confidence 1124567899999998 69999882 246889999999999999999999 88999999999999997
Q ss_pred cCCcEEEcccCcccccccCCc--cccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc
Q 005691 462 ADMRARVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~ 538 (683)
+++.+||+|||+++....... .......||..|+|||.+.. ..++.++||||||+++|||++|+.||......
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 231 (320)
T 2i6l_A 156 EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---- 231 (320)
T ss_dssp TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH----
Confidence 567999999999987643221 12234567999999998865 67899999999999999999999999743211
Q ss_pred cchhhhhhhhhhcCc---------ccccc----CccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 539 CLITDWVWSLVKAGK---------VWQAL----DPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~---------l~e~v----D~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.......... +...+ ...+.................+.+++..|++.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 ----EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp ----HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00111110000 00000 000000000000000112456788999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=343.24 Aligned_cols=274 Identities=20% Similarity=0.253 Sum_probs=199.7
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc--------CCCcccccceeeecC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK--------HRNLVPLRGCCVVDG 382 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~--------H~NLV~L~G~c~~~~ 382 (683)
.++|...++||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 6889999998643 223467889999999996 788999999986432
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCceeec
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNILLD 461 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNILLd 461 (683)
. .+...++||||+ +|+|.+++... ....+++..++.|+.|++.||+||| +. +|+||||||+|||++
T Consensus 115 ~--~~~~~~lv~e~~-~~~l~~~~~~~-------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 115 V--NGTHICMVFEVL-GHHLLKWIIKS-------NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLS 181 (397)
T ss_dssp T--TEEEEEEEECCC-CCBHHHHHHHT-------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEEC
T ss_pred C--CCceEEEEEecc-CccHHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEe
Confidence 1 345789999999 55666665322 1246999999999999999999999 76 999999999999999
Q ss_pred cCC-------------------------------------------------cEEEcccCcccccccCCccccccccCCC
Q 005691 462 ADM-------------------------------------------------RARVADFGLAKQSREGQSHLTTRVAGTH 492 (683)
Q Consensus 462 ~~~-------------------------------------------------~~KLaDFGla~~~~~~~~~~~~~~~GT~ 492 (683)
.++ .+||+|||+++..... .+...||.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~ 257 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTR 257 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCG
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCC
Confidence 775 7999999999876432 23457899
Q ss_pred cccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCc-cchhhhhhhh--------hhcCccc-cccCcc-
Q 005691 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA-CLITDWVWSL--------VKAGKVW-QALDPS- 561 (683)
Q Consensus 493 ~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~-~~l~~~v~~~--------~~~g~l~-e~vD~~- 561 (683)
.|+|||++.+..++.++|||||||++|||++|+.||.......... .......... +..+... +..+..
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 9999999999999999999999999999999999997544322100 0000000000 0001000 000000
Q ss_pred -ccccccc-----------cCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 562 -LLKEDDF-----------LSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 562 -l~~~~~~-----------~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+...... ....+.+....+.+++..|++.||++|||+.|+++
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000 00013455667889999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.97 Aligned_cols=272 Identities=26% Similarity=0.330 Sum_probs=195.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.+|...+.||+|+||.||+|+.. +|+.||||++..... .+.+|++++++++|+|||++++++............+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888899999999999999985 589999999865322 2346999999999999999999987543322334567
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC-CcEEEcc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVAD 470 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-~~~KLaD 470 (683)
+||||+++ +|.+.+.... .....+++..++.++.|+++||+||| +.+|+||||||+||||+.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~-----~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYS-----RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHH-----HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHh-----hccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEecc
Confidence 99999986 5555442111 12357999999999999999999999 8999999999999999965 6789999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh-
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL- 548 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~- 548 (683)
||+++....+.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+..+
T Consensus 201 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~----~~l~~i~~~lg 274 (420)
T 1j1b_A 201 FGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLG 274 (420)
T ss_dssp CTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHC
T ss_pred chhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhC
Confidence 999987654332 2345789999999998764 7999999999999999999999999743211 1111111100
Q ss_pred ------hh--cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 ------VK--AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ------~~--~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+. .....+...+.+... .+...........+.+++..|++.||++|||+.|+++.
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAH-PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCC-CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccCccCCC-CHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 001111111111110 00000011123467889999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=338.52 Aligned_cols=269 Identities=20% Similarity=0.307 Sum_probs=200.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...++||+|+||.||+++.. +++.||||++....... .+.+.+|++++.+++||||+++++++..... .....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-EQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST-TTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc-cccce
Confidence 468999999999999999999975 68889999987543222 3568999999999999999999999864321 23356
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++ |+|.+++. ...+++..++.|+.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK----------TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp EEEEEECCS-EEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEEEEcccC-cCHHHHHH----------hCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEE
Confidence 899999997 58988882 246899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCcc--ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 470 DFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 470 DFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|||+++........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+ ....+.
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~ 245 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHIL 245 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-----HHHHHH
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-----HHHHHH
Confidence 99999876543322 2345689999999998764 458999999999999999999999996533211 111111
Q ss_pred hhhhcCcc---------------ccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 SLVKAGKV---------------WQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 ~~~~~g~l---------------~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.....-.. .....+.-..... ........+.+++..|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 246 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH----HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHH----hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 0000000000000 001123457789999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=339.69 Aligned_cols=260 Identities=21% Similarity=0.303 Sum_probs=196.3
Q ss_pred eehHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--cChHHHHHHHHHHHhcc--CCCccccccee
Q 005691 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLK--HRNLVPLRGCC 378 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~--H~NLV~L~G~c 378 (683)
+.++.+....++|...+.||+|+||.||++...+++.||||++..... ...+.+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 444455556788999999999999999999998899999999865432 23467899999999997 59999999998
Q ss_pred eecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCce
Q 005691 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNI 458 (683)
Q Consensus 379 ~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNI 458 (683)
. .....++||| +.+++|.+++.. ...+++..++.|+.++++||.||| +.+|+||||||+||
T Consensus 98 ~------~~~~~~lv~e-~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NI 158 (313)
T 3cek_A 98 I------TDQYIYMVME-CGNIDLNSWLKK---------KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANF 158 (313)
T ss_dssp E------CSSEEEEEEC-CCSEEHHHHHHH---------CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred e------cCCEEEEEEe-cCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccE
Confidence 7 5567999999 678899999842 347899999999999999999999 78999999999999
Q ss_pred eeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCcccccc-----------CCCCccccEEEcchhHHHHhhCCC
Q 005691 459 LLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALY-----------GQLTEKSDVYSFGVVILEIMCGRK 526 (683)
Q Consensus 459 LLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDVwSfGvlLlELltGr~ 526 (683)
|+++ +.+||+|||+++........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.
T Consensus 159 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (313)
T 3cek_A 159 LIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237 (313)
T ss_dssp EEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence 9965 89999999999876543322 2334579999999999875 478899999999999999999999
Q ss_pred CCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 527 ALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 527 p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
||..... ......... ++..... .+......+.+++..|++.||++|||+.|+++.
T Consensus 238 pf~~~~~-------~~~~~~~~~---------~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 238 PFQQIIN-------QISKLHAII---------DPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTTTCCS-------HHHHHHHHH---------CTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhHHH-------HHHHHHHHH---------hcccccC------CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 9864321 001111111 1111111 001112356788899999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.83 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=183.2
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++..........
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999964 688999999865322 22456889999999999999999999986432222346
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++|+||+ +++|.+++. ...+++..++.++.|+++||+||| +.+|+||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----------~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CCEEEEECC-CEECC---------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEeccc-CCCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEE
Confidence 689999999 789998882 246999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++..... .+...||..|+|||.+.+ ..++.++|||||||+++||++|+.||...... .....+.+
T Consensus 174 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~l~~i~~ 244 (367)
T 2fst_X 174 LDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILR 244 (367)
T ss_dssp CC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred eecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHH
Confidence 999999875432 334678999999999886 68899999999999999999999999643211 00011111
Q ss_pred hhhc-----------CccccccCccccccccccCCCh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVKA-----------GKVWQALDPSLLKEDDFLSLNP----KAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~~-----------g~l~e~vD~~l~~~~~~~~~~~----~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.... ....+.+. .+..... ... ......+.+++..|++.||++|||+.|+++.
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQ-SLTQMPK---MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHH-TSCCCCC---CCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCCHHHHHHhhhHHHHHHHh-ccCCCCC---CCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 00000000 0000000 000 0112456789999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.07 Aligned_cols=209 Identities=24% Similarity=0.395 Sum_probs=155.5
Q ss_pred cCccc-ceeeeecCceEEEEEEEc---CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQ-KNFIGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~-~~~LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+.|.. .++||+|+||.||+|+.. +++.||||++.... ....+.+|++++++++|||||++++++... ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH----ADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEET----TTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecC----CCC
Confidence 44555 457999999999999976 57889999986532 245688999999999999999999998642 356
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee----ccCC
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL----DADM 464 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL----d~~~ 464 (683)
..++||||++ |+|.+++..............+++..++.|+.|++.||+||| +.+|+||||||+|||| +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence 7999999997 477777632211111112335999999999999999999999 8899999999999999 7789
Q ss_pred cEEEcccCcccccccCCc--cccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 465 RARVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999999999987654322 22345689999999999887 45899999999999999999999999654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.48 Aligned_cols=275 Identities=23% Similarity=0.272 Sum_probs=200.9
Q ss_pred HHhcCcccceeeeecCceEEEEEEE--cCCcEEEEEEeeccCc--cChHHHHHHHHHHHhc---cCCCcccccceeeecC
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGIL--QDGTTVAVKKVIESDF--QGDAEFCNEVEIISNL---KHRNLVPLRGCCVVDG 382 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l--~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L---~H~NLV~L~G~c~~~~ 382 (683)
.+.++|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3567899999999999999999997 4688999999865332 2234577888888776 8999999999986322
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
. ......++||||++ |+|.+++.... ...+++..++.++.|++.||.||| +.+|+||||||+|||++.
T Consensus 88 ~-~~~~~~~lv~e~~~-~~L~~~l~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 88 T-DRETKLTLVFEHVD-QDLTTYLDKVP-------EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTS 155 (326)
T ss_dssp C-SSEEEEEEEEECCS-CBHHHHHHHSC-------TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred c-CCCceEEEEEecCC-CCHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcC
Confidence 1 13467899999998 69999884321 235899999999999999999999 889999999999999999
Q ss_pred CCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 463 DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
++.+||+|||+++...... ......||..|+|||.+....++.++||||||+++|||++|+.||...... ...
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~ 228 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQL 228 (326)
T ss_dssp TCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH
T ss_pred CCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHH
Confidence 9999999999998664322 234467899999999999999999999999999999999999999743221 011
Q ss_pred hhhhhhhhcC---cccc---ccCccccc-cccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAG---KVWQ---ALDPSLLK-EDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g---~l~e---~vD~~l~~-~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+....... .... .....+.. ...............+..++..|++.||++|||+.++++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111100000 0000 00000000 000000001123346778999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=357.22 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=199.1
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-------------cChHHHHHHHHHHHhccCCCcccccc
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-------------QGDAEFCNEVEIISNLKHRNLVPLRG 376 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-------------~~~~~f~~Ev~iL~~L~H~NLV~L~G 376 (683)
..++|...++||+|+||+||+|+.. +++.||||++..... ...+++.+|+.++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999975 578999999875432 23467999999999999999999999
Q ss_pred eeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCC
Q 005691 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKAT 456 (683)
Q Consensus 377 ~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKps 456 (683)
++. .....++||||+++|+|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+
T Consensus 114 ~~~------~~~~~~lv~e~~~gg~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~ 175 (504)
T 3q5i_A 114 VFE------DKKYFYLVTEFYEGGELFEQIIN---------RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPE 175 (504)
T ss_dssp EEE------CSSEEEEEEECCTTCBHHHHHHH---------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred EEE------cCCEEEEEEecCCCCcHHHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHH
Confidence 997 56789999999999999998832 346999999999999999999999 889999999999
Q ss_pred ceeeccCC---cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCC
Q 005691 457 NILLDADM---RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533 (683)
Q Consensus 457 NILLd~~~---~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~ 533 (683)
|||++.++ .+||+|||+++...... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.....
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99998775 69999999998765432 234457999999999876 5799999999999999999999999964321
Q ss_pred CCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 534 GSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 534 ~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+ +...+..+...- +.. ........+.+++..|++.||.+|||+.|+++
T Consensus 253 --------~~-~~~~i~~~~~~~--~~~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 253 --------QD-IIKKVEKGKYYF--DFN----------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --------HH-HHHHHHHCCCCC--CHH----------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------HH-HHHHHHcCCCCC--Ccc----------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11 122222222110 000 00122346778999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=370.23 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=201.8
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~ 385 (683)
..++|...++||+|+||.||+|+.. +++.||||++... .....+.+..|..++..+ +|+||+++++++.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~------ 412 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ------ 412 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB------
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE------
Confidence 3568999999999999999999976 5788999999753 233456788999999988 7999999999886
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....+|||||+++|+|.+++.. ...+++..++.|+.||+.||+||| +.+||||||||+|||||.++.
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~---------~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQ---------VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCc
Confidence 56789999999999999999942 246999999999999999999999 889999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.
T Consensus 481 ikL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~- 550 (674)
T 3pfq_A 481 IKIADFGMCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DEL- 550 (674)
T ss_dssp EEECCCTTCEECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH-
T ss_pred EEEeecceeeccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHH-
Confidence 99999999986433222 24457899999999999999999999999999999999999999964321 111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI-----SDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm-----~eVl~ 603 (683)
...+..+.. . .+......+..++..|++.||++||++ .||++
T Consensus 551 ~~~i~~~~~------~----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 551 FQSIMEHNV------A----------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHHSSCC------C----------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHHhCCC------C----------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 122222211 0 111234467789999999999999997 67653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=344.99 Aligned_cols=273 Identities=25% Similarity=0.310 Sum_probs=197.0
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
..+|...++||+|+||.||+|+..++..||+|++...... ..+|+++++.++|||||++++++............+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3578899999999999999999988888999998654322 236999999999999999999997654333444578
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec-cCCcEEEcc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD-ADMRARVAD 470 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd-~~~~~KLaD 470 (683)
+||||++++.+....... .....+++..++.++.|+++||+||| +.+|+||||||+|||++ .++.+||+|
T Consensus 115 lv~e~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYA------KLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp EEEECCSEEHHHHHHHHH------HTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeccCccHHHHHHHHH------hhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 999999876544332111 12357899999999999999999999 88999999999999999 799999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh-
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL- 548 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~- 548 (683)
||+++....+.. .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ..+...+..+
T Consensus 186 FG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~~g 259 (394)
T 4e7w_A 186 FGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKVLG 259 (394)
T ss_dssp CTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHC
T ss_pred CCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhC
Confidence 999987654332 2345789999999998764 5899999999999999999999999743211 0111111000
Q ss_pred ------hh--cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 ------VK--AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ------~~--~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
+. .....+..-+.+... .+....+......+.+++..|++.||++|||+.|+++.
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPH-PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCC-CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccccccCC-cHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 000000000000000 00000011123467889999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.34 Aligned_cols=272 Identities=22% Similarity=0.292 Sum_probs=197.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++..+. ......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS-FENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC-STTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc-cCccce
Confidence 468999999999999999999976 688999999864332 22456889999999999999999999886332 123467
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||++ |+|.+++. ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~----------~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIS----------TQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp EEEEECCCS-EEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEEeccC-ccHHHHHh----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEE
Confidence 899999997 68988873 246899999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCcc---------ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 470 DFGLAKQSREGQSH---------LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 470 DFGla~~~~~~~~~---------~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
|||+++........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 230 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---- 230 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----
Confidence 99999876432211 1223578999999998764 778999999999999999999999996432100
Q ss_pred chhhhhhhhhhc----CccccccCcc-------cccc-ccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 540 LITDWVWSLVKA----GKVWQALDPS-------LLKE-DDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 540 ~l~~~v~~~~~~----g~l~e~vD~~-------l~~~-~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
....+...... .......++. +... ..............+.+++..|++.||++|||+.|+++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 231 -QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp -HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 0000000000 0000 00000000122346778999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.24 Aligned_cols=285 Identities=20% Similarity=0.255 Sum_probs=193.0
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 306 ~el~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.+.....++|...+.||+|+||.||+|+.. +|+.||||++..... ....+.+|++.++.++||||+++++++......
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456777899999999999999999999975 689999999865433 334577889999999999999999999754321
Q ss_pred -CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-
Q 005691 385 -ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA- 462 (683)
Q Consensus 385 -~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~- 462 (683)
......++||||+++ +|.+.+.... .....+++..++.++.+++.||.|||.. +.+|+||||||+|||++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY-----RRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH-----TTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh-----hcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCC
Confidence 122347899999986 4444332111 1235688999999999999999999933 678999999999999997
Q ss_pred CCcEEEcccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 463 DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~ 241 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA----GQL 241 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHH
T ss_pred CCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH----HHH
Confidence 89999999999987654332 2345789999999998755 4899999999999999999999999753221 111
Q ss_pred hhhhh----------hhhhcC-ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 542 TDWVW----------SLVKAG-KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 542 ~~~v~----------~~~~~g-~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..... ..+... ...+..+..-............+....+.+++..|++.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111 000000 0000000000000000000111234578899999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.66 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=194.3
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++..........
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367889999999999999999975 6899999998654322 2356889999999999999999999986432211223
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||++ |+|.+++ ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 103 ~~~lv~e~~~-~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIM-----------GLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CCEEEEECCS-EEGGGTT-----------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEE
T ss_pred eEEEEecccc-CCHHHHh-----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEE
Confidence 4699999997 6888877 135899999999999999999999 789999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++..... .....||..|+|||.+.. ..++.++||||||++++||++|+.||......+ .+. .+..
T Consensus 168 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~-~i~~ 238 (353)
T 3coi_A 168 LDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLT-QILK 238 (353)
T ss_dssp CSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH----HHH-HHHH
T ss_pred eecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH-HHHH
Confidence 999999865432 234578999999999876 678999999999999999999999997432110 000 0000
Q ss_pred hh-----------hcCccc---cccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LV-----------KAGKVW---QALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~-----------~~g~l~---e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.. ...... +.+....... +. .........+..++..|++.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD--FT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCC--TT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCcc--HH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000000 0000000000 00 0011234567889999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.39 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=194.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|+.+++.++||||+++++++..........
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999975 68999999987643222 456889999999999999999999997433222223
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||++ |+|.+++ ...+++..++.++.+++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----------GMEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----------TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEcccc-ccHHHHh-----------hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEE
Confidence 4599999997 6888777 235899999999999999999999 789999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+++..... .....||+.|+|||.+.. ..++.++||||||++++||++|+.||...... +....
T Consensus 186 ~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~ 253 (371)
T 4exu_A 186 LDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--------DQLTQ 253 (371)
T ss_dssp CSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHH
T ss_pred EecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHH
Confidence 999999865432 234578999999999887 78899999999999999999999999743211 11111
Q ss_pred hhh-cCcc-cc---ccCc--------ccccc--ccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 548 LVK-AGKV-WQ---ALDP--------SLLKE--DDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 548 ~~~-~g~l-~e---~vD~--------~l~~~--~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+ .+.. .+ .++. .+... .... .........+.+++..|++.||++|||+.|+++.
T Consensus 254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 100 0000 00 0000 00000 0000 0001123467889999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=327.14 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=191.7
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCC------
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD------ 383 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~------ 383 (683)
..++|...+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999974 7899999998653 2334678999999999999999999999864321
Q ss_pred -CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 384 -NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 384 -~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.......++||||+++|+|.+++... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--------NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--------CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--------ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcC
Confidence 12356789999999999999999422 245788899999999999999999 789999999999999999
Q ss_pred CCcEEEcccCcccccccCC-------------ccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCC
Q 005691 463 DMRARVADFGLAKQSREGQ-------------SHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~-------------~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
++.+||+|||+++...... ........||..|+|||.+.+ +.++.++||||||+++|||++ |+
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 9999999999998654321 112234578999999999875 478999999999999999998 33
Q ss_pred CCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 529 DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 529 ~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... ....... ..+..... .+.+.+ .......+.+++..|++.||.+|||+.++++
T Consensus 229 ~~~-------~~~~~~~-~~~~~~~~--~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 229 STG-------MERVNIL-KKLRSVSI--EFPPDF----------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SSH-------HHHHHHH-HHHHSTTC--CCCTTC----------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCc-------hhHHHHH-Hhcccccc--ccCccc----------cccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 211 0011111 11111111 011111 1122345678999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=329.76 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=198.2
Q ss_pred hcCcccceeeeecCceEEEEEEE--cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC------cccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL--QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN------LVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l--~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N------LV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+++. .+++.||||++.... ...+.+.+|+++++.++|+| ++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---- 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---- 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence 46899999999999999999987 368899999986432 23466889999999998765 899999986
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA- 462 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~- 462 (683)
.....++||||+ +++|.+++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 88 --~~~~~~lv~e~~-~~~l~~~l~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 88 --HHGHICIVFELL-GLSTYDFIKEN-------GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154 (339)
T ss_dssp --ETTEEEEEEECC-CCBHHHHHHHT-------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCC
T ss_pred --cCCcEEEEEcCC-CCCHHHHHHhc-------CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEecc
Confidence 456899999999 89999988432 1236889999999999999999999 889999999999999987
Q ss_pred ------------------CCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhC
Q 005691 463 ------------------DMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524 (683)
Q Consensus 463 ------------------~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltG 524 (683)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 678999999999865432 2345789999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCccch-------hhhhhhhhhcCccc------------------cccCccccccccccCCChHHHHHH
Q 005691 525 RKALDLSTSGSPRACLI-------TDWVWSLVKAGKVW------------------QALDPSLLKEDDFLSLNPKAIMER 579 (683)
Q Consensus 525 r~p~~~~~~~~~~~~~l-------~~~v~~~~~~g~l~------------------e~vD~~l~~~~~~~~~~~~e~~~~ 579 (683)
+.||......+.. ..+ ....+......... +...+ +... ........+.
T Consensus 231 ~~pf~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~ 304 (339)
T 1z57_A 231 FTVFPTHDSKEHL-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEF----MLSQDVEHER 304 (339)
T ss_dssp SCSCCCSCHHHHH-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGG----CSCCSHHHHH
T ss_pred CCCCCCCChHHHH-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhh----cccchhhHHH
Confidence 9999643221100 000 00000000000000 00000 0000 0112234567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 005691 580 FVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 580 l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.+++..|++.||++|||+.|+++
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhCcCcccccCHHHHhc
Confidence 889999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=333.82 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=175.7
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHH-HHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVE-IISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~-iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++. ...
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~------~~~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF------REG 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE------CSS
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE------eCC
Confidence 367888999999999999999985 689999999976432 22345666666 677789999999999997 556
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCceeeccCCcEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNILLd~~~~~K 467 (683)
..++||||+++ +|.+++..... .....+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+|
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYS----VLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHH----TTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEE
T ss_pred ceEEEEeecCC-ChHHHHHHHHh----hhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEE
Confidence 89999999985 77776632110 11357899999999999999999999 66 999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCcccc----ccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA----LYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD 543 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~ 543 (683)
|+|||+++....... .....||..|+|||.+ ....++.++||||||+++|||++|+.||........
T Consensus 167 l~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------- 237 (327)
T 3aln_A 167 LCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------- 237 (327)
T ss_dssp ECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------
T ss_pred EccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------
Confidence 999999987644322 2334799999999998 466789999999999999999999999964322110
Q ss_pred hhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...... .+.. +.+... ........+.+++..|++.||++|||+.+|++
T Consensus 238 ~~~~~~-~~~~-----~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 238 QLTQVV-KGDP-----PQLSNS------EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCC-CSCC-----CCCCCC------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHh-cCCC-----CCCCCc------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111100 1111 111110 01122346788999999999999999999965
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.96 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=201.2
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
....++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------ 91 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE------ 91 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe------
Confidence 344578999999999999999999976 68999999986543 234567999999999999999999999987
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC--
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-- 463 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~-- 463 (683)
.....++|+||+++++|.+++.. ...+++..++.++.+++.||.||| +.+|+||||||+||+++.+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~ 159 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIK---------RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEK 159 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSST
T ss_pred CCCeEEEEEEccCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCC
Confidence 56789999999999999988842 246899999999999999999999 7899999999999999764
Q ss_pred -CcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 464 -MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 464 -~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
+.+||+|||+++....... .....||..|+|||.+.+ .++.++||||||+++|||++|+.||..... .
T Consensus 160 ~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~ 228 (287)
T 2wei_A 160 DCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------Y 228 (287)
T ss_dssp TCCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred cccEEEeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------H
Confidence 4799999999987654322 233458999999998764 589999999999999999999999864321 1
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+. ...+..+.... .+. ........+.+++..|++.||++|||+.|+++
T Consensus 229 ~~-~~~~~~~~~~~----~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 229 DI-LKRVETGKYAF----DLP--------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HH-HHHHHHCCCCC----CSG--------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH-HHHHHcCCCCC----Cch--------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11 12222222110 000 00112346778999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.12 Aligned_cols=255 Identities=23% Similarity=0.276 Sum_probs=185.0
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCeeEE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +|||||++++++. .....++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~------~~~~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET------TDRFLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE------CSSEEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe------cCCeEEE
Confidence 44556889999999998776778999999998653 245688999999986 8999999999886 5678999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC---------
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD--------- 463 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~--------- 463 (683)
||||++ |+|.+++...... .......++..++.|+.||+.||+||| +.+|+||||||+|||++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~--~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVS--DENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EECCCS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEecCC-CCHHHHHhccCCC--chhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCccccccccc
Confidence 999995 6999999543211 001112355677899999999999999 8899999999999999754
Q ss_pred ----CcEEEcccCcccccccCCcc---ccccccCCCcccCcccccc-------CCCCccccEEEcchhHHHHhh-CCCCC
Q 005691 464 ----MRARVADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALY-------GQLTEKSDVYSFGVVILEIMC-GRKAL 528 (683)
Q Consensus 464 ----~~~KLaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSfGvlLlELlt-Gr~p~ 528 (683)
+.+||+|||+++........ ......||++|+|||++.+ ..++.++|||||||++|||++ |+.||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999877654322 1234679999999999875 678999999999999999999 99998
Q ss_pred CCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 529 DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 529 ~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
...... .... . .+... . +.+.. .........+.+++..|++.||++|||+.+|++
T Consensus 241 ~~~~~~------~~~i----~-~~~~~-~--~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 241 GDKYSR------ESNI----I-RGIFS-L--DEMKC------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CSTTTH------HHHH----H-HTCCC-C--CCCTT------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhh------HHHH----h-cCCCC-c--ccccc------cccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 642210 0011 1 11100 0 00000 122345667889999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.90 Aligned_cols=198 Identities=23% Similarity=0.311 Sum_probs=168.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhc------cCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNL------KHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L------~H~NLV~L~G~c~~~~~~ 384 (683)
..+|...++||+|+||.||+|+.. +++.||||++... ....+++.+|++++..+ .|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~----- 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT----- 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence 457999999999999999999875 5889999998642 22345688899999888 4679999999987
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....++||||+. ++|.+++.... ...++|..++.|+.|++.||+||| +.+|+||||||+||||+.++
T Consensus 170 -~~~~~~lv~e~~~-~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 170 -FRNHICMTFELLS-MNLYELIKKNK-------FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQG 237 (429)
T ss_dssp -ETTEEEEEECCCC-CBHHHHHHHTT-------TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTT
T ss_pred -cCCeEEEEEeccC-CCHHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCC
Confidence 4578999999996 68988884321 235899999999999999999999 78999999999999999998
Q ss_pred c--EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 465 R--ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 465 ~--~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 238 ~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7 999999999764332 23457899999999999999999999999999999999999998643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.00 Aligned_cols=260 Identities=20% Similarity=0.274 Sum_probs=174.5
Q ss_pred hcCcccc-eeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHH-HHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQK-NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEV-EIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~-~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev-~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|... ++||+|+||.||+|+.. +|+.||||++... .....|+ ..+..++|+||+++++++..... .+.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~--~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHH--GKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET--TEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccC--CCc
Confidence 5688884 46999999999999986 6899999998652 2233343 34667799999999999864221 245
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc---CCc
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DMR 465 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---~~~ 465 (683)
..++||||+++|+|.+++... ....+++..++.|+.|++.||.||| +.+|+||||||+|||++. ++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER-------GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--------CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCC
T ss_pred eEEEEEeccCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCce
Confidence 589999999999999999532 1246999999999999999999999 789999999999999976 455
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||+++..... ......||+.|+|||++....++.++||||||+++|||++|+.||........ ....
T Consensus 170 ~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~ 241 (336)
T 3fhr_A 170 LKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI-----SPGM 241 (336)
T ss_dssp EEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred EEEeccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh-----hhhH
Confidence 999999999865432 22345789999999999989999999999999999999999999964432110 0000
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK--MLEGD 608 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~--~L~~~ 608 (683)
......+.. ....+ ........+.+++..|++.||++|||+.|+++ .+.+.
T Consensus 242 ~~~~~~~~~-~~~~~-----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 242 KRRIRLGQY-GFPNP-----------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----------CCCTT-----------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HHhhhcccc-ccCch-----------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 010111100 00000 11123446778999999999999999999997 44443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.22 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=190.1
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc------ChHHHHHHHHHHHhc----cCCCccccc
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ------GDAEFCNEVEIISNL----KHRNLVPLR 375 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L----~H~NLV~L~ 375 (683)
+.+...++|...+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4455678899999999999999999986 46889999998654332 223466899999999 899999999
Q ss_pred ceeeecCCCCCCCeeEEEEee-cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 376 GCCVVDGDNERGSERYLVYDY-MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 376 G~c~~~~~~~~~~~~~LV~Ey-~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
+++. .....++|+|| +++++|.+++.. ...+++..++.++.|++.||+||| +.+|+|||||
T Consensus 105 ~~~~------~~~~~~~v~e~~~~~~~L~~~l~~---------~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk 166 (312)
T 2iwi_A 105 DWFE------TQEGFMLVLERPLPAQDLFDYITE---------KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIK 166 (312)
T ss_dssp EEC-----------CEEEEECCSSEEEHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCS
T ss_pred EEEe------cCCeEEEEEEecCCCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCC
Confidence 9986 45678999999 899999999842 346899999999999999999999 7899999999
Q ss_pred CCceeec-cCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCC-ccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 455 ATNILLD-ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLT-EKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 455 psNILLd-~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
|+||+++ .++.+||+|||+++...... .....||..|+|||++....+. .++||||||+++|||++|+.||....
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence 9999999 88999999999998765432 2345699999999999877664 58999999999999999999985310
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.. . .... .+. ......+.+++..|++.||++|||+.|+++.
T Consensus 244 ----------~~----~-~~~~------~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ----------EI----L-EAEL------HFP----------AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----------HH----H-HTCC------CCC----------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------HH----h-hhcc------CCc----------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 0100 010 1123456789999999999999999999973
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.42 Aligned_cols=270 Identities=19% Similarity=0.224 Sum_probs=197.3
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-----------CCCcccccceee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-----------HRNLVPLRGCCV 379 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-----------H~NLV~L~G~c~ 379 (683)
.++|...+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35789999999999999999996 46899999998642 223456889999999886 899999999987
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCce
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNI 458 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNI 458 (683)
.... .+...++||||+ +++|.+++... ....+++..++.|+.|++.||+||| +. +|+||||||+||
T Consensus 97 ~~~~--~~~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 97 HKGP--NGVHVVMVFEVL-GENLLALIKKY-------EHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENV 163 (373)
T ss_dssp EEET--TEEEEEEEECCC-CEEHHHHHHHT-------TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGE
T ss_pred ccCC--CCceEEEEEecC-CCCHHHHHHHh-------hccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHe
Confidence 4321 234789999999 89999998432 1245899999999999999999999 76 999999999999
Q ss_pred eec------cCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 459 LLD------ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 459 LLd------~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
|++ .++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 994 4458999999999876432 234578999999999999999999999999999999999999997543
Q ss_pred CCCCC--ccchhhhh----------h-------hhhhcCccccccCc-c-------ccccccccCCChHHHHHHHHHHHH
Q 005691 533 SGSPR--ACLITDWV----------W-------SLVKAGKVWQALDP-S-------LLKEDDFLSLNPKAIMERFVLVGI 585 (683)
Q Consensus 533 ~~~~~--~~~l~~~v----------~-------~~~~~g~l~e~vD~-~-------l~~~~~~~~~~~~e~~~~l~~lal 585 (683)
..... ...+.... + ..+........+.. . +... ...+......+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK----YKFSKDEAKEISDFLS 315 (373)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT----TCCCHHHHHHHHHHHG
T ss_pred ccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc----ccCCcchHHHHHHHHH
Confidence 21110 00000000 0 00000000000000 0 0000 0122455678889999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 005691 586 LCAHVMVALRPTISDALK 603 (683)
Q Consensus 586 ~C~~~dP~~RPtm~eVl~ 603 (683)
.|++.||++|||+.|+++
T Consensus 316 ~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp GGGCSSTTTCBCHHHHHT
T ss_pred HHhccCccccCCHHHHhh
Confidence 999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.22 Aligned_cols=204 Identities=23% Similarity=0.292 Sum_probs=170.3
Q ss_pred HHHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CC-----Ccccccceeee
Q 005691 308 LERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HR-----NLVPLRGCCVV 380 (683)
Q Consensus 308 l~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~-----NLV~L~G~c~~ 380 (683)
.+...++|...++||+|+||+||+|+.. +++.||||++... .....++..|++++..++ |+ +++++.+++.
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~- 126 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM- 126 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-
Confidence 3445689999999999999999999976 6789999998642 222456788999999885 55 3899999887
Q ss_pred cCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 381 ~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
.....++||||++ |+|.+++.... ...+++..++.|+.|++.||.|||.. +.+|+||||||+|||+
T Consensus 127 -----~~~~~~lv~e~~~-~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 127 -----FRNHLCLVFEMLS-YNLYDLLRNTN-------FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL 192 (382)
T ss_dssp -----ETTEEEEEEECCC-CBHHHHHHHTT-------TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred -----cCCceEEEEecCC-CCHHHHHhhcC-------cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence 4578999999996 59999884321 24589999999999999999999932 4789999999999999
Q ss_pred c--cCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 461 D--ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 461 d--~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
+ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4 5788999999999876432 23467899999999999999999999999999999999999999743
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=341.66 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=185.5
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCCe
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
...+|...++||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++. ....
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~------~~~~ 92 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK------DRQF 92 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE------ETTE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe------cCCE
Confidence 3457889999999999996655566799999999865332 3366899999999 8999999999986 4567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-----CC
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-----DM 464 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-----~~ 464 (683)
.++||||++ |+|.+++... ...+.+..++.|+.||+.||+||| +.+|+||||||+|||++. ..
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQK--------DFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--------SCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEEEEECCC-CCHHHHHHhc--------CCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCce
Confidence 899999996 6999998432 234556677899999999999999 889999999999999943 34
Q ss_pred cEEEcccCcccccccCCc--cccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCc
Q 005691 465 RARVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRA 538 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~ 538 (683)
.+||+|||+++....... .......||++|+|||++. ...++.++|||||||++|||++ |+.||.....
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----- 235 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----- 235 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----
Confidence 688999999987754432 2234567999999999997 4677889999999999999999 8999853211
Q ss_pred cchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 539 ~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
............ +... ........+.+++..|++.||++|||+.+|++
T Consensus 236 ----~~~~~~~~~~~~-~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 ----RQANILLGACSL-DCLH------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----HHHHHHTTCCCC-TTSC------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHhccCCc-cccC------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111111110 1110 11123345678999999999999999999983
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.30 Aligned_cols=198 Identities=23% Similarity=0.373 Sum_probs=166.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CC-cEEEEEEeeccCccChHHHHHHHHHHHhccCCC------cccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DG-TTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN------LVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g-~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N------LV~L~G~c~~~~~ 383 (683)
.++|...+.||+|+||.||+++.. ++ +.||||++... ....+.+.+|++++++++|+| ++.+.+++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---- 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---- 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence 468999999999999999999975 34 68999998643 233456889999999998877 888888876
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee---
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL--- 460 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL--- 460 (683)
.....++||||+ +++|.+++... ....+++..++.|+.|++.||+||| +.+|+||||||+|||+
T Consensus 93 --~~~~~~lv~e~~-~~~l~~~l~~~-------~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 93 --FHGHMCIAFELL-GKNTFEFLKEN-------NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp --ETTEEEEEEECC-CCBHHHHHHHT-------TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCC
T ss_pred --eCCeEEEEEecc-CCChHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecc
Confidence 456899999999 66676666322 1246899999999999999999999 8899999999999999
Q ss_pred ----------------ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhC
Q 005691 461 ----------------DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524 (683)
Q Consensus 461 ----------------d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltG 524 (683)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 235 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence 67889999999999864432 2345799999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 005691 525 RKALDLS 531 (683)
Q Consensus 525 r~p~~~~ 531 (683)
+.||...
T Consensus 236 ~~pf~~~ 242 (355)
T 2eu9_A 236 FTLFQTH 242 (355)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999743
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.26 Aligned_cols=246 Identities=22% Similarity=0.381 Sum_probs=197.1
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc------ChHHHHHHHHHHHhcc--CCCcccccce
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLK--HRNLVPLRGC 377 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~--H~NLV~L~G~ 377 (683)
+.+...++|...+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999986 46889999999765332 2245778999999996 5999999999
Q ss_pred eeecCCCCCCCeeEEEEeecCC-CCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCC
Q 005691 378 CVVDGDNERGSERYLVYDYMPN-GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKAT 456 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKps 456 (683)
+. .....++|+||+.+ ++|.+++.. ...+++..++.|+.|++.||+||| +.+|+||||||+
T Consensus 117 ~~------~~~~~~lv~e~~~~~~~L~~~l~~---------~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~ 178 (320)
T 3a99_A 117 FE------RPDSFVLILERPEPVQDLFDFITE---------RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDE 178 (320)
T ss_dssp EE------CSSEEEEEEECCSSEEEHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGG
T ss_pred Ee------cCCcEEEEEEcCCCCccHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHH
Confidence 97 56789999999976 899999832 346899999999999999999999 889999999999
Q ss_pred ceeec-cCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCC
Q 005691 457 NILLD-ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSG 534 (683)
Q Consensus 457 NILLd-~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~ 534 (683)
|||++ +++.+||+|||+++...... .....||+.|+|||++....+ +.++||||||+++|||++|+.||....
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-- 253 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-- 253 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred HEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--
Confidence 99999 78999999999998765322 234579999999999987766 688999999999999999999985311
Q ss_pred CCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 535 SPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 535 ~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.. . .+.. .+.. .....+.+++..|++.||++|||+.+|++.
T Consensus 254 --------~~----~-~~~~------~~~~----------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 --------EI----I-RGQV------FFRQ----------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------HH----H-HCCC------CCSS----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------hh----h-cccc------cccc----------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 1110 0001 123456789999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=324.02 Aligned_cols=252 Identities=20% Similarity=0.323 Sum_probs=176.2
Q ss_pred HhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC-hH-HHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-DA-EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~-~~-~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
..++|...+.||+|+||.||+|+.. +|+.||||++....... .. .+..+..+++.++||||+++++++. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~------~~ 96 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI------TN 96 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE------CS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe------cC
Confidence 3578899999999999999999985 68999999997643322 22 3444555788889999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC-CccccCCCCCceeeccCCcE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP-AIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~-~IiHrDIKpsNILLd~~~~~ 466 (683)
...++||||+ ++.+..+. .. ....+++..++.++.+++.||.||| +. +|+||||||+|||++.++.+
T Consensus 97 ~~~~lv~e~~-~~~~~~l~-~~-------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLK-KR-------MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp SEEEEEECCC-SEEHHHHH-HH-------HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCE
T ss_pred CcEEEEEecc-CCcHHHHH-HH-------hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCE
Confidence 7899999999 44444433 11 1346899999999999999999999 64 89999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
||+|||+++....... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||..... .
T Consensus 165 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~ 235 (318)
T 2dyl_A 165 KLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------D 235 (318)
T ss_dssp EECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------H
T ss_pred EEEECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------c
Confidence 9999999976544322 23457999999999984 56788999999999999999999999864221 0
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+.......... +.+... ......+..++..|++.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~------~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 236 FEVLTKVLQEEP------PLLPGH--------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHHHSCC------CCCCSS--------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHhccCC------CCCCcc--------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111111111 111110 012345678899999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=354.54 Aligned_cols=270 Identities=24% Similarity=0.308 Sum_probs=199.2
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC-ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD-FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|||||++++++........+...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999974 68999999986542 23345699999999999999999999987533222346778
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc---EE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR---AR 467 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~---~K 467 (683)
++||||+++|+|.+++.... ....+++..++.|+.+++.||+||| +.+|+||||||+|||++.++. +|
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~------~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE------NCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS------CTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred EEEEEeCCCCCHHHHHHhcc------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEE
Confidence 99999999999999995432 2246999999999999999999999 789999999999999997664 99
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.... ....|...
T Consensus 165 L~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------~~~~~~~~ 235 (676)
T 3qa8_A 165 IIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-------QPVQWHGK 235 (676)
T ss_dssp ECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-------HHHHSSTT
T ss_pred Eccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-------chhhhhhh
Confidence 99999998765433 2344679999999999999999999999999999999999999996421 11223222
Q ss_pred hhhcCccccccCccccccccc------cCCChHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDF------LSLNPKAIMERFVLVGILCAHVMVALRPTISD 600 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~------~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~e 600 (683)
....+......+..+.+...+ ...........+..++..|++.||++|||+.+
T Consensus 236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 211111111111111111000 00112335667889999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=353.58 Aligned_cols=242 Identities=19% Similarity=0.287 Sum_probs=190.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc--CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ--DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~--~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+.||+|+||.||+|+.. +|+.||||++..... ...+.|.+|++++++++|||||++++++...... ...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~-~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH-GDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT-SCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC-CCc
Confidence 478999999999999999999975 589999999865332 2345689999999999999999999999754321 112
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++. ..++|.+++.|+.||+.||.||| +.+||||||||+|||++.+ .+||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-----------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-----------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEEECCCCEECC---------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEE
T ss_pred eeEEEEEeCCCCcHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEE
Confidence 3699999999999998772 26999999999999999999999 8899999999999999986 8999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++..... ....||++|+|||++.++. +.++|||||||+++||++|..|+......
T Consensus 223 ~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------- 282 (681)
T 2pzi_A 223 IDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------- 282 (681)
T ss_dssp CCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------
T ss_pred EecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------
Confidence 999999876443 3467999999999987654 89999999999999999999887531100
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHh
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-ISDALKMLE 606 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-m~eVl~~L~ 606 (683)
+ + ... .........+..++..|++.||++||+ +.++...|.
T Consensus 283 ---~-~--------~~~-----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 283 ---G-L--------PED-----DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ---S-C--------CTT-----CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---c-c--------ccc-----ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0 000 011122346778999999999999995 555555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.61 Aligned_cols=228 Identities=11% Similarity=0.068 Sum_probs=178.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+|+.. +|+.||||++....... .+.|.+|++++.+++|+||+++++++. ..+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~------~~~ 104 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH------TRA 104 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------ETT
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE------ECC
Confidence 67999999999999999999986 48999999997654332 367999999999999999999999987 456
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++++|.+++.. .....+..+|+.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~-----------~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl 170 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT-----------SPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVL 170 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEE
T ss_pred cEEEEEEecCCCCHHHHHhc-----------CCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEE
Confidence 79999999999999999821 1344567889999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+++| |++| ++.++||||||+++|||++|+.||........ + ..+...
T Consensus 171 ~~~~---------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~----~-~~~~~~ 217 (286)
T 3uqc_A 171 AYPA---------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG----L-APAERD 217 (286)
T ss_dssp CSCC---------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC----S-EECCBC
T ss_pred Eecc---------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh----h-HHHHHH
Confidence 8543 4443 68899999999999999999999975433211 0 000000
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. +.. ..+.. ...+....+..++..|++.||++| |+.|+++.|+.
T Consensus 218 ~~-~~~---~~~~~---------~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 218 TA-GQP---IEPAD---------IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp TT-SCB---CCHHH---------HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred hc-cCC---CChhh---------cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 00 000 00000 001223457789999999999999 99999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=333.84 Aligned_cols=253 Identities=15% Similarity=0.143 Sum_probs=181.3
Q ss_pred HHhcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCc---cChHHHHHHHHHHHhccC-CCcccccce-------
Q 005691 310 RATDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDF---QGDAEFCNEVEIISNLKH-RNLVPLRGC------- 377 (683)
Q Consensus 310 ~at~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H-~NLV~L~G~------- 377 (683)
..+.+|...++||+|+||.||+|+. .+|+.||||++..... ...+.|.+|+.+++.++| +|......+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3456688889999999999999995 4699999999874332 235679999999999987 332221111
Q ss_pred --eeecC-----------CCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc
Q 005691 378 --CVVDG-----------DNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV 444 (683)
Q Consensus 378 --c~~~~-----------~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~ 444 (683)
+.... ........+++|+++ +++|.+++...... ......++|..++.|+.|+++||+|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH--- 228 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH--SSTHKSLVHHARLQLTLQVIRLLASLH--- 228 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH--TTTSHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc--cccCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 11000 000122356666654 68999887311000 012346889999999999999999999
Q ss_pred CCCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCcccc----------ccCCCCccccEEEc
Q 005691 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYA----------LYGQLTEKSDVYSF 514 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~----------~~~~~s~ksDVwSf 514 (683)
+.+|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 889999999999999999999999999998865433 344567 999999999 55568899999999
Q ss_pred chhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCC
Q 005691 515 GVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL 594 (683)
Q Consensus 515 GvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~ 594 (683)
||++|||++|+.||....... .... .+... ....+.+..++..|++.||++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~-----~~~~----------------~~~~~--------~~~~~~~~~li~~~l~~dP~~ 354 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALG-----GSEW----------------IFRSC--------KNIPQPVRALLEGFLRYPKED 354 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGS-----CSGG----------------GGSSC--------CCCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHCCCCCCCcchhh-----hHHH----------------HHhhc--------ccCCHHHHHHHHHHccCChhh
Confidence 999999999999996432211 0010 01111 011245778899999999999
Q ss_pred CCCHHHHH
Q 005691 595 RPTISDAL 602 (683)
Q Consensus 595 RPtm~eVl 602 (683)
|||+.+++
T Consensus 355 Rpt~~~~l 362 (413)
T 3dzo_A 355 RLLPLQAM 362 (413)
T ss_dssp SCCHHHHT
T ss_pred CcCHHHHH
Confidence 99977764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=306.20 Aligned_cols=234 Identities=18% Similarity=0.257 Sum_probs=176.7
Q ss_pred cCcccc-eeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHH-HhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQK-NFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEII-SNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~-~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL-~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|... ++||+|+||.||++... +++.||||++.. ...+.+|++++ +.++||||+++++++.... .....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~--~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY--AGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE--TTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhc--CCCce
Confidence 566666 78999999999999974 689999999854 45678899988 5569999999999986311 12567
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc---CCcE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DMRA 466 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---~~~~ 466 (683)
.++||||+++|+|.+++... ....+++..++.|+.+++.||+||| +.+|+||||||+|||++. ++.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR-------GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC-------TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeecCCCcHHHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcE
Confidence 89999999999999999532 1246999999999999999999999 889999999999999998 7899
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+++... ...++.++||||||+++|||++|+.||......... ....
T Consensus 160 kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~~~~ 211 (299)
T 3m2w_A 160 KLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMK 211 (299)
T ss_dssp EECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSC
T ss_pred EEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----HHHH
Confidence 999999986432 245678999999999999999999999643321100 0000
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.....+.. .+... ........+..++..|++.||++|||+.|+++
T Consensus 212 ~~~~~~~~------~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 212 TRIRMGQY------EFPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCTTCC------SSCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhccc------cCCch------hcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000 00000 00123456788999999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=312.00 Aligned_cols=245 Identities=19% Similarity=0.209 Sum_probs=183.5
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--------cChHHHHHHHHHHHhcc---------CCCcccc
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--------QGDAEFCNEVEIISNLK---------HRNLVPL 374 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--------~~~~~f~~Ev~iL~~L~---------H~NLV~L 374 (683)
.++|...+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+++++.++ |+|+|++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 689999999976532 22367999999999986 6666666
Q ss_pred cceeeecCC------------------------CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhH
Q 005691 375 RGCCVVDGD------------------------NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430 (683)
Q Consensus 375 ~G~c~~~~~------------------------~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia 430 (683)
.+.+..... .......++||||+++|++.+.+. +..+++..++.|+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----------~~~~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----------TKLSSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----------TTCCCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----------hcCCCHHHHHHHH
Confidence 665432110 012568999999999998777662 2468999999999
Q ss_pred HHHHHHHHHHhcccCCCccccCCCCCceeeccCC--------------------cEEEcccCcccccccCCccccccccC
Q 005691 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM--------------------RARVADFGLAKQSREGQSHLTTRVAG 490 (683)
Q Consensus 431 ~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~--------------------~~KLaDFGla~~~~~~~~~~~~~~~G 490 (683)
.|++.||+|||+ +.+|+||||||+||||+.++ .+||+|||+|+..... ...|
T Consensus 168 ~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~g 239 (336)
T 2vuw_A 168 HQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVF 239 (336)
T ss_dssp HHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEEC
T ss_pred HHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEE
Confidence 999999999992 36899999999999999887 9999999999876542 3479
Q ss_pred CCcccCccccccCCCCccccEEEcchh-HHHHhhCCCCCCCCCCCCCCccchhhhhhhh----hhcCccccccCcccccc
Q 005691 491 THGYLAPEYALYGQLTEKSDVYSFGVV-ILEIMCGRKALDLSTSGSPRACLITDWVWSL----VKAGKVWQALDPSLLKE 565 (683)
Q Consensus 491 T~~Y~APE~~~~~~~s~ksDVwSfGvl-LlELltGr~p~~~~~~~~~~~~~l~~~v~~~----~~~g~l~e~vD~~l~~~ 565 (683)
|+.|+|||.+.+.. +.++||||+|++ .+++++|..||.. ..|.... ....... .....
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~----~~~~~- 302 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFK----TKCNT- 302 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCS----SCCCS-
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccC----cccch-
Confidence 99999999998655 899999998777 7889999988741 1121111 1110000 00000
Q ss_pred ccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 566 DDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 566 ~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
.........+.+++..|++.| |+.|++
T Consensus 303 -----~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 303 -----PAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp -----HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred -----hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 012356678899999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=290.21 Aligned_cols=185 Identities=17% Similarity=0.131 Sum_probs=129.2
Q ss_pred eeecCceEEEEEE-EcCCcEEEEEEeeccCcc----------ChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCC
Q 005691 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQ----------GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 321 LG~GgfG~Vykg~-l~~g~~VAVK~l~~~~~~----------~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.+.|++|.+.+++ +.-|+.+|||.+...... ..++|.+|+++|+++ .|+||+++++++. +..
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e------d~~ 315 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE------NAQ 315 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE------CSS
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE------ECC
Confidence 5667777666654 335889999999654221 134699999999999 7999999999986 677
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
+.||||||++||+|.+.|.. ..+++. .+|+.||+.||+||| +.+||||||||+||||++++++||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~---------~~~l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL 380 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA---------GEEIDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARL 380 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT---------TCCCCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHh---------CCCCCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEE
Confidence 89999999999999999932 234543 358999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
+|||+|+........ .+...||++|||||.+. +++..++|+||+|++++++.+|..++
T Consensus 381 ~DFGlAr~~~~~~~~-~~t~vGTp~YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 381 IDFGSIVTTPQDCSW-PTNLVQSFFVFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCCTTEESCC---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred eecccCeeCCCCCcc-ccCceechhhccHHHhC-CCCCCcccccccccchhhhccccchh
Confidence 999999977554332 34467999999999886 45778899999999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=268.66 Aligned_cols=186 Identities=16% Similarity=0.201 Sum_probs=146.0
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccC--------hHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQG--------DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~--------~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
.+...++||+|+||.||+|.. .++.+++|+........ .+.|.+|++++++++||||+++..++.
T Consensus 337 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~------ 409 (540)
T 3en9_A 337 RKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV------ 409 (540)
T ss_dssp -----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE------
T ss_pred cCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE------
Confidence 334567899999999999954 47899999875533221 234899999999999999998777776
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++||||+++|+|.+++.. ++.|+.|+++||.||| +.+|+||||||+|||++. +
T Consensus 410 ~~~~~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~ 467 (540)
T 3en9_A 410 DLDNKRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--D 467 (540)
T ss_dssp ETTTTEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--S
T ss_pred eCCccEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--e
Confidence 34457999999999999999821 6789999999999999 889999999999999999 9
Q ss_pred EEEcccCcccccccCCccc------cccccCCCcccCcccccc--CCCCccccEEEcchhHHHHhhCCCCC
Q 005691 466 ARVADFGLAKQSREGQSHL------TTRVAGTHGYLAPEYALY--GQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~------~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
+||+|||+++......... .....||+.|||||++.. ..|+.++|+|+..+-.+|-+.++.++
T Consensus 468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999999999875533221 235789999999999986 66888999999999999988888765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=219.22 Aligned_cols=153 Identities=12% Similarity=0.096 Sum_probs=123.7
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc------------------ChHHHHHHHHHHHhc
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ------------------GDAEFCNEVEIISNL 366 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~------------------~~~~f~~Ev~iL~~L 366 (683)
+..+......|...+.||+|+||.||+|...+|+.||||.+...... ....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34455556677788999999999999999977999999998643211 234689999999999
Q ss_pred cCCCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCC
Q 005691 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKP 446 (683)
Q Consensus 367 ~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~ 446 (683)
+ | +++.+++. .+..++||||+++|+|.+ +. ......++.|++.||.||| +.
T Consensus 162 ~--~-~~v~~~~~-------~~~~~lvmE~~~g~~L~~-l~---------------~~~~~~i~~qi~~~l~~lH---~~ 212 (282)
T 1zar_A 162 Q--G-LAVPKVYA-------WEGNAVLMELIDAKELYR-VR---------------VENPDEVLDMILEEVAKFY---HR 212 (282)
T ss_dssp T--T-SSSCCEEE-------EETTEEEEECCCCEEGGG-CC---------------CSCHHHHHHHHHHHHHHHH---HT
T ss_pred c--C-CCcCeEEe-------ccceEEEEEecCCCcHHH-cc---------------hhhHHHHHHHHHHHHHHHH---HC
Confidence 9 6 77777653 245799999999999988 51 1234579999999999999 89
Q ss_pred CccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccc
Q 005691 447 AIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL 501 (683)
Q Consensus 447 ~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~ 501 (683)
+|+||||||+|||++ ++.+||+|||+|+. +..|+|||++.
T Consensus 213 giiHrDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 213 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TEECSCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CCEeCCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999999999999999 99999999999863 34578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6.7e-19 Score=181.22 Aligned_cols=140 Identities=16% Similarity=0.090 Sum_probs=105.9
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcE--EEEEEeeccCccC------------------------hHHHHHHHHHHHhc
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTT--VAVKKVIESDFQG------------------------DAEFCNEVEIISNL 366 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~--VAVK~l~~~~~~~------------------------~~~f~~Ev~iL~~L 366 (683)
-|...+.||+|+||.||+|.. .+|+. ||||.+....... ...+.+|++++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 67999 9999875431110 12588999999999
Q ss_pred cCCCcccccceeeecCCCCCCCeeEEEEeecC-CC----CccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHh
Q 005691 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMP-NG----NVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLH 441 (683)
Q Consensus 367 ~H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~-~G----sL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH 441 (683)
+|+|+.....+.. ...+|||||+. +| +|.++.. ..++.....++.+++.||.|||
T Consensus 128 ~~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~------------~~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 128 KEAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGR------------ELKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGG------------GGGGSCHHHHHHHHHHHHHHHH
T ss_pred HhCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhh------------ccChHHHHHHHHHHHHHHHHHH
Confidence 9987532222211 24689999994 35 4444331 1335677899999999999999
Q ss_pred cccCCCccccCCCCCceeeccCCcEEEcccCccccc
Q 005691 442 YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477 (683)
Q Consensus 442 ~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~ 477 (683)
. +.+|+||||||+|||++. .+||+|||+|...
T Consensus 188 ~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 Q--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp H--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred H--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 3 468999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=171.44 Aligned_cols=144 Identities=13% Similarity=0.071 Sum_probs=102.3
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--------------cChHHHHHHHHHHHhccCCCcccccceee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--------------QGDAEFCNEVEIISNLKHRNLVPLRGCCV 379 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--------------~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~ 379 (683)
-|+..+.||+|+||.||+|...+|+.||||.++.... ........++++.+...|+||++++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4888999999999999999999999999998753211 01123344555555555666666543221
Q ss_pred ecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCcee
Q 005691 380 VDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNIL 459 (683)
Q Consensus 380 ~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNIL 459 (683)
.....-.....+|||||+++++|.+... ......++.|++.+|.||| +.+||||||||.|||
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~---------------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS---------------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNIL 237 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC---------------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc---------------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEE
Confidence 0000001122479999999988876541 1234578899999999999 789999999999999
Q ss_pred eccCC----------cEEEcccCccc
Q 005691 460 LDADM----------RARVADFGLAK 475 (683)
Q Consensus 460 Ld~~~----------~~KLaDFGla~ 475 (683)
+++++ .+.|+||+-+-
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred EeCCCCcccccccccceEEEEeCCcc
Confidence 98877 38999999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=126.34 Aligned_cols=149 Identities=13% Similarity=0.052 Sum_probs=114.5
Q ss_pred HHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCC
Q 005691 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 307 el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~ 385 (683)
.+....+.|.....++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |.++.++++++.
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~------ 80 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER------ 80 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE------
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe------
Confidence 34455667888888888889999999755 7899999886532233446889999999995 667778888875
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcc----------------------
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYG---------------------- 443 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~---------------------- 443 (683)
.....++||||++|.+|.+.+. +......++.+++++|+.||.-
T Consensus 81 ~~~~~~lv~e~i~G~~l~~~~~--------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 81 HDGWSNLLMSEADGVLCSEEYE--------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHCC--------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred cCCceEEEEEecCCeehhhccC--------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 3467899999999999877541 1223457899999999999961
Q ss_pred ----------------------------------cCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 444 ----------------------------------VKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 444 ----------------------------------~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
....++|+|+++.|||++++..+.|.||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 015589999999999998766678999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=122.60 Aligned_cols=138 Identities=14% Similarity=0.080 Sum_probs=98.5
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCc-c-cccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL-V-PLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NL-V-~L~G~c~~~~~~~~~~~~ 390 (683)
.++....+.+.|..+.||+....+|+.+++|..... ....+..|+.+++.+++.++ | +++++.. .++..
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~------~~~~~ 90 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT------EAGRD 90 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE------CSSCE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc------CCCCC
Confidence 344443333345569999998877888999986543 23457899999999976554 4 4777654 34568
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc--------------------------
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV-------------------------- 444 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~-------------------------- 444 (683)
++||||+++.+|. .. . .....++.++++.|+.||.-.
T Consensus 91 ~~v~e~i~G~~l~--~~------------~---~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS------------H---LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV 153 (264)
T ss_dssp EEEEECCSSEETT--TS------------C---CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred EEEEEecCCcccC--cC------------c---CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence 9999999998884 21 0 112367777888888888421
Q ss_pred -----------------------------CCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 445 -----------------------------KPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 445 -----------------------------~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
...++|+|++|.|||++++..++|.|||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998877778999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-09 Score=116.63 Aligned_cols=146 Identities=14% Similarity=0.194 Sum_probs=106.4
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEee--ccC-ccChHHHHHHHHHHHhcc--CCCcccccceeeecCCCCCCCeeE
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVI--ESD-FQGDAEFCNEVEIISNLK--HRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~--~~~-~~~~~~f~~Ev~iL~~L~--H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.++ +.++.++++++... ...+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~---~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE---SVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT---TTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC---CccCCeE
Confidence 3457899999999998876 4678888765 322 122346889999999997 45577788777421 1124579
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc---------------------------
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV--------------------------- 444 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~--------------------------- 444 (683)
+||||+++..+.+.. ...++..++..++.++++.|+.||.-.
T Consensus 118 ~vme~v~G~~l~~~~-----------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS-----------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp EEEECCCCBCCCCTT-----------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCc-----------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 999999998875432 124677888999999999999999520
Q ss_pred ----------------------------CCCccccCCCCCceeeccCCc--EEEcccCccccc
Q 005691 445 ----------------------------KPAIYHRDIKATNILLDADMR--ARVADFGLAKQS 477 (683)
Q Consensus 445 ----------------------------~~~IiHrDIKpsNILLd~~~~--~KLaDFGla~~~ 477 (683)
...++|+|+++.|||++.++. +.|.||+.+...
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.8e-10 Score=118.04 Aligned_cols=188 Identities=19% Similarity=0.220 Sum_probs=118.3
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCc--ccccceeeecCCCCCCCeeEEEEe
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNL--VPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NL--V~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
+.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +..+ .+.+++.. ........++|||
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~---~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGM---PSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECC---CCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecC---CCCCCCcceEEEc
Confidence 458999999999863 56888875332 23456899999999984 3332 22332221 1111124588999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcc--------------------------------
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYG-------------------------------- 443 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~-------------------------------- 443 (683)
|++|.+|.+... ..++..++..++.++++.|+.||.-
T Consensus 97 ~i~G~~l~~~~~-----------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 97 KIKGVPLTPLLL-----------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp CCCCEECCHHHH-----------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred ccCCeECCcccc-----------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 999988875331 2456666777888888888888741
Q ss_pred -----------------------cCCCccccCCCCCceeecc--CCcEEEcccCcccccccCCccccc------------
Q 005691 444 -----------------------VKPAIYHRDIKATNILLDA--DMRARVADFGLAKQSREGQSHLTT------------ 486 (683)
Q Consensus 444 -----------------------~~~~IiHrDIKpsNILLd~--~~~~KLaDFGla~~~~~~~~~~~~------------ 486 (683)
....++|+|+++.||++++ +..+.|.||+.+............
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHH
Confidence 1246899999999999998 566899999988754321110000
Q ss_pred -cccCCCcccC-ccccccCCCCccccEEEcchhHHHHhhCCCCC
Q 005691 487 -RVAGTHGYLA-PEYALYGQLTEKSDVYSFGVVILEIMCGRKAL 528 (683)
Q Consensus 487 -~~~GT~~Y~A-PE~~~~~~~s~ksDVwSfGvlLlELltGr~p~ 528 (683)
.....+++.. |++... .....+.|++|.+++++.+|+.++
T Consensus 246 ~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000111112 221111 112358899999999999999765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=5e-06 Score=87.06 Aligned_cols=137 Identities=16% Similarity=0.155 Sum_probs=89.5
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCC---CcccccceeeecCCCCCCCeeEEEEe
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHR---NLVPLRGCCVVDGDNERGSERYLVYD 395 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~---NLV~L~G~c~~~~~~~~~~~~~LV~E 395 (683)
+.++.|....||+. |..++||+-. .......+..|.++|+.|.+. .+.+.++++.. ..+..++|||
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-----~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-----SDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-----TTSCEEEEEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-----CCCceEEEEe
Confidence 46788888899987 5678888742 122245689999999999753 23444555431 2345789999
Q ss_pred ecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcc--------------------------------
Q 005691 396 YMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYG-------------------------------- 443 (683)
Q Consensus 396 y~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~-------------------------------- 443 (683)
|++|..|.+... ..++..++..++.++++.|+.||.-
T Consensus 94 ~i~G~~l~~~~~-----------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~ 162 (306)
T 3tdw_A 94 KVQGQILGEDGM-----------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP 162 (306)
T ss_dssp CCCSEECHHHHH-----------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred ccCCeECchhhh-----------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence 999988865321 1123333444444444444444421
Q ss_pred -------------------------cCCCccccCCCCCceeecc---CCc-EEEcccCccccc
Q 005691 444 -------------------------VKPAIYHRDIKATNILLDA---DMR-ARVADFGLAKQS 477 (683)
Q Consensus 444 -------------------------~~~~IiHrDIKpsNILLd~---~~~-~KLaDFGla~~~ 477 (683)
....++|+|+++.|||++. ++. ..|.||+.+...
T Consensus 163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2446799999999999987 455 489999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=8.7e-06 Score=82.77 Aligned_cols=135 Identities=17% Similarity=0.140 Sum_probs=89.7
Q ss_pred eeeecCce-EEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCeeEEEEee
Q 005691 320 FIGRGGFG-LVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 320 ~LG~GgfG-~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
.+..|..| .||+.... ++..++||+-... ...++..|..+|+.+. +-.+-++++++. ..+..++|||+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~------~~~~~~lvme~ 101 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIR------TPDDAWLLTTA 101 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEE------ETTEEEEEEEC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEE------ECCeEEEEEEe
Confidence 45556555 68987754 4667889875432 2456889999999884 333556677765 34578999999
Q ss_pred cCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhc----------------------------------
Q 005691 397 MPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHY---------------------------------- 442 (683)
Q Consensus 397 ~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~---------------------------------- 442 (683)
+++.++.+... .....+..+..++++.|+-||.
T Consensus 102 l~G~~~~~~~~-------------~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (272)
T 4gkh_A 102 IPGKTAFQVLE-------------EYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFD 168 (272)
T ss_dssp CCSEEHHHHHH-------------HCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCC
T ss_pred eCCcccccccc-------------CCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcc
Confidence 99987665431 1112223344444444444442
Q ss_pred ---------------------ccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 443 ---------------------GVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 443 ---------------------~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
.....++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 169 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 169 DERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0123489999999999999887778999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=6.9e-06 Score=87.26 Aligned_cols=85 Identities=8% Similarity=0.002 Sum_probs=56.0
Q ss_pred ceee-eecCceEEEEEEEc-------CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccC---CCcccccceeeecCC
Q 005691 318 KNFI-GRGGFGLVYKGILQ-------DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKH---RNLVPLRGCCVVDGD 383 (683)
Q Consensus 318 ~~~L-G~GgfG~Vykg~l~-------~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H---~NLV~L~G~c~~~~~ 383 (683)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.|.. ..+.++++++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~- 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD- 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence 3567 77888999998765 26678888754322 1122457889999998853 24556676653110
Q ss_pred CCCCCeeEEEEeecCCCCcccc
Q 005691 384 NERGSERYLVYDYMPNGNVDDH 405 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~ 405 (683)
.....++||||+++..+.+.
T Consensus 104 --~~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 104 --VLGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp --TTSSCEEEEECCCCBCCCBT
T ss_pred --ccCCceEEEEecCCCChhhc
Confidence 11356899999999887653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.2e-05 Score=84.86 Aligned_cols=75 Identities=13% Similarity=0.029 Sum_probs=49.1
Q ss_pred ceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-------cChHHHHHHHHHHHhccC--CCcc-cccceeeecCCCCC
Q 005691 318 KNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-------QGDAEFCNEVEIISNLKH--RNLV-PLRGCCVVDGDNER 386 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-------~~~~~f~~Ev~iL~~L~H--~NLV-~L~G~c~~~~~~~~ 386 (683)
.+.||.|.++.||++... +++.++||....... ...+.+..|.++++.+.+ +..+ +++.+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------- 106 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------- 106 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--------
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--------
Confidence 457899999999999754 468899998643211 123457889999988843 3444 344331
Q ss_pred CCeeEEEEeecCCC
Q 005691 387 GSERYLVYDYMPNG 400 (683)
Q Consensus 387 ~~~~~LV~Ey~~~G 400 (683)
....++||||+++.
T Consensus 107 ~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 107 TEMAVTVMEDLSHL 120 (397)
T ss_dssp TTTTEEEECCCTTS
T ss_pred CCccEEEEEeCCCc
Confidence 23468999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.93 E-value=6.3e-05 Score=77.61 Aligned_cols=80 Identities=19% Similarity=0.174 Sum_probs=59.1
Q ss_pred CcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCC---CcccccceeeecCCCCCCCee
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHR---NLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~---NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.+.....+|.|..+.||+.++.||+.|.||+-..........|..|...|+.|.-. .+.+.+++ +..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----------~~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----------DDR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----------ETT
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----------cCc
Confidence 45666789999999999999999999999986655444455688999999988532 22333332 124
Q ss_pred EEEEeecCCCCcc
Q 005691 391 YLVYDYMPNGNVD 403 (683)
Q Consensus 391 ~LV~Ey~~~GsL~ 403 (683)
++||||++.+...
T Consensus 86 ~lv~e~l~~~~~~ 98 (288)
T 3f7w_A 86 TLAMEWVDERPPT 98 (288)
T ss_dssp EEEEECCCCCCCC
T ss_pred eEEEEeecccCCC
Confidence 8899999887654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00016 Score=75.47 Aligned_cols=151 Identities=19% Similarity=0.269 Sum_probs=83.0
Q ss_pred eeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCC--CcccccceeeecCC--CCCCCeeEEEE
Q 005691 319 NFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHR--NLVPLRGCCVVDGD--NERGSERYLVY 394 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~--NLV~L~G~c~~~~~--~~~~~~~~LV~ 394 (683)
..|+.|..+.||+....+| .+++|+... ...++..|+.++..|... ++.+++... ++. ...++..+++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~--~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNK--KGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCT--TSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecC--CCCEEEEECCEEEEEE
Confidence 3465567889999987655 588988754 234455667777666422 223333210 000 00235678999
Q ss_pred eecCCCCccc--------------cccCCCCC---CCC--CCCCCCCccchh----------------------------
Q 005691 395 DYMPNGNVDD--------------HLFPSFND---GSG--VAKRPLTWPQRK---------------------------- 427 (683)
Q Consensus 395 Ey~~~GsL~~--------------~L~~~~~~---~~~--~~~~~L~w~~r~---------------------------- 427 (683)
||++|..+.. .+|..... ... .....-.|...+
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 9999876641 11111000 000 001112342211
Q ss_pred ---hhHHHHHHHHHHHhc----------ccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 428 ---NIILDVAKGLAYLHY----------GVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 428 ---~Ia~~iA~gL~yLH~----------~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
.+...+.+++.+|+. .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123345667763 1367899999999999998888999999997643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00066 Score=70.66 Aligned_cols=169 Identities=11% Similarity=0.081 Sum_probs=92.1
Q ss_pred eehHHHHHHhcCccc-----ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCc--cccc
Q 005691 303 FKIQDLERATDKFSQ-----KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL--VPLR 375 (683)
Q Consensus 303 f~~~el~~at~~f~~-----~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NL--V~L~ 375 (683)
++.+++......|.. .+.|+.|....+|+....+| .+++|..... ...+++..|+.++..|....+ .+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445666666666654 23466687889999987766 5778877542 123456778888888753333 2233
Q ss_pred ceeeecCC--CCCCCeeEEEEeecCCCCcccc--------------ccCCCCCCCCC---CCCCCCccchh---------
Q 005691 376 GCCVVDGD--NERGSERYLVYDYMPNGNVDDH--------------LFPSFNDGSGV---AKRPLTWPQRK--------- 427 (683)
Q Consensus 376 G~c~~~~~--~~~~~~~~LV~Ey~~~GsL~~~--------------L~~~~~~~~~~---~~~~L~w~~r~--------- 427 (683)
... ++. ....+..++++||++|..+... +|.....-... ......|...+
T Consensus 84 ~~~--~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 84 PRK--DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp CBT--TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred CCC--CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 210 000 0012457899999998765421 11110000000 00111232210
Q ss_pred ---hhHHHHHHHHHHHhcc----cCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 428 ---NIILDVAKGLAYLHYG----VKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 428 ---~Ia~~iA~gL~yLH~~----~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
.+...+.+.++++++. ....++|+|+++.|||++++..+.|.||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 0111244555666532 245799999999999999876668999987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0013 Score=69.25 Aligned_cols=145 Identities=18% Similarity=0.152 Sum_probs=90.5
Q ss_pred cceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc---CCCcccccceeeecCCCCCCCeeEEE
Q 005691 317 QKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK---HRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~---H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
..+.|+.|....+|+... ++..++||+.... ....|..|.+.|+.|. ...+.+.++++. ..+..++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~------~~g~~~lv 109 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN------SQGHSFLL 109 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE------CSSEEEEE
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee------cCCceEEE
Confidence 345789999999999876 4678889876542 2556889999999884 245677777764 34578999
Q ss_pred EeecCCCCccc-----------cccCCCC-CCCCC------------CCCCCCccc-----hhhhH--------------
Q 005691 394 YDYMPNGNVDD-----------HLFPSFN-DGSGV------------AKRPLTWPQ-----RKNII-------------- 430 (683)
Q Consensus 394 ~Ey~~~GsL~~-----------~L~~~~~-~~~~~------------~~~~L~w~~-----r~~Ia-------------- 430 (683)
|||+++..+.. .||.... ..-+. ....-+|.. |+.-.
T Consensus 110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~ 189 (312)
T 3jr1_A 110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI 189 (312)
T ss_dssp EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 99999987642 1121110 00000 000123432 11111
Q ss_pred HHHHHH-HHHHh-cccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 431 LDVAKG-LAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 431 ~~iA~g-L~yLH-~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
..+..- ...|. ....+.++|+|+.+.||+++.++ +.|.||.
T Consensus 190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111111 22343 13367899999999999999887 8899974
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0016 Score=67.97 Aligned_cols=166 Identities=12% Similarity=0.060 Sum_probs=91.2
Q ss_pred ehHHHHHHhcCccc-----ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC--cccccc
Q 005691 304 KIQDLERATDKFSQ-----KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN--LVPLRG 376 (683)
Q Consensus 304 ~~~el~~at~~f~~-----~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N--LV~L~G 376 (683)
+.+++..+.+.|.. ...|+ |....||+....+|+.+++|...... ...+.+..|..++..+.... +.+++.
T Consensus 12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~ 89 (328)
T 1zyl_A 12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVA 89 (328)
T ss_dssp CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceee
Confidence 34455554444432 23566 78889999887778789999875332 23556778999888885333 334443
Q ss_pred eeeecCC--CCCCCeeEEEEeecCCCCcccc--------------ccCCCCCCCCCCCCCCCccch--------------
Q 005691 377 CCVVDGD--NERGSERYLVYDYMPNGNVDDH--------------LFPSFNDGSGVAKRPLTWPQR-------------- 426 (683)
Q Consensus 377 ~c~~~~~--~~~~~~~~LV~Ey~~~GsL~~~--------------L~~~~~~~~~~~~~~L~w~~r-------------- 426 (683)
. ++. ...++..+++|||+++..+... +|.............+++...
T Consensus 90 ~---~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 90 F---NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp B---TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred c---CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 2 110 0023466889999998665420 111000000001111222110
Q ss_pred -----hhhHHHHHHHHHHHhc----ccCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 427 -----KNIILDVAKGLAYLHY----GVKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 427 -----~~Ia~~iA~gL~yLH~----~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
..+...+.+.+..+.. .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0011111122333321 1256689999999999999 4 899999987754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00082 Score=73.19 Aligned_cols=80 Identities=13% Similarity=0.042 Sum_probs=50.0
Q ss_pred CCCccccCCCCCceeeccCCcEEEcccCcccccccCCccccccccCCCcccCccccccC---CCCccccEEEcchhHHHH
Q 005691 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG---QLTEKSDVYSFGVVILEI 521 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSfGvlLlEL 521 (683)
...++|+|+++.|||++.++ ++|.||+.+......-........-...|.+|++.... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 67899999999999998876 99999998876442211100000012346666655421 112234555777778887
Q ss_pred hhCC
Q 005691 522 MCGR 525 (683)
Q Consensus 522 ltGr 525 (683)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0022 Score=70.27 Aligned_cols=73 Identities=19% Similarity=0.301 Sum_probs=50.4
Q ss_pred eeeeecCceEEEEEEEcC--------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCc-ccccceeeecCCCCCCCe
Q 005691 319 NFIGRGGFGLVYKGILQD--------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL-VPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NL-V~L~G~c~~~~~~~~~~~ 389 (683)
+.|+.|-...||+....+ +..+.+|+.... ...+.+..|..+++.+...++ .++++.+. +
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~-------~-- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS-------G-- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET-------T--
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC-------C--
Confidence 467888889999998763 478888876332 122567789999998865455 45565541 1
Q ss_pred eEEEEeecCCCCcc
Q 005691 390 RYLVYDYMPNGNVD 403 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~ 403 (683)
.+||||+++.+|.
T Consensus 148 -g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 148 -GRLEEYIPSRPLS 160 (429)
T ss_dssp -EEEECCCCEEECC
T ss_pred -CEEEEEeCCcccC
Confidence 3899999875654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0018 Score=67.05 Aligned_cols=72 Identities=10% Similarity=0.013 Sum_probs=44.9
Q ss_pred ceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCCeeEEEEee
Q 005691 318 KNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
.+.|+.|....+|+. ..+++|+....... .....+|+.+++.+....+. +++++. ...-++++||
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--------~~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--------PATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--------TTTCCEEEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--------CCCCEEEEee
Confidence 467888999999998 45888876543211 11235688888887544444 444432 2234789999
Q ss_pred c-CCCCcc
Q 005691 397 M-PNGNVD 403 (683)
Q Consensus 397 ~-~~GsL~ 403 (683)
+ ++.+|.
T Consensus 89 i~~g~~l~ 96 (301)
T 3dxq_A 89 IAGAQTMS 96 (301)
T ss_dssp CTTCEECC
T ss_pred cCCCccCC
Confidence 9 665554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.018 Score=63.69 Aligned_cols=74 Identities=11% Similarity=0.017 Sum_probs=47.7
Q ss_pred eeeeecCceEEEEEEEcC-CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCCeeEEEEee
Q 005691 319 NFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
+.|+.|-...+|+....+ +..+.+|+..... ...-.-..|..++..|...+++ ++++++. + .+||||
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-------~---G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT-------N---GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-------T---EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-------C---eEEEEe
Confidence 467878889999998875 4778888764322 1111125899999999766664 5565541 1 259999
Q ss_pred cCCCCcc
Q 005691 397 MPNGNVD 403 (683)
Q Consensus 397 ~~~GsL~ 403 (683)
+++.+|.
T Consensus 183 I~G~~l~ 189 (458)
T 2qg7_A 183 MDGYALS 189 (458)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9986664
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0012 Score=58.36 Aligned_cols=47 Identities=19% Similarity=0.333 Sum_probs=40.3
Q ss_pred cccccCCCCChhhhHHHHHhhhhhccc-cccccCCccccccceeEeeec
Q 005691 157 DSSCKSDLTDLSACDSCVAAGFKVQSQ-LIAVDGNTSHATDCFYFTILY 204 (683)
Q Consensus 157 ~~~C~~dL~~~~~C~~Cl~~~~~~~~~-l~~~~g~~~~~~~c~~~~~~~ 204 (683)
-+||++|| ++.+|..|++.++..+.+ +++..|.+.....|++|++.|
T Consensus 59 l~qC~~Dl-s~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~ 106 (108)
T 3a2e_A 59 RATCKQSI-SQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQR 106 (108)
T ss_dssp EEEECTTS-CHHHHHHHHHHHHTTHHHHTTSBSSEEEEETTEEEEEESS
T ss_pred EEEEcCCC-CHHHHHHHHHHHHHHHHHHCCCCceEEEECCCEEEEEeCC
Confidence 48999999 899999999999887665 677778888888999997655
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.011 Score=61.89 Aligned_cols=33 Identities=36% Similarity=0.437 Sum_probs=28.5
Q ss_pred CCCccccCCCCCceeeccC----CcEEEcccCccccc
Q 005691 445 KPAIYHRDIKATNILLDAD----MRARVADFGLAKQS 477 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~----~~~KLaDFGla~~~ 477 (683)
...++|+|+.+.||+++.+ ..+.|.||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5679999999999999875 68999999988654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.012 Score=63.45 Aligned_cols=146 Identities=18% Similarity=0.205 Sum_probs=80.7
Q ss_pred eeeecCceEEEEEEEc--------CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCc-ccccceeeecCCCCCCCee
Q 005691 320 FIGRGGFGLVYKGILQ--------DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL-VPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 320 ~LG~GgfG~Vykg~l~--------~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NL-V~L~G~c~~~~~~~~~~~~ 390 (683)
.|..|-...+|+.... +++.+.+|+... .......+.+|.++++.|.-.++ .++++++. +
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-------~--- 125 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP-------E--- 125 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-------T---
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-------C---
Confidence 4666777788998865 247888887532 22345567789999988854344 34555542 2
Q ss_pred EEEEeecCCCCcccc-ccC------------CCCCCCCCCCCCCC--ccchhhhHHHHH-------------------HH
Q 005691 391 YLVYDYMPNGNVDDH-LFP------------SFNDGSGVAKRPLT--WPQRKNIILDVA-------------------KG 436 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~-L~~------------~~~~~~~~~~~~L~--w~~r~~Ia~~iA-------------------~g 436 (683)
.+||||++|..|..- +.. ..+.......+... |.+..++..++. ..
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 299999998776531 100 00000000011122 333333332221 12
Q ss_pred HHH----Hhc-ccCCCccccCCCCCceeeccC----CcEEEcccCcccc
Q 005691 437 LAY----LHY-GVKPAIYHRDIKATNILLDAD----MRARVADFGLAKQ 476 (683)
Q Consensus 437 L~y----LH~-~~~~~IiHrDIKpsNILLd~~----~~~KLaDFGla~~ 476 (683)
+.. |.. .....++|+|+.+.|||++.+ +.+.|.||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 321 224579999999999999876 7899999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0077 Score=64.07 Aligned_cols=73 Identities=11% Similarity=0.056 Sum_probs=43.6
Q ss_pred eeeeecCceEEEEEEEcC---------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCC
Q 005691 319 NFIGRGGFGLVYKGILQD---------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGS 388 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~---------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~ 388 (683)
..|+.|....+|+....+ +..+++|+..... ....+...|.++++.+...+++ ++++.. .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-------~-- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF-------N-- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-------T--
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec-------C--
Confidence 457777788999988764 2678887654321 1111246788888888644544 455432 1
Q ss_pred eeEEEEeecCCCCc
Q 005691 389 ERYLVYDYMPNGNV 402 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL 402 (683)
-++||||+++..+
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2689999998655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.016 Score=61.19 Aligned_cols=32 Identities=25% Similarity=0.361 Sum_probs=28.3
Q ss_pred CCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 445 KPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 445 ~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 46799999999999999888899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.34 E-value=0.31 Score=53.16 Aligned_cols=74 Identities=7% Similarity=-0.002 Sum_probs=47.6
Q ss_pred eeeeecCceEEEEEEEcC--------CcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCCe
Q 005691 319 NFIGRGGFGLVYKGILQD--------GTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGSE 389 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~--------g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~~ 389 (683)
+.|..|-...+|+....+ ++.+.+|+..... ...-...+|..+++.+.-.+++ ++++.+ .
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~-------~--- 144 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF-------P--- 144 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-------T---
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc-------C---
Confidence 456667778999998763 5778888754322 1112245788888888544443 444432 1
Q ss_pred eEEEEeecCCCCcc
Q 005691 390 RYLVYDYMPNGNVD 403 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~ 403 (683)
-++||||+++..|.
T Consensus 145 ~~~I~efI~G~~l~ 158 (424)
T 3mes_A 145 EGRIEEFIDGEPLT 158 (424)
T ss_dssp TEEEEECCCSEECC
T ss_pred CCEEEEEeCCccCC
Confidence 27899999997654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.46 E-value=0.098 Score=51.96 Aligned_cols=102 Identities=19% Similarity=0.156 Sum_probs=64.7
Q ss_pred CCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCccccccc
Q 005691 400 GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479 (683)
Q Consensus 400 GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~ 479 (683)
-||.+.|. ....++++.+.|.++.|.+.+|.-+-....+ ..+=+-|..|+|..+|++.+.+ ..+.
T Consensus 33 vSL~eIL~--------~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---- 97 (229)
T 2yle_A 33 LSLEEILR--------LYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---- 97 (229)
T ss_dssp EEHHHHHH--------HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred ccHHHHHH--------HcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----
Confidence 36777773 2356899999999999999998776211011 1233446899999999988764 1110
Q ss_pred CCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCC
Q 005691 480 GQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK 526 (683)
Q Consensus 480 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~ 526 (683)
.....+.|||... ...+.+.=|||+|++||..+-=..
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122456888763 355788899999999999875433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.23 E-value=0.12 Score=37.86 Aligned_cols=9 Identities=11% Similarity=-0.130 Sum_probs=3.6
Q ss_pred HHHHHhhhc
Q 005691 261 GLYFWWDKK 269 (683)
Q Consensus 261 ~~~~~~~rk 269 (683)
.+++|+||+
T Consensus 30 ~~~~~RRRr 38 (44)
T 2l2t_A 30 FAVYVRRKS 38 (44)
T ss_dssp HHHHHHTTC
T ss_pred HHHHhhhhh
Confidence 334444433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.49 E-value=1.6 Score=46.80 Aligned_cols=30 Identities=27% Similarity=0.422 Sum_probs=24.9
Q ss_pred CccccCCCCCceee------ccCCcEEEcccCcccc
Q 005691 447 AIYHRDIKATNILL------DADMRARVADFGLAKQ 476 (683)
Q Consensus 447 ~IiHrDIKpsNILL------d~~~~~KLaDFGla~~ 476 (683)
.++|+|+.+.|||+ +++..+++.||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4466799999988754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.49 E-value=0.19 Score=36.71 Aligned_cols=8 Identities=13% Similarity=-0.085 Sum_probs=3.1
Q ss_pred HHHHHhhh
Q 005691 261 GLYFWWDK 268 (683)
Q Consensus 261 ~~~~~~~r 268 (683)
.+++++||
T Consensus 31 ~~~~~RRr 38 (44)
T 2ks1_B 31 IGLFMRRR 38 (44)
T ss_dssp HHHHHHTT
T ss_pred HHHHhhhh
Confidence 33344333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=86.12 E-value=0.35 Score=35.30 Aligned_cols=8 Identities=0% Similarity=-0.184 Sum_probs=3.1
Q ss_pred HHHHhhhc
Q 005691 262 LYFWWDKK 269 (683)
Q Consensus 262 ~~~~~~rk 269 (683)
+++++||+
T Consensus 32 ~~~~RRR~ 39 (44)
T 2jwa_A 32 GILIKRRQ 39 (44)
T ss_dssp HHHHHHHC
T ss_pred Hhheehhh
Confidence 33333333
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=84.70 E-value=0.3 Score=34.61 Aligned_cols=25 Identities=0% Similarity=-0.142 Sum_probs=9.8
Q ss_pred ceEEEeehhHHHHHHHHHHHHHHHH
Q 005691 240 SALVFGLTGAGVAIFVMFALLGLYF 264 (683)
Q Consensus 240 ~~~ii~ii~~~~~~vv~l~~~~~~~ 264 (683)
.+.|.++++..++.+++++.+.+++
T Consensus 10 ~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 10 GGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCceeeeehHHHHHHHHHHHHHHHH
Confidence 3445553333333333333333333
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.08 E-value=0.14 Score=56.64 Aligned_cols=58 Identities=7% Similarity=0.059 Sum_probs=17.1
Q ss_pred eeeeecCceEEEEEEEcC-CcEEEE------EEeeccCc--cChHHHHHHHHHHHhccCCCcccccceee
Q 005691 319 NFIGRGGFGLVYKGILQD-GTTVAV------KKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCV 379 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~-g~~VAV------K~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~ 379 (683)
+.|| ||.||+|.+.. ..+||| |+...... +....|.+|..++..++|+|+++.++|..
T Consensus 148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3465 99999999864 367898 77655332 22346888999999999999999999875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=81.77 E-value=0.15 Score=56.47 Aligned_cols=29 Identities=21% Similarity=0.161 Sum_probs=24.4
Q ss_pred cChHHHHHHHHHHHhccCCCcccccceee
Q 005691 351 QGDAEFCNEVEIISNLKHRNLVPLRGCCV 379 (683)
Q Consensus 351 ~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~ 379 (683)
++.++|..|++++++++|+|||+++|||.
T Consensus 321 ~g~~eF~~Eve~L~~i~HrNLV~L~gyC~ 349 (487)
T 3oja_A 321 QGSETERLECERENQARQREIDALKEQYR 349 (487)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred ccHHHHHHHHHHHhcccccchhhHHHHhc
Confidence 44678999999999999999999999996
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 683 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-67
Identities = 76/304 (25%), Positives = 119/304 (39%), Gaps = 41/304 (13%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL 366
D E + + IG G FG VYKG V + V Q F NEV ++
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
+H N++ G + +V + ++ HL + + +
Sbjct: 62 RHVNILLFMGYST-------APQLAIVTQWCEGSSLYHHLH--------IIETKFEMIKL 106
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-SREGQSHLT 485
+I A+G+ YLH +I HRD+K+ NI L D+ ++ DFGLA SR SH
Sbjct: 107 IDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 486 TRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542
+++G+ ++APE + +SDVY+FG+V+ E+M G+ +
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------R 215
Query: 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602
D + +V G L P L K K +M C RP L
Sbjct: 216 DQIIFMVGRGY----LSPDLSKVRSNCPKAMKRLMAE-------CLKKKRDERPLFPQIL 264
Query: 603 KMLE 606
+E
Sbjct: 265 ASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-62
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 42/305 (13%)
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVE 361
W++ + E + +G G FG V+ G T VAVK ++ F E
Sbjct: 3 WWE-DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEAN 60
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
++ L+H+ LV L + Y++ +YM NG++ D L + L
Sbjct: 61 LMKQLQHQRLVRLYAVVTQE-------PIYIITEYMENGSLVDFLKTP-------SGIKL 106
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
T + ++ +A+G+A++ + HRD++A NIL+ + ++ADFGLA+ + +
Sbjct: 107 TINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541
+ APE YG T KSDV+SFG+++ EI+ + P +
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI--------PYPGMT 215
Query: 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601
V ++ G + + P E + LC RPT
Sbjct: 216 NPEVIQNLERG---------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260
Query: 602 LKMLE 606
+LE
Sbjct: 261 RSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 78/324 (24%), Positives = 125/324 (38%), Gaps = 43/324 (13%)
Query: 295 RPNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDA 354
+P T + E + + +G+G FG V+ G T VA+K ++
Sbjct: 1 KPQTQGL--AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPE 57
Query: 355 EFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGS 414
F E +++ L+H LV L + Y+V +YM G++ D L
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVVSEE-------PIYIVTEYMSKGSLLDFLK------- 103
Query: 415 GVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLA 474
G + L PQ ++ +A G+AY+ HRD++A NIL+ ++ +VADFGLA
Sbjct: 104 GETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLA 160
Query: 475 KQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSG 534
+ + + + APE ALYG+ T KSDV+SFG+++ E+ +
Sbjct: 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV------- 213
Query: 535 SPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL 594
P ++ V V+ G P E + C
Sbjct: 214 -PYPGMVNREVLDQVERGYRMPC---------------PPECPESLHDLMCQCWRKEPEE 257
Query: 595 RPTISDALKMLEGDIEVPPLPDRP 618
RPT LE +P
Sbjct: 258 RPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 35/302 (11%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVV 380
IG+G FG V++G G VAVK + S + E+ L+H N++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADN- 67
Query: 381 DGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYL 440
DN ++ +LV DY +G++ D+L + +T + L A GLA+L
Sbjct: 68 -KDNGTWTQLWLVSDYHEHGSLFDYLN----------RYTVTVEGMIKLALSTASGLAHL 116
Query: 441 H-----YGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL---TTRVAGTH 492
H KPAI HRD+K+ NIL+ + +AD GLA + + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 493 GYLAPEYAL------YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP--RACLITDW 544
Y+APE + + +++D+Y+ G+V EI + + +D
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604
++ Q L P++ + + C + A R T K
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNR-----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291
Query: 605 LE 606
L
Sbjct: 292 LS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-60
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 22/228 (9%)
Query: 308 LERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISN 365
+E D F + + +G G G+V+K G +A K + +E + E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
+V G DG E + ++M G++D L +
Sbjct: 61 CNSPYIVGFYGAFYSDG------EISICMEHMDGGSLDQVLK---------KAGRIPEQI 105
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ + V KGL YL K I HRD+K +NIL+++ ++ DFG++ Q +
Sbjct: 106 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 160
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTS 533
GT Y++PE + +SD++S G+ ++E+ GR + +
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 71/298 (23%), Positives = 115/298 (38%), Gaps = 41/298 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+ + IG G FGLV+ G + VA+K I + +F E E++ L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L G C + LV+++M +G + D+L + LD
Sbjct: 64 QLYGVC------LEQAPICLVFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLD 109
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
V +G+AYL + + HRD+ A N L+ + +V+DFG+ + + Q +T
Sbjct: 110 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552
+ +PE + + + KSDV+SFGV++ E+ K P V + G
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK--------IPYENRSNSEVVEDISTG 218
Query: 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610
++ P L + C RP S L+ L E
Sbjct: 219 --FRLYKPRL-------------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 42/297 (14%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+ +G G FG+V G + VA+K +I+ + EF E +++ NL H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L G C + +++ +YM NG + ++L + Q + D
Sbjct: 63 QLYGVC------TKQRPIFIITEYMANGCLLNYLREM--------RHRFQTQQLLEMCKD 108
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
V + + YL HRD+ A N L++ +V+DFGL++ + + +
Sbjct: 109 VCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552
+ PE +Y + + KSD+++FGV++ EI K P + G
Sbjct: 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK--------MPYERFTNSETAEHIAQG 217
Query: 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609
P E+ + C H RPT L + D+
Sbjct: 218 LRLY---------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL-DV 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 1e-57
Identities = 75/330 (22%), Positives = 127/330 (38%), Gaps = 55/330 (16%)
Query: 304 KIQDLERATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKV-IESDFQGDAEF 356
K+ LE + IG G FG V++ + T VAVK + E+ A+F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 357 CNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF--------- 407
E +++ + N+V L G C G L+++YM G++++ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVC------AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117
Query: 408 ------PSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461
+ S PL+ ++ I VA G+AYL + HRD+ N L+
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVG 174
Query: 462 ADMRARVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520
+M ++ADFGL++ A ++ PE Y + T +SDV+++GVV+ E
Sbjct: 175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234
Query: 521 IMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERF 580
I P + + V V+ G + P+
Sbjct: 235 IFSYGL--------QPYYGMAHEEVIYYVRDGNILAC---------------PENCPLEL 271
Query: 581 VLVGILCAHVMVALRPTISDALKMLEGDIE 610
+ LC + A RP+ ++L+ E
Sbjct: 272 YNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 2e-57
Identities = 70/312 (22%), Positives = 126/312 (40%), Gaps = 41/312 (13%)
Query: 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQD-GTTVAVKKVIESDFQGDAEFCNEVEIIS 364
E + K+ +G G +G VY+G+ + TVAVK + E + + EF E ++
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMK 68
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
+KH NLV L G C R Y++ ++M GN+ D+L ++ ++
Sbjct: 69 EIKHPNLVQLLGVC------TREPPFYIITEFMTYGNLLDYLREC-------NRQEVSAV 115
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
+ ++ + YL K HRD+ A N L+ + +VADFGL++
Sbjct: 116 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 485 TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544
+ APE Y + + KSDV++FGV++ EI + P +
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--------PYPGIDLSQ 224
Query: 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604
V+ L++ + P+ E+ + C + RP+ ++ +
Sbjct: 225 VYELLEKDYRMER---------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 269
Query: 605 LEGDIEVPPLPD 616
E + + D
Sbjct: 270 FETMFQESSISD 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 6e-57
Identities = 77/294 (26%), Positives = 113/294 (38%), Gaps = 45/294 (15%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV 372
+ IG+G FG V G G VAVK + F E +++ L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L G V E Y+V +YM G++ D+L + L LD
Sbjct: 64 QLLGVIV-----EEKGGLYIVTEYMAKGSLVDYLRSR-------GRSVLGGDCLLKFSLD 111
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
V + + YL HRD+ A N+L+ D A+V+DFGL K++ S
Sbjct: 112 VCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPV 164
Query: 493 GYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552
+ APE + + KSDV+SFG+++ EI + P + V V+ G
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV--------PYPRIPLKDVVPRVEKG 216
Query: 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606
A P V C H+ A+RP+ + LE
Sbjct: 217 YKMDA---------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-56
Identities = 80/315 (25%), Positives = 121/315 (38%), Gaps = 57/315 (18%)
Query: 296 PNTGSIWFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD- 353
P+ ++FK + FS IG G FG VY +++ VA+KK+ S Q +
Sbjct: 2 PDVAELFFK----DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 354 --AEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFN 411
+ EV + L+H N + RGC R +LV +Y D
Sbjct: 58 KWQDIIKEVRFLQKLRHPNTIQYRGCY------LREHTAWLVMEYCLGSASDLLE----- 106
Query: 412 DGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471
V K+PL + + +GLAYLH + HRD+KA NILL ++ DF
Sbjct: 107 ----VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKAL 528
G A GT ++APE L GQ K DV+S G+ +E+ + L
Sbjct: 160 GSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
Query: 529 DLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCA 588
+ + + L + Q P+L + S + ++ C
Sbjct: 215 F---NMNAMSALY-----------HIAQNESPAL--QSGHWSEYFRNFVDS-------CL 251
Query: 589 HVMVALRPTISDALK 603
+ RPT LK
Sbjct: 252 QKIPQDRPTSEVLLK 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 5e-56
Identities = 63/308 (20%), Positives = 112/308 (36%), Gaps = 48/308 (15%)
Query: 306 QDLERATDKFSQKNF-IGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQGDAE-FCNEV 360
+ L D + +G G FG V +G+ + VA+K + + + D E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 361 EIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRP 420
+I+ L + +V L G C + LV + G + L +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-------QAEALMLVMEMAGGGPLHKFLVGK--------REE 105
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
+ ++ V+ G+ YL HRD+ A N+LL A+++DFGL+K
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
Query: 481 QSHLTTR--VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRA 538
S+ T R + APE + + + +SDV+S+GV + E + + P
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ--------KPYK 214
Query: 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598
+ V + ++ GK ++ A+M C RP
Sbjct: 215 KMKGPEVMAFIEQGK--------RMECPPECPPELYALMSD-------CWIYKWEDRPDF 259
Query: 599 SDALKMLE 606
+ +
Sbjct: 260 LTVEQRMR 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 3e-55
Identities = 71/328 (21%), Positives = 126/328 (38%), Gaps = 58/328 (17%)
Query: 303 FKIQDLERATDKFSQK---------NFIGRGGFGLVYKGIL----QDGTTVAVKKV-IES 348
F +D A +F+++ IG G FG V G L + VA+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 349 DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFP 408
+ +F +E I+ H N++ L G + + ++ ++M NG++D L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVV------TKSTPVMIITEFMENGSLDSFLRQ 120
Query: 409 SFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468
+ T Q ++ +A G+ YL HRD+ A NIL+++++ +V
Sbjct: 121 ND--------GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKV 169
Query: 469 ADFGLAKQSREGQSHLTTRVA----GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCG 524
+DFGL++ + S T A + APE Y + T SDV+S+G+V+ E+M
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 525 RKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVG 584
+ + + V A++ D+ P +
Sbjct: 230 GERP-----------------YWDMTNQDVINAIE------QDYRLPPPMDCPSALHQLM 266
Query: 585 ILCAHVMVALRPTISDALKMLEGDIEVP 612
+ C RP + L+ I P
Sbjct: 267 LDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-55
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 39/296 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD--AEFCNEVEIISNLKHR 369
+ + IG G +G K DG + K++ +EV ++ LKH
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N+V + + + Y+V +Y G++ + ++ L +
Sbjct: 64 NIVRYYDRII----DRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRV 114
Query: 430 ILDVAKGLAYLHYGVKPA--IYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
+ + L H + HRD+K N+ LD ++ DFGLA+ S
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA- 173
Query: 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547
GT Y++PE EKSD++S G ++ E+ P +
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM---------PPFTAFSQKELAG 224
Query: 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
++ GK + S I+ R ++ RP++ + L+
Sbjct: 225 KIREGK--------FRRIPYRYSDELNEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-55
Identities = 70/295 (23%), Positives = 109/295 (36%), Gaps = 44/295 (14%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAEFCNEVEIISNLKHRN 370
+ + +G G +G V + VAVK V ++ E+ I L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V G G+ +YL +Y G + D + P + P +
Sbjct: 65 VVKFYGHR------REGNIQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFF 109
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG-QSHLTTRVA 489
+ G+ YLH I HRDIK N+LLD +++DFGLA R + L ++
Sbjct: 110 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 490 GTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548
GT Y+APE + E DV+S G+V+ ++ G D S +DW
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKE-- 221
Query: 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
+ L + P A++ + + R TI D K
Sbjct: 222 ----------KKTYLNPWKKIDSAPLALLHK-------ILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-54
Identities = 67/298 (22%), Positives = 116/298 (38%), Gaps = 46/298 (15%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN 370
D + +G G FG VYK + A K + + ++ E++I+++ H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L + + +++ ++ G VD + +RPLT Q + +
Sbjct: 71 IVKLLDAFYYENN------LWILIEFCAGGAVDAVMLEL--------ERPLTESQIQVVC 116
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
L YLH I HRD+KA NIL D ++ADFG++ ++ + + G
Sbjct: 117 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-G 172
Query: 491 THGYLAPEYALYGQL-----TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545
T ++APE + K+DV+S G+ ++E+ P L V
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE---------PPHHELNPMRV 223
Query: 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
+ +P L + S N K +++ C V R T S L+
Sbjct: 224 LLKIAKS------EPPTLAQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 67/316 (21%), Positives = 119/316 (37%), Gaps = 49/316 (15%)
Query: 313 DKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQGDAE-FCNEVEIISN 365
++ S +G G FG V + TVAVK + S + E +E++++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 366 LK-HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF---------PSFNDGSG 415
L H N+V L G C + G ++ +Y G++ + L +
Sbjct: 83 LGNHMNIVNLLGACTIGG------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475
+ L + VAKG+A+L HRD+ A NILL ++ DFGLA+
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 476 QSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSG 534
+ ++ + ++APE T +SDV+S+G+ + E+ +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP- 252
Query: 535 SPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL 594
+ + ++K G F L+P+ + C
Sbjct: 253 ------VDSKFYKMIKEG---------------FRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 595 RPTISDALKMLEGDIE 610
RPT ++++E I
Sbjct: 292 RPTFKQIVQLIEKQIS 307
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-54
Identities = 73/294 (24%), Positives = 111/294 (37%), Gaps = 44/294 (14%)
Query: 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGD--AEFCNEVEIISNLKHRN 370
KF + IGRG F VYKG+ + VA ++ + F E E++ L+H N
Sbjct: 12 KFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V ++ LV + M +G + +L + + ++
Sbjct: 70 IVRFYDSWESTVKGKK--CIVLVTELMTSGTLKTYLK---------RFKVMKIKVLRSWC 118
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQSREGQSHLTTRVA 489
+ KGL +LH P I HRD+K NI + ++ D GLA R + V
Sbjct: 119 RQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVI 174
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549
GT ++APE + E DVY+FG+ +LE+ S A I V S V
Sbjct: 175 GTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPY----SECQNAAQIYRRVTSGV 229
Query: 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
K + P + K I+E C R +I D L
Sbjct: 230 KPASFDKVAIPEV-----------KEIIEG-------CIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 8e-54
Identities = 74/310 (23%), Positives = 120/310 (38%), Gaps = 49/310 (15%)
Query: 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQGD-AEFCNE 359
+ F++ IGRG FG VY G L D AVK + G+ ++F E
Sbjct: 21 VIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 360 VEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR 419
I+ + H N++ L G C+ +V YM +G++ + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICL-----RSEGSPLVVLPYMKHGDLRNFIRNE--------TH 125
Query: 420 PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSRE 479
T L VAKG+ +L HRD+ A N +LD +VADFGLA+ +
Sbjct: 126 NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 480 GQS---HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536
+ H T ++A E + T KSDV+SFGV++ E+M +
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--- 239
Query: 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP 596
D L++ ++ L P+ + V + C H +RP
Sbjct: 240 ----TFDITVYLLQGRRL----------------LQPEYCPDPLYEVMLKCWHPKAEMRP 279
Query: 597 TISDALKMLE 606
+ S+ + +
Sbjct: 280 SFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-53
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 48/309 (15%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGT-----TVAVKKVIESDFQGD-AEFCNEVEIISNL 366
+++ IG G FG VYKG+L+ + VA+K + + +F E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 367 KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQR 426
H N++ L G ++ +YM NG +D L + Q
Sbjct: 67 SHHNIIRLEGVISKYK------PMMIITEYMENGALDKFLREK--------DGEFSVLQL 112
Query: 427 KNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTT 486
++ +A G+ YL HRD+ A NIL+++++ +V+DFGL++ + T
Sbjct: 113 VGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
Query: 487 RVA--GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544
+ APE Y + T SDV+SFG+V+ E+M +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-----------------R 212
Query: 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604
+ + +V +A++ P + + C A RP +D + +
Sbjct: 213 PYWELSNHEVMKAINDGFRLPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
Query: 605 LEGDIEVPP 613
L+ I P
Sbjct: 267 LDKLIRAPD 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-53
Identities = 64/293 (21%), Positives = 107/293 (36%), Gaps = 49/293 (16%)
Query: 321 IGRGGFGLVYKGILQD---GTTVAVKKVIESDFQGDA--EFCNEVEIISNLKHRNLVPLR 375
+G G FG V KG Q TVAVK + E E ++ L + +V +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 376 GCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAK 435
G C + LV + G ++ +L R + ++ V+
Sbjct: 75 GICEAE-------SWMLVMEMAELGPLNKYLQQ---------NRHVKDKNIIELVHQVSM 118
Query: 436 GLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR--VAGTHG 493
G+ YL HRD+ A N+LL A+++DFGL+K R +++ +
Sbjct: 119 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 494 YLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGK 553
+ APE Y + + KSDV+SFGV++ E + P + V ++++ G+
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--------PYRGMKGSEVTAMLEKGE 227
Query: 554 VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606
+ +M C V RP + L
Sbjct: 228 --------RMGCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-52
Identities = 74/332 (22%), Positives = 126/332 (37%), Gaps = 46/332 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDG---TTVAVKKV-IESDFQGDAEFCNEVEIISNL-K 367
+ ++ IG G FG V K ++ A+K++ + +F E+E++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA-------KRP 420
H N++ L G C E YL +Y P+GN+ D L S + A
Sbjct: 70 HPNIINLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 421 LTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREG 480
L+ Q + DVA+G+ YL + HRD+ A NIL+ + A++ADFGL++
Sbjct: 124 LSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540
T ++A E Y T SDV+S+GV++ EI+ +P +
Sbjct: 181 VK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------TPYCGM 230
Query: 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600
++ + G + P + + C RP+ +
Sbjct: 231 TCAELYEKLPQGYRLEK---------------PLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 601 ALKMLEGDIEVPPLPDRPMPLGHPSFYGDDST 632
L L +E ++ G D +
Sbjct: 276 ILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 9e-52
Identities = 64/317 (20%), Positives = 114/317 (35%), Gaps = 54/317 (17%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQD------GTTVAVKKVIESDFQGDAE-FCNEVEIISN 365
+ +G G FG V VAVK + E + E +E+++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 366 L-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF--------------PSF 410
L H N+V L G C + G YL+++Y G++ ++L
Sbjct: 97 LGSHENIVNLLGACTLSG------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 411 NDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470
LT+ VAKG+ +L + HRD+ A N+L+ ++ D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICD 207
Query: 471 FGLAKQSREGQSHLT-TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD 529
FGLA+ +++ ++APE G T KSDV+S+G+++ EI
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 530 LSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAH 589
+ + L++ G + + + + IM+ C
Sbjct: 268 PGIP-------VDANFYKLIQNGFK--------MDQPFYATEEIYIIMQS-------CWA 305
Query: 590 VMVALRPTISDALKMLE 606
RP+ + L
Sbjct: 306 FDSRKRPSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 9e-52
Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 50/295 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGD---AEFCNEVEIISNLKH 368
+ F +G+G FG VY Q +A+K + ++ + + EVEI S+L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
N++ L G + YL+ +Y P G V L +
Sbjct: 66 PNILRLYGYF------HDATRVYLILEYAPLGTVYRELQK---------LSKFDEQRTAT 110
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
I ++A L+Y H + HRDIK N+LL + ++ADFG + + + +
Sbjct: 111 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TL 164
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548
GT YL PE EK D++S GV+ E + G+ + +T
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------------- 209
Query: 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
+ ++ + DF++ + ++ R + RP + + L+
Sbjct: 210 ---QETYKRISRVEFTFPDFVTEGARDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-51
Identities = 63/293 (21%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN 370
K+++ IG+G G VY + + G VA++++ NE+ ++ K+ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V +V E ++V +Y+ G++ D + + + Q +
Sbjct: 79 IVNYLDSYLVGD------ELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVC 122
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
+ + L +LH + HRDIK+ NILL D ++ DFG Q QS +T V G
Sbjct: 123 RECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 178
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550
T ++APE K D++S G++ +E++ G ++ +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIAT 230
Query: 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603
G L+ + LS + + R C + V R + + L+
Sbjct: 231 NGTPE-------LQNPEKLSAIFRDFLNR-------CLDMDVEKRGSAKELLQ 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 9e-51
Identities = 67/313 (21%), Positives = 126/313 (40%), Gaps = 41/313 (13%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGIL------QDGTTVAVKKVIESDFQGD-AEFCNE 359
+ E A +K + +G+G FG+VY+G+ + T VA+K V E+ + EF NE
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 360 VEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR 419
++ ++V L G +G ++ + M G++ +L +
Sbjct: 74 ASVMKEFNCHHVVRLLGVV------SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 420 -PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR 478
P + + + ++A G+AYL+ HRD+ A N ++ D ++ DFG+ +
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 479 EGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537
E + + +++PE G T SDV+SFGVV+ EI + P
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------QPY 236
Query: 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT 597
L + V V G + P + + +C +RP+
Sbjct: 237 QGLSNEQVLRFVMEGGLLDK---------------PDNCPDMLFELMRMCWQYNPKMRPS 281
Query: 598 ISDALKMLEGDIE 610
+ + ++ ++E
Sbjct: 282 FLEIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-50
Identities = 59/305 (19%), Positives = 105/305 (34%), Gaps = 46/305 (15%)
Query: 307 DLERATDKFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKVIESDFQGDAE-FCNEVE 361
D E ++ IG G FG V++GI VA+K E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
+ H ++V L G + +++ + G + L L
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-------PVWIIMELCTLGELRSFLQVRK--------YSL 105
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
++ LAYL HRDI A N+L+ ++ ++ DFGL++ +
Sbjct: 106 DLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 482 SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541
+ ++ ++APE + + T SDV+ FGV + EI+ P +
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV--------KPFQGVK 214
Query: 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDA 601
+ V ++ G+ L ++M + C + RP ++
Sbjct: 215 NNDVIGRIENGE--------RLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTEL 259
Query: 602 LKMLE 606
L
Sbjct: 260 KAQLS 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 8e-50
Identities = 70/328 (21%), Positives = 130/328 (39%), Gaps = 54/328 (16%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGILQD-----GTTVAVKKVIES-DFQGDAEFCNEVEII 363
+ T+ F + +G G FG VYKG+ VA+K++ E+ + + E +E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 364 SNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTW 423
+++ + ++ L G C+ L+ MP G + D++ K +
Sbjct: 66 ASVDNPHVCRLLGICLTS-------TVQLITQLMPFGCLLDYVREH--------KDNIGS 110
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQ-SREGQS 482
N + +AKG+ YL + HRD+ A N+L+ ++ DFGLAK E +
Sbjct: 111 QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542
+ ++A E L+ T +SDV+S+GV + E+M P +
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--------KPYDGIPA 219
Query: 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602
+ S+++ G+ L + +++ IM + C + RP + +
Sbjct: 220 SEISSILEKGER--------LPQPPICTIDVYMIMVK-------CWMIDADSRPKFRELI 264
Query: 603 KMLEGDIEVPP-----LPDRPMPLGHPS 625
P D M L P+
Sbjct: 265 IEFSKMARDPQRYLVIQGDERMHLPSPT 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 63/295 (21%), Positives = 104/295 (35%), Gaps = 49/295 (16%)
Query: 321 IGRGGFGLVYKGIL----QDGTTVAVKKV---IESDFQGDAEFCNEVEIISNLKHRNLVP 373
+G G FG+V +G +VAVK + + S + +F EV + +L HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
L G + +V + P G++ D L + + V
Sbjct: 76 LYGVVLTP-------PMKMVTELAPLGSLLDRLRKH--------QGHFLLGTLSRYAVQV 120
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSH--LTTRVAGT 491
A+G+ YL HRD+ A N+LL ++ DFGL + + H +
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 492 HGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551
+ APE + SD + FGV + E+ + + +GS + + K
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKE 230
Query: 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606
G+ P+ + V + C RPT L
Sbjct: 231 GERLPR---------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (432), Expect = 4e-48
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 22/216 (10%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
D + +G G FG+V++ G A K V+ E++ +S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
V L E +E ++Y++M G + + + ++ + +
Sbjct: 86 VNLHDAF------EDDNEMVMIYEFMSGGELFEKVADE--------HNKMSEDEAVEYMR 131
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADM--RARVADFGLAKQSREGQSHLTTRVA 489
V KGL ++H + H D+K NI+ ++ DFGL QS T
Sbjct: 132 QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-- 186
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT + APE A + +D++S GV+ ++ G
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-48
Identities = 72/314 (22%), Positives = 118/314 (37%), Gaps = 46/314 (14%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI------LQDGTTVAVKKVIESDFQGDA-EFCNEVEIISN 365
D+ +GRG FG V + TVAVK + E + +E++I+ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 366 LKHR-NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLF-------PSFNDGSGVA 417
+ H N+V L G C + G ++ ++ GN+ +L P +
Sbjct: 73 IGHHLNVVNLLGACT-----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 127
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
K LT VAKG+ +L HRD+ A NILL ++ DFGLA+
Sbjct: 128 KDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 478 REGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536
+ ++ ++APE T +SDV+SFGV++ EI +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--- 241
Query: 537 RACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP 596
I + +K G +A P + C H + RP
Sbjct: 242 ----IDEEFCRRLKEGTRMRA---------------PDYTTPEMYQTMLDCWHGEPSQRP 282
Query: 597 TISDALKMLEGDIE 610
T S+ ++ L ++
Sbjct: 283 TFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 23/225 (10%)
Query: 306 QDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD---AEFCNEVE 361
Q ++ + F +G G F V L A+K + + + E +
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 362 IISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
++S L H V L + + Y Y NG + ++
Sbjct: 61 VMSRLDHPFFVKLYFTF------QDDEKLYFGLSYAKNGELLKYIRK---------IGSF 105
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK-QSREG 480
+ ++ L YLH I HRD+K NILL+ DM ++ DFG AK S E
Sbjct: 106 DETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162
Query: 481 QSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
+ GT Y++PE + SD+++ G +I +++ G
Sbjct: 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 71/317 (22%), Positives = 126/317 (39%), Gaps = 50/317 (15%)
Query: 313 DKFSQKNFIGRGGFGLVYKGIL--------QDGTTVAVKKV-IESDFQGDAEFCNEVEII 363
D+ +G G FG V T VAVK + ++ + ++ +E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 364 SNL-KHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SG 415
+ KH+N++ L G C + Y++ +Y GN+ ++L G S
Sbjct: 73 KMIGKHKNIINLLGAC------TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475
+ L+ + VA+G+ YL HRD+ A N+L+ D ++ADFGLA+
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 476 QSREGQSHLTTRVA-GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSG 534
+ T ++APE T +SDV+SFGV++ EI
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-------- 235
Query: 535 SPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL 594
SP + + ++ L+K G P ++ C H + +
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDK---------------PSNCTNELYMMMRDCWHAVPSQ 280
Query: 595 RPTISDALKMLEGDIEV 611
RPT ++ L+ + +
Sbjct: 281 RPTFKQLVEDLDRIVAL 297
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 2e-46
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 20/220 (9%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV---IESDFQGDAEFCNEVEIISNLK 367
+D++ +G GG V+ L+ VAVK + + D F E + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H +V + + G Y+V +Y+ + D + + P+T +
Sbjct: 66 HPAIVAVYDTGEAE--TPAGPLPYIVMEYVDGVTLRDIVHT---------EGPMTPKRAI 114
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL--T 485
+I D + L + H + I HRD+K NI++ A +V DFG+A+ + + + T
Sbjct: 115 EVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
V GT YL+PE A + +SDVYS G V+ E++ G
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-45
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 28/229 (12%)
Query: 302 WFKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD-AEFCNE 359
W + +D+ D + ++ +G G F V + VA+K + + +G NE
Sbjct: 1 WKQAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 57
Query: 360 VEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKR 419
+ ++ +KH N+V L E G YL+ + G + D + V K
Sbjct: 58 IAVLHKIKHPNIVALDDIY------ESGGHLYLIMQLVSGGELFDRI---------VEKG 102
Query: 420 PLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL---DADMRARVADFGLAKQ 476
T +I V + YLH I HRD+K N+L D D + ++DFGL+K
Sbjct: 103 FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159
Query: 477 SREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
E + + GT GY+APE ++ D +S GV+ ++CG
Sbjct: 160 --EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 4e-45
Identities = 45/216 (20%), Positives = 86/216 (39%), Gaps = 22/216 (10%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
D + +G G FG+V++ + G K + NE+ I++ L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
+ L E E L+ +++ G + D + ++ + N +
Sbjct: 89 INLHDAF------EDKYEMVLILEFLSGGELFDRIAAE--------DYKMSEAEVINYMR 134
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV--ADFGLAKQSREGQSHLTTRVA 489
+GL ++H + +I H DIK NI+ + + V DFGLA + + +
Sbjct: 135 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTT 189
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
T + APE + +D+++ GV+ ++ G
Sbjct: 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-44
Identities = 82/346 (23%), Positives = 128/346 (36%), Gaps = 47/346 (13%)
Query: 315 FSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVP 373
++ IG G FG+VY+ L G VA+KKV+ Q E++I+ L H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 374 LRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDV 433
LR G+ + LV DY+P S K+ L K + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQL 131
Query: 434 AKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQSREGQSHLTTRVAGTH 492
+ LAY+H I HRDIK N+LLD D ++ DFG AKQ G+ +++ +
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SR 186
Query: 493 GYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALD-----------LSTSGSPRACL 540
Y APE T DV+S G V+ E++ G+ + G+P
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600
I + + + P A+ R R T +
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR-------LLEYTPTARLTPLE 299
Query: 601 ALK------MLEGDIEVPPLPDRPMPLGHPSFYGDDSTFGISPALS 640
A + + ++++P D P F +P L+
Sbjct: 300 ACAHSFFDELRDPNVKLPNGRDTP-----ALFNFTTQELSSNPPLA 340
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 64/351 (18%), Positives = 131/351 (37%), Gaps = 47/351 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
+K+ +GRG FG+V++ + T K ++ E+ I++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
+ L E E ++++++ ++ + + S L + + +
Sbjct: 64 LHLHESF------ESMEELVMIFEFISGLDIFERINTS--------AFELNEREIVSYVH 109
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV--ADFGLAKQSREGQSHLTTRVA 489
V + L +LH I H DI+ NI+ + + +FG A+Q + G +
Sbjct: 110 QVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-- 164
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549
Y APE + ++ +D++S G ++ ++ G +P + +
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI---------NPFLAETNQQIIENI 215
Query: 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM--LEG 607
+ D KE +S+ ++R R T S+AL+ L+
Sbjct: 216 MNAEY--TFDEEAFKE---ISIEAMDFVDR-------LLVKERKSRMTASEALQHPWLKQ 263
Query: 608 DIEVPPLPDRPMPLGHPSFYGDDSTFGISPALSGLQLHTGDMLRRPRVDSV 658
IE L H +Y ++ +S ++ G +R + SV
Sbjct: 264 KIE-RVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSV 313
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (388), Expect = 8e-43
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV---------IESDFQGDAEFCNEVEI 362
+ + K +GRG +V + I AVK + E + EV+I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 363 ISNLK-HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPL 421
+ + H N++ L+ E + +LV+D M G + D+L K L
Sbjct: 63 LRKVSGHPNIIQLKDTY------ETNTFFFLVFDLMKKGELFDYL---------TEKVTL 107
Query: 422 TWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ 481
+ + + I+ + + + LH K I HRD+K NILLD DM ++ DFG + Q G+
Sbjct: 108 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE 164
Query: 482 SHLTTRVAGTHGYLAPEYAL------YGQLTEKSDVYSFGVVILEIMCGR 525
V GT YLAPE + ++ D++S GV++ ++ G
Sbjct: 165 K--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 54/303 (17%), Positives = 110/303 (36%), Gaps = 26/303 (8%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE-FCNEVEIISNLKHR 369
+++ ++IG G +G+V + VA+KK+ + Q + E++I+ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N++ + + + ++ ++ L + L+
Sbjct: 67 NIIGINDII--RAPTIEQMKDVYLVTHLMGADLYKLL----------KTQHLSNDHICYF 114
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT--TR 487
+ + +GL Y+H + HRD+K +N+LL+ ++ DFGLA+ + H T
Sbjct: 115 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 488 VAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGR------KALDLSTSGSPRACL 540
T Y APE L + T+ D++S G ++ E++ R LD
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
Query: 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600
+ + + K L K + + + + R +
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291
Query: 601 ALK 603
AL
Sbjct: 292 ALA 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 154 bits (389), Expect = 6e-42
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 29/221 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDF---QGDAEFCNEVEIIS---N 365
+ FS IGRGGFG VY G A+K + + QG+ NE ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
+V + + + D M G++ HL +
Sbjct: 64 GDCPFIVCMSYAF------HTPDKLSFILDLMNGGDLHYHLS---------QHGVFSEAD 108
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
+ ++ GL ++H + +RD+K NILLD R++D GLA + +
Sbjct: 109 MRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 162
Query: 486 TRVAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGR 525
GTHGY+APE G +D +S G ++ +++ G
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 24/218 (11%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE---FCNEVEIIS-NLK 367
+ F +G+G FG V+ + A+K + + D + E ++S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 368 HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRK 427
H L + + V +Y+ G++ H+ + +
Sbjct: 62 HPFLTHMFCTFQTKE------NLFFVMEYLNGGDLMYHIQ---------SCHKFDLSRAT 106
Query: 428 NIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTR 487
++ GL +LH I +RD+K NILLD D ++ADFG+ K++ G + T
Sbjct: 107 FYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF 163
Query: 488 VAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT Y+APE L + D +SFGV++ E++ G+
Sbjct: 164 C-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 6e-41
Identities = 52/307 (16%), Positives = 98/307 (31%), Gaps = 46/307 (14%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH 368
R +++ IG G FG +Y G + G VA+K +E + E +I ++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQG 61
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
+P C +GD +V + + D F R +
Sbjct: 62 GVGIPTIRWCGAEGDY-----NVMVMELLGPSLEDLFNFC---------SRKFSLKTVLL 107
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNIL---LDADMRARVADFGLAKQSREGQSH-- 483
+ + + Y+H HRD+K N L + DFGLAK+ R+ ++H
Sbjct: 108 LADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164
Query: 484 ----LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539
+ GT Y + L + + + D+ S G V++ G +
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL--------PWQGL 216
Query: 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS 599
+ + + +L + + C + +P S
Sbjct: 217 KAATKRQKYERISEKKMSTPIEVLCKG--YPSEFATYLNF-------CRSLRFDDKPDYS 267
Query: 600 DALKMLE 606
++
Sbjct: 268 YLRQLFR 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-40
Identities = 78/323 (24%), Positives = 118/323 (36%), Gaps = 43/323 (13%)
Query: 319 NFIGRGGFGLVYKGI-LQDGTTVAVKKV-----IESDFQGDAEFCNEVEIISNLKHRNLV 372
+F+G G F VYK VA+KK+ E+ + E++++ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 373 PLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
L S LV+D+M LT K +L
Sbjct: 64 GLLDAF------GHKSNISLVFDFMETDLEVIIKDN---------SLVLTPSHIKAYMLM 108
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAGTH 492
+GL YLH + I HRD+K N+LLD + ++ADFGLAK T +V T
Sbjct: 109 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTR 164
Query: 493 GYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551
Y APE ++ D+++ G ++ E++ L G +T +L
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP----GDSDLDQLTRIFETLGTP 220
Query: 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL-------RPTISDALKM 604
+ SL F S + F G ++ L R T + ALKM
Sbjct: 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
Query: 605 --LEGDIEVPPLPDRPMPLGHPS 625
P P L P+
Sbjct: 281 KYFSNR----PGPTPGCQLPRPN 299
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 33/308 (10%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKG--ILQDGTTVAVKKVIESDFQGDAE--FCNEVEIISN 365
RA ++ IG G +G V+K + G VA+K+V + EV ++ +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 366 LK---HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLT 422
L+ H N+V L C +R ++ LV++++ V + +
Sbjct: 64 LETFEHPNVVRLFDVCT-VSRTDRETKLTLVFEHVDQDLTTYLDK--------VPEPGVP 114
Query: 423 WPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS 482
K+++ + +GL +LH + HRD+K NIL+ + + ++ADFGLA+ +
Sbjct: 115 TETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 171
Query: 483 HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542
T V T Y APE L D++S G + E+ + S+ ++
Sbjct: 172 L--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
Query: 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL-------R 595
++ L F S + + I + + L +++ R
Sbjct: 230 -----VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284
Query: 596 PTISDALK 603
+ AL
Sbjct: 285 ISAYSALS 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 58/305 (19%), Positives = 110/305 (36%), Gaps = 38/305 (12%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV-IESDFQGDAE-FCNEVEIISNLKHR 369
+ F + IG G +G+VYK G VA+KK+ ++++ +G E+ ++ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N+V L ++ YLV++++ A + P K+
Sbjct: 62 NIVKLLDVI------HTENKLYLVFEFLHQDLKKFMD--------ASALTGIPLPLIKSY 107
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
+ + +GLA+ H + HRD+K N+L++ + ++ADFGLA+ T V
Sbjct: 108 LFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALD-----------LSTSGSPRA 538
+ D++S G + E++ R T G+P
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 539 CLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTI 598
+ + K L + ++++ + H R +
Sbjct: 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ-------MLHYDPNKRISA 277
Query: 599 SDALK 603
AL
Sbjct: 278 KAALA 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 65/312 (20%), Positives = 112/312 (35%), Gaps = 55/312 (17%)
Query: 303 FKIQDLERATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD------AE 355
F+ ++++ D + +G G F +V K G A K + + + +
Sbjct: 3 FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 356 FCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSG 415
EV I+ ++H N++ L E ++ L+ + + G + D L
Sbjct: 60 IEREVSILKEIQHPNVITLHEVY------ENKTDVILILELVAGGELFDFLA-------- 105
Query: 416 VAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD----MRARVADF 471
K LT + + + G+ YLH I H D+K NI+L R ++ DF
Sbjct: 106 -EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531
GLA + G + GT ++APE Y L ++D++S GV+ ++ G
Sbjct: 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS----- 214
Query: 532 TSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVM 591
P + V A + S K + R
Sbjct: 215 ----PFLGDTKQETLANVSAVNY-----EFEDEYFSNTSALAKDFIRR-------LLVKD 258
Query: 592 VALRPTISDALK 603
R TI D+L+
Sbjct: 259 PKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (363), Expect = 3e-39
Identities = 59/300 (19%), Positives = 106/300 (35%), Gaps = 30/300 (10%)
Query: 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKV--IESDFQGDAEFCNEVEIISNLKHRN 370
+K+ IG G +G+VYK G T A+KK+ + D + E+ I+ LKH N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
+V L LV++++ + L K+ +
Sbjct: 62 IVKLYDVIHTK------KRLVLVFEHLDQDLKKLLDVC---------EGGLESVTAKSFL 106
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVAG 490
L + G+AY H + HRD+K N+L++ + ++ADFGLA+ T +
Sbjct: 107 LQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT 163
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550
+ + D++S G + E++ G S L+ +
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP---GVSEADQLMRIFRILGTP 220
Query: 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL-------RPTISDALK 603
K W + + +F P + ++ + R T AL+
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 55/302 (18%), Positives = 110/302 (36%), Gaps = 43/302 (14%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCC 378
+G G G V + + A+K + Q + EVE+ + ++V +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 379 VVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLA 438
+ +V + + G + + + + T + I+ + + +
Sbjct: 75 --ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQ 125
Query: 439 YLHYGVKPAIYHRDIKATNILLDA---DMRARVADFGLAKQSREGQSHLTTRVAGTHGYL 495
YLH I HRD+K N+L + + ++ DFG AK++ S T T Y+
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYV 180
Query: 496 APEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAGKVW 555
APE + + D++S GV++ ++CG S I+ + + ++ G+
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPGMKTRIRMGQY- 234
Query: 556 QALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM--LEGDIEVPP 613
E +S K ++ R TI++ + + +VP
Sbjct: 235 ----EFPNPEWSEVSEEVKMLIRN-------LLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283
Query: 614 LP 615
P
Sbjct: 284 TP 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 7e-39
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 31/221 (14%)
Query: 315 FSQKNF-----IGRGGFGLVYKGI-LQDGTTVAVKKV---IESDFQGDAEFCNEVEIISN 365
+S ++F +G G FG V+ +G A+K + I + +E ++S
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 366 LKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQ 425
+ H ++ + G + + +++ DY+ G + L S P
Sbjct: 61 VTHPFIIRMWGTF------QDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPV 105
Query: 426 RKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLT 485
K +V L YLH I +RD+K NILLD + ++ DFG AK +
Sbjct: 106 AKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---- 158
Query: 486 TRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK 526
+ GT Y+APE + D +SFG++I E++ G
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-38
Identities = 62/313 (19%), Positives = 124/313 (39%), Gaps = 34/313 (10%)
Query: 306 QDLERATDKFSQK----NFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDA---EFC 357
Q++ + + +G G +G V + + G VA+KK + FQ +
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK-LYRPFQSELFAKRAY 65
Query: 358 NEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVA 417
E+ ++ +++H N++ L D + ++ YLV +M G L +
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL---------MK 114
Query: 418 KRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQS 477
L + + ++ + KGL Y+H I HRD+K N+ ++ D ++ DFGLA+Q+
Sbjct: 115 HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171
Query: 478 REGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPR 537
S +T V + + T+ D++S G ++ E++ G+ S
Sbjct: 172 ---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228
Query: 538 ACLI------TDWVWSLVKAGKVWQALDP-SLLKEDDFLSLNPKAIMERFVLVGILCAHV 590
++ +++ + + L++ DF S+ A L+ +
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE-KMLVL 287
Query: 591 MVALRPTISDALK 603
R T +AL
Sbjct: 288 DAEQRVTAGEALA 300
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (353), Expect = 8e-38
Identities = 41/225 (18%), Positives = 77/225 (34%), Gaps = 31/225 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNL 371
+ IG G FG++++G L + VA+K E + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 372 VPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIIL 431
+P +G + LV D + D R +
Sbjct: 63 IPNVYYFGQEGLH-----NVLVIDLLGPSLEDLLDLC---------GRKFSVKTVAMAAK 108
Query: 432 DVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR-----ARVADFGLAKQSREGQS---- 482
+ + +H + ++ +RDIK N L+ V DFG+ K R+ +
Sbjct: 109 QMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 483 --HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
++GT Y++ L + + + D+ + G V + + G
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-38
Identities = 73/310 (23%), Positives = 124/310 (40%), Gaps = 28/310 (9%)
Query: 310 RATDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDA--EFCNEVEIISNL 366
K+ + IG+G FG V+K + G VA+KKV+ + + E++I+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 367 KHRNLVPLRGCCVVDGD--NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
KH N+V L C N YLV+D+ + T
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---------LVKFTLS 117
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQS-- 482
+ K ++ + GL Y+H + I HRD+KA N+L+ D ++ADFGLA+ ++
Sbjct: 118 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 483 -HLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540
+ T T Y PE L + D++ G ++ E+ + +T A +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 541 ------ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGIL-CAHVMVA 593
IT VW V ++++ L+ ++ + + + L I + A
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 594 LRPTISDALK 603
R DAL
Sbjct: 295 QRIDSDDALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-36
Identities = 48/224 (21%), Positives = 84/224 (37%), Gaps = 31/224 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE------FCNEVEIISN 365
++ +G GGFG VY GI + D VA+K V + E EV ++
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 366 LK--HRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTW 423
+ ++ L ER L+ + + L
Sbjct: 64 VSSGFSGVIRLLDWF------ERPDSFVLILERPEPVQDLFDFI--------TERGALQE 109
Query: 424 PQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQSREGQS 482
++ V + + + H + HRDIK NIL+D + ++ DFG ++
Sbjct: 110 ELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV- 165
Query: 483 HLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGR 525
T GT Y PE+ Y + + V+S G+++ +++CG
Sbjct: 166 --YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-35
Identities = 56/217 (25%), Positives = 85/217 (39%), Gaps = 23/217 (10%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGD---AEFCNEVEIISNLKH 368
+ F +G+G FG V G A+K + + A E ++ N +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
L L+ V +Y G + HL +R T + +
Sbjct: 65 PFLTALKYAFQTHD------RLCFVMEYANGGELFFHLSR---------ERVFTEERARF 109
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
++ L YLH + +RDIK N++LD D ++ DFGL K+ + + T
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT YLAPE D + GVV+ E+MCGR
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 50/301 (16%), Positives = 107/301 (35%), Gaps = 30/301 (9%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV--IESDFQGDAEFCNEVEIISNLKHR 369
K+ + IG G +G V+K + VA+K+V + D + E+ ++ LKH+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N+V L + LV+++ L K+
Sbjct: 62 NIVRLHDVL------HSDKKLTLVFEFCDQDLKKYFDSC---------NGDLDPEIVKSF 106
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
+ + KGL + H + HRD+K N+L++ + ++A+FGLA+ + V
Sbjct: 107 LFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549
+ D++S G + E+ + L + I + +
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVAL-------RPTISDAL 602
+ + W ++ + + +++ + ++ L R + +AL
Sbjct: 224 E--EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
Query: 603 K 603
+
Sbjct: 282 Q 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 7e-34
Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 26/217 (11%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAE---FCNEVEIISNLKH 368
D+F + +G G FG V + G A+K + + + NE I+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
LV L + S Y+V +Y+ G + HL + P +
Sbjct: 101 PFLVKLEFSF------KDNSNLYMVMEYVAGGEMFSHLR---------RIGRFSEPHARF 145
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+ YLH + +RD+K N+L+D +V DFG AK+ T +
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTL 198
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
GT LAPE L + D ++ GV+I E+ G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-34
Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 20/216 (9%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV--IESDFQGDAEFCNEVEIISNLKHR 369
++ IG G G+V VA+KK+ + E+ ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 370 NLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNI 429
N++ L E + YLV + M + L + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------------QMELDHERMSYL 124
Query: 430 ILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRVA 489
+ + G+ +LH I HRD+K +NI++ +D ++ DFGLA+ G S + T
Sbjct: 125 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYV 179
Query: 490 GTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
T Y APE L E D++S G ++ E++ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (320), Expect = 5e-33
Identities = 54/308 (17%), Positives = 113/308 (36%), Gaps = 41/308 (13%)
Query: 313 DKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRN 370
D + +GRG + V++ I + + V VK + + + E++I+ NL+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
++ L LV++++ N + + LT + +
Sbjct: 92 IITLADIVKDPVSR----TPALVFEHVNNTDFKQLY------------QTLTDYDIRFYM 135
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD-MRARVADFGLAKQSREGQSHLTTRVA 489
++ K L Y H I HRD+K N+++D + + R+ D+GLA+ GQ +
Sbjct: 136 YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRV 190
Query: 490 GTHGYLAPEYAL-YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548
+ + PE + Y D++S G ++ ++ ++ + I + +
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGIL-------------CAHVMVALR 595
+ + + +D L + + ERFV R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 596 PTISDALK 603
T +A++
Sbjct: 311 LTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 60/308 (19%), Positives = 118/308 (38%), Gaps = 40/308 (12%)
Query: 312 TDKFSQKNFIGRGGFGLVYKGI-LQDGTTVAVKKV--IESDFQGDAEFCNEVEIISNLKH 368
+++ + +G G +G V + G VAVKK+ E+ ++ ++KH
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKN 428
N++ L + + ++ ++++ V + LT +
Sbjct: 77 ENVIGLLDVF-TPARSLEEFNDVYLVTHLMGADLNNI----------VKCQKLTDDHVQF 125
Query: 429 IILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHLTTRV 488
+I + +GL Y+H I HRD+K +N+ ++ D ++ DFGLA+ + +T V
Sbjct: 126 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYV 179
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR-----------KALDLSTSGSPR 537
A + + D++S G ++ E++ GR L L G+P
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 538 ACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAI--MERFVLVGILCAHVMVALR 595
A L+ + P + + F+ NP A+ +E+ + R
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-------MLVLDSDKR 292
Query: 596 PTISDALK 603
T + AL
Sbjct: 293 ITAAQALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-30
Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 27/223 (12%)
Query: 313 DKFSQKNFIGRGGFGLVYKGIL----QDGTTVAVKKV----IESDFQGDAEFCNEVEIIS 364
+ F +G G +G V+ G A+K + I + E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 365 NLKHRNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWP 424
+++ + +L+ DY+ G + HL + T
Sbjct: 84 HIRQSPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQ---------RERFTEH 129
Query: 425 QRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQSHL 484
+ + + ++ L +LH K I +RDIK NILLD++ + DFGL+K+ ++
Sbjct: 130 EVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186
Query: 485 TTRVAGTHGYLAPEYALYGQ--LTEKSDVYSFGVVILEIMCGR 525
GT Y+AP+ G + D +S GV++ E++ G
Sbjct: 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (273), Expect = 1e-26
Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 19/215 (8%)
Query: 321 IGRGGFGLVYKGI-LQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCV 379
+G G F V+ + + T VA+ K++ D +E++++ + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAM-KIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 380 VD-------GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILD 432
+++ + ++V + G L + R + K I
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE------HRGIPLIYVKQISKQ 133
Query: 433 VAKGLAYLHYGVKPAIYHRDIKATNILLDA-DMRARVADFGLAKQSREGQSHLT-TRVAG 490
+ GL Y+H + I H DIK N+L++ D + +A T
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 491 THGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR 525
T Y +PE L +D++S +I E++ G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 3e-22
Identities = 35/212 (16%), Positives = 64/212 (30%), Gaps = 40/212 (18%)
Query: 321 IGRGGFGLVYKGILQDGTTVAVK----------KVIESDFQGDAEFCNEVEIISNLKHRN 370
+G G V+ + VK KV E GD F + + R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 371 LVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNII 430
L L+G V VY + N + + + + ++
Sbjct: 68 LQKLQGLAVPK-----------VYAWEGNAVLMELIDAKEL-------YRVRVENPDEVL 109
Query: 431 LDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGLAKQSR--EGQSHLTTRV 488
+ + +A + I H D+ N+L+ + + DF + + + L V
Sbjct: 110 DMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV 165
Query: 489 AGTHGYLAPEYALYGQLTEKSDVYSFGVVILE 520
Y + Y + D+ S IL+
Sbjct: 166 RNIITYFSRTY------RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 683 | |||
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.33 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.18 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.96 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.96 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=435.99 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=210.4
Q ss_pred HhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..++|...+.||+|+||+||+|++++++.||||++.... ...++|.+|++++++++|||||+++|++. .+..
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-------~~~~ 82 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-------QEPI 82 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-------SSSC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-------cCCe
Confidence 356888899999999999999999988999999986543 44678999999999999999999999884 3457
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||+++|+|.+++... ....++|..+++|+.|||+||.||| +.+|+||||||+|||||+++.+||+|
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~-------~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTP-------SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp EEEEECCTTCBHHHHTTSH-------HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeecc
Confidence 9999999999999988432 2346999999999999999999999 78999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
||+|+..........+...||+.|||||++..+.++.|+|||||||++|||+||.+|+..... . .-+...+.
T Consensus 153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~-~~~~~~i~ 224 (272)
T d1qpca_ 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------N-PEVIQNLE 224 (272)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------H-HHHHHHHH
T ss_pred ccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------H-HHHHHHHH
Confidence 999998776655555667899999999999999999999999999999999997666542211 0 11222222
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+.. +. .+....+.+.+++..|++.||++||||++|+++|+.
T Consensus 225 ~~~~-----~~----------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 225 RGYR-----MV----------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TTCC-----CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCC-----CC----------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2211 11 111223467789999999999999999999999984
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=427.77 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=196.9
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|+..+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|. .....++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL------EQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSSCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceec------cCCceEE
Confidence 467888999999999999999998999999998753 345678999999999999999999999997 5567999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ...++|..+++|+.|||+||+||| +.+|+||||||+|||+|+++++||+|||
T Consensus 78 v~E~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ--------RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp EEECCTTCBHHHHHHTT--------TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred EEEecCCCcHHHHhhcc--------ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccc
Confidence 99999999999998432 356899999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhcC
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKAG 552 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~g 552 (683)
+++..............||+.|+|||++..+.++.|+|||||||++|||+||.+|+..... ..+. ...+..+
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~-~~~i~~~ 218 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEV-VEDISTG 218 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHH-HHHHHHT
T ss_pred hheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHH-HHHHHhc
Confidence 9988765554445557899999999999999999999999999999999996555432111 1111 1222222
Q ss_pred ccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 553 KVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 553 ~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.. ...| .....++.+++..||+.||++||||+||+++|++
T Consensus 219 ~~--~~~p-------------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 219 FR--LYKP-------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp CC--CCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC--CCCc-------------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 1111 1223467789999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=431.79 Aligned_cols=265 Identities=26% Similarity=0.418 Sum_probs=200.1
Q ss_pred eehHHHHHHhcCc---------ccceeeeecCceEEEEEEEcC-C---cEEEEEEeeccCc-cChHHHHHHHHHHHhccC
Q 005691 303 FKIQDLERATDKF---------SQKNFIGRGGFGLVYKGILQD-G---TTVAVKKVIESDF-QGDAEFCNEVEIISNLKH 368 (683)
Q Consensus 303 f~~~el~~at~~f---------~~~~~LG~GgfG~Vykg~l~~-g---~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H 368 (683)
|+|++++.++.+| ...++||+|+||+||+|++.. + ..||||++..... ...++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4566777776555 445789999999999999753 3 2589998865433 334579999999999999
Q ss_pred CCcccccceeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCc
Q 005691 369 RNLVPLRGCCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAI 448 (683)
Q Consensus 369 ~NLV~L~G~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~I 448 (683)
||||+++|+|. .....++||||+++|+|.+++.. ....++|.++++|+.|||+||+||| +.+|
T Consensus 87 pnIv~l~g~~~------~~~~~~iv~Ey~~~g~L~~~~~~--------~~~~l~~~~~~~i~~qia~gl~yLH---~~~i 149 (299)
T d1jpaa_ 87 PNVIHLEGVVT------KSTPVMIITEFMENGSLDSFLRQ--------NDGQFTVIQLVGMLRGIAAGMKYLA---DMNY 149 (299)
T ss_dssp TTBCCEEEEEC------SSSSCEEEEECCTTEEHHHHHHT--------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred CCCccEEEEEe------eCCEEEEEEEecCCCcceeeecc--------ccCCCCHHHHHHHHHHHHHHHHHHh---hCCC
Confidence 99999999996 56779999999999999998843 2346999999999999999999999 8899
Q ss_pred cccCCCCCceeeccCCcEEEcccCcccccccCCccc----cccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-
Q 005691 449 YHRDIKATNILLDADMRARVADFGLAKQSREGQSHL----TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC- 523 (683)
Q Consensus 449 iHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~~----~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt- 523 (683)
+||||||+|||||.++++||+|||+|+......... .....||+.|||||.+..+.++.++|||||||++|||+|
T Consensus 150 iHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp CCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhC
Confidence 999999999999999999999999999775443221 223468999999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 524 GRKALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 524 Gr~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
|+.||..... . +.. ..+..+.. + . .+.+..+.+.+++..||+.||++||||.||++
T Consensus 230 g~~Pf~~~~~-----~---~~~-~~i~~~~~-------~--~------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 230 GERPYWDMTN-----Q---DVI-NAIEQDYR-------L--P------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp SCCTTTTCCH-----H---HHH-HHHHTTCC-------C--C------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCH-----H---HHH-HHHHcCCC-------C--C------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 8999864321 1 111 22222211 0 0 11223456788999999999999999999999
Q ss_pred HHhcC
Q 005691 604 MLEGD 608 (683)
Q Consensus 604 ~L~~~ 608 (683)
.|+..
T Consensus 286 ~L~~~ 290 (299)
T d1jpaa_ 286 TLDKM 290 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99853
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=428.49 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=202.0
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|...+.||+|+||+||+|+++ ..||||++.... .+..++|.+|++++++++|||||+++|++. ...
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-------~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-------APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-------SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-------ccE
Confidence 467888899999999999999865 369999986543 333567999999999999999999999974 356
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++... +..++|..++.|+.|||+||+||| +.+||||||||+|||||.++.+||+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~ 146 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII--------ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIG 146 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS--------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEEC
T ss_pred EEEEEecCCCCCHHHHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEc
Confidence 89999999999999999432 346999999999999999999999 7899999999999999999999999
Q ss_pred ccCcccccccCC-ccccccccCCCcccCcccccc---CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 470 DFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALY---GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 470 DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|||+|+...... ....+...||+.|||||++.+ +.++.|+|||||||++|||+||+.||..... ...+
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~ 218 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQI 218 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHH
T ss_pred cccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHH
Confidence 999998765433 234456789999999999864 4589999999999999999999999964322 1122
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
......+.. .+.+.. .+.++.+.+.+++..||+.||++||||.||+++|+..
T Consensus 219 ~~~~~~~~~----~p~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 219 IFMVGRGYL----SPDLSK-------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp HHHHHHTSC----CCCGGG-------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCC----CCcchh-------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222333322 121111 1112345677899999999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-52 Score=431.99 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=214.0
Q ss_pred HHHhcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 309 ERATDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 309 ~~at~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
+...++|...+.||+|+||+||+|++. +|+.||||++... ....++|.+|++++++++|||||+++|+|. .+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~------~~ 85 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT------RE 85 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEe------eC
Confidence 334568888999999999999999986 5889999998654 344678999999999999999999999996 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++... ....++|..++.|+.|||+||+||| +.+|+||||||+|||||+++++|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~-------~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~K 155 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLREC-------NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 155 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHS-------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred CeeEEEeecccCcchHHHhhhc-------cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEE
Confidence 7889999999999999998532 2357999999999999999999999 78999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+|+..........+...||+.|+|||++.++.++.|+|||||||++|||++|..|+..... . .-+.+
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~-~~~~~ 227 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------L-SQVYE 227 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------H-HHHHH
T ss_pred EccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------H-HHHHH
Confidence 999999998766555555566789999999999999999999999999999999998777642211 1 11222
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+..+.. +. .+......+.+++..||+.||++||||.||++.|+..
T Consensus 228 ~i~~~~~-----~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 228 LLEKDYR-----ME----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHTTCC-----CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHhcCCC-----CC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3332211 11 1112345678899999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=424.76 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=204.3
Q ss_pred hcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
.++|+..+.||+|+||.||+|++++++.||||++... ....++|.+|+.++++++|+|||+++|+|. .++.+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-------~~~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-------EEPIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-------SSSCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-------cCCeE
Confidence 3679999999999999999999998889999998653 445678999999999999999999999984 34589
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++... ....++|.+++.|+.|||.||+||| +.+|+||||||+|||||.++++||+||
T Consensus 88 lv~Ey~~~g~l~~~~~~~-------~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGE-------TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp EEECCCTTCBHHHHHSHH-------HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EEEEecCCCchhhhhhhc-------ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEccc
Confidence 999999999999988542 2346999999999999999999999 789999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+|+..........+...||+.|+|||++..+.++.|+|||||||++|||++|.+|+..... ..+. ...+..
T Consensus 158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~-~~~i~~ 229 (285)
T d1fmka3 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREV-LDQVER 229 (285)
T ss_dssp CTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHH-HHHHHT
T ss_pred chhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHH-HHHHHh
Confidence 99998765555455567899999999999999999999999999999999998776643221 1111 122222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCCC
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIEV 611 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~~ 611 (683)
+.. +.. +.++.+.+.+++..|++.||++||||.+|+++|+.-...
T Consensus 230 ~~~-----~~~----------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 230 GYR-----MPC----------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TCC-----CCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cCC-----CCC----------CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 211 111 112345678899999999999999999999999975443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=411.30 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=212.1
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|. .....++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~------~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT------KQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC------CSSSEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe------eCCceEE
Confidence 5788889999999999999999989999999987644 34678999999999999999999999996 4567999
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ...++|..+++|+.|+|+||+||| +.+|+||||||+|||+++++.+||+|||
T Consensus 77 v~Ey~~~g~l~~~~~~~--------~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREM--------RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp EEECCTTEEHHHHHHSG--------GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEccCCCcHHHhhhcc--------ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcch
Confidence 99999999999997432 357899999999999999999999 7899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..............||+.|+|||.+..+.++.|+|||||||++|||+| |+.||..... .+ +...+..
T Consensus 146 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~-~~~~i~~ 216 (258)
T d1k2pa_ 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SE-TAEHIAQ 216 (258)
T ss_dssp SCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HH-HHHHHHT
T ss_pred hheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--------HH-HHHHHHh
Confidence 998776655555556779999999999999999999999999999999998 8989864322 11 2222333
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. ...| ....+.+.+++..||+.||++|||+.+|++.|..
T Consensus 217 ~~~--~~~p-------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 217 GLR--LYRP-------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCC--CCCC-------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCC--CCCc-------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 211 1111 1223467789999999999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=419.84 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=198.6
Q ss_pred cCcccceeeeecCceEEEEEEEcCC-----cEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDG-----TTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g-----~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
+.|+..++||+|+||+||+|++++. ..||||++...... ...+|.+|++++++++|||||+++|+|. .
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~------~ 80 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS------K 80 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe------c
Confidence 4678889999999999999997643 36999998654333 2457999999999999999999999997 5
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||+++|+|.+++.. ....++|.++++|+.||+.||+||| +.+|+||||||+|||||.++.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~ 149 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLRE--------KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 149 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH--------TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred CCceEEEEEecccCcchhhhhc--------ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeE
Confidence 6778999999999999988742 2357999999999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCc--cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQS--HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+++....... .......||+.|||||++..+.++.|+|||||||++|||++|..|+...... .-
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--------~~ 221 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HE 221 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--------HH
Confidence 9999999997654432 2334467899999999999999999999999999999999977665432111 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCC
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDI 609 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~ 609 (683)
+.+.+..+.. +. .+.+....+.+++.+||+.||++||||.||+++|+...
T Consensus 222 ~~~~i~~~~~-----~~----------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 222 VMKAINDGFR-----LP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp HHHHHHTTCC-----CC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHhccCC-----CC----------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 1222333211 11 11223456788999999999999999999999998643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=417.76 Aligned_cols=253 Identities=23% Similarity=0.386 Sum_probs=205.4
Q ss_pred cCccccee-eeecCceEEEEEEEc---CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNF-IGRGGFGLVYKGILQ---DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~-LG~GgfG~Vykg~l~---~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+. ||+|+||+||+|+++ ++..||||++...... ..++|.+|+++|++++|||||+++|+|. .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-------~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-------A 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-------S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-------c
Confidence 56666664 999999999999864 3557999999764333 3467999999999999999999999985 2
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
+..++||||+++|+|.+++.. .+..++|..+++|+.|||+||+||| +.+|+||||||+||||+.++.+|
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~--------~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVG--------KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTT--------CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEE
T ss_pred CeEEEEEEeCCCCcHHHHhhc--------cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCcee
Confidence 458999999999999998742 2357999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 468 VADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 468 LaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
|+|||+++........ ......||+.|||||++..+.++.|+|||||||++|||+| |+.||..... . +
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~---~- 220 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----P---E- 220 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----H---H-
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----H---H-
Confidence 9999999977544332 2344678999999999999999999999999999999998 9999974322 1 1
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+...+..|...+ + +..+...+.+++..||+.||++||||.+|++.|+.
T Consensus 221 ~~~~i~~~~~~~-----~----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 221 VMAFIEQGKRME-----C----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp HHHHHHTTCCCC-----C----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-----C----------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 223333332211 1 11233467789999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=414.03 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=196.5
Q ss_pred eeeeecCceEEEEEEEcC---CcEEEEEEeeccCccC--hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEEE
Q 005691 319 NFIGRGGFGLVYKGILQD---GTTVAVKKVIESDFQG--DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYLV 393 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~---g~~VAVK~l~~~~~~~--~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~LV 393 (683)
++||+|+||+||+|.+.+ ++.||||++....... .++|.+|++++++++|||||+++|+|. .+..+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-------~~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-------AESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-------SSSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-------cCCEEEE
Confidence 479999999999998753 4689999986543322 457999999999999999999999984 2357899
Q ss_pred EeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccCc
Q 005691 394 YDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFGL 473 (683)
Q Consensus 394 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGl 473 (683)
|||+++|+|.+++.. ...++|..+++|+.|||+||+||| +.+|+||||||+||||+.++.+||+|||+
T Consensus 86 mE~~~~g~L~~~l~~---------~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGl 153 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQ---------NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL 153 (277)
T ss_dssp EECCTTEEHHHHHHH---------CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEcCCCCcHHHHHhh---------ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhh
Confidence 999999999999842 347999999999999999999999 78999999999999999999999999999
Q ss_pred ccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhh
Q 005691 474 AKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVK 550 (683)
Q Consensus 474 a~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~ 550 (683)
++........ ......||+.|||||.+.++.++.|+|||||||++|||+| |+.||..... .-+...+.
T Consensus 154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---------~~~~~~i~ 224 (277)
T d1xbba_ 154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------SEVTAMLE 224 (277)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------HHHHHHHH
T ss_pred hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---------HHHHHHHH
Confidence 9876544332 2344679999999999999999999999999999999998 8999864321 11222333
Q ss_pred cCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 551 AGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 551 ~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.+...+ .+..+...+.+++..||+.||++||||++|+++|+.
T Consensus 225 ~~~~~~---------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 225 KGERMG---------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TTCCCC---------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCCCCC---------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 332111 111223467789999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=408.65 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=202.1
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|+..+.||+|+||+||+|+.. +|+.||||++..... +..+++.+|++++++++|||||++++++. ..+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~------~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR------EGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE------ETTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec------cCce
Confidence 357899999999999999999975 689999999875433 23456999999999999999999999997 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+++|+|.+++. ....+++.+.+.|+.|++.||+||| +.+|+||||||+|||+++++++||+
T Consensus 78 ~~ivmEy~~gg~L~~~l~---------~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIE---------PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp EEEEEECCTTEEGGGGSB---------TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEeccCCCcHHHHHh---------cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEc
Confidence 999999999999999993 2347999999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCC-ccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 470 DFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 470 DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|||+|+...... ....+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... ... .
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~-----~ 217 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEY-----S 217 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HHH-----H
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HHH-----H
Confidence 999999875443 333456789999999999988776 578999999999999999999997543221 111 1
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
......... .........+.+++..|++.||++|||+.|+++
T Consensus 218 ~~~~~~~~~--------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 218 DWKEKKTYL--------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHTTCTTS--------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCCCC--------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111100 011222345678889999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=419.30 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=205.9
Q ss_pred hcCcccceeeeecCceEEEEEEEcC-C-----cEEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeecCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD-G-----TTVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~-g-----~~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~ 383 (683)
.++|...++||+|+||+||+|+... + ..||||++.... ......|.+|+.++.++ +|||||+++|++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~---- 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---- 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence 4688999999999999999999653 2 369999986543 33456799999999998 8999999999997
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCC--------------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcc
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDG--------------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIY 449 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~--------------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~Ii 449 (683)
..+..++||||+++|+|.++|....... .......++|..++.|+.||++||+||| +.+||
T Consensus 112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~Ii 186 (325)
T d1rjba_ 112 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV 186 (325)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred --eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 5667999999999999999996542110 0012346899999999999999999999 78999
Q ss_pred ccCCCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCC
Q 005691 450 HRDIKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKA 527 (683)
Q Consensus 450 HrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p 527 (683)
||||||+|||++.++++||+|||+|+........ ......||+.|||||++..+.++.++|||||||++|||+| |+.|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred eccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 9999999999999999999999999876554433 3345678999999999999999999999999999999998 8999
Q ss_pred CCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005691 528 LDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLE 606 (683)
Q Consensus 528 ~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~ 606 (683)
|...... .-..+.++.+.. +. .+....+.+.+++..|++.||++||||+||+++|.
T Consensus 267 f~~~~~~--------~~~~~~~~~~~~-----~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVD--------ANFYKLIQNGFK-----MD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCS--------HHHHHHHHTTCC-----CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHH--------HHHHHHHhcCCC-----CC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 8643221 112223333211 11 11122346788999999999999999999999995
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=404.47 Aligned_cols=245 Identities=26% Similarity=0.409 Sum_probs=203.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++. ...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~------~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH------DAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE------CSS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE------ECC
Confidence 57889999999999999999985 6889999998653 2334567999999999999999999999997 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++...+.|+.||+.||+||| +.+|+||||||+||||+.++.+||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~---------~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl 147 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK---------LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 147 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeecCCCcHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEee
Confidence 89999999999999999832 347999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+|+...... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 148 ~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------~~~~~~ 215 (263)
T d2j4za1 148 ADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------QETYKR 215 (263)
T ss_dssp CCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHH
T ss_pred cccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---------HHHHHH
Confidence 9999998765432 3446799999999999999999999999999999999999999964221 112222
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..+.. .+ +....+.+.+++..|++.||++|||+.|+++
T Consensus 216 i~~~~~------~~----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 216 ISRVEF------TF----------PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTTCC------CC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCC------CC----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 222221 11 1112345678899999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-49 Score=414.92 Aligned_cols=272 Identities=26% Similarity=0.413 Sum_probs=213.4
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccce
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGC 377 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~ 377 (683)
+.+++..+++|+..+.||+|+||+||+|+.. +++.||||++....... .++|.+|++++++++||||++++|+
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667789999999999999999999864 35789999987644332 4579999999999999999999999
Q ss_pred eeecCCCCCCCeeEEEEeecCCCCccccccCCCCC---------------CCCCCCCCCCccchhhhHHHHHHHHHHHhc
Q 005691 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFND---------------GSGVAKRPLTWPQRKNIILDVAKGLAYLHY 442 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~---------------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~ 442 (683)
|. .....++||||+++|+|.++++..... ........++|..++.|+.|+|.||+|||
T Consensus 85 ~~------~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH- 157 (301)
T d1lufa_ 85 CA------VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS- 157 (301)
T ss_dssp EC------SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred ec------cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc-
Confidence 97 567899999999999999998543210 01122346899999999999999999999
Q ss_pred ccCCCccccCCCCCceeeccCCcEEEcccCcccccccCC-ccccccccCCCcccCccccccCCCCccccEEEcchhHHHH
Q 005691 443 GVKPAIYHRDIKATNILLDADMRARVADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 521 (683)
Q Consensus 443 ~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlEL 521 (683)
+.+||||||||+|||||.++++||+|||+++...... ....+...||+.|+|||.+.+..++.|+|||||||++|||
T Consensus 158 --~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el 235 (301)
T d1lufa_ 158 --ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235 (301)
T ss_dssp --HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence 8999999999999999999999999999998765433 3334567899999999999999999999999999999999
Q ss_pred hhCC-CCCCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005691 522 MCGR-KALDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISD 600 (683)
Q Consensus 522 ltGr-~p~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~e 600 (683)
++|. +||..... .+.. ..+.++...+ + +..+..++.+|+..||+.+|++||||.|
T Consensus 236 l~~~~~p~~~~~~--------~e~~-~~v~~~~~~~-----~----------p~~~~~~~~~li~~cl~~~P~~RPt~~e 291 (301)
T d1lufa_ 236 FSYGLQPYYGMAH--------EEVI-YYVRDGNILA-----C----------PENCPLELYNLMRLCWSKLPADRPSFCS 291 (301)
T ss_dssp HTTTCCTTTTSCH--------HHHH-HHHHTTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HccCCCCCCCCCH--------HHHH-HHHHcCCCCC-----C----------CccchHHHHHHHHHHcCCChhHCcCHHH
Confidence 9996 45543221 1111 2233333211 1 1122346788999999999999999999
Q ss_pred HHHHHhcCC
Q 005691 601 ALKMLEGDI 609 (683)
Q Consensus 601 Vl~~L~~~~ 609 (683)
|+++|+...
T Consensus 292 v~~~L~~i~ 300 (301)
T d1lufa_ 292 IHRILQRMC 300 (301)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHhc
Confidence 999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=408.26 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=206.8
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|...+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++. ..+..+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~------~~~~~~ 93 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL------VGDELW 93 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE------ETTEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE------ECCEEE
Confidence 4789999999999999999996 469999999998766666778999999999999999999999997 456899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++. +..+++.+.+.|+.|++.||+||| +.+|+||||||+|||++.++++||+||
T Consensus 94 ivmEy~~gg~L~~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DF 160 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (293)
T ss_dssp EEEECCTTCBHHHHHH----------HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCcHHHHhh----------ccCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccc
Confidence 9999999999998872 246899999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
|+|+....... ......||+.|||||++.++.++.++|||||||++|||++|+.||..... .+........
T Consensus 161 G~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~ 231 (293)
T d1yhwa1 161 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATN 231 (293)
T ss_dssp TTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHH
T ss_pred hhheeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--------HHHHHHHHhC
Confidence 99987654432 23456799999999999999999999999999999999999999964221 1122222222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+.. .+. .+......+.+++..|++.||++|||+.|+++
T Consensus 232 ~~~------~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 232 GTP------ELQ--------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSC------CCS--------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCC------CCC--------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 211 110 12233456778999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=409.93 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=192.5
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.|.+|++++++++|||||++++++... ....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~----~~~~ 79 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR----TNTT 79 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC--------C
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC----CCCE
Confidence 67999999999999999999975 6899999998765432 235689999999999999999999998621 3456
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc--CCCccccCCCCCceeeccCCcEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV--KPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~--~~~IiHrDIKpsNILLd~~~~~K 467 (683)
.++||||+++|+|.+++.... .....+++..++.|+.|++.||.|||+.. ..+||||||||+||||+.++.+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~-----~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGT-----KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHH-----HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHHhcc-----ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 899999999999999984322 12457999999999999999999999432 24599999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+|+....+.. ......||+.|||||.+.+..++.|+|||||||++|||++|+.||..... ..+..
T Consensus 155 l~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---------~~~~~ 224 (269)
T d2java1 155 LGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------KELAG 224 (269)
T ss_dssp ECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHH
T ss_pred EeeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---------HHHHH
Confidence 999999998754332 33457899999999999999999999999999999999999999963221 11222
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+..+.... + +....+.+.+++..|++.||++|||+.|+++
T Consensus 225 ~i~~~~~~~-----~----------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 KIREGKFRR-----I----------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHTCCCC-----C----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCC-----C----------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 233333211 1 1112345778899999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=405.62 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=203.9
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
+.|+..+.||+|+||+||+|+.. +|+.||||++........+.|.+|++++++++|||||++++++. .....+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~------~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY------YENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE------ETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------eCCeEE
Confidence 46888899999999999999975 68899999998766666678999999999999999999999997 457899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEccc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADF 471 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDF 471 (683)
+||||+++|+|.+++.. ..+.+++.++..|+.|++.||.||| +.+|+||||||+|||++.++++||+||
T Consensus 86 lvmEy~~~g~L~~~~~~--------~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLE--------LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEEECCTTEEHHHHHHH--------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEec
Confidence 99999999999998742 2346999999999999999999999 889999999999999999999999999
Q ss_pred CcccccccCCccccccccCCCcccCccccc-----cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYAL-----YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|+|+....... ......||+.|||||++. ...++.|+|||||||++|||++|+.||...... +...
T Consensus 155 G~a~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------~~~~ 225 (288)
T d2jfla1 155 GVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------RVLL 225 (288)
T ss_dssp TTCEECHHHHH-HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHH
T ss_pred hhhhccCCCcc-cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--------HHHH
Confidence 99976543221 233467999999999984 456899999999999999999999999643221 1111
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... .+.. +.+. .+......+.+++..|++.||++|||+.|+++
T Consensus 226 ~i~-~~~~-----~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 226 KIA-KSEP-----PTLA--------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHH-HSCC-----CCCS--------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHH-cCCC-----CCCC--------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1111 1110 12233456778999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=409.19 Aligned_cols=270 Identities=26% Similarity=0.334 Sum_probs=202.6
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHH--HHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNE--VEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~E--v~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
+.|...+.||+|+||.||+|+++ |+.||||++.... .+++..| +..+.+++|||||+++|+|..... .....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~--~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNG--TWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS--SSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC--cceEE
Confidence 35667789999999999999975 8999999986432 3344444 445567899999999999985432 33468
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhccc-----CCCccccCCCCCceeeccCCc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGV-----KPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~-----~~~IiHrDIKpsNILLd~~~~ 465 (683)
++||||+++|+|.++|. +..++|..+++++.++|.||+|||... +++|+||||||+|||||.+++
T Consensus 77 ~lv~Ey~~~g~L~~~l~----------~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLN----------RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEEECCTTCBHHHHHH----------HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEEEecccCCCHHHHHh----------cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 99999999999999993 236999999999999999999999431 479999999999999999999
Q ss_pred EEEcccCcccccccCCcc---ccccccCCCcccCccccccC------CCCccccEEEcchhHHHHhhCCCCCCCCCCCCC
Q 005691 466 ARVADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALYG------QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSP 536 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~ 536 (683)
+||+|||+++........ ......||++|||||++... .++.|+|||||||++|||+||+.|+........
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 999999999987544322 23457899999999998754 367899999999999999999988754332211
Q ss_pred Ccc------chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 537 RAC------LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 537 ~~~------~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
... ............ +.++|.+... ....+.++.+.+++..||+.||++||||.||+++|+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~----~~~~p~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCE----QKLRPNIPNR-----WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTT----SCCCCCCCGG-----GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhc----cccCCCCCcc-----cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 000 011111222211 2223333222 1233556778899999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=396.46 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=194.8
Q ss_pred ccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 316 SQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
...++||+|+||+||+|+.. +++.||+|++..... ...+.|.+|++++++++|||||++++++..... .....++
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--~~~~~~i 89 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK--GKKCIVL 89 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS--SCEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc--cCCEEEE
Confidence 44568999999999999975 588999999876432 234569999999999999999999999864221 3456899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCC--ccccCCCCCceeec-cCCcEEEc
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPA--IYHRDIKATNILLD-ADMRARVA 469 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~--IiHrDIKpsNILLd-~~~~~KLa 469 (683)
||||+++|+|.+++.. ...+++..++.|+.||++||+||| +.+ |+||||||+||||+ +++.+||+
T Consensus 90 vmE~~~~g~L~~~l~~---------~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR---------FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEeCCCCCcHHHHHhc---------cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 9999999999999932 347999999999999999999999 655 99999999999996 57899999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+|+..... ......||+.|||||++. ++++.++|||||||++|||++|+.||...... .-+.+.+
T Consensus 158 DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--------~~~~~~i 225 (270)
T d1t4ha_ 158 DLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--------AQIYRRV 225 (270)
T ss_dssp CTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--------HHHHHHH
T ss_pred ecCcceeccCC---ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccH--------HHHHHHH
Confidence 99999864432 234568999999999876 46999999999999999999999999632211 1122222
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+.... .+.. .....+.+++..|++.||++|||+.|+++
T Consensus 226 ~~~~~~~----~~~~----------~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 226 TSGVKPA----SFDK----------VAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTCCCG----GGGG----------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HcCCCCc----ccCc----------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2221111 1111 11234678899999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=403.93 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=194.1
Q ss_pred hcCcccceeeeecCceEEEEEEEcC----CcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD----GTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~----g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
.++|...+.||+|+||.||+|++.. +..||||++....... .+.|.+|++++++++|||||+++|++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-------
Confidence 4688899999999999999998753 3468999886543332 456999999999999999999999984
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
.+..++||||+++|+|.+++.. ....++|..++.++.||++||.||| +.+|+||||||+|||++.++.+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~--------~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQV--------RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH--------TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred cCeEEEEEEeccCCcHHhhhhc--------cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcE
Confidence 3568999999999999998742 2357999999999999999999999 8999999999999999999999
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v 545 (683)
||+|||+|+.........++...||+.|+|||.+..+.++.++|||||||++|||++ |++|+..... .. +
T Consensus 148 Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~----~ 218 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----ND----V 218 (273)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG----H
T ss_pred EEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HH----H
Confidence 999999999876655555666789999999999999999999999999999999998 8888865332 11 1
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
...+..+.... + +......+.+++..||+.||++|||+.||++.|+.
T Consensus 219 ~~~i~~~~~~~-----~----------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 219 IGRIENGERLP-----M----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp HHHHHTTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCCCC-----C----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 22223332111 1 11223467789999999999999999999998874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=406.98 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=200.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCc----EEEEEEeecc-CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGT----TVAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNER 386 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~----~VAVK~l~~~-~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~ 386 (683)
++|+..++||+|+||+||+|++. +|+ .||||++... ..+..++|.+|++++++++|||||+++|+|.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~------- 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL------- 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEE-------
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-------
Confidence 35899999999999999999975 344 5899988653 3445678999999999999999999999996
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++++||+.+|+|.+++.. ....++|..+++|+.|||.||+||| +.+||||||||+||||+.++.+
T Consensus 82 ~~~~~~v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 82 TSTVQLITQLMPFGCLLDYVRE--------HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp SSSEEEEEECCTTCBHHHHHHH--------TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred cCCeeEEEEeccCCcccccccc--------cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCe
Confidence 2457899999999999998743 2457999999999999999999999 7899999999999999999999
Q ss_pred EEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhh
Q 005691 467 RVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~ 544 (683)
||+|||+|+........ ......||+.|||||++.++.++.|+|||||||++|||+| |+.||+.... ..
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~---- 221 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SE---- 221 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GG----
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----HH----
Confidence 99999999987654433 3445679999999999999999999999999999999999 7888864321 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+...+..|.... .+..+...+.+++..||+.||++||||.||++.|+.
T Consensus 222 ~~~~i~~~~~~~---------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 222 ISSILEKGERLP---------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp HHHHHHHTCCCC---------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHcCCCCC---------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 122233322110 111234567889999999999999999999998865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=412.58 Aligned_cols=199 Identities=24% Similarity=0.399 Sum_probs=175.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC-hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~-~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.++|+..++||+|+||+||+|+.. +|+.||+|++....... .+++.+|+.+|++++|||||++++++. ...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------~~~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY------SDGE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE------CSSE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE------ECCE
Confidence 578999999999999999999975 68999999997653333 467999999999999999999999997 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccC-CCccccCCCCCceeeccCCcEEE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVK-PAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~-~~IiHrDIKpsNILLd~~~~~KL 468 (683)
.++||||+++|+|.+++.. ...+++..++.++.|++.||.||| + .+|+||||||+||||+.++++||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~---------~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKK---------AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp EEEEEECCTTEEHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEcCCCCcHHHHHhh---------cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEE
Confidence 9999999999999999942 346999999999999999999999 5 48999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCC
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLS 531 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~ 531 (683)
+|||+|+...+.. .+..+||+.|||||++.+.+++.++||||+||+++||++|+.||...
T Consensus 147 ~DFGla~~~~~~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 147 CDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CCCCCCHHHHHHT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred eeCCCccccCCCc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999998765422 33468999999999999999999999999999999999999999653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=403.20 Aligned_cols=252 Identities=29% Similarity=0.424 Sum_probs=200.6
Q ss_pred ceeeeecCceEEEEEEEcCC----cEEEEEEeecc-CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 318 KNFIGRGGFGLVYKGILQDG----TTVAVKKVIES-DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 318 ~~~LG~GgfG~Vykg~l~~g----~~VAVK~l~~~-~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
.++||+|+||+||+|++.++ ..||||++... .....++|.+|++++++++|||||+++|+|.. .....++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-----SEGSPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE-----TTTEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe-----cCCceEE
Confidence 46899999999999997542 25899998653 33334679999999999999999999999873 3457899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.+++... ...++|..+++++.|+|+||.||| +.+|+||||||+|||||+++.+||+|||
T Consensus 107 v~E~~~~g~l~~~~~~~--------~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNE--------THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EEECCTTCBHHHHHHCT--------TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred EEEEeecCchhhhhccc--------cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEeccc
Confidence 99999999999988432 346788899999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCcc---ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 473 LAKQSREGQSH---LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 473 la~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
+++........ ......||+.|+|||++..+.++.|+||||||+++|||+||+.|+...... . ++... +
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~---~~~~~-i 247 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----F---DITVY-L 247 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHH-H
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----H---HHHHH-H
Confidence 99876544332 234467999999999999999999999999999999999988887543221 1 11111 2
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
..|... .+| ......+.+++..||+.||++||+|.||++.|++.
T Consensus 248 ~~g~~~--~~p-------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 248 LQGRRL--LQP-------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp HTTCCC--CCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCC--CCc-------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223211 111 11234677899999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=398.96 Aligned_cols=249 Identities=29% Similarity=0.387 Sum_probs=194.9
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
++|...+.||+|+||.||+|+++ |+.||||+++.. ...++|.+|++++++++|||||+++|+|.. .....++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-----EKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC-----C--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----cCCcEEE
Confidence 56778899999999999999986 789999998653 335679999999999999999999999862 2345799
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcccC
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVADFG 472 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaDFG 472 (683)
||||+++|+|.++|+... ...++|..+++|+.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 79 v~ey~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRG-------RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp EECCCTTEEHHHHHHHHH-------HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEeccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccc
Confidence 999999999999995321 235899999999999999999999 8899999999999999999999999999
Q ss_pred cccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchhhhhhhhhhc
Q 005691 473 LAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLITDWVWSLVKA 551 (683)
Q Consensus 473 la~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~~~v~~~~~~ 551 (683)
+++..... .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+..... ..+..+ +..
T Consensus 149 ~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~----i~~ 215 (262)
T d1byga_ 149 LTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR----VEK 215 (262)
T ss_dssp C----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHH----HTT
T ss_pred cceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHH----HHc
Confidence 99865432 223467899999999999999999999999999999998 6777654321 112222 222
Q ss_pred CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 552 GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 552 g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+.. +.+. .....++.+++..|++.||++||||.+|+++|+.
T Consensus 216 ~~~-----~~~~----------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 216 GYK-----MDAP----------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TCC-----CCCC----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-----CCCC----------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 211 1111 1123466789999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=403.27 Aligned_cols=245 Identities=31% Similarity=0.420 Sum_probs=198.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
+.|+..+.||+|+||+||+|+.. +|+.||||++....... .+.|.+|++++++++|||||+++|++. ...
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~------~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL------REH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE------ETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE------ECC
Confidence 45888999999999999999964 68899999997654433 346899999999999999999999997 457
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|+.++. .+..++|.+++.|+.||+.||.||| +.+|+||||||+||||+.++++||
T Consensus 89 ~~~iv~E~~~~g~l~~~~~---------~~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl 156 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEV---------HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 156 (309)
T ss_dssp EEEEEEECCSEEHHHHHHH---------HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEE
T ss_pred EEEEEEEecCCCchHHHHH---------hCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEE
Confidence 8999999999999987662 2357999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccc---cCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYAL---YGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+|||+|+..... ....||+.|||||++. .++|+.++|||||||++|||++|+.||..... .+..
T Consensus 157 ~DFG~a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~ 223 (309)
T d1u5ra_ 157 GDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSAL 223 (309)
T ss_dssp CCCTTCBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH
T ss_pred eecccccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHH
Confidence 999999865432 3457999999999986 35689999999999999999999999863221 1111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..... +.. +.+.. ....+.+.+++..|++.||++|||+.|+++
T Consensus 224 ~~i~~-~~~-----~~~~~---------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 YHIAQ-NES-----PALQS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHH-SCC-----CCCSC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHh-CCC-----CCCCC---------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 22221 111 11111 112345778899999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=401.53 Aligned_cols=272 Identities=26% Similarity=0.337 Sum_probs=202.4
Q ss_pred hHHHHHHhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccc
Q 005691 305 IQDLERATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRG 376 (683)
Q Consensus 305 ~~el~~at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G 376 (683)
..+++...++|...++||+|+||.||+|+.. +++.||||++...... ..+++.+|+.++.++ +|+|||.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3444444578999999999999999999864 3468999998754332 345688899888887 6899999999
Q ss_pred eeeecCCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCcc
Q 005691 377 CCVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIY 449 (683)
Q Consensus 377 ~c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~Ii 449 (683)
++.. .+...++||||+++|+|.++|....... .......++|.+++.++.||++||+||| +.+||
T Consensus 85 ~~~~-----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iv 156 (299)
T d1ywna1 85 ACTK-----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCI 156 (299)
T ss_dssp EECS-----TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred eecc-----CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCc
Confidence 8863 3456899999999999999995432110 0112346899999999999999999999 88999
Q ss_pred ccCCCCCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCC-CC
Q 005691 450 HRDIKATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR-KA 527 (683)
Q Consensus 450 HrDIKpsNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr-~p 527 (683)
||||||+||||++++++||+|||+|+........ ..+...||+.|||||.+.++.++.++|||||||++|||+||. .|
T Consensus 157 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 9999999999999999999999999876544332 345678999999999999999999999999999999999975 46
Q ss_pred CCCCCCCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 528 LDLSTSGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 528 ~~~~~~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
|..... .+.+...++.+...+ + +.....++.+++..|++.||++||||.||+++|++
T Consensus 237 ~~~~~~--------~~~~~~~~~~~~~~~-----~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 237 YPGVKI--------DEEFCRRLKEGTRMR-----A----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp STTCCC--------SHHHHHHHHHTCCCC-----C----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCH--------HHHHHHHHhcCCCCC-----C----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 643221 122333333332211 1 11123467789999999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-48 Score=401.93 Aligned_cols=247 Identities=20% Similarity=0.277 Sum_probs=200.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++. ...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~------~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ------DDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE------CSS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE------ECC
Confidence 57999999999999999999974 68999999986532 234567999999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++. ..+.+++...+.++.|++.||+||| +.+||||||||+|||+++++.+||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~---------~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIR---------KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEEECCCTTEEHHHHHH---------HHSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEEccCCCCHHHhhh---------ccCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEe
Confidence 8999999999999999883 2357999999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCC-ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQ-SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||+|+...... ........||+.|||||++.+..++.++|||||||++|||++|+.||...+. ..+..
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------~~~~~ 220 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------YLIFQ 220 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---------HHHHH
Confidence 9999999775433 2334557899999999999999999999999999999999999999964221 11122
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDAL 602 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl 602 (683)
.+..+.. .+ +......+.+++..|++.||++|||+.|++
T Consensus 221 ~i~~~~~------~~----------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 221 KIIKLEY------DF----------PEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHTTCC------CC----------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred HHHcCCC------CC----------CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 2222221 11 111234567899999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-48 Score=406.36 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=188.0
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
.+.|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++. .++.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~------~~~~ 81 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE------SGGH 81 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE------CSSE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE------ECCE
Confidence 467999999999999999999975 6899999999765433 2456889999999999999999999987 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec---cCCcE
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD---ADMRA 466 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd---~~~~~ 466 (683)
.++||||+++|+|.++|.. ...+++.....++.|++.||+||| +.+|+||||||+|||+. +++.+
T Consensus 82 ~~lvmE~~~gg~L~~~l~~---------~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVE---------KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp EEEEECCCCSCBHHHHHHT---------CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeccCCCcHHHhhhc---------ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceE
Confidence 9999999999999999942 347999999999999999999999 88999999999999994 57899
Q ss_pred EEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 467 RVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
||+|||+|+....... .....||+.|||||.+.+..++.++|||||||++|||++|+.||..... . + ..
T Consensus 150 kl~DFG~a~~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~---~-~~ 218 (307)
T d1a06a_ 150 MISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----A---K-LF 218 (307)
T ss_dssp EECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----H---H-HH
T ss_pred EEeccceeEEccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----H---H-HH
Confidence 9999999987654332 3346799999999999999999999999999999999999999964221 1 1 11
Q ss_pred hhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 547 SLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 547 ~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.....+... .+.. ...+....+.+++..|++.||++|||+.|+++
T Consensus 219 ~~i~~~~~~--~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 219 EQILKAEYE--FDSP----------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHTTCCC--CCTT----------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhccCCC--CCCc----------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 122222110 0000 11223456788999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=396.48 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=194.3
Q ss_pred cCcccceeeeecCceEEEEEEEcC--C--cEEEEEEeeccCc---cChHHHHHHHHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD--G--TTVAVKKVIESDF---QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~--g--~~VAVK~l~~~~~---~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++|+..+.||+|+||.||+|++.. + ..||||++..... +..++|.+|++++++++|||||+++|+|.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~------ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL------ 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe------
Confidence 568889999999999999998642 2 3789999865422 22457999999999999999999999995
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
....++||||+++|+|.+++... ...++|..+++++.|+|+||.||| +.+|+||||||+||||+.+++
T Consensus 82 -~~~~~lv~e~~~~~~l~~~~~~~--------~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 82 -TPPMKMVTELAPLGSLLDRLRKH--------QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHH--------GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTE
T ss_pred -ecchheeeeeecCcchhhhhhcc--------cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccc
Confidence 24578999999999999987432 346999999999999999999999 789999999999999999999
Q ss_pred EEEcccCcccccccCCcc--ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCCCCCCCccchh
Q 005691 466 ARVADFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~~~~~~~~~l~ 542 (683)
+||+|||+++........ ......||..|+|||.+.+..++.++|||||||++|||+| |+.||..... .
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~ 221 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------S 221 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------H
Confidence 999999999987554332 2345678999999999999999999999999999999998 8999863221 1
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
+......+.+...+ .+......+.+++..||+.||++||||.||+++|++
T Consensus 222 ~~~~~i~~~~~~~~---------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 222 QILHKIDKEGERLP---------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHHHHHHTSCCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCC---------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 22222223321111 111223457789999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.9e-47 Score=405.07 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=205.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. .....+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~------~~~~~~ 99 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE------DDNEMV 99 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE------ETTEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE------ECCEEE
Confidence 58999999999999999999974 68999999997765555667999999999999999999999987 567899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec--cCCcEEEc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD--ADMRARVA 469 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd--~~~~~KLa 469 (683)
+||||+++|+|.+++.. ....+++..++.|+.||+.||.||| +.+||||||||+||||+ .++.+||+
T Consensus 100 ivmE~~~gg~L~~~l~~--------~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~ 168 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD--------EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 168 (350)
T ss_dssp EEECCCCSCBHHHHHTC--------TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEEC
T ss_pred EEEEcCCCCCHHHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEe
Confidence 99999999999999842 2346999999999999999999999 89999999999999995 46789999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+|+....... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... .+.... .
T Consensus 169 DFG~a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~-i 237 (350)
T d1koaa2 169 DFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRN-V 237 (350)
T ss_dssp CCTTCEECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-H
T ss_pred ecchheecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHH-H
Confidence 9999987654332 3446799999999999999999999999999999999999999963221 111111 2
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
..+... .+.. ......+.+.+++..|++.||++|||+.|+++.
T Consensus 238 ~~~~~~--~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 238 KSCDWN--MDDS----------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHTCCC--SCCG----------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HhCCCC--CCcc----------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 221110 0111 111223467788999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=402.45 Aligned_cols=267 Identities=24% Similarity=0.398 Sum_probs=210.6
Q ss_pred HhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCc-cChHHHHHHHHHHHhccCCCcccccceeeecCC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDF-QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD 383 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~ 383 (683)
..++|...+.||+|+||+||+|.+. +++.||||++..... +....|.+|++++++++|||||+++|+|.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~---- 93 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS---- 93 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC----
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe----
Confidence 3478888999999999999999864 357899999975432 22346899999999999999999999996
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCC-CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDG-SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
.....++||||+++|+|.+++....... .......++|..+.+|+.++|+||.||| +.+|+||||||+|||||+
T Consensus 94 --~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 94 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECT
T ss_pred --cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecC
Confidence 5567999999999999999985321100 0012245789999999999999999999 789999999999999999
Q ss_pred CCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCC-CCCCCCCCCCCCccc
Q 005691 463 DMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGR-KALDLSTSGSPRACL 540 (683)
Q Consensus 463 ~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr-~p~~~~~~~~~~~~~ 540 (683)
++++||+|||+|+........ ......||+.|+|||.+.++.++.++||||||+++|||+||+ .|+....
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------- 240 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------- 240 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------
Confidence 999999999999877554433 344567999999999999999999999999999999999996 5553221
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCCC
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGDIE 610 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~~~ 610 (683)
..++. ..+.++...+ .+......+.+++..||+.||++||||.+|+++|++..+
T Consensus 241 ~~~~~-~~i~~~~~~~---------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 241 NEQVL-RFVMEGGLLD---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHH-HHHHTTCCCC---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHH-HHHHhCCCCC---------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11222 2233332211 111223467889999999999999999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=393.62 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=203.4
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc------ChHHHHHHHHHHHhccCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~ 384 (683)
.++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.|.+|+++|++++|||||++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 367999999999999999999974 6899999999654322 2467999999999999999999999997
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
.....++||||+++|+|.+++.. ...+++...+.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 84 -~~~~~~iv~E~~~gg~L~~~i~~---------~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 84 -NKTDVILILELVAGGELFDFLAE---------KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSS
T ss_pred -ECCEEEEEEEcCCCccccchhcc---------ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCC
Confidence 56789999999999999999832 347999999999999999999999 88999999999999998776
Q ss_pred ----cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 465 ----RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 465 ----~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
.+||+|||+|+....+.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------- 221 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------- 221 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred CcccceEecchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------
Confidence 599999999987654432 3446799999999999999999999999999999999999999964321
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.+ ....+..+.. ..... ........+.+++..|++.||++|||+.|+++
T Consensus 222 -~~-~~~~i~~~~~------~~~~~------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 -QE-TLANVSAVNY------EFEDE------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -HH-HHHHHHTTCC------CCCHH------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HH-HHHHHHhcCC------CCCch------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1112222211 00000 01122345678999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=399.15 Aligned_cols=267 Identities=24% Similarity=0.339 Sum_probs=209.9
Q ss_pred HhcCcccceeeeecCceEEEEEEEc------CCcEEEEEEeeccCcc-ChHHHHHHHHHHHhc-cCCCcccccceeeecC
Q 005691 311 ATDKFSQKNFIGRGGFGLVYKGILQ------DGTTVAVKKVIESDFQ-GDAEFCNEVEIISNL-KHRNLVPLRGCCVVDG 382 (683)
Q Consensus 311 at~~f~~~~~LG~GgfG~Vykg~l~------~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~ 382 (683)
..++|+..++||+|+||.||+|++. +++.||||++...... ...+|.+|+.+++++ +|||||+++|+|.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--- 97 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--- 97 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe---
Confidence 3468888999999999999999862 4678999999765433 345699999999999 6999999999996
Q ss_pred CCCCCCeeEEEEeecCCCCccccccCCCCCC---------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCC
Q 005691 383 DNERGSERYLVYDYMPNGNVDDHLFPSFNDG---------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDI 453 (683)
Q Consensus 383 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~---------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDI 453 (683)
.....++||||+++|+|.++++...... .......++|..+++|+.||++||+||| +.+|+||||
T Consensus 98 ---~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDL 171 (311)
T d1t46a_ 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDL 171 (311)
T ss_dssp ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred ---eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccc
Confidence 5667999999999999999986432110 0122346999999999999999999999 889999999
Q ss_pred CCCceeeccCCcEEEcccCcccccccCCc-cccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCC
Q 005691 454 KATNILLDADMRARVADFGLAKQSREGQS-HLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLST 532 (683)
Q Consensus 454 KpsNILLd~~~~~KLaDFGla~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~ 532 (683)
||+|||++.++.+||+|||+++....... ...+...||+.|+|||++..+.++.++|||||||++|||+|++.|+....
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765443 33456789999999999999999999999999999999999555543222
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
... +-+++.++.+.. +. .+......+.+++..||+.||++||||.||+++|++.
T Consensus 252 ~~~-------~~~~~~i~~~~~-----~~----------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 252 PVD-------SKFYKMIKEGFR-----ML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp CSS-------HHHHHHHHHTCC-----CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHH-------HHHHHHHhcCCC-----CC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 211 112233333211 00 1112235678899999999999999999999999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=395.37 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=206.0
Q ss_pred hcCcccceeeeecCceEEEEEEEcC--------CcEEEEEEeeccCc-cChHHHHHHHHHHHhc-cCCCcccccceeeec
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQD--------GTTVAVKKVIESDF-QGDAEFCNEVEIISNL-KHRNLVPLRGCCVVD 381 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~~--------g~~VAVK~l~~~~~-~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~ 381 (683)
.++|...+.||+|+||.||+|+... +..||||++..... ....++.+|+..+.++ +|||||+++|+|.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence 3678888999999999999998632 34799999876543 2346799999999998 8999999999997
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCC-------CCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCC
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDG-------SGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIK 454 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~-------~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIK 454 (683)
.....++||||+++|+|.++|....... .......++|.++++++.|++.||+||| +.+|||||||
T Consensus 90 ----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiK 162 (299)
T d1fgka_ 90 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLA 162 (299)
T ss_dssp ----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred ----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeec
Confidence 5567999999999999999995442110 1123456999999999999999999999 8999999999
Q ss_pred CCceeeccCCcEEEcccCcccccccCCcc-ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhh-CCCCCCCCC
Q 005691 455 ATNILLDADMRARVADFGLAKQSREGQSH-LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMC-GRKALDLST 532 (683)
Q Consensus 455 psNILLd~~~~~KLaDFGla~~~~~~~~~-~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELlt-Gr~p~~~~~ 532 (683)
|+|||++.++.+||+|||+++........ ......||+.|+|||.+..+.++.|+|||||||++|||++ |+.||....
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999999977654333 3456789999999999999999999999999999999998 677775322
Q ss_pred CCCCCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 533 SGSPRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 533 ~~~~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+.++..+..+...+ . +......+.+++.+|++.||++||||.||+++|++.
T Consensus 243 ---------~~~~~~~i~~~~~~~-----~----------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 243 ---------VEELFKLLKEGHRMD-----K----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---------HHHHHHHHHTTCCCC-----C----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHHHHHHHHcCCCCC-----C----------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122334444442211 1 111234678899999999999999999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-46 Score=401.83 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=207.4
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++. .+...+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~------~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE------DKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE------CSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE------ECCEEE
Confidence 57999999999999999999974 69999999997765555567899999999999999999999987 567899
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec--cCCcEEEc
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD--ADMRARVA 469 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd--~~~~~KLa 469 (683)
+||||+++|+|.+++.. ....+++.+.+.|+.||+.||+||| +.+||||||||+||||+ .++.+||+
T Consensus 103 ivmE~~~gg~L~~~~~~--------~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 103 LILEFLSGGELFDRIAA--------EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp EEEECCCCCBHHHHTTC--------TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEEcCCCChHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEe
Confidence 99999999999887732 2346999999999999999999999 89999999999999998 57899999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
|||+|+....+. ......||+.|||||++.+..++.++|||||||++|||++|+.||..... .+.. ..+
T Consensus 172 DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~-~~i 240 (352)
T d1koba_ 172 DFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETL-QNV 240 (352)
T ss_dssp CCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHH-HHH
T ss_pred ecccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHH
Confidence 999998876543 23446799999999999999999999999999999999999999963221 1111 112
Q ss_pred hcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 005691 550 KAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM--LEGD 608 (683)
Q Consensus 550 ~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~--L~~~ 608 (683)
..+... ..+. ........+.+++..|++.||++|||+.|+++. +++.
T Consensus 241 ~~~~~~--~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 241 KRCDWE--FDED----------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHCCCC--CCSS----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HhCCCC--CCcc----------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 222110 0000 111223466789999999999999999999874 5543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=397.14 Aligned_cols=261 Identities=27% Similarity=0.379 Sum_probs=201.5
Q ss_pred cCcccceeeeecCceEEEEEEEcC-Cc--EEEEEEeeccC-ccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQD-GT--TVAVKKVIESD-FQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~-g~--~VAVK~l~~~~-~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|+..+.||+|+||+||+|++.+ |. .||||++.... ....++|.+|+++|.++ +|||||+++|+|. .+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~------~~ 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE------HR 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE------ET
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe------cC
Confidence 678888999999999999999764 43 57888886543 33456799999999999 7999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCC-------CCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceee
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFND-------GSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILL 460 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~-------~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILL 460 (683)
+..++||||+++|+|.++|+..... ........++|..++.++.|||+||.||| +.+|+||||||+|||+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 160 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEE
Confidence 7899999999999999999543100 00123457999999999999999999999 8899999999999999
Q ss_pred ccCCcEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCC-CCCCCCCCCCCcc
Q 005691 461 DADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRK-ALDLSTSGSPRAC 539 (683)
Q Consensus 461 d~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~-p~~~~~~~~~~~~ 539 (683)
+.++.+||+|||+++....... .....||..|+|||.+..+.++.++|||||||++|||++|.. |+..... .
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-----~ 233 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----A 233 (309)
T ss_dssp CGGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H
T ss_pred cCCCceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----H
Confidence 9999999999999986543322 234568999999999999999999999999999999999765 5542211 1
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEGD 608 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~~ 608 (683)
.+ ...+.++.. +.. +......+.+++..||+.||++||||+||++.|+..
T Consensus 234 ~~----~~~i~~~~~-----~~~----------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 234 EL----YEKLPQGYR-----LEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HH----HHHGGGTCC-----CCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHHHhcCC-----CCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 122222211 111 112234677899999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-45 Score=388.26 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=201.7
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.++++++|||||++++++. ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~------~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ------DAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE------CSS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe------eCC
Confidence 57899999999999999999974 6899999999653 2334567999999999999999999999997 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|..++. ....+++...+.++.||+.||+||| +.+||||||||+||||+.++.+||
T Consensus 78 ~~~ivmE~~~gg~l~~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL 145 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLR---------KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI 145 (316)
T ss_dssp EEEEEECCCCSCBHHHHHH---------HTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred eeeeEeeecCCcccccccc---------ccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEE
Confidence 8999999999999999883 3456888899999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... .+ ....
T Consensus 146 ~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~-~~~~ 212 (316)
T d1fota_ 146 TDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MK-TYEK 212 (316)
T ss_dssp CCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HH-HHHH
T ss_pred ecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HH-HHHH
Confidence 999999876532 2346899999999999999999999999999999999999999964221 11 1122
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
+..+.. .+ +......+..++..|++.||++|| |+.++++
T Consensus 213 i~~~~~------~~----------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 213 ILNAEL------RF----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHCCC------CC----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCC------CC----------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 222211 01 111234567889999999999996 8999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-45 Score=382.46 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=201.6
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC---hHHHHHHHHHHHhccCCCcccccceeeecCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG---DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~---~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
.++|...+.||+|+||+||+|+. .+|+.||||++....... .+.|.+|++++++++|||||++++++..+.. .+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~--~~ 83 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP--AG 83 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS--SS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC--CC
Confidence 46799999999999999999996 479999999997654333 3468999999999999999999999875432 33
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++. ..+.++|.+.+.|+.|++.||+||| +.+|+||||||+|||++.++..+
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~---------~~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVH---------TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHH---------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEE
T ss_pred ceEEEEEECCCCCEehhhhc---------ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccce
Confidence 46899999999999999883 2347999999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCC--ccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 468 VADFGLAKQSREGQ--SHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 468 LaDFGla~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
|+|||.++...... ........||+.|||||++.+..++.++|||||||++|||+||+.||..... .+..
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~ 223 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVA 223 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHH
Confidence 99999987654332 2234457899999999999999999999999999999999999999964221 1223
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhc
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-TISDALKMLEG 607 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-tm~eVl~~L~~ 607 (683)
.+..+.+... +.. ...+..+.+.+++..|++.||++|| |+++++..|..
T Consensus 224 ~~~~~~~~~~----~~~---------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 224 YQHVREDPIP----PSA---------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHCCCCC----GGG---------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHhcCCCC----Cch---------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 3333332211 100 0112234677899999999999999 89999888763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=391.01 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=203.6
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|...+.||+|+||.||+++. .+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++. +..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~------~~~ 78 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ------THD 78 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE------CSS
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec------ccc
Confidence 6799999999999999999997 47999999999753 2334567899999999999999999999997 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++. ....+++...+.++.|++.||+||| +.+||||||||+|||+|.++.+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~---------~~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl 146 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS---------RERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH---------HHSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred ccccceeccCCCchhhhhh---------cccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEE
Confidence 8999999999999999983 2347888999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+|+....... .....+||+.|||||++.+..++.++||||+||++|||++|+.||..... .+ +.+.
T Consensus 147 ~DFG~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~-~~~~ 216 (337)
T d1o6la_ 147 TDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ER-LFEL 216 (337)
T ss_dssp CCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HH-HHHH
T ss_pred eecccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HH-HHHH
Confidence 99999987543322 23457899999999999999999999999999999999999999964321 11 1122
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
...+.+ .+ +......+..++..|++.||++||+ +.|+++
T Consensus 217 i~~~~~------~~----------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 217 ILMEEI------RF----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHCCC------CC----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhcCCC------CC----------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222221 11 1122345678899999999999995 778775
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-45 Score=381.01 Aligned_cols=265 Identities=25% Similarity=0.247 Sum_probs=193.9
Q ss_pred cceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccC-----hHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 317 QKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQG-----DAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 317 ~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~-----~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
..++||+|+||+||+|+.. +|+.||||++....... .+.+.+|++++++++|||||++++++. .++..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~------~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG------HKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC------CTTCC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCce
Confidence 3578999999999999974 68999999986543222 246889999999999999999999997 55679
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++||||++++++...+. ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 76 ~ivmE~~~~~~~~~~~~---------~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~D 143 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKD---------NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLAD 143 (299)
T ss_dssp EEEEECCSEEHHHHHTT---------CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eehhhhhcchHHhhhhh---------cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCcccccc
Confidence 99999999988776652 2357999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||+|+........ .....||+.|+|||.+..+ .++.++|||||||++|||++|+.||...... ....-+.+..
T Consensus 144 FG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----~~l~~i~~~~ 217 (299)
T d1ua2a_ 144 FGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----DQLTRIFETL 217 (299)
T ss_dssp CGGGSTTTSCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHH
T ss_pred CccccccCCCccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----HHHHHHHHhc
Confidence 9999876544322 2345799999999998754 5799999999999999999999998643211 0000011100
Q ss_pred hcCcccccc------CccccccccccCCCh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhc
Q 005691 550 KAGKVWQAL------DPSLLKEDDFLSLNP----KAIMERFVLVGILCAHVMVALRPTISDALK--MLEG 607 (683)
Q Consensus 550 ~~g~l~e~v------D~~l~~~~~~~~~~~----~e~~~~l~~lal~C~~~dP~~RPtm~eVl~--~L~~ 607 (683)
......... +........ .... ....+.+.+++..|++.||++|||+.|+++ .|.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 218 GTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CCCChhhccchhccchhhhhccCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 000000000 000000000 0000 012346788999999999999999999987 3554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.2e-45 Score=380.61 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=203.2
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccC---------hHHHHHHHHHHHhcc-CCCcccccceeeec
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQG---------DAEFCNEVEIISNLK-HRNLVPLRGCCVVD 381 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~---------~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~ 381 (683)
++|...+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|+.++++++ |||||++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 6899999999999999999997 478999999997653321 235889999999997 999999999997
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
+++..++||||+++|+|.++|.. ...+++.+++.++.||+.||+||| +.+|+||||||+|||++
T Consensus 81 ----~~~~~~ivmE~~~~g~L~~~l~~---------~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~ 144 (277)
T d1phka_ 81 ----TNTFFFLVFDLMKKGELFDYLTE---------KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLD 144 (277)
T ss_dssp ----CSSEEEEEEECCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred ----cCcceEEEEEcCCCchHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEc
Confidence 56789999999999999999942 347999999999999999999999 88999999999999999
Q ss_pred cCCcEEEcccCcccccccCCccccccccCCCcccCcccccc------CCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 462 ADMRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY------GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 462 ~~~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
.++.+||+|||+++....+. ..+...||..|+|||++.. ..++.++||||+||+++||++|+.||.....
T Consensus 145 ~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-- 220 (277)
T d1phka_ 145 DDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-- 220 (277)
T ss_dssp TTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred CCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--
Confidence 99999999999998876533 2345689999999998863 4578899999999999999999999974321
Q ss_pred CCccchhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 536 PRACLITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 536 ~~~~~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
......+..+... ...+ ......+.+.+++..|++.||++|||+.||++
T Consensus 221 -------~~~~~~i~~~~~~-~~~~-----------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 -------MLMLRMIMSGNYQ-FGSP-----------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -------HHHHHHHHHTCCC-CCTT-----------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -------HHHHHHHHhCCCC-CCCc-----------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122223333221 0000 11223456788999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=386.93 Aligned_cols=256 Identities=19% Similarity=0.248 Sum_probs=198.6
Q ss_pred hcCcccce-eeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhc-cCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKN-FIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNL-KHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~-~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L-~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...+ +||+|+||+||+|+. .+|+.||||++.. ...+.+|++++.++ +|||||++++++..... ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~--~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA--GRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET--TEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc--CCC
Confidence 35787764 699999999999997 4689999999864 45688899997665 89999999998853111 245
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc---CCc
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA---DMR 465 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~---~~~ 465 (683)
..++||||+++|+|.++|... ....+++.+.+.|+.|++.||+||| +.+|+||||||+|||++. ++.
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~-------~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~ 152 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDR-------GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAI 152 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSC-------SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCC
T ss_pred EEEEEEECCCCCcHHHHHHhc-------CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccc
Confidence 689999999999999999432 1346999999999999999999999 899999999999999985 567
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV 545 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v 545 (683)
+||+|||+|+....... .....||+.|||||++.+..++.++|||||||++|||+||+.||........ ....
T Consensus 153 ~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~ 225 (335)
T d2ozaa1 153 LKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGM 225 (335)
T ss_dssp EEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------
T ss_pred ccccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHH
Confidence 99999999987655432 3456799999999999999999999999999999999999999965432111 0111
Q ss_pred hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 ~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
......+.. .+.. .........+.+++..|++.||++|||+.|+++
T Consensus 226 ~~~i~~~~~------~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 KTRIRMGQY------EFPN------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CCCSCSS------SCCT------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhcCCC------CCCC------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111110 0000 011234557888999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-44 Score=383.55 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=201.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeecc---CccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIES---DFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~---~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++|+.++|||||++++++. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~------~~~ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK------DNS 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE------CSS
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc------ccc
Confidence 57999999999999999999975 6999999998643 2233567899999999999999999999987 567
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+++|+|.+++.. ...+++...+.|+.||+.||.||| +.+||||||||+||||+.++.+||
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~---------~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL 182 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHH---------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred ccccccccccccchhhhHhh---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEe
Confidence 89999999999999999842 347999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 183 ~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---------~~~~~~ 249 (350)
T d1rdqe_ 183 TDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------IQIYEK 249 (350)
T ss_dssp CCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHH
T ss_pred eeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---------HHHHHH
Confidence 999999876532 2346799999999999999999999999999999999999999964211 111122
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCC-----CCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALR-----PTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~R-----Ptm~eVl~ 603 (683)
+..+.. . .+......+.+++..|++.||++| ||+.++++
T Consensus 250 i~~~~~------~----------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 250 IVSGKV------R----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHCCC------C----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HhcCCC------C----------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 222211 0 111223456789999999999999 48999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-44 Score=390.47 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=196.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHH---HHHHHhccCCCcccccceeeecCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNE---VEIISNLKHRNLVPLRGCCVVDGDNE 385 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~E---v~iL~~L~H~NLV~L~G~c~~~~~~~ 385 (683)
++|...++||+|+||.||+|+.. +|+.||||++.... ......+.+| +++++.++|||||++++++.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~------ 77 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH------ 77 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE------
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE------
Confidence 67999999999999999999975 68999999986432 2233445555 56667778999999999987
Q ss_pred CCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCc
Q 005691 386 RGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMR 465 (683)
Q Consensus 386 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~ 465 (683)
.....++||||+++|+|.++|.. ...+++...+.++.||+.||+||| +.+||||||||+||||+.++.
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~---------~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~ 145 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ---------HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 145 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH---------HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh---------cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCc
Confidence 56789999999999999999832 346889999999999999999999 899999999999999999999
Q ss_pred EEEcccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 466 ARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
+||+|||+|+...... .....||+.|||||++.. ..++.++|||||||++|||++|+.||....... . ..
T Consensus 146 iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~-~~ 216 (364)
T d1omwa3 146 VRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----K-HE 216 (364)
T ss_dssp EEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----H-HH
T ss_pred EEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----H-HH
Confidence 9999999998765432 344679999999999975 468999999999999999999999997543321 1 11
Q ss_pred hhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005691 545 VWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPT-----ISDALK 603 (683)
Q Consensus 545 v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPt-----m~eVl~ 603 (683)
+.+...... ..+ +......+.+++..|++.||++||| +.|+++
T Consensus 217 ~~~~~~~~~------~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 217 IDRMTLTMA------VEL----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHSSSCC------CCC----------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHhcccCC------CCC----------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111111110 011 1122345678999999999999999 588864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=385.54 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=200.8
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC---ccChHHHHHHHHHHH-hccCCCcccccceeeecCCCCCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD---FQGDAEFCNEVEIIS-NLKHRNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~---~~~~~~f~~Ev~iL~-~L~H~NLV~L~G~c~~~~~~~~~ 387 (683)
++|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+..|+.++. .++|||||++++++. .+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~------~~ 75 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ------TK 75 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE------CS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc------cC
Confidence 57899999999999999999975 68999999997532 233456778888775 689999999999997 56
Q ss_pred CeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEE
Q 005691 388 SERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRAR 467 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~K 467 (683)
...++||||+++|+|.+++.. ...+++.+.+.++.||+.||+||| +.+|+||||||+|||+++++++|
T Consensus 76 ~~~yivmEy~~~g~L~~~i~~---------~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 76 ENLFFVMEYLNGGDLMYHIQS---------CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---------HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CceeEEEeecCCCcHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCcee
Confidence 789999999999999999942 346889999999999999999999 88999999999999999999999
Q ss_pred EcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 468 VADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 468 LaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
|+|||+++....... ..+...||+.|+|||++.++.++.++|||||||++|||++|+.||..... ..++.
T Consensus 144 l~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---------~~~~~ 213 (320)
T d1xjda_ 144 IADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---------EELFH 213 (320)
T ss_dssp ECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH
T ss_pred ccccchhhhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---------HHHHH
Confidence 999999986654332 33456899999999999999999999999999999999999999964321 12233
Q ss_pred hhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 005691 548 LVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTIS-DAL 602 (683)
Q Consensus 548 ~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~-eVl 602 (683)
....+.. .+ +......+..++..|++.||++|||+. +++
T Consensus 214 ~i~~~~~------~~----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 214 SIRMDNP------FY----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHHHCCC------CC----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHcCCC------CC----------CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 3322221 11 111234567889999999999999995 675
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-44 Score=373.65 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=196.6
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...+.||+|+||+||+|+. .+|+.||||++..... ...+++.+|++++++++|||||++++++. .+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~------~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH------TENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE------ETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc------cccc
Confidence 6899999999999999999997 4689999999965332 23567999999999999999999999997 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+.++.+.... .. ....+++..++.++.|++.||+||| +.+||||||||+|||++.++++||+
T Consensus 76 ~~iv~e~~~~~~~~~~~-~~-------~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~ 144 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMD-AS-------ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLA 144 (298)
T ss_dssp EEEEEECCSEEHHHHHH-HT-------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred eeEEEeecCCchhhhhh-hh-------cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceec
Confidence 99999999765444332 11 2356999999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCC-CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||+|+....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+.. +-....
T Consensus 145 DFG~a~~~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--------~~~~~i 215 (298)
T d1gz8a_ 145 DFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--------DQLFRI 215 (298)
T ss_dssp STTHHHHHCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHH
T ss_pred cCCcceeccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--------HHHHHH
Confidence 9999987654332 233457999999999877655 588999999999999999999999643211 000010
Q ss_pred hh-cCccccccCcccc------cc-ccccCCCh----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 549 VK-AGKVWQALDPSLL------KE-DDFLSLNP----KAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 549 ~~-~g~l~e~vD~~l~------~~-~~~~~~~~----~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.+ .+...+..-+... .. ........ ......+.+++..|++.||++|||+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0110000000000 00 00000000 0123467788999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=381.58 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=201.9
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
.++|...+.||+|+||+||+|+.. +|+.||||.+.... .....+.+|+++|++++|||||++++++. .....
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~------~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE------SMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE------ETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEE------ECCEE
Confidence 468999999999999999999975 68899999986543 22456889999999999999999999987 46789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC--CcEEE
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD--MRARV 468 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~--~~~KL 468 (683)
++||||+++|+|.+++.. ....+++.+.+.|+.||+.||+||| +.+|+||||||+|||++.+ ..+||
T Consensus 77 ~lvmE~~~gg~L~~~i~~--------~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINT--------SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEEECCCCCCBHHHHHTS--------SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEecCCCCcHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEE
Confidence 999999999999999942 1236899999999999999999999 8999999999999999854 58999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
+|||+++....... .....||+.|+|||...+..++.++||||+||++|||++|+.||..... .+....
T Consensus 146 ~DFG~~~~~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~- 214 (321)
T d1tkia_ 146 IEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIEN- 214 (321)
T ss_dssp CCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH-
T ss_pred cccchhhccccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHH-
Confidence 99999987654332 3345789999999999999999999999999999999999999964321 111111
Q ss_pred hhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+..+... ++... .......+.+++..|++.||++|||+.|+++
T Consensus 215 i~~~~~~--~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 215 IMNAEYT--FDEEA----------FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTCCC--CCHHH----------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhCCCC--CChhh----------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2122110 00000 0122345778999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.2e-44 Score=369.86 Aligned_cols=267 Identities=23% Similarity=0.289 Sum_probs=197.3
Q ss_pred cCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCc--cChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDF--QGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||+||+|+.++|+.||||++..... ...+.+.+|+.++++++|||||++++++. .....
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~------~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH------TKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE------CSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc------cCCce
Confidence 58899999999999999999999999999999965432 23567999999999999999999999997 56789
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEcc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVAD 470 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLaD 470 (683)
++++||+.++.+..+.. ..+.+++...+.|+.||+.||+||| +.+||||||||+|||++.++.+||+|
T Consensus 76 ~i~~e~~~~~~~~~~~~---------~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~D 143 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV---------CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIAD 143 (286)
T ss_dssp EEEEECCSEEHHHHHHT---------STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeehhhhHHHHHh---------hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecc
Confidence 99999998887777662 2457999999999999999999999 78999999999999999999999999
Q ss_pred cCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhhh
Q 005691 471 FGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSLV 549 (683)
Q Consensus 471 FGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~~ 549 (683)
||++........ ......||+.|+|||.+.. ..++.++|||||||+++||++|+.||......+ .+.. +....
T Consensus 144 fG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~----~~~~-i~~~~ 217 (286)
T d1ob3a_ 144 FGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMR-IFRIL 217 (286)
T ss_dssp TTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH-HHHHH
T ss_pred cccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH----HHHH-HHHhh
Confidence 999987654322 2334468999999999875 457999999999999999999999996432110 0000 00000
Q ss_pred hcC------cccc--ccCccccc-cccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 550 KAG------KVWQ--ALDPSLLK-EDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 550 ~~g------~l~e--~vD~~l~~-~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..- ...+ ..+..... ...............+.+++..|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000 00000000 000000011122346778999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=373.94 Aligned_cols=272 Identities=23% Similarity=0.247 Sum_probs=197.7
Q ss_pred hcCcccceeeeecCceEEEEEEEc-C-CcEEEEEEeeccCc--cChHHHHHHHHHHHhc---cCCCcccccceeeecCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-D-GTTVAVKKVIESDF--QGDAEFCNEVEIISNL---KHRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~-g~~VAVK~l~~~~~--~~~~~f~~Ev~iL~~L---~H~NLV~L~G~c~~~~~~ 384 (683)
.++|+..++||+|+||+||+|+.. + ++.||||++..... .....+.+|+.+++.| +|||||++++++.....
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~- 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT- 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC-
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc-
Confidence 468999999999999999999974 4 56799999865422 2234577888887766 79999999999864321
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM 464 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~ 464 (683)
......+++|||+++|.+...... ....+++...+.++.|++.||+||| +.+|+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~ 153 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--------PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSG 153 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--------CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred ccCceEEEEEEeccCCchhhhhhc--------cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCC
Confidence 134678999999999877654421 2356899999999999999999999 88999999999999999999
Q ss_pred cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh
Q 005691 465 RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW 544 (683)
Q Consensus 465 ~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~ 544 (683)
.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .+...
T Consensus 154 ~~kl~dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i 227 (305)
T d1blxa_ 154 QIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKI 227 (305)
T ss_dssp CEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHH
T ss_pred Ceeecchhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH----HHHHH
Confidence 99999999998654332 3345689999999999999999999999999999999999999997432210 00000
Q ss_pred hhhh-------hhc-CccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 545 VWSL-------VKA-GKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 545 v~~~-------~~~-g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.... +.. .............. ..........+.+.+++..|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQ--PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCC--CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhhcccccc--chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 000 00000000000000 000011122345678899999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=370.09 Aligned_cols=239 Identities=23% Similarity=0.398 Sum_probs=192.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc------ChHHHHHHHHHHHhcc--CCCcccccceeeecCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ------GDAEFCNEVEIISNLK--HRNLVPLRGCCVVDGD 383 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~------~~~~f~~Ev~iL~~L~--H~NLV~L~G~c~~~~~ 383 (683)
++|...++||+|+||+||+|+.. +|+.||||++...... ...++.+|+.++++++ |||||++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~---- 79 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE---- 79 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence 57999999999999999999974 6899999999754322 1234778999999996 899999999987
Q ss_pred CCCCCeeEEEEeecCC-CCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc
Q 005691 384 NERGSERYLVYDYMPN-GNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA 462 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~ 462 (683)
..+..++||||+.+ +++.+++. ....+++...+.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 80 --~~~~~~lv~e~~~~~~~l~~~~~---------~~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 80 --RPDSFVLILERPEPVQDLFDFIT---------ERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDL 145 (273)
T ss_dssp --CSSEEEEEEECCSSEEEHHHHHH---------HHCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEET
T ss_pred --eCCeEEEEEEeccCcchHHHHHh---------ccCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEec
Confidence 56789999999976 56767762 2357999999999999999999999 899999999999999985
Q ss_pred C-CcEEEcccCcccccccCCccccccccCCCcccCccccccCCC-CccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc
Q 005691 463 D-MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQL-TEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL 540 (683)
Q Consensus 463 ~-~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~ 540 (683)
+ +.+||+|||+|+..... ..+...||+.|+|||++.+.++ +.++|||||||++|||++|+.||.... .
T Consensus 146 ~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~ 215 (273)
T d1xwsa_ 146 NRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E 215 (273)
T ss_dssp TTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H
T ss_pred CCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------H
Confidence 4 79999999999865432 2345689999999999987766 567999999999999999999986311 0
Q ss_pred hhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 541 ITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 541 l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+ . .+.. .+.+ .....+.+++..|++.||++|||+.|+++
T Consensus 216 i-------~-~~~~--~~~~--------------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 I-------I-RGQV--FFRQ--------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp H-------H-HCCC--CCSS--------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-------h-hccc--CCCC--------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 1 1111 0011 12345678899999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=367.97 Aligned_cols=269 Identities=26% Similarity=0.339 Sum_probs=194.8
Q ss_pred CcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeEE
Q 005691 314 KFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERYL 392 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~L 392 (683)
+|...++||+|+||+||+|+.. +|+.||||++...... +.+|+++|++++|+|||++++++............++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777889999999999999975 6899999999764322 3479999999999999999999976544344566899
Q ss_pred EEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cEEEccc
Q 005691 393 VYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARVADF 471 (683)
Q Consensus 393 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~KLaDF 471 (683)
||||+++|.+....... .....+++.+++.|+.||+.||+||| +.+|+||||||+||||+.++ .+||+||
T Consensus 97 v~Ey~~~~~~~~l~~~~------~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS------RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp EEECCSEEHHHHHHHHH------HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred EEeccCCccHHHHHhhh------hccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecc
Confidence 99999876544433211 12457999999999999999999999 89999999999999999775 8999999
Q ss_pred CcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhh-----
Q 005691 472 GLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWV----- 545 (683)
Q Consensus 472 Gla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v----- 545 (683)
|+++........ ....||..|+|||.+.. ..++.++||||+||++|||++|+.||......+ .+....
T Consensus 168 G~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~----~l~~i~~~~g~ 241 (350)
T d1q5ka_ 168 GSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGT 241 (350)
T ss_dssp TTCEECCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHCC
T ss_pred cchhhccCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH----HHHHHHHHhCC
Confidence 999876544332 33579999999998765 578999999999999999999999996432210 111100
Q ss_pred -----hhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 546 -----WSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 546 -----~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
+........ +..-+.+... .............+.+++..|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 242 PTREQIREMNPNYT-EFKFPQIKAH-PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCHHHHHHHCC----CCCCCCCCCC-CGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHhhhhhccchh-hccccccccC-chhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111100000 0000000000 0000011122345778899999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-42 Score=358.76 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=197.1
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCeeE
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSERY 391 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~~~ 391 (683)
++|+..+.||+|+||+||+|+.. +|+.||||.+..... .+++..|++++++++|+|+|..++.+.. .+...+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~-----~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-----EGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE-----ETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe-----cCCEEE
Confidence 57999999999999999999974 689999998766432 3458899999999998888887777654 456789
Q ss_pred EEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec---cCCcEEE
Q 005691 392 LVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD---ADMRARV 468 (683)
Q Consensus 392 LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd---~~~~~KL 468 (683)
+||||+. |+|.+.+.. ..+.+++..++.++.|++.||+||| +.+||||||||+|||++ .+..+||
T Consensus 80 ivme~~~-~~l~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl 147 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNF--------CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYI 147 (299)
T ss_dssp EEEECCC-CBHHHHHHH--------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred EEEEEcC-Cchhhhhhh--------ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeee
Confidence 9999994 566555522 2357999999999999999999999 89999999999999875 4567999
Q ss_pred cccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 469 ADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 469 aDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
+|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~----- 222 (299)
T d1ckia_ 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----- 222 (299)
T ss_dssp CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------
T ss_pred eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-----
Confidence 999999987654322 234568999999999999999999999999999999999999999754432211
Q ss_pred hhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 543 DWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
..+... ...... ...+.+. ......+.+++..|++.+|++||+++++.++|+.
T Consensus 223 ~~~~~~-~~~~~~-~~~~~~~----------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 223 QKYERI-SEKKMS-TPIEVLC----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp --HHHH-HHHHHH-SCHHHHT----------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred HHHHHh-hcccCC-CChhHhc----------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 111110 000000 0000010 1123457788999999999999999999888874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=369.46 Aligned_cols=271 Identities=19% Similarity=0.270 Sum_probs=195.8
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc-ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ-GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~-~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
+++|...++||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++++|||+|++++++..+.. ....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~--~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI--EQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST--TTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc--cccc
Confidence 45799999999999999999986 47999999999754322 24578999999999999999999999864322 2233
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++++||+.+|+|.+++. ...+++..++.++.|++.||+||| +.+||||||||+||||+.++.+||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~----------~~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~ 151 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLK----------TQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC 151 (345)
T ss_dssp CEEEEEECCCEEHHHHHH----------HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEeecCCchhhhhh----------cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEc
Confidence 455567788999999983 236999999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCcc--ccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhh
Q 005691 470 DFGLAKQSREGQSH--LTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVW 546 (683)
Q Consensus 470 DFGla~~~~~~~~~--~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~ 546 (683)
|||+++........ ......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+ ......
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-----~~~~~~ 226 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHIL 226 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-----HHHHHh
Confidence 99999876543322 2455779999999999854 567899999999999999999999996432210 000000
Q ss_pred hhhhcCcc-----------cc--ccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 547 SLVKAGKV-----------WQ--ALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 547 ~~~~~g~l-----------~e--~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.....-.. .. ...+..... .... .......++..++..|++.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKV-PWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC-CHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhccCCChhhhhhhhhhhhhcccccCCccCCC-CHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00 000000000 0000 000112357789999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=369.78 Aligned_cols=272 Identities=23% Similarity=0.318 Sum_probs=194.6
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|...++||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++..........
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 6999999999754322 2356889999999999999999999997554444455
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++||||+ +++|..++ ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 97 ~~~lv~e~~-~~~l~~~~----------~~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----------KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----------HHCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-cccHHHHH----------HhccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccc
Confidence 789999999 55666655 2346999999999999999999999 899999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCcccccc-CCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhh---
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALY-GQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDW--- 544 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~--- 544 (683)
+|||+|+..... .+...||+.|+|||.+.+ ..++.++||||+||+++||++|+.||....... .+...
T Consensus 163 ~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~----~~~~~~~~ 234 (346)
T d1cm8a_ 163 LDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKV 234 (346)
T ss_dssp CCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHH
T ss_pred ccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH----HHHHHHhc
Confidence 999999876433 244679999999999876 456899999999999999999999996432110 00000
Q ss_pred -------hhhhhhcCccc--cccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc
Q 005691 545 -------VWSLVKAGKVW--QALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM--LEG 607 (683)
Q Consensus 545 -------v~~~~~~g~l~--e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~--L~~ 607 (683)
.+......... ....+..... ... .........+.+++..|++.||++|||+.|+++. |++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKK-DFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCC-CGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCccccc-chH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 00000000000 0000000000 000 0001122356788999999999999999999974 554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=360.00 Aligned_cols=274 Identities=25% Similarity=0.280 Sum_probs=194.7
Q ss_pred hcCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccC--ccChHHHHHHHHHHHhccCCCcccccceeeecCC--CCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESD--FQGDAEFCNEVEIISNLKHRNLVPLRGCCVVDGD--NER 386 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~--~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~--~~~ 386 (683)
.++|+..++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|+|++++++.+..... ...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 378999999999999999999974 79999999985432 2335678999999999999999999999864321 112
Q ss_pred CCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcE
Q 005691 387 GSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRA 466 (683)
Q Consensus 387 ~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~ 466 (683)
....++||||++++.+..+.. ....++....+.|+.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---------~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---------VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---------TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhh---------cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcE
Confidence 456899999999888776552 2346888899999999999999999 8899999999999999999999
Q ss_pred EEcccCcccccccCCcc---ccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchh
Q 005691 467 RVADFGLAKQSREGQSH---LTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLIT 542 (683)
Q Consensus 467 KLaDFGla~~~~~~~~~---~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~ 542 (683)
||+|||+++........ ......||+.|+|||.+.+. .++.|+|||||||++|||++|+.||...... ...
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-----~~~ 231 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQL 231 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-----HHH
Confidence 99999999876543221 22335799999999998765 6899999999999999999999999643211 000
Q ss_pred hhhhhhhhcCccccccCccc-----ccc---ccccCCChHH------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 543 DWVWSLVKAGKVWQALDPSL-----LKE---DDFLSLNPKA------IMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 543 ~~v~~~~~~g~l~e~vD~~l-----~~~---~~~~~~~~~e------~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
.-..+.. +.......... ... .........+ ....+.+++..|++.||++|||+.|+++.
T Consensus 232 ~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 232 ALISQLC--GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHHHHH--CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhc--CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000100 11000000000 000 0000001111 12345678999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=359.66 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=199.2
Q ss_pred cCcccceeeeecCceEEEEEEEc----CCcEEEEEEeeccC----ccChHHHHHHHHHHHhccC-CCcccccceeeecCC
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ----DGTTVAVKKVIESD----FQGDAEFCNEVEIISNLKH-RNLVPLRGCCVVDGD 383 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~----~g~~VAVK~l~~~~----~~~~~~f~~Ev~iL~~L~H-~NLV~L~G~c~~~~~ 383 (683)
++|+..++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---- 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---- 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence 67999999999999999999852 47899999985432 2334568899999999977 79999999986
Q ss_pred CCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccC
Q 005691 384 NERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDAD 463 (683)
Q Consensus 384 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~ 463 (683)
.....++||||+.+|+|.+++.. ...+.....+.++.|++.||.||| +.+|+||||||+|||||.+
T Consensus 100 --~~~~~~~v~e~~~~~~L~~~i~~---------~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~ 165 (322)
T d1vzoa_ 100 --TETKLHLILDYINGGELFTHLSQ---------RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN 165 (322)
T ss_dssp --ETTEEEEEECCCCSCBHHHHHHH---------HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred --cCCceeeeeecccccHHHHHHHh---------cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCC
Confidence 45689999999999999999843 345677888899999999999999 8899999999999999999
Q ss_pred CcEEEcccCcccccccCCccccccccCCCcccCccccccC--CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccch
Q 005691 464 MRARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG--QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLI 541 (683)
Q Consensus 464 ~~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l 541 (683)
+.+||+|||+++..............||+.|+|||.+... .++.++|||||||+||||++|+.||........ .
T Consensus 166 ~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~ 241 (322)
T d1vzoa_ 166 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----Q 241 (322)
T ss_dssp SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----H
T ss_pred CCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence 9999999999987755544445557899999999998754 468899999999999999999999975543221 1
Q ss_pred hhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 005691 542 TDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRP-----TISDALK 603 (683)
Q Consensus 542 ~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RP-----tm~eVl~ 603 (683)
.-+.+....... . .+.+...++.+++..|+++||++|| |++|+++
T Consensus 242 -~~i~~~~~~~~~------~----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 242 -AEISRRILKSEP------P----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -HHHHHHHHHCCC------C----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -HHHHHhcccCCC------C----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111111111110 0 1122345677899999999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=352.64 Aligned_cols=265 Identities=20% Similarity=0.236 Sum_probs=199.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.+++.++|||||++++++. ....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~------~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH------SDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE------CSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc------cccc
Confidence 57999999999999999999974 7889999999654332 2467899999999999999999999997 5678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++|+|++.+++|..++. ..+.+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+
T Consensus 76 ~~iv~~~~~~~~l~~~~~---------~~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~ 143 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDS---------CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_dssp EEEEEECCSEEHHHHHHH---------TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred eeEEeeeccccccccccc---------cccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeee
Confidence 999999999999988773 2357889999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCC-CCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhhh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQ-LTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWSL 548 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~~ 548 (683)
|||.++........ .....++..|+|||.+.... ++.++|||||||+++||++|+.|+...... .++....
T Consensus 144 DFG~a~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-------~~~~~~~ 215 (292)
T d1unla_ 144 NFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRI 215 (292)
T ss_dssp CCTTCEECCSCCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-------HHHHHHH
T ss_pred ecchhhcccCCCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-------HHHHHHH
Confidence 99999876544332 33346788999999887655 689999999999999999999997432211 1111111
Q ss_pred hh-cCcc--------ccccCc---cccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 549 VK-AGKV--------WQALDP---SLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 549 ~~-~g~l--------~e~vD~---~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
.. .+.. ....+. ...................+.+++..|++.||.+|||++||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 216 FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000 000000 0000000000011122345678889999999999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-41 Score=355.52 Aligned_cols=267 Identities=19% Similarity=0.258 Sum_probs=197.2
Q ss_pred cCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||+||+|+. .+|+.||||++... ..+++.+|+++|++++ ||||+++++++... .....
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~----~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP----VSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT----TTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec----CCCce
Confidence 5899999999999999999997 46899999998643 3567899999999995 99999999998632 34568
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCC-cEEEc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADM-RARVA 469 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~-~~KLa 469 (683)
++||||+++|+|..+. +.+++...+.++.||+.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 108 ~~v~e~~~~~~L~~~~------------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~ 172 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY------------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLI 172 (328)
T ss_dssp EEEEECCCSCBGGGTT------------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred eEEEeecCCCcHHHHh------------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeec
Confidence 9999999999997764 35889999999999999999999 89999999999999998655 69999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhh-----
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITD----- 543 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~----- 543 (683)
|||+|+....... .....||+.|+|||.+... .++.++||||+||+++|+++|+.||............+..
T Consensus 173 DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 173 DWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp CGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred ccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 9999987655432 3446789999999998765 5799999999999999999999998643321100000000
Q ss_pred hhhhhhhcCcc------ccccCccccc--cccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 544 WVWSLVKAGKV------WQALDPSLLK--EDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 544 ~v~~~~~~g~l------~e~vD~~l~~--~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
..+........ .......... ...............+.+++..|++.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 0000000000 000000112223456788999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6e-41 Score=350.52 Aligned_cols=258 Identities=17% Similarity=0.204 Sum_probs=200.3
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCccChHHHHHHHHHHHhccC-CCcccccceeeecCCCCCCCee
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQGDAEFCNEVEIISNLKH-RNLVPLRGCCVVDGDNERGSER 390 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H-~NLV~L~G~c~~~~~~~~~~~~ 390 (683)
++|...++||+|+||+||+|+.. +|+.||||.+.... ..+++.+|+++++.++| +|++.+++++. .+...
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~------~~~~~ 76 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ------EGLHN 76 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE------ETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee------cCCcc
Confidence 68999999999999999999965 68899999875533 23457889999999975 89999998886 56788
Q ss_pred EEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeecc-----CCc
Q 005691 391 YLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDA-----DMR 465 (683)
Q Consensus 391 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~-----~~~ 465 (683)
++||||+ +|+|.+++.. ....+++.++..|+.|++.||+||| +.+||||||||+|||++. ++.
T Consensus 77 ~~vme~~-~~~l~~~~~~--------~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~ 144 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDL--------CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANM 144 (293)
T ss_dssp EEEEECC-CCBHHHHHHH--------TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred EEEEEec-CCCHHHHHHh--------hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCc
Confidence 9999998 6899988742 2346899999999999999999999 999999999999999974 578
Q ss_pred EEEcccCcccccccCCcc------ccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCcc
Q 005691 466 ARVADFGLAKQSREGQSH------LTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRAC 539 (683)
Q Consensus 466 ~KLaDFGla~~~~~~~~~------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~ 539 (683)
+||+|||+|+........ ......||+.|||||.+.+..++.++|||||||++|||++|+.||........
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~--- 221 (293)
T d1csna_ 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--- 221 (293)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH---
T ss_pred eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH---
Confidence 999999999986543221 23346799999999999999999999999999999999999999975443221
Q ss_pred chhhhhhhhhhcCccccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 005691 540 LITDWVWSLVKAGKVWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKMLEG 607 (683)
Q Consensus 540 ~l~~~v~~~~~~g~l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~L~~ 607 (683)
.... ..+...+... .-+.+.. ...+++.+++..|++.+|++||+...+.+.|+.
T Consensus 222 --~~~~-~~i~~~~~~~-~~~~l~~----------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 222 --KQKY-ERIGEKKQST-PLRELCA----------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp --HHHH-HHHHHHHHHS-CHHHHTT----------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred --HHHH-HHHHhccCCC-ChHHhcC----------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 1111110000 0000111 122456778889999999999999998888765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=355.80 Aligned_cols=272 Identities=21% Similarity=0.241 Sum_probs=192.6
Q ss_pred cCcccceeeeecCceEEEEEEEc-CCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCCe
Q 005691 313 DKFSQKNFIGRGGFGLVYKGILQ-DGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGSE 389 (683)
Q Consensus 313 ~~f~~~~~LG~GgfG~Vykg~l~-~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~~ 389 (683)
++|...++||+|+||+||+|+.. +|+.||||++...... ....+.+|+.++++++|||||++++++...+..+....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999975 6999999999764332 23468899999999999999999999975544445678
Q ss_pred eEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEEc
Q 005691 390 RYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARVA 469 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KLa 469 (683)
.++||||+.++.+.... ..+++...+.++.|++.||+||| +.+|+||||||+|||++.++.+|++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~ 161 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_dssp EEEEEECCSEEHHHHHT------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEeccchHHHHhhh------------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeee
Confidence 99999999766554332 35889999999999999999999 8899999999999999999999999
Q ss_pred ccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccc-------hh
Q 005691 470 DFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACL-------IT 542 (683)
Q Consensus 470 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~-------l~ 542 (683)
|||+++...... ..+...||+.|+|||++.+..++.++||||+||+++||++|+.||............ ..
T Consensus 162 df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 162 DFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred chhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 999988765432 234567999999999999999999999999999999999999998633210000000 00
Q ss_pred hh-------hhhhhhcCc------cccccCccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005691 543 DW-------VWSLVKAGK------VWQALDPSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALKM 604 (683)
Q Consensus 543 ~~-------v~~~~~~g~------l~e~vD~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~~ 604 (683)
++ ......... ............ ...........+.+++..|++.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA---DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCC---SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccc---cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000000000 000111111000 000122345678889999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-41 Score=356.28 Aligned_cols=267 Identities=21% Similarity=0.287 Sum_probs=193.2
Q ss_pred hcCcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCcc--ChHHHHHHHHHHHhccCCCcccccceeeecCCCCCCC
Q 005691 312 TDKFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQ--GDAEFCNEVEIISNLKHRNLVPLRGCCVVDGDNERGS 388 (683)
Q Consensus 312 t~~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~--~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~~~~~~~~ 388 (683)
.++|+..++||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++++|+|+|++++++...... +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~-~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL-EEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST-TTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc-ccC
Confidence 56899999999999999999996 47999999998754322 234688999999999999999999998644322 233
Q ss_pred eeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeeccCCcEEE
Q 005691 389 ERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLDADMRARV 468 (683)
Q Consensus 389 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd~~~~~KL 468 (683)
..++++||+.+|+|.+++. .+.+++...+.|+.||+.||+||| +.+|+||||||+|||++.++.+|+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~----------~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK----------CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT----------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ceEEEEEeecCCchhhhcc----------cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccc
Confidence 4566778889999999983 246999999999999999999999 889999999999999999999999
Q ss_pred cccCcccccccCCccccccccCCCcccCccccccC-CCCccccEEEcchhHHHHhhCCCCCCCCCCCCCCccchhhhhhh
Q 005691 469 ADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYG-QLTEKSDVYSFGVVILEIMCGRKALDLSTSGSPRACLITDWVWS 547 (683)
Q Consensus 469 aDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~~~~~~l~~~v~~ 547 (683)
+|||++...... .....||..|+|||..... .++.++|||||||++|||++|+.||...... .....+..
T Consensus 163 ~dfg~a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-----~~~~~i~~ 233 (348)
T d2gfsa1 163 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-----DQLKLILR 233 (348)
T ss_dssp CCC----CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred cccchhcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHHHH
Confidence 999998765332 2346789999999987665 5689999999999999999999999643210 00000000
Q ss_pred hhh-----------cCccccccC--ccccccccccCCChHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005691 548 LVK-----------AGKVWQALD--PSLLKEDDFLSLNPKAIMERFVLVGILCAHVMVALRPTISDALK 603 (683)
Q Consensus 548 ~~~-----------~g~l~e~vD--~~l~~~~~~~~~~~~e~~~~l~~lal~C~~~dP~~RPtm~eVl~ 603 (683)
... ......... +..... ... .........+.+++..|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 234 LVGTPGAELLKKISSESARNYIQSLTQMPKM-NFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC-CHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcCCCChHHhhhccchhhhhhhhhcccCCCc-chh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 000000000 000000 000 000012345678999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-36 Score=321.80 Aligned_cols=274 Identities=19% Similarity=0.165 Sum_probs=189.6
Q ss_pred CcccceeeeecCceEEEEEEE-cCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-----------CCCcccccceeeec
Q 005691 314 KFSQKNFIGRGGFGLVYKGIL-QDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-----------HRNLVPLRGCCVVD 381 (683)
Q Consensus 314 ~f~~~~~LG~GgfG~Vykg~l-~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-----------H~NLV~L~G~c~~~ 381 (683)
+|...++||+|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 588999999999999999997 4799999999865322 2456788999998886 47899999887642
Q ss_pred CCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCceeec
Q 005691 382 GDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATNILLD 461 (683)
Q Consensus 382 ~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsNILLd 461 (683)
.....++++++...+......... .....+++..+..++.||+.||+|||+ ..+|+||||||+||||+
T Consensus 93 ----~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 93 ----GPNGVHVVMVFEVLGENLLALIKK------YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLME 160 (362)
T ss_dssp ----ETTEEEEEEEECCCCEEHHHHHHH------TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEE
T ss_pred ----cccceeeeeeeccccccccccccc------ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeee
Confidence 234567777777665443332111 134568888999999999999999993 37899999999999998
Q ss_pred cCC------cEEEcccCcccccccCCccccccccCCCcccCccccccCCCCccccEEEcchhHHHHhhCCCCCCCCCCCC
Q 005691 462 ADM------RARVADFGLAKQSREGQSHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEIMCGRKALDLSTSGS 535 (683)
Q Consensus 462 ~~~------~~KLaDFGla~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvlLlELltGr~p~~~~~~~~ 535 (683)
.++ .+|++|||.++..... .....||+.|+|||.+....++.++||||+||+++||++|+.||.......
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred ccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 765 4999999998765432 234679999999999999999999999999999999999999986433211
Q ss_pred CCc--cchhhhhhh-------hhhcC-ccccccCc-----ccccc--------ccccCCChHHHHHHHHHHHHHhcccCC
Q 005691 536 PRA--CLITDWVWS-------LVKAG-KVWQALDP-----SLLKE--------DDFLSLNPKAIMERFVLVGILCAHVMV 592 (683)
Q Consensus 536 ~~~--~~l~~~v~~-------~~~~g-~l~e~vD~-----~l~~~--------~~~~~~~~~e~~~~l~~lal~C~~~dP 592 (683)
... ..+...++. .+..+ ......+. .+... ..............+.+++..|++.||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 100 001111100 00000 00000000 00000 000001223456788999999999999
Q ss_pred CCCCCHHHHHHH
Q 005691 593 ALRPTISDALKM 604 (683)
Q Consensus 593 ~~RPtm~eVl~~ 604 (683)
++|||++|+++.
T Consensus 317 ~~Rpta~e~L~H 328 (362)
T d1q8ya_ 317 RKRADAGGLVNH 328 (362)
T ss_dssp TTCBCHHHHHTC
T ss_pred hHCcCHHHHhcC
Confidence 999999999874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.4e-23 Score=200.54 Aligned_cols=167 Identities=13% Similarity=0.081 Sum_probs=119.0
Q ss_pred ccceeeeecCceEEEEEEEcCCcEEEEEEeeccCcc-----C-------------hHHHHHHHHHHHhccCCCcccccce
Q 005691 316 SQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQ-----G-------------DAEFCNEVEIISNLKHRNLVPLRGC 377 (683)
Q Consensus 316 ~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~-----~-------------~~~f~~Ev~iL~~L~H~NLV~L~G~ 377 (683)
...++||+|+||+||+|+..+|+.||||.++..... . ...+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999999999999987532110 0 1234568888999999999887755
Q ss_pred eeecCCCCCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhcccCCCccccCCCCCc
Q 005691 378 CVVDGDNERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHYGVKPAIYHRDIKATN 457 (683)
Q Consensus 378 c~~~~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~~~~~~IiHrDIKpsN 457 (683)
. ..+++|||++++.+. .+++....+++.|++++|+||| +.+|+||||||+|
T Consensus 83 ~----------~~~lvme~~~~~~~~----------------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~N 133 (191)
T d1zara2 83 E----------GNAVLMELIDAKELY----------------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYN 133 (191)
T ss_dssp E----------TTEEEEECCCCEEGG----------------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTS
T ss_pred c----------CCEEEEEeecccccc----------------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhh
Confidence 3 247999999875443 2445666789999999999999 8899999999999
Q ss_pred eeeccCCcEEEcccCcccccccCCccc-cccccCCCcccCccccccCCCCccccEEEcchh
Q 005691 458 ILLDADMRARVADFGLAKQSREGQSHL-TTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVV 517 (683)
Q Consensus 458 ILLd~~~~~KLaDFGla~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGvl 517 (683)
||++++ .++|+|||+|.......... ..+... . -.|++ ...|+.++|+||..--
T Consensus 134 ILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~---~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 134 VLVSEE-GIWIIDFPQSVEVGEEGWREILERDVR---N-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp EEEETT-EEEECCCTTCEETTSTTHHHHHHHHHH---H-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred eeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHH---H-HHHHH-cCCCCCcccHHHHHHH
Confidence 999965 48999999997654322110 000000 0 00111 3567889999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.33 E-value=1.6e-06 Score=85.40 Aligned_cols=150 Identities=13% Similarity=0.060 Sum_probs=97.5
Q ss_pred HHHHHHhcCcccceeeeecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhcc-CCCcccccceeeecCCC
Q 005691 306 QDLERATDKFSQKNFIGRGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLK-HRNLVPLRGCCVVDGDN 384 (683)
Q Consensus 306 ~el~~at~~f~~~~~LG~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~-H~NLV~L~G~c~~~~~~ 384 (683)
.|+++.-.+|+..+..+-+....||+... +++.+.||+...........+..|+..+..+. +--+-+++.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----- 80 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----- 80 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----
Confidence 46777778887655433333468998864 46778899876654444556788999988774 333445565554
Q ss_pred CCCCeeEEEEeecCCCCccccccCCCCCCCCCCCCCCCccchhhhHHHHHHHHHHHhc----------------------
Q 005691 385 ERGSERYLVYDYMPNGNVDDHLFPSFNDGSGVAKRPLTWPQRKNIILDVAKGLAYLHY---------------------- 442 (683)
Q Consensus 385 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~L~w~~r~~Ia~~iA~gL~yLH~---------------------- 442 (683)
.++..++||+++++.++.+.... .....+++.++++.|+.||.
T Consensus 81 -~~~~~~lv~~~l~G~~~~~~~~~--------------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T d1j7la_ 81 -HDGWSNLLMSEADGVLCSEEYED--------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp -ETTEEEEEEECCSSEEHHHHTTT--------------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred -cCCceEEEEEecccccccccccc--------------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence 34678999999999877543311 11122333444444444442
Q ss_pred -------------------------------c---cCCCccccCCCCCceeeccCCcEEEcccCcccc
Q 005691 443 -------------------------------G---VKPAIYHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 443 -------------------------------~---~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
. ....++|+|+.|.|||++++...-|.||+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 123489999999999999877778999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.80 E-value=5.7e-05 Score=73.42 Aligned_cols=76 Identities=14% Similarity=0.129 Sum_probs=51.6
Q ss_pred eeeecCc-eEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCC--cccccceeeecCCCCCCCeeEEEEee
Q 005691 320 FIGRGGF-GLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRN--LVPLRGCCVVDGDNERGSERYLVYDY 396 (683)
Q Consensus 320 ~LG~Ggf-G~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~N--LV~L~G~c~~~~~~~~~~~~~LV~Ey 396 (683)
.+..|.. +.||+...+++..+.+|.-.... ...+..|...++.+.... +.+++++.. .++..++||||
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~------~~~~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT------EAGRDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE------CSSCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc------cccceEEEEEe
Confidence 3445553 67999988888888888754432 234678888888775433 345566554 34568999999
Q ss_pred cCCCCccc
Q 005691 397 MPNGNVDD 404 (683)
Q Consensus 397 ~~~GsL~~ 404 (683)
+++.++.+
T Consensus 88 i~G~~~~~ 95 (255)
T d1nd4a_ 88 VPGQDLLS 95 (255)
T ss_dssp CSSEETTT
T ss_pred eecccccc
Confidence 99877654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.18 E-value=0.00049 Score=71.96 Aligned_cols=76 Identities=12% Similarity=0.082 Sum_probs=47.2
Q ss_pred eeeeecCceEEEEEEEcC-CcEEEEEEeecc------Cc-cChHHHHHHHHHHHhcc-C--CCcccccceeeecCCCCCC
Q 005691 319 NFIGRGGFGLVYKGILQD-GTTVAVKKVIES------DF-QGDAEFCNEVEIISNLK-H--RNLVPLRGCCVVDGDNERG 387 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~-g~~VAVK~l~~~------~~-~~~~~f~~Ev~iL~~L~-H--~NLV~L~G~c~~~~~~~~~ 387 (683)
+.||.|....||+....+ ++.|+||+-... .. ...+....|.+.|+.+. + ..+.+++++. .
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--------~ 103 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--------T 103 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--------C
Confidence 468999999999998654 678999975321 11 12234556888887663 2 2344444442 3
Q ss_pred CeeEEEEeecCCCCc
Q 005691 388 SERYLVYDYMPNGNV 402 (683)
Q Consensus 388 ~~~~LV~Ey~~~GsL 402 (683)
...++||||+++..+
T Consensus 104 ~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMAVTVMEDLSHLKI 118 (392)
T ss_dssp TTTEEEECCCTTSEE
T ss_pred CCCEEEEeccCCccc
Confidence 456899999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.96 E-value=0.0011 Score=67.13 Aligned_cols=147 Identities=12% Similarity=0.041 Sum_probs=81.2
Q ss_pred eEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccceeeec-CCCCCCCeeEEEEeecCCCCcccc
Q 005691 327 GLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGCCVVD-GDNERGSERYLVYDYMPNGNVDDH 405 (683)
Q Consensus 327 G~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~c~~~-~~~~~~~~~~LV~Ey~~~GsL~~~ 405 (683)
-.||+....+|+.+++|..+.. ....+++..|...+..|....+.-..-..... .....+...+.+++|++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5899999999999999986543 34567788999999888543331111111000 001134567899999987554321
Q ss_pred --------------ccCCCCCCCCCCCCCCCc-------------------cchhhhHHHHHHHHHHHh----cccCCCc
Q 005691 406 --------------LFPSFNDGSGVAKRPLTW-------------------PQRKNIILDVAKGLAYLH----YGVKPAI 448 (683)
Q Consensus 406 --------------L~~~~~~~~~~~~~~L~w-------------------~~r~~Ia~~iA~gL~yLH----~~~~~~I 448 (683)
+|..........+..+++ ..+..+...+.+.++.+. .....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 000000000011112221 111112222223333332 2234679
Q ss_pred cccCCCCCceeeccCCcEEEcccCcccc
Q 005691 449 YHRDIKATNILLDADMRARVADFGLAKQ 476 (683)
Q Consensus 449 iHrDIKpsNILLd~~~~~KLaDFGla~~ 476 (683)
||+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899997754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.07 E-value=0.012 Score=60.84 Aligned_cols=73 Identities=18% Similarity=0.233 Sum_probs=48.7
Q ss_pred eeeeecCceEEEEEEEcCC--------cEEEEEEeeccCccChHHHHHHHHHHHhccCCCcc-cccceeeecCCCCCCCe
Q 005691 319 NFIGRGGFGLVYKGILQDG--------TTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLV-PLRGCCVVDGDNERGSE 389 (683)
Q Consensus 319 ~~LG~GgfG~Vykg~l~~g--------~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV-~L~G~c~~~~~~~~~~~ 389 (683)
+.|+-|---.+|+...+++ +.|.++... . ........+|..+++.+.-.+++ ++++++.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------- 115 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS---------- 115 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----------
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----------
Confidence 4677788889999987643 345555443 2 23344566899999888544555 6666652
Q ss_pred eEEEEeecCCCCcc
Q 005691 390 RYLVYDYMPNGNVD 403 (683)
Q Consensus 390 ~~LV~Ey~~~GsL~ 403 (683)
-.+|+||+++..|.
T Consensus 116 ~g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 GGRLEEYIPSRPLS 129 (395)
T ss_dssp TEEEECCCCEEECC
T ss_pred CceEEEEeccccCC
Confidence 26899999876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.96 E-value=0.041 Score=54.39 Aligned_cols=170 Identities=10% Similarity=0.003 Sum_probs=86.8
Q ss_pred eehHHHHHHhcCcccceeee-----ecCceEEEEEEEcCCcEEEEEEeeccCccChHHHHHHHHHHHhccCCCcccccce
Q 005691 303 FKIQDLERATDKFSQKNFIG-----RGGFGLVYKGILQDGTTVAVKKVIESDFQGDAEFCNEVEIISNLKHRNLVPLRGC 377 (683)
Q Consensus 303 f~~~el~~at~~f~~~~~LG-----~GgfG~Vykg~l~~g~~VAVK~l~~~~~~~~~~f~~Ev~iL~~L~H~NLV~L~G~ 377 (683)
.+.+|++....+|...++.. .|---+.|+...++|+ +++|+..... ..++...|++++..|.+.++.--.-.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 35678888888887754433 4444778998887665 8888765432 23445567777777754332110000
Q ss_pred eeecCC--CCCCCeeEEEEeecCCCCcccccc--------------C--CCCCCCCCCCCC----------------CCc
Q 005691 378 CVVDGD--NERGSERYLVYDYMPNGNVDDHLF--------------P--SFNDGSGVAKRP----------------LTW 423 (683)
Q Consensus 378 c~~~~~--~~~~~~~~LV~Ey~~~GsL~~~L~--------------~--~~~~~~~~~~~~----------------L~w 423 (683)
-..++. .........++.++.+......-. . ............ -..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 000000 012345667777777654432110 0 000000000000 001
Q ss_pred cchhhhHHHHHHHHHHHh-cccCCCccccCCCCCceeeccCCcEEEcccCccc
Q 005691 424 PQRKNIILDVAKGLAYLH-YGVKPAIYHRDIKATNILLDADMRARVADFGLAK 475 (683)
Q Consensus 424 ~~r~~Ia~~iA~gL~yLH-~~~~~~IiHrDIKpsNILLd~~~~~KLaDFGla~ 475 (683)
......+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222222 1235679999999999999998877899999864
|